"date_created","prevalence_estimate_name","source_name","publication_date","grade_of_estimate_scope","country_or_area","specific_geography","sampling_start_date","sampling_end_date","sample_frame_groups_of_interest","sample_frame_age","denominator_value","serum_positive_prevalence","sampling_method","test_manufacturer","isotype_reported","overall_risk_of_bias","source_type","first_author_full_name","lead_institution","url","data_quality_status","serum_pos_prevalence_95pct_ci_lower","serum_pos_prevalence_95pct_ci_upper","sensitivity","specificity","test_type","adm0_isocode","adm1_isocode"
"2020-04-28","200902_Lille_InstitutPasteur_BloodDonors_ELISA-N","A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations","2020-09-02","Local","France","France; Hauts-de-France; Clermont, Noyon, Lille","2020-03-20","2020-03-24","Blood donors","Multiple groups",200.0,0.0,"Sequential","Author-designed","IgA; IgE; IgD; IgM; IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Ludivine Grzelak","Institut Pasteur","https://stm.sciencemag.org/content/12/559/eabc3103","Verified","","","",0.95,"ELISA-N","FR","FR-HDF"
"2020-05-01","210419_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj","Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study","2021-04-19","Local","Japan","Japan; Hyogo Prefecture; Kobe","2020-03-31","2020-04-07","Residual sera","Multiple groups",1000.0,0.027,"Simplified probability","Kurabo Industries","IgG","High","Journal Article (Peer-Reviewed)","Asaka Doi","Kobe City Medical Center General Hospital","https://dx.doi.org/10.1016/j.cegh.2021.100747","Verified",0.018,0.039,0.764,1.0,"LFIA: Lateral flow immunoassay","JP","JP-28"
"2020-05-02","200422_Idaho_CrushTheCurveIdaho_Patients","CrushTheCurveIdaho finds small population with antibodies: 'We are far from herd immunity'","2020-04-22","Regional","United States of America","United States of America; Idaho","","2020-04-22","Residual sera","Multiple groups",1946.0,0.018,"Convenience","University of Washington","IgG","High","News and Media","Ryan Morrison","Crush The Curve Idaho","https://idahonews.com/news/coronavirus/crushthecurveidaho-finds-small-population-with-antibodies-we-are-far-from-herd-immunity","Verified","","",1.0,0.996,"Not reported","US","US-ID"
"2020-05-02","200424_Brevard_OMNI_GeneralPopulation","OMNI Healthcare's COVID-19 antibody testing data for Brevard shows low rates of immunity","2020-04-24","Local","United States of America","United States of America; Florida","2020-04-17","2020-04-24","Household and community samples","Multiple groups",1000.0,0.01,"Self-referral","Not reported","IgM; IgG","High","News and Media","Alessandro Sassoon","OMNI Healthcare","https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/","Verified","","",1.0,1.0,"LFIA: Lateral flow immunoassay","US","US-FL"
"2020-05-02","200429_Singapore_NCID_GeneralPopulation","Coronavirus: Community transmission in  S'pore very low","2020-04-29","Local","Singapore","Singapore","2020-02-15","2020-04-15","Household and community samples","Multiple groups",774.0,0.0,"Unclear","Not reported","Not reported","Unclear","News and Media","Rei Kurohi","Singapore National Centre for Infectious Diseases","https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says","Verified","","","","","Not reported","SG",""
"2020-05-02","200429_Singapore_Singapore_NCID_HCW","Coronavirus: Community transmission in  S'pore very low","2020-04-29","Local","Singapore","Singapore","2020-02-15","2020-04-15","Health care workers and caregivers","Multiple groups",1096.0,0.0,"Unclear","Not reported","Not reported","Unclear","News and Media","Rei Kurohi","Singapore National Centre for Infectious Diseases","https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says","Verified","","","","","Not reported","SG",""
"2020-05-03","200423_BatonRouge_BatonRougeGeneralHospital_GenPop","Takeaways from coronavirus antibody tests: Infections might be more widespread than cases suggest","2020-04-28","Local","United States of America","United States of America; Louisiana; Baton Rouge","","2020-04-21","Household and community samples","Multiple groups",432.0,0.044,"Unclear","Mayo Clinic","Not reported","Unclear","News and Media","Blake Paterson","Baton Rouge General Hospital","https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html","Verified","","","",0.986,"Not reported","US","US-LA"
"2020-05-03","200508_Seattle_UniversityofWashington_Adults","Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24–April 21, 2020","2020-05-08","Local","United States of America","United States of America; Washington; Seattle","2020-03-01","2020-03-31","Residual sera","Adults (18-64 years)",221.0,0.004,"Convenience","Not reported","Not reported","High","Institutional Report","Anne Schuchat","University of Washington","https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf","Verified","","","","","Not reported","US","US-WA"
"2020-05-14","200503_SaltLakeCity_UniversityofUtah_HCW","Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees","2020-05-03","Local","United States of America","United States of America; Utah; Salt Lake City","2020-04-13","2020-04-19","Health care workers and caregivers","Adults (18-64 years)",270.0,0.059,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Troy Madsen","University of Utah","https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext","Verified","","",0.954,0.983,"ELISA","US","US-UT"
"2020-05-14","200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG","Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents","2020-05-06","Local","United States of America","United States of America; Georgia; Atlanta","2020-04-17","2020-04-27","Household and community samples","Multiple groups",127.0,0.024,"Convenience","Author-designed","IgG","High","Preprint","Jun Zou","Georgia State University","https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1","Verified","","","","","ELISA","US","US-GA"
"2020-05-14","200508_Bari_IstitutoTumoriGPaolo_HCW_IgG","COVID-19 SCREENING AND MONITORING OF ASYMPTOMATIC HEALTH WORKERS WITH A RAPID SEROLOGICAL TEST","2020-05-08","Local","Italy","Italy; Puglia; Bari","2020-03-26","2020-04-17","Health care workers and caregivers","Adults (18-64 years)",606.0,0.003,"Convenience","Snibe Diagnostic","IgG","High","Preprint","Angelo Virgilio Paradiso","Istituto Tumori G. Paolo II","https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1","Verified","","","","","Chemiluminescence Immunoassay","IT","IT-75"
"2020-05-18","200515_Winona_WinonaHealth_GeneralPopulation","New COVID-19;   antibody testing in Winona gives health officials a better picture of the;   spread","2020-05-15","Local","United States of America","United States of America; Minnesota; Winona","2020-05-10","2020-05-15","Household and community samples","Multiple groups",1000.0,0.07,"Self-referral","NR","IgG","High","News and Media","Mal Meyer","Winona Health","https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA","Verified","","","","","Not reported","US","US-MN"
"2020-05-19","200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj","Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020","2020-07-24","Regional","United States of America","United States of America; Indiana","2020-04-25","2020-04-29","Household and community samples","Multiple groups",3518.0,0.011,"Stratified probability","Author derived","IgG","Moderate","Institutional Report","Nir Menachemi","Indiana University Fairbanks School of Public Health","https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w","Verified",0.008,0.015,1.0,0.996,"Chemiluminescence Immunoassay","US","US-IN"
"2020-05-21","200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_TestAdj","Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020","2020-05-18","Local","United States of America","United States of America; California","2020-04-10","2020-04-14","Household and community samples","Multiple groups",863.0,0.047,"Stratified probability","Premier Biotech","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Neeraj Sood","Stanford University School of Medicine","https://jamanetwork.com/journals/jama/fullarticle/2766367","Verified",0.025,0.071,0.827,0.995,"LFIA: Lateral flow immunoassay","US","US-CA"
"2020-05-21","200520_England_RutherfordHealth_HCW_IgG","Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff","2020-05-20","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Reading, Newport, Liverpool, Bedlington","2020-04-14","2020-04-24","Health care workers and caregivers","Adults (18-64 years)",161.0,0.012,"Convenience","Sugentech","IgG","High","Preprint","Karol Sikora","Rutherford Health","https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html","Verified","","","","","Colloidal Gold Immunochromatography Assay (LFIA)","GB","GB-ENG"
"2020-05-21","210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj","SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan","2021-02-03","Local","Italy","Italy; Lombardy; Milan","2020-02-24","2020-04-08","Blood donors","Adults (18-64 years)",789.0,0.051,"Convenience","Prima Lab","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luca Valenti","Fondazione IRCCS Ca' Granda Ospedale Maggiore","https://dx.doi.org/10.2450/2021.0324-20","Verified","","","","","LFIA: Lateral flow immunoassay","IT","IT-25"
"2020-05-25","201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test","Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands.","2020-11-12","National","Netherlands","Netherlands","2020-04-01","2020-04-15","Blood donors","Multiple groups",7361.0,0.034,"Sequential","Wantai Biological Pharmacy Enterprise","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Ed Slot","Amsterdam UMC","https://www.nature.com/articles/s41467-020-19481-7","Verified","","",1.0,0.991,"ELISA","NL",""
"2020-05-26","200523_SouthCarolina_MUSCHealthLancaster_HCW","Antibody tests;   show just 2% exposure rate to COVID-19","2020-05-23","Local","United States of America","United States of America; South Carolina; Lancaster","2020-03-16","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",230.0,0.022,"Unclear","Abbott","Not reported","High","News and Media","Lisa Geraci","MUSC Health-Lancaster","https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA","Verified","","","","","Not reported","US","US-SC"
"2020-05-26","200525_Frankfurt_Goethe-UniversityFrankfurt_Employees","Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area","2020-05-25","Local","Germany","Germany; Hesse; Frankfurt","2020-04-06","2020-04-14","Essential non-healthcare workers","Adults (18-64 years)",998.0,0.004,"Convenience","Author-designed","IgG","High","Preprint","Verena Kraehling","Goethe-University Frankfurt","https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1","Verified",0.002,0.01,"",0.992,"ELISA","DE","DE-HE"
"2020-05-30","200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation","Iowa begins to release serology test results, showing greater local spread of COVID-19","2020-05-20","Regional","United States of America","United States of America; Iowa","2020-04-01","2020-05-20","Household and community samples","Adults (18-64 years)",18160.0,0.1,"Self-referral","Not reported","IgG","High","News and Media","Jeff Montgomery","Iowa Department of Public Health","https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q","Verified","","","","","Not reported","US","US-IA"
"2020-05-30","200526_AlzintanCity_Al-ZintanUniversity_GenPopulation","Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya","2020-05-26","Local","Libya","Libya; Libya; Alzintan City","2020-04-02","2020-05-18","Multiple populations","Multiple groups",142.0,0.042,"Simplified probability","Guangzhou Wondfo Biotech","IgM; IgG","High","Preprint","Abdulwahab Kammon","Al-Zintan University","https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1","Verified","","",0.864,0.996,"LFIA: Lateral flow immunoassay","LY",""
"2020-05-30","200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers","Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya","2020-05-26","Local","Libya","Libya; Libya; Alzintan City","2020-04-02","2020-05-18","Health care workers and caregivers","Multiple groups",77.0,0.0,"Stratified probability","Guangzhou Wondfo Biotech","IgM; IgG","High","Preprint","Abdulwahab Kammon","Al-Zintan University","https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1","Verified","","",0.864,0.996,"LFIA: Lateral flow immunoassay","LY",""
"2020-05-30","200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj","Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York","2020-06-17","Regional","United States of America","United States of America; New York","2020-04-19","2020-04-28","Household and community samples","Multiple groups",15101.0,0.14,"Convenience","NYSDOH Wadsworth Center","IgG","Moderate","Journal Article (Peer-Reviewed)","Eli Rosenberg","New York State Department of Health","https://dx.doi.org/10.1016/j.annepidem.2020.06.004","Verified",0.133,0.147,0.879,0.998,"Microsphere immunoassay","US","US-NY"
"2020-06-02","200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1","Bergamo serological tests, the results of Nembro and Alzano arrive: 61% positive","2020-04-30","Local","Italy","Italy; Lombardy; Alzano, Nembro","2020-04-23","2020-04-28","Household and community samples","Multiple groups",750.0,0.61,"Unclear","Not reported","Not reported","Unclear","News and Media","Armando Di Landro","ATS Bergamo","https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp","Verified","","","","","Not reported","IT","IT-25"
"2020-06-02","200430_Bergamo_HospitalofBergamo_HCW","Bergamo serological tests, the results of Nembro and Alzano arrive: 61% positive","2020-04-30","Local","Italy","Italy; Lombardy; Bergamo","","2020-04-24","Health care workers and caregivers","Adults (18-64 years)",3000.0,0.13,"Unclear","Not reported","Not reported","Unclear","News and Media","Armando Di Landro","Hospital of Bergamo","https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp","Verified","","","","","Not reported","IT","IT-25"
"2020-06-02","200510_US_StanfordUniversity_MajorLeagueBaseballEmployees","MLB antibody study: 0.7% of those tested had been exposed to coronavirus","2020-05-10","National","United States of America","United States of America","2020-04-08","2020-04-21","Non-essential workers and unemployed persons","Adults (18-64 years)",5603.0,0.007,"Convenience","Not reported","Not reported","Unclear","News and Media","Susan Slusser","Stanford University","https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php","Verified",0.003,0.012,"","","Not reported","US",""
"2020-06-02","200517_SaoPaolo_GrupoFleury_GenPop","In the neighborhoods of São Paulo most affected by Covid-19, only 5% had contact with the virus","2020-05-17","Local","Brazil","Brazil; São Paulo; São Paulo","2020-05-04","2020-05-12","Household and community samples","Multiple groups",520.0,0.052,"Stratified probability","Not reported","Not reported","Unclear","News and Media","Phillippe Watanabe","Grupo Fleury","https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml","Verified","","",0.9,"","Not reported","BR","BR-SP"
"2020-06-02","200601_LongHillTownship_SummitMedicalCenter_FirstResponders","Few among Long Hill first responders test positive for COVID-19 antibodies","2020-06-01","Local","United States of America","United States of America; New Jersey; Long Hill Township","2020-05-01","2020-05-14","Essential non-healthcare workers","Adults (18-64 years)",70.0,0.043,"Convenience","Not reported","Not reported","High","News and Media","Alex Parker Magyar","Summit Medical Center","https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw","Verified","","","","","Not reported","US","US-NJ"
"2020-06-03","200601_Israel_PandemicTaskForce_GenPop","Initial antibody tests indicate 200000  Israelis have had COVID-19 - report","2020-06-02","National","Israel","Israel; Israel","","2020-06-02","Household and community samples","Multiple groups",1700.0,0.025,"Stratified probability","Not reported","IgG","Moderate","News and Media","Michael Bachner","Israeli Pandemic Task Force","https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg","Verified","","","","","Not reported","IL",""
"2020-06-04","200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers","Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City","2020-06-03","Local","United States of America","United States of America; New York; New York City","2020-03-24","2020-04-04","Health care workers and caregivers","Multiple groups",285.0,0.326,"Self-referral","Not reported","IgG","High","Journal Article (Peer-Reviewed)","Mayce Mansour","Icahn School of Medicine at Mount Sinai","https://link.springer.com/article/10.1007/s11606-020-05926-8","Verified","","","","","ELISA","US","US-NY"
"2020-06-04","200602_Wuhan_HuazhongUniversityofScienceandTechnology_HealthCareWorkers","The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19","2020-06-02","Local","China","China; Hubei; Wuhan","2020-02-12","2020-03-17","Health care workers and caregivers","Adults (18-64 years)",797.0,0.044,"Convenience","Not reported","IgG","Unclear","Preprint","Shue Xiong","Huazhong University of Science and Technology","https://www.medrxiv.org/content/10.1101/2020.05.28.20110767v1.full.pdf","Verified","","","","","ELISA","CN","CN-42"
"2020-06-06","200605_China_NationalClinicalResearchCentre_CommunitySetting","Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","2020-06-05","National","China","China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Chengdu","2020-03-09","2020-04-10","Multiple populations","Adults (18-64 years)",10449.0,0.008,"Self-referral","Bioscience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","National Clinical Research Centre for Kidney Disease","https://www.nature.com/articles/s41591-020-0949-6","Verified","","","",0.993,"Chemiluminescence Immunoassay","CN",""
"2020-06-07","200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop","1%  of early Humboldt County coronavirus tests show antibodies","2020-06-02","Local","United States of America","United States of America; California","","2020-05-26","Household and community samples","Multiple groups",1000.0,0.01,"Unclear","Not reported","Not reported","High","News and Media","Shomik Mukherjee","Humboldt County Department of Health and Human Services","https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA","Verified","","","","","Not reported","US","US-CA"
"2020-06-12","200602_Wuhan_SunYat-senUniversity_HCW_IgG","Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study","2020-06-10","Local","China","China; Hubei; Wuhan","2020-02-07","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",420.0,0.0,"Convenience","YHLO","IgG","High","Journal Article (Peer-Reviewed)","Min Liu","Sun Yat-sen University","https://www.bmj.com/content/369/bmj.m2195","Verified","","",0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-12","200612_Guam_USNavy","SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020.","2020-06-12","Local","United States of America","United States of America; Guam","2020-04-20","2020-04-24","Essential non-healthcare workers","Adults (18-64 years)",382.0,0.597,"Convenience","CDC","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Daniel Payne","US Navy","https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm","Verified","","",0.96,0.993,"ELISA","US",""
"2020-06-13","200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj","The Prevalence of SARS-CoV-2 IgG Antibodies in Intensive Care Unit (ICU) Healthcare Personnel (HCP) and its Implications - A Single-Center, Prospective, Pilot Study","2020-06-12","Local","United States of America","United States of America; New Jersey; Long Branch","2020-05-14","2020-05-19","Health care workers and caregivers","Adults (18-64 years)",121.0,0.008,"Convenience","SD Biosensor","IgG","High","Journal Article (Peer-Reviewed)","Mohsin Mughal","Monmouth Medical Centre","https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7","Verified","","",0.962,0.966,"LFIA: Lateral flow immunoassay","US","US-NJ"
"2020-06-15","200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop","One new positive COVID-19 case in Routt County, antibody testing ramping up","2020-06-14","Local","United States of America","United States of America; Colorado; Steamboat Springs","","2020-06-10","Household and community samples","Multiple groups",649.0,0.026,"Self-referral","Not reported","Not reported","High","News and Media","Kari Harden","Routt County Board of Health","https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ","Verified","","","","","Not reported","US","US-CO"
"2020-06-18","200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers","Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium","2020-06-15","Local","Belgium","Belgium; Limburg; Genk","2020-04-22","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",3056.0,0.064,"Convenience","Multi-G","IgG","High","Journal Article (Peer-Reviewed)","Deborah Steensels","ZiekenhuisOost-Limburg","https://jamanetwork.com/journals/jama/fullarticle/2767382","Verified",0.055,0.073,0.922,0.97,"LFIA: Lateral flow immunoassay","BE",""
"2020-06-18","200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban","A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage","2020-06-16","Regional","Brazil","Brazil; Espírito Santo","2020-05-13","2020-05-15","Household and community samples","Multiple groups",1163.0,0.003,"Stratified probability","Celer Technologies Inc.","IgG; IgM","High","Preprint","Cristiana Gomes","Secretaria de Estado da Saúde do Espírito Santo","https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf","Verified",0.0,0.008,0.864,0.976,"Rapid immunochromatographic test","BR","BR-ES"
"2020-06-18","200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban","A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage","2020-06-16","Regional","Brazil","Brazil; Espírito Santo","2020-05-13","2020-05-15","Household and community samples","Multiple groups",4612.0,0.021,"Stratified probability","Celer Technologies Inc.","IgG; IgM","High","Preprint","Cristiana Gomes","Secretaria de Estado da Saúde do Espírito Santo","https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf","Verified",0.017,0.025,0.864,0.976,"Rapid immunochromatographic test","BR","BR-ES"
"2020-06-18","200616_Madrid_UniversidadAutónomadeMadrid_TotalPop","SARS-CoV-2 antibodies in adults in Madrid, Spain","2020-06-16","Local","Spain","Spain; Community of Madrid; Madrid","2020-04-26","2020-05-16","Multiple populations","Multiple groups",674.0,0.138,"Sequential","PCL Inc.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Vicente Soriano","Universidad Autónoma de Madrid","https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269","Verified","","","","","Rapid immunochromatographic test","ES","ES-MD"
"2020-06-18","200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG","Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan, Implications for the Longevity of Antibodies Against SARS-CoV-2","2020-11-02","Local","China","China; Hubei; Wuhan","2020-02-29","2020-04-29","Household and community samples","Multiple groups",19555.0,0.046,"Convenience","YHLO","IgG","Moderate","Preprint","Tao Liu","Zhongnan Hospital of Wuhan University","https://www.researchsquare.com/article/rs-99748/v1","Verified",0.043,0.049,0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-18","200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG","Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan, Implications for the Longevity of Antibodies Against SARS-CoV-2","2020-11-02","Local","China","China; Hubei; Wuhan","2020-02-29","2020-04-29","Health care workers and caregivers","Multiple groups",3832.0,0.04,"Convenience","YHLO","IgG","Moderate","Preprint","Tao Liu","Zhongnan Hospital of Wuhan University","https://www.researchsquare.com/article/rs-99748/v1","Verified",0.034,0.047,0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-18","200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG","Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan, Implications for the Longevity of Antibodies Against SARS-CoV-2","2020-11-02","Local","China","China; Hubei; Wuhan","2020-02-29","2020-04-29","Residual sera","Multiple groups",1616.0,0.01,"Sequential","YHLO","IgG","Moderate","Preprint","Tao Liu","Zhongnan Hospital of Wuhan University","https://www.researchsquare.com/article/rs-99748/v1","Verified",0.005,0.015,0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-19","200514_Saalfeld_Thuringia_IgG","Prevalence of antibodies against COVID-19 in the staff of a COVID-19 regular ward","2020-05-14","Local","Germany","Germany; Thuringia; Saalfeld","2020-04-16","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",18.0,0.0,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Igor Harsch","Thuringia Clinic","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf","Verified","","","",0.985,"ELISA","DE","DE-TH"
"2020-06-23","200609_Milan_UniMilan_OverallAb","SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy","2020-06-09","Local","Italy","Italy; Lombardy; Milan","2020-03-30","2020-03-31","Household and community samples","Adults (18-64 years)",197.0,0.102,"Self-referral","Beijing Wantai Biological Pharmacy Enterprise , EUROIMMUN","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Gregorio Milani","University of Milan","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf","Verified","","","","","ELISA","IT","IT-25"
"2020-06-23","200617_Gibraltar_GibraltarGovernment_HCW","After in-house GHA screening programme, Govt rethinks its plans for anti-body tests","2020-06-17","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Gibraltar","2020-06-03","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",1247.0,0.014,"Convenience","Not reported","IgG","Unclear","News and Media","Priya Gulraj","Gibraltar Government","https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg","Verified","","","","","Not reported","GB",""
"2020-06-23","200617_Indiana_IndianaUniversity_Wave2GenPop","Fairbanks study indicates that 'virus has  slowed its spread' in Indiana","2020-06-17","Regional","United States of America","United States of America; Indiana","2020-06-03","2020-06-08","Household and community samples","Multiple groups",3600.0,0.015,"Stratified probability","Not reported","Not reported","Moderate","News and Media","Shari Rudavsky","Indiana University Fairbanks School of Public Health","https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ","Verified","","","","","Not reported","US","US-IN"
"2020-06-24","200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders","Prevalence Of COVID-19 Antibodies In Washoe Co. Expected To Be Low","2020-06-22","Local","United States of America","United States of America; Nevada","2020-05-01","2020-05-31","Essential non-healthcare workers","Adults (18-64 years)",132.0,0.14,"Convenience","Not reported","Not reported","High","News and Media","Anh Gray","Truckee Meadows Fire Protection District","https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0","Verified","","","","","Not reported","US","US-NV"
"2020-06-26","200615_Germany_UniversityofHannover_hcw","Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff","2020-06-15","Local","Germany","Germany; Lower Saxony; Hannover","2020-04-20","2020-04-30","Health care workers and caregivers","Multiple groups",385.0,0.029,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Simone Schmidt","University of Hannover","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417","Verified","","",0.946,0.998,"ELISA","DE","DE-NI"
"2020-06-26","200625_Denmark_GeneralPopTestAdj","Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors","2020-06-25","National","Denmark","Denmark","2020-04-06","2020-05-03","Blood donors","Adults (18-64 years)",20640.0,0.019,"Entire sample","Livzon Diagnostics","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Christian Erikstrup","Copenhagen University Hospital","https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661","Verified",0.008,0.023,0.826,0.995,"LFIA: Lateral flow immunoassay","DK",""
"2020-06-27","200424_Romania_MedLife_HCW","Concluzii preliminare, studiu MedLife: “Cel mai probabil populatia nu are imunitate dobandita natural pentru COVID 19. Respectarea masurilor de protectie si extinderea testarii reprezinta sansa noastra de a functiona in siguranta si de a reporni economia""","2020-04-24","National","Romania","Romania; Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov; Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti","2020-03-24","2020-04-21","Health care workers and caregivers","Multiple groups",371.0,0.03,"Convenience","Abbott, Maglumi, YHLO","IgG; IgM","Unclear","Institutional Report","MedLife","MedLife","https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a","Verified","","","","","Chemiluminescence; ELISA","RO",""
"2020-06-27","200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders","Results show 2% of tested MUSC staff have COVID-19 antibodies","2020-05-04","Local","United States of America","United States of America; South Carolina; Charleston","2020-04-27","2020-05-02","Multiple populations","Adults (18-64 years)",920.0,0.02,"Unclear","Abbott","Not reported","High","News and Media","Nick Reagan","Medical University South Carolina","https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/","Verified","","","","","Not reported","US","US-SC"
"2020-06-27","200520_LosAngeles_UniSouthernCalifornia_GenPop","LA County 'Still Far Away From Herd Immunity"" New Antibody Numbers Show","2020-05-20","Local","United States of America","United States of America; California","2020-05-08","2020-05-12","Household and community samples","Multiple groups",1014.0,0.021,"Self-referral","Not reported","Not reported","Unclear","News and Media","CBS Los Angeles","University of Southern California","https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg","Verified","","","","","Not reported","US","US-CA"
"2020-06-27","200520_Madison_UWHealth_UniWisconsinHealthClinic","Antibody tests for coronavirus so far trend overwhelmingly negative","2020-05-20","Local","United States of America","United States of America; Wisconsin; Madison","2020-05-13","2020-05-20","Household and community samples","Multiple groups",5303.0,0.015,"Self-referral","Not reported","Not reported","Unclear","News and Media","Michelle Alfini","UW Health","https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ","Verified","","","","","Not reported","US","US-WI"
"2020-06-27","200520_Madison_UWHealth_UnityPointClinic","Antibody tests for coronavirus so far trend overwhelmingly negative","2020-05-20","Local","United States of America","United States of America; Wisconsin; Madison","2020-05-13","2020-05-20","Household and community samples","Multiple groups",433.0,0.003,"Self-referral","Not reported","Not reported","Unclear","News and Media","Michelle Alfini","UW Health","https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ","Verified","","","","","Not reported","US","US-WI"
"2020-06-27","200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees","South Florida Cities Begin Testing Employees For COVID-19 Antibodies","2020-05-22","Local","United States of America","United States of America; Florida; Coral Springs","2020-05-17","2020-05-22","Essential non-healthcare workers","Multiple groups",700.0,0.0,"Self-referral","Cellex","Not reported","Unclear","News and Media","Jenny Staletovich","Coral Springs City Government","https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw","Verified","","","","","Not reported","US","US-FL"
"2020-06-27","200606_Bengaluru_SJICSR_Staff","Covid-19: Jayadeva says its survey hints at herd immunity","2020-06-06","Local","India","India; Karnataka; Bengaluru","2020-05-23","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",1000.0,0.01,"Convenience","New Life Healthcare","IgG","Unclear","News and Media","Sunitha Rao","Sri Jayadeva Institute of Cardiovascular Sciences and Research","https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q","Verified","","","","","Not reported","IN","IN-KA"
"2020-06-27","200611_Russia_NationalCouncilCombatingCoronavirus_GenPop","1 in 7 Russians Have ‘Coronavirus Immunity’ – Official","2020-06-10","National","Russian Federation","Russian Federation","","2020-06-10","Household and community samples","Multiple groups",650000.0,0.14,"Unclear","Invitro","Not reported","Moderate","News and Media","Sergei Kiselyov","Russian National Council for Combating Coronavirus","https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617","Verified","","",0.95,0.98,"Not reported","RU",""
"2020-06-27","200621_Japan_SoftBank_HCW","Japanese firm's blanket testing of employees  could serve as model","2020-06-21","Local","","Japan","2020-05-12","2020-05-18","Health care workers and caregivers","Multiple groups",5850.0,0.018,"Convenience","Innovita, ""Zhejiang Orient Gene Biotech Co., LTD""","Not reported","Unclear","News and Media","Simon Denyer","SoftBank","https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw","Verified","","","","","Not reported","JP",""
"2020-06-29","200624_BaskingRidge_FellowshipVillage_Residents2_Overall","Fellowship;   Village Benefits from Covid-19 Antibody Tests","2020-06-24","Local","United States of America","United States of America; New Jersey; Basking Ridge","2020-04-15","2020-05-06","Assisted living and long-term care facilities","Seniors (65+ years)",371.0,0.348,"Convenience","NR","IgG; IgM","Unclear","News and Media","Tim Regan","Fellowship Village","https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g","Verified","","","","","","US","US-NJ"
"2020-06-29","201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall","Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City","2020-11-03","Local","United States of America","United States of America; New York; New York City","2020-02-02","2020-07-05","Residual sera","Multiple groups",6590.0,0.111,"Sequential","Mount Sinai Hospital New York","IgG","High","Journal Article (Peer-Reviewed)","Daniel Stadlbauer","Icahn School of Medicine at Mount Sinai","http://dx.doi.org/10.1038/s41586-020-2912-6","Verified","","",0.95,1.0,"ELISA","US","US-NY"
"2020-07-04","200529_CoachellaValley_Desert Healthcare District_GenPop","Coachella Valley far from COVID-19 herd  immunity, preliminary antibody test results show","2020-05-29","Local","United States of America","United States of America; California","","2020-05-28","Household and community samples","Multiple groups",896.0,0.06,"Self-referral","Phamatech","IgG; IgM","Unclear","News and Media","Nicole Hayden","Desert Healthcare District","https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg","Verified","","","","","LFIA: Lateral flow immunoassay","US","US-CA"
"2020-07-04","200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop","Antibody testing continues in Burke County","2020-05-29","Local","United States of America","United States of America; North Carolina","2020-05-29","2020-05-29","Household and community samples","Multiple groups",329.0,0.015,"Self-referral","Not reported","Not reported","Unclear","News and Media","Steve Ohnesorge","Psalms/Solid Rock Medicine Group","https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA","Verified","","","","","Not reported","US","US-NC"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_DetroitRC","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America","United States of America; Michigan; Detroit","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",57.0,0.35,"Convenience","Not reported","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","","","","","Not reported","US","US-MI"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America","United States of America; Michigan","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",867.0,0.122,"Convenience","Not reported","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","","","","","Not reported","US","US-MI"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_MacombCF","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America","United States of America; Michigan; Lenox Township","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",1201.0,0.656,"Convenience","Not reported","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","","","","","Not reported","US","US-MI"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America","United States of America; Michigan","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",1248.0,0.92,"Convenience","Not reported","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","","","","","Not reported","US","US-MI"
"2020-07-06","200609_Bergamo_HealthAgency_GenPop","Over half of people tested in Italy's  Bergamo have COVID-19 antibodies","2020-06-09","Regional","Italy","Italy; Lombardy","2020-04-23","2020-06-03","Household and community samples","Multiple groups",9965.0,0.57,"Simplified probability","Not reported","Not reported","Moderate","News and Media","Angelo Amante","Bergamo Health Agency","https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw","Verified","","","","","Not reported","IT","IT-25"
"2020-07-06","200614_Thiruvananthapuram_HealthDepartment_GenPop","Initial trend: Positivity rate low in antibody testing","2020-06-14","Local","India","India; Kerala; Thiruvananthapuram","2020-06-09","2020-06-12","Household and community samples","Multiple groups",450.0,0.027,"Unclear","Not reported","IgM; IgG","Unclear","News and Media","Aswin Kumar","Thiruvanathapuram Health Department","https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg","Verified","","","","","Not reported","IN","IN-KL"
"2020-07-07","200603_WuhantoUSAtravel_CDC_PassengersGenPop","Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020","2020-07-03","Local","China","China; Hubei; Wuhan","2020-01-28","2020-01-28","Household and community samples","Multiple groups",186.0,0.005,"Convenience","SeraCare Life Sciences","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Benjamin Hallowell","US Centers for Disease Control and Prevention","https://wwwnc.cdc.gov/eid/article/26/9/20-1590_article","Verified","","","","","ELISA","CN","CN-42"
"2020-07-09","200707_Lousiana_TulaneUniversity_AllChildren","SARS-CoV-2 Seroprevalence Rates of Children in Louisiana During the State Stay at Home Order.","2020-07-08","Local","United States of America","United States of America; Louisiana; Orleans","2020-03-18","2020-05-15","Residual sera","Children and Youth (0-17 years)",812.0,0.076,"Convenience","Author-designed","IgG","High","Preprint","Monika Dietrich","Tulane University","https://www.medrxiv.org/content/10.1101/2020.07.07.20147884v1","Verified","","","","","ELISA","US","US-LA"
"2020-07-10","200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj","Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil","2020-07-06","Local","Brazil","Brazil; Rio de Janeiro; Rio de Janeiro","2020-04-14","2020-04-27","Blood donors","Adults (18-64 years)",2857.0,0.033,"Sequential","MedLevensohn","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Amorim Filho","Universidade do Estado do Rio de Janeiro","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/","Verified",0.026,0.041,0.85,0.99,"Rapid immunochromatographic test","BR","BR-RJ"
"2020-07-12","200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj","Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.","2020-05-18","National","Luxembourg","Luxembourg","2020-04-15","2020-05-05","Household and community samples","Multiple groups",1820.0,0.021,"Stratified probability","EUROIMMUN","IgG","Moderate","Preprint","Chantal Snoeck","Luxembourg Institute of Health","https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1","Verified",0.014,0.028,0.857,0.978,"ELISA","LU",""
"2020-07-13","200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj","SARS-CoV-2 Seroprevalence Among Parturient Women","2020-07-29","Local","United States of America","United States of America; Pennsylvania; Philadelphia","2020-04-04","2020-06-03","Pregnant or parturient women","Adults (18-64 years)",1293.0,0.052,"Sequential","Author-designed","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Dustin Flannery","University of Pennsylvania","https://immunology.sciencemag.org/content/5/49/eabd5709","Verified","","",1.0,0.989,"ELISA","US","US-PA"
"2020-07-15","200629_Crepy-en-Valois_PasteurInstitute_Overall","SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission","2020-06-29","Local","France","France; Hauts-de-France; Crepy-en-Valois","2020-04-28","2020-04-30","Multiple populations","Multiple groups",1340.0,0.104,"Convenience","Institut Pasteur","Not reported","Moderate","Preprint","Arnaud Fontanet","Institut Pasteur","https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2","Verified","","",0.994,1.0,"Flow cytometry assay","FR","FR-HDF"
"2020-07-16","200529_Washington_CDC_KnownContacts","Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, Washington, USA","2020-05-29","Regional","United States of America","United States of America; Washington","2020-01-20","2020-02-03","Contacts of COVID patients","Multiple groups",32.0,0.0,"Convenience","Author-designed","Not reported","High","Journal Article (Peer-Reviewed)","Victoria Chu","US Centers for Disease Control and Prevention","https://wwwnc.cdc.gov/eid/article/26/8/20-1423_article","Verified","","",0.96,0.99,"ELISA","US","US-WA"
"2020-07-16","200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj","Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020","2020-07-15","Regional","Canada","Canada; British Columbia","2020-03-05","2020-03-13","Residual sera","Multiple groups",869.0,0.003,"Stratified probability","Abbott, Ortho-Clinical Diagnostics","IgA; IgM; IgG","Moderate","Preprint","Danuta Skowronski","British Columbia Centre for Disease Control","https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1","Verified",0.0,0.01,"","","Chemiluminescence Immunoassay","CA","CA-BC"
"2020-07-16","200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj","Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020","2020-07-15","Regional","Canada","Canada; British Columbia","2020-05-15","2020-05-27","Residual sera","Multiple groups",885.0,0.006,"Stratified probability","Abbott, Ortho-Clinical Diagnostics, Siemens Healthineers","IgA; IgM; IgG","Moderate","Preprint","Danuta Skowronski","British Columbia Centre for Disease Control","https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1","Verified",0.002,0.014,"","","Chemiluminescence Immunoassay","CA","CA-BC"
"2020-07-17","200515_Croatia_UniversityofSplit_IndustryWorkers_Overall","SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Sibenik-Knin County, Croatia","2020-05-15","Local","Croatia","Croatia","2020-04-23","2020-04-28","Essential non-healthcare workers","Multiple groups",1494.0,0.013,"Convenience","AMP Diagnostics","IgM; IgG","High","Journal Article (Peer-Reviewed)","Ivan Jerkovic","University of Split","https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx","Verified",0.008,0.02,0.918,0.964,"Rapid immunochromatographic test","HR",""
"2020-07-17","200604_Nanjing_NanjingUniversityMedicalSchool_HCWs/ContactsofCOVID-19patients","High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients","2020-06-04","Local","China","China; Jiangsu; Nanjing","2020-02-19","2020-02-19","Health care workers and caregivers","Adults (18-64 years)",105.0,0.171,"Convenience","Author-designed","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yuxin Chen","Nanjing University Medical School","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270786/pdf/main.pdf","Verified","","",0.933,1.0,"ELISA","CN","CN-32"
"2020-07-17","200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless","Community-level SARS-CoV-2 Seroprevalence Survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research.","2020-07-18","Local","Argentina","Argentina; Buenos Aires; Buenos Aires","2020-06-10","2020-07-01","Persons experiencing homelessness","Multiple groups",60.0,0.36,"Convenience","Laboratio Lemos","IgG","High","Preprint","Silvana Figar","Minister of Health, Buenos Aires City","https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1","Verified","","",0.95,1.0,"ELISA","AR","AR-B"
"2020-07-17","200721_Tokyo_NavitasClinicTachikawa_Overall","Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic–Based Point-of-Care Antibody Testing","2020-07-21","Local","Japan","Japan; Kantō, Chūbu ; Tokyo, Kangawa, Saitama, Chiba, Yamanashi","2020-04-20","2020-05-20","Household and community samples","Multiple groups",1071.0,0.038,"Self-referral","Kurabo Industries","IgG","High","Journal Article (Peer-Reviewed)","Morihito Takita","Navitas Clinic Tachikawa","https://dx.doi.org/10.1177/2150132720942695","Verified",0.028,0.052,0.764,1.0,"Rapid immunochromatographic test","JP",""
"2020-07-17","210226_Iwate_IwatePrefecturalCentralHospital_HCW_Abbot&Roche","Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020","2021-02-26","Local","Japan","Japan; Honshu; Morioka","2020-05-18","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",1000.0,0.0,"Convenience","Abbott Laboratories: Roche","IgG","High","Journal Article (Peer-Reviewed)","Akihiro Nakamura","Iwate Prefectural Central Hospital","https://dx.doi.org/10.5387/fms.2020-21","Verified","","","","","Chemiluminescence Immunoassay; Electro chemiluminescence immunoassay","JP",""
"2020-07-18","200507_Boise_UniversityofWashington_GenPop","Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho","2020-05-07","Local","United States of America","United States of America; Idaho; Boise","2020-04-20","2020-04-26","Household and community samples","Multiple groups",4856.0,0.018,"Self-referral","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Andrew Bryan","University of Washington School of Medicine","https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20","Verified","","",1.0,1.0,"Chemiluminescence Immunoassay","US","US-ID"
"2020-07-18","200617_Italy_D.CotugnoHospital_HCW_IgG","COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study","2020-06-17","Local","Italy","Italy; Campania; Naples","2020-03-23","2020-04-02","Health care workers and caregivers","Adults (18-64 years)",115.0,0.017,"Convenience","Snibe Diagnostic","IgG","High","Journal Article (Peer-Reviewed)","Francesco Fusco","D. Cotugno’ Hospital","https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext","Verified","","","","","Chemiluminescence Immunoassay","IT","IT-72"
"2020-07-18","200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22","PHE England week 28","2020-07-09","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-05-04","2020-05-31","Blood donors","Adults (18-64 years)",7686.0,0.083,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.075,0.092,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27","PHE England week 28","2020-07-09","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-28","Blood donors","Multiple groups",10318.0,0.072,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.066,0.078,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-26","2020-03-27","Blood donors","Adults (18-64 years)",757.0,0.026,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.011,0.044,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200717_Ilm-Kreis_JenaUniversityHospital_Overall","Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study","2020-07-17","Local","Germany","Germany; Thuringia","2020-05-12","2020-05-22","Household and community samples","Multiple groups",620.0,0.084,"Convenience","Epitope Diagnostics, EUROIMMUN, DiaSorin, Snibe Diagnostic, Abbott, Roche","IgG","Moderate","Preprint","Sebastian Weis","Jena University Hospital","https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1","Verified","","","","","ELISA; Chemiluminescence Immunoassay","DE","DE-TH"
"2020-07-18","200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch","PHE England week 34","2020-08-21","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-02-01","2020-03-31","Residual sera","Children and Youth (0-17 years)",443.0,0.008,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.0,0.025,0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200821_England_PHE_WhatsTheStory_TestAdj_FebMarch","PHE England week 34","2020-08-21","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-02-01","2020-03-31","Household and community samples","Children and Youth (0-17 years)",106.0,0.005,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.0,0.036,0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients","Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China","2020-04-20","Local","China","China; Hubei; Wuhan","2020-04-03","2020-04-15","Residual sera","Multiple groups",381.0,0.105,"Unclear","Innovita Biological Technology Co. Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xiaodong Wu","Wuhan University","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904","Verified","","",0.873,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-07-19","200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork","Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China","2020-04-20","Local","China","China; Hubei; Wuhan","2020-04-03","2020-04-15","Essential non-healthcare workers","Adults (18-64 years)",1021.0,0.096,"Unclear","Innovita Biological Technology Co. Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xiaodong Wu","Wuhan University","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904","Verified","","",0.873,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-07-19","200501_France_ CentreLeonBerard_CancerPatient","Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19","2020-05-01","Local","France","France; Auvergne-Rhône-Alpes; Lyon","2020-03-01","2020-04-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",244.0,0.053,"Sequential","TODA Pharma","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Solodky","Centre Leon Berard","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/","Verified","","",1.0,1.0,"LFIA: Lateral flow immunoassay","FR","FR-ARA"
"2020-07-19","200501_France_ CentreLeonBerard_HCW","Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19","2020-05-01","Local","France","France; Auvergne-Rhône-Alpes; Lyon","2020-03-01","2020-04-16","Health care workers and caregivers","Adults (18-64 years)",85.0,0.059,"Convenience","TODA Pharma","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Solodky","Centre Leon Berard","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/","Verified","","",1.0,1.0,"LFIA: Lateral flow immunoassay","FR","FR-ARA"
"2020-07-19","200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW","Anesthesiologists' and intensive care;   providers' exposure to COVID-19 infection in a New York City academic center:;   a prospective cohort study assessing symptoms and COVID-19 antibody testing","2020-06-09","Local","United States of America","United States of America; New York; New York City","2020-03-01","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",91.0,0.121,"Convenience","""Zhejiang Orient Gene Biotech Co., LTD""","IgG; IgM","High","Journal Article (Peer-Reviewed)","Miguel Morcuende","Columbia University Irving Medical Center","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/","Verified","","",0.931,0.992,"LFIA: Lateral flow immunoassay","US","US-NY"
"2020-07-19","200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-14","2020-04-16","Blood donors","Adults (18-64 years)",1017.0,0.046,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.03,0.064,0.79,0.99,"ELISA","GB","GB-ENG"
"2020-07-19","200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-15","2020-04-20","Blood donors","Adults (18-64 years)",936.0,0.062,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.044,0.084,0.79,0.99,"ELISA","GB","GB-ENG"
"2020-07-19","200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-24","2020-04-26","Blood donors","Adults (18-64 years)",865.0,0.05,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.032,0.07,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200615_Bergen_UniversityofBergen_HouseholdMembers","Seroconversion in household members of COVID-19 outpatients","2020-06-15","Local","Norway","Norway; Western Norway; Bergen","2020-02-28","2020-04-04","Contacts of COVID patients","Multiple groups",77.0,0.312,"Convenience","Amant et al.","IgM; IgG; IgA","High","Journal Article (Peer-Reviewed)","Rebecca Cox","University of Bergen","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/","Verified","","","","","ELISA","NO",""
"2020-07-19","200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-02","2020-04-03","Blood donors","Adults (18-64 years)",916.0,0.024,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.01,0.04,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-23","2020-04-24","Blood donors","Adults (18-64 years)",1043.0,0.073,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.054,0.094,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16","PHE England week 35","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-04-09","2020-04-13","Blood donors","Adults (18-64 years)",1085.0,0.111,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.089,0.136,0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun","PHE England week 32","2020-08-07","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-03-16","2020-06-30","Residual sera","Seniors (65+ years)",6000.0,0.039,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","","","","","ELISA","GB","GB-ENG"
"2020-07-19","200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April","PHE England week 34","2020-08-21","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-01","2020-04-30","Residual sera","Children and Youth (0-17 years)",647.0,0.061,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.041,0.084,0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May","PHE England week 37","2020-09-11","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-05-01","2020-05-31","Residual sera","Children and Youth (0-17 years)",1061.0,0.073,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.056,0.092,0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200821_England_PHE_WhatsTheStory_TestAdj_April","PHE England week 34","2020-08-21","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-04-01","2020-04-30","Household and community samples","Children and Youth (0-17 years)",201.0,0.038,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.012,0.075,0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-20","200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM","SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria","2020-05-27","Local","Bulgaria","Bulgaria; Varna;  Varna","2020-03-26","2020-04-20","Residual sera","Multiple groups",586.0,0.048,"Convenience","""Zhejiang Orient Gene Biotech Co., LTD""","IgG; IgM","High","Journal Article (Peer-Reviewed)","Denitsa Tsaneva-Damyanova","Medical Diagnostic Laboratory ""STATUS""","https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true","Verified",0.032,0.068,"","","LFIA: Lateral flow immunoassay","BG","BG-03"
"2020-07-20","200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW","SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England","2020-07-07","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-05-04","2020-05-06","Health care workers and caregivers","Adults (18-64 years)",281.0,0.06,"Convenience","Snibe Diagnostic","IgG","High","Journal Article (Peer-Reviewed)","Dimitrios Poulikakos","Salford Royal NHS Foundation Trust","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/","Verified","","","","","Chemiluminescence Immunoassay","GB","GB-ENG"
"2020-07-21","200619_Rome_UniversityofRome_IgG","Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.","2020-06-19","Local","Italy","Italy; Lazio; Rome","2020-04-07","2020-04-27","Health care workers and caregivers","Adults (18-64 years)",1084.0,0.007,"Convenience","Medical Systems","IgG","High","Journal Article (Peer-Reviewed)","Edith Lahner","University of Rome","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/","Verified","","",0.5,0.991,"Chemiluminescence Immunoassay","IT","IT-62"
"2020-07-21","200625_Brussels_UniversitéLibredeBruxelles_OverallHCW","Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk health care workers and hospital staff","2020-06-25","Local","Belgium","Belgium; Brussels; City of Brussels","2020-04-15","2020-05-18","Health care workers and caregivers","Adults (18-64 years)",326.0,0.11,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Charlotte Martin","Université Libre de Bruxelles","https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext","Verified","","","","","ELISA","BE","BE-BRU"
"2020-07-25","200605_China_NationalClinicalResearchCentre_HospitalSetting","Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","2020-06-05","National","China","China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan","2020-03-09","2020-04-10","Multiple populations","Adults (18-64 years)",6919.0,0.025,"Self-referral","Bioscience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","National Clinical Research Centre for Kidney Disease","https://www.nature.com/articles/s41591-020-0949-6","Verified","","","",0.993,"Chemiluminescence Immunoassay","CN",""
"2020-07-26","200710_Santiago_UniversidadDeChile_AllStaff","SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.","2020-07-10","Local","Chile","Chile; Santiago; Vitacura","2020-05-04","2020-05-19","Essential non-healthcare workers","Adults (18-64 years)",235.0,0.166,"Stratified probability","Genrui Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Juan Pablo Torres","Universidade de Chile","https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860","Verified",0.121,0.219,0.91,0.954,"Colloidal gold","CL",""
"2020-07-26","200710_Santiago_UniversidadDeChile_AllStudents","SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.","2020-07-10","Local","Chile","Chile; Santiago; Vitacura","2020-05-04","2020-05-19","Students and Daycares","Children and Youth (0-17 years)",1009.0,0.099,"Stratified probability","Genrui Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Juan Pablo Torres","Universidade de Chile","https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860","Verified",0.086,0.115,0.91,0.954,"Colloidal gold","CL",""
"2020-07-29","200709_London_UniversityCollegeLondonHospitals_HCW","Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers","2020-07-09","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-26","2020-04-08","Health care workers and caregivers","Adults (18-64 years)",181.0,0.453,"Convenience","in-house flow cytometry and ELISA assays developed as part of the Crick-COVID-Consortium","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Catherine Houlihan","University College London Hospitals","https://dx.doi.org/10.1016/S0140-6736(20)31484-7","Verified","","","","","ELISA; Flow cytometry assay","GB","GB-ENG"
"2020-07-30","200606_Leon_UniversidadedeLeon_HCWs_TestAdj2","Prevalence of SARS-CoV-2 infection in general practitioners and nurses in primary care and nursing homes in the Healthcare Area of Leon and associated factors","2020-06-06","Local","Spain","Spain; Léon; Léon","2020-04-01","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",676.0,0.074,"Convenience","Hangzhou All Test Biotech Co Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Vicente Martin","Gerencia de Atención Primaria del Área de Salud de León, Spain","https://dx.doi.org/10.1016/j.semerg.2020.05.014","Verified",0.055,0.1,"","","RDT","ES",""
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-04-19","2020-04-19","Household and community samples","Multiple groups",900.0,0.006,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.002,0.013,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-04-26","2020-04-26","Household and community samples","Multiple groups",900.0,0.009,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.004,0.018,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-05-10","2020-05-10","Household and community samples","Multiple groups",900.0,0.02,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.012,0.031,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-05-17","2020-05-17","Household and community samples","Multiple groups",900.0,0.038,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.026,0.052,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-05-24","2020-05-24","Household and community samples","Multiple groups",900.0,0.058,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.043,0.073,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-05-03","2020-05-03","Household and community samples","Multiple groups",900.0,0.014,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.008,0.024,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil","Brazil; Piaui; Teresina","2020-05-31","2020-05-31","Household and community samples","Multiple groups",900.0,0.083,"Stratified probability","Wondfo Biotech Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified",0.066,0.103,0.86,0.99,"RDT","BR","BR-PI"
"2020-07-31","200626_Moscow_CityofMoscow","Large-scale antibody testing reveals that over 2 million Muscovites may already have contracted ...","2020-06-26","Local","Russian Federation","Russian Federation; Central Russia; Moscow","2020-06-05","2020-06-18","Household and community samples","Multiple groups",90000.0,0.199,"Simplified probability","Not reported","Not reported","High","News and Media","Jonny Tickle","City of Moscow","https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA","Verified","","","","","Not reported","RU",""
"2020-07-31","200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total","0.03% of Koreans developed coronavirus antibodies: KCDC","2020-07-09","National","Republic of Korea","Republic of Korea; Korea","","2020-07-09","Household and community samples","Multiple groups",3055.0,0.0,"Unclear","Not reported","Not reported","Unclear","News and Media","Ock Hyun-ju","Korea Centers for Disease Control and Prevention","https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw","Verified","","","","","Not reported","KR",""
"2020-07-31","200720_Uppsala_UppsalaUniversity_Total","Work at inpatient care units is  associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden.","2020-07-20","Regional","Sweden","Sweden; Uppsala","2020-05-27","2020-06-25","Health care workers and caregivers","Multiple groups",8679.0,0.066,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna-Karin Lidstrom","Uppsala University","https://dx.doi.org/10.1080/03009734.2020.1793039","Verified","","","","","Chemiluminescence Immunoassay","SE","SE-C"
"2020-07-31","200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop","Pvt lab says 16-20% sero-prevalence in Gurugram, health dept distances itself from data","2020-07-21","Regional","India","India; Haryana; Gurugram, Faridabad, Ambala, Panchkula, Sonipat","2020-06-21","2020-07-15","Household and community samples","Adults (18-64 years)",1544.0,0.12,"Stratified probability","Not reported","IgG","High","News and Media","Prayag Arora Desai","Haryana Health Department","https://www.hindustantimes.com/gurugram/pvt-lab-says-16-20-sero-prevalence-in-gurugram-health-dept-distances-itself-from-data/story-265qYKX4XhRPeMVc5HrKEO.html","Verified","","","","","ELISA","IN","IN-HR"
"2020-08-01","200630_Yerevan_ArmeniaMinistryofHealth_HCWs","Antibodies found in Armenia's 61 medical workers from 380 examinations: testing continues","2020-06-30","Local","Armenia","Armenia; Yerevan; Yerevan","","2020-06-29","Health care workers and caregivers","Adults (18-64 years)",380.0,0.16,"Convenience","Not reported","Not reported","High","News and Media","Anna Grigoryan","Ministry of Health of the Republic of Armenia","https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA","Verified","","",1.0,0.998,"Not reported","AM","AM-ER"
"2020-08-01","200707_Turin_University of Turin_PregnantWomen_IgGonly","The ""scar"" of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy.","2020-07-07","Local","Italy","Italy; Piedmont; Turin","2020-04-16","2020-06-04","Pregnant or parturient women","Adults (18-64 years)",138.0,0.058,"Sequential","Boditech","IgG","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267","Verified","","","","","LFIA: Lateral flow immunoassay","IT","IT-21"
"2020-08-01","200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop","Nevada COVID-19 infection rate 5 times higher, antibody tests show","2020-07-08","Local","United States of America","United States of America; Nevada","2020-06-09","2020-06-10","Household and community samples","Adults (18-64 years)",234.0,0.023,"Stratified probability","Abbott","Not reported","High","News and Media","Mary Hynes","Washoe County Health District","https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw","Verified","","","",0.996,"Not reported","US","US-NV"
"2020-08-01","200715_France_UnitedesVirusEmergents_BloodDonors","Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors","2020-07-15","National","France","France; Provence-Alpes-Côte d'Azur, Grand-Est, Hauts-de-France, Île-de-France","2020-03-25","2020-04-07","Blood donors","Adults (18-64 years)",998.0,0.027,"Sequential","Author-designed","Not reported","High","Journal Article (Peer-Reviewed)","Pierre Gallian","Unite des Virus Emergents","https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72","Verified","","","",1.0,"Neutralization assay","FR",""
"2020-08-01","200717_Chittenden_UniversityVermont_GenPop","Early results of UVM research tracking COVID's spread in Vermont","2020-07-17","Local","United States of America","United States of America; Vermont","","2020-06-30","Household and community samples","Multiple groups",455.0,0.022,"Convenience","University of Vermont","Not reported","High","News and Media","Cat Viglienzoni","University of Vermont","https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw","Verified","","","","","Not reported","US","US-VT"
"2020-08-01","200717_Hungary_SemmelweisUniversity__GenPop_PopAdj","Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary","2020-07-17","National","Hungary","Hungary","2020-05-01","2020-05-16","Household and community samples","Multiple groups",10474.0,0.007,"Stratified probability","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Bela Merkely","Semmelweis University","https://dx.doi.org/10.1007/s11357-020-00226-9","Verified",0.005,0.009,"","","Chemiluminescence Immunoassay","HU",""
"2020-08-01","200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors","4% 'healthy' blood donors in Lucknow found with Covid antibodies","2020-07-19","Local","India","India; Uttar Pradesh; Lucknow","2020-07-05","2020-07-19","Blood donors","Multiple groups",1235.0,0.037,"Convenience","Not reported","IgG","High","News and Media","Yusra Husain","King George's Medical University","https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA","Verified","","","","","Not reported","IN","IN-UP"
"2020-08-01","200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM","Serosurvey of SARS-CoV-2 among hospital visitors in China","2020-07-20","Local","China","China; Guangdong; Guangzhou","2020-01-20","2020-04-30","Multiple populations","Multiple groups",8782.0,0.006,"Convenience","Shenzhen YHLO Biotech Co","IgG; IgM","High","Journal Article (Peer-Reviewed)","Wenhua Liang","The First Affiliated Hospital of Guangzhou Medical University","https://dx.doi.org/10.1038/s41422-020-0371-0","Verified","","","",1.0,"Chemiluminescence Immunoassay","CN","CN-44"
"2020-08-01","200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG","Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection","2020-07-20","Regional","Austria","Austria; Tyrol","2020-03-20","2020-03-27","Health care workers and caregivers","Adults (18-64 years)",377.0,0.003,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Dorothea Orth-Holler","Innsbruck Clinical Microbiology Laboratory","https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690","Verified",0.0,0.015,"","","ELISA","AT","AT-7"
"2020-08-01","200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM","Serosurvey of SARS-CoV-2 among hospital visitors in China","2020-07-20","Local","China","China; Hubei; Wuhan","2020-01-19","2020-04-30","Multiple populations","Multiple groups",8272.0,0.021,"Convenience","Innovita","IgG; IgM","High","Journal Article (Peer-Reviewed)","Wenhua Liang","The First Affiliated Hospital of Guangzhou Medical University","https://dx.doi.org/10.1038/s41422-020-0371-0","Verified","","",0.873,1.0,"Colloidal gold","CN","CN-42"
"2020-08-02","200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM","Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China","2020-07-03","Local","China","China; Hubei; Wuhan","2020-03-08","2020-03-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",1027.0,0.046,"Convenience","""Tangshan Yingnuote Biotechnology Enterprise Co., Ltd.""","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Hui Tang","Tongji Medical College","https://dx.doi.org/10.1053/j.ajkd.2020.06.008","Verified","","",0.873,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-08-02","200714_CzechRepublic_ResearchCenterIBD_HCW","Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?","2020-07-14","Local","Czechia","Czechia; Central Bohemian; Prague","","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",92.0,0.022,"Convenience","EUROIMMUN","IgG","Unclear","Journal Article (Peer-Reviewed)","Karin Malickova","Clinical and Research Center for Inflammatory Bowel Disease","https://dx.doi.org/10.1080/00365521.2020.1791244","Verified","","","","","ELISA","CZ","CZ-ST"
"2020-08-02","200715_WashintonDC_DCPublicHealth_GenPop","The DC health lab has tested 13706 blood samples. Only 809 people carried coronavirus antibodies.","2020-07-15","Local","United States of America","United States of America; Washington D.C; Washington DC","2020-06-15","2020-07-15","Household and community samples","Multiple groups",13706.0,0.059,"Self-referral","DiaSorin LIAISON, Abbot Alinity i","Not reported","High","News and Media","Julie Zauzmer","Washington DC Public Health","https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw","Verified","","","","","Chemiluminescence Immunoassay","US","US-DC"
"2020-08-02","200722_France_PicardieUniversity_IBDPatients_Overall","Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics","2020-07-22","Local","France","France; Somme; Amiens","2020-03-25","2020-05-11","Patients seeking care for non-COVID-19 reasons","Multiple groups",146.0,0.048,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Mathurin Fumery","Picardie University","https://dx.doi.org/10.1093/ecco-jcc/jjaa154","Verified","","",0.974,0.985,"Chemiluminescence Immunoassay","FR","FR-HDF"
"2020-08-02","200723_Delhi_IndianCentreforDiseaseControl_GenPop","Sero-prevalence study conducted by National Center for Disease Control NCDC, MoHFW, in Delhi, June 2020","2020-07-21","Regional","India","India; NCT Delhi","2020-06-27","2020-07-10","Household and community samples","Multiple groups",21387.0,0.235,"Stratified probability","Zydus Cadila Healthcare","IgG","Moderate","Institutional Report","Ministry of Health and Family Welfare","Indian Center for Disease Control","https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137","Verified","","",0.987,1.0,"ELISA","IN","IN-DL"
"2020-08-02","200723_Sweden_Werlabs_GenPop","14% of coronavirus antibody tests positive in Sweden in July","2020-07-23","Local","Sweden","Sweden; Skåne, Västra Götaland, Uppland; Stockholm, Gothenburg, Malmo","2020-07-01","2020-07-22","Household and community samples","Multiple groups",83000.0,0.144,"Unclear","Werlabs","Not reported","High","News and Media","The Local","Werlabs","https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ","Verified","","","","","Not reported","SE",""
"2020-08-03","200721_Idaho_UniversityofWashington_TotalPopTestAdj","High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results","2020-07-21","Local","United States of America","United States of America; Idaho","2020-05-04","2020-05-19","Household and community samples","Multiple groups",917.0,0.231,"Self-referral","Abbott","IgG","Moderate","Preprint","Colleen McLaughlin","University of Washington","https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1","Verified",0.198,0.265,0.929,0.996,"Chemiluminescence Immunoassay","US","US-ID"
"2020-08-04","200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj","Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020","2020-07-24","Local","United States of America","United States of America; Indiana; Indianapolis","2020-05-02","2020-05-03","Household and community samples","Multiple groups",898.0,0.058,"Convenience","Author derived","IgG","High","Institutional Report","Nir Menachemi","Indiana University Fairbanks School of Public Health","https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w","Verified","","",1.0,0.996,"Chemiluminescence Immunoassay","US","US-IN"
"2020-08-04","200723_India_Thyrocare_GenPop","COVID-19: People From Bhiwandi, Anand Vihar Have Antibodies Against Corona? Check Report","2020-07-23","National","India","India","2020-06-28","2020-07-19","Household and community samples","Multiple groups",53000.0,0.15,"Simplified probability","Not reported","Not reported","High","News and Media","India com News Desk","Thyrocare","https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q","Verified","","","","","ELISA; Chemiluminescence Immunoassay","IN",""
"2020-08-05","200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA","Screening of Mothers in a COVID-19;   Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers;   from Rostock by ELISA and Confirmation by Immunofluorescence","2020-06-22","Local","Germany","Germany; Mecklenburg-Westpomerania; Rostock","2020-04-20","2020-04-22","Household and community samples","Adults (18-64 years)",401.0,0.0,"Self-referral","EUROIMMUN","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Emil Reisinger","Universitätsmedizin Rostock","https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293","Verified","","","","","ELISA","DE","DE-MV"
"2020-08-06","200730_Ontario_PublicHealthOntario_June_GenPop_PopTestAdj","COVID-19 Seroprevalence in Ontario: March 27, 2020 to June 30, 2020","2020-07-30","Regional","Canada","Canada; Ontario","2020-06-05","2020-06-30","Residual sera","Multiple groups",7014.0,0.011,"Stratified probability","Abbott, Ortho-Clinical Diagnostics","IgG","Moderate","Institutional Report","Public Health Ontario","Public Health Ontario","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en","Verified",0.008,0.013,0.904,1.0,"Chemiluminescence Immunoassay","CA","CA-ON"
"2020-08-06","200730_Ontario_PublicHealthOntario_March_GenPop_PopTestAdj","COVID-19 Seroprevalence in Ontario: March 27, 2020 to June 30, 2020","2020-07-30","Regional","Canada","Canada; Ontario","2020-03-27","2020-04-30","Residual sera","Multiple groups",827.0,0.005,"Stratified probability","Abbott, Ortho-Clinical Diagnostics","IgG","Moderate","Institutional Report","Public Health Ontario","Public Health Ontario","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en","Verified",0.001,0.015,0.904,1.0,"Chemiluminescence Immunoassay","CA","CA-ON"
"2020-08-06","200730_Ontario_PublicHealthOntario_May_GenPop_PopTestAdj","COVID-19 Seroprevalence in Ontario: March 27, 2020 to June 30, 2020","2020-07-30","Regional","Canada","Canada; Ontario","2020-05-26","2020-05-31","Residual sera","Multiple groups",1061.0,0.015,"Stratified probability","Abbott, Ortho-Clinical Diagnostics","IgG","Moderate","Institutional Report","Public Health Ontario","Public Health Ontario","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en","Verified",0.007,0.022,0.904,1.0,"Chemiluminescence Immunoassay","CA","CA-ON"
"2020-08-08","200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj","High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi","2020-08-05","National","Malawi","Malawi; Southern Region Malawi; Blantyre","2020-05-22","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",500.0,0.123,"Convenience","Omega diagnostics","IgG","High","Preprint","Marah Chibwana","Malawi-Liverpool-Wellcome Trust Clinical Research Programme","https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf","Verified",0.082,0.165,0.881,0.932,"ELISA","MW","MW-S"
"2020-09-23","200807_Lome_UniversiteDeLome_Overall","Prevalence of SARS-CoV-2 among high-risk populations in Lome (Togo) in 2020","2020-08-07","Local","Togo","Togo","2020-04-23","2020-05-08","Non-essential workers and unemployed persons","Adults (18-64 years)",955.0,0.009,"Convenience","""Hangzhou Clongene Biotech Co, Ltd.""","IgM; IgG","High","Journal Article (Peer-Reviewed)","Wemboo Halatoko","Universite de Lome","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124","Verified",0.004,0.018,0.771,0.954,"LFIA: Lateral flow immunoassay","TG",""
"2020-09-24","200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall","Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative","2020-08-04","Local","United States of America","United States of America; Florida; Miami","2020-04-23","2020-04-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",677.0,0.056,"Convenience","Diazyme Laboratories Inc","IgG; IgM","High","Preprint","Dena Cohen","DaVita Clinical Research","https://doi.org/10.1101/2020.08.03.20163642","Verified",0.04,0.076,0.571,0.85,"Chemiluminescence Immunoassay","US","US-FL"
"2020-09-24","201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj","Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study","2020-10-28","Regional","United States of America","United States of America; Connecticut","2020-06-04","2020-06-23","Household and community samples","Multiple groups",567.0,0.04,"Simplified probability","Ortho-Clinical Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Shiwani Mahajan","Yale School of Medicine","http://dx.doi.org/10.1016/j.amjmed.2020.09.024","Verified",0.02,0.06,0.9,1.0,"Chemiluminescence Immunoassay","US","US-CT"
"2020-09-25","200807_Bavaria_UniversityHospitalMunich","Infection with SARS-CoV-2 in primary care health care workers assessed by antibody testing","2020-08-07","Regional","Germany","Germany; Bavaria; Dachau","2020-04-02","2020-04-06","Health care workers and caregivers","Adults (18-64 years)",151.0,0.026,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Korbinian Lackermair","University Hospital Munich","http://dx.doi.org/10.1093/fampra/cmaa078","Verified",0.008,0.071,"","","ELISA","DE","DE-BY"
"2020-09-25","200808_Italy_UniversityofTurin_CLLPatients_Overall","All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions","2020-08-08","Local","Italy","Italy; Piedmont; Turin, Novara, Alessandria, Verbania","2020-03-08","2020-04-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",24.0,0.125,"Convenience","DiaSorin, In3diagnostic, Medical Systems","IgG","High","Journal Article (Peer-Reviewed)","Marco Denina","University of Turin","http://dx.doi.org/10.1016/j.jaad.2020.08.021","Verified","","","","","Chemiluminescence Immunoassay; ELISA","IT","IT-21"
"2020-09-26","200716_Daegu_DaeguCatholicUniversityHospital_Overall","IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.","2020-07-16","Local","Republic of Korea","Republic of Korea; North Gyeongsang; Daegu","2020-05-25","2020-06-05","Multiple populations","Multiple groups",198.0,0.076,"Convenience","Shin Jin Medics Inc","IgG","High","Journal Article (Peer-Reviewed)","Suk-Kyoon Song","Daegu Catholic University Hospital","https://dx.doi.org/10.3346/jkms.2020.35.e269","Verified","","",1.0,0.92,"Solid phase immunochromatography","KR","KR-47"
"2020-09-26","200721_NewYork_ShermanAbramsLaboratory_Overall","SARS-CoV-2 IgG antibody responses in New York City","2020-07-21","Local","United States of America","United States of America; New York; New York","2020-05-15","2020-06-15","Residual sera","Multiple groups",28523.0,0.44,"Convenience","DiaSorin LIAISON","IgG","High","Journal Article (Peer-Reviewed)","Josh Reifer","Sherman Abrams Laboratory","https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128","Verified","","","","","Chemiluminescence Immunoassay","US","US-NY"
"2020-09-26","200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1","Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients","2020-07-24","Local","Nigeria","Nigeria; Cross River State; Calabar","2020-06-17","2020-06-24","Multiple populations","Adults (18-64 years)",66.0,0.26,"Unclear","Healgen Scientific","IgG","High","Preprint","Marcus Inyama Asuquo","Joseph Ukpo Hospitals and Research Institutes","https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2","Verified","","","","","LFIA: Lateral flow immunoassay","NG","NG-CR"
"2020-09-26","200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop","Riverside County may have more than 100,000 COVID-19 cases, antibody study suggests","2020-07-27","Local","United States of America","United States of America; California","2020-07-06","2020-07-20","Household and community samples","Multiple groups",1726.0,0.059,"Simplified probability","Not Reported","Not reported","Unclear","News and Media","ABC7 com staff","Riverside University Health System","https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/","Verified","","","","","Not reported","US","US-CA"
"2020-09-27","200726_RhodeIsland_NewYorkBloodCenter_BloodDonors","Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats","2020-07-26","Regional","United States of America","United States of America; Rhode Island","2020-04-27","2020-05-11","Blood donors","Multiple groups",1996.0,0.039,"Sequential","Ortho-Clinical Diagnostics, SD Biosensor","IgG; IgM","Moderate","Preprint","Daniel Nesbitt","New York Blood Center","https://www.medrxiv.org/content/10.1101/2020.07.20.20157743v1","Verified","","","","","Chemiluminescence Immunoassay; LFIA: Lateral flow immunoassay","US","US-RI"
"2020-09-27","200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj","Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands","2020-07-27","Regional","Faroe Islands","Faroe Islands; Faroe Islands","2020-04-27","2020-05-01","Household and community samples","Adults (18-64 years)",1075.0,0.007,"Simplified probability","Beijing Wantai Biological Pharmacy Enterprise","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Maria Skaalum Petersen","University of the Faroe Islands","http://dx.doi.org/10.3201/eid2611.202736","Verified","","",0.944,1.0,"ELISA","FO",""
"2020-09-27","200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall","Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: results from a large-scale screening program based on rapid serological testing.","2020-08-04","Regional","Italy","Italy; Tuscany","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",17098.0,0.031,"Convenience","Screen Italia S.R.L, ""Zhejiang Orient Gene Biotech Co., LTD""","IgG; IgM","High","Preprint","Francesca Carozzi","Arezzo Hospital","https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1","Verified","","","","","LFIA: Lateral flow immunoassay","IT","IT-52"
"2020-09-27","200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM","Caveats in interpreting SARS-CoV-2 IgM(+)/IgG(-)antibody profile in asymptomatic health care workers","2020-08-06","Local","Spain","Spain; Valencia; Valencia","2020-04-13","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",1153.0,0.035,"Unclear","Snibe Diagnostic","IgG; IgM","High","Journal Article (Peer-Reviewed)","Arantxa Valdivia","Hospital Clínico Universitario","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400","Verified","","",0.956,0.96,"Chemiluminescence Immunoassay","ES","ES-VC"
"2020-09-27","200807_Zurich_UniversityofZurich_BDSCohort_AprilQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland","Switzerland; Zurich; Zurich","2020-04-01","2020-04-30","Blood donors","Adults (18-64 years)",1469.0,0.012,"Sequential","Author-designed","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified",0.007,"",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_BDSCohort_earlyJulyQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland","Switzerland; Zurich; Zurich","2020-07-01","2020-07-15","Blood donors","Adults (18-64 years)",1067.0,0.007,"Sequential","Author-designed","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified",0.003,0.012,1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_USZCohort_AprilQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland","Switzerland; Zurich; Zurich","2020-04-01","2020-04-30","Residual sera","Adults (18-64 years)",4275.0,0.014,"Sequential","Author-designed","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified",0.01,0.017,1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_USZCohort_MarchQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland","Switzerland; Zurich; Zurich","2020-03-15","2020-03-31","Residual sera","Adults (18-64 years)",3806.0,0.003,"Sequential","Author-designed","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified",0.001,0.005,1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_USZCohort_May-JulyAveQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland","Switzerland; Zurich; Zurich","2020-05-15","2020-07-15","Residual sera","Adults (18-64 years)",12831.0,0.009,"Sequential","Author-designed","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified","","",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200813_Foggia_UniversityofFoggia_OverallIgG/IgM","Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2","2020-08-13","Local","Italy","Italy;  Apulia; Foggia","2020-05-01","2020-05-31","Blood donors","Adults (18-64 years)",904.0,0.01,"Convenience","""New Industries Biomedical Engineering Co., Ltd""","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jose Ramon Fiore","University of Foggia","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425","Verified","","","","","Chemiluminescence Immunoassay","IT","IT-75"
"2020-09-28","200721_Arezzo_OspedaleSanDonato_Total","Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity","2020-07-21","Local","Italy","Italy; Tuscany; Arezzo","2020-03-17","2020-03-21","Residual sera","Adults (18-64 years)",516.0,0.13,"Sequential","Acro Biotech Inc.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alessandro Pancrazzi","Ospedale San Donato","http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002","Verified","","",0.37,0.94,"Rapid immunochromatographic test","IT","IT-52"
"2020-09-28","200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall","Period Prevalence of SARS-CoV-2 in an Unselected Sample of Pregnant Women in Jena, Thuringia","2020-08-24","Local","Germany","Germany; Thuringia; Jena","2020-04-06","2020-05-13","Pregnant or parturient women","Multiple groups",180.0,0.006,"Sequential","Epitope Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Janine Zollkau","Universitätsklinikum Jena","https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033","Verified",0.0,0.017,"","","ELISA","DE","DE-TH"
"2020-09-28","200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG","Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals","2020-09-04","Local","Germany","Germany; Lower Saxony; Hannover","2020-03-23","2020-04-17","Health care workers and caregivers","Adults (18-64 years)",217.0,0.014,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Georg Behrens","Hannover Medical School","https://link.springer.com/article/10.1007/s40121-020-00334-1","Verified","","",0.872,0.993,"ELISA","DE","DE-NI"
"2020-09-28","200904_USA_CDC_HCWs_Overall","Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network-13 Academic Medical Centers, April-June 2020","2020-09-04","National","United States of America","United States of America; New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio; Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus","2020-04-03","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",3248.0,0.06,"Convenience","CDC","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Wesley Self","CDC COVID-19 Response Team","https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm","Verified","","",0.96,0.99,"ELISA","US",""
"2020-09-28","200906_Madinah_KingFahadGeneralHospital_HCWs_Overall","Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers","2020-09-06","Local","Saudi Arabia","Saudi Arabia; Hejaz; Madinah","2020-04-18","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",330.0,0.242,"Unclear","Vircell Microbiologists","IgM; IgA; IgG","High","Journal Article (Peer-Reviewed)","Suliman Alharbi","King Fahad General Hospital","https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf","Verified","","","","","ELISA","SA",""
"2020-09-28","201004_SEEngland_King’sCollegeLondon","Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England","2020-10-14","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; South East England","2020-04-27","2020-06-02","Household and community samples","Multiple groups",431.0,0.12,"Convenience","Imperial College London","IgG; IgM","High","Journal Article (Peer-Reviewed)","Philippa M Wells","King’s College London","http://dx.doi.org/10.1016/j.jinf.2020.10.011","Verified",0.091,0.152,0.9,1.0,"ELISA","GB","GB-ENG"
"2020-09-29","200721_Egypt_CairoUniversity_TotalHCW_Overall","SARS-CoV-2 infection among healthcare workers of a gastroenterological service in a tertiary care facility","2020-07-21","Local","Egypt","Egypt","2020-06-01","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",74.0,0.122,"Convenience","Artron Laboratories","IgG; IgM","High","Journal Article (Peer-Reviewed)","Abdel Meguid Kassem","Cairo University","https://dx.doi.org/10.1016/j.ajg.2020.07.005","Verified","","",0.934,0.977,"LFIA: Lateral flow immunoassay","EG",""
"2020-09-29","200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj","COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce.","2020-07-25","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; King's Lynn","2020-06-01","2020-06-07","Health care workers and caregivers","Adults (18-64 years)",70.0,0.214,"Unclear","Unclear","IgG","High","Journal Article (Peer-Reviewed)","D M Favara","The Queen Elizabeth Hospital","https://dx.doi.org/10.1016/j.clon.2020.07.015","Verified","","","","","Luminex","GB","GB-ENG"
"2020-09-29","200725_Wuhan_WuhanInstituteofVirology_IgG","Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2","2020-07-25","Local","China","China; Hubei; Wuhan","2020-03-19","2020-03-20","Health care workers and caregivers","Adults (18-64 years)",325.0,0.431,"Stratified probability","Vazyme, Zhu Hai Livzon Diagnostics Ins, NZK Biotech Co","IgG","High","Journal Article (Peer-Reviewed)","Danna Tu","Wuhan Institute of Virology","http://dx.doi.org/10.1016/j.jinf.2020.07.023","Verified","","","","","ELISA; Colloidal gold; Dual-target immuno-fluorescence assay (DTFA)","CN","CN-42"
"2020-09-29","200728_Prato_SantoStefanoHospital_Overall","Universal screening for SARS-CoV-2 in pregnant women admitted for delivery: how to manage antibody testing?","2020-07-28","Local","Italy","Italy; Tuscany; Prato","2020-04-04","2020-05-16","Pregnant or parturient women","Adults (18-64 years)",134.0,0.045,"Sequential","Acro Biotech Inc.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anna Cavaliere","Santo Stefano Hospital","http://dx.doi.org/10.1080/14767058.2020.1793317","Verified","","","","","Rapid point-of care","IT","IT-52"
"2020-09-29","200729_Milan_UniversitadegliStudidiMilano_Overall_IgG","SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital","2020-07-29","Local","Italy","Italy; Lombardy; Milan","2020-04-02","2020-04-16","Health care workers and caregivers","Adults (18-64 years)",202.0,0.074,"Convenience","BioMedomics","IgG","High","Journal Article (Peer-Reviewed)","Giovanni Sotgiu","Università degli Studi di Milano","https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0","Verified",0.038,0.11,0.887,0.906,"LFIA: Lateral flow immunoassay","IT","IT-25"
"2020-09-30","200723_JeffersonCounty_UniversityofLouisville_genpop","Study Finds Rate of Exposure to COVID-19 in Louisville Higher Than Expected","2020-07-23","Local","United States of America","United States of America; Kentucky","2020-06-10","2020-06-19","Household and community samples","Multiple groups",2237.0,0.04,"Self-referral","Not reported","Not reported","High","News and Media","Spectrum News Staff","University of Louisville","https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results","Verified","","","","","Not reported","US","US-KY"
"2020-10-01","200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate","SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.","2020-07-16","Regional","Germany","Germany; North Rhine-Westphalia, Lower Saxony, Hesse","2020-03-09","2020-06-03","Residual sera","Multiple groups",3186.0,0.009,"Sequential","Abbott, EUROIMMUN, DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Bastian Fischer","Heart and Diabetes Center NRW","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285","Verified",0.006,0.012,"","","ELISA","DE",""
"2020-10-01","200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG","Seroprevalence of COVID-19 antibodies in the cleaning and oncological staff of a municipal clinic.","2020-07-23","Local","Germany","Germany; Thuringia; Saalfeld","2020-06-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",45.0,0.0,"Convenience","PerkinElmer Inc","IgG","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000353","Verified","","","",0.985,"ELISA","DE","DE-TH"
"2020-10-01","200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG","Seroprevalence of COVID-19 antibodies in the cleaning and oncological staff of a municipal clinic.","2020-07-23","Local","Germany","Germany; Thuringia; Saalfeld","2020-06-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",20.0,0.05,"Convenience","PerkinElmer Inc","IgG","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000353","Verified","","","",0.985,"ELISA","DE","DE-TH"
"2020-10-01","200729_Wuhan_WuhanUniversity_Overall","Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China","2020-08-03","Local","China","China; Hubei; Wuhan","2020-01-14","2020-02-21","Health care workers and caregivers","Multiple groups",1060.0,0.083,"Convenience","Shenzhen YHLO Biotech Co","IgG; IgM","High","Journal Article (Peer-Reviewed)","Dong Zhao","Renmin Hospital of Wuhan University","https://dx.doi.org/10.1016/j.ijid.2020.07.082","Verified","","","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-01","200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020","Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.","2020-07-30","Local","Japan","Japan; Hokkaido; Sapporo","2020-03-01","2020-03-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",300.0,0.003,"Unclear","Roche Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Goki Suda","Hokkaido University Graduate School of Medicine","https://dx.doi.org/10.1111/hepr.13551","Verified",0.0,0.018,1.0,0.998,"Electro chemiluminescence immunoassay","JP","JP-01"
"2020-10-01","200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020","Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.","2020-07-30","Local","Japan","Japan; Hokkaido; Sapporo","2020-05-01","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",300.0,0.0,"Unclear","Roche Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Goki Suda","Hokkaido University Graduate School of Medicine","https://dx.doi.org/10.1111/hepr.13551","Verified",0.0,0.0,1.0,0.998,"Electro chemiluminescence immunoassay","JP","JP-01"
"2020-10-01","200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM","Risk of COVID-19 in health-care workers in Denmark: an observational cohort study","2020-08-03","Regional","Denmark","Denmark; Capital Region of Denmark","2020-04-15","2020-04-22","Blood donors","Adults (18-64 years)",4672.0,0.03,"Sequential","Livzon Diagnostics","IgM; IgG","High","Journal Article (Peer-Reviewed)","Kasper Iversen","University of Copenhagen","https://dx.doi.org/10.1016/S1473-3099(20)30589-2","Verified",0.026,0.036,0.734,0.999,"LFIA: Lateral flow immunoassay","DK","DK-84"
"2020-10-02","200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj","Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.","2020-07-24","Local","United States of America","United States of America; Georgia","2020-04-28","2020-05-03","Household and community samples","Multiple groups",696.0,0.025,"Stratified probability","Ortho-Clinical Diagnostics","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Holly Biggs","CDC COVID-19 Response Team","https://dx.doi.org/10.15585/mmwr.mm6929e2","Verified",0.014,0.045,0.932,0.99,"Not reported","US","US-GA"
"2020-10-02","200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall","SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador","2020-07-27","Local","Ecuador","Ecuador; El Oro","2020-05-01","2020-05-25","Household and community samples","Multiple groups",673.0,0.45,"Convenience","Biohit Health Care Ltd","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Universidad Peruana Cayetano Heredia","http://dx.doi.org/10.1093/cid/ciaa1055","Verified","","","","","LFIA: Lateral flow immunoassay","EC","EC-O"
"2020-10-02","200813_Selangor_UniversityMalaya_OverallPopAdj","Low postpandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia","2020-08-13","Regional","Malaysia","Malaysia; Selangor; Kuala Lumpur","2020-01-29","2020-06-06","Residual sera","Multiple groups",588.0,0.004,"Convenience","Author-designed","IgG","High","Journal Article (Peer-Reviewed)","I Ching Sam","University Malaya","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426","Verified",0.0,0.009,"","","ELISA","MY","MY-10"
"2020-10-03","200720_Lahore_ChughtaiInstituteofPathology_Overall","Frequency of COVID-19 IgG Antibodies among Special Police Squad Lahore, Pakistan","2020-08-19","Local","Pakistan","Pakistan","2020-05-20","2020-05-30","Essential non-healthcare workers","Adults (18-64 years)",154.0,0.156,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Omar Chughtai","Chughtai Institute of Pathology","https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan","Verified","","",0.968,0.99,"Chemiluminescence Immunoassay","PK",""
"2020-10-03","200806_Greece_UniversityofThessaly_Overall","Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020","2020-08-06","National","Greece","Greece; Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus","2020-03-01","2020-04-30","Residual sera","Multiple groups",6586.0,0.004,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Zacharoula Bogogiannidou","University of Thessaly","https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369","Verified","","",0.84,0.997,"Chemiluminescence Immunoassay","GR",""
"2020-10-03","200808_UK_PortlandHospitalforWomenandChildren_HCW","SARS-CoV-2-specific antibody detection in healthcare workers in a UK maternity Hospital: Correlation with SARS-CoV-2 RT-PCR results","2020-08-08","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-15","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",190.0,0.22,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Asma Khalil","St George’s University of London","http://dx.doi.org/10.1093/cid/ciaa893","Verified","","",0.969,0.999,"ELISA","GB","GB-ENG"
"2020-10-03","200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM","Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience","2020-08-10","Local","Spain","Spain","2020-04-15","2020-04-25","Health care workers and caregivers","Adults (18-64 years)",498.0,0.022,"Convenience","""Zhejiang Orient Gene Biotech Co., LTD""","IgG; IgM","High","Journal Article (Peer-Reviewed)","Julian Olalla","Hospital Costa del Sol","http://dx.doi.org/10.1093/qjmed/hcaa238","Verified","","","","","Solid phase immunochromatography","ES",""
"2020-10-04","200725_Shenzhen_ ShenzhenSecondPeoplesHospital_Builders","Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen","2020-07-25","Local","China","China; Guangdong; Shenzhen","2020-02-29","2020-03-18","Non-essential workers and unemployed persons","Multiple groups",1589.0,0.004,"Convenience","Shenzhen Sciarray Biotech Ltd","IgG","High","Journal Article (Peer-Reviewed)","Cantong Zhang","Shenzhen Second People's Hospital","http://dx.doi.org/10.1002/jmv.26355","Verified","","","","","ELISA","CN","CN-44"
"2020-10-04","200803_Indiana_IndianaUniversity_healthcareworkers","Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.","2020-08-03","Regional","United States of America","United States of America; Indiana; Indianapolis","2020-04-29","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",734.0,0.016,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Benton Hunter","Indiana University","https://dx.doi.org/10.1017/ice.2020.390","Verified","","",1.0,0.996,"Chemiluminescence Immunoassay","US","US-IN"
"2020-10-04","200803_Italy_ItalianMinistryOfHealth_Overall","FIRST RESULTS OF THE SEROPREVALENCE SURVEY ON SARS-CoV-2","2020-08-03","National","Italy","Italy; Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, Friuli-Venezia Giulia, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, Trentino-Alto Adige, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto","2020-05-25","2020-07-15","Household and community samples","Multiple groups",64660.0,0.025,"Stratified non-probability","Abbott","IgG","Unclear","Institutional Report","Instituto Nazionale di Statistica","Italian Ministry of Health","https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf","Verified","","","","","Chemiluminescence Immunoassay","IT",""
"2020-10-04","200810_London_UniversityCollegeLondon_Total","A cross-sectional study of immune seroconversion to SARS-CoV-2 in front-line maternity health professionals","2020-08-10","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-11","2020-06-05","Health care workers and caregivers","Multiple groups",200.0,0.145,"Unclear","Abbott","IgG","High","Journal Article (Peer-Reviewed)","S Bampoe","University College London","https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229","Verified",0.099,0.201,1.0,0.996,"Chemiluminescence Immunoassay","GB","GB-ENG"
"2020-10-04","200824_Seoul_KoreaUniversity_Overall","Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea","2020-08-24","Local","Republic of Korea","Republic of Korea","2020-05-25","2020-05-29","Residual sera","Multiple groups",1500.0,0.001,"Convenience","Roche elecsys","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ji Noh","Korea University","https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311","Verified","","",0.995,0.998,"Chemiluminescence Immunoassay","KR",""
"2020-10-04","200829_Hubei_HuazhongUniversity_HospitalizedChildren","Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China","2020-08-29","Local","China","China; Hubei; Wuhan, Xiangyang","2020-01-23","2020-04-24","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",299.0,0.0,"Unclear","Not reported","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Song mi Want","Huazhong University of Science and Technology","https://link.springer.com/article/10.1007/s11596-020-2228-7","Verified","","","","","magnetic particle chemiluminescence","CN","CN-42"
"2020-10-05","200729_London_WhittingtonHealthNHSTrust_Overall","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust","2020-08-04","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-15","2020-06-05","Health care workers and caregivers","Multiple groups",2004.0,0.316,"Convenience","Roche Diagnostics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Joseph Grant","Whittington Health NHS Trust","https://dx.doi.org/10.1017/ice.2020.402","Verified","","","",0.998,"Electro chemiluminescence immunoassay","GB","GB-ENG"
"2020-10-05","200730_Belgium_IrisHospitalsSouth_HCW_UnAdj","Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.","2020-07-30","Local","Belgium","Belgium; Brussels; City of Brussels","2020-05-25","2020-06-19","Health care workers and caregivers","Multiple groups",1485.0,0.146,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Laurent Blairon","Iris Hospitals South","https://dx.doi.org/10.1016/j.jinf.2020.07.033","Verified","","",1.0,"","Chemiluminescence Immunoassay","BE","BE-BRU"
"2020-10-05","200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted","Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020","2020-07-30","Local","United States of America","United States of America; Louisiana","2020-05-09","2020-05-15","Household and community samples","Adults (18-64 years)",2640.0,0.069,"Stratified probability","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Amy K Feehan","Oschner Clinic Foundation","https://dx.doi.org/10.3201/eid2611.203029","Verified",0.068,0.069,"","","Chemiluminescence Immunoassay","US","US-LA"
"2020-10-06","200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj","Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia","2021-01-03","Local","Colombia","Colombia; Capital District Cundinamarca; Bogotá","2020-06-25","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",351.0,0.083,"Self-referral","Abbott, Columbia; SD Biosensor","IgG","High","Journal Article (Peer-Reviewed)","Beatriz Ariza","Pontificia Universidad Javeriana","http://www.revistainfectio.org/index.php/infectio/article/view/938","Verified",0.058,0.116,1.0,1.0,"Not reported","CO","CO-DC"
"2020-10-08","200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM","Los test serológicos de Torrejón de Ardoz arrojan un 20,18 % de personas con anticuerpos de coronavirus","2020-06-17","Local","Spain","Spain","2020-05-29","2020-06-03","Household and community samples","Multiple groups",104299.0,0.231,"Entire sample","Not reported","IgG; IgM","Moderate","Institutional Report","Daniel Flores","Municipality of Torrejon de Ardoz","https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml","Verified","","","","","Not reported","ES",""
"2020-10-08","200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients","Results and Impact of Intensive SARS-CoV-2 Testing in a High Volume, Outpatient Radiation Oncology Clinic in a Pandemic Hotspot","2020-08-14","Local","United States of America","United States of America; New York; New York City","2020-05-07","2020-06-25","Patients seeking care for non-COVID-19 reasons","Multiple groups",952.0,0.055,"Convenience","Abbott","IgG","High","Preprint","Sean McBride","Memorial Sloan Kettering Cancer Center","https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1","Verified","","","","","chemiluminescent microparticle immunoassay","US","US-NY"
"2020-10-09","200701_HongKong_QueenMaryHospital_Evacuees_EnzymeImmunoAssay","Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study","2020-06-03","Regional","China","China; Hubei","2020-03-04","2020-03-17","Household and community samples","Multiple groups",452.0,0.029,"Convenience","Author-designed","IgG","Moderate","Journal Article (Peer-Reviewed)","Kelvin To","Queen Mary Hospital","https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext","Verified","","",0.733,1.0,"Enzyme immunoassay","CN","CN-42"
"2020-10-09","200701_HongKong_QueenMaryHospital_Feb2020_EnzymeImmunoAssay","Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study","2020-06-03","Local","China","China; Hong Kong; Hong Kong","2020-02-01","2020-02-13","Residual sera","Multiple groups",233.0,0.004,"Sequential","Author-designed","IgG","High","Journal Article (Peer-Reviewed)","Kelvin To","Queen Mary Hospital","https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext","Verified",0.0,0.024,0.733,1.0,"Enzyme immunoassay","CN",""
"2020-10-09","200701_HongKong_QueenMaryHospital_Jan2020_EnzymeImmunoAssay","Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study","2020-06-03","Local","China","China; Hong Kong; Hong Kong","2020-01-01","2020-01-31","Residual sera","Multiple groups",580.0,0.026,"Sequential","Author-designed","IgG","High","Journal Article (Peer-Reviewed)","Kelvin To","Queen Mary Hospital","https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext","Verified",0.015,0.042,0.733,1.0,"Enzyme immunoassay","CN",""
"2020-10-09","200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj","Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: A cross-sectional study","2020-08-06","Local","United States of America","United States of America; Florida","2020-04-16","2020-04-17","Essential non-healthcare workers","Multiple groups",203.0,0.089,"Convenience","BioMedomics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alberto J Caban Martinez","University of Miami","http://dx.doi.org/10.1136/oemed-2020-106676","Verified","","",0.887,0.906,"LFIA: Lateral flow immunoassay","US","US-FL"
"2020-10-09","200811_NewYork_StFrancisHospital_Overall","Prevalence of SARS-CoV-2 Infection among Health Care Workers in a Tertiary Community Hospital","2020-08-11","Local","United States of America","United States of America; New York; New York City","2020-03-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",1699.0,0.098,"Convenience","EUROIMMUN, Abbott","IgG","High","Journal Article (Peer-Reviewed)","Allen Jeremias","St Francis Hospital","http://dx.doi.org/10.1001/jamainternmed.2020.4214","Verified","","","","","Not reported","US","US-NY"
"2020-10-09","200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG","Prevention of COVID-19 infection in a pediatric oncology ward in Wuhan","2020-08-11","Local","China","China; Hubei; Wuhan","2020-01-23","2020-03-27","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",44.0,0.0,"Sequential","Not reported","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ai Zhang","Huazhong University of Science and Technology","https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424","Verified","","","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-10","200814_Oregon_OregonHealthAuthority_Overall_UnAdj","Seroprevalence Estimates of SARS- CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020","2020-08-14","Regional","United States of America","United States of America; Oregon","2020-05-11","2020-06-15","Residual sera","Multiple groups",897.0,0.01,"Stratified probability","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Melissa Sutton","Oregon Health Authority","https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm","Verified",0.002,0.018,0.968,0.991,"chemiluminescent microparticle immunoassay","US","US-OR"
"2020-10-11","200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG","Studie zur immunitat gegen sars-cov-2","2020-06-29","Local","Germany","Germany","2020-04-09","2020-04-16","Multiple populations","Multiple groups",1780.0,0.01,"Unclear","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Peter Kern","Universitätsmedizin Marburg","http://dx.doi.org/10.1055/a-1198-1243","Verified",0.006,0.015,0.938,0.99,"ELISA","DE",""
"2020-10-13","200820_Hubei_NanjingUniversity_hcw_IgG","Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak.","2020-08-20","Local","China","China; Hubei; Wuhan","2020-05-12","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",191.0,0.0,"Convenience","Shenzhen YHLO Biotech Co","IgG","High","Journal Article (Peer-Reviewed)","Xin Tong","Nanjing University Medical School","https://dx.doi.org/10.1002/iid3.340","Verified","","","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-13","200826_India_AllIndiaInstituteofMedicalSciences_HospitalPatients_UnAdj","Seroprevalence of anti-SARS-CoV-2 IgG antibodies in hospitalized patients at a tertiary referral center in North India","2020-08-26","Local","India","India; Punjab; New Delhi","2020-06-08","2020-08-08","Residual sera","Multiple groups",212.0,0.198,"Convenience","""Translational Health Science and Technology Institute (THSTI), Faridabad""","IgG","High","Preprint","Animesh Ray","All India Institute of Medical Sciences","https://www.medrxiv.org/content/10.1101/2020.08.22.20179937v2","Verified",0.147,0.258,0.882,0.998,"ELISA","IN","IN-PB"
"2020-10-13","200901_Iceland_deCODEGenetics_OverallPopAdj","Humoral Immune Response to SARS-CoV-2 in Iceland","2020-09-01","National","Iceland","Iceland","2020-04-27","2020-06-12","Household and community samples","Multiple groups",23452.0,0.003,"Convenience","Roche International, Wantai/Nordic BioSite","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Daniel Gudbjartsson","deCODE Genetics","http://dx.doi.org/10.1056/NEJMoa2026116","Verified","","",0.911,"","Chemiluminescence Immunoassay","IS",""
"2020-10-14","200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj","Seroprevalence of COVID-19 in Niger State","2020-08-05","Regional","Nigeria","Nigeria; Niger State","2020-06-26","2020-06-30","Household and community samples","Multiple groups",185.0,0.254,"Stratified probability","Cambridge Network","IgG","Moderate","Preprint","Hussaini Majiya","Ibrahim Badamasi Babangida University","https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf","Verified","","",1.0,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","NG","NG-NI"
"2020-10-14","200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM","High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden","2020-08-05","Local","Sweden","Sweden","2020-04-01","2020-04-20","Health care workers and caregivers","Adults (18-64 years)",1005.0,0.229,"Convenience","Zhejiang Orient Gene Biotech Co Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Johanna Lindahl","Uppsala University","https://dx.doi.org/10.1080/20008686.2020.1789036","Verified",0.204,0.257,"","","LFIA: Lateral flow immunoassay","SE",""
"2020-10-14","200907_Bari_PoliclinicoHospital_Overall","The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department","2020-09-07","Local","Italy","Italy;  Apulia; Bari","2020-03-23","2020-04-21","Residual sera","Multiple groups",819.0,0.086,"Sequential","VivaChek Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Daniela Loconsole","Policlinico Hospital","https://dx.doi.org/10.3390/ijerph17186493","Verified","","",0.351,0.973,"Colloidal gold","IT","IT-75"
"2020-10-14","200922_Gateshead_NHSFoundationTrust_Overall","Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2)","2020-09-22","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Gateshead","2020-05-28","2020-06-08","Health care workers and caregivers","Adults (18-64 years)",2521.0,0.194,"Convenience","Roche","IgG; IgM","High","Journal Article (Peer-Reviewed)","Salman Razvi","Gateshead Health NHS Foundation Trust","https://dx.doi.org/10.7861/clinmed.2020-0566","Verified","","","","","Chemiluminescence Immunoassay","GB","GB-ENG"
"2020-10-15","200818_Brescia_UniversityofBrescia_Overall","The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures","2020-08-18","Local","Italy","Italy; Lombardy; Brescia","2020-04-27","2020-04-27","Health care workers and caregivers","Adults (18-64 years)",76.0,0.118,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Alberto Dalla Volta","University of Brescia","http://dx.doi.org/10.3389/fonc.2020.01574","Verified","","","","","Not reported","IT","IT-25"
"2020-10-15","200818_Cambridge_CambridgeHealthAllianceOverall","Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic","2020-08-18","Local","United States of America","United States of America; Massachusetts; Cambridge","2020-04-13","2020-05-24","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",24.0,0.167,"Convenience","Abbott, DiaSorin, EUROIMMUN","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Robert Stavert","Cambridge Health Alliance","http://dx.doi.org/10.1016/j.jaad.2020.08.049","Verified","","","","","Not reported","US","US-MA"
"2020-10-15","200823_Bergamo_HospitalPapaGiovanniXXIII_Overall","Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment","2020-08-26","Local","Italy","Italy; Lombardy; Bergamo","2020-03-04","2020-07-10","Patients seeking care for non-COVID-19 reasons","Multiple groups",90.0,0.211,"Convenience","VivaChek","IgG; IgM","High","Journal Article (Peer-Reviewed)","Lorenzo Norsa","Papa Giovani XXII","http://dx.doi.org/10.1053/j.gastro.2020.08.046","Verified","","","","","LFIA: Lateral flow immunoassay","IT","IT-25"
"2020-10-15","200827_LiguriaLombardia_UniversityofGenoa_Overall","Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors","2020-08-27","Regional","Italy","Italy; Lombardy, Liguria","2020-03-01","2020-04-30","Residual sera","Adults (18-64 years)",3609.0,0.11,"Convenience","Maglumi, Realy-Tech, Biosynex","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonio Vena","University of Genoa","https://dx.doi.org/10.3390/jcm9092780","Verified",0.1,0.121,"","","Chemiluminescence Immunoassay; Rapid immunochromatographic test; LFIA: Lateral flow immunoassay","IT",""
"2020-10-16","200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting","Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study","2020-08-03","Regional","Australia","Australia; New South Wales","2020-01-25","2020-04-10","Contacts of COVID patients","Multiple groups",173.0,0.023,"Convenience","Author-designed","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Kristine Macartney","University of Sydney","https://dx.doi.org/10.1016/S2352-4642(20)30251-0","Verified","","",0.913,0.989,"immunofluorescence assay (IFA)","AU","AU-NSW"
"2020-10-16","200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive","Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden.","2020-08-11","Local","Sweden","Sweden; Södermanland, Uppland; Stockholm","2020-06-17","2020-06-18","Household and community samples","Adults (18-64 years)",123.0,0.041,"Simplified probability","Zhejiang Orient Gene Biotech Co Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ake Lundkvist","Uppsala University","https://dx.doi.org/10.1080/20008686.2020.1806505","Verified",0.006,0.076,1.0,0.955,"Rapid point-of care","SE","SE-AB"
"2020-10-16","200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive","Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden.","2020-08-11","Local","Sweden","Sweden; Södermanland, Uppland; Stockholm","2020-06-17","2020-06-18","Household and community samples","Adults (18-64 years)",90.0,0.3,"Simplified probability","Zhejiang Orient Gene Biotech Co Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ake Lundkvist","Uppsala University","https://dx.doi.org/10.1080/20008686.2020.1806505","Verified",0.203,0.397,1.0,0.955,"Rapid point-of care","SE","SE-AB"
"2020-10-17","200818_SanFrancisco_UniversityofCaliforniaSanFrancisco","SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco","2020-08-21","Local","United States of America","United States of America; California; San Francisco","2020-04-25","2020-04-28","Household and community samples","Multiple groups",3861.0,0.034,"Self-referral","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Gabriel Chamie","University of California, San Francisco","http://dx.doi.org/10.1093/cid/ciaa1234","Verified",0.029,0.041,"","","chemiluminescent microparticle immunoassay","US","US-CA"
"2020-10-17","200826_Croatia_UniversityofZagreb_HCWsIgG","Severe acute respiratory syndrome coronavirus 2 seroprevalence among personnel in the healthcare facilities of Croatia, 2020.","2020-08-26","National","Croatia","Croatia","2020-04-25","2020-05-24","Health care workers and caregivers","Adults (18-64 years)",592.0,0.027,"Convenience","Vircell Spain S.L.U","IgG","High","Journal Article (Peer-Reviewed)","Tatjana Vilibic Cavlek","University of Zagreb","https://dx.doi.org/10.1590/0037-8682-0458-2020","Verified","","","","","ELISA","HR",""
"2020-10-18","200818_Oregon_EarleA.ChilesResearchInstitute_Overall","Longitudinal SARS-CoV-2 serosurveillance of over ten thousand health care workers in the Providence Oregon cohort","2020-08-18","Regional","United States of America","United States of America; Oregon; Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie","2020-04-08","2020-05-22","Health care workers and caregivers","Multiple groups",10019.0,0.025,"Convenience","Author-designed","IgG","High","Preprint","Rom Leidner","Chiles Research Institute","https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1","Verified","","",0.8,1.0,"ELISA","US","US-OR"
"2020-10-18","200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM","Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population","2020-08-19","Local","Austria","Austria","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",130.0,0.023,"Convenience","Epitope Diagnostics","IgG; IgM","High","Preprint","Klaus Hackner","Karl Landsteiner University of Health Sciences","https://www.researchsquare.com/article/rs-50887/v1","Verified","","","","","ELISA","AT",""
"2020-10-18","200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti","Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China","2020-08-19","Local","China","China; Guangdong; Guangzhou","2020-03-23","2020-04-02","Blood donors","Adults (18-64 years)",2199.0,0.003,"Simplified probability","Wantai Biological Pharmacy Enterprise, Lizhu Diagnostics","IgA; IgG","High","Journal Article (Peer-Reviewed)","Ru Xu","Institute of Blood Transfusion","http://dx.doi.org/10.1002/jmv.26445","Verified","","","","","ELISA","CN","CN-44"
"2020-10-19","200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31","PHE England week 32","2020-08-07","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-29","2020-07-28","Blood donors","Multiple groups",9388.0,0.059,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.053,0.065,0.83,0.993,"ELISA","GB","GB-ENG"
"2020-10-19","200824_Rotterdam_ErasmusMedicalCentre_1_March","Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands","2020-08-24","Local","Netherlands","Netherlands","2020-03-02","2020-03-06","Residual sera","Multiple groups",879.0,0.002,"Convenience","Author-designed","IgG","High","Preprint","Brenda Westerhuis","Erasmus Medical Centre","https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1","Verified","","","",1.0,"Not reported","NL",""
"2020-10-19","200824_Rotterdam_ErasmusMedicalCentre_2_April","Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands","2020-08-24","Local","Netherlands","Netherlands","2020-04-03","2020-04-07","Residual sera","Multiple groups",729.0,0.025,"Convenience","Author-designed","IgG","High","Preprint","Brenda Westerhuis","Erasmus Medical Centre","https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1","Verified","","","",1.0,"Not reported","NL",""
"2020-10-19","200824_Wuhan_WuhanUniversity_IgG_T2","Positive Rate of Serology and RT-PCR for COVID-19 among Healthcare Workers during Different Periods in Wuhan, China","2020-08-24","Local","China","China; Hubei; Wuhan","2020-05-13","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",1059.0,0.093,"Convenience","Livzon Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Lu He","Wuhan University","http://dx.doi.org/10.1016/j.jinf.2020.08.027","Verified","","","","","Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-10-19","200902_Lisbon_UniversityofLisbon_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers","2020-09-02","Local","Portugal","Portugal; Estremadura; Lisbon","2020-05-13","2020-07-10","Non-essential workers and unemployed persons","Adults (18-64 years)",2571.0,0.015,"Convenience","Krammer, et al. [Independent third party]","IgG; IgM; IgA","Moderate","Preprint","Patricia Figueiredo Campos","University of Lisbon","https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1","Verified","","",0.947,0.98,"ELISA","PT",""
"2020-10-20","200726_Peru_NationalCenterforEpidemiology_Overall","Minsa publishes technical data of the study that reveals that 25.3% of Lima and Callao acquired COVID-19","2020-07-27","Local","Peru","Peru; Lima, Callao; Lima, Callao","2020-06-28","2020-07-09","Household and community samples","Multiple groups",3118.0,0.216,"Stratified probability","Not reported","IgG; IgM","High","News and Media","Peruvian Government","National Center for Epidemiology, Prevention and Control of Diseases","https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/","Verified",0.187,0.246,0.4,"","Rapid immunochromatographic test","PE",""
"2020-10-20","200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall","Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan","2020-08-24","Local","Pakistan","Pakistan; Sindh; Karachi","2020-05-15","2020-07-15","Blood donors","Adults (18-64 years)",370.0,0.346,"Sequential","Roche Diagnostics","IgA; IgM; IgG","High","Journal Article (Peer-Reviewed)","Amber Younas","National Institute of Blood Diseases & Bone Marrow Transplantation","https://dx.doi.org/10.1016/j.transci.2020.102923","Verified","","","","","Electro chemiluminescence immunoassay","PK","PK-SD"
"2020-10-20","200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj","Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data","2020-08-31","Local","Spain","Spain; Community of Madrid; Torrejon de Ardoz","2020-06-01","2020-06-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",229.0,0.314,"Convenience","Hangzhou Testsea Biotechnology","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luis Cabezon-Gutierrez","Hospital General Universitario Gregorio Maranon","https://dx.doi.org/10.1016/j.ctrv.2020.102102","Verified","","",0.96,1.0,"Not reported","ES","ES-MD"
"2020-10-21","200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers","Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx","2020-08-26","Local","United States of America","United States of America; New York; New York City","2020-04-28","2020-05-04","Health care workers and caregivers","Multiple groups",1700.0,0.192,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Elana Sydney","Jacobi Medical Center","http://dx.doi.org/10.1017/ice.2020.437","Verified","","",1.0,0.996,"chemiluminescent microparticle immunoassay","US","US-NY"
"2020-10-21","200827_Paris_RothschildFoundationHospital_HealthcareProfessionals","Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study)","2020-08-27","Local","France","France; Paris; Paris","2020-06-08","2020-06-22","Health care workers and caregivers","Adults (18-64 years)",646.0,0.12,"Convenience","Roche","IgG","High","Journal Article (Peer-Reviewed)","Malcie Mesnil","Rothschild Foundation Hospital","http://dx.doi.org/10.1016/j.accpm.2020.08.003","Verified","","",0.995,0.998,"ELISA","FR","FR-IDF"
"2020-10-21","200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents","Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial PCR Testing, and Cohorting of Positive SARS-CoV-2 Patients in a Skilled Nursing Facility","2020-08-28","Local","United States of America","United States of America; California; Los Angeles","2020-06-05","2020-06-12","Assisted living and long-term care facilities","Multiple groups",150.0,0.173,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Amy V Dora","Veterans Affairs Healthcare System","http://dx.doi.org/10.1093/cid/ciaa1286","Verified","","",0.92,0.98,"Chemiluminescence Immunoassay","US","US-CA"
"2020-10-21","200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj","High seroprevalence of anti-SARS-CoV-2 antibodies in Chelsea, Massachusetts","2020-09-09","Local","United States of America","United States of America; Massachusetts; Chelsea","2020-04-14","2020-04-15","Household and community samples","Adults (18-64 years)",200.0,0.328,"Convenience","BioMedomics","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Vivek Naranbhai","Massachusetts General Hospital","http://dx.doi.org/10.1093/infdis/jiaa579","Verified",0.272,0.388,0.9,0.99,"ELISA","US","US-MA"
"2020-10-22","200911_Osaka_ToyonakaMunicipalHospital_Overall","Seroprevalence of SARS-CoV-2 Antibodies Among 925 Staff Members in an Urban Hospital Accepting COVID-19 Patients in Osaka Prefecture, Japan","2020-09-11","Local","Japan","Japan; Kansai; Osaka","2020-06-12","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",925.0,0.004,"Convenience","Abbott","IgG","Moderate","Preprint","Tsutomu Nishida","Toyonaka Municipal Hospital","https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1","Verified",0.002,0.011,1.0,0.996,"Chemiluminsescent microparticle immunoassay","JP",""
"2020-10-24","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-04-20","2020-04-26","Residual sera","Multiple groups",1200.0,0.053,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.038,0.071,0.994,"","Multiplex immunoassay","SE",""
"2020-10-24","200811_Belgium_universitairesSaint-Luc_Overall","SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis","2020-08-10","Local","Belgium","Belgium","2020-04-16","2020-05-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",149.0,0.027,"Convenience","""SNIBE – Shenzhen New Industries Biomedical Engineering Co., Ltd""","IgG; IgM","High","Journal Article (Peer-Reviewed)","Silvia Berardis","Cliniques universitaires Saint-Luc","https://www.sciencedirect.com/science/article/pii/S1569199320308213","Verified","","",0.956,0.96,"Chemiluminescence Immunoassay","BE",""
"2020-10-24","200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine","COVID-19 Infection Among Healthcare Workers: Serological Findings Supporting Routine Testing.","2020-08-21","Local","United States of America","United States of America; New York; New York City","2020-04-04","2020-04-20","Health care workers and caregivers","Adults (18-64 years)",98.0,0.153,"Convenience","Epitope Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Ariel D Stock","Albert Einstein College of Medicine","https://dx.doi.org/10.3389/fmed.2020.00471","Verified","","","","","ELISA","US","US-NY"
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-04-27","2020-05-03","Residual sera","Multiple groups",1200.0,0.04,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.027,0.057,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-04","2020-05-10","Residual sera","Multiple groups",1200.0,0.039,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.026,0.054,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-11","2020-05-17","Residual sera","Multiple groups",1200.0,0.045,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.031,0.062,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-18","2020-05-24","Residual sera","Multiple groups",1200.0,0.052,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.037,0.07,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-25","2020-05-31","Residual sera","Multiple groups",1200.0,0.057,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.04,0.077,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-06-01","2020-06-07","Residual sera","Multiple groups",1200.0,0.068,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.051,0.088,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-06-08","2020-06-14","Residual sera","Multiple groups",1200.0,0.052,"Stratified non-probability","Sci LifeLab / KTH","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified",0.037,0.071,0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200716_Stockholm_RegionStockholm","16 juli: Lägesrapport om arbetet med det nya coronaviruset","2020-07-16","Local","Sweden","Sweden; Uppland; Stockholm","2020-06-15","2020-07-15","Household and community samples","Multiple groups",149616.0,0.176,"Self-referral","Not reported","Not reported","High","Institutional Report","Stockholm Region","Sweden Public Health Authority","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/","Verified","","","","","Not reported","SE","SE-AB"
"2020-10-25","200806_Milan_UniversityofMilan_Overall","Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave","2020-08-06","Local","Italy","Italy; Lombardy; Milan","2020-04-15","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",663.0,0.051,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Antonella Amendola","University of Milan","http://dx.doi.org/10.1017/ice.2020.401","Verified","","","","","ELISA","IT","IT-25"
"2020-10-25","200930_Scotland_PublicHealthScotland_BloodDonors_Overall_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 30 Sept 2020","2020-09-30","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-06-29","2020-08-09","Blood donors","Multiple groups",3220.0,0.031,"Sequential","Not reported","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/","Verified",0.025,0.038,0.875,0.986,"Not reported","GB","GB-SCT"
"2020-10-28","200724_UK_ChelseaandWestminsterHospital_HCW","Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study","2020-07-24","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-04-08","2020-06-12","Health care workers and caregivers","Multiple groups",504.0,0.106,"Convenience","CTK Biotech , Zhuhai Encode Medical Engineering","IgG; IgM","High","Journal Article (Peer-Reviewed)","Scott Pallett","Chelsea and Westminster Hospital NHS Trust","https://dx.doi.org/10.1016/S2213-2600(20)30315-5","Verified",0.076,0.136,"","","LFIA: Lateral flow immunoassay","GB","GB-ENG"
"2020-10-29","200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal","Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey","2020-09-14","Local","China","China; Hubei; Wuhan","2020-03-16","2020-03-25","Health care workers and caregivers","Adults (18-64 years)",3674.0,0.017,"Convenience","Shenzhen Yahuilong Biotechnology Co.","IgG","Moderate","Journal Article (Peer-Reviewed)","Fuling Zhou","Zhongnan Hospital of Wuhan University","http://dx.doi.org/10.1016/j.eclinm.2020.100510","Verified","","","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-30","200915_Tehran_IranUniversityOfMedicalSciences_Patients_Overall","Role of Screening for COVID-19 in Hemodialysis Wards, Results of a Single Center Study.","2020-09-01","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Tehran; Tehran","2020-02-20","2020-03-20","Multiple populations","Multiple groups",178.0,0.18,"Convenience","Pishtaz Diagnostics Iran","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shahrzad Ossareh","Iran University of Medical Sciences","http://www.ijkd.org/index.php/ijkd/article/view/5832/1205","Verified","","","","","ELISA","IR","IR-07"
"2020-10-30","200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall","SARS-CoV-2 Antibodies in Pregnant Women Admitted to Labor and Delivery","2020-09-20","Regional","United States of America","United States of America; New York","2020-05-27","2020-07-24","Pregnant or parturient women","Adults (18-64 years)",1671.0,0.161,"Convenience","Roche","IgG","High","Journal Article (Peer-Reviewed)","Lylach Haizler Cohen","Donald and Barbara Zucker School of Medicine","https://dx.doi.org/10.1016/j.ajog.2020.09.022","Verified","","","","","","US","US-NY"
"2020-11-02","200911_NewYorkCity_WeillCornellMedicine_IgGorIgM","COVID-19 Viral and Serology Testing in New York City Health Care Workers","2020-09-11","Local","United States of America","United States of America; New York; New York City","2020-04-17","2020-05-07","Health care workers and caregivers","Adults (18-64 years)",2274.0,0.354,"Convenience","ET Healthcare","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Sabrina Racine Brzostek","Weill Cornell Medicine","http://dx.doi.org/10.1093/ajcp/aqaa142","Verified","","","",0.988,"Cyclic enhanced fluorescence assay (CEFA)","US","US-NY"
"2020-11-03","200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall","SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study","2020-09-11","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Birmingham","2020-04-24","2020-04-25","Health care workers and caregivers","Adults (18-64 years)",516.0,0.244,"Self-referral","University of Birmingham Clinical Immunology Service","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Adrian Shields","University Hospitals Birmingham NHS Foundation Trust","http://dx.doi.org/10.1136/thoraxjnl-2020-215414","Verified","","",1.0,0.978,"ELISA","GB","GB-ENG"
"2020-11-04","201023_BatonRouge_LouisianaStateUniversity_Total_popadj","Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA","2020-10-23","Local","United States of America","United States of America; Louisiana; Baton Rouge","2020-07-15","2020-07-31","Household and community samples","Multiple groups",2138.0,0.036,"Stratified probability","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Amy K Feehan","Louisiana State University","https://dx.doi.org/10.3201/eid2701.203808","Verified",0.028,0.044,"","","Chemiluminescence Immunoassay","US","US-LA"
"2020-11-05","200808_Vienna_MedicalUniversityOfVienna_HCP","SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.","2020-09-02","Local","Austria","Austria; Vienna; Vienna","2020-04-01","2020-06-04","Health care workers and caregivers","Adults (18-64 years)",62.0,0.032,"Convenience","Roche, Abbott","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Thorsten Fuereder","Medical University of Vienna","https://dx.doi.org/10.1136/esmoopen-2020-000889","Verified",0.004,0.112,"","","Electro chemiluminescence immunoassay; Chemiluminescence Immunoassay","AT","AT-9"
"2020-11-05","200808_Vienna_MedicalUniversityOfVienna_Patients","SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.","2020-09-02","Local","Austria","Austria; Vienna; Vienna","2020-03-21","2020-06-04","Patients seeking care for non-COVID-19 reasons","Multiple groups",84.0,0.024,"Convenience","Roche, Abbott","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Thorsten Fuereder","Medical University of Vienna","https://dx.doi.org/10.1136/esmoopen-2020-000889","Verified",0.003,0.083,"","","Electro chemiluminescence immunoassay; Chemiluminescence Immunoassay","AT","AT-9"
"2020-11-05","200914_PaschimMedinipur_MedicalCollegeKolkata_Overall","Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India(Conducted during last week of July and 1st week of August 2020) - A Joint Venture of VRDL Lab (ICMR), Midnapore Medical College &","2020-09-14","Regional","India","India; West Bengal","2020-07-26","2020-08-08","Household and community samples","Multiple groups",458.0,0.042,"Stratified probability","Calbiotech Inc.","IgG","Moderate","Preprint","Parthasarathi Satpati","Medical College Kolkata","https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1","Verified",0.025,0.064,0.983,0.981,"ELISA","IN","IN-WB"
"2020-11-06","200903_NewDelhi_MaxSuperSpecialtyHospital_Overall","SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting","2020-09-03","Local","India","India; NCT Delhi; New Delhi","2020-04-15","2020-08-15","Multiple populations","Multiple groups",780.0,0.195,"Convenience","Roche Diagnostics","Total Antibody","High","Preprint","Samreen Siddiqui","Max Super Specialty Hospital","https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1","Verified","","",0.945,0.994,"Electrochemiluminescence","IN","IN-DL"
"2020-11-06","200917_SanFrancisco_UniversityofCalifornia_BloodDonors","SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood","2020-09-17","Local","United States of America","United States of America; California; San Francisco","2020-03-01","2020-03-31","Blood donors","Multiple groups",1000.0,0.001,"Sequential","Abbott, Ortho-Clinical Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Dianna Ng","University of California, San Francisco","https://dx.doi.org/10.1038/s41467-020-18468-8","Verified",0.0,0.006,"","","Chemiluminescence Immunoassay; Neutralization assay","US","US-CA"
"2020-11-06","200917_SanFrancisco_UniversityofCalifornia_Patients","SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood","2020-09-17","Local","United States of America","United States of America; California; San Francisco","2020-03-17","2020-04-13","Residual sera","Multiple groups",387.0,0.003,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Dianna Ng","University of California, San Francisco","https://dx.doi.org/10.1038/s41467-020-18468-8","Verified",0.0,0.008,0.99,0.998,"Chemiluminescence Immunoassay","US","US-CA"
"2020-11-09","200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj","Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report","2020-09-21","Local","Greece","Greece","2020-06-15","2020-07-15","Non-essential workers and unemployed persons","Multiple groups",2500.0,0.009,"Convenience","Roche Diagnostics","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ourania Tsitsilonis","National and Kapodistrian University of Athens","https://dx.doi.org/10.3390/life10090214","Verified",0.003,0.021,1.0,0.998,"Electro chemiluminescence immunoassay","GR",""
"2020-11-10","200903_Paris_HopitalEuropeenGeorgesPompidou_Overall","Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris.","2020-09-03","Local","France","France;  Île-de-France; Paris","2020-05-02","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",3569.0,0.119,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Helene Pere","Hopital Europeen Georges Pompidou","https://dx.doi.org/10.1016/j.jcv.2020.104617","Verified","","","","","Chemiluminescence Immunoassay","FR","FR-IDF"
"2020-11-10","200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall","Seroprevalence of the SARS-CoV-2 infection in health workers of the Sanitary Region VIII, at province of Buenos Aires","2020-09-09","Local","Argentina","Argentina; Buenos Aires; Buenos Aires","2020-06-03","2020-07-06","Health care workers and caregivers","Multiple groups",738.0,0.008,"Stratified probability","CONICET","IgG; IgM","Moderate","Preprint","Andrea Silva","Instituto Nacional de Epidemiologia","https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1","Verified",0.0,0.081,"","","ELISA","AR","AR-B"
"2020-11-12","200916_Lajeado_UniversidadedoValedodoTaquari_Survey1","Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil","2020-09-16","Local","Brazil","Brazil; Rio Grande do Sul; Lajeado","2020-05-30","2020-06-04","Household and community samples","Multiple groups",1450.0,0.04,"Stratified probability","Guangzhou Wondfo Biotech","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Rafael Picon","Universidade do Vale do Taquari","http://dx.doi.org/10.1016/j.ijid.2020.09.028","Verified",0.031,0.052,0.762,0.996,"LFIA: Lateral flow immunoassay","BR","BR-RS"
"2020-11-12","200916_Lajeado_UniversidadedoValedodoTaquari_Survey2","Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil","2020-09-16","Local","Brazil","Brazil; Rio Grande do Sul; Lajeado","2020-06-13","2020-06-17","Household and community samples","Multiple groups",1127.0,0.026,"Stratified probability","Guangzhou Wondfo Biotech","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Rafael Picon","Universidade do Vale do Taquari","http://dx.doi.org/10.1016/j.ijid.2020.09.028","Verified",0.018,0.037,0.762,0.996,"LFIA: Lateral flow immunoassay","BR","BR-RS"
"2020-11-12","200918_Madrid_UniversityHospitalGregorioMarañón_Overall","SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study","2020-09-18","Local","Spain","Spain","2020-05-06","2020-05-21","Pregnant or parturient women","Adults (18-64 years)",100.0,0.13,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Maria Vinuela","University Hospital Gregorio Marañón","http://dx.doi.org/10.37201/req/088.2020","Verified","","","","","Chemiluminsescent microparticle immunoassay","ES",""
"2020-11-18","200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj","Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression","2020-09-22","Local","India","India; NCT Delhi; New Delhi","2020-06-26","2020-07-10","Household and community samples","Multiple groups",21387.0,0.235,"Unclear","ICMR-National Institute of Virology","IgG","Unclear","Preprint","Smarajit Dey","National Centre for Disease Control","https://www.researchsquare.com/article/rs-80259/v1","Verified",0.23,0.24,0.924,0.979,"ELISA","IN","IN-DL"
"2020-11-18","200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj","Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression","2020-09-22","Local","India","India; NCT Delhi; New Delhi","2020-08-01","2020-08-07","Household and community samples","Multiple groups",15311.0,0.291,"Unclear","ICMR-National Institute of Virology","IgG","Unclear","Preprint","Smarajit Dey","National Centre for Disease Control","https://www.researchsquare.com/article/rs-80259/v1","Verified",0.285,0.3,0.924,0.979,"ELISA","IN","IN-DL"
"2020-11-19","200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall","Highlighted prospects of an IgM/IgG antibodies test in identifying individuals with asymptomatic SARS CoV-2 infection","2020-09-23","Local","China","China; Hubei; Wuhan","2020-02-10","2020-03-22","Contacts of COVID patients","Multiple groups",300.0,0.477,"Convenience","Innovita Biological Technology Co. Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yaqing Li","National Center for Medical Service Administration","https://dx.doi.org/10.5858/arpa.2020-0310-SA","Verified","","",0.971,0.953,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-11-22","200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj","SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia","2020-09-18","Local","Georgia","Georgia; Tbilisi; Tbilisi","2020-05-18","2020-05-27","Household and community samples","Multiple groups",1086.0,0.01,"Convenience","Zhejiang Orient Gene Biotech Co Ltd","IgG","Moderate","Preprint","Tengiz Tsertsvadze","Infectious Diseases, AIDS and Clinical Immunology Research Center","https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1","Verified",0.004,0.022,0.931,0.992,"LFIA: Lateral flow immunoassay","GE","GE-TB"
"2020-11-22","200923_Beijing_PekingUniversity_Overall","A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China","2020-09-23","Local","China","China; Hebei; Beijing","2020-04-15","2020-04-18","Household and community samples","Multiple groups",2184.0,0.002,"Stratified probability","Wondfo Biotech Co., Innovita Biological Technology Co Ltd","IgG; IgM","Moderate","Preprint","Xiaoli Wang","Peking University","https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1","Verified","","","","","Colloidal gold","CN","CN-13"
"2020-11-22","200925_UnitedStates_StanfordUniversity_OverallPopAdj","Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study","2020-09-25","National","United States of America","United States of America","2020-07-01","2020-07-31","Residual sera","Multiple groups",28503.0,0.093,"Stratified probability","Siemens Healthineers","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Shuchi Anand","Stanford University","https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext","Verified",0.088,0.099,1.0,0.998,"Chemiluminescence","US",""
"2020-11-23","200918_Arizona_VincereCancerCenter_Total","COVID-19 Exposure among First Responders in Arizona","2020-09-18","Regional","United States of America","United States of America; Arizona; Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler","2020-04-24","2020-05-21","Essential non-healthcare workers","Multiple groups",3326.0,0.015,"Convenience","Ray Biotech","IgG","Moderate","Journal Article (Peer-Reviewed)","Vershalee Shukla","Vincere Cancer Center","https://dx.doi.org/10.1097/JOM.0000000000002027","Verified","","",0.904,0.983,"LFIA: Lateral flow immunoassay","US","US-AZ"
"2020-11-23","200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem","Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection Among VA Healthcare System Employees Suggests Higher Risk of Infection When Exposed to SARS-CoV-2 Outside of the Work Environment","2020-09-23","Local","United States of America","United States of America; Michigan","2020-06-08","2020-07-08","Health care workers and caregivers","Multiple groups",1476.0,0.049,"Self-referral","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Derek Dimcheff","Veterans Affairs Ann Arbor Healthcare System","https://dx.doi.org/10.1017/ice.2020.1220","Verified",0.038,0.061,1.0,0.99,"Chemiluminsescent microparticle immunoassay","US","US-MI"
"2020-11-23","200930_Sergipe_FederalUniversityofSergipe_OverallIgG","Anti-SARS-CoV-2 IgM and IgG antibodies in health workers in Sergipe, Brazil","2020-09-30","Regional","Brazil","Brazil; Sergipe","2020-06-01","2020-06-30","Health care workers and caregivers","Multiple groups",471.0,0.136,"Convenience","Boditech Med Inc.","IgG","High","Preprint","Monica de Melo","Federal University of Sergipe","https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf","Verified","","",0.958,0.97,"immunofluorescence assay (IFA)","BR","BR-SE"
"2020-11-24","200917_Nashville_VanderbiltUniversityMedicalCenter_60DaysOverall","Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee","2020-09-17","Local","United States of America","United States of America; Tennessee; Nashville","2020-06-02","2020-06-27","Health care workers and caregivers","Multiple groups",230.0,0.035,"Convenience","CDC","Total Antibody","High","Journal Article (Peer-Reviewed)","Manish Patel","Vanderbilt University Medical Center","http://dx.doi.org/10.1001/jama.2020.18796","Verified","","",0.96,0.99,"ELISA","US","US-TN"
"2020-11-24","201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff","SARS-CoV-2 IgG Seroprevalence among Medical Staff in a General Hospital that Treated COVID-19 Patients in Japan: Retrospective Evaluation of Nosocomial Infection Control","2020-10-08","Local","Japan","Japan; Kanagawa; Fujisawa","2020-06-01","2020-07-30","Health care workers and caregivers","Adults (18-64 years)",806.0,0.007,"Convenience","Abbott","IgG","Unclear","Journal Article (Peer-Reviewed)","M Hibino","Shonan Fujisawa Tokushukai Hospital","https://dx.doi.org/10.1016/j.jhin.2020.10.001","Verified",0.003,0.016,1.0,"","Chemiluminescence Immunoassay","JP","JP-14"
"2020-11-24","201106_BC_BCChildrensHospital_Overall_Adj","Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 months","2020-11-06","Local","Canada","Canada; British Columbia; Vancouver","2020-05-17","2020-06-19","Multiple populations","Adults (18-64 years)",276.0,0.006,"Convenience","Ortho-Clinical Diagnostics, Meso Scale Diagnostics","IgA; IgG; IgM; Total Antibody","High","Preprint","Abdelilah Majdoubi","BC Children’s Hospital","https://www.medrxiv.org/content/10.1101/2020.10.05.20206664v7","Verified",0.0,0.027,"","","Chemiluminescence Immunoassay","CA","CA-BC"
"2020-11-25","200921_Wuhan_TongjiMedicalCollege_Overall","Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.","2020-09-21","Local","China","China; Hubei; Wuhan","2020-02-17","2020-04-28","Multiple populations","Multiple groups",11766.0,0.005,"Sequential","YHLO","IgM; IgG","High","Journal Article (Peer-Reviewed)","Qing Lei","Tongji Medical College","https://dx.doi.org/10.1111/all.14622","Verified","","",0.667,0.995,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-11-26","200917_India_MinistryofHealth&FamilyWelfare_OverallPopTestAdj","Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020","2020-09-17","National","India","India","2020-05-11","2020-06-04","Household and community samples","Multiple groups",28000.0,0.007,"Stratified probability","Cadila Healthcare Limited, EUROIMMUN","IgG","Low","Journal Article (Peer-Reviewed)","Manoj Murhekar","Indian Council of Medical Research","http://dx.doi.org/10.4103/ijmr.IJMR_3290_20","Verified",0.003,0.011,"","","ELISA","IN",""
"2020-11-28","200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW","Testing the backbone of the healthcare system: a prospective serological-epidemiological cohort study of healthcare workers in rural Germany","2020-09-29","Local","Germany","Germany; Brandenburg; Oberspreewald-Lausitz","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",156.0,0.013,"Convenience","Author-designed","Total Antibody","High","Preprint","Stephanie Hoffmann","Brandenburg University of Technology Cottbus-Senftenberg","https://doi.org/10.21203/rs.3.rs-84703/v1","Verified","","",0.995,0.998,"chemiluminescent microparticle immunoassay","DE","DE-BB"
"2020-11-30","201119_Shanghai_FudanUniversity_Overall","Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases","2020-11-19","Local","China","China; Shanghai Municipality; Shanghai","2020-05-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",6414.0,0.003,"Convenience","Bioscience","IgG; IgM","High","Preprint","Shengjie Li","Fudan University","https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v2","Verified","","","","","","CN","CN-31"
"2020-12-02","200806_Regensburg_UniversityofRegensburg_12Wks","Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study","2020-08-06","Local","Germany","Germany; Bavaria; Regensburg","2020-03-15","2020-06-07","Health care workers and caregivers","Adults (18-64 years)",139.0,0.0,"Convenience","EUROIMMUN AG, Roche Diagnostics","IgG; IgA","High","Journal Article (Peer-Reviewed)","Sara Malfertheiner","University of Regensburg","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf","Verified","","","","","","DE","DE-BY"
"2020-12-04","200921_Detroit_Region2SouthHealthcareCoalition_Overall","SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.","2020-09-21","Local","United States of America","United States of America; Michigan; Detroit","2020-05-18","2020-06-13","Health care workers and caregivers","Adults (18-64 years)",16397.0,0.069,"Convenience","Ortho Clinical Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Lara Akinbami","Region 2 South Healthcare Coalition","https://dx.doi.org/10.3201/eid2612.203764","Verified",0.065,0.073,0.9,1.0,"","US","US-MI"
"2020-12-06","200922_AddisAbaba_KuwaitUniversity_GenPop","SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia","2020-09-22","Local","Ethiopia","Ethiopia; Oromia; Addis Ababa","2020-05-18","2020-05-21","Residual sera","Multiple groups",99.0,0.03,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","John Kempen","Kuwait University","https://dx.doi.org/10.4269/ajtmh.20-0816","Verified",0.006,0.086,1.0,0.999,"","ET","ET-OR"
"2020-12-07","200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall","SARS-CoV-2 seroprevalence among a southern U.S. population indicates limited asymptomatic spread under physical distancing measures","2020-09-29","Regional","United States of America","United States of America; North Carolina","2020-03-03","2020-06-04","Residual sera","Adults (18-64 years)",1449.0,0.007,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Amir Barzin","University of North Carolina Chapel Hill","http://dx.doi.org/10.1128/mBio.02426-20","Verified","","",1.0,0.989,"","US","US-NC"
"2020-12-07","200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj","SARS-CoV-2 seroprevalence among a southern U.S. population indicates limited asymptomatic spread under physical distancing measures","2020-09-29","Regional","United States of America","United States of America; North Carolina","2020-04-28","2020-06-19","Residual sera","Adults (18-64 years)",2973.0,0.0,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Amir Barzin","University of North Carolina Chapel Hill","http://dx.doi.org/10.1128/mBio.02426-20","Verified",0.0,0.009,1.0,0.989,"","US","US-NC"
"2020-12-07","210205_Ontario_PublicHealthOntario_August_Abbott","SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline","2021-02-02","Regional","Canada","Canada; Ontario","2020-08-01","2020-08-21","Residual sera","Multiple groups",5764.0,0.016,"Stratified non-probability","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Shelly Bolotin","Public Health Ontario","https://dx.doi.org/10.1093/infdis/jiaa796","Verified","","",0.842,1.0,"","CA","CA-ON"
"2020-12-07","210205_Ontario_PublicHealthOntario_July_Abbott","SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline","2021-02-02","Regional","Canada","Canada; Ontario","2020-07-04","2020-07-31","Residual sera","Multiple groups",7001.0,0.014,"Stratified non-probability","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Shelly Bolotin","Public Health Ontario","https://dx.doi.org/10.1093/infdis/jiaa796","Verified","","",0.842,1.0,"","CA","CA-ON"
"2020-12-08","200922_Wuhan_WuhanUniversity_IgM/IgG","Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign","2020-10-06","Local","China","China; Hubei; Wuhan","2020-05-15","2020-05-26","Household and community samples","Multiple groups",61437.0,0.024,"Stratified probability","Nanjing Vazyme Medical technology Co., Ltd","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Yunbao Pan","Wuhan University","https://dx.doi.org/10.1016/j.cmi.2020.09.044","Verified",0.023,0.025,0.915,0.97,"","CN","CN-42"
"2020-12-10","201006_Turin_UniversityofTorino_TotalHCWs","Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy","2020-10-06","Local","Italy","Italy; Piemonte; Torino (Turin)","2020-04-17","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",5444.0,0.069,"Convenience","DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Andrea Calcagno","University of Torino","https://dx.doi.org/10.3201/eid2701.203027","Verified","","",0.979,0.985,"","IT","IT-21"
"2020-12-10","201008_Stockholm_DanderydHospital","SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden","2020-10-08","Local","Sweden","Sweden; Sodermanland; Stockholm","2020-04-14","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",2149.0,0.191,"Convenience","Author designed","IgG","Moderate","Journal Article (Peer-Reviewed)","Ann Sofie Rudberg","Danderyd Hospital","http://dx.doi.org/10.1038/s41467-020-18848-0","Verified","","",0.992,0.998,"","SE","SE-D"
"2020-12-11","201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj","Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia","2020-10-13","Local","Ethiopia","Ethiopia","2020-04-23","2020-04-28","Household and community samples","Adults (18-64 years)",301.0,0.088,"Simplified probability","Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China","IgG; IgM","Moderate","Preprint","Berhanu Alemu","Ministry of Health, Ethiopia","https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1","Verified",0.055,0.116,0.879,1.0,"","ET",""
"2020-12-15","200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW","Successful management plan of COVID-19 in a pediatric hemato-oncology department: A single-centre experience","2020-09-15","Local","Italy","Italy; Campania; Naples","2020-04-03","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",249.0,0.02,"Convenience","VivaDiag, N/A, N/A","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pio Stellato","Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon","http://dx.doi.org/10.1136/bmjpo-2020-000818","Verified","","","","","","IT","IT-72"
"2020-12-15","200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers","Successful management plan of COVID-19 in a pediatric hemato-oncology department: A single-centre experience","2020-09-15","Local","Italy","Italy; Campania; Naples","2020-04-03","2020-05-29","Multiple populations","Multiple groups",1397.0,0.004,"Convenience","VivaDiag, N/A, N/A","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pio Stellato","Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon","http://dx.doi.org/10.1136/bmjpo-2020-000818","Verified","","","","","","IT","IT-72"
"2020-12-16","200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts","Household Transmission of SARS-CoV-2 in the United States","2020-08-16","Local","United States of America","United States of America; Utah, Wisconsin; Salt Lake City, Milwaukee","2020-03-22","2020-04-25","Contacts of COVID patients","Multiple groups",178.0,0.258,"Convenience","CDC","Not reported","High","Journal Article (Peer-Reviewed)","Nathaniel M Lewis","Centers for Disease Control","https://dx.doi.org/10.1093/cid/ciaa1166","Verified","","","","","","US",""
"2020-12-16","201116_Tennessee_VanderbiltUniversity_HCW_Overall","Prevalence of IgG antibodies against the severe acute respiratory syndrome coronavirus-2 among healthcare workers in Tennessee during May and June, 2020","2020-11-16","Regional","United States of America","United States of America; Tennessee","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",11787.0,0.01,"Convenience","Abbott","IgG","High","Preprint","Peter Rebeiro","Vanderbilt University","https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1","Verified","","","","","","US","US-TN"
"2020-12-17","201030_Indianapolis_IndianaUniversity_Overall","Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients","2020-10-30","Local","United States of America","United States of America; Indiana; Indianapolis","2020-05-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",31.0,0.032,"Convenience","Abnova, Eli Lilly and Co & IUSM, Mount Sinai medical center","IgM; IgG","High","Journal Article (Peer-Reviewed)","Corina Nailescu","Indiana University","https://dx.doi.org/10.3389/fped.2020.601327","Verified","","",0.944,0.985,"","US","US-IN"
"2020-12-17","201105_Michigan_OaklandUniversity_testadj","COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.","2020-11-05","Local","United States of America","United States of America; Michigan; Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton","2020-04-13","2020-05-28","Health care workers and caregivers","Multiple groups",20614.0,0.081,"Convenience","EUROIMMUN Lübeck","IgG","Moderate","Journal Article (Peer-Reviewed)","Matthew D Sims","Oakland University","https://dx.doi.org/10.1093/cid/ciaa1684","Verified",0.068,0.089,0.981,0.993,"","US","US-MI"
"2020-12-18","201013_PimaCounty_UniversityofArizona_Overall","Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity","2020-10-13","Local","United States of America","United States of America; Arizona","2020-04-30","2020-05-07","Household and community samples","Multiple groups",5882.0,0.012,"Self-referral","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Tyler Ripperger","University of Arizona","http://dx.doi.org/10.1016/j.immuni.2020.10.004","Verified","","",0.976,1.0,"","US","US-AZ"
"2020-12-18","201017_Vancouver_UniversityofBritishColumbia_LTCF_overall","Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policies","2020-10-17","Local","Canada","Canada; British Columbia; Vancouver","2020-05-04","2020-05-14","Assisted living and long-term care facilities","Multiple groups",291.0,0.39,"Convenience","DiaSorin, Ortho Vitros , Abbott, Siemens","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Rohit Vijh","University of British Columbia","https://dx.doi.org/10.1016/j.ajic.2020.10.009","Verified","","","","","","CA","CA-BC"
"2020-12-18","201021_NewYork_Serimmune_Overall","Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York","2020-10-21","Local","United States of America","United States of America; New York; New York City","2020-03-01","2020-07-07","Blood donors","Multiple groups",1559.0,0.044,"Sequential","Serimmune","IgG","High","Preprint","Kathy Kamath","Serimmune","https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1","Verified","","",0.91,0.993,"","US","US-NY"
"2020-12-18","201027_Montreal_ShrinersHospital_accompanying_unadj","Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital","2020-10-27","Local","","Canada; Québec; Montreal","2020-06-10","2020-07-27","Hospital visitors","Adults (18-64 years)",61.0,0.115,"Convenience","Omega Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Ghalib Bardai","Shriners Hospital for Children","https://doi.org/10.1111/pan.14047","Verified","","","",0.97,"","CA","CA-QC"
"2020-12-18","201027_Montreal_ShrinersHospital_children_unadj","Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital","2020-10-27","Local","Canada","Canada; Québec; Montreal","2020-06-10","2020-07-27","Residual sera","Children and Youth (0-17 years)",39.0,0.08,"Convenience","Omega Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Ghalib Bardai","Shriners Hospital for Children","https://doi.org/10.1111/pan.14047","Verified","","","",0.97,"","CA","CA-QC"
"2020-12-18","201027_Montreal_ShrinersHospital_employees_unadj","Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital","2020-10-27","Local","","Canada; Québec; Montreal","2020-06-10","2020-07-27","Health care workers and caregivers","Adults (18-64 years)",99.0,0.12,"Convenience","Omega Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Ghalib Bardai","Shriners Hospital for Children","https://doi.org/10.1111/pan.14047","Verified","","","",0.97,"","CA","CA-QC"
"2020-12-18","201107_Lubbock_TexasTechUniversity_Overall","Prevalence of Coronavirus Antibody Among First Responders in Lubbock, Texas","2020-11-07","Local","United States of America","United States of America; Texas; Lubbock","2020-05-12","2020-05-13","Essential non-healthcare workers","Multiple groups",683.0,0.007,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Kenneth Iwuji","Texas Tech University","https://dx.doi.org/10.1177/2150132720971390","Verified","","",1.0,0.999,"","US","US-TX"
"2020-12-18","201201_NewHeaven_Yale_SchoolofMedicine_newborns","NEWBORN DRIED BLOOD SPOTS FOR SEROLOGIC SURVEYS OF COVID-19.","2020-12-12","Local","United States of America","United States of America; Connecticut; New Haven","2020-02-19","2020-05-26","Residual sera","Children and Youth (0-17 years)",3048.0,0.059,"Sequential","In-house","IgG","High","Journal Article (Peer-Reviewed)","Feimei  Liu","Yale School of Medicine","https://dx.doi.org/10.1097/INF.0000000000002918","Verified","","","","","","US","US-CT"
"2020-12-19","201003_Denmark_AarhusUniversity_HCW_testadj","Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region","2020-10-03","Regional","Denmark","Denmark; Central Denmark Region","2020-05-18","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",17948.0,0.034,"Convenience","Wantai Biological Pharmacy Enterprise Co, Ltd, Beijing,; China","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Senne Jespersen","Aarhus University Hospital","https://dx.doi.org/10.1093/cid/ciaa1471","Verified",0.024,0.038,0.967,0.995,"","DK","DK-82"
"2020-12-19","201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall","SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic","2020-10-15","Local","United States of America","United States of America; New York; New York City","2020-03-01","2020-05-01","Health care workers and caregivers","Adults (18-64 years)",500.0,0.27,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Usha Venugopal","NYC Health + Hospitals/Lincoln","http://dx.doi.org/10.1016/j.ijid.2020.10.036","Verified","","",1.0,0.996,"","US","US-NY"
"2020-12-20","201006_Brazil_FederalUniversityofSergipe_genpop_IgG","Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil","2020-10-06","Regional","Brazil","Brazil; Sergipe; Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória","2020-05-02","2020-05-09","Household and community samples","Multiple groups",2635.0,0.083,"Convenience","Boditech Med Inc.","IgG","High","Journal Article (Peer-Reviewed)","Lysandro Pinto Borges","Federal University of Sergipe","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/","Verified",0.072,0.094,"","","","BR","BR-SE"
"2020-12-21","201030_Cleveland_CaseWesternReserveUniversity_Overall","SARS-CoV-2 Infection Among Serially Tested Emergency Medical Services Workers","2020-10-30","Local","United States of America","United States of America; Ohio; Cleveland","2020-04-20","2020-05-19","Essential non-healthcare workers","Adults (18-64 years)",296.0,0.054,"Convenience","Epitope Diagnostics, Inc","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yasir Tarabichi","Case Western Reserve University","https://dx.doi.org/10.1080/10903127.2020.1831668","Verified",0.031,0.086,"","","","US","US-OH"
"2020-12-28","201026_UpstateNewYork_BassettMedicalCenter_Overall","SARS-CoV-2 IgG Results Among Healthcare Workers in a Rural Upstate New York Hospital System","2020-10-26","Local","United States of America","United States of America; New York; Upstate New York","2020-05-04","2020-05-29","Health care workers and caregivers","Multiple groups",764.0,0.02,"Unclear","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Wendy M Brunner","Bassett Medical Center","https://dx.doi.org/10.1017/ice.2020.1296","Verified","","",1.0,0.996,"","US","US-NY"
"2021-01-03","200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall","Seroprevalence and presentation of SARS-CoV-2 in pregnancy","2020-08-06","Local","Spain","Spain","2020-04-14","2020-05-05","Pregnant or parturient women","Adults (18-64 years)",874.0,0.14,"Convenience","Vircell Microbiologist, Ortho Clinical Diagnostics","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Francesca Crovetto","Universitat de Barcelona","https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext","Verified","","","","","","ES",""
"2021-01-04","200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM","Universal screening of SARS-CoV-2 of oncology healthcare workers - a Brazilian experience","2020-09-01","Local","Brazil","Brazil; Rio de Janeiro; Petrópolis","2020-04-09","2020-04-29","Health care workers and caregivers","Adults (18-64 years)",61.0,0.049,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","P Ismael Amaral Silva","Centro de Terapia Oncológica","http://dx.doi.org/10.1016/j.annonc.2020.08.1825","Verified","","","","","","BR","BR-RJ"
"2021-01-05","200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall","The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)","2020-08-13","Regional","Germany","Germany; North Rhine-Westphalia","2020-03-26","2020-06-04","Residual sera","Multiple groups",415.0,0.012,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Burkhard Herrmann","Internal medicine and laboratory medicine specialist practice and laboratory","http://dx.doi.org/10.1007/s15006-020-0750-y","Verified","","",0.944,0.996,"","DE","DE-NW"
"2021-01-05","200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall","Seroprevalence of SARS-CoV-2 Among Pediatric Healthcare Workers in Spain","2020-09-11","Local","Spain","Spain; Galicia; Santiago de Compostela","2020-04-14","2020-04-16","Health care workers and caregivers","Adults (18-64 years)",175.0,0.04,"Convenience","Genobio Pharmaceutical (Shanghai; China)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ana Dacosta Urbieta","Hospital Clinico Universitario de Santiago de Compostela","http://dx.doi.org/10.3389/fped.2020.00547","Verified",0.011,0.069,"","","","ES","ES-GA"
"2021-01-05","201027_Indiana_Harvard_Overall_testadj","Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States","2020-11-27","Local","United States of America","United States of America; Indiana; St. John Township","2020-07-15","2020-07-20","Essential non-healthcare workers","Multiple groups",753.0,0.017,"Self-referral","Abbott Alinity","IgG","Moderate","Preprint","Lilah Lopez","Harvard Medical School","https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1","Verified",0.003,0.033,1.0,0.99,"","US","US-IN"
"2021-01-05","201119_LosAngeles_CedarsSinaiMedicalCenter_Overall","BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers","2020-11-19","Local","United States of America","United States of America; California; Los Angeles","2020-05-11","2020-06-28","Health care workers and caregivers","Adults (18-64 years)",6201.0,0.035,"Self-referral","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Magali Rivas","Cedars-Sinai Medical Center","https://dx.doi.org/10.1172/JCI145157","Verified","","",0.969,0.999,"","US","US-CA"
"2021-01-05","201120_Rochester_MayoClinic_HighRiskCohort_1_Overall","Unrecognized SARS-CoV-2 Seroprevalence among healthcare personnel in a low prevalence area","2020-11-20","Local","United States of America","United States of America; Minnesota; Rochester","2020-05-25","2020-07-09","Health care workers and caregivers","Adults (18-64 years)",320.0,0.006,"Unclear","EUROIMMUN, Ortho-Clinical Diagnostics, Roche Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Vishal Shah","Mayo Clinic","https://dx.doi.org/10.1017/ice.2020.1341","Verified","","","","","","US","US-MN"
"2021-01-05","201120_Rochester_MayoClinic_LowRiskCohort_2_Overall","Unrecognized SARS-CoV-2 Seroprevalence among healthcare personnel in a low prevalence area","2020-11-20","Local","United States of America","United States of America; Minnesota; Rochester","2020-05-25","2020-07-09","Health care workers and caregivers","Adults (18-64 years)",248.0,0.0,"Unclear","EUROIMMUN, Ortho-Clinical Diagnostics, Roche Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Vishal Shah","Mayo Clinic","https://dx.doi.org/10.1017/ice.2020.1341","Verified","","","","","","US","US-MN"
"2021-01-06","200810_USA_Illinois_PhysicianPractice_Overall","Observational study of SARS-CoV-2 antibody immune response in a cohort of patients at a North Suburban Chicago, Illinois, in a physician's practice","2020-08-06","Local","United States of America","United States of America; Illinois; Chicago","2020-04-22","2020-05-26","Residual sera","Multiple groups",113.0,0.159,"Convenience","CLUNGENE","IgG; IgM","High","Journal Article (Peer-Reviewed)","Gerald Osher","BioSolutions Services LLC","https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007","Verified","","","","","","US","US-IL"
"2021-01-07","200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos","Surveillance and control actions before notification of confirmed cases to COVID-19. Aguada de Pasajeros, Cienfuegos. Cuba","2020-08-23","Local","Cuba","Cuba; Cienfuegos; Aguada de Pasajeros","2020-03-23","2020-04-06","Contacts of COVID patients","Multiple groups",200.0,0.0,"Convenience","NR","IgM; IgG","Unclear","Journal Article (Peer-Reviewed)","Alain Morejon Giraldoni","University of Medical Sciences of Cienfuegos","http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721","Verified","","","","","","CU","CU-06"
"2021-01-07","201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall","Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center","2020-10-13","Local","United States of America","United States of America; Pennsylvania; Pittsburgh","2020-03-15","2020-07-04","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",485.0,0.01,"Convenience","Euroimmun, Beckman Coulter, Siemens","IgG","High","Journal Article (Peer-Reviewed)","Megan Freeman","University of Pittsburgh School of Medicine","http://dx.doi.org/10.1093/jpids/piaa123","Verified",0.003,0.024,"","","","US","US-PA"
"2021-01-07","201027_Illinois_CDC_Contacts","Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020","2020-10-27","Regional","United States of America","United States of America; Illinois","2020-03-03","2020-03-06","Contacts of COVID patients","Adults (18-64 years)",59.0,0.0,"Convenience","CDC","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Tristan McPherson","US Centers for Disease Control and Prevention","https://dx.doi.org/10.1177/0033354920966064","Verified","","",0.96,0.99,"","US","US-IL"
"2021-01-07","201103_Germany_UniversityofWitten","[Corona in Children: the Co-Ki Study]","2020-11-03","National","Germany","Germany","2020-06-15","2020-09-01","Residual sera","Children and Youth (0-17 years)",731.0,0.112,"Convenience","Euroimmun IgG, Diasorin IgG, Microgen IgG, Roche IgM, Cleartest IgM, Nadal IgM, Euroimmun IgA","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Silke Schwarz","University of Witten","https://dx.doi.org/10.1007/s00112-020-01050-3","Verified","","","","","","DE",""
"2021-01-07","201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall","A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population","2020-12-01","Local","United States of America","United States of America; California; Los Angeles","2020-04-29","2020-05-08","Students and Daycares","Adults (18-64 years)",790.0,0.04,"Convenience","EUROIMMUN","IgG","Moderate","Journal Article (Peer-Reviewed)","Kimberly Tilley","University of Southern California","http://dx.doi.org/10.1016/j.jadohealth.2020.09.001","Verified",0.03,0.051,0.9,1.0,"","US","US-CA"
"2021-01-08","200610_Munich_TechnicalUniversityofMunich_hcw","Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany","2020-10-06","Local","Germany","Germany; Bavaria; Munich","2020-04-14","2020-05-29","Health care workers and caregivers","Multiple groups",4554.0,0.024,"Convenience","Unclear","IgG","High","Preprint","Johanna Erber","Technical University of Munich","https://www.medrxiv.org/content/10.1101/2020.10.04.20206136v1","Verified",0.019,0.029,"","","","DE","DE-BY"
"2021-01-08","200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall","Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain","2020-09-11","Local","Spain","Spain; Catalonia; Barcelona","2020-04-21","2020-04-24","Household and community samples","Multiple groups",311.0,0.055,"Stratified probability","Livzlon, Lysine and Sure Screen","IgG; IgM","High","Journal Article (Peer-Reviewed)","Patricia Montenegro","Sardenya Primary Health Care Center","http://dx.doi.org/10.1093/fampra/cmaa096","Verified",0.034,0.086,"","","","ES","ES-CT"
"2021-01-08","201021_Spain_IVIRMA_Overall","RISK FACTOR ANALYSIS FOR SARS-COV-2 SEROPOSITIVITY WITHIN ASSISTED REPRODUCTIVE","2020-09-01","National","Spain","Spain","2020-04-27","2020-06-26","Residual sera","Adults (18-64 years)",6140.0,0.007,"Convenience","Epitope Diagnostics","IgM","Unclear","Journal Article (Peer-Reviewed)","Nicolas Prados","IVIRMA Global Headquarters","http://dx.doi.org/10.1016/j.fertnstert.2020.09.077","Verified","","","","","","ES",""
"2021-01-08","201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall","SARS-CoV-2 infection among hospital workers of one of the most severely affected institutions in Madrid, Spain: a surveillance cross-sectional study","2020-10-29","Local","Spain","Spain","2020-05-01","2020-05-30","Health care workers and caregivers","Adults (18-64 years)",2424.0,0.224,"Convenience","AllTest Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Felipe Perez Garcia","Hospital Universitario Príncipe de Asturias","https://dx.doi.org/10.1017/ice.2020.1303","Verified","","",0.88,1.0,"","ES",""
"2021-01-08","201103_NewYorkCity_MountSinai_UrgentCare_2_Overall","Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City","2020-11-03","Local","United States of America","United States of America; New York; New York City","2020-02-02","2020-07-05","Residual sera","Multiple groups",4101.0,0.26,"Sequential","Mount Sinai Hospital New York","IgG","High","Journal Article (Peer-Reviewed)","Daniel Stadlbauer","Icahn School of Medicine at Mount Sinai","http://dx.doi.org/10.1038/s41586-020-2912-6","Verified","","",0.95,1.0,"","US","US-NY"
"2021-01-09","200624_BaskingRidge_FellowshipVillage_Staff1_Overall","Fellowship;   Village Benefits from Covid-19 Antibody Tests","2020-06-24","Local","United States of America","United States of America; New Jersey; Basking Ridge","2020-04-15","2020-05-06","Assisted living and long-term care facilities","Adults (18-64 years)",305.0,0.236,"Convenience","NR","IgG; IgM","Unclear","News and Media","Tim Regan","Fellowship Village","https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g","Verified","","","","","","US","US-NJ"
"2021-01-09","201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns","2020-10-27","Local","Denmark","Denmark; Capital Region of Denmark; Copenhagen","2020-04-04","2020-07-03","Hospital visitors","Adults (18-64 years)",1188.0,0.035,"Sequential","Shenzhen Yhlo Biotech","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Pia Egerup","Copenhagen University Hospital Hvidovre","https://dx.doi.org/10.1097/AOG.0000000000004199","Verified",0.023,0.051,0.94,0.993,"","DK","DK-84"
"2021-01-09","201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns","2020-10-27","Local","Denmark","Denmark; Capital Region of Denmark; Copenhagen","2020-04-04","2020-07-03","Pregnant or parturient women","Adults (18-64 years)",1313.0,0.026,"Sequential","Shenzhen Yhlo Biotech","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Pia Egerup","Copenhagen University Hospital Hvidovre","https://dx.doi.org/10.1097/AOG.0000000000004199","Verified",0.017,0.04,0.94,0.993,"","DK","DK-84"
"2021-01-09","201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM","Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery.","2020-11-03","Local","Italy","Italy; Sardinia; Cagliari","2020-03-31","2020-06-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",86.0,0.058,"Convenience","Snibe","IgG; IgM","High","Journal Article (Peer-Reviewed)","Fabio Medas","University of Cagliari","https://dx.doi.org/10.1016/j.amsu.2020.11.006","Verified","","","","","","IT","IT-88"
"2021-01-10","201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj","SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study","2020-10-26","National","Denmark","Denmark","2020-06-02","2020-06-19","Blood donors","Seniors (65+ years)",1200.0,0.014,"Simplified probability","Beijing Wantai Biological Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ole Birger Pedersen","Copenhagen University Hospital Rigshospitalet","https://dx.doi.org/10.1093/cid/ciaa1627","Verified",0.003,0.025,0.967,0.995,"","DK",""
"2021-01-10","201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns","2020-10-27","Local","Denmark","Denmark; Capital Region of Denmark; Copenhagen","2020-04-04","2020-07-03","Perinatal","Children and Youth (0-17 years)",1206.0,0.014,"Sequential","Shenzhen Yhlo Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pia Egerup","Copenhagen University Hospital Hvidovre","https://dx.doi.org/10.1097/AOG.0000000000004199","Verified","","",0.94,0.993,"","DK","DK-84"
"2021-01-10","201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG","Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV","2020-10-27","Local","Italy","Italy; Umbria; Perugia","2020-05-04","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",270.0,0.037,"Sequential","Screen Italia","IgG","High","Journal Article (Peer-Reviewed)","Chiara Papalini","University of Perugia","https://dx.doi.org/10.4084/MJHID.2020.080","Verified","","","","","","IT","IT-55"
"2021-01-12","201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj","SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study","2020-10-26","National","Denmark","Denmark","2020-06-01","2020-06-26","Blood donors","Adults (18-64 years)",1110.0,0.025,"Sequential","Beijing Wantai Biological Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ole Birger Pedersen","Copenhagen University Hospital Rigshospitalet","https://dx.doi.org/10.1093/cid/ciaa1627","Verified",0.013,0.038,0.967,0.995,"","DK",""
"2021-01-12","201027_Athens_NationalandKapodistrianUniversityofAthens_Overall","Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece","2020-10-27","Local","Greece","Greece; Attica; Athens","2020-04-25","2020-05-10","Health care workers and caregivers","Adults (18-64 years)",321.0,0.022,"Unclear","EUROIMMUN, Germany","IgG","High","Journal Article (Peer-Reviewed)","Panayiotis Vlachoyiannopoulosa","National and Kapodistrian University of Athens/Laiko University Hospital","http://dx.doi.org/10.1016/j.clim.2020.108619","Verified","","",0.93,1.0,"","GR","GR-I"
"2021-01-12","201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG","SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic","2020-10-31","Local","Italy","Italy; Lombardy; Milan","2020-03-15","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",40.0,0.05,"Convenience","Prima lab SA, Diasorin","IgG","High","Journal Article (Peer-Reviewed)","Diana Canetti","San Raffaele Scientific Institute","https://pubmed.ncbi.nlm.nih.gov/33135083/","Verified","","","","","","IT","IT-25"
"2021-01-12","201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG","Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic","2020-12-02","National","Dominican Republic","Dominican Republic","2020-04-15","2020-06-15","Household and community samples","Multiple groups",12897.0,0.055,"Simplified probability","GenBody Inc.","IgG","High","Journal Article (Peer-Reviewed)","Robert Paulino Ramirez","Universidad Iberoamericana","https://dx.doi.org/10.4269/ajtmh.20-0907","Verified","","",0.567,1.0,"","DO",""
"2021-01-12","201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest","Prevalence of COVID-19 antibodies in healthcare workers at the peak of the pandemic in Mumbai, India: A preliminary study.","2020-12-07","Local","India","India; Maharashtra; Mumbai","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",208.0,0.125,"Convenience","1) Abbott 2) Roche","Not reported","High","Journal Article (Peer-Reviewed)","Tanu Singhal","Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute","https://dx.doi.org/10.4103/ijmm.IJMM_20_308","Verified","","","","","","IN","IN-MH"
"2021-01-13","201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients","COVID-19 infection in kidney transplant recipients at the epicenter of pandemics","2020-10-15","Local","United States of America","United States of America; New York; New York City","2020-05-03","2020-07-29","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",912.0,0.167,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Yorg Azzi","Albert Einstein College of Medicine","http://dx.doi.org/10.1016/j.kint.2020.10.004","Verified","","",1.0,1.0,"","US","US-NY"
"2021-01-13","201023_Berlin_CharitéUniversity_primary","LOW SEROPREVALENCE OF SARS-COV-2 ANTIBODIES DURING SYSTEMATIC SCREENING FOR COVID-19 INFECTION IN A GERMAN COHORT OF KIDNEY TRANSPLANT RECIPIENTS","2020-10-23","Local","Germany","Germany; Berlin; Berlin","2020-03-19","2020-05-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",223.0,0.071,"Unclear","Euroimmun Medizinische Labordiagnostika AG","IgA; IgG","High","Journal Article (Peer-Reviewed)","Mira Choi","Charité University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690804/","Verified","","","","","","DE","DE-BE"
"2021-01-14","200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex","SARS-CoV-2 antigen and antibody prevalence among UK staff working with cancer patients during the COVID-19 pandemic","2020-09-20","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; East of England","2020-06-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",434.0,0.184,"Convenience","Cambridge University Hospitals","IgG","High","Preprint","David Favara","Cambridge University Hospitals NHS Foundation Trust","https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1","Verified","","",0.84,1.0,"","GB","GB-ENG"
"2021-01-14","201126_Germany_RobertKochInstitute_BloodDonors_TestAdj","Serological tests of blood donations for antibodies against SARS-CoV-2 (SeBluCo study)","2020-11-26","National","Germany","Germany","2020-04-15","2020-11-05","Blood donors","Multiple groups",48976.0,0.014,"Simplified probability","NR","IgG","Moderate","Institutional Report","Robert Koch Institute","Robert Koch Institute","https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102","Verified","","","","","","DE",""
"2021-01-15","201027_Cuiabá_UniversidadeFederaldeMatoGrosso_Overall","PREVALENCE OF MOLECULAR AND SEROLOGICAL TESTS OF THE NEW CORONAVIRUS (SARS-CoV-2) IN CARLOS CHAGAS-SABIN LABORATORIES IN CUIABA","2020-10-27","Local","Brazil","Brazil; Mato Grosso; Cuiabá","2020-04-01","2020-07-31","Residual sera","Multiple groups",6392.0,0.221,"Convenience","Carlos Chagas Laboratory","IgG; IgM","High","Preprint","Cristiane Coimbra de Paula","Universidade Federal de Mato Grosso (UFMT)","https://www.medrxiv.org/content/10.1101/2020.10.26.20219683v1","Verified","","","","","","BR","BR-MT"
"2021-01-15","201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall","SARS-CoV-2 in first trimester pregnancy: a cohort study","2020-12-27","Local","Denmark","Denmark; Copenhagen; Copenhagen","2020-04-14","2020-05-21","Pregnant or parturient women","Adults (18-64 years)",36.0,0.0,"Self-referral","YHLO Biotechnology","IgG; IgM","High","Journal Article (Peer-Reviewed)","‪Nina Freiesleben","Copenhagen University Hospital","https://dx.doi.org/10.1093/humrep/deaa311","Verified","","","","","","DK","DK-84"
"2021-01-16","201007_MinistryofHealthofRussianFederation_employees","Detection of antibodies to SARS-CoV-2 in healthcare professionals of the national center during the COVID-19 pandemic (April-June 2020)","2020-10-07","Local","Russian Federation","Russian Federation","2020-04-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",1589.0,0.089,"Unclear","""NMITs Hematology"" Ministry of Health of the Russian Federation","IgG","Unclear","Journal Article (Peer-Reviewed)","LV Krechetova","Ministry of Health of Russia","http://dx.doi.org/10.18565/aig.2020.7.122-128","Verified","","","","","","RU",""
"2021-01-16","201015_Paris_ParisSaclayUniversity_unadj","Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France","2020-10-15","Local","France","France; Paris; Paris","2020-05-04","2020-05-31","Pregnant or parturient women","Adults (18-64 years)",249.0,0.08,"Sequential","Abbott, Ortho-Clinical Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Jeremie Mattern","Paris Saclay University","http://dx.doi.org/10.1371/journal.pone.0240782","Verified","","","","","","FR","FR-IDF"
"2021-01-16","201018_Belgium_UniversityHospitalsLeuven_Overall_unadj","Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020","2020-10-18","Local","Belgium","Belgium; Limburg; Lanaken","2020-04-14","2020-04-16","Multiple populations","Multiple groups",188.0,0.186,"Convenience","SureScreen Diagnostics, Derby, UK","IgG; IgM","High","Journal Article (Peer-Reviewed)","Frank Buntinx","University of Leuven","http://dx.doi.org/10.1080/17843286.2020.1834285","Verified","","",0.747,0.951,"","BE",""
"2021-01-16","201021_Italy_IRCCS_Overall_IgG_unadj","Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2","2020-10-21","Regional","Italy","Italy; Lombardy","2020-03-30","2020-05-11","Multiple populations","Multiple groups",166.0,0.416,"Convenience","PRIMA Lab SA","IgG","High","Journal Article (Peer-Reviewed)","Antonio Marra","Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","https://dx.doi.org/10.1016/j.annonc.2020.10.473","Verified","","","","","","IT","IT-25"
"2021-01-16","201113_London_ImperialCollegeLondon_KidneyTransplantPatients","Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening","2020-11-13","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-01","2020-07-03","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",855.0,0.104,"Sequential","Abbott, Fortress Diagnostics","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Michelle Willicombe","Imperial College London","https://dx.doi.org/10.1097/TP.0000000000003526","Verified",0.085,0.126,"","","","GB","GB-ENG"
"2021-01-17","201008_StGallen_CantonalHospitalStGallen_hcw","Prevalence of SARS-CoV-2 Antibodies among Swiss Hospital Workers - Results of a Prospective Cohort Study","2020-10-08","Regional","Switzerland","Switzerland; St. Gallen; St. Gallen","2020-03-19","2020-04-03","Health care workers and caregivers","Adults (18-64 years)",1012.0,0.01,"Convenience","lateral flow immunochromatographic assay; (LFIA, Sugentech, Yuseong-gu, Daejeon, Republic of Korea), a; chemiluminescence microparticle immunoassay (CMIA, Abbott; Diagnostics, Lake Bluff, IL), and an electro-chemiluminescence; immunoassay (ECLIA, Roche Diagnostics, Basel, Switzerland)","IgG","High","Journal Article (Peer-Reviewed)","Phillipp Kohler","Cantonal Hospital St. Gallen","https://dx.doi.org/10.1017/ice.2020.1244","Verified","","","","","","CH",""
"2021-01-17","201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren","Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study","2020-11-10","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Ireland, Wales, Scotland, England; Belfast, Cardiff, Glasgow, London, Manchester","2020-04-16","2020-07-03","Family of essential workers","Children and Youth (0-17 years)",992.0,0.069,"Convenience","Abbott, Roche, DiaSorin","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Thomas Waterfield","Royal Belfast Hospital for Sick Children","https://dx.doi.org/10.1136/archdischild-2020-320558","Verified",0.054,0.086,"","","","GB",""
"2021-01-17","201021_SaoPaulo_AdolfoLutzCentralInstitute","Prevalence of antibodies against sars-cov-2 in professionals of a public health laboratory at Sao Paulo, sp, Brazil","2020-10-21","Local","Brazil","Brazil; State of Sao Paulo; Sao Paulo","2020-06-05","2020-07-31","Multiple populations","Multiple groups",406.0,0.086,"Convenience","Guangzhou Wondfo Biotech Co., Ltd., China; Roche Diagnostics, Rotkreuz, Switzerland","IgG; IgM","High","Preprint","Valeria Oliveira Silva","Adolfo Lutz Central Institute","https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1","Verified","","","","","","BR","BR-SP"
"2021-01-17","201021_VeracruzCity_UniversidadVeracruzana_unadj","Prevalence of SARS-CoV-2 IgG antibodies in a population from Veracruz (Southeastern Mexico)","2020-10-21","Local","Mexico","Mexico; Veracruz; Veracruz City","2020-06-01","2020-07-31","Residual sera","Multiple groups",2174.0,0.295,"Sequential","Abbott, Ortho-Clinical Diagnostics","IgG","High","Preprint","Jose Maria Remes-Troche","Universidad Veracruzana","https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1","Verified",0.276,0.315,"","","","MX","MX-VER"
"2021-01-17","201106_Lyon_UniversitéClaudeBernardLyon_Overall","Clinical and microbiological assessments of COVID-19 in healthcare workers: a prospective longitudinal study","2020-11-06","Local","France","France; Auvergne-Rhône-Alpes; Lyon","2020-04-10","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",190.0,0.037,"Unclear","Wantai, Beijing, China; bioMérieux, Lyon, France","Total Antibody; IgG","High","Preprint","Antonin Bal","Université Claude Bernard Lyon","https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1","Verified","","","","","","FR","FR-ARA"
"2021-01-17","201108_Geneva_GenevaUniversityHospital_Overall","Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care","2020-11-08","Local","Switzerland","Switzerland","2020-04-01","2020-04-30","Residual sera","Children and Youth (0-17 years)",208.0,0.087,"Sequential","Euroimmun, N/A, N/A","IgG","High","Journal Article (Peer-Reviewed)","Klara Posfay Barbe","Geneva University Hospital","https://dx.doi.org/10.1093/cid/ciaa1702","Verified","","","","","","CH",""
"2021-01-17","201109_ Peshawar_HayatabadMedicalComplex_Overall","Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?","2020-11-09","Local","Pakistan","Pakistan; Khyber Pakhtunkhwa; Peshawar","2020-07-13","2020-07-15","Health care workers and caregivers","Multiple groups",1011.0,0.308,"Stratified probability","Roche","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mohammad Noor","Hayatabad Medical Complex","https://dx.doi.org/10.7759/cureus.11389","Verified","","",0.87,1.0,"","PK","PK-KP"
"2021-01-18","201008_Udine_UniversityofUdine_SCTrecipients","Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up","2020-10-08","Local","Italy","Italy; Udine; Udine","2020-04-01","2020-05-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",70.0,0.014,"Sequential","Cellex","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alessandra Sperotto","The University of Udine","https://dx.doi.org/10.1002/jmv.26586","Verified","","",0.938,0.964,"","IT","IT-36"
"2021-01-18","201104_Geneva_JohnHopkins_Overall","Household Transmission of SARS-CoV-2: Insights from a Population-based Serological Survey","2021-01-16","Regional","Switzerland","Switzerland; Geneva","2020-04-03","2020-06-30","Household and community samples","Multiple groups",4534.0,0.066,"Convenience","Euroimmun","IgG","Moderate","Preprint","Qifang Bi","Johns Hopkins Bloomberg School of Public Health","https://www.medrxiv.org/content/10.1101/2020.11.04.20225573v2","Verified",0.06,0.07,0.93,0.99,"","CH","CH-GE"
"2021-01-18","201104_India_HindujaHospital_GenPop","Duration of anti-SARS-CoV-2 antibodies much shorter in India","2020-11-04","Local","India","India; Maharashtra; Mumbai","2020-06-01","2020-06-30","Health care workers and caregivers","Multiple groups",801.0,0.111,"Unclear","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Nishant Kumar","Postgraduate Institute of Medical Education and Research","https://dx.doi.org/10.1016/j.vaccine.2020.10.094","Verified",0.091,0.135,0.998,1.0,"","IN","IN-MH"
"2021-01-18","201105_Corsica_UniversitédeCorse_Totaladj","Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020","2020-11-05","Regional","France","France; Corsica; Ajaccio; Corte","2020-04-16","2020-06-15","Residual sera","Multiple groups",1973.0,0.055,"Sequential","EUROIMMUN, Bussy-Saint Martin, France","IgG","Moderate","Journal Article (Peer-Reviewed)","Lisandru Capai","Université de Corse","https://www.mdpi.com/2077-0383/9/11/3569","Verified",0.045,0.066,0.864,0.962,"","FR","FR-COR"
"2021-01-18","201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall","Seroprevalence of COVID-19 Amongst Health Care Workers in a Tertiary Care Hospital of a Metropolitan City from India.","2020-11-09","Local","India","India; West Bengal; Kolkata","2020-07-12","2020-08-23","Health care workers and caregivers","Adults (18-64 years)",1122.0,0.119,"Stratified probability","Ortho Clinical Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Mahesh Goenka","Apollo Gleneagles Hospitals","https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india","Verified","","",0.9,1.0,"","IN","IN-WB"
"2021-01-19","200928_FrenchGuiana_InstitutPasteur_OverallPopAdjyes","Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana","2020-09-28","National","French Guiana","French Guiana","2020-07-15","2020-07-23","Residual sera","Multiple groups",480.0,0.154,"Sequential","Euroimmun","IgG","Moderate","Preprint","Claude Flamand","Institut Pasteur","https://www.medrxiv.org/content/10.1101/2020.09.27.20202465v1","Verified",0.093,0.244,0.938,0.979,"","GF",""
"2021-01-19","200930_PeshawarCity_RiphahInternationalUniversity_Overall","Seroprevalence and Risk Factors of SARS CoV-2 in Health Care Workers of Tertiary-Care Hospitals in the Province of Khyber Pakhtunkhwa, Pakistan","2020-09-30","Local","Pakistan","Pakistan; Khyber Pakhtunkhwa; Peshawar City","2020-06-15","2020-06-29","Health care workers and caregivers","Adults (18-64 years)",1011.0,0.307,"Stratified non-probability","Roche Diagnostics","Total Antibody","Moderate","Preprint","Mohsina Haq","Riphah International University","https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1","Verified",0.278,0.336,0.988,1.0,"","PK","PK-KP"
"2021-01-19","201120_LosAngeles_TheLundquistInstitute_genpop","COVID-19 IgG/IgM antibody testing in Los Angeles County, California","2020-11-25","Local","United States of America","United States of America; California","2020-04-21","2020-05-22","Multiple populations","Multiple groups",244.0,0.209,"Unclear","Hangzhou Testsea Biotechnology Co.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Khadije Ahmad","The Lundquist Institute","https://dx.doi.org/10.1007/s10096-020-04111-3","Verified","","",0.96,1.0,"","US","US-CA"
"2021-01-20","201130_USA_AmericanRedCross_BloodDonors","Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020.","2020-11-30","National","United States of America","United States of America; Massachusetts, California, Connecticut, Iowa, Michigan, Oregon, Rhode Island, Washington, Wisconsin","2019-12-13","2020-01-17","Blood donors","Multiple groups",7389.0,0.014,"Sequential","CDC","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sridhar V Basavaraju","American Red Cross","https://dx.doi.org/10.1093/cid/ciaa1785","Verified","","",0.96,0.993,"","US",""
"2021-01-20","210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj","COVID-19 Seroprevalence Report January 12, 2021 Report #4: November 2020 Survey","2021-01-12","National","Canada","Canada","2020-11-07","2020-11-25","Blood donors","Multiple groups",17049.0,0.015,"Sequential","Abbott","IgG","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a","Verified",0.013,0.017,0.927,0.999,"","CA",""
"2021-01-21","200806_Lombardy_BrunoKesslerFoundation","Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020","2020-08-06","Regional","Italy","Italy; Lombardy","2020-04-16","2020-05-25","Contacts of COVID patients","Multiple groups",4120.0,0.531,"Stratified non-probability","LIAISON®","IgG","Moderate","Journal Article (Peer-Reviewed)","Piero Poletti","Bruno Kessler Foundation","http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383","Verified","","",0.944,0.983,"","IT","IT-25"
"2021-01-21","201022_Oxford_UniversityOfOxford_unadj","SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020.","2020-10-22","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-04-14","2020-06-15","Pregnant or parturient women","Adults (18-64 years)",1000.0,0.053,"Sequential","University of Oxford","IgG","Moderate","Journal Article (Peer-Reviewed)","Sheila F Lumley","University of Oxford","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721","Verified",0.04,0.069,0.991,0.99,"","GB",""
"2021-01-21","201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj","Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults","2020-10-27","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-07-31","2020-08-13","Household and community samples","Multiple groups",105829.0,0.048,"Simplified probability","Fortress Diagnostics, Northern Ireland","IgG","Moderate","Preprint","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf","Verified",0.047,0.05,0.844,0.986,"","GB",""
"2021-01-21","201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj","Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults","2020-10-27","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-09-15","2020-09-28","Household and community samples","Multiple groups",159367.0,0.044,"Simplified probability","Fortress Diagnostics, Northern Ireland","IgG","Moderate","Preprint","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf","Verified",0.042,0.045,0.844,0.986,"","GB",""
"2021-01-21","201111_Italy_IstitutoNazionaleTumori_primaryest","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2019-09-01","2020-03-10","Residual sera","Multiple groups",959.0,0.116,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-01-21","201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders","Incidence of SARS-CoV-2 infection among asymptomatic frontline health workers in Los Angeles County, California","2020-11-21","Local","United States of America","United States of America; California","2020-05-19","2020-08-31","Essential non-healthcare workers","Multiple groups",679.0,0.081,"Unclear","NR","IgG","Moderate","Preprint","Megan Halbrook","University of California Los Angeles","https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1","Verified","","","","","","US","US-CA"
"2021-01-21","201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW","Incidence of SARS-CoV-2 infection among asymptomatic frontline health workers in Los Angeles County, California","2020-11-21","Local","United States of America","United States of America; California","2020-04-08","2020-08-31","Health care workers and caregivers","Multiple groups",1108.0,0.039,"Unclear","NR","IgG","Moderate","Preprint","Megan Halbrook","University of California Los Angeles","https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1","Verified","","","","","","US","US-CA"
"2021-01-21","201123_OrangeCounty_StJudeMedicalCenter_Overall","Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California","2020-11-23","Local","United States of America","United States of America; California; Fullerton","2020-07-15","2020-07-27","Residual sera","Multiple groups",865.0,0.094,"Sequential","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Jason Yamaki","St. Jude Medical Center","https://dx.doi.org/10.1007/s40615-020-00918-0","Verified",0.08,0.12,1.0,1.0,"","US","US-CA"
"2021-01-21","201127_DistrictofColumbia_DCHealth_Overall","SARS-CoV-2 Seroprevalence among First Responders in the District of Columbia, May – July 2020","2020-11-27","Regional","United States of America","United States of America; Washington D.C; Washington","2020-05-28","2020-07-15","Essential non-healthcare workers","Adults (18-64 years)",310.0,0.036,"Self-referral","DiaSorin Inc.","IgG","High","Preprint","Jacqueline Reuben","District of Columbia Department of Health (DC Health)","https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1","Verified","","",0.97,"","","US","US-DC"
"2021-01-21","201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3","Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study","2020-11-30","Local","Germany","Germany; Hamburg; Hamburg","2020-06-22","2020-07-17","Health care workers and caregivers","Adults (18-64 years)",1253.0,0.018,"Convenience","Euroimmun","IgG","Moderate","Journal Article (Peer-Reviewed)","Thomas Brehm","University Medical Center Hamburg-Eppendorf","https://dx.doi.org/10.1016/j.ijheh.2020.113671","Verified",0.01,0.025,0.944,0.996,"","DE","DE-HH"
"2021-01-21","201218_Canada_CBS_BloodDonors_Overall_PopTestAdj","COVID-19 Seroprevalence Report December 18, 2020 Report #3: October 2020 Survey","2020-12-18","National","Canada","Canada","2020-10-12","2020-10-31","Blood donors","Multiple groups",16811.0,0.009,"Sequential","Abbott","IgG","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.007,0.01,0.927,0.999,"","CA",""
"2021-01-22","200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall","COVID-19 Seroconversion in Emergency Professionals at an Urban Academic Emergency Department in New York City.","2020-06-22","Local","United States of America","United States of America; New York; New York City","2020-02-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",50.0,0.46,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Jordan Jeong","Columbia University Medical Center","https://dx.doi.org/10.1016/j.annemergmed.2020.06.038","Verified","","","","","","US","US-NY"
"2021-01-22","201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall","A COVID-19 Hotspot Area: Activities and Epidemiological Findings.","2020-10-31","Local","Italy","Italy; Abruzzo; Villa Caldari","2020-04-18","2020-04-19","Household and community samples","Multiple groups",667.0,0.109,"Entire sample","Beijing Wantai Biological Pharmacy Enterprise Co., Beijing, China","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Francesa Cito","Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale","https://dx.doi.org/10.3390/microorganisms8111711","Verified",0.088,0.135,0.93,1.0,"","IT","IT-65"
"2021-01-22","201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW","Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19","2020-11-17","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-05-01","2020-05-31","Contacts of COVID patients","Children and Youth (0-17 years)",44.0,0.362,"Convenience","Abbott Commerce","IgG","High","Journal Article (Peer-Reviewed)","Shamez Ladhani","Immunisation and Countermeasures Division","https://dx.doi.org/10.1093/cid/ciaa1737","Verified",0.09,0.634,"","","","GB",""
"2021-01-22","201130_SanFrancisco_StanfordUniversity_Overall","Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2","2020-11-30","Local","United States of America","United States of America; California; San Francisco","2020-04-20","2020-06-08","Health care workers and caregivers","Adults (18-64 years)",12418.0,0.009,"Self-referral","Stanford Health Care","IgG","High","Journal Article (Peer-Reviewed)","Catherine Hogan","Stanford University","https://dx.doi.org/10.3201/eid2701.203892","Verified",0.007,0.011,"",0.998,"","US","US-CA"
"2021-01-22","201210_Atlanta_CDC_Lab_OverallPopTestAdj","Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey","2020-12-10","Local","United States of America","United States of America; Georgia; Atlanta","2020-04-27","2020-05-01","Residual sera","Multiple groups",1343.0,0.049,"Convenience","Centers for Disease Control and Prevention (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/cid/ciaa1804","Verified",0.033,0.066,0.96,0.993,"","US","US-GA"
"2021-01-23","200826_London_ImperialCollegeLondon_LTC","High rates of SARS-CoV-2 seropositivity in nursing home residents","2020-08-26","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-01","2020-06-30","Assisted living and long-term care facilities","Seniors (65+ years)",241.0,0.718,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Neil Graham","Imperial College London","https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext","Verified",0.66,0.77,0.939,1.0,"","GB","GB-ENG"
"2021-01-23","200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35","PHE England week 37","2020-09-11","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-07-27","2020-08-30","Blood donors","Multiple groups",8764.0,0.053,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.048,0.058,0.83,0.993,"","GB","GB-ENG"
"2021-01-23","200911_England_PHE_WhatsTheStory_Summary_5_May_August","PHE England week 37","2020-09-11","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-05-01","2020-08-05","Household and community samples","Children and Youth (0-17 years)",568.0,0.052,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.032,0.078,0.957,0.991,"","GB","GB-ENG"
"2021-01-23","201002_England_PHE_BloodDonors_Summary_Final","PHE England week 40","2020-10-02","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-08-24","2020-09-18","Blood donors","Multiple groups",8230.0,0.061,"Stratified probability","EUROIMMUN","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.054,0.068,0.83,0.993,"","GB","GB-ENG"
"2021-01-23","201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott","PHE England week 40","2020-10-02","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-15","2020-08-16","Residual sera","Seniors (65+ years)",4315.0,0.065,"Stratified probability","Abbott","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.055,0.076,0.957,0.991,"","GB","GB-ENG"
"2021-01-23","201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott","PHE England week 40","2020-10-02","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-15","2020-08-16","Residual sera","Multiple groups",1212.0,0.052,"Stratified probability","Abbott","IgG","Low","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified",0.039,0.07,0.957,0.991,"","GB","GB-ENG"
"2021-01-23","201023_Egypt_AinShamsUniversity_Overall","Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.","2020-10-23","Local","Egypt","Egypt; Cairo Governorate; Cairo","2020-04-22","2020-05-14","Health care workers and caregivers","Multiple groups",4040.0,0.013,"Convenience","Artron Laboratories","IgG; IgM","High","Journal Article (Peer-Reviewed)","Aya Mostafa","Ain Shams University","https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053","Verified","","",0.833,1.0,"","EG","EG-C"
"2021-01-23","201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj","Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China","2020-10-23","Local","China","China; Hubei; Wuhan","2020-03-27","2020-05-26","Household and community samples","Multiple groups",35040.0,0.039,"Unclear","Bioscience, Tianjin, China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anding Liu","Huazhong University of Science and Technology","https://dx.doi.org/10.1001/jamanetworkopen.2020.25717","Verified",0.037,0.041,"","","","CN","CN-42"
"2021-01-23","201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM","First wave of COVID-19 did not reach the homeless population in Aarhus.","2020-11-20","Local","Denmark","Denmark; Central Denmark Region; Aarhus","2020-06-01","2020-06-04","Persons experiencing homelessness","Adults (18-64 years)",129.0,0.047,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Signe Storgaard","Aarhus Department of Public Health","https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.","Verified",0.021,0.098,0.989,0.976,"","DK","DK-82"
"2021-01-23","201030_Colombia_UniversidadIndustrialdeSantander_primary","Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises.","2020-10-30","National","Colombia","Colombia","2020-04-17","2020-07-14","Essential non-healthcare workers","Multiple groups",4234.0,0.04,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alvaro J Idrovo","Universidad Industrial de Santander","https://dx.doi.org/10.7705/biomedica.5829","Verified","","","","","","CO",""
"2021-01-23","201103_London_PHE_LTCStaff","Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic","2020-11-03","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-03","2020-06-30","Health care workers and caregivers","Multiple groups",327.0,0.471,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Thomas Rowland","Public Health England","https://dx.doi.org/10.1016/j.jinf.2020.10.035","Verified","","",0.939,1.0,"","GB","GB-ENG"
"2021-01-23","201103_Vaud_UniversityofLausanne_CloseContacts2_Roche","Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies","2020-11-03","Regional","Switzerland","Switzerland; Vaud","2020-05-04","2020-06-27","Contacts of COVID patients","Multiple groups",177.0,0.322,"Unclear","Roche","Total Antibody","High","Journal Article (Peer-Reviewed)","Craig Fenwick","Lausanne University Hospital and University of Lausanne","http://dx.doi.org/10.1128/JVI.01828-20","Verified","","",0.93,1.0,"","CH","CH-VD"
"2021-01-23","201103_Vaud_UniversityofLausanne_GenPop1_Roche","Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies","2020-11-03","Regional","Switzerland","Switzerland; Vaud","2020-05-04","2020-06-27","Household and community samples","Multiple groups",311.0,0.039,"Simplified probability","Roche","Total Antibody","High","Journal Article (Peer-Reviewed)","Craig Fenwick","Lausanne University Hospital and University of Lausanne","http://dx.doi.org/10.1128/JVI.01828-20","Verified","","",0.93,1.0,"","CH","CH-VD"
"2021-01-23","201104_Paris_CochinAPHP_HCW","Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries.","2020-11-04","Local","France","France; Île-de-France; Paris","2020-05-14","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",4607.0,0.115,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Chantal Delmas","Cochin APHP","https://dx.doi.org/10.1017/ice.2020.1309","Verified",0.106,0.124,"","","","FR","FR-IDF"
"2021-01-23","201109_Milan_UniversitadegliStudidiMilano_patients_antiN_S","Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy","2020-11-20","Local","Italy","Italy; Lombardy ; Milan","2020-05-11","2020-07-05","Residual sera","Multiple groups",2753.0,0.033,"Sequential","Abbott, Abbott Park, Illinois, US; DiaSorin S.p.A., Saluggia, Italy","IgG","Moderate","Journal Article (Peer-Reviewed)","Valeria Cento","Universita degli Studi di Milano","http://dx.doi.org/10.1371/journal.pone.0242765","Verified","","","","","","IT","IT-25"
"2021-01-23","201109_UK_WatfordGeneralHospital_ACU","Prevalence of COVID-19 Among Typical Ambulatory Care Patients in a District General Hospital in the United Kingdom.","2020-11-09","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; NR; Watford","2020-03-27","2020-06-08","Residual sera","Multiple groups",443.0,0.016,"Sequential","NR","Not reported","High","Journal Article (Peer-Reviewed)","Muhammad Arif","Watford General Hospital","https://dx.doi.org/10.7759/cureus.11398","Verified","","","","","","GB",""
"2021-01-23","201110_Tehran_TehranUniversityofMedicalSciences_unadj","Antibody Rapid Test Results in Emergency Medical Services Personnel during COVID-19 Pandemic; a Cross Sectional study.","2020-11-10","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Tehran; Tehran","2020-03-20","2020-05-20","Essential non-healthcare workers","Adults (18-64 years)",243.0,0.416,"Convenience","KarmaAzmaAndish Co.","IgM; IgG","High","Journal Article (Peer-Reviewed)","Peyman Saberian","Tehran University of Medical Sciences","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/","Verified","","",0.711,0.587,"","IR","IR-07"
"2021-01-23","201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest","Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain","2020-11-12","Local","Spain","Spain; Catalonia; Barcelona","2020-04-28","2020-06-03","Contacts of COVID patients","Multiple groups",1084.0,0.18,"Convenience","Innovita Tangshan Biological Technology Co","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Pedro Brotons","University Hospital Sant Joan de Deu","https://dx.doi.org/10.1093/cid/ciaa1721","Verified","","",0.833,"","","ES","ES-CT"
"2021-01-23","201112_Prague_CharlesUniversityandThomayer'sHospital_Roche","Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack","2020-11-12","Local","Czechia","Czechia; Prague; Prague","2020-07-03","2020-08-19","Residual sera","Children and Youth (0-17 years)",200.0,0.0,"Sequential","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Marketa Bloomfield","Charles University and Thomayer’s Hospital","http://dx.doi.org/10.3389/fped.2020.597736","Verified",0.0,0.005,0.995,0.998,"","CZ","CZ-PR"
"2021-01-23","201113_SaoPaulo_UniversidadeSaoPaulo_primary","Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil","2020-11-13","Local","Brazil","Brazil; State of Sao Paulo; Sao Paulo","2020-06-30","2020-08-04","Residual sera","Multiple groups",439.0,0.139,"Convenience","DiaSorin S.p.A., Roche Diagnostics","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Luanda Mara da Silva Oliveira","Universidade de São Paulo","https://dx.doi.org/10.1590/S1678-9946202062091","Verified","","","","","","BR","BR-SP"
"2021-01-23","201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall","Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.","2020-11-18","Local","Viet Nam","Viet Nam; Đông Nam Bộ; Ho Chi Minh City","2020-08-23","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",408.0,0.0,"Convenience","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Nguyen Van Vinh Chau","Oxford University Clinical Research Unit","https://dx.doi.org/10.1016/j.jinf.2020.11.018","Verified","","",0.972,0.998,"","VN",""
"2021-01-23","201119_Italy_UniversityofCagliari_Milano1_IBDPatients","Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy","2020-11-19","Local","Italy","Italy","2020-04-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",354.0,0.023,"Convenience","University of Cagliari","IgG; IgA","High","Journal Article (Peer-Reviewed)","Roberto Berte","University of Cagliari","https://dx.doi.org/10.1093/ecco-jcc/jjaa237","Verified",0.008,0.038,0.976,0.952,"","IT",""
"2021-01-23","201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop","Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy","2020-11-19","Local","Italy","Italy; Lombardy; Milan","2020-04-15","2020-06-15","Household and community samples","Multiple groups",129.0,0.07,"Sequential","University of Cagliari","IgG; IgA","High","Journal Article (Peer-Reviewed)","Roberto Berte","University of Cagliari","https://dx.doi.org/10.1093/ecco-jcc/jjaa237","Verified",0.044,0.096,0.976,0.952,"","IT","IT-25"
"2021-01-23","201119_SaoPaulo_ClínicaDeReumatologia_RheumaticPatients","Seroconversion for SARS-CoV-2 in rheumatic patients on synthetic and biologics Disease Modifying Anti-Rheumatic Drugs in Sao Paulo, Brazil","2020-11-19","Local","Brazil","Brazil; State of Sao Paulo; São Paulo","2020-03-15","2020-08-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",100.0,0.21,"Convenience","Snibe Diagnostics","IgG; IgM","High","Preprint","Felipe Santana","Clínica de Reumatologia","https://www.researchsquare.com/article/rs-97191/v1","Verified","","","","","","BR","BR-SP"
"2021-01-23","201119_UK_QueensUniversityBelfast_adj","Kinetics and seroprevalence of SARS-CoV-2 antibodies in children","2020-11-19","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-06-26","2020-08-15","Family of essential workers","Children and Youth (0-17 years)",849.0,0.077,"Convenience","Roche, Basel, Switzerland; DiaSorin, Saluggia, Italy","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Cathal Roarty","Queens University Belfast","https://dx.doi.org/10.1016/S1473-3099(20)30884-7","Verified",0.06,0.096,"","","","GB",""
"2021-01-23","201119_USA_QuestDiagnostics_Overall","Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020","2020-11-19","National","United States of America","United States of America","2020-04-21","2020-07-10","Household and community samples","Multiple groups",2402282.0,0.118,"Sequential","Abbott Laboratories, Ortho-Clinical Diagnostics, EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Harvey W Kaufman","Quest Diagnostics","http://dx.doi.org/10.1089/pop.2020.0256","Verified","","","","","","US",""
"2021-01-23","201120_SaudiArabia_SaudiCDC_Overall","Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.","2020-11-20","National","Saudi Arabia","Saudi Arabia; Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Emirate of the Eastern Province, Aseer, Madinah, Makkah","2020-05-20","2020-05-30","Health care workers and caregivers","Adults (18-64 years)",12621.0,0.024,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Haleema Ali Alserehi","Saudi Center for Disease Prevention and Control","https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273","Verified","","","","","","SA",""
"2021-01-23","201124_Qatar_MinistryofPublicHealth_Overall_popadj","Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar","2020-11-24","National","Qatar","Qatar","2020-07-26","2020-09-09","Non-essential workers and unemployed persons","Multiple groups",2641.0,0.553,"Stratified probability","Roche, Switzerland","Total Antibody","Moderate","Preprint","Mohamed H Al Thani","Ministry of Public Health","https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1","Verified",0.533,0.573,0.95,0.998,"","QA",""
"2021-01-23","201125_Valencia_HospitalArnauDeVilanova_Overall","Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population","2020-11-25","Local","Spain","Spain; Valencia; Valencia","2020-05-02","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",166.0,0.018,"Sequential","DiaSorin","IgG; IgM","High","Journal Article (Peer-Reviewed)","Javier Garde Noguera","Hospital Arnau de Vilanova de Valencia, Spain","https://dx.doi.org/10.3390/cancers12123513","Verified","","","","","","ES","ES-VC"
"2021-01-23","201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj","Prevalence of SARS-CoV-2 IgG antibodies in an area of North-eastern Italy with a high incidence of COVID-19 cases: a population-based study.","2020-11-27","Regional","Italy","Italy; Trento","2020-05-05","2020-05-15","Household and community samples","Multiple groups",6075.0,0.257,"Convenience","Abbott Laboratories","IgG","Low","Journal Article (Peer-Reviewed)","Paola Stefanelli","Azienda Provinciale per i Servizi Sanitari","https://dx.doi.org/10.1016/j.cmi.2020.11.013","Verified","","",0.9,1.0,"","IT","IT-32"
"2021-01-23","201130_Spain_UniversityofZaragoza_unadj","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery","2020-11-30","Local","Spain","Spain","2020-03-31","2020-08-31","Pregnant or parturient women","Adults (18-64 years)",260.0,0.069,"Sequential","Biozek, Abbott, Vircell","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ricardo Saviron Cornudella","University of Zaragoza","https://dx.doi.org/10.1016/j.ejogrb.2020.11.069","Verified","","","","","","ES",""
"2021-01-23","201130_Strasbourg_StrasbourgUniversityHospital_Abbott","Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France","2020-11-30","Local","France","France; Grand-Est ; Strasbourg","2020-05-07","2020-06-26","Contacts of COVID patients","Adults (18-64 years)",11.0,0.0,"Unclear","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Floriane Gallais","Strasbourg University Hospital","https://dx.doi.org/10.3201/eid2701.203611","Verified","","",1.0,1.0,"","FR","FR-GES"
"2021-01-23","201205_Kuwait_KuwaitUniversity_Overall_unadj","Seroprevalence of SARS-CoV-2 in migrant workers in Kuwait","2020-12-05","National","Kuwait","Kuwait","2020-05-23","2020-06-26","Essential non-healthcare workers","Adults (18-64 years)",525.0,0.381,"Stratified probability","Biozek Medical, Netherlands","IgG; IgM","High","Journal Article (Peer-Reviewed)","Walid Q Alali","University of Kuwait","https://dx.doi.org/10.1093/jtm/taaa223","Verified",0.34,0.423,0.66,0.97,"","KW",""
"2021-01-23","201210_ Paris_UniversitéParis-Saclay","SARS-COV-2 IgG antibody response in pregnant women at delivery","2020-12-10","Local","France","France; Île-de-France; Paris","2020-04-29","2020-06-26","Pregnant or parturient women","Adults (18-64 years)",529.0,0.047,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Vassilis Tsatsarisa","Université Paris-Saclay","https://dx.doi.org/10.1016/j.jogoh.2020.102041","Verified",0.03,0.067,0.927,0.99,"","FR","FR-IDF"
"2021-01-23","201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall","SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission","2020-12-13","Local","Brazil","Brazil; São Paulo State; São Paulo","2020-05-14","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",4987.0,0.141,"Convenience","Wondfo-China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Silvia Costa","Faculdade De Medicina da Universidade","https://dx.doi.org/10.1093/cid/ciaa1845","Verified",0.131,0.15,"","","","BR","BR-SP"
"2021-01-23","201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall","COVID-19 seroprevalence among healthcare workers in a low prevalence region.","2020-12-14","Local","United States of America","United States of America; Virginia; Richmond","2020-07-27","2020-10-02","Health care workers and caregivers","Multiple groups",1962.0,0.014,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Emily Godbout","Virginia Commonwealth University","https://dx.doi.org/10.1017/ice.2020.1374","Verified","","","","","","US","US-VA"
"2021-01-23","201215_SanDiego_SharpHealthCare_Overall","Point prevalence survey to evaluate the seropositivity for coronavirus disease 2019 (COVID-19) among high-risk healthcare workers","2020-12-15","Local","United States of America","United States of America; California; San Diego","2020-05-20","2020-06-08","Health care workers and caregivers","Multiple groups",1770.0,0.022,"Convenience","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Norihiro Yogo","Sharp Healthcare","https://dx.doi.org/10.1017/ice.2020.1370","Verified","","",1.0,0.998,"","US","US-CA"
"2021-01-23","201218_Lisbon_NovaUniversityofLisbon","Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures","2020-12-18","Local","Portugal","Portugal; Lisboa Region; Lisbon","2020-06-15","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",1636.0,0.03,"Convenience","NOVA University of Lisbon","IgG","Moderate","Journal Article (Peer-Reviewed)","Juliana Goncalves","NOVA University of Lisbon","https://dx.doi.org/10.3389/fmed.2020.603996","Verified","","",0.947,0.995,"","PT","PT-11"
"2021-01-23","201219_Tuscany_UniversityOfFlorence_Overall","SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)","2020-12-19","Regional","Italy","Italy; Prato","2020-05-01","2020-05-31","Multiple populations","Multiple groups",4656.0,0.03,"Convenience","Hangzhou Laihe Biotech Co., Ltd, Hangzhou China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Vieri Lastrucci","University of Florence","https://dx.doi.org/10.3390/vaccines8040778","Verified",0.025,0.035,1.0,0.988,"","IT","IT-52"
"2021-01-23","201221_Guilan_TehranUniversityofMedicalSciences_overall","Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020","2020-12-21","Regional","Iran (Islamic Republic of)","Iran (Islamic Republic of); Guilan","2020-04-11","2020-04-19","Household and community samples","Multiple groups",528.0,0.222,"Stratified probability","VivaChek","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maryam Shakiba","Tehran University of Medical Sciences","https://dx.doi.org/10.3201/eid2702.201960","Verified",0.164,0.285,0.833,0.99,"","IR","IR-19"
"2021-01-23","201222_Rome_EleemosynariaApostolica_overall","Assessment of SARS-CoV-2 infection through rapid serology testing in the homeless population in the City of Rome, Italy. Preliminary results","2020-12-22","Local","Italy","Italy; Lazio; Rome","2020-04-14","2020-07-31","Multiple populations","Multiple groups",173.0,0.018,"Convenience","Inzek B.V","IgG; IgM","High","Journal Article (Peer-Reviewed)","Massimo Ralli","Eleemosynaria Apostolica","https://dx.doi.org/10.4081/jphr.2020.1986","Verified","","",0.96,0.96,"","IT","IT-62"
"2021-01-23","201222_Vienna_MedicalUniversityofVienna_overall","A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms","2020-12-22","Local","Austria","Austria; Vienna; Vienna","2020-04-02","2020-04-17","Non-essential workers and unemployed persons","Adults (18-64 years)",1655.0,0.102,"Convenience","Euroimmun Medizinische Labordiagnostika","IgA; IgG","High","Preprint","Angelika Wagner","Medical University of Vienna","https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1","Verified","","","","","","AT","AT-9"
"2021-01-23","201223_Oxford_OxfordUniversityHospitals_HCW_Spike","Antibody status and incidence of SARS-CoV-2 infection in health care workers","2020-12-23","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-04-23","2020-11-30","Health care workers and caregivers","Multiple groups",12541.0,0.101,"Convenience","University of Oxford","IgG","Moderate","Journal Article (Peer-Reviewed)","Sheila Lumley","Oxford University Hospitals","https://dx.doi.org/10.1056/NEJMoa2034545","Verified","","",0.991,0.99,"","GB",""
"2021-01-23","210101_Seattle_SeattleChildren'sResearchInstitute_FollowUp_Overall","Prevalence of health care and hospital worker SARS-CoV-2 IgG antibody in a pediatric hospital","2021-01-01","Local","United States of America","United States of America; Washington ; Seattle","2020-07-06","2020-08-07","Health care workers and caregivers","Adults (18-64 years)",481.0,0.01,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Yekaterina Tokareva","Seattle Childrens Research Institute","https://dx.doi.org/10.1542/hpeds.2020-003517","Verified","","",1.0,"","","US","US-WA"
"2021-01-23","210103_Munich_LudwigMaximillianUniversityofMunich_Overall","Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany","2021-01-03","Local","Germany","Germany","2020-03-24","2020-07-07","Health care workers and caregivers","Adults (18-64 years)",300.0,0.047,"Convenience","1. EuroImmun; 2. Roche; 3.DiaSorin; 4.Abbott","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Tobias Weinberger","Ludwig Maximillian University of Munich","https://dx.doi.org/10.1093/cid/ciaa1935","Verified","","","","","","DE",""
"2021-01-23","210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj","Serological Testing for COVID-19 in the Fertility Setting: The Lockdown Impact and Subsequent Dynamics Reflected in the Seroprevalence of Sars-Cov-2 Antibodies","2021-01-04","Local","Romania","Romania","2020-05-17","2020-12-01","Multiple populations","Adults (18-64 years)",546.0,0.06,"Convenience","LIAISON","IgG; IgM","High","Preprint","Corina Manolea","Carol Davila University of Medicine and Pharmacy","https://www.preprints.org/manuscript/202101.0024/v1","Verified","","",0.907,0.986,"","RO",""
"2021-01-23","210115_Cairo_CairoUniversity","SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility","2021-01-15","Local","Egypt","Egypt","2020-06-01","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",203.0,0.182,"Convenience","Artron Laboratories, Burnaby, Canada","IgG; IgM","High","Journal Article (Peer-Reviewed)","Reham Abdelmoniem","Cairo University","https://dx.doi.org/10.1016/j.jcv.2020.104710","Verified","","",0.934,0.977,"","EG",""
"2021-01-23","210205_IledeFrance_Epicentre_Shelters","Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study","2021-02-05","Local","France","France; Ile de France; Paris","2020-06-23","2020-07-02","Persons experiencing homelessness","Multiple groups",818.0,0.52,"Convenience","N/A - Author Designed","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Thomas Roederer","Médecins sans Frontières (Epicentre)","https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3","Verified","","","","","","FR","FR-IDF"
"2021-01-24","201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall","Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave","2020-11-28","National","Netherlands","Netherlands","2020-03-31","2020-05-11","Household and community samples","Multiple groups",570.0,0.029,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Eric Vos","Centre for Infectious Disease Control","https://dx.doi.org/10.1136/jech-2020-215678","Verified",0.014,0.063,0.844,0.99,"","NL",""
"2021-01-25","201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall","Seroprevalence of SARS-CoV-2 antibodies among physicians from a children's hospital","2020-12-01","Local","Argentina","Argentina; Province of Buenos Aires; Autonomous City of Buenos Aires","2020-06-08","2020-06-09","Health care workers and caregivers","Adults (18-64 years)",116.0,0.009,"Simplified probability","Snibe (Shenzen New Industries)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Claudia Insua","Hospital General de Niños Pedro de Elizalde","https://dx.doi.org/10.5546/aap.2020.eng.381","Verified",0.001,0.055,0.956,0.96,"","AR","AR-B"
"2021-01-25","201212_Bavaria_UniversityofRegensburg_overall","Coronavirus antibody screening identifies children with mild to moderate courses of PMIS","2020-12-12","Regional","Germany","Germany; Bavaria","2020-05-22","2020-07-22","Household and community samples","Children and Youth (0-17 years)",2832.0,0.057,"Convenience","1. Roche Diagnostics","IgA; IgG; IgM","Moderate","Preprint","Otto Laub","University of Regensburg","https://www.authorea.com/users/382535/articles/498454-coronavirus-antibody-screening-identifies-children-with-mild-to-moderate-courses-of-pmis","Verified","","","","","","DE","DE-BY"
"2021-01-27","201026_Zaragoza_HospitalSanJuandeDios_HCW_primary","[Prevalence of SARS-CoV-2 coronavirus infection in patients and professional staff at a medium or long-stay hospital in Spain]","2020-11-13","Local","Spain","Spain; Aragon; Zaragoza","2020-03-20","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",289.0,0.059,"Convenience","Master Labor S.L., Madrid","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luis Antonio Moreno Borraz","Hospital San Juan de Dios","https://dx.doi.org/10.1016/j.regg.2020.10.005","Verified","","",1.0,0.98,"","ES","ES-AR"
"2021-01-27","201026_Zaragoza_HospitalSanJuandeDios_patients_primary","[Prevalence of SARS-CoV-2 coronavirus infection in patients and professional staff at a medium or long-stay hospital in Spain]","2020-11-13","Local","Spain","Spain; Aragon; Zaragoza","2020-03-20","2020-04-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",229.0,0.07,"Convenience","Master Labor S.L., Madrid","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luis Antonio Moreno Borraz","Hospital San Juan de Dios","https://dx.doi.org/10.1016/j.regg.2020.10.005","Verified","","",1.0,0.98,"","ES","ES-AR"
"2021-01-27","201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall","Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - The CoNAN study.","2020-11-19","Local","Germany","Germany; Thuringia","2020-05-13","2020-05-16","Household and community samples","Multiple groups",620.0,0.084,"Self-referral","Epitope Diagnostics Inc., San Diego, USA; Euroimmun, Lübeck, Germany; DiaSorin, Saluggia, Italy; Snibe Co., Ltd., Shenzhen, China; Abbott, Chicago, USA; Roche, Basel Switzerland","IgG","Moderate","Journal Article (Peer-Reviewed)","Sebastian Weis","Friedrich Schiller University","https://dx.doi.org/10.1016/j.cmi.2020.11.009","Verified","","","","","","DE","DE-TH"
"2021-01-27","201203_Tirschenreuth_MunichClinic_HCW_Overall","[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate]","2020-12-03","Local","Germany","Germany; Bavaria; Tirschenreuth, Wieden","2020-06-29","2020-07-29","Health care workers and caregivers","Adults (18-64 years)",1838.0,0.151,"Convenience","Roche Diagnostics","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","T Finkenzeller","Munich Clinic","https://dx.doi.org/10.1007/s00063-020-00761-5","Verified","","",0.995,0.998,"","DE","DE-BY"
"2021-01-27","201203_Tirschenreuth_MunichClinic_NMU_Overall","[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate]","2020-12-03","Local","Germany","Germany; Bavaria; Tirschenreuth, Wieden","2020-06-29","2020-07-29","Essential non-healthcare workers","Adults (18-64 years)",986.0,0.037,"Convenience","Roche DIagnostics","IgM; IgG","High","Journal Article (Peer-Reviewed)","T Finkenzeller","Munich Clinic","https://dx.doi.org/10.1007/s00063-020-00761-5","Verified","","",0.995,0.998,"","DE","DE-BY"
"2021-01-27","201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine","Prevalence of SARS-CoV-2 Specific Antibodies in the Staff of a Children's Hospital, in Tehran, Iran","2020-12-06","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Tehran; Tehran","2020-04-20","2020-05-05","Health care workers and caregivers","Adults (18-64 years)",475.0,0.294,"Convenience","Hangzhou AllTest Biotech Co.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shahnaz Armin","High Institute for Research and Education in Transfusion Medicine","https://sites.kowsarpub.com/jjm/articles/108592.html","Verified","","",0.999,0.98,"","IR","IR-07"
"2021-01-27","201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants","Low prevalence of SARS-COV-2 antibodies in people with multiple sclerosis residing in massachusetts","2020-12-07","Local","United States of America","United States of America; Massachusetts; Boston","2020-05-29","2020-07-23","Multiple populations","Multiple groups",143.0,0.063,"Sequential","Massachusetts General Hospital","IgG","High","Journal Article (Peer-Reviewed)","E Klawiter","Massachusetts General Hospital","https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1","Verified","","",0.997,1.0,"","US","US-MA"
"2021-01-27","201207_Massachusetts_MassachusettsGeneralHospital_MS","Low prevalence of SARS-COV-2 antibodies in people with multiple sclerosis residing in massachusetts","2020-12-07","Local","United States of America","United States of America; Massachusetts; Boston","2020-05-29","2020-07-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",227.0,0.035,"Sequential","Massachusetts General Hospital","IgG","High","Journal Article (Peer-Reviewed)","E Klawiter","Massachusetts General Hospital","https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1","Verified","","",0.997,1.0,"","US","US-MA"
"2021-01-27","201215_Leicester_UniversityHospitalsofLeicesterNHSTrust","Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre","2020-12-15","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Leicester","2020-05-29","2020-08-03","Health care workers and caregivers","Adults (18-64 years)",200.0,0.12,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","John Black","University Hospitals of Leicester NHS Trust","https://dx.doi.org/10.1111/tri.13791","Verified","","",0.927,1.0,"","GB","GB-ENG"
"2021-01-28","200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium","Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area","2020-08-06","Local","United States of America","United States of America; New York; New York City","2020-04-20","2020-06-23","Health care workers and caregivers","Multiple groups",40329.0,0.137,"Convenience","Euroimmun, AnshLabs, Abbott Laboratories, Ortho Clinical Diagnostics, DiaSorin, Roche","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Joseph Moscola","Northwell Health COVID-19 Research Consortium","https://pubmed.ncbi.nlm.nih.gov/32780804/","Verified","","","","","","US","US-NY"
"2021-01-28","201203_AraphoeCounty_UniversityofColorado","Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders - the COVID-19 Arapahoe SErosurveillance Study (CASES) Project.","2020-12-03","Local","United States of America","United States of America; Colorado","2020-07-15","2020-08-15","Essential non-healthcare workers","Adults (18-64 years)",264.0,0.04,"Convenience","Exsera BioLabs","IgG","High","Journal Article (Peer-Reviewed)","Katherine Sabourin","University of Colorado","https://pubmed.ncbi.nlm.nih.gov/33298759/","Verified","","",0.85,0.986,"","US","US-CO"
"2021-01-28","201209_Liechtenstein_KantonsspitalGraubunden_Overall","Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.","2020-12-09","National","Liechtenstein","Liechtenstein","2020-06-02","2020-10-06","Multiple populations","Multiple groups",1159.0,0.078,"Convenience","Roche Diagnostics, Rotkreuz, Switzerland; Abbott Diagnostics Baar, Switzerland; Diasorin; Euroimmun","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Anna Schaffner","Kantonsspital Graunbunden","https://dx.doi.org/10.3390/jcm9123989","Verified",0.064,0.095,"","","","LI",""
"2021-01-28","201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW","Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China.","2020-12-25","Local","China","China; Hubei; Wuhan","2020-05-15","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",4614.0,0.033,"Convenience","Livzon Diagnostics Inc.","IgG","Unclear","Journal Article (Peer-Reviewed)","Lu He","Renmin Hospital of Wuhan University","https://dx.doi.org/10.7883/yoken.JJID.2020.691","Verified","","","","","","CN","CN-42"
"2021-01-28","201225_Wuhan_RenminHospitalofWuhanUniversity_Community","Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China.","2020-12-25","Local","China","China; Hubei; Wuhan","2020-05-15","2020-05-29","Household and community samples","Multiple groups",4454.0,0.029,"Convenience","Livzon Diagnostics Inc.","IgG","Unclear","Journal Article (Peer-Reviewed)","Lu He","Renmin Hospital of Wuhan University","https://dx.doi.org/10.7883/yoken.JJID.2020.691","Verified","","","","","","CN","CN-42"
"2021-01-29","201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall","Prevalence of current and past SARS-CoV-2 infections among police employees in Poland, june-july 2020","2020-10-11","Regional","Poland","Poland; Mazowieckie Province","2020-06-22","2020-07-08","Essential non-healthcare workers","Multiple groups",5082.0,0.043,"Stratified probability","Vircell S.L","IgG","Moderate","Journal Article (Peer-Reviewed)","Mariusz Gujski","Medical University of Warsaw","http://dx.doi.org/10.3390/jcm9103245","Verified",0.037,0.049,0.97,0.94,"","PL","PL-14"
"2021-01-29","201014_Alicante_COVID-19GroupoftheInfectionsCommission","Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department","2020-10-14","Local","Spain","Spain; Alacant; Alicante","2020-04-24","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",4179.0,0.066,"Unclear","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Paula Gras-Valenti","COVID-19 Group of the Infections Commission","https://dx.doi.org/10.1016/j.eimc.2020.09.015","Verified",0.058,0.073,"","","","ES","ES-VC"
"2021-01-29","201128_Bergen_UniversityofBergen_primaryest_HCW","SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study.","2020-11-28","Local","Norway","Norway; Midhordland; Bergen","2020-03-06","2020-04-09","Health care workers and caregivers","Multiple groups",607.0,0.053,"Convenience","Sigma-Aldrich","IgG","High","Journal Article (Peer-Reviewed)","Mai Chi Trieu","University of Bergen","https://dx.doi.org/10.1093/infdis/jiaa737","Verified","","","","","","NO","NO-12"
"2021-01-29","201130_Sergipe_FederalUniversityofSergipe_residualsera_primary","SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients","2020-11-30","Local","Brazil","Brazil; Sergipe; Aracaju","2020-01-15","2020-04-15","Residual sera","Multiple groups",987.0,0.016,"Sequential","Nantong Egens Biotechnology CO, Ltd., China and Bodytech Med Inc.","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Ricardo Queiroz Gurgel","Federal University of Sergipe","http://dx.doi.org/10.1016/j.jinf.2020.11.037","Verified","","","","","","BR","BR-SE"
"2021-01-29","201230_SanDiego_ScrippsClinic_Overall","Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego","2020-12-30","Local","United States of America","United States of America; California; San Diego","2020-04-14","2020-07-28","Health care workers and caregivers","Adults (18-64 years)",11993.0,0.009,"Convenience","Diazyme, Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Laura Nicholson","Scripps Clinic","https://dx.doi.org/10.1016/j.ajic.2020.12.017","Verified","","","","","","US","US-CA"
"2021-01-30","200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall","Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital","2020-10-16","Local","Germany","Germany; Schleswig-Holstein; Hamburg","2020-04-14","2020-06-16","Health care workers and caregivers","Multiple groups",871.0,0.026,"Convenience","Mikrogen Diagnostik, Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Jonas Herzberg","University Hospitals of the Ruhr‑University of Bochum","http://dx.doi.org/10.1016/j.ijid.2020.10.026","Verified","","","","","","DE","DE-SH"
"2021-01-30","201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall","COVID-19 prevalence among health-care workers of Gastroenterology department: An audit from a tertiary-care hospital in India","2020-11-09","Local","India","India; West Bengal; Kolkata","2020-08-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",117.0,0.325,"Convenience","Ortho Clinical Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Mahesh Goenka","Apollo Gleneagles Hospitals","http://dx.doi.org/10.1002/jgh3.12447","Verified","","","","","","IN","IN-WB"
"2021-01-30","201201_Verona_InstitutoDiRicoveroECuraACaratterre_Overall","Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020.","2020-12-01","Local","Italy","Italy; Veneto; Verona","2020-04-25","2020-05-08","Household and community samples","Multiple groups",1515.0,0.027,"Simplified probability","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Massimo Guerriero","Instituto di Ricovero e Cura A Caratterre","https://dx.doi.org/10.3201/eid2701.202740","Verified","","","","","","IT","IT-34"
"2021-01-30","201222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall","High SARS-COV2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo","2020-12-22","Local","Congo","Congo","2020-04-01","2020-07-31","Household and community samples","Adults (18-64 years)",754.0,0.197,"Self-referral","Wuhan UNniscience Biotechnology, Salofa Oy manufacturer, Finland","IgG; IgM","High","Journal Article (Peer-Reviewed)","Armel Batchi Bouyou","Fondation Congolaise pour la Recherche Médicale","https://dx.doi.org/10.1016/j.ijid.2020.12.065","Verified","","","","","","CD",""
"2021-01-30","201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary","Seroprevalence of SARS-CoV-2 IgG Specific Antibodies among Healthcare Workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave","2020-12-28","Local","Spain","Spain","2020-05-04","2020-05-22","Health care workers and caregivers","Multiple groups",7563.0,0.103,"Self-referral","DiaSorin, Vercelli, Italy; Abbott Diagnostics, Sligo, Italy","IgG","High","Journal Article (Peer-Reviewed)","Jaume Barallat","Institut Català de la Salut","https://dx.doi.org/10.1371/journal.pone.0244348","Verified","","","","","","ES",""
"2021-01-30","210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary","Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses","2021-01-06","Regional","Brazil","Brazil; Espírito Santo","2019-12-01","2020-06-30","Representative patient population","Multiple groups",7370.0,0.028,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lorenzzo Lyrio Stringari","Secretaria de Estado da Saúde do Espírito Santo","https://dx.doi.org/10.1371/journal.pone.0244937","Verified","","","","","","BR","BR-ES"
"2021-01-31","201126_Naples_UniversityofNaples_HighRisk","Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg","2020-11-26","Local","Italy","Italy; Campania; Naples","2020-05-11","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",235.0,0.106,"Convenience","Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Nicola Capasso","University of Naples","https://dx.doi.org/10.3390/jcm9124066","Verified","","",0.66,0.966,"","IT","IT-72"
"2021-01-31","201126_Naples_UniversityofNaples_LowRisk","Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg","2020-11-26","Local","Italy","Italy; Campania;  Naples","2020-05-11","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",862.0,0.013,"Convenience","Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Nicola Capasso","University of Naples","https://dx.doi.org/10.3390/jcm9124066","Verified","","",0.66,0.966,"","IT","IT-72"
"2021-01-31","201126_Naples_UniversityofNaples_MS","Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg","2020-11-26","Local","Italy","Italy; Campania; Naples","2020-05-11","2020-06-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",310.0,0.029,"Sequential","Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Nicola Capasso","University of Naples","https://dx.doi.org/10.3390/jcm9124066","Verified","","",0.66,0.966,"","IT","IT-72"
"2021-01-31","201130_Bristol_NorthBristolNHSTrust_hcw","Seroprevalence of SARS-CoV-2 IgG in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis","2020-11-30","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Bristol, South Gloucestershire, North Somerset","2020-01-15","2020-06-15","Health care workers and caregivers","Multiple groups",6858.0,0.093,"Self-referral","Abbott laboratories; RocheDiagnostics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Christopher Jones","North Bristol NHS Trust","https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext","Verified","","","","","","GB","GB-ENG"
"2021-01-31","201130_Madrid_UniversidadComplutensedeMadrid_primary","Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome","2020-11-30","Local","Spain","Spain","2020-02-28","2020-05-10","Pregnant or parturient women","Adults (18-64 years)",769.0,0.112,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Cecilia Villalaın","The Universidad Complutense de Madrid","https://dx.doi.org/10.1371/journal.pone.0243029","Verified","","","","","","ES",""
"2021-01-31","201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary","Pre-Procedural Antibody Testing for SARS-CoV-2 in routine endoscopic practice","2020-12-02","Local","Spain","Spain; Canary Islands; Tenerife","2020-04-27","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",211.0,0.019,"Sequential","Roche Diagnostics, Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Alejandro Hernandez Camba","Quironsalud Tenerife Hospital","https://dx.doi.org/10.17235/reed.2020.7434/2020","Verified",0.001,0.048,"","","","ES","ES-CN"
"2021-01-31","201203_Edmonton_UniversityofAlberta_Children","Increased Mask Use and Fewer Gatherings Associated with Lower SARS-CoV-2 Seropositivity Among Young School-Age Children","2020-12-03","Local","Canada","Canada; Alberta; Edmonton","2020-08-14","2020-10-23","Household and community samples","Children and Youth (0-17 years)",565.0,0.016,"Convenience","Abbott Laboratories","IgG","High","Preprint","Emilie Manny","University of Alberta","https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE","Verified","","",0.842,1.0,"","CA","CA-AB"
"2021-01-31","201204_Germany_SaarlandUniversity_overall","Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases","2020-12-04","National","Germany","Germany","2020-06-16","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",1007.0,0.021,"Self-referral","EUROimmun, Roche, NR","IgG; Not reported","High","Journal Article (Peer-Reviewed)","Dietrich Mack","Saarland University","https://dx.doi.org/10.1016/j.cmi.2020.11.033","Verified",0.014,0.032,"","","","DE",""
"2021-01-31","201228_Beijing_CapitalMedicalUniversity_IgG","Seroprevalence of SARS-CoV-2 infections among children visiting a hospital","2020-12-28","Local","China","China","2020-01-01","2020-08-31","Residual sera","Children and Youth (0-17 years)",19797.0,0.001,"Sequential","Beijing Innovita Biological Technology","IgG","Moderate","Journal Article (Peer-Reviewed)","Ran Wang","Capital Medical University","https://dx.doi.org/10.1002/ped4.12231","Verified","","","","","","CN",""
"2021-01-31","210109_GiglioIsland_UniversitàdegliStudidiMilano","The Conundrum of Giglio Island: unraveling the dynamics of an apparent resistance to COVID-19. A descriptive study","2021-01-09","Local","Italy","Italy; Tuscany; Giglio Island","2020-04-29","2020-05-03","Household and community samples","Adults (18-64 years)",723.0,0.004,"Self-referral","Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China","IgG; IgM","High","Preprint","Antonio Bognanni","Università degli Studi di Milano","https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1","Verified","","",0.879,1.0,"","IT","IT-52"
"2021-02-01","201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter","Quantitative SARS-CoV-2 antibody screening of healthcare workers in the southern part of Kyoto city during the COVID-19 peri-pandemic period","2020-12-07","Local","Japan","Japan; Kansai; Kyoto","2020-04-10","2020-04-20","Health care workers and caregivers","Adults (18-64 years)",92.0,0.054,"Convenience","DRG international, Inc.","IgG","High","Journal Article (Peer-Reviewed)","Kohei Fujita","National Hospital Organization Kyoto Medical Center","https://dx.doi.org/10.3389/fpubh.2020.595348","Verified","","","","","","JP",""
"2021-02-01","201213_Helsinki_UniversityofHelsinki_HCW_unadj","SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: serosurvey, symptoms and risk factors.","2020-12-13","Local","Finland","Finland; Uusimaa; Helsinki","2020-04-22","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",1095.0,0.03,"Convenience","Euroimmun, Abbott Laboratories, University of Helsinki (In-House)","IgG","High","Journal Article (Peer-Reviewed)","Anu Kantele","University of Helsinki","https://dx.doi.org/10.1016/j.tmaid.2020.101949","Verified","","","","","","FI","FI-18"
"2021-02-01","201217_Naples_UniversityofCampania_ELISA","Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2","2020-12-17","Local","Italy","Italy; Campania; Naples","2020-03-27","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",65.0,0.0,"Convenience","Xiamen","Total Antibody","High","Journal Article (Peer-Reviewed)","Antonio Russo","University of Campania","https://dx.doi.org/10.2147/IDR.S282652","Verified","","",1.0,1.0,"","IT","IT-72"
"2021-02-01","201231_Zagreb_ZagrebUniversity_overall","The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital","2020-12-31","Local","Croatia","Croatia","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1678.0,0.006,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Ivana Lapic","Zagreb University","https://pubmed.ncbi.nlm.nih.gov/33410294/","Verified","","",1.0,0.996,"","HR",""
"2021-02-02","201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary","Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study","2020-12-14","Local","India","India; Gujarat; Ahmedabad","2020-06-16","2020-07-07","Residual sera","Multiple groups",29891.0,0.176,"Convenience","Zydus Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://dx.doi.org/10.1136/bmjopen-2020-044101","Verified",0.172,0.18,0.924,0.979,"","IN","IN-GJ"
"2021-02-02","201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust","SARS-CoV-2 testing of 11,884 healthcare workers at an acute NHS hospital trust in England: a retrospective analysis","2020-12-22","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England ; Newcastle-Upon-Tyne","2020-05-29","2020-07-06","Health care workers and caregivers","Adults (18-64 years)",11103.0,0.084,"Convenience","Roche Diagnostics","IgG","High","Preprint","Aidan Hanrath","Newcastle-upon-Tyne Hospitals NHS Trust","https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1","Verified","","","","","","GB","GB-ENG"
"2021-02-02","201222_Stockholm_KarolinskaUniversityHospital_LTCFstaff_primary","SARS-CoV-2 infections among personnel providing home care services for the elderly in Stockholm, Sweden","2020-12-22","Local","Sweden","Sweden","2020-05-11","2020-06-17","Assisted living and long-term care facilities","Multiple groups",403.0,0.201,"Convenience","(Luminex Corp)","IgG","High","Preprint","Sadaf Sakina Hassan","Karolinska University Hospital","https://www.medrxiv.org/content/10.1101/2020.12.18.20248511v1","Verified","","",0.992,0.998,"","SE",""
"2021-02-02","201223_RafsanjanCounty_UniversityofPecs","A contact tracing prospective cohort retrieving epidemiological facts on SARS-CoV-2 transmission aspects; a serological analysis","2020-12-23","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Kerman","2020-03-01","2020-04-30","Contacts of COVID patients","Multiple groups",238.0,0.156,"Sequential","NR","IgG; IgM","High","Preprint","Reza Vazirinejad","University of Pecs","https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-","Verified","","","","","","IR","IR-15"
"2021-02-03","201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj","Population Changes in Seroprevalence among a Statewide Sample in the United States","2020-12-22","Regional","United States of America","United States of America; Wisconsin","2020-10-18","2020-12-14","Household and community samples","Multiple groups",994.0,0.068,"Stratified probability","Abbott","IgG","Moderate","Preprint","Kristen Maleck","University of Wisconsin","https://doi.org/10.1101/2020.12.18.20248479","Verified",0.043,0.094,"",0.996,"","US","US-WI"
"2021-02-03","201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj","Population Changes in Seroprevalence among a Statewide Sample in the United States","2020-12-22","Regional","United States of America","United States of America; Wisconsin","2020-07-01","2020-08-31","Household and community samples","Multiple groups",996.0,0.016,"Stratified probability","Abbott","IgG","Moderate","Preprint","Kristen Maleck","University of Wisconsin","https://doi.org/10.1101/2020.12.18.20248479","Verified",0.006,0.025,"",0.996,"","US","US-WI"
"2021-02-03","201223_Bergamo_OspedalePapaGiovanniXXIII_overall","Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.","2020-12-23","Local","Italy","Italy; Lombardy; Bergamo","2020-04-01","2020-04-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",560.0,0.31,"Sequential","Moers, Germany","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alberto Zambelli","Ospedale Papa Giovanni XXIII","https://dx.doi.org/10.1002/onco.13654","Verified","","",0.921,0.992,"","IT","IT-25"
"2021-02-03","210105_USA_MayoClinic_overall","Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders","2021-01-05","Local","United States of America","United States of America; Minnesota; Rochester","2020-05-16","2020-05-17","Essential non-healthcare workers","Adults (18-64 years)",255.0,0.012,"Convenience","N/A  - Author designed","IgG","High","Journal Article (Peer-Reviewed)","Sarayna S McGuire","Mayo Clinic","https://dx.doi.org/10.1017/S1049023X2000151X","Unverified","","",0.881,0.996,"","US","US-MN"
"2021-02-03","210111_Pavia_University of Pavia_overall","Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients","2021-01-13","Local","Italy","Italy","2020-05-04","2020-06-03","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",104.0,0.135,"Convenience","Roche","IgG","High","Journal Article (Peer-Reviewed)","Giulia Mallucci","University of Pavia","https://doi.org/10.1016/j.msard.2021.102754","Verified","","","","","","IT",""
"2021-02-04","201106_Utah_UniversityofUtah_immunosupressed_primary","Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations","2020-11-06","Local","United States of America","United States of America; Utah; Salt Lake City","2020-04-18","2020-05-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",39.0,0.026,"Unclear","in house - ARUP","IgG","High","Preprint","Quinn Pritchett","University of Utah","https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/","Verified","","","","","","US","US-UT"
"2021-02-04","201126_Kupferzell_RobertKochInstitute_OverallAdj","Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020","2020-11-26","Local","Germany","Germany; Baden-Württemberg; Kupferzell","2020-05-20","2020-06-09","Household and community samples","Multiple groups",2203.0,0.12,"Simplified probability","Euroimmun","IgG","Low","Journal Article (Peer-Reviewed)","Claudia Santos Hovener","Robert Koch Institute","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752","Verified",0.104,0.14,0.883,0.992,"","DE","DE-BW"
"2021-02-04","201209_SantaClara_StanfordHealthCare","Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic.","2020-12-09","Local","United States of America","United States of America; California; San Francisco Bay Area","2020-04-20","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",10449.0,0.013,"Convenience","Stanford Clinical Laboratory","IgG","High","Journal Article (Peer-Reviewed)","Joelle Rosser","Stanford Health Care","https://dx.doi.org/10.1017/ice.2020.1358","Verified","","",0.87,0.998,"","US","US-CA"
"2021-02-04","201211_London_RichmondPharmacologyLtd","Why the SARS-CoV-2 antibody test results may be misleading: insights from a longitudinal analysis of COVID-19","2020-12-11","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-19","2020-12-02","Multiple populations","Multiple groups",6061.0,0.064,"Unclear","NR","IgG","High","Preprint","Jorg Taubel","Richmond Pharmacology Ltd","https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2","Verified","","","","","","GB","GB-ENG"
"2021-02-04","201223_NewYork_MemorialSloanKetteringCancerCenter","COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City","2020-12-23","Local","United States of America","United States of America; New York; New York City","2020-05-05","2020-09-10","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",257.0,0.078,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Lauren Jimenez Kurlander","Memorial Sloan Kettering Cancer Center","https://dx.doi.org/10.1002/pbc.28857","Verified","","","","","","US","US-NY"
"2021-02-04","210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall","Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital","2021-01-04","Local","India","India; Tamil Nadu; Chennai","2020-07-30","2020-08-07","Health care workers and caregivers","Adults (18-64 years)",95.0,0.168,"Convenience","Shenzhen YHLO Biotech Co","IgG","High","Preprint","Manoj Madhusudan","Kanchi Kamakoti CHILDS Trust Hospital,","https://pubmed.ncbi.nlm.nih.gov/33408287/","Unverified","","","","","","IN","IN-TN"
"2021-02-04","210111_Michigan_ UniversityofMichigan_overall","Seroprevalence of SARS-CoV-2 antibodies by risk of exposure in a community health system","2021-01-11","Local","United States of America","United States of America; Michigan","2020-08-17","2020-09-04","Health care workers and caregivers","Adults (18-64 years)",1385.0,0.019,"Convenience","Siemens, Eagle Bioscience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jeffrey J Fletcher","Metro Health University of Michigan Health","http://dx.doi.org/10.1017/ice.2020.1438","Unverified","","","","","","US","US-MI"
"2021-02-04","210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG","Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain.","2021-01-14","Local","Spain","Spain","2020-04-14","2020-05-13","Health care workers and caregivers","Adults (18-64 years)",2439.0,0.169,"Convenience","Snibe diagnostic","IgG","High","Journal Article (Peer-Reviewed)","Javier Fernandez","Hospital Universitario de Fuenlabrada","https://dx.doi.org/10.1371/journal.pone.0245001","Verified","","",1.0,"","","ES",""
"2021-02-04","210119_NewJersey_CooperUniversityHospital_overall","COVID-19 Serologic Testing Among the Highest Risk Healthcare Workers","2021-01-19","Local","United States of America","United States of America; New Jersey","2020-06-10","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",172.0,0.052,"Convenience","1) Roche 2) EUROIMMUN","Total Antibody","High","Journal Article (Peer-Reviewed)","Snehal Gandhi","Cooper University Hospital","https://dx.doi.org/10.1007/s11606-020-06462-1","Unverified",0.024,0.097,"","","","US","US-NJ"
"2021-02-04","210624_NuevoLeon_AutonomousUniversityofNuevoLeon_primary","Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.","2021-06-24","Regional","Mexico","Mexico; Nuevo Leon","2020-01-01","2020-12-15","Blood donors","Adults (18-64 years)",2068.0,0.053,"Sequential","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Natalia Martinez-Acu a","Autonomous University of Nuevo Leon","https://dx.doi.org/10.3390/v13071225","Verified","","",0.9,1.0,"","MX","MX-NLE"
"2021-02-05","201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool","Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospital Workers: Results From a Screening Study in New Jersey, United States in Spring 2020.","2020-10-31","Local","United States of America","United States of America; New Jersey; New Brunswick, Somerville","2020-04-28","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",3907.0,0.096,"Convenience","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Emily Barrett","Rutgers Robert Wood Johnson Medical School","https://dx.doi.org/10.1093/ofid/ofaa534","Verified","","",0.969,0.996,"","US","US-NJ"
"2021-02-05","201112_Monteria_UniversidaddeCórdoba_GenPopAdj","Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?","2020-11-12","Local","Colombia","Colombia; Caribbean Region; Monteria","2020-08-04","2020-09-01","Household and community samples","Multiple groups",1368.0,0.553,"Stratified probability","Ingenasa","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Salim Mattar","Universidad de Córdoba","https://dx.doi.org/10.1093/ofid/ofaa550","Verified",0.525,0.578,0.92,1.0,"","CO",""
"2021-02-05","201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW","SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital","2020-12-13","Local","Italy","Italy; Apulia, Province of Foggia; Foggia","2020-03-17","2020-05-18","Health care workers and caregivers","Adults (18-64 years)",3242.0,0.019,"Convenience","Shenzhen YHLO Biotech","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Armando De Carlo","Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia","https://dx.doi.org/10.3390/ijerph17249324","Verified",0.014,0.023,0.97,0.988,"","IT",""
"2021-02-05","210102_Munich_MUCResearch","HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'","2021-01-02","Local","Germany","Germany","2020-05-29","2020-07-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",500.0,0.015,"Sequential","Mikrogen, Neuried, Germany","IgG","Moderate","Journal Article (Peer-Reviewed)","S Noe","MUC Research","https://dx.doi.org/10.1007/s15010-020-01564-8","Unverified",0.007,0.031,"","","","DE",""
"2021-02-05","210112_Dammam_KingFahadSpecialistHospital_Overall","Detection of SARS-COV-2 Antibodies in Pediatric Kidney Transplant Patients","2021-01-12","Local","Saudi Arabia","Saudi Arabia; Eastern Province; Dammam","2020-08-15","2020-10-12","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",72.0,0.125,"Sequential","DIasorine, Abbott Laboratories","IgG","High","Preprint","Alanoud Alshami","King Fahad Specialist Hospital","https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf","Verified","","","","","","SA","SA-04"
"2021-02-06","200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre","SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India","2020-09-16","Local","India","India; Kerala","2020-07-11","2020-07-24","Health care workers and caregivers","Multiple groups",635.0,0.0,"Convenience","Abbott, Roche Diagnostics, Ortho-Clinical Diagnostics","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Anil Kumar","Amrita Institute of Medical Sciences & Research Centre","http://dx.doi.org/10.1016/j.cmi.2020.09.013","Verified","","","","","Not reported","IN","IN-KL"
"2021-02-06","201022_Scotland_UniversityOfOxford_overall","Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.","2020-10-22","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-03-17","2020-05-18","Blood donors","Adults (18-64 years)",3500.0,0.032,"Simplified probability","N/A - Author designed","Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Craig P Thompson","University of Oxford","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685","Verified","","",0.94,1.0,"","GB","GB-SCT"
"2021-02-06","201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff","SARS-CoV-2 Seroprevalence in a Cohort of Asymptomatic, RT-PCR Negative Croatian First League Football Players","2020-11-04","Local","Croatia","Croatia","2020-05-29","2020-07-31","Non-essential workers and unemployed persons","Adults (18-64 years)",305.0,0.2,"Convenience","Euroimmun Medizinische Labordiagnostika AG","IgA; IgG","Moderate","Preprint","Adriana Vince","Croatian Football Federation","https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1","Verified","","","","","","HR",""
"2021-02-06","201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj","SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study","2020-12-15","National","Iran (Islamic Republic of)","Iran (Islamic Republic of)","2020-04-17","2020-06-02","Household and community samples","Multiple groups",3530.0,0.171,"Stratified probability","Pishtaz Teb","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Hossein Poustchi","Tehran University of Medical Sciences","http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6","Verified",0.146,0.195,0.669,0.982,"","IR",""
"2021-02-06","201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj","SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study","2020-12-15","National","Iran (Islamic Republic of)","Iran (Islamic Republic of)","2020-04-17","2020-06-02","Multiple populations","Multiple groups",5372.0,0.2,"Stratified probability","Pishtaz Teb","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Hossein Poustchi","Tehran University of Medical Sciences","http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6","Verified",0.185,0.217,0.669,0.982,"","IR",""
"2021-02-06","201216_Germany_Ruhr-UniversityBochum_overall","Coronavirus Disease 2019 Associated Risk Score, Behavior, and Symptom Prevalence in German Transplant Recipients.","2020-12-16","Local","Germany","Germany","2020-04-01","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",99.0,0.03,"Sequential","Euroimmun","IgG; IgA","High","Journal Article (Peer-Reviewed)","Constantin J Thieme","Ruhr-University Bochum","https://dx.doi.org/10.1016/j.transproceed.2020.12.001","Verified","","","","","","DE",""
"2021-02-06","210112_Spain_HMHospitales_overall","Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain","2021-01-12","National","Spain","Spain","2020-04-15","2020-06-30","Health care workers and caregivers","Multiple groups",6038.0,0.11,"Convenience","Snibe Diagnostic","IgG","Moderate","Journal Article (Peer-Reviewed)","Jose Varona","HM Hospidales","https://dx.doi.org/10.1093/ije/dyaa277","Unverified","","",0.912,0.977,"","ES",""
"2021-02-06","210120_Antwerp_UniversityofAntwerp_primary","Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium","2021-01-20","Local","Belgium","Belgium","2020-06-03","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",431.0,0.032,"Convenience","Euroimmune, AG, Lubeck","IgG","High","Journal Article (Peer-Reviewed)","Kawtar El Abdellati","University of Antwerp","https://dx.doi.org/10.1192/bjo.2020.172","Verified",0.019,0.054,0.8,0.985,"","BE",""
"2021-02-07","201120_Japan_TokyoNationalHospital_overall","Detection of anti-SARS-CoV-2 antibodies in patients with rheumatoid arthritis","2020-11-20","Local","Japan","Japan","2020-06-01","2020-10-30","Patients seeking care for non-COVID-19 reasons","Seniors (65+ years)",93.0,0.161,"Convenience","1) Roche Diagnostics,; 2) GenBody","IgG; IgM","High","Preprint","Shomi Oka","Tokyo National Hospital","https://www.researchsquare.com/article/rs-112294/v1","Verified","","","","","","JP",""
"2021-02-07","201203_Athens_UniversityOfAthens_Overall_BothAdj","Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19","2020-12-03","Local","Greece","Greece; Attica; Athens","2020-04-13","2020-05-15","Health care workers and caregivers","Multiple groups",1495.0,0.013,"Convenience","Genebody Inc","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mina Psichogiou","University of Athens","https://dx.doi.org/10.1371/journal.pone.0243025","Verified",0.004,0.033,0.741,1.0,"","GR","GR-I"
"2021-02-07","201221_Spain_HospitalClínicoUniversitarioLozanoBlesa","SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: a false friend?","2020-12-21","Local","Spain","Spain; Zaragoza; Zaragoza","2020-04-27","2020-05-29","Pregnant or parturient women","Adults (18-64 years)",169.0,0.083,"Sequential","Guangzhou Wondfo Biotech Co. , Abbott, Vircell Microbiologists","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Fabre","Hospital Clínico Universitario Lozano Blesa","https://dx.doi.org/10.1177/0004563220980495","Verified","","","","","","ES","ES-AR"
"2021-02-07","210107_China_WuhanUniversity","Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China","2021-01-07","Regional","China","China; Hubei","2020-03-06","2020-05-03","Essential non-healthcare workers","Multiple groups",63107.0,0.007,"Unclear","Innovita, Tangshan, China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shuhui Duan","Wuhan University","https://dx.doi.org/10.1371/journal.pntd.0008975","Unverified","","","","","","CN","CN-42"
"2021-02-07","210113_Wakayama_WakayamaMedicalUniversity_overall","Immunochromatographic SARS-CoV-2 IgG antibody assay: a cross-sectional study conducted at Wakayama Medical University in Japan","2021-01-13","Local","Japan","Japan","2020-07-07","2020-09-15","Health care workers and caregivers","Multiple groups",1528.0,0.008,"Convenience","Kurabo Industries Ltd","IgG","High","Preprint","Sadahiro Iwabuchi","Wakayama Medical University","https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1","Unverified",0.003,0.012,0.764,1.0,"","JP",""
"2021-02-07","210116_SaudiArabia_MinistryofHealth_overall","Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early month of the pandemic in Saudi Arabia","2021-01-16","National","Saudi Arabia","Saudi Arabia","2020-05-20","2020-05-25","Blood donors","Adults (18-64 years)",837.0,0.014,"Convenience","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Ayman Banjar","Ministry of Health (Saudi Arabia)","https://dx.doi.org/10.1016/j.ijid.2021.01.028","Verified","","",0.998,0.995,"","SA",""
"2021-02-08","201101_ Borgosesia_ASLVercelli_overall","[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].","2020-11-01","Local","Italy","Italy; Piedmont; Borgosesia","2020-05-23","2020-05-24","Household and community samples","Multiple groups",4987.0,0.049,"Self-referral","Prima Lab SA","IgG; IgM","High","Journal Article (Peer-Reviewed)","Daniela Alessi","ASL Vercelli","https://dx.doi.org/10.19191/EP20.5-6.S2.119","Verified",0.043,0.056,1.0,0.98,"","IT","IT-21"
"2021-02-08","211104_Karnataka_Mapmygenome_primary_adj","Prevalence of SARS-CoV-2 in Karnataka, India","2021-02-04","Regional","India","India; Karnataka","2020-06-15","2020-08-29","Household and community samples","Multiple groups",1197.0,0.467,"Stratified probability","Translational Health Science and Technology Institute, India","IgG","Moderate","Journal Article (Peer-Reviewed)","Manoj Mohanan","Mapmygenome","https://dx.doi.org/10.1001/jama.2021.0332","Verified",0.433,0.5,0.847,1.0,"","IN","IN-KA"
"2021-02-09","210306_Rome_UniversitaCattolicadelSacroCuore_VenousBloodTest_overall","COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests","2021-03-06","Local","Italy","Italy","2020-06-04","2020-07-03","Health care workers and caregivers","Multiple groups",4694.0,0.012,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Giuseppe Vetrugno","Università Cattolica del Sacro Cuore","http://dx.doi.org/10.3390/ijerph18052650","Verified","","",0.788,0.994,"","IT",""
"2021-02-10","210105_Jeddah_KingAbdulazizUniversity_overall","Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia","2021-01-05","Local","Saudi Arabia","Saudi Arabia","2020-01-01","2020-05-31","Blood donors","Adults (18-64 years)",956.0,0.015,"Sequential","Authors","IgG","High","Journal Article (Peer-Reviewed)","Thamir Alandijany","King Abdulaziz University","https://dx.doi.org/10.3390/healthcare9010051","Verified","","",1.0,0.984,"","SA",""
"2021-02-11","210111_UK_PublicHealthEngland_Round1_overall","Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020","2021-01-20","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-15","Multiple populations","Multiple groups",2198.0,0.136,"Simplified probability","Abbott","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198","Verified",0.124,0.151,"","","","GB","GB-ENG"
"2021-02-11","210111_UK_PublicHealthEngland_Round2_overall","Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020","2021-01-20","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-07-07","2020-07-21","Household and community samples","Multiple groups",1431.0,0.121,"Simplified probability","Abbott","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198","Verified",0.105,0.139,"","","","GB","GB-ENG"
"2021-02-11","210111_UK_PublicHealthEngland_Round3_overall","Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020","2021-01-20","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-11-17","2020-11-30","Household and community samples","Multiple groups",1216.0,0.104,"Simplified probability","Abbott","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198","Verified",0.088,0.123,"","","","GB","GB-ENG"
"2021-02-11","210115_Massachusetts_HarvardUniversity_Overall","Development of at-home sample collection logistics for large scale SARS-CoV-2 seroprevalence studies","2021-01-15","Regional","United States of America","United States of America; Massachusetts","2020-06-16","2020-08-24","Household and community samples","Multiple groups",1872.0,0.032,"Convenience","Euroimmun","IgG","Moderate","Preprint","Aishani Aatresh","Harvard University","https://www.medrxiv.org/content/10.1101/2021.01.14.21249824v1","Verified","","","","","","US","US-MA"
"2021-02-12","201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj","Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in five localities in an Indian metropolitan city","2020-11-30","Local","India","India; Maharashtra; Pune","2020-07-20","2020-08-05","Household and community samples","Multiple groups",1659.0,0.513,"Stratified probability","In-house developed.","IgG","Moderate","Preprint","Aurnab Ghose","Indian Institute of Science Education and Research","https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text","Verified",0.399,0.624,"","","","IN","IN-MH"
"2021-02-12","201231_Modena_OspedaleCivileS.AgostinoEstense_overall","The prevalence of antibodies to SARS-CoV-2 in healthcare workers of Modena. the screening on more than 7000 subjects","2020-12-31","Local","Italy","Italy; Emilia-Romagna Region; Modena","2020-03-30","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",7711.0,0.05,"Convenience","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Valentina Pecoraro","Ospedale Civile S.Agostino Estense","https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696","Verified","","","","","","IT","IT-45"
"2021-02-12","210120_Iquitos_DIRESA_1monthFollowUp_overall_adj","Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru","2021-01-20","Local","Peru","Peru; Loreto; Iquitos","2020-08-13","2020-08-18","Household and community samples","Multiple groups",621.0,0.66,"Stratified probability","Zhejiang Orient Gene (Biotech Co LTD, China)","IgG; IgM","Low","Preprint","Carlos Alvarez-Antonio","Universidad de Ingeniería y Tecnología","https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1","Verified",0.62,0.701,0.958,1.0,"","PE","PE-LOR"
"2021-02-12","210204_Milan_ASSTFatebenefratelliSacco_PhaseII","Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy","2021-02-04","Local","Italy","Italy","2020-04-14","2020-04-22","Health care workers and caregivers","Adults (18-64 years)",608.0,0.042,"Convenience","Beijing Wantai Biolog- ical Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Milazzo","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.1136/oemed-2020-107060","Unverified","","",0.78,1.0,"","IT",""
"2021-02-12","210204_Milan_ASSTFatebenefratelliSacco_PhaseIII","Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy","2021-02-04","Local","Italy","Italy","2020-05-20","2020-05-27","Health care workers and caregivers","Adults (18-64 years)",629.0,0.046,"Convenience","Beijing Wantai Biolog- ical Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Milazzo","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.1136/oemed-2020-107060","Unverified","","",0.78,1.0,"","IT",""
"2021-02-12","210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall","Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy","2021-02-04","Local","Italy","Italy","2020-03-04","2020-03-12","Health care workers and caregivers","Adults (18-64 years)",679.0,0.004,"Convenience","Beijing Wantai Biolog- ical Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Milazzo","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.1136/oemed-2020-107060","Unverified","","",0.78,1.0,"","IT",""
"2021-02-13","201104_Cambridge_CambridgeUniversityHospitalsNHSFoundationTrust_HCW&HospitalStaff","A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital","2020-11-04","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Cambridge","2020-06-10","2020-08-07","Health care workers and caregivers","Multiple groups",5698.0,0.072,"Convenience","Siemens Healthcare Limited","Total Antibody","Moderate","Preprint","Daniel Cooper","Cambridge University Hospitals NHS Foundation Trust","https://doi.org/10.1101/2020.11.03.20220699","Verified","","",0.981,0.999,"","GB","GB-ENG"
"2021-02-13","201116_Leicester_UniversityofLeicester_HCW","Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff","2020-11-16","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; East Midlands; Leicester","2020-05-29","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",10662.0,0.108,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Christopher Martin","University of Leicester","https://dx.doi.org/10.1093/pubmed/fdaa199","Verified","","",0.935,1.0,"","GB","GB-ENG"
"2021-02-13","201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall","SARS-CoV-2 in first trimester pregnancy: a cohort study","2020-12-27","Local","Denmark","Denmark; Copenhagen; Copenhagen","2020-02-17","2020-04-17","Pregnant or parturient women","Adults (18-64 years)",1019.0,0.018,"Convenience","YHLO Biotechnology","IgG; IgM","High","Journal Article (Peer-Reviewed)","‪Nina Freiesleben","Copenhagen University Hospital","https://dx.doi.org/10.1093/humrep/deaa311","Verified","","","","","","DK","DK-84"
"2021-02-13","210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall","Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs","2021-01-05","Local","Italy","Italy","2020-05-01","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",245.0,0.009,"Convenience","1) Kehua Bio- engineering; 2) Tecan","IgG; IgM","High","Journal Article (Peer-Reviewed)","Fabrizio Bossa","Fondazione Casa Sollievo della Sofferenza","http://dx.doi.org/10.1016/j.dld.2020.12.120","Verified","","","","","","IT",""
"2021-02-14","210129_Eschweiler_St.AntoniusHospitalEschweiler_IgG","[Prevalence of SARS-CoV-2 in employees of a general hospital in Northrhine-Westphalia, Germany]","2021-01-29","Local","Germany","Germany; North Rhine-Westphalia; Eschweiler","2020-04-27","2020-05-20","Health care workers and caregivers","Multiple groups",1212.0,0.033,"Convenience","EUROIMMUN","IgG","Moderate","Journal Article (Peer-Reviewed)","Martin Platten","St. Antonius Hospital Eschweiler","https://dx.doi.org/10.1055/a-1322-5355","Verified","","",0.944,0.996,"","DE","DE-NW"
"2021-02-16","201230_Fukushima_ HirataCentralHospital_CLIA_IgG","The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers","2020-12-30","Local","Japan","Japan; Fukushima Prefecture; Hirata","2020-05-08","2020-05-28","Health care workers and caregivers","Multiple groups",637.0,0.009,"Unclear","YHLO Biotech Shenzhen, China","IgG","High","Journal Article (Peer-Reviewed)","Yurie Kobashi","Hirata Central Hospital","https://dx.doi.org/10.1016/j.intimp.2020.107360","Verified","","","","","","JP","JP-07"
"2021-02-16","210114_Puducherry_JawaharlalInstitute_August_primary","Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020","2021-01-14","Regional","India","India; Puducherry","2020-08-11","2020-08-16","Household and community samples","Multiple groups",869.0,0.049,"Stratified probability","Roche","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sitanshu Sekhar Kar","Jawaharlal Institute","https://dx.doi.org/10.3201/2702.204480","Verified",0.035,0.064,0.995,0.998,"","IN","IN-PY"
"2021-02-16","210114_Puducherry_JawaharlalInstitute_Oct_primary","Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020","2021-01-14","Regional","India","India; Puducherry","2020-10-12","2020-10-16","Household and community samples","Multiple groups",900.0,0.345,"Stratified probability","Roche","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sitanshu Sekhar Kar","Jawaharlal Institute","https://dx.doi.org/10.3201/2702.204480","Verified",0.315,0.377,0.995,0.998,"","IN","IN-PY"
"2021-02-16","210114_Puducherry_JawaharlalInstitute_Sep_primary","Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020","2021-01-14","Regional","India","India; Puducherry","2020-09-10","2020-09-16","Household and community samples","Multiple groups",898.0,0.207,"Stratified probability","Roche","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sitanshu Sekhar Kar","Jawaharlal Institute","https://dx.doi.org/10.3201/2702.204480","Verified",0.18,0.233,0.995,0.998,"","IN","IN-PY"
"2021-02-16","210129_Vienna_WroclawMedicalUniversity_overall","Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: a cross-sectional study","2021-01-29","Local","Austria","Austria; Vienna; Vienna","2020-05-18","2020-07-02","Students and Daycares","Children and Youth (0-17 years)",2042.0,0.012,"Convenience","1) Beijing Wantai Biological Pharmacy Enterprise; 2) N/A - author designed; 3) EUROIMMUN; 4) EUROIMMUN","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Zsolt Szepfalusi","Wroclaw Medical University","https://dx.doi.org/10.1111/pai.13459","Unverified","","","","","","AT","AT-9"
"2021-02-17","201206_Al-Madinah_TaibahUniversity_Overall","The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia","2020-12-11","Local","Saudi Arabia","Saudi Arabia","2020-05-15","2020-07-15","Blood donors","Adults (18-64 years)",1212.0,0.193,"Convenience","In-house, NR","IgG","High","Journal Article (Peer-Reviewed)","Waleed H Mahallawi","Taibah University","https://dx.doi.org/10.1016/j.sjbs.2020.12.009","Verified",0.171,0.216,"","","","SA",""
"2021-02-17","201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy","Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate","2020-10-21","Local","United States of America","United States of America; Washington; Seattle","2020-05-01","2020-05-31","Essential non-healthcare workers","Adults (18-64 years)",120.0,0.025,"Convenience","Abbott, unclear","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Amin Addetia","University of Washington","https://jcm.asm.org/content/58/11/e02107-20","Verified","","","","","","US","US-WA"
"2021-02-17","210203_Austria_MedicalUniversityOfVienna_Overall","Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel","2021-02-03","National","Austria","Austria","2020-05-11","2020-12-21","Health care workers and caregivers","Adults (18-64 years)",3301.0,0.005,"Convenience","LFA: TAmiRNA GmbH Austria; Roche; Diasorin","IgA; IgM; IgG","High","Preprint","Iris Leister","Medical University of Vienna","10.1101/2021.02.01.21250898","Verified","","","","","","AT",""
"2021-02-17","210203_England_TheUniversityofNottingham_HCW_primary","SARS-CoV-2 transmission from the healthcare setting into the home: a prospective longitudinal cohort study","2021-02-03","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; East Midlands","2020-04-24","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",633.0,0.18,"Convenience","Study authors","IgG; IgA; IgM","High","Preprint","Simon Craxford","The University of Nottingham","https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1","Unverified","","","","","","GB","GB-ENG"
"2021-02-17","210203_England_TheUniversityofNottingham_HHC_primary","SARS-CoV-2 transmission from the healthcare setting into the home: a prospective longitudinal cohort study","2021-02-03","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-09-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",178.0,0.073,"Convenience","Study authors","IgG; IgA; IgM","High","Preprint","Simon Craxford","The University of Nottingham","https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1","Unverified","","","","","","GB","GB-ENG"
"2021-02-18","210107_BuenosAires_UniversityOfBuenosAires_Primary","Assesment of SARS-CoV-2 infection-in dentists and supporting staff at a university dental hospital in Argentina","2021-01-07","Local","Argentina","Argentina","2020-03-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",317.0,0.03,"Stratified non-probability","NR","Not reported","High","Journal Article (Peer-Reviewed)","Puia Sebastian","University of Buenos Aires","https://dx.doi.org/10.1016/j.jobcr.2021.01.006","Verified",0.02,0.05,0.85,0.95,"","AR",""
"2021-02-18","210107_WestBank_ArabAmericanUniversity_Households_overall_adj","Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study","2021-01-07","Local","occupied Palestinian territory, including east Jerusalem","occupied Palestinian territory - including east Jerusalem","2020-06-15","2020-06-30","Household and community samples","Multiple groups",1355.0,0.0,"Stratified probability","Roche","Total Antibody","Low","Journal Article (Peer-Reviewed)","Nouar Qutob","Arab American University","https://bmjopen.bmj.com/content/11/2/e044552","Verified",0.0,0.004,0.839,1.0,"","PS",""
"2021-02-18","210107_WestBank_ArabAmericanUniversity_LabReferrals_overall_adj","Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study","2021-01-07","Local","occupied Palestinian territory, including east Jerusalem","occupied Palestinian territory - including east Jerusalem","2020-05-01","2020-07-09","Residual sera","Multiple groups",1136.0,0.003,"Convenience","Roche","Total Antibody","High","Journal Article (Peer-Reviewed)","Nouar Qutob","Arab American University","https://bmjopen.bmj.com/content/11/2/e044552","Verified",0.001,0.012,1.0,0.839,"","PS",""
"2021-02-19","210103_Pakistan_LiaquatUniversity_primary","Do COVID-19 Antibodies Provide Long-Term Protection?","2021-01-03","Local","Pakistan","Pakistan; NR; NR","2020-06-15","2020-08-15","Residual sera","Multiple groups",728.0,0.108,"Convenience","nr","Not reported","High","Journal Article (Peer-Reviewed)","Sheeba Ansari","Liaquat University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/","Verified","","",1.0,0.998,"","PK",""
"2021-02-19","210122_Germany_HeidelbergUniversity_Children_Overall_unadj","Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.","2021-01-22","Regional","Germany","Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","2020-04-22","2020-05-15","Students and Daycares","Children and Youth (0-17 years)",2482.0,0.009,"Self-referral","Euroimmun; Roche Elecsys' Mikrogen in-house","IgG","High","Journal Article (Peer-Reviewed)","Burkhard Tonshoff","Heidelberg University","https://dx.doi.org/10.1001/jamapediatrics.2021.0001","Verified","","","",0.996,"","DE","DE-BW"
"2021-02-19","210122_Germany_HeidelbergUniversity_Parents_Overall_unadj","Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.","2021-01-22","Regional","Germany","Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","2020-04-22","2020-05-15","Household and community samples","Adults (18-64 years)",2482.0,0.019,"Self-referral","Euroimmun; Roche Elecsys' Mikrogen in-house","IgG","High","Journal Article (Peer-Reviewed)","Burkhard Tonshoff","Heidelberg University","https://dx.doi.org/10.1001/jamapediatrics.2021.0001","Verified","","","",0.996,"","DE","DE-BW"
"2021-02-19","210208_Canada_CBS_BloodDonors_Overall_PopTestAdj","COVID-19 Seroprevalence Report February 8, 2021 Report #5: December 2020 Survey","2021-02-08","National","Canada","Canada","2020-12-10","2020-12-23","Blood donors","Multiple groups",16961.0,0.014,"Sequential","Abbott","IgG","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.012,0.016,0.927,0.999,"","CA",""
"2021-02-19","210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj","SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study","2021-02-08","National","France","France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","2020-06-04","2020-07-03","Students and Daycares","Children and Youth (0-17 years)",327.0,0.037,"Convenience","Biosynex","IgM; IgG","High","Journal Article (Peer-Reviewed)","Eric Lachassinne","Jean Verdier Hospital","https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext","Verified",0.013,0.068,0.918,0.992,"","FR",""
"2021-02-20","200930_Toulouse_CentreHospitalierUniversitaireDeToulouse_HCW&Staff","Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France","2020-09-30","Local","France","France","2020-06-10","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",8758.0,0.032,"Convenience","Beijing Wantai Biological Pharmacy Enterprise Co.","Total Antibody","High","Journal Article (Peer-Reviewed)","Chloe Dimeglio","Centre Hospitalier Universitaire (CHU) de Toulouse","http://dx.doi.org/10.1016/j.jinf.2020.09.035","Verified",0.028,0.035,"","","","FR",""
"2021-02-20","210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj","Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios","2021-01-29","Local","United States of America","United States of America; Pennsylvania; Philadelphia","2020-04-09","2020-08-08","Pregnant or parturient women","Adults (18-64 years)",1471.0,0.06,"Convenience","Authors","IgM; IgG","High","Journal Article (Peer-Reviewed)","Dustin D Flannery","University of Pennsylvania","https://dx.doi.org/10.1001/jamapediatrics.2021.0038","Verified","","","","","","US","US-PA"
"2021-02-20","210205_Ekaterinburg_RussianAcademyOfSciences_overall","SARS-CoV-2 Seropositivity among Dental Staff and the Role of Aspirating Systems.","2021-02-05","Local","Russian Federation","Russian Federation","2020-05-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",157.0,0.115,"Convenience","VECTOR-BEST","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Sarapultseva","Russian Academy of Sciences","https://dx.doi.org/10.1177/2380084421993099","Verified","","","","","","RU",""
"2021-02-21","210120_Chennai_NationalInstituteOfEpidemiology_primary_adj","Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India","2021-01-20","Local","India","India","2020-07-01","2020-07-31","Household and community samples","Multiple groups",12405.0,0.184,"Stratified probability","Abbott","IgG","Low","Journal Article (Peer-Reviewed)","Sriram Selvaraju","National Institute of Epidemiology","https://dx.doi.org/10.3201/eid2702.203938","Verified",0.148,0.226,1.0,0.996,"","IN",""
"2021-02-21","210129_Stockholm_KarolinskaInstitutet_HCW","Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care","2021-01-29","Local","Sweden","Sweden; Uppland; Stockholm","2020-05-11","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",3981.0,0.177,"Convenience","NR","IgG","Moderate","Preprint","Susanna Klevebro","Karolinska Institutet","https://doi.org/10.1101/2021.01.28.21250664","Verified","","",0.992,0.998,"","SE","SE-AB"
"2021-02-22","201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj","Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India","2020-11-13","Local","India","India; Maharashtra; Mumbai","2020-06-29","2020-07-19","Household and community samples","Multiple groups",2702.0,0.171,"Stratified probability","Abbott Laboratories","IgG","Low","Journal Article (Peer-Reviewed)","Anup Malani","Tata Institute for Fundamental Research","http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8","Verified",0.158,0.184,0.9,0.99,"","IN","IN-MH"
"2021-02-22","201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj","Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India","2020-11-13","Local","India","India; Maharashtra; Mumbai","2020-06-29","2020-07-19","Persons living in slums","Multiple groups",4202.0,0.583,"Stratified probability","Abbott Laboratories","IgG","Low","Journal Article (Peer-Reviewed)","Anup Malani","Tata Institute for Fundamental Research","http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8","Verified",0.568,0.599,0.9,0.99,"","IN","IN-MH"
"2021-02-22","210117_Maryland_UniversityofMaryland_overall_adj","Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers","2021-01-17","Local","United States of America","United States of America; Maryland; Baltimore","2020-06-03","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",8399.0,0.035,"Convenience","1) Ortho Vitros ; 2) N/A - institution desgined","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Kristin E Mullins","University of Maryland","http://dx.doi.org/10.1016/j.clinbiochem.2021.01.004","Verified",0.03,0.04,"","","","US","US-MD"
"2021-02-22","210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall","SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study","2021-01-29","Local","Germany","Germany","2020-11-02","2020-11-16","Household and community samples","Multiple groups",576.0,0.014,"Stratified probability","NR","IgG","Moderate","Preprint","Stefanie Theuring","Universitätsmedizin Berlin","https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1","Verified",0.006,0.027,"","","","DE",""
"2021-02-22","210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall","SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study","2021-01-29","Local","Germany","Germany","2020-11-02","2020-11-16","Essential non-healthcare workers","Adults (18-64 years)",141.0,0.014,"Stratified probability","NR","IgG","Moderate","Preprint","Stefanie Theuring","Universitätsmedizin Berlin","https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1","Verified",0.002,0.05,"","","","DE",""
"2021-02-22","210129_Berlin_UniversitätsmedizinBerlin_Students_Overall","SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study","2021-01-29","Local","Germany","Germany","2020-11-02","2020-11-16","Students and Daycares","Children and Youth (0-17 years)",347.0,0.02,"Stratified probability","NR","IgG","Moderate","Preprint","Stefanie Theuring","Universitätsmedizin Berlin","https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1","Verified",0.008,0.041,"","","","DE",""
"2021-02-22","210131_USA_NIH_primary","Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States","2021-01-31","National","United States of America","United States of America","2020-04-01","2020-08-04","Household and community samples","Multiple groups",8058.0,0.046,"Stratified non-probability","N/A - author designed","IgG; IgM; IgA","Moderate","Preprint","Heather Kalish","National Institute of Health","https://pubmed.ncbi.nlm.nih.gov/33532807/","Verified",0.026,0.065,"","","","US",""
"2021-02-23","201124_Vasteras_HospitalofVastmanland_HCW","Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.","2020-11-24","Local","Sweden","Sweden","2020-05-04","2020-08-19","Health care workers and caregivers","Adults (18-64 years)",131.0,0.191,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Mulki Rashid Abdi","The Hospital of Vastmanland","https://dx.doi.org/10.1080/23744235.2020.1849787","Verified","","",1.0,0.999,"","SE",""
"2021-02-23","210125_Canada_UniversityofToronto_Phase1_Overall_Popdj_sp","COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada","2021-01-25","National","Canada","Canada","2020-05-15","2020-06-15","Household and community samples","Multiple groups",7068.0,0.017,"Stratified non-probability","Network Biology Collaborative; Centre at Sinai Health","IgG","Moderate","Preprint","Xuyang Tang","University of Toronto","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659","Verified","","","","","","CA",""
"2021-02-23","210127_Merano_FranzTappeinerHospital_HCW_primary","Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers","2021-01-27","Local","Italy","Italy","2020-06-22","2020-07-17","Health care workers and caregivers","Adults (18-64 years)",36.0,0.055,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Dominic Fong","Franz Tappeiner Hospital","https://dx.doi.org/10.1007/s00508-020-01807-6","Unverified","","",1.0,0.996,"","IT",""
"2021-02-23","210127_Merano_FranzTappeinerHospital_patients_primary","Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers","2021-01-27","Local","Italy","Italy","2020-06-22","2020-07-17","Patients seeking care for non-COVID-19 reasons","Multiple groups",250.0,0.008,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Dominic Fong","Franz Tappeiner Hospital","https://dx.doi.org/10.1007/s00508-020-01807-6","Verified","","",1.0,0.996,"","IT",""
"2021-02-23","210205_Poland_CentralClinicalHospital_HCWs_IgG","Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","2021-02-05","National","Poland","Poland","2020-05-01","2020-06-15","Health care workers and caregivers","Multiple groups",432.0,0.016,"Stratified non-probability","Vircell Microbiologists","IgG","High","Journal Article (Peer-Reviewed)","Michal Lodyga","Central Clinical Hospital of the Ministry of the Interior and Administration","https://dx.doi.org/10.20452/pamw.15796","Verified","","",0.85,0.98,"","PL",""
"2021-02-23","210205_Poland_CentralClinicalHospital_IBDPatients_IgG","Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","2021-02-05","National","Poland","Poland","2020-05-01","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",432.0,0.046,"Sequential","Vircell Microbiologists","IgG","High","Journal Article (Peer-Reviewed)","Michal Lodyga","Central Clinical Hospital of the Ministry of the Interior and Administration","https://dx.doi.org/10.20452/pamw.15796","Verified","","",0.88,0.99,"","PL",""
"2021-02-24","201021_London_BartsHealthNHSTrust_primary","COVID-19 prevalence and seroconversion in an urban hemodialysis unit in the United Kingdom","2020-10-21","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-05-01","2020-06-04","Patients seeking care for non-COVID-19 reasons","Multiple groups",1253.0,0.18,"Convenience","Roche","IgG; IgM","High","Journal Article (Peer-Reviewed)","Kieran McCafferty","Barts Health NHS Trust","http://dx.doi.org/10.1111/hdi.12883","Verified","","","","","","GB",""
"2021-02-24","201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1","Serologic Evaluation of Healthcare Workers Caring for COVID-19 Patients in the Republic of Korea.","2020-11-20","National","Republic of Korea","Republic of Korea","2020-04-26","2020-05-09","Health care workers and caregivers","Adults (18-64 years)",309.0,0.003,"Convenience","PCL Inc","Total Antibody","High","Journal Article (Peer-Reviewed)","Jae Hoon Ko","Sungkyunkwan University School of Medicine","https://dx.doi.org/10.3389/fmicb.2020.587613","Verified","","",0.982,1.0,"","KR",""
"2021-02-24","201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1","Serologic Evaluation of Healthcare Workers Caring for COVID-19 Patients in the Republic of Korea.","2020-11-20","National","Republic of Korea","Republic of Korea","2020-04-26","2020-05-09","Health care workers and caregivers","Adults (18-64 years)",123.0,0.0,"Convenience","PCL Inc","Total Antibody","High","Journal Article (Peer-Reviewed)","Jae Hoon Ko","Sungkyunkwan University School of Medicine","https://dx.doi.org/10.3389/fmicb.2020.587613","Verified","","",0.982,1.0,"","KR",""
"2021-02-24","210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj","Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study","2021-01-19","Local","China","China","2020-04-17","2020-04-23","Household and community samples","Multiple groups",350.0,0.0,"Convenience","Beijing Wantai Biological Pharmacy Enterprise","Total Antibody","High","Journal Article (Peer-Reviewed)","Zhen Zhang","Shenzhen Center for Disease Control and Prevention","https://dx.doi.org/10.1016/S2666-5247(20)30200-7","Verified",0.0,0.011,0.98,0.99,"","CN",""
"2021-02-24","210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj","Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study","2021-01-19","Local","China","China","2020-04-17","2020-04-23","Household and community samples","Multiple groups",50.0,0.0,"Convenience","Beijing Wantai Biological Pharmacy Enterprise","Total Antibody","High","Journal Article (Peer-Reviewed)","Zhen Zhang","Shenzhen Center for Disease Control and Prevention","https://dx.doi.org/10.1016/S2666-5247(20)30200-7","Verified",0.0,0.068,0.98,0.99,"","CN",""
"2021-02-24","210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj","Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study","2021-01-19","Local","China","China","2020-04-12","2020-05-04","Contacts of COVID patients","Multiple groups",880.0,0.041,"Convenience","Beijing Wantai Biological Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Zhen Zhang","Shenzhen Center for Disease Control and Prevention","https://dx.doi.org/10.1016/S2666-5247(20)30200-7","Verified",0.029,0.057,0.98,0.99,"","CN",""
"2021-02-25","210121_Denmark_CopenhagenUniversityHospital_Denmark","Prevalence of SARS-CoV-2 IgG/IgM antibodies among Danish and Swedish Falck emergency and non-emergency healthcare workers","2021-01-21","National","Denmark","Denmark","2020-06-22","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",2024.0,0.028,"Convenience","Livson Diagnostics, Zhuhai, Gunangdong, China; Guangzhou Wondfo Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jannie Laursen","Copenhagen University Hospital","https://dx.doi.org/10.3390/ijerph18030923","Verified","","","","","","DK",""
"2021-02-25","210121_Sweden_CopenhagenUniversityHospital_Sweden","Prevalence of SARS-CoV-2 IgG/IgM antibodies among Danish and Swedish Falck emergency and non-emergency healthcare workers","2021-01-21","National","Sweden","Sweden","2020-06-22","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",1248.0,0.083,"Convenience","Livson Diagnostics, Zhuhai, Gunangdong, China; Guangzhou Wondfo Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jannie Laursen","Copenhagen University Hospital","https://dx.doi.org/10.3390/ijerph18030923","Verified","","","","","","SE",""
"2021-02-25","210201_Minnesota_UniversityofMinnesota_HCW_Primary","Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA","2021-02-01","Regional","United States of America","United States of America; Minnesota","2020-04-13","2020-05-21","Health care workers and caregivers","Multiple groups",1282.0,0.03,"Convenience","N/A - author designed","Total Antibody","High","Journal Article (Peer-Reviewed)","Stefani Thomas","University of Minnesota","https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010","Verified",0.02,0.039,0.861,1.0,"","US","US-MN"
"2021-02-25","210201_Minnesota_UniversityofMinnesota_OutPatients_Primary","Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA","2021-02-01","Regional","United States of America","United States of America; Minnesota","2020-04-13","2020-05-21","Residual sera","Multiple groups",2379.0,0.045,"Convenience","N/A - author designed","Total Antibody","High","Journal Article (Peer-Reviewed)","Stefani Thomas","University of Minnesota","https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010","Verified",0.036,0.053,0.861,1.0,"","US","US-MN"
"2021-02-26","210118_France_SorbonneUniversité_primary","Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population","2021-01-18","National","France","France; Île-de-France and Grand Est","2020-05-15","2020-06-15","Household and community samples","Multiple groups",9782.0,0.035,"Simplified probability","1) EuroImmun; 2) EuroImmun; 3) N/A - author desgined","IgG","Moderate","Journal Article (Peer-Reviewed)","Nathanael Lapidus","Sorbonne Université","https://dx.doi.org/10.1016/j.idnow.2020.12.007","Verified","","","","","","FR",""
"2021-02-26","210226_Estonia_UniversityOfTartu_Stage14_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","Estonia","Estonia","2021-02-11","2021-02-22","Household and community samples","Multiple groups",2626.0,0.115,"Stratified probability","Synlab","IgG","Moderate","Institutional Report","University of Tartu","University of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.103,0.128,"","","","EE",""
"2021-02-27","201026_UpstateNewYork_BassettMedicalCenter_Overall copy","SARS-CoV-2 IgG Results Among Healthcare Workers in a Rural Upstate New York Hospital System","2020-10-26","Local","United States of America","United States of America; New York; Upstate New York","2020-05-04","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",762.0,0.045,"Unclear","Ortho-Clinical Diagnostics, Linden, NJ","IgG","High","Journal Article (Peer-Reviewed)","Wendy M Brunner","Bassett Medical Center","https://dx.doi.org/10.1017/ice.2020.1296","Verified","","",1.0,0.996,"","US","US-NY"
"2021-02-27","201027_Perugia_UniversityofPerugia_HIVNegative2_Overall","Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV","2020-10-27","Local","Italy","Italy; Umbria; Perugia","2020-05-04","2020-05-31","Multiple populations","Multiple groups",2843.0,0.054,"Unclear","Screen Italia","IgG","Unclear","Journal Article (Peer-Reviewed)","Chiara Papalini","University of Perugia","https://dx.doi.org/10.4084/MJHID.2020.080","Verified","","","","","","IT","IT-55"
"2021-02-27","210115_Norway_NorwegianArmedForcesJointMedicalServices_primary","Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts","2021-01-15","National","Norway","Norway","2020-04-19","2020-04-27","Essential non-healthcare workers","Adults (18-64 years)",1170.0,0.007,"Convenience","Roche","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Einar Kristian Borud","Norwegian Armed Forces Joint Medical Services","https://dx.doi.org/10.1002/hsr2.233","Verified","","","","","","NO",""
"2021-02-27","210125_Canada_UniversityofToronto_Phase2_Overall_PopAdj","COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada","2021-01-25","National","Canada","Canada","2020-08-15","2020-09-15","Household and community samples","Multiple groups",1899.0,0.019,"Stratified non-probability","Network Biology Collaborative; Centre at Sinai Health","IgG","Moderate","Preprint","Xuyang Tang","University of Toronto","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659","Verified","","","","","","CA",""
"2021-02-27","210127_Madrid_UH-FundacionJimenezDiazUAM_primary","Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients","2021-01-27","Local","Spain","Spain; Community of Madrid; Madrid","2020-03-01","2020-03-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",28.0,0.429,"Convenience","Vircell","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Soledad Pizarro Sanchez","UH-Fundacion Jimenez Diaz UAM","https://dx.doi.org/10.1159/000512535","Verified","","","","","","ES","ES-MD"
"2021-02-28","201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children","Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: A cross-sectional study","2020-11-19","Local","France","France; Île-de-France; Paris","2020-04-14","2020-05-12","Residual sera","Children and Youth (0-17 years)",605.0,0.107,"Sequential","Biosynex","IgG; IgM","High","Journal Article (Peer-Reviewed)","Robert Cohen","Centre Hospitalier Intercommunal de Créteil","http://dx.doi.org/10.1136/bmjpo-2020-000887","Verified",0.084,0.135,0.918,0.992,"","FR","FR-IDF"
"2021-02-28","210120_Japan_ResearchInstituteOfTuberculosis_GenPop","Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020","2021-01-20","National","Japan","Japan","2020-06-01","2020-06-07","Household and community samples","Multiple groups",7950.0,0.001,"Stratified probability","Roche Diagnostics, Abbott Laboratories, NA","Total Antibody; IgG","Low","Journal Article (Peer-Reviewed)","Takashi Yoshiyama","Government of Japan","https://dx.doi.org/10.3201/eid2702.204088","Verified",0.0,0.002,"","","","JP",""
"2021-03-01","210101_London_LewishamGreenwichNHSTrust_HCW_Overall","Prevalence and socio-demographic factors of SARS-CoV-2 antibody in multi-ethnic healthcare workers","2021-01-01","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Lewisham, Greenwich","2020-05-27","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",6212.0,0.26,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Mehool Patel","Lewisham and greenwich NHS Trust","https://dx.doi.org/10.7861/clinmed.2020-0619","Verified","","",0.99,1.0,"","GB","GB-ENG"
"2021-03-03","200928_CapeTown_UniversityofCapeTown_overall_testadj","SARS-CoV-2 Seroprevalence in the Cape Town Metropolitan sub-districts after the peak of infectons","2020-09-20","Local","South Africa","South Africa","2020-06-15","2020-08-07","Residual sera","Adults (18-64 years)",2791.0,0.446,"Sequential","Roche Diagnostics","IgG; IgM","High","Institutional Report","Marvin Hsiao","University of Cape Town","https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf","Verified",0.426,0.466,0.912,0.997,"","ZA",""
"2021-03-03","210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG","Correlation of SARS-CoV-2 serology and clinical phenotype amongst hospitalised children in a tertiary children's hospital in India","2021-02-01","Local","India","India; Tamil Nadu; Chennai","2020-06-01","2020-09-30","Residual sera","Children and Youth (0-17 years)",463.0,0.196,"Convenience","YHLO Biotechnology Corporation","IgG","High","Preprint","Aishwarya Venkataraman","Bristol Royal Hospital for Children","https://www.medrxiv.org/content/10.1101/2021.01.29.21250660v1","Verified",0.154,0.225,"","","","IN","IN-TN"
"2021-03-04","201123_Quebec_InstitutNationaldeSantePublique_overall","COVID-19 : Étude de séroprévalence chez des travailleurs de la santé de centres hospitaliers au Québec","2020-11-23","Regional","Canada","Canada; Québec","2020-07-06","2020-09-24","Health care workers and caregivers","Multiple groups",2056.0,0.117,"Stratified non-probability","DiaSorin","IgG","High","Institutional Report","Nicholas Brousseau","Institut National de Sante Publique","https://www.inspq.qc.ca/publications/3084-etude-seroprevalence-travailleurs-sante-centres-hospitaliers-quebec-covid19","Verified","","",0.884,"","","CA","CA-QC"
"2021-03-04","210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall","Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study","2021-01-12","Local","Italy","Italy; Province of Avellino in the Campania region; Ariano Irpino","2020-05-16","2020-05-19","Household and community samples","Multiple groups",13218.0,0.056,"Convenience","Roche","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Pellegrino Cerino","The Zoo-Prophylactic Institute of Southern Italy","https://www.future-science.com/doi/10.2144/fsoa-2020-0203","Verified",0.052,0.06,"","","","IT","IT-72"
"2021-03-04","210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall","Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia","2021-01-31","Local","Saudi Arabia","Saudi Arabia","2020-06-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",400.0,0.075,"Unclear","N/A - Author designed","IgG","High","Preprint","Naif Khalaf Alharbi","King Abdullah International Medical Research Center","https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1","Verified",0.05,0.102,"","","","SA",""
"2021-03-04","210131_SaudiArabia_KingAbdullahInternationalMedicalResearchCenter_genpop_overall","Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia","2021-01-31","National","Saudi Arabia","Saudi Arabia; Riyadh, Jazan, Qassim, Hail, Al-Ahsa, Makkah","2020-06-15","2020-11-15","Multiple general populations","Multiple groups",11275.0,0.109,"Convenience","1) N/A - author designed; 2) EUROIMMUN","IgG","Moderate","Preprint","Naif Khalaf Alharbi","King Abdullah International Medical Research Center","https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1","Verified",0.103,0.116,"","","","SA",""
"2021-03-04","210201_Washington_ChildrensNationalHospital_Overall_TestAdj","Estimated SARS-CoV-2 Seroprevalence in Healthy Children and Those with Chronic Illnesses in The Washington Metropolitan Area as of October 2020","2021-02-01","Local","United States of America","United States of America; Washington, D.C, Maryland, Virginia, West Virginia; Washington D.C","2020-07-07","2020-10-29","Residual sera","Children and Youth (0-17 years)",385.0,0.095,"Convenience","Diasorin","IgG","High","Journal Article (Peer-Reviewed)","Burak Bahar","Children's National Hospital","https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text","Verified",0.067,0.13,0.976,0.993,"","US",""
"2021-03-04","210203_NewYorkCity_IcahnSchoolOfMedicine_Overall","Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study, New York City","2021-02-03","Local","United States of America","United States of America; New York; New York City","2020-04-20","2020-08-15","Pregnant or parturient women","Adults (18-64 years)",696.0,0.15,"Convenience","Icahn School of Medicine at Mount Sinai (FDA EUA)","IgG","Moderate","Preprint","Nina Molenaar","Icahn School of Medicine at Mount Sinai","10.1101/2021.02.01.21250943","Verified","","",0.95,1.0,"","US","US-NY"
"2021-03-05","210125_NewYork_CDC+NewYorkCity_Total","Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020","2021-01-25","Local","United States of America","United States of America; New York; New York City","2020-05-18","2020-07-02","Essential non-healthcare workers","Multiple groups",22647.0,0.225,"Convenience","ORTHO Clinical Diagnostics Inc., https://www.orthoclinicaldiagnostics.com","IgG","Moderate","Journal Article (Peer-Reviewed)","Samira Sami","CDC and New York City Department of Health and Mental Hygiene","https://dx.doi.org/10.3201/eid2703.204340","Unverified",0.219,0.23,0.9,1.0,"","US","US-NY"
"2021-03-06","201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall","Maricopa County COVID-19 serosurvey results reported","2020-12-14","Local","United States of America","United States of America; Arizona","2020-09-11","2020-09-21","Household and community samples","Multiple groups",260.0,0.107,"Stratified probability","NR","Not reported","Unclear","News and Media","Fountain Hills Times","Maricopa County Department of Public Health","https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html","Verified","","","","","","US","US-AZ"
"2021-03-06","210209_Singapore_MinistryOfHealthSingapore","Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore","2021-02-09","Local","Singapore","Singapore; Singapore; Singapore","2020-03-25","2020-07-25","Multiple populations","Adults (18-64 years)",135760.0,0.601,"Convenience","Siemens, Abbott, or Roche","Not reported","Moderate","Journal Article (Peer-Reviewed)","Iain Tan","Ministry of Health Singapore","https://dx.doi.org/10.1001/jama.2020.24071","Verified","","","","","","SG",""
"2021-03-07","200830_VenturaCounty_OxnardFireDepartment_overall","Study reveals data on COVID-19 antibody prevalence in Ventura County","2020-08-30","Local","United States of America","United States of America; California","2020-06-22","2020-07-06","Household and community samples","Multiple groups",6794.0,0.013,"Self-referral","1) Abbott; 2) Bio-Rad","Not reported","High","News and Media","Jeremy Childs","Oxnard Fire Department","https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/","Verified","","","","","","US","US-CA"
"2021-03-07","201005_Wisconsin_UW-Madison_overall","Less than 2% of Wisconsinites have coronavirus antibodies, preliminary results from study show","2020-10-05","Regional","United States of America","United States of America; Wisconsin","2020-07-15","2020-08-15","Household and community samples","Multiple groups",1056.0,0.016,"Stratified probability","NR","Not reported","Unclear","News and Media","Madeline Heim","UW-Madison","https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/","Verified","","","","","","US","US-WI"
"2021-03-07","201031_Bhubaneswar_RegionalMedicalResearchCentre_overall","Survey: 50% of Bhubaneswar residents have antibodies","2020-10-31","Local","India","India","2020-10-16","2020-10-18","Household and community samples","Multiple groups",1403.0,0.5,"Simplified probability","NR","Not reported","Unclear","News and Media","Riyan Ramanath","The Regional Medical Research Centre in Bhubaneswar","https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms","Verified","","","","","","IN",""
"2021-03-07","201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop","COVID-19 Serology Tests Still Show Low Antibody Rate of 0.07%","2020-11-23","National","Republic of Korea","Republic of Korea","2020-08-15","2020-10-15","Household and community samples","Multiple groups",1379.0,0.002,"Unclear","NR","Not reported","Unclear","News and Media","KBS World","Korea Disease Control and Prevention Agency","https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801","Verified","","","","","","KR",""
"2021-03-07","201123_Korea_KoreaDiseaseControlAndPreventionAgency_military","COVID-19 Serology Tests Still Show Low Antibody Rate of 0.07%","2020-11-23","National","Republic of Korea","Republic of Korea","2020-08-15","2020-10-15","Essential non-healthcare workers","Adults (18-64 years)",6900.0,0.004,"Unclear","NR","Not reported","Unclear","News and Media","KBS World","Korea Disease Control and Prevention Agency","https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801","Verified","","","","","","KR",""
"2021-03-07","201203_Florida_FloridaDepartmentOfHealth_primary","Lake, Sumter residents testing positive for COVID antibody remain below state average","2020-12-03","Regional","United States of America","United States of America; Florida","2020-05-01","2020-11-30","Household and community samples","Multiple groups",630838.0,0.11,"Self-referral","NR","IgG; Total Antibody","Unclear","News and Media","Frank Jolley","Florida Department of Health","https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/","Verified","","","","","","US","US-FL"
"2021-03-07","201222_Warsaw_CentralClinicalHospitalMSWiA","The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy.","2020-12-22","Local","Poland","Poland","2020-04-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",61.0,0.164,"Sequential","Vircell Microbiologist, Granada, Spain:","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Piotr Ciechanowicz","Central ClinicalHospital MSWiA","https://dx.doi.org/10.1080/09546634.2020.1861177","Verified","","","","","","PL",""
"2021-03-08","200824_Louiseville_UniversityOfLouiseville_HCW_July","New Co-Immunity Project data show COVID-19 infection among health care workers may be lower than the general population","2020-08-24","Local","United States of America","United States of America; Kentucky; Louiseville","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1100.0,0.022,"Convenience","NR","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/","Verified","","","","","","US","US-KY"
"2021-03-08","201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling","Co-Immunity Project shows COVID-19 infection rate in Jefferson County increased tenfold since September","2020-11-24","Local","United States of America","United States of America; Kentucky","2020-11-09","2020-11-16","Household and community samples","Multiple groups",1091.0,0.02,"Stratified probability","NR","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/","Verified","","","","","","US","US-KY"
"2021-03-08","201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall","Co-Immunity Project shows COVID-19 infection rate in Jefferson County increased tenfold since September","2020-11-24","Local","United States of America","United States of America; Kentucky","2020-11-09","2020-11-16","Household and community samples","Multiple groups",1709.0,0.033,"Self-referral","NR","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/","Verified","","","","","","US","US-KY"
"2021-03-09","200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay","New Co-Immunity Project data show COVID-19 infection among health care workers may be lower than the general population","2020-08-24","Local","United States of America","United States of America; Kentucky; Louiseville","2020-04-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1372.0,0.01,"Convenience","NR","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/","Verified","","","","","","US","US-KY"
"2021-03-09","210128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall","High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacaja (Kayapo) indigenous population in the brazilian Amazon","2021-01-28","Local","Brazil","Brazil; Pará; Xikrin of Bacaja Villages","2020-09-01","2020-09-30","Household and community samples","Multiple groups",100.0,0.73,"Unclear","Euroimmun, Brazil","IgG","High","Journal Article (Peer-Reviewed)","Eliene Putira Sacuema Rodrigues","Instituto de Ciências Biológicas da Universidade Federal do Pará","https://dx.doi.org/10.1186/s12939-021-01392-8","Verified","","","","","Rapid immunochromatographic test; ELISA","BR","BR-PA"
"2021-03-09","210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj","Seroprevalence COVID-19 Düsseldorf: SERODUS I & II","2021-02-03","Local","Germany","Germany","2020-11-23","2020-11-27","Essential non-healthcare workers","Adults (18-64 years)",745.0,0.044,"Convenience","Roche","IgG; IgM; IgA","High","Institutional Report","Insa Backhaus","Institute Of Medical Sociology","https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus","Verified",0.031,0.062,0.9,0.998,"","DE",""
"2021-03-09","210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj","Seroprevalence COVID-19 Düsseldorf: SERODUS I & II","2021-02-03","Local","Germany","Germany","2020-11-02","2020-11-23","Household and community samples","Adults (18-64 years)",2186.0,0.031,"Simplified probability","Roche","IgG; IgA; IgM","Low","Institutional Report","Insa Backhaus","Institute Of Medical Sociology","https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus","Verified",0.024,0.04,0.9,0.998,"","DE",""
"2021-03-11","200731_Bremen_UniversityOfBremen_IgG/IgA","Low anti-SARS-CoV-2 seroprevalence among public sector employees in Bremen","2020-07-31","Local","Germany","Germany","2020-03-31","2020-05-16","Multiple populations","Adults (18-64 years)",281.0,0.021,"Unclear","Euroimmun","IgG; IgA","High","Journal Article (Peer-Reviewed)","Jan Neumann","University of Bremen","https://www.asu-arbeitsmedizin.com/node/153868/print","Verified","","","","","","DE",""
"2021-03-11","200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall","Assessment of the Herd Immunity to SARS-CoV-2 among the Population of the Leningrad Region during the COVID-19 Epidemic","2020-09-16","Regional","Russian Federation","Russian Federation; Northwestern Federal District","2020-06-23","2020-06-26","Household and community samples","Multiple groups",3130.0,0.207,"Simplified probability","State Scientific Center of Applied Microbiology and Biotechnology (Obolensk)","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology","https://journal.microbe.ru/jour/article/view/1371/1150#","Verified","","","","","","RU",""
"2021-03-11","210115_France_InstitutNationaldelaStatistiqueetdesÉtudesÉconomiques_Overall","In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2","2021-01-15","National","France","France","2020-05-02","2020-06-02","Household and community samples","Multiple groups",12114.0,0.045,"Stratified probability","EUROIMMUN","IgG","Low","Institutional Report","Josiane Warszawski","l’Institut national de la santé et de la recherche médicale (Inserm)","https://drees.solidarites-sante.gouv.fr/sites/default/files/2021-01/er1167-en.pdf","Verified",0.039,0.05,0.944,1.0,"","FR",""
"2021-03-11","210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj","Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: perspectives for public health","2021-01-27","Local","Italy","Italy; Puglia; Bari","2020-04-08","2020-06-07","Health care workers and caregivers","Adults (18-64 years)",2407.0,0.024,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Luigi Vimercati","University of Bari","https://dx.doi.org/10.1016/j.envres.2021.110793","Verified","","",0.5,0.98,"","IT","IT-75"
"2021-03-11","210131_Calgary_UniversityOfCalgary_overall","Alberta Childhood COVID-19 Cohort (AB3C) Aim 3: Longitudinal Sero-Epidemiology Study First Interim Report January 31, 2021","2021-01-31","Local","Canada","Canada; Alberta; Calgary","2020-07-30","2020-11-18","Household and community samples","Children and Youth (0-17 years)",911.0,0.003,"Self-referral","Abbott","IgG","Moderate","Institutional Report","James Kellner","University of Calgary","https://prism.ucalgary.ca/bitstream/handle/1880/113084/AB3C%20Aim%203%201st%20Interim%20Report-final.pdf?sequence=5&isAllowed=y","Unverified",0.001,0.01,0.761,"","","CA","CA-AB"
"2021-03-11","210201_Portugal_InstitutoNacionalDeSaúdeDoutorRicardoJorge_overall_TestAdj_PopAdj","Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19)","2021-02-01","National","Portugal","Portugal; Norte Region, Centro Region, Lisboa Region, Alentejo Region, Algarve Region, Madeira, Azores","2020-05-21","2020-07-08","Residual sera","Multiple groups",2301.0,0.017,"Stratified non-probability","1) Wantai; 2) EUROIMMUN","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Irina Kislaya","Instituto Nacional de Saúde Doutor Ricardo Jorge","https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15122","Verified",0.0,0.033,"","","","PT",""
"2021-03-11","210209_Madrid_HospitalUniversitarioVirgendelRocio","High Rates of SARS-CoV-2 Family Transmission in Children of Healthcare Workers During the First Pandemic Wave in Madrid, Spain: Serologic Study","2021-02-09","Local","Spain","Spain; Community of Madrid; Madrid","2020-03-15","2020-05-15","Contacts of COVID patients","Children and Youth (0-17 years)",113.0,0.416,"Convenience","Vircell","IgG","High","Journal Article (Peer-Reviewed)","Ana Mendez Echevarria","Hospital Universitario Virgen del Rocio","https://dx.doi.org/10.1097/INF.0000000000003088","Verified","","","","","","ES","ES-MD"
"2021-03-12","200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop","Coronavirus (COVID-19) Infection Survey: May_June 2020","2020-06-25","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-05-08","2020-06-04","Household and community samples","Multiple groups",1575.0,0.063,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.045,0.087,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop","Coronavirus (COVID-19) Infection Survey: June_July 2020","2020-07-31","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-05","2020-07-02","Household and community samples","Multiple groups",2392.0,0.042,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","","",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200826_UK_OfficeforNationalStatistics_July_020_England_genpop","Coronavirus (COVID-19) Infection Survey: July_August2020","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-07-03","2020-07-30","Household and community samples","Multiple groups",3236.0,0.065,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.052,0.081,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop","Coronavirus (COVID-19) Infection Survey: July_August2020","2020-08-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-07-31","2020-08-27","Household and community samples","Multiple groups",6189.0,0.056,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.047,0.065,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop","Coronavirus (COVID-19) Infection Survey: August_September2020","2020-09-25","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-08-28","2020-09-24","Household and community samples","Multiple groups",8742.0,0.058,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.051,0.065,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop","Coronavirus (COVID-19) Infection Survey: August_September2020","2020-09-25","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Wales","2020-08-28","2020-09-24","Household and community samples","Multiple groups",236.0,0.047,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.02,0.092,0.99,0.991,"","GB","GB-WLS"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-09-25","2020-10-22","Household and community samples","Multiple groups",15687.0,0.069,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.064,0.075,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-09-25","2020-10-22","Household and community samples","Multiple groups",249.0,0.028,"Stratified probability","University of Oxford","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.012,0.055,0.99,0.991,"","GB","GB-NIR"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-09-25","2020-10-22","Household and community samples","Multiple groups",383.0,0.068,"Stratified probability","University of Oxford","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.043,0.102,0.99,0.991,"","GB","GB-SCT"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Wales","2020-09-25","2020-10-22","Household and community samples","Multiple groups",473.0,0.047,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.029,0.073,0.99,0.991,"","GB","GB-WLS"
"2021-03-12","201102_Singapore_NationalCentreForInfectiousDiseases_overall","SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study","2020-11-02","National","Singapore","Singapore","2020-01-23","2020-04-03","Contacts of COVID patients","Multiple groups",1150.0,0.038,"Entire sample","N/A - author designed","Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Oon Tek Ng","National Centre for Infectious Diseases, Singapore","https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email","Verified","","",0.989,1.0,"","SG",""
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-10-23","2020-11-19","Household and community samples","Multiple groups",397.0,0.078,"Stratified probability","University of Oxford","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.05,0.117,0.99,0.991,"","GB","GB-SCT"
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-10-23","2020-11-19","Household and community samples","Multiple groups",15834.0,0.087,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.081,0.094,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-10-23","2020-11-19","Household and community samples","Multiple groups",333.0,0.035,"Stratified probability","University of Oxford","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.016,0.064,0.99,0.991,"","GB","GB-NIR"
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Wales","2020-10-23","2020-11-19","Household and community samples","Multiple groups",497.0,0.061,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.04,0.09,0.99,0.991,"","GB","GB-WLS"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-11-20","2020-12-17","Household and community samples","Multiple groups",21684.0,0.101,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.096,0.106,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-11-20","2020-12-17","Household and community samples","Multiple groups",248.0,0.037,"Stratified probability","University of Oxford","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.017,0.071,0.99,0.991,"","GB","GB-NIR"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-20","2020-12-17","Household and community samples","Multiple groups",1034.0,0.059,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.044,0.076,0.99,0.991,"","GB","GB-SCT"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Wales","2020-11-20","2020-12-17","Household and community samples","Multiple groups",631.0,0.072,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.051,0.099,0.99,0.991,"","GB","GB-WLS"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-12-18","2021-01-14","Household and community samples","Multiple groups",24150.0,0.153,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.147,0.159,0.99,0.991,"","GB","GB-ENG"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-12-18","2021-01-14","Household and community samples","Multiple groups",313.0,0.12,"Stratified probability","University of Oxford","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.078,0.174,0.99,0.991,"","GB","GB-NIR"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-12-18","2021-01-14","Household and community samples","Multiple groups",1832.0,0.107,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.091,0.124,0.99,0.991,"","GB","GB-SCT"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Wales","2020-12-18","2021-01-14","Household and community samples","Multiple groups",732.0,0.115,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified",0.086,0.149,0.99,0.991,"","GB","GB-WLS"
"2021-03-13","201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj","Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study","2020-10-28","Regional","United States of America","United States of America; Connecticut","2020-06-23","2020-07-22","Household and community samples","Multiple groups",148.0,0.064,"Simplified probability","Ortho-Clinical Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Shiwani Mahajan","Yale School of Medicine","http://dx.doi.org/10.1016/j.amjmed.2020.09.024","Verified",0.009,0.119,0.9,1.0,"","US","US-CT"
"2021-03-13","201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj","Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study","2020-10-28","Regional","United States of America","United States of America; Connecticut","2020-06-23","2020-07-22","Household and community samples","Multiple groups",171.0,0.199,"Simplified probability","Ortho-Clinical Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Shiwani Mahajan","Yale School of Medicine","http://dx.doi.org/10.1016/j.amjmed.2020.09.024","Verified",0.132,0.266,0.9,1.0,"","US","US-CT"
"2021-03-13","201130_Fribourg_UniversitéDeFribourg_overall","Corona Immunitas Fribourg Immunté de la population Episode 1/2020","2020-11-30","Regional","Switzerland","Switzerland; Canton of Fribourg","2020-07-08","2020-10-14","Household and community samples","Multiple groups",418.0,0.08,"Simplified probability","N/A - institutionally designed (Centre Hospitalier Universitaire Vaudois (CHUV), l'École Polytechnique Fédérale de Lausanne (EPFL) et l’Institut Suisse de Recherche sur les Vaccins)","IgG; IgA","Moderate","Institutional Report","Daniela Anker","Université de Fribourg","https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf","Verified",0.04,0.12,0.966,0.997,"","CH","CH-FR"
"2021-03-13","210107_Austria_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Austria","Austria","2020-07-17","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",196.0,0.0,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Unverified",0.0,0.019,"","","","AT",""
"2021-03-13","210107_CapeTown_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","South Africa","South Africa; NR; Capetown","2020-06-10","2020-08-17","Health care workers and caregivers","Adults (18-64 years)",222.0,0.104,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.07,0.151,"","","","ZA",""
"2021-03-13","210107_Estonia_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Estonia","Estonia; NR; NR","2020-06-10","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",130.0,0.0,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.0,0.029,"","","","EE",""
"2021-03-13","210107_Greece_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Greece","Greece; NR; NR","2020-06-19","2020-07-16","Health care workers and caregivers","Adults (18-64 years)",77.0,0.013,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.002,0.07,"","","","GR",""
"2021-03-13","210107_Latvia_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Latvia","Latvia; NR; NR","2020-05-19","2020-06-20","Health care workers and caregivers","Adults (18-64 years)",177.0,0.0,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.0,0.021,"","","","LV",""
"2021-03-13","210107_Lithuania_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Lithuania","Lithuania; NR; NR","2020-06-01","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",300.0,0.007,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.002,0.024,"","","","LT",""
"2021-03-13","210107_London_UniversityCollegeLondon_June_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1134.0,0.169,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.149,0.192,"","","","GB","GB-ENG"
"2021-03-13","210107_London_UniversityCollegeLondon_May_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1754.0,0.153,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Unverified",0.137,0.171,"","","","GB","GB-ENG"
"2021-03-13","210107_Romania_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Romania","Romania; NR; NR","2020-05-14","2020-05-27","Health care workers and caregivers","Adults (18-64 years)",124.0,0.008,"Convenience","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified",0.001,0.043,"","","","RO",""
"2021-03-13","210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj","Seroprevalence and seroconversions for SARS-CoV-2 infections in workers at Bogota Airport, Colombia, 2020","2021-01-22","Local","Colombia","Colombia; Capital District Cundinamarca; Bogota","2020-06-01","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",212.0,0.16,"Convenience","Abbott Laboratories","Total Antibody","High","Journal Article (Peer-Reviewed)","Jeadran Malagon Rojas","Instituto Nacional de Salud","https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1","Verified",0.104,0.216,0.855,0.973,"","CO","CO-DC"
"2021-03-13","210122_USA_YourCareChoice_GenPop","COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders","2021-01-22","National","United States of America","United States of America","2020-04-24","2020-05-13","Household and community samples","Multiple groups",407.0,0.216,"Stratified probability","NR","Not reported","High","Journal Article (Peer-Reviewed)","Robert Morlock","YourCareChoice","https://dx.doi.org/10.1371/journal.pone.0245586","Verified","","","","","","US",""
"2021-03-13","210123_Norfolk_NavalMedicalCenterPortsmouth_Overall","SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic","2021-01-23","Local","United States of America","United States of America; Virginia; Norfolk","2020-04-28","2020-05-12","Essential non-healthcare workers","Adults (18-64 years)",432.0,0.03,"Convenience","LakePharma, Inc","IgG","Moderate","Journal Article (Peer-Reviewed)","Tahaniyat Lalani","Naval Medical Center Portsmouth","https://dx.doi.org/10.1093/ofid/ofaa654","Verified",0.016,0.051,0.98,1.0,"","US","US-VA"
"2021-03-13","210201_France_TissueBankofLille_overall_unadj","Retrospective study of COVID-19 seroprevalence among tissue donors at the onset of the outbreak before implementation of strict lockdown measures in France","2021-02-01","Local","France","France","2019-11-01","2020-03-16","Tissue donor","Multiple groups",235.0,0.017,"Sequential","1) Abbott ; 2)Wantai","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Nicolas Germain","CHU Lille","https://dx.doi.org/10.1007/s10561-021-09901-3","Verified","","","","","","FR",""
"2021-03-13","210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj","Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA","2021-02-03","Local","United States of America","United States of America; Missouri; St Louis","2020-04-27","2020-05-12","Residual sera","Multiple groups",503.0,0.031,"Sequential","Authors","IgG","High","Journal Article (Peer-Reviewed)","Brittany Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.01207-20","Verified",0.009,0.053,0.982,0.987,"","US","US-MO"
"2021-03-13","210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj","Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA","2021-02-03","Local","United States of America","United States of America; Missouri; St Louis","2020-04-14","2020-05-08","Residual sera","Children and Youth (0-17 years)",555.0,0.017,"Sequential","Authors","IgG","High","Journal Article (Peer-Reviewed)","Brittany Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.01207-20","Verified",0.0,0.034,0.982,0.987,"","US","US-MO"
"2021-03-13","210219_Jena_JenaUniversityHospital_Overall","Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff","2021-02-19","Local","Germany","Germany; Thuringia; Jena","2020-05-19","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",660.0,0.027,"Convenience","Epitope Diagnostics Inc.; Roche Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Christina Bahrs","Jena University Hospital","https://dx.doi.org/10.1111/tbed.14041","Verified",0.016,0.043,"","","","DE","DE-TH"
"2021-03-13","210309_Zambia_ZambiaMinistryofHealth_overall","Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey","2021-03-09","National","Zambia","Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi","2020-07-04","2020-07-27","Household and community samples","Multiple groups",2704.0,0.021,"Stratified probability","PerkinElmer","IgG","Moderate","Journal Article (Peer-Reviewed)","Lloyd B Mulenga","Zambia Ministry of Health","https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00053-X/fulltext","Verified",0.011,0.031,"","","","ZM",""
"2021-03-14","201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall","Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic","2020-10-01","Regional","Germany","Germany; Southwest","2020-03-15","2020-06-15","Blood donors","Multiple groups",3880.0,0.009,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Stefan Runkel","University Medical Center of The Johannes Gutenberg-University Mainz","https://pubmed.ncbi.nlm.nih.gov/33073955/","Verified","","","",0.996,"","DE",""
"2021-03-14","201019_Irkutsk_SaintPetersburgPasteurResearchInstitute_Overall","Experience in Studying Seroprevalence to SARS-CoV-2 Virus in the Population of the Irkutsk Region during COVID-19 Outbreak","2020-10-10","Regional","Russian Federation","Russian Federation; Irkutsk Region","2020-06-28","2020-07-19","Household and community samples","Multiple groups",2674.0,0.058,"Simplified probability","State Scientific Center Applied Microbiology and Biotechnology","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","Saint-Petersburg Pasteur Research Institute","https://journal.microbe.ru/jour/article/view/1370/1149","Verified",0.054,0.062,"","","","RU","RU-IRK"
"2021-03-14","210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall","A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan","2021-01-09","Local","China","China; Taiwan; Taipei","2020-07-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",194.0,0.0,"Convenience","Abbott; Roche; Mikrogen Diagnostik","IgG","High","Journal Article (Peer-Reviewed)","Sung Ching Pan","National Taiwan University Hospital","https://dx.doi.org/10.1016/j.jfma.2021.01.002","Unverified","","","","","","CN",""
"2021-03-14","210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel","Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey","2021-01-20","Regional","United States of America","United States of America; North Dakota; Fargo, Grand Forks","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",247.0,0.146,"Convenience","BioSys Laboratories","IgG; IgM","High","Journal Article (Peer-Reviewed)","Amanda Johnson","North Dakota State University","https://www.japha.org/article/S1544-3191(21)00025-X/abstract","Verified",0.104,0.196,0.935,1.0,"","US","US-ND"
"2021-03-14","2101_Zahedan_TehranUniversityofMedicalSciences","The seroprevalence of COVID-19 in intravenous drug users in comparison to non-drug users","2021-01-01","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan","2020-07-01","2020-07-31","Persons experiencing homelessness","Adults (18-64 years)",167.0,0.097,"Convenience","Pishtaz Teb, Tehran, Iran","IgG; IgM","High","Journal Article (Peer-Reviewed)","Zahra Mohammadi","Tehran University of Medical Sciences","http://dx.doi.org/10.34172/mejdd.2021.206a","Verified","","","","","","IR","IR-13"
"2021-03-14","2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers","The seroprevalence of COVID-19 in intravenous drug users in comparison to non-drug users","2021-01-01","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan","2020-07-01","2020-07-31","Household and community samples","Adults (18-64 years)",134.0,0.048,"Simplified probability","Pishtaz Teb Tehran, Iran","IgG; IgM","High","Journal Article (Peer-Reviewed)","Zahra Mohammadi","Tehran University of Medical Sciences","http://dx.doi.org/10.34172/mejdd.2021.206a","Verified","","","","","","IR","IR-13"
"2021-03-14","210209_Catania_UniversityofCatania","SARS-CoV-2 Seroprevalence Post-First Wave among Primary Care Physicians in Catania (Italy)","2021-02-09","Local","Italy","Italy; Sicily; Catania","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",133.0,0.03,"Convenience","NovaTec Immundiagnostics GmbH, Dietzenbach, Germany","IgG","High","Journal Article (Peer-Reviewed)","Caterina Ledda","University of Catania","https://dx.doi.org/10.3390/tropicalmed6010021","Verified","","","","","","IT","IT-82"
"2021-03-14","210212_Arizona_KingmanRegionalMedicalCenter_Overall","The seroprevalence of SARS-CoV-2 in a rural southwest community","2021-02-12","Local","United States of America","United States of America; Arizona; Kingman","2020-09-28","2020-10-09","Household and community samples","Adults (18-64 years)",566.0,0.08,"Self-referral","Ortho-Clinical Diagnostics Inc.","IgG","High","Journal Article (Peer-Reviewed)","Anthony Santarelli","Kingman Regional Medical Center","https://dx.doi.org/10.1515/jom-2020-0287","Verified","","",0.875,1.0,"","US","US-AZ"
"2021-03-14","210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA","High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo","2021-02-16","Local","Democratic Republic of the Congo","Democratic Republic of the Congo; South-Kivu; Bukavu","2020-07-02","2020-08-19","Health care workers and caregivers","Adults (18-64 years)",359.0,0.412,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Denis Mukwege","Université Libre de Bruxelles (ULB)","https://dx.doi.org/10.4269/ajtmh.20-1526","Verified","","",0.617,0.986,"","CD","CD-SK"
"2021-03-14","210225_Denver_UniversityofColorado_EstablishedDiabetes","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America","United States of America; Colorado; Denver","2020-01-03","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",94.0,0.043,"Sequential","In-House: University of Colorado","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified",0.017,0.104,1.0,0.999,"","US","US-CO"
"2021-03-14","210225_Denver_UniversityofColorado_GenPopAdults","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America","United States of America; Colorado; Denver","2020-07-08","2020-10-23","Household and community samples","Adults (18-64 years)",102.0,0.039,"Convenience","In-House: University of Colorado","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified",0.015,0.097,1.0,0.999,"","US","US-CO"
"2021-03-14","210225_Denver_UniversityofColorado_GenPopChildren","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America","United States of America; Colorado; Denver","2020-07-08","2020-10-23","Household and community samples","Children and Youth (0-17 years)",562.0,0.028,"Convenience","In-House: University of Colorado","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified",0.018,0.046,1.0,0.999,"","US","US-CO"
"2021-03-14","210225_Denver_UniversityofColorado_NewOnsetDiabetes","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America","United States of America; Colorado; Denver","2020-01-03","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",129.0,0.008,"Sequential","In-House: University of Colorado","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified",0.001,0.042,1.0,0.999,"","US","US-CO"
"2021-03-15","210219_England_PHE_UniversityStudents_Overall","Seroprevalence of SARS-CoV-2 Antibodies in University Students: Cross-sectional Study, December 2020, England","2021-02-19","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-12-02","2020-12-11","Students and Daycares","Adults (18-64 years)",2905.0,0.178,"Convenience","Abbott Laboratories; In-House (PHE)","IgG","Moderate","Preprint","Amoolya Vusirikala","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684","Verified",0.165,0.193,"","","","GB","GB-ENG"
"2021-03-16","201027_DistrictSrinagar_GovernmentMedicalCollege_Overall","SARS-CoV-2 seroprevalence in healthcare workers of dedicated-COVID hospitals and nonâ€“COVID hospitals of District Srinagar, Kashmir","2020-10-27","Local","India","India; Kashmir","2020-06-15","2020-06-29","Health care workers and caregivers","Adults (18-64 years)",2905.0,0.025,"Convenience","Abbott Laboratories","IgG","Moderate","Preprint","Muhammad Salim Khan","Government Medical College","https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text","Verified",0.02,0.031,1.0,"","","IN","IN-JK"
"2021-03-16","201031_Veneto_NationalAssociationofCompanyandCompetentDoctors","Effectiveness of the measures aimed at containing Sars-cov-2 virus spreading in work settings: a survey in companies based in the Veneto region of Italy","2020-10-31","Local","Italy","Italy; Veneto","2020-04-11","2020-04-29","Essential non-healthcare workers","Adults (18-64 years)",1267.0,0.016,"Convenience","NR, MAGLUMI, NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Danilo Bontadi","National Association of Company and Competent Doctors","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/","Verified","","","","","","IT","IT-34"
"2021-03-16","210119_Madrid_HospitalInfantilUniversitarioNiñoJesús","Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a pediatric monographic hospital in Madrid (Spain)","2021-01-19","Local","Spain","Spain; Community of Madrid; Madrid","2020-04-13","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",1292.0,0.172,"Convenience","All Test","IgG; IgM","High","Journal Article (Peer-Reviewed)","Eva Escribano Ceruelo","Hospital Infantil Universitario Niño Jesús","https://dx.doi.org/10.1016/j.eimc.2020.12.011","Verified",0.152,0.194,"","","","ES","ES-MD"
"2021-03-16","210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIA","SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic","2021-02-06","Local","Lithuania","Lithuania","2020-06-15","2020-09-21","Health care workers and caregivers","Multiple groups",432.0,0.012,"Convenience","AMEDA Labordiagnostik GmbH","IgG; IgM","High","Journal Article (Peer-Reviewed)","Laura Pereckaite","The Hospital of Lithuanian University of Health Sciences Kauno Klinikos","https://dx.doi.org/10.3390/medicina57020148","Verified","","",0.918,0.964,"","LT",""
"2021-03-16","210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj","Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya","2021-02-17","National","Kenya","Kenya","2020-09-30","2020-10-23","Essential non-healthcare workers","Adults (18-64 years)",830.0,0.423,"Convenience","NR","IgG","Moderate","Preprint","E Wangeci Kagucia","KEMRI-Wellcome Trust Research Programme","https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1","Verified",0.384,0.463,0.93,0.99,"","KE",""
"2021-03-17","210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj","Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran","2021-01-05","Regional","Iran (Islamic Republic of)","Iran (Islamic Republic of); Mazandaran","2020-03-15","2020-05-15","Household and community samples","Multiple groups",1588.0,0.173,"Stratified probability","Danesh Bonyan Pishtaz Teb Company","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Seyed Abbas Mousavi","Mazandaran University of Medical Sciences","https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi","Verified",0.148,0.178,0.59,1.0,"","IR","IR-21"
"2021-03-17","210127_India_ICRM_overall_adj","SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey","2021-01-27","National","India","India","2020-08-18","2020-09-20","Household and community samples","Multiple groups",29082.0,0.066,"Stratified probability","Abbott","IgG","Low","Journal Article (Peer-Reviewed)","Manoj V Murhekar","The Indian Council of Medical Research (ICMR)","https://dx.doi.org/10.1016/S2214-109X(20)30544-1","Verified",0.058,0.074,1.0,0.996,"","IN",""
"2021-03-17","210127_UK_UniversityCollegeLondon_overall","Longitudinal Assessment of Symptoms and Risk of SARS-CoV-2 Infection in Healthcare Workers Across 5 Hospitals to Understand Ethnic Differences in Infection Risk","2021-01-27","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Nottingham, London","2020-03-23","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",1364.0,0.199,"Convenience","Euroimmun; Roche Diagnostics; In House ELISA","IgG","High","Preprint","Ana Valdes","University College London","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805","Verified","","","","","","GB","GB-ENG"
"2021-03-17","210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai","SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020","2021-02-02","Local","United States of America","United States of America; North Carolina; Parris Island","2020-05-11","2020-09-07","Essential non-healthcare workers","Adults (18-64 years)",3196.0,0.09,"Convenience","Independent authors, Amanat et al","IgG","Moderate","Journal Article (Peer-Reviewed)","Andrew Letizia","Icahn School of Medicine at Mount Sinai","http://dx.doi.org/10.3201/eid2704.204732","Verified","","",0.961,0.971,"","US","US-NC"
"2021-03-17","210205_India_ICRM_overall","ICMR sero survey: One in five Indians exposed to Covid-19","2021-02-05","National","India","India","2020-12-17","2021-01-08","Household and community samples","Multiple groups",28589.0,0.215,"Stratified probability","NR","Not reported","Unclear","News and Media","BBC News","The Indian Council of Medical Research (ICMR)","https://www.bbc.com/news/world-asia-india-55945382","Verified","","","","","","IN",""
"2021-03-17","210209_Atlanta_EmoryUniversity","Occupational Risk Factors for SARS-CoV-2 Infection among Healthcare Personnel: A Cross-Sectional Analysis of Subjects Enrolled in the COPE Study","2021-02-09","Local","United States of America","United States of America; Georgia; Atlanta","2020-05-06","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",353.0,0.065,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Jessica Howard Anderson","Emory University","https://dx.doi.org/10.1017/ice.2021.54","Verified","","",0.867,0.993,"","US","US-GA"
"2021-03-17","210226_CentreCounty_PennsylvaniaStateUniversity_Community","SARS-CoV-2 Seroprevalence in a University Community: A Longitudinal Study of the Impact of Student Return to Campus on Infection Risk Among Community Members","2021-02-26","Local","United States of America","United States of America; Pennsylvania","2020-08-07","2020-12-20","Household and community samples","Adults (18-64 years)",345.0,0.082,"Convenience","In-House: Pennsylvania State University","IgG","High","Preprint","Callum Arnold","Pennsylvania State University","https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3","Verified","","",0.933,0.99,"","US","US-PA"
"2021-03-17","210226_CentreCounty_PennsylvaniaStateUniversity_Students","SARS-CoV-2 Seroprevalence in a University Community: A Longitudinal Study of the Impact of Student Return to Campus on Infection Risk Among Community Members","2021-02-26","Local","United States of America","United States of America; Pennsylvania","2020-10-26","2020-11-23","Students and Daycares","Adults (18-64 years)",625.0,0.312,"Convenience","In-House: Pennsylvania State University","IgG","Moderate","Preprint","Callum Arnold","Pennsylvania State University","https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3","Verified","","",0.933,0.99,"","US","US-PA"
"2021-03-18","210106_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall","Seroprevalence of SARS-CoV-2 antibodies In 2115 blood donors from Romania","2021-01-06","Local","Romania","Romania","2020-07-08","2020-09-01","Blood donors","Adults (18-64 years)",2115.0,0.015,"Sequential","Roche Diagnostics GmbH, Mannheim, Germany","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Tudor Rares Olariu","Victor Babes University of Medicine and Pharmacy","http://dx.doi.org/10.1016/j.cmi.2020.12.027","Verified",0.011,0.021,1.0,0.998,"","RO",""
"2021-03-18","210129_Botuacato_InstitutoButantan_Primary","COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting","2021-01-29","Local","Brazil","Brazil; Sao Paolo; Botucato","2020-06-22","2020-07-08","Assisted living and long-term care facilities","Multiple groups",209.0,0.115,"Convenience","Guangzhou Wondfo Biotech Co., Ltd","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Eliana Nogueira Castro de Barros","Instituto Butantan","https://dx.doi.org/10.1590/S1678-9946202163010","Verified",0.071,0.166,0.864,0.996,"","BR","BR-SP"
"2021-03-18","210201_NewYorkCity_ColumbiaUniversity","919 Rates of seroprevalance of COVID-19 among pregnant patients in New York City","2021-02-01","Local","United States of America","United States of America; New York; ; New York City","2020-06-24","2020-07-16","Pregnant or parturient women","Adults (18-64 years)",47.0,0.404,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Caitlin Baptiste","Columbia University","http://dx.doi.org/10.1016/j.ajog.2020.12.944","Verified","","",0.92,"","","US","US-NY"
"2021-03-18","210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj","Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020","2021-02-03","Local","Australia","Australia; New South Wales; Sydney","2020-04-20","2020-05-22","Residual sera","Multiple groups",3231.0,0.002,"Stratified probability","N/A - Authors designed","IgG","Moderate","Journal Article (Peer-Reviewed)","Heather F Gidding","Children's Hospital at Westmead","https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940","Unverified",0.0,0.004,0.907,0.993,"","AU","AU-NSW"
"2021-03-18","210204_UnitedStates_DaVitaClinicalResearch_Overall","SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States.","2021-02-04","National","United States of America","United States of America","2020-05-27","2020-07-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",12932.0,0.058,"Simplified probability","Diazyme Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Adam Walker","DaVita Clinical Research","https://dx.doi.org/10.1016/j.xkme.2021.01.002","Verified",0.054,0.062,"","","","US",""
"2021-03-18","210208_Virginia_UniversityOfVirginia_Overall_PopAdj","Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia","2021-02-08","Regional","United States of America","United States of America; Virginia","2020-06-01","2020-08-14","Residual sera","Multiple groups",4675.0,0.024,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Elizabeth T Rogawski McQuade","University of Virginia","https://dx.doi.org/10.1001/jamanetworkopen.2020.35234","Verified",0.018,0.031,0.927,0.999,"","US","US-VA"
"2021-03-18","210211_Kingston_UniversityOfTheWestIndies_Overall","SARS-CoV-2 Seroprevalence Among Antenatal Clinic Attendees in Kingston, Jamaica, September-November 2020","2021-02-11","Local","Jamaica","Jamaica","2020-03-01","2020-11-30","Pregnant or parturient women","Adults (18-64 years)",249.0,0.149,"Sequential","Abbott","IgG","High","Preprint","TeAnne Chisolm","University of the West Indies","10.1101/2021.02.08.21251367","Verified","","",0.8,0.962,"","JM",""
"2021-03-18","210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall","A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children","2021-02-12","Regional","Germany","Germany; Bavaria","2020-04-01","2020-06-30","Pregnant or parturient women","Adults (18-64 years)",1916.0,0.005,"Convenience","N/A - author desgined","Total Antibody","High","Journal Article (Peer-Reviewed)","Markus Hippich","German Research Center for Environmental Health","https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue","Verified","","",0.973,1.0,"","DE","DE-BY"
"2021-03-18","210212_Copenhagen_Herlev-GentofteHospital_Overall","Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen","2021-02-12","Local","Denmark","Denmark; Capital Region; Copenhagen","2020-10-19","2020-10-26","Health care workers and caregivers","Adults (18-64 years)",1096.0,0.346,"Convenience","Beijing Wantai Biological Pharmacy Enterprise","IgG; IgA; IgM","Moderate","Preprint","Johannes R Madsen","Herlev-Gentofte Hospital","https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1","Verified",0.318,0.375,0.97,0.995,"","DK","DK-84"
"2021-03-18","210318_Barcelona_UniversitatDeBarcelona_overall","Impact of SARS-CoV-2 Infection on Pregnancy Outcomes: A Population-Based Study","2021-02-08","Local","Spain","Spain","2020-03-15","2020-05-31","Pregnant or parturient women","Adults (18-64 years)",2225.0,0.141,"Sequential","1) Vircell; 2) Ortho Clinical Diagnostics; 3) N/A - institution designed","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Francesca Crovetto","Universitat de Barcelona","https://dx.doi.org/10.1093/cid/ciab104","Unverified","","","","","","ES",""
"2021-03-19","201223_Paris_InstitutCurie_overall","High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris","2020-12-23","Local","France","France;  Île-de-France; Paris","2020-04-28","2020-07-31","Health care workers and caregivers","Multiple groups",1847.0,0.116,"Convenience","Institut Curie - author designed","IgG; Total Antibody; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Francois Anna","Institut Curie","https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058","Verified",0.102,0.132,"",0.99,"","FR","FR-IDF"
"2021-03-19","210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW","Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria","2021-01-08","Local","Austria","Austria; Upper Austria; Linz","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",1757.0,0.02,"Convenience","1) Roche Diagnostics; 2) Abbott Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Margot Egger","Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz","https://dx.doi.org/10.1515/cclm-2020-1681","Verified","","",1.0,1.0,"","AT","AT-4"
"2021-03-19","210109_Australia_AustralianNationalUniversity_overall_adj","Prevalence of asymptomatic SARS‐CoV‐2 infection in elective surgical patients in Australia: a prospective surveillance study","2021-01-09","National","Australia","Australia; New South Wales, South Australia, Victoria and Western Australia","2020-06-02","2020-07-17","Residual sera","Multiple groups",2991.0,0.002,"Sequential","N/A - in house","IgG","Low","Journal Article (Peer-Reviewed)","Nicholas Coatsworth","Australian National University","https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564","Verified",0.0,0.005,1.0,0.989,"","AU",""
"2021-03-19","210115_UK_UKBiobank_Overall","UK Biobank SARS-CoV-2 Serology Study","2021-01-15","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England, Scotland, Wales","2020-05-27","2020-12-04","Household and community samples","Multiple groups",18893.0,0.09,"Convenience","NR","Not reported","Unclear","Institutional Report","UK Biobank","UK Biobank","https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf","Unverified","","","","","","GB",""
"2021-03-19","210129_Atlanta_EmoryUniversityHospital_primary","Quantification of occupational and community risk factors for SARS-CoV-2 seropositivity among healthcare workers in a large U.S. healthcare system","2021-01-29","Local","United States of America","United States of America; Georgia; Atlanta","2020-04-19","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",10275.0,0.038,"Self-referral","Emory University","IgG","Moderate","Journal Article (Peer-Reviewed)","Julia M Baker","Emory University Hospital","https://dx.doi.org/10.7326/M20-7145","Verified",0.034,0.043,0.975,0.98,"","US","US-GA"
"2021-03-19","210130_USA_UniversityofArizona_primary","Coronavirus Disease 2019 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020","2021-01-30","Local","United States of America","United States of America","2020-05-17","2020-07-02","Health care workers and caregivers","Multiple groups",40938.0,0.162,"Self-referral","VITROS Immunodiagnostic Products","IgG","Moderate","Journal Article (Peer-Reviewed)","Lara J Akinbami","University of Arizona","https://dx.doi.org/10.1093/cid/ciab080","Verified",0.159,0.166,"","","","US",""
"2021-03-19","210203_Sydney_Children'sHospitalAtWestmead_AntenatalScreening_overall_TestAdj","Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020","2021-02-03","Local","Australia","Australia; New South Wales; Sydney","2020-05-04","2020-05-23","Pregnant or parturient women","Adults (18-64 years)",560.0,0.008,"Stratified probability","N/A - Authors designed","IgG","Moderate","Journal Article (Peer-Reviewed)","Heather F Gidding","Children's Hospital at Westmead","https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940","Unverified",0.0,0.019,0.907,0.993,"","AU","AU-NSW"
"2021-03-19","210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj","Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020","2021-02-03","Local","Australia","Australia; New South Wales; Sydney","2020-05-05","2020-06-02","Blood donors","Adults (18-64 years)",1548.0,0.003,"Stratified probability","N/A - Authors designed","IgG","Moderate","Journal Article (Peer-Reviewed)","Heather F Gidding","Children's Hospital at Westmead","https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940","Unverified",0.0,0.008,0.907,0.993,"","AU","AU-NSW"
"2021-03-19","210204_Milan_UniversityOfMilan_Overall","Serological Profile of Children and Young Adults with at Least One SARS-CoV-2 Positive Cohabitant: An Observational Study","2021-02-04","Local","Italy","Italy; Lombardy; Milan","2020-06-13","2020-08-06","Contacts of COVID patients","Children and Youth (0-17 years)",49.0,0.163,"Convenience","Livzon","IgG; IgM","High","Journal Article (Peer-Reviewed)","Marco Farronato","University of Milan","https://dx.doi.org/10.3390/ijerph18041488","Verified","","","","","","IT","IT-25"
"2021-03-19","210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall","SARS-CoV-2 Seroprevalence Survey Among District Residents Presenting for Serologic Testing at Three Community-Based Test Sites â€” Washington, DC, July-August, 2020","2021-02-18","Local","United States of America","United States of America","2020-07-27","2020-08-21","Household and community samples","Multiple groups",671.0,0.076,"Convenience","DiaSorin","IgG","High","Preprint","Adrienne Sherman","Government of the District of Columbia","10.1101/2021.02.15.21251764","Verified",0.057,0.099,0.97,"","","US",""
"2021-03-19","210301_London_King’sCollegeHospital_primary","Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the Bedside","2021-03-01","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-04-22","2020-04-24","Health care workers and caregivers","Adults (18-64 years)",625.0,0.21,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Kat El Bouzidi","King’s College Hospital","https://dx.doi.org/10.1097/CCM.0000000000004878","Verified","","","","","","GB",""
"2021-03-20","200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall","Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic","2020-09-23","Local","Russian Federation","Russian Federation","2020-06-15","2020-06-20","Household and community samples","Multiple groups",2713.0,0.26,"Simplified probability","State Scientific Center for Applied Microbiology and Biotechnologies (Obolensk)","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology","https://journal.microbe.ru/jour/article/view/1372/1151","Verified",0.243,0.277,"","","","RU",""
"2021-03-20","200924_Estonia_UniversityofTartu_overall","Seroprevalence of SARS‐CoV‐2 antibodies among pregnant women in Estonia: A call for epidemiological studies","2020-09-24","National","Estonia","Estonia","2020-05-04","2020-06-10","Pregnant or parturient women","Adults (18-64 years)",433.0,0.005,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Piret Veerus","University of Tartu","https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995","Verified","","","","","","EE",""
"2021-03-20","201001_TyumenRegion_SaintPetersburgPasteurInstitute","Distribution of SARS-CоV-2 seroprevalence among residents of the Tyumen Region during the COVID-19 epidemic period","2020-10-01","Regional","Russian Federation","Russian Federation; Tyumen region","2020-06-07","2020-06-20","Household and community samples","Multiple groups",2758.0,0.245,"Simplified probability","State Research Center for Applied Microbiology and Biotechnology of Rospotrebnadzor","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","Saint Petersburg Pasteur Institute","https://microbiol.elpub.ru/jour/article/view/890/520","Verified",0.229,0.261,"","","","RU","RU-TYU"
"2021-03-20","201124_USA_CDC_August/September3_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alabama","2020-08-26","2020-09-08","Residual sera","Multiple groups",955.0,0.099,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.072,0.128,"","","","US","US-AL"
"2021-03-20","201124_USA_CDC_August/September3_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alaska","2020-08-26","2020-09-09","Residual sera","Multiple groups",610.0,0.01,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.002,0.022,"","","","US","US-AK"
"2021-03-20","201124_USA_CDC_August/September3_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arizona","2020-08-26","2020-09-09","Residual sera","Multiple groups",1030.0,0.049,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.03,0.071,"","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_August/September3_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arkansas","2020-08-24","2020-09-08","Residual sera","Multiple groups",992.0,0.049,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.035,0.064,"","","","US","US-AR"
"2021-03-20","201124_USA_CDC_August/September3_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; California","2020-08-28","2020-09-09","Residual sera","Multiple groups",983.0,0.06,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.042,0.078,"","","","US","US-CA"
"2021-03-20","201124_USA_CDC_August/September3_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Colorado","2020-08-24","2020-09-04","Residual sera","Multiple groups",1025.0,0.036,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.051,"","","","US","US-CO"
"2021-03-20","201124_USA_CDC_August/September3_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Connecticut","2020-08-26","2020-09-04","Residual sera","Multiple groups",983.0,0.043,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.029,0.057,"","","","US","US-CT"
"2021-03-20","201124_USA_CDC_August/September3_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Delaware","2020-08-26","2020-09-10","Residual sera","Multiple groups",914.0,0.045,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.024,0.071,"","","","US","US-DE"
"2021-03-20","201124_USA_CDC_August/September3_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Florida","2020-08-27","2020-09-09","Residual sera","Multiple groups",981.0,0.057,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.039,0.075,"","","","US","US-FL"
"2021-03-20","201124_USA_CDC_August/September3_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Georgia","2020-08-25","2020-09-10","Residual sera","Multiple groups",1020.0,0.087,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.067,0.111,"","","","US","US-GA"
"2021-03-20","201124_USA_CDC_August/September3_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Idaho","2020-08-26","2020-09-10","Residual sera","Multiple groups",790.0,0.057,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.029,0.097,"","","","US","US-ID"
"2021-03-20","201124_USA_CDC_August/September3_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Illinois","2020-08-26","2020-09-03","Residual sera","Multiple groups",979.0,0.056,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.039,0.077,"","","","US","US-IL"
"2021-03-20","201124_USA_CDC_August/September3_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Indiana","2020-08-26","2020-09-09","Residual sera","Multiple groups",984.0,0.024,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.014,0.035,"","","","US","US-IN"
"2021-03-20","201124_USA_CDC_August/September3_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Iowa","2020-08-25","2020-09-10","Residual sera","Multiple groups",1006.0,0.084,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.062,0.107,"","","","US","US-IA"
"2021-03-20","201124_USA_CDC_August/September3_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Kansas","2020-08-24","2020-09-03","Residual sera","Multiple groups",1025.0,0.029,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.016,0.043,"","","","US","US-KS"
"2021-03-20","201124_USA_CDC_August/September3_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Kentucky","2020-08-26","2020-09-08","Residual sera","Multiple groups",983.0,0.031,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.019,0.043,"","","","US","US-KY"
"2021-03-20","201124_USA_CDC_August/September3_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Louisiana","2020-08-26","2020-09-08","Residual sera","Multiple groups",1001.0,0.086,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.066,0.113,"","","","US","US-LA"
"2021-03-20","201124_USA_CDC_August/September3_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maine","2020-08-26","2020-09-10","Residual sera","Multiple groups",759.0,0.015,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.004,0.032,"","","","US","US-ME"
"2021-03-20","201124_USA_CDC_August/September3_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maryland","2020-08-26","2020-09-08","Residual sera","Multiple groups",980.0,0.079,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.057,0.104,"","","","US","US-MD"
"2021-03-20","201124_USA_CDC_August/September3_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Massachusetts","2020-08-27","2020-09-05","Residual sera","Multiple groups",981.0,0.036,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.024,0.051,"","","","US","US-MA"
"2021-03-20","201124_USA_CDC_August/September3_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Michigan","2020-08-26","2020-09-03","Residual sera","Multiple groups",976.0,0.034,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.05,"","","","US","US-MI"
"2021-03-20","201124_USA_CDC_August/September3_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Minnesota","2020-08-26","2020-09-08","Residual sera","Multiple groups",974.0,0.092,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.067,0.12,"","","","US","US-MN"
"2021-03-20","201124_USA_CDC_August/September3_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Mississippi","2020-08-26","2020-09-10","Residual sera","Multiple groups",987.0,0.084,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.049,0.127,"","","","US","US-MS"
"2021-03-20","201124_USA_CDC_August/September3_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Missouri","2020-08-24","2020-09-10","Residual sera","Multiple groups",1024.0,0.029,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.017,0.042,"","","","US","US-MO"
"2021-03-20","201124_USA_CDC_August/September3_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Montana","2020-08-24","2020-09-09","Residual sera","Multiple groups",518.0,0.009,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.002,0.018,"","","","US","US-MT"
"2021-03-20","201124_USA_CDC_August/September3_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nebraska","2020-08-24","2020-09-10","Residual sera","Multiple groups",938.0,0.063,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.045,0.083,"","","","US","US-NE"
"2021-03-20","201124_USA_CDC_August/September3_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nevada","2020-08-27","2020-08-29","Residual sera","Multiple groups",980.0,0.065,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.046,0.086,"","","","US","US-NV"
"2021-03-20","201124_USA_CDC_August/September3_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Hampshire","2020-08-26","2020-09-03","Residual sera","Multiple groups",1147.0,0.016,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.007,0.028,"","","","US","US-NH"
"2021-03-20","201124_USA_CDC_August/September3_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Jersey","2020-08-26","2020-09-07","Residual sera","Multiple groups",944.0,0.128,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.105,0.154,"","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_August/September3_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Mexico","2020-08-25","2020-09-08","Residual sera","Multiple groups",985.0,0.037,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.056,"","","","US","US-NM"
"2021-03-20","201124_USA_CDC_August/September3_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New York","2020-08-26","2020-09-10","Residual sera","Multiple groups",1043.0,0.195,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.169,0.224,"","","","US","US-NY"
"2021-03-20","201124_USA_CDC_August/September3_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Carolina","2020-08-26","2020-09-09","Residual sera","Multiple groups",982.0,0.038,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.053,"","","","US","US-NC"
"2021-03-20","201124_USA_CDC_August/September3_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Dakota","2020-08-26","2020-09-09","Residual sera","Multiple groups",109.0,0.002,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.01,"","","","US","US-ND"
"2021-03-20","201124_USA_CDC_August/September3_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Ohio","2020-08-27","2020-09-10","Residual sera","Multiple groups",983.0,0.05,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.032,0.071,"","","","US","US-OH"
"2021-03-20","201124_USA_CDC_August/September3_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oklahoma","2020-08-24","2020-09-01","Residual sera","Multiple groups",979.0,0.054,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.038,0.073,"","","","US","US-OK"
"2021-03-20","201124_USA_CDC_August/September3_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oregon","2020-08-26","2020-09-10","Residual sera","Multiple groups",968.0,0.019,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.009,0.029,"","","","US","US-OR"
"2021-03-20","201124_USA_CDC_August/September3_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Pennsylvania","2020-08-26","2020-09-09","Residual sera","Multiple groups",845.0,0.095,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.066,0.136,"","","","US","US-PA"
"2021-03-20","201124_USA_CDC_August/September3_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Puerto Rico","2020-08-24","2020-09-03","Residual sera","Multiple groups",980.0,0.025,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.014,0.038,"","","","US","US-PR"
"2021-03-20","201124_USA_CDC_August/September3_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Rhode Island","2020-08-27","2020-09-10","Residual sera","Multiple groups",786.0,0.031,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.017,0.046,"","","","US","US-RI"
"2021-03-20","201124_USA_CDC_August/September3_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Carolina","2020-08-26","2020-09-10","Residual sera","Multiple groups",927.0,0.072,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.051,0.096,"","","","US","US-SC"
"2021-03-20","201124_USA_CDC_August/September3_SouthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Dakota","2020-08-26","2020-09-10","Residual sera","Multiple groups",97.0,0.007,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.025,"","","","US","US-SD"
"2021-03-20","201124_USA_CDC_August/September3_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Tennessee","2020-08-25","2020-09-08","Residual sera","Multiple groups",950.0,0.054,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.036,0.073,"","","","US","US-TN"
"2021-03-20","201124_USA_CDC_August/September3_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Texas","2020-08-25","2020-09-02","Residual sera","Multiple groups",979.0,0.058,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.04,0.079,"","","","US","US-TX"
"2021-03-20","201124_USA_CDC_August/September3_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Utah","2020-08-24","2020-09-08","Residual sera","Multiple groups",1104.0,0.049,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.028,0.077,"","","","US","US-UT"
"2021-03-20","201124_USA_CDC_August/September3_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Vermont","2020-08-26","2020-09-10","Residual sera","Multiple groups",485.0,0.004,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.009,"","","","US","US-VT"
"2021-03-20","201124_USA_CDC_August/September3_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Virginia","2020-08-26","2020-09-08","Residual sera","Multiple groups",1007.0,0.035,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.02,0.053,"","","","US","US-VA"
"2021-03-20","201124_USA_CDC_August/September3_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington","2020-08-25","2020-09-10","Residual sera","Multiple groups",820.0,0.045,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.026,0.069,"","","","US","US-WA"
"2021-03-20","201124_USA_CDC_August/September3_WashingtonD.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington D.C","2020-08-27","2020-09-10","Residual sera","Multiple groups",643.0,0.05,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.028,0.076,"","","","US","US-DC"
"2021-03-20","201124_USA_CDC_August/September3_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  West Virginia","2020-08-26","2020-09-10","Residual sera","Multiple groups",1128.0,0.015,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.008,0.024,"","","","US","US-WV"
"2021-03-20","201124_USA_CDC_August/September3_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Wisconsin","2020-08-25","2020-09-10","Residual sera","Multiple groups",976.0,0.026,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.015,0.04,"","","","US","US-WI"
"2021-03-20","201124_USA_CDC_August2_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alabama","2020-08-12","2020-08-26","Residual sera","Multiple groups",974.0,0.076,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.053,0.098,"","","","US","US-AL"
"2021-03-20","201124_USA_CDC_August2_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alaska","2020-08-12","2020-08-26","Residual sera","Multiple groups",704.0,0.013,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.005,0.023,"","","","US","US-AK"
"2021-03-20","201124_USA_CDC_August2_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arizona","2020-08-12","2020-08-26","Residual sera","Multiple groups",1304.0,0.047,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.027,0.076,"","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_August2_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arkansas","2020-08-11","2020-08-25","Residual sera","Multiple groups",998.0,0.03,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.044,"","","","US","US-AR"
"2021-03-20","201124_USA_CDC_August2_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; California","2020-08-13","2020-08-19","Residual sera","Multiple groups",980.0,0.043,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.028,0.061,"","","","US","US-CA"
"2021-03-20","201124_USA_CDC_August2_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Colorado","2020-08-10","2020-08-25","Residual sera","Multiple groups",1019.0,0.033,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.048,"","","","US","US-CO"
"2021-03-20","201124_USA_CDC_August2_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Connecticut","2020-08-11","2020-08-24","Residual sera","Multiple groups",983.0,0.024,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.014,0.035,"","","","US","US-CT"
"2021-03-20","201124_USA_CDC_August2_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Delaware","2020-08-12","2020-08-27","Residual sera","Multiple groups",1004.0,0.085,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.058,0.112,"","","","US","US-DE"
"2021-03-20","201124_USA_CDC_August2_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Florida","2020-08-14","2020-08-14","Residual sera","Multiple groups",978.0,0.045,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.032,0.061,"","","","US","US-FL"
"2021-03-20","201124_USA_CDC_August2_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Georgia","2020-08-13","2020-08-26","Residual sera","Multiple groups",1031.0,0.074,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.055,0.095,"","","","US","US-GA"
"2021-03-20","201124_USA_CDC_August2_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Idaho","2020-08-12","2020-08-26","Residual sera","Multiple groups",651.0,0.046,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.017,0.091,"","","","US","US-ID"
"2021-03-20","201124_USA_CDC_August2_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Illinois","2020-08-12","2020-08-27","Residual sera","Multiple groups",985.0,0.049,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.034,0.066,"","","","US","US-IL"
"2021-03-20","201124_USA_CDC_August2_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Indiana","2020-08-12","2020-08-26","Residual sera","Multiple groups",906.0,0.031,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.015,0.048,"","","","US","US-IN"
"2021-03-20","201124_USA_CDC_August2_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Iowa","2020-08-12","2020-08-27","Residual sera","Multiple groups",980.0,0.094,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.071,0.116,"","","","US","US-IA"
"2021-03-20","201124_USA_CDC_August2_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Kansas","2020-08-11","2020-08-25","Residual sera","Multiple groups",1016.0,0.037,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.02,0.055,"","","","US","US-KS"
"2021-03-20","201124_USA_CDC_August2_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Kentucky","2020-08-12","2020-08-26","Residual sera","Multiple groups",1126.0,0.031,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.02,0.045,"","","","US","US-KY"
"2021-03-20","201124_USA_CDC_August2_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Louisiana","2020-08-12","2020-08-25","Residual sera","Multiple groups",989.0,0.118,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.093,0.148,"","","","US","US-LA"
"2021-03-20","201124_USA_CDC_August2_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maine","2020-08-12","2020-08-27","Residual sera","Multiple groups",609.0,0.006,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.014,"","","","US","US-ME"
"2021-03-20","201124_USA_CDC_August2_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maryland","2020-08-10","2020-08-26","Residual sera","Multiple groups",1174.0,0.07,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.049,0.093,"","","","US","US-MD"
"2021-03-20","201124_USA_CDC_August2_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Massachusetts","2020-08-12","2020-08-27","Residual sera","Multiple groups",980.0,0.037,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.052,"","","","US","US-MA"
"2021-03-20","201124_USA_CDC_August2_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Michigan","2020-08-12","2020-08-25","Residual sera","Multiple groups",983.0,0.042,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.029,0.058,"","","","US","US-MI"
"2021-03-20","201124_USA_CDC_August2_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Minnesota","2020-08-11","2020-08-27","Residual sera","Multiple groups",978.0,0.045,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.03,0.059,"","","","US","US-MN"
"2021-03-20","201124_USA_CDC_August2_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Mississippi","2020-08-12","2020-08-27","Residual sera","Multiple groups",968.0,0.1,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.067,0.147,"","","","US","US-MS"
"2021-03-20","201124_USA_CDC_August2_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Missouri","2020-08-12","2020-08-21","Residual sera","Multiple groups",1021.0,0.035,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.051,"","","","US","US-MO"
"2021-03-20","201124_USA_CDC_August2_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Montana","2020-08-12","2020-08-24","Residual sera","Multiple groups",383.0,0.013,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.004,0.025,"","","","US","US-MT"
"2021-03-20","201124_USA_CDC_August2_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nebraska","2020-08-11","2020-08-25","Residual sera","Multiple groups",990.0,0.079,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.055,0.106,"","","","US","US-NE"
"2021-03-20","201124_USA_CDC_August2_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nevada","2020-08-12","2020-08-26","Residual sera","Multiple groups",972.0,0.079,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.061,0.098,"","","","US","US-NV"
"2021-03-20","201124_USA_CDC_August2_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Hampshire","2020-08-13","2020-08-25","Residual sera","Multiple groups",1125.0,0.008,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.003,0.012,"","","","US","US-NH"
"2021-03-20","201124_USA_CDC_August2_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Jersey","2020-08-10","2020-08-26","Residual sera","Multiple groups",1127.0,0.122,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.102,0.145,"","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_August2_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Mexico","2020-08-10","2020-08-27","Residual sera","Multiple groups",976.0,0.025,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.015,0.038,"","","","US","US-NM"
"2021-03-20","201124_USA_CDC_August2_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New York","2020-08-10","2020-08-26","Residual sera","Multiple groups",1122.0,0.206,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.18,0.231,"","","","US","US-NY"
"2021-03-20","201124_USA_CDC_August2_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Carolina","2020-08-11","2020-08-27","Residual sera","Multiple groups",982.0,0.038,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.053,"","","","US","US-NC"
"2021-03-20","201124_USA_CDC_August2_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Dakota","2020-08-12","2020-08-26","Residual sera","Multiple groups",135.0,0.006,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.014,"","","","US","US-ND"
"2021-03-20","201124_USA_CDC_August2_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Ohio","2020-08-12","2020-08-27","Residual sera","Multiple groups",985.0,0.021,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.011,0.033,"","","","US","US-OH"
"2021-03-20","201124_USA_CDC_August2_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oklahoma","2020-08-10","2020-08-18","Residual sera","Multiple groups",979.0,0.04,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.027,0.055,"","","","US","US-OK"
"2021-03-20","201124_USA_CDC_August2_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oregon","2020-08-10","2020-08-27","Residual sera","Multiple groups",1086.0,0.024,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.014,0.036,"","","","US","US-OR"
"2021-03-20","201124_USA_CDC_August2_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Pennsylvania","2020-08-10","2020-08-26","Residual sera","Multiple groups",887.0,0.101,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.075,0.137,"","","","US","US-PA"
"2021-03-20","201124_USA_CDC_August2_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Puerto Rico","2020-08-10","2020-08-17","Residual sera","Multiple groups",986.0,0.022,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.012,0.033,"","","","US","US-PR"
"2021-03-20","201124_USA_CDC_August2_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Rhode Island","2020-08-12","2020-08-27","Residual sera","Multiple groups",570.0,0.036,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.017,0.059,"","","","US","US-RI"
"2021-03-20","201124_USA_CDC_August2_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Carolina","2020-08-12","2020-08-27","Residual sera","Multiple groups",1063.0,0.06,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.044,0.08,"","","","US","US-SC"
"2021-03-20","201124_USA_CDC_August2_SouthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Dakota","2020-08-12","2020-08-26","Residual sera","Multiple groups",83.0,0.0,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.044,"","","","US","US-SD"
"2021-03-20","201124_USA_CDC_August2_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Tennessee","2020-08-12","2020-08-26","Residual sera","Multiple groups",1029.0,0.067,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.051,0.086,"","","","US","US-TN"
"2021-03-20","201124_USA_CDC_August2_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Texas","2020-08-12","2020-08-24","Residual sera","Multiple groups",1001.0,0.065,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.047,0.085,"","","","US","US-TX"
"2021-03-20","201124_USA_CDC_August2_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Utah","2020-08-15","2020-08-25","Residual sera","Multiple groups",871.0,0.055,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.029,0.087,"","","","US","US-UT"
"2021-03-20","201124_USA_CDC_August2_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Vermont","2020-08-13","2020-08-27","Residual sera","Multiple groups",382.0,0.003,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.008,"","","","US","US-VT"
"2021-03-20","201124_USA_CDC_August2_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Virginia","2020-08-10","2020-08-26","Residual sera","Multiple groups",1243.0,0.047,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.025,0.072,"","","","US","US-VA"
"2021-03-20","201124_USA_CDC_August2_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington","2020-08-12","2020-08-27","Residual sera","Multiple groups",1238.0,0.03,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.045,"","","","US","US-WA"
"2021-03-20","201124_USA_CDC_August2_Washington D.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington D.C","2020-08-13","2020-08-27","Residual sera","Multiple groups",781.0,0.068,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.046,0.092,"","","","US","US-DC"
"2021-03-20","201124_USA_CDC_August2_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  West Virginia","2020-08-13","2020-08-27","Residual sera","Multiple groups",637.0,0.022,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.005,0.049,"","","","US","US-WV"
"2021-03-20","201124_USA_CDC_August2_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Wisconsin","2020-08-12","2020-08-27","Residual sera","Multiple groups",838.0,0.033,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.02,0.047,"","","","US","US-WI"
"2021-03-20","201124_USA_CDC_August2_Wyoming","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Wyoming","2020-08-13","2020-08-24","Residual sera","Multiple groups",86.0,0.008,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.031,"","","","US","US-WY"
"2021-03-20","201124_USA_CDC_July/August1_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alabama","2020-07-29","2020-08-13","Residual sera","Multiple groups",938.0,0.058,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.042,0.077,"","","","US","US-AL"
"2021-03-20","201124_USA_CDC_July/August1_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alaska","2020-08-06","2020-08-11","Residual sera","Multiple groups",242.0,0.003,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.011,"","","","US","US-AK"
"2021-03-20","201124_USA_CDC_July/August1_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arizona","2020-07-31","2020-08-11","Residual sera","Multiple groups",591.0,0.082,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.041,0.136,"","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_July/August1_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arkansas","2020-07-29","2020-08-13","Residual sera","Multiple groups",937.0,0.041,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.027,0.056,"","","","US","US-AR"
"2021-03-20","201124_USA_CDC_July/August1_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; California","2020-07-30","2020-08-05","Residual sera","Multiple groups",980.0,0.057,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.04,0.078,"","","","US","US-CA"
"2021-03-20","201124_USA_CDC_July/August1_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Colorado","2020-07-30","2020-08-07","Residual sera","Multiple groups",1001.0,0.024,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.009,0.045,"","","","US","US-CO"
"2021-03-20","201124_USA_CDC_July/August1_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Connecticut","2020-07-30","2020-08-03","Residual sera","Multiple groups",994.0,0.034,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.02,0.047,"","","","US","US-CT"
"2021-03-20","201124_USA_CDC_July/August1_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Delaware","2020-07-29","2020-08-13","Residual sera","Multiple groups",804.0,0.057,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.036,0.082,"","","","US","US-DE"
"2021-03-20","201124_USA_CDC_July/August1_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Florida","2020-07-31","2020-08-03","Residual sera","Multiple groups",980.0,0.043,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.028,0.059,"","","","US","US-FL"
"2021-03-20","201124_USA_CDC_July/August1_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Georgia","2020-08-02","2020-08-11","Residual sera","Multiple groups",985.0,0.068,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.048,0.088,"","","","US","US-GA"
"2021-03-20","201124_USA_CDC_July/August1_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Idaho","2020-08-04","2020-08-11","Residual sera","Multiple groups",246.0,0.045,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.08,"","","","US","US-ID"
"2021-03-20","201124_USA_CDC_July/August1_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Illinois","2020-07-29","2020-08-10","Residual sera","Multiple groups",1004.0,0.039,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.025,0.052,"","","","US","US-IL"
"2021-03-20","201124_USA_CDC_July/August1_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Indiana","2020-07-31","2020-08-11","Residual sera","Multiple groups",579.0,0.022,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.011,0.036,"","","","US","US-IN"
"2021-03-20","201124_USA_CDC_July/August1_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Iowa","2020-07-29","2020-08-13","Residual sera","Multiple groups",811.0,0.086,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.06,0.113,"","","","US","US-IA"
"2021-03-20","201124_USA_CDC_July/August1_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Kansas","2020-07-29","2020-08-08","Residual sera","Multiple groups",962.0,0.016,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.007,0.028,"","","","US","US-KS"
"2021-03-20","201124_USA_CDC_July/August1_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Kentucky","2020-07-30","2020-08-13","Residual sera","Multiple groups",975.0,0.024,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.013,0.036,"","","","US","US-KY"
"2021-03-20","201124_USA_CDC_July/August1_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Louisiana","2020-07-28","2020-08-13","Residual sera","Multiple groups",1002.0,0.096,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.069,0.123,"","","","US","US-LA"
"2021-03-20","201124_USA_CDC_July/August1_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maine","2020-07-30","2020-08-11","Residual sera","Multiple groups",598.0,0.005,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.012,"","","","US","US-ME"
"2021-03-20","201124_USA_CDC_July/August1_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maryland","2020-07-31","2020-08-11","Residual sera","Multiple groups",783.0,0.097,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.073,0.129,"","","","US","US-MD"
"2021-03-20","201124_USA_CDC_July/August1_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Massachusetts","2020-07-30","2020-08-10","Residual sera","Multiple groups",978.0,0.042,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.029,0.058,"","","","US","US-MA"
"2021-03-20","201124_USA_CDC_July/August1_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Michigan","2020-07-30","2020-08-11","Residual sera","Multiple groups",982.0,0.034,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.048,"","","","US","US-MI"
"2021-03-20","201124_USA_CDC_July/August1_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Minnesota","2020-07-29","2020-08-13","Residual sera","Multiple groups",879.0,0.035,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.021,0.05,"","","","US","US-MN"
"2021-03-20","201124_USA_CDC_July/August1_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Mississippi","2020-07-30","2020-08-13","Residual sera","Multiple groups",769.0,0.071,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.038,0.111,"","","","US","US-MS"
"2021-03-20","201124_USA_CDC_July/August1_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Missouri","2020-07-28","2020-08-10","Residual sera","Multiple groups",979.0,0.025,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.014,0.036,"","","","US","US-MO"
"2021-03-20","201124_USA_CDC_July/August1_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Montana","2020-07-29","2020-08-10","Residual sera","Multiple groups",199.0,0.005,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.017,"","","","US","US-MT"
"2021-03-20","201124_USA_CDC_July/August1_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nebraska","2020-07-28","2020-08-13","Residual sera","Multiple groups",954.0,0.074,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.052,0.098,"","","","US","US-NE"
"2021-03-20","201124_USA_CDC_July/August1_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nevada","2020-07-30","2020-08-02","Residual sera","Multiple groups",979.0,0.051,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.036,0.067,"","","","US","US-NV"
"2021-03-20","201124_USA_CDC_July/August1_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Hampshire","2020-07-30","2020-08-11","Residual sera","Multiple groups",809.0,0.008,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.002,0.015,"","","","US","US-NH"
"2021-03-20","201124_USA_CDC_July/August1_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Jersey","2020-07-31","2020-08-11","Residual sera","Multiple groups",871.0,0.148,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.122,0.176,"","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_July/August1_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Mexico","2020-07-29","2020-08-13","Residual sera","Multiple groups",964.0,0.02,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.011,0.03,"","","","US","US-NM"
"2021-03-20","201124_USA_CDC_July/August1_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New York","2020-07-31","2020-08-11","Residual sera","Multiple groups",846.0,0.233,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.201,0.263,"","","","US","US-NY"
"2021-03-20","201124_USA_CDC_July/August1_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Carolina","2020-07-29","2020-08-10","Residual sera","Multiple groups",928.0,0.025,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.013,0.037,"","","","US","US-NC"
"2021-03-20","201124_USA_CDC_July/August1_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Dakota","2020-07-29","2020-08-12","Residual sera","Multiple groups",121.0,0.073,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.013,0.143,"","","","US","US-ND"
"2021-03-20","201124_USA_CDC_July/August1_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Ohio","2020-07-29","2020-08-11","Residual sera","Multiple groups",786.0,0.023,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.011,0.036,"","","","US","US-OH"
"2021-03-20","201124_USA_CDC_July/August1_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oklahoma","2020-07-28","2020-08-04","Residual sera","Multiple groups",979.0,0.016,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.008,0.025,"","","","US","US-OK"
"2021-03-20","201124_USA_CDC_July/August1_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oregon","2020-08-05","2020-08-11","Residual sera","Multiple groups",658.0,0.023,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.01,0.038,"","","","US","US-OR"
"2021-03-20","201124_USA_CDC_July/August1_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Pennsylvania","2020-07-31","2020-08-11","Residual sera","Multiple groups",575.0,0.102,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.057,0.172,"","","","US","US-PA"
"2021-03-20","201124_USA_CDC_July/August1_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Puerto Rico","2020-07-27","2020-08-07","Residual sera","Multiple groups",984.0,0.011,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.004,0.018,"","","","US","US-PR"
"2021-03-20","201124_USA_CDC_July/August1_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Rhode Island","2020-07-30","2020-08-11","Residual sera","Multiple groups",684.0,0.03,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.012,0.055,"","","","US","US-RI"
"2021-03-20","201124_USA_CDC_July/August1_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Carolina","2020-07-30","2020-08-13","Residual sera","Multiple groups",840.0,0.081,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.058,0.107,"","","","US","US-SC"
"2021-03-20","201124_USA_CDC_July/August1_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Tennessee","2020-07-30","2020-08-11","Residual sera","Multiple groups",1003.0,0.063,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.044,0.082,"","","","US","US-TN"
"2021-03-20","201124_USA_CDC_July/August1_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Texas","2020-07-29","2020-08-05","Residual sera","Multiple groups",986.0,0.059,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.04,0.08,"","","","US","US-TX"
"2021-03-20","201124_USA_CDC_July/August1_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Utah","2020-07-30","2020-08-11","Residual sera","Multiple groups",880.0,0.032,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.017,0.05,"","","","US","US-UT"
"2021-03-20","201124_USA_CDC_July/August1_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Vermont","2020-07-30","2020-08-11","Residual sera","Multiple groups",346.0,0.005,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.018,"","","","US","US-VT"
"2021-03-20","201124_USA_CDC_July/August1_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Virginia","2020-07-31","2020-08-11","Residual sera","Multiple groups",730.0,0.041,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.069,"","","","US","US-VA"
"2021-03-20","201124_USA_CDC_July/August1_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington","2020-07-29","2020-08-11","Residual sera","Multiple groups",684.0,0.021,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.008,0.037,"","","","US","US-WA"
"2021-03-20","201124_USA_CDC_July/August1_Washington D.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington D.C","2020-07-30","2020-08-13","Residual sera","Multiple groups",717.0,0.039,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.058,"","","","US","US-DC"
"2021-03-20","201124_USA_CDC_July/August1_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  West Virginia","2020-07-30","2020-08-13","Residual sera","Multiple groups",317.0,0.012,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.002,0.025,"","","","US","US-WV"
"2021-03-20","201124_USA_CDC_July/August1_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Wisconsin","2020-07-30","2020-08-13","Residual sera","Multiple groups",814.0,0.018,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.008,0.032,"","","","US","US-WI"
"2021-03-20","201124_USA_CDC_September4_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alabama","2020-09-09","2020-09-18","Residual sera","Multiple groups",905.0,0.087,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.062,0.113,"","","","US","US-AL"
"2021-03-20","201124_USA_CDC_September4_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Alaska","2020-09-09","2020-09-18","Residual sera","Multiple groups",681.0,0.004,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.001,0.008,"","","","US","US-AK"
"2021-03-20","201124_USA_CDC_September4_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arizona","2020-09-09","2020-09-23","Residual sera","Multiple groups",1208.0,0.054,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.031,0.085,"","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_September4_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Arkansas","2020-09-09","2020-09-18","Residual sera","Multiple groups",990.0,0.063,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.046,0.08,"","","","US","US-AR"
"2021-03-20","201124_USA_CDC_September4_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; California","2020-09-10","2020-09-16","Residual sera","Multiple groups",979.0,0.049,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.032,0.068,"","","","US","US-CA"
"2021-03-20","201124_USA_CDC_September4_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Colorado","2020-09-09","2020-09-18","Residual sera","Multiple groups",1032.0,0.033,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.019,0.049,"","","","US","US-CO"
"2021-03-20","201124_USA_CDC_September4_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Connecticut","2020-09-09","2020-09-14","Residual sera","Multiple groups",982.0,0.031,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.021,0.044,"","","","US","US-CT"
"2021-03-20","201124_USA_CDC_September4_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Delaware","2020-09-09","2020-09-24","Residual sera","Multiple groups",980.0,0.075,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.049,0.105,"","","","US","US-DE"
"2021-03-20","201124_USA_CDC_September4_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Florida","2020-09-11","2020-09-11","Residual sera","Multiple groups",979.0,0.085,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.066,0.107,"","","","US","US-FL"
"2021-03-20","201124_USA_CDC_September4_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Georgia","2020-09-09","2020-09-18","Residual sera","Multiple groups",1100.0,0.13,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.105,0.158,"","","","US","US-GA"
"2021-03-20","201124_USA_CDC_September4_Hawaii","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Hawaii","2020-09-08","2020-09-22","Residual sera","Multiple groups",516.0,0.008,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.022,"","","","US","US-HI"
"2021-03-20","201124_USA_CDC_September4_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Idaho","2020-09-08","2020-09-18","Residual sera","Multiple groups",732.0,0.052,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.027,0.085,"","","","US","US-ID"
"2021-03-20","201124_USA_CDC_September4_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Illinois","2020-09-08","2020-09-17","Residual sera","Multiple groups",992.0,0.045,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.031,0.061,"","","","US","US-IL"
"2021-03-20","201124_USA_CDC_September4_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Indiana","2020-09-09","2020-09-23","Residual sera","Multiple groups",1155.0,0.04,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.014,0.088,"","","","US","US-IN"
"2021-03-20","201124_USA_CDC_September4_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Iowa","2020-09-09","2020-09-24","Residual sera","Multiple groups",977.0,0.076,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.056,0.1,"","","","US","US-IA"
"2021-03-20","201124_USA_CDC_September4_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Kansas","2020-09-09","2020-09-19","Residual sera","Multiple groups",1007.0,0.035,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.048,"","","","US","US-KS"
"2021-03-20","201124_USA_CDC_September4_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Kentucky","2020-09-09","2020-09-18","Residual sera","Multiple groups",980.0,0.036,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.023,0.052,"","","","US","US-KY"
"2021-03-20","201124_USA_CDC_September4_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Louisiana","2020-09-09","2020-09-19","Residual sera","Multiple groups",952.0,0.125,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.1,0.156,"","","","US","US-LA"
"2021-03-20","201124_USA_CDC_September4_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maine","2020-09-08","2020-09-24","Residual sera","Multiple groups",987.0,0.005,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.001,0.009,"","","","US","US-ME"
"2021-03-20","201124_USA_CDC_September4_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Maryland","2020-09-10","2020-09-23","Residual sera","Multiple groups",1242.0,0.102,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.079,0.127,"","","","US","US-MD"
"2021-03-20","201124_USA_CDC_September4_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Massachusetts","2020-09-09","2020-09-15","Residual sera","Multiple groups",988.0,0.037,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.052,"","","","US","US-MA"
"2021-03-20","201124_USA_CDC_September4_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Michigan","2020-09-08","2020-09-22","Residual sera","Multiple groups",980.0,0.037,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.025,0.049,"","","","US","US-MI"
"2021-03-20","201124_USA_CDC_September4_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Minnesota","2020-09-09","2020-09-23","Residual sera","Multiple groups",1033.0,0.08,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.047,0.114,"","","","US","US-MN"
"2021-03-20","201124_USA_CDC_September4_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Mississippi","2020-09-09","2020-09-22","Residual sera","Multiple groups",980.0,0.079,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.054,0.109,"","","","US","US-MS"
"2021-03-20","201124_USA_CDC_September4_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Missouri","2020-09-08","2020-09-24","Residual sera","Multiple groups",1031.0,0.035,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.05,"","","","US","US-MO"
"2021-03-20","201124_USA_CDC_September4_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Montana","2020-09-09","2020-09-23","Residual sera","Multiple groups",508.0,0.022,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.007,0.044,"","","","US","US-MT"
"2021-03-20","201124_USA_CDC_September4_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nebraska","2020-09-09","2020-09-18","Residual sera","Multiple groups",976.0,0.067,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.048,0.089,"","","","US","US-NE"
"2021-03-20","201124_USA_CDC_September4_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Nevada","2020-09-09","2020-09-12","Residual sera","Multiple groups",979.0,0.078,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.059,0.1,"","","","US","US-NV"
"2021-03-20","201124_USA_CDC_September4_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Hampshire","2020-09-09","2020-09-17","Residual sera","Multiple groups",1034.0,0.007,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.003,0.013,"","","","US","US-NH"
"2021-03-20","201124_USA_CDC_September4_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Jersey","2020-09-09","2020-09-23","Residual sera","Multiple groups",1050.0,0.151,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.126,0.176,"","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_September4_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New Mexico","2020-09-08","2020-09-24","Residual sera","Multiple groups",1014.0,0.024,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.012,0.036,"","","","US","US-NM"
"2021-03-20","201124_USA_CDC_September4_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  New York","2020-09-11","2020-09-24","Residual sera","Multiple groups",1168.0,0.17,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.147,0.192,"","","","US","US-NY"
"2021-03-20","201124_USA_CDC_September4_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Carolina","2020-09-09","2020-09-17","Residual sera","Multiple groups",925.0,0.068,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.048,0.089,"","","","US","US-NC"
"2021-03-20","201124_USA_CDC_September4_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  North Dakota","2020-09-09","2020-09-24","Residual sera","Multiple groups",113.0,0.012,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.034,"","","","US","US-ND"
"2021-03-20","201124_USA_CDC_September4_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Ohio","2020-09-10","2020-09-22","Residual sera","Multiple groups",978.0,0.028,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.017,0.042,"","","","US","US-OH"
"2021-03-20","201124_USA_CDC_September4_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oklahoma","2020-09-09","2020-09-18","Residual sera","Multiple groups",980.0,0.05,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.034,0.065,"","","","US","US-OK"
"2021-03-20","201124_USA_CDC_September4_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Oregon","2020-09-08","2020-09-22","Residual sera","Multiple groups",971.0,0.026,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.015,0.041,"","","","US","US-OR"
"2021-03-20","201124_USA_CDC_September4_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Pennsylvania","2020-09-09","2020-09-23","Residual sera","Multiple groups",1341.0,0.111,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.088,0.137,"","","","US","US-PA"
"2021-03-20","201124_USA_CDC_September4_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Puerto Rico","2020-09-08","2020-09-15","Residual sera","Multiple groups",970.0,0.03,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.043,"","","","US","US-PR"
"2021-03-20","201124_USA_CDC_September4_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Rhode Island","2020-09-09","2020-09-24","Residual sera","Multiple groups",795.0,0.027,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.012,0.049,"","","","US","US-RI"
"2021-03-20","201124_USA_CDC_September4_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Carolina","2020-09-09","2020-09-18","Residual sera","Multiple groups",975.0,0.078,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.056,0.102,"","","","US","US-SC"
"2021-03-20","201124_USA_CDC_September4_SouthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  South Dakota","2020-09-09","2020-09-23","Residual sera","Multiple groups",99.0,0.018,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.048,"","","","US","US-SD"
"2021-03-20","201124_USA_CDC_September4_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Tennessee","2020-09-08","2020-09-16","Residual sera","Multiple groups",1028.0,0.067,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.05,0.086,"","","","US","US-TN"
"2021-03-20","201124_USA_CDC_September4_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Texas","2020-09-09","2020-09-24","Residual sera","Multiple groups",988.0,0.082,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.062,0.105,"","","","US","US-TX"
"2021-03-20","201124_USA_CDC_September4_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Utah","2020-09-09","2020-09-18","Residual sera","Multiple groups",1022.0,0.051,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.033,0.079,"","","","US","US-UT"
"2021-03-20","201124_USA_CDC_September4_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Vermont","2020-09-09","2020-09-24","Residual sera","Multiple groups",497.0,0.017,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.003,0.042,"","","","US","US-VT"
"2021-03-20","201124_USA_CDC_September4_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Virginia","2020-09-10","2020-09-23","Residual sera","Multiple groups",1111.0,0.032,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.018,0.051,"","","","US","US-VA"
"2021-03-20","201124_USA_CDC_September4_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington","2020-09-09","2020-09-22","Residual sera","Multiple groups",968.0,0.025,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.013,0.038,"","","","US","US-WA"
"2021-03-20","201124_USA_CDC_September4_Washington D.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America; Washington D.C","2020-09-08","2020-09-24","Residual sera","Multiple groups",976.0,0.065,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.045,0.083,"","","","US","US-DC"
"2021-03-20","201124_USA_CDC_September4_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  West Virginia","2020-09-09","2020-09-22","Residual sera","Multiple groups",968.0,0.013,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.005,0.022,"","","","US","US-WV"
"2021-03-20","201124_USA_CDC_September4_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Wisconsin","2020-09-09","2020-09-24","Residual sera","Multiple groups",976.0,0.038,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.022,0.057,"","","","US","US-WI"
"2021-03-20","201124_USA_CDC_September4_Wyoming","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America","United States of America;  Wyoming","2020-09-09","2020-09-24","Residual sera","Multiple groups",111.0,0.015,"Stratified non-probability","Roche, Abbott, Ortho-Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified",0.0,0.04,"","","","US","US-WY"
"2021-03-20","210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall","Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan","2021-01-29","Regional","Japan","Japan; Kansai","2020-08-06","2020-10-01","Residual sera","Multiple groups",10377.0,0.006,"Sequential","1) Roche Diagnostics; 2) Sysmex","IgG","Moderate","Journal Article (Peer-Reviewed)","Koichi Furukawa","Kobe University Graduate School of Medicine","https://dx.doi.org/10.31662/jmaj.2020-0094","Verified","","","","","","JP",""
"2021-03-20","210129_NewYork_NorthwellHealth","610 ABO and Rh blood groups and SARS-CoV-2 susceptibility in pregnancy","2021-01-29","Regional","United States of America","United States of America; New York","2020-05-27","2020-08-23","Pregnant or parturient women","Adults (18-64 years)",2930.0,0.153,"Sequential","NR","Not reported","Unclear","Journal Article (Peer-Reviewed)","Lylach Haizler Cohen","Northwell Health","http://dx.doi.org/10.1016/j.ajog.2020.12.631","Verified","","","","","","US","US-NY"
"2021-03-21","201127_Germany_IfoInstitue_overall_PopAdj","Die Deutschen und Corona Schlussbericht der BMG-„Corona-BUND-Studie“","2020-11-27","National","Germany","Germany","2020-10-26","2020-11-18","Household and community samples","Multiple groups",9929.0,0.011,"Convenience","Roche","Total Antibody","Unclear","Institutional Report","Clemens Fuest","ifo Institute","https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona","Verified",0.009,0.013,"",0.998,"","DE",""
"2021-03-21","210127_London_King'sCollegeLondon_September_PostgradStudents&Staff","The King’s College London Coronavirus Health and Experiences of Colleagues at King’s Study: SARS-CoV-2 antibody response in a higher education sample","2021-01-27","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-09-01","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",1675.0,0.054,"Convenience","SureScreen Diagnostics","IgG; IgM","High","Preprint","Daniel Leightley","King's College London","https://doi.org/10.1101/2021.01.26.21249744","Verified","","","","","","GB",""
"2021-03-21","210201_Canada_CanadianBloodServices_Overall_adj","SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada","2021-02-01","National","Canada","Canada; All provinces & territories except Quebec","2020-05-09","2020-07-21","Blood donors","Multiple groups",74642.0,0.007,"Sequential","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Sahar Saeed","Canadian Blood Services","http://dx.doi.org/10.1111/trf.16296","Verified",0.006,0.008,0.927,0.999,"","CA",""
"2021-03-21","210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN","Challenges in interpreting SARS-CoV-2 serological results in African countries","2021-02-17","Local","Democratic Republic of the Congo","Democratic Republic of the Congo; Kinhasa; Kinhasa","2020-07-17","2020-08-13","Health care workers and caregivers","Adults (18-64 years)",562.0,0.36,"Stratified probability","EUROIMMUN, Lübeck, Germany","IgG","Moderate","Journal Article (Peer-Reviewed)","Antoine Nkuba Ndaye","Institut National de Recherche Biomedicale","https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext","Verified","","",0.946,0.998,"","CD","CD-KN"
"2021-03-21","210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_December_Adults","Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania","2021-02-20","Local","Albania","Albania","2020-12-21","2020-12-28","Household and community samples","Adults (18-64 years)",815.0,0.482,"Stratified probability","Euroimmun","IgG","High","Preprint","Genc Sulcebe","University of Medicine and University Hospital Center of Tirana","https://doi.org/10.1101/2021.02.18.21251776","Verified",0.448,0.517,"","","","AL",""
"2021-03-21","210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_July_Adults","Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania","2021-02-20","Local","Albania","Albania","2020-06-27","2020-07-03","Household and community samples","Adults (18-64 years)",266.0,0.075,"Stratified probability","Euroimmun","IgG","High","Preprint","Genc Sulcebe","University of Medicine and University Hospital Center of Tirana","https://doi.org/10.1101/2021.02.18.21251776","Verified",0.043,0.107,"","","","AL",""
"2021-03-22","201021_UniversidadeDeLisboa_UniversidadeDeLisboa_overall","Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset","2020-10-21","Local","Portugal","Portugal","2020-05-13","2020-07-10","Non-essential workers and unemployed persons","Adults (18-64 years)",2715.0,0.026,"Convenience","N/A - author designed","IgG","High","Journal Article (Peer-Reviewed)","Patricia Figueiredo Campos","Universidade de Lisboa","https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970","Verified","","",0.99,1.0,"","PT",""
"2021-03-22","210120_LosAngelesCounty_CedarsSinaiMedicalCenter_overall_adj","Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study","2021-02-12","Local","United States of America","United States of America","2020-05-11","2020-05-11","Health care workers and caregivers","Multiple groups",6062.0,0.041,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Joseph Ebinger","Cedars-Sinai Medical Center","https://dx.doi.org/10.1136/bmjopen-2020-043584","Verified",0.031,0.057,0.883,"","","US",""
"2021-03-22","210205_UnitedStates_BrownUniversity","SARS-CoV-2 antibody detection in skilled nursing facility residents","2021-02-05","National","United States of America","United States of America; Multiple states","","2020-08-01","Assisted living and long-term care facilities","Seniors (65+ years)",272.0,0.43,"Convenience","NR","IgG; IgM; Total Antibody","High","Journal Article (Peer-Reviewed)","Elizabeth White","Brown University","http://dx.doi.org/10.1111/jgs.17061","Verified","","","","","","US",""
"2021-03-22","210216_Toronto_UniversityHealthNetwork_Euroimmun+Microarray","Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center","2021-02-16","Local","Canada","Canada; Ontario; Toronto","2020-04-17","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",996.0,0.005,"Convenience","EUROIMMUN; In-House","IgG","Moderate","Journal Article (Peer-Reviewed)","Victor Ferreira","University Health Network","https://dx.doi.org/10.1371/journal.pone.0247258","Verified","","","","","","CA","CA-ON"
"2021-03-22","210305_Chicago_NorthwesternUniversity_overall","Geographic disparities in COVID-19 case rates are not reflected in seropositivity rates using a neighborhood survey in Chicago","2021-03-05","Local","United States of America","United States of America; Illinois; Chicago","2020-06-24","2020-11-23","Household and community samples","Multiple groups",1667.0,0.187,"Stratified non-probability","In-House - Northwestern University","IgG","Moderate","Preprint","Brian Mustanski","Northwestern University","https://www.medrxiv.org/content/10.1101/2021.03.02.21252767v1","Verified","","","","","","US","US-IL"
"2021-03-22","210316_UnitedStates_ClinicalReferenceLaboratoryInc_OverallGenPop","Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020","2021-03-16","National","United States of America","United States of America","2020-09-01","2020-09-30","Household and community samples","Multiple groups",61910.0,0.066,"Sequential","Roche Diagnostics","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Robert Stout","Clinical Reference Laboratory Inc","https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777502?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621","Verified","","",0.995,0.998,"","US",""
"2021-03-23","210223_Lorenskog_AkershusUniversityHospital_Overall","Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital","2021-02-23","Local","Norway","Norway","2020-05-11","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",360.0,0.033,"Convenience","Roche Diagnostics, Basel, Switzerland","IgG; IgM","High","Journal Article (Peer-Reviewed)","Nina Handal","Akershus University Hospital","https://dx.doi.org/10.1080/23744235.2021.1885734","Verified","","","","","","NO",""
"2021-03-24","201218_Madrid_HospitalUniversitarioFundaciónAlcorcón_HCW_Overall","Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital","2020-12-18","Local","Spain","Spain","2020-04-14","2020-04-27","Health care workers and caregivers","Adults (18-64 years)",2590.0,0.316,"Convenience","Palex","IgG","High","Journal Article (Peer-Reviewed)","Isabel Galan","Hospital Universitario Fundación Alcorcón","https://dx.doi.org/10.1016/j.eimc.2020.11.015","Verified","","",0.889,0.918,"","ES",""
"2021-03-24","210201_Indianapolis_IndianaUniversity_HCW_primary","Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit","2021-02-01","Local","United States of America","United States of America; Indiana; Indianapolis","2020-04-01","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",34.0,0.35,"Convenience","1) Abnova ; 2-5) N/A (author or institutiona desgined)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jorge J Canas","Indiana University","https://dx.doi.org/10.1016/j.kint.2020.11.014","Verified","","",0.944,0.985,"","US","US-IN"
"2021-03-24","210201_Indianapolis_IndianaUniversity_HDpatients_primary","Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit","2021-02-01","Local","United States of America","United States of America; Indiana; Indianapolis","2020-04-01","2020-06-24","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",14.0,0.36,"Convenience","1) Abnova ; 2-5) N/A (author or institutiona desgined)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jorge J Canas","Indiana University","https://dx.doi.org/10.1016/j.kint.2020.11.014","Verified","","",0.944,0.985,"","US","US-IN"
"2021-03-24","210203_VaticanCity_UniversitàCattolicadelSacroCuore_Overall","SARS-CoV-2 seroprevalence in the Vatican City State","2021-02-03","National","Vatican City","Vatican City; Vatican City State; Vatican City","2020-06-08","2021-01-04","Household and community samples","Multiple groups",1539.0,0.044,"Convenience","Siemens Healthineers AG","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Massimo Ralli","Università Cattolica del Sacro Cuore","https://dx.doi.org/10.1016/j.ejim.2021.01.029","Verified","","",0.975,0.998,"","VA",""
"2021-03-24","210206_China_ChineseCenterforDiseaseControlandPrevention_Overall","Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China","2021-02-06","National","China","China","2020-04-10","2020-04-18","Household and community samples","Multiple groups",34857.0,0.012,"Stratified probability","Wondfo, Innovita, Bioscience, In-House (China CDC)","IgM; IgG; Neutralizing ; Total Antibody","Low","Journal Article (Peer-Reviewed)","Zhongjie Li","Chinese Center for Disease Control and Prevention","https://dx.doi.org/10.1016/j.lanwpc.2021.100094","Verified","","","","","","CN",""
"2021-03-24","210222_Vorarlberg_VorarlbergInstituteforVascularInvestigationandTreatment","SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021","2021-02-22","Regional","Austria","Austria; Vorarlberg","2020-06-26","2021-01-20","Health care workers and caregivers","Adults (18-64 years)",395.0,0.18,"Convenience","Technoclone","IgG","High","Preprint","Michele Atzl","Vorarlberg Institute for Vascular Investigation and Treatment","https://www.medrxiv.org/content/10.1101/2021.02.19.21252045v1","Verified","","","","","","AT","AT-8"
"2021-03-24","210225_England_ImperialCollegeLondon_Round4_overall_adj","REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England","2021-02-25","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-10-27","2020-11-10","Household and community samples","Multiple groups",161537.0,0.056,"Stratified probability","Fortress Diagnostics","IgG","Moderate","Institutional Report","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1","Verified",0.054,0.057,0.844,0.986,"","GB","GB-ENG"
"2021-03-24","210301_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall","Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India","2021-03-01","Local","India","India; NCT Delhi; New Delhi","2020-06-22","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",3739.0,0.13,"Convenience","Siemens AG, Munich, Germany","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ritu Gupta","All India Institute of Medical Sciences","https://pubmed.ncbi.nlm.nih.gov/33642348/","Verified","","","","","","IN","IN-DL"
"2021-03-24","210302_Milan_FondazioneIRCCSIstitutoNazionaleDeiTumori_HCW_overall","Sars-cov-2 serology monitoring of a cancer center staff in the pandemic most infected italian region","2021-03-02","Local","Italy","Italy","2020-04-09","2020-09-09","Health care workers and caregivers","Adults (18-64 years)",110.0,0.2,"Simplified probability","Diagnostic Bioprobes, Dia.Pro, Sesto San Giovanni, Milan, Italy; PRIMA LAB SA, Switzerland), DiaSorin, Saluggia, Italy; FDA-EUA)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Chiara Maura Ciniselli","Fondazione IRCCS Istituto Nazionale dei Tumori (INT)","http://dx.doi.org/10.3390/cancers13051035","Verified","","","","","","IT",""
"2021-03-24","210320_Wuhan_ChineseAcademyOfMedicalSciences_overall_Roche","Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study","2021-03-20","Regional","China","China; Wuhan","2020-04-14","2020-04-15","Household and community samples","Multiple groups",9542.0,0.069,"Stratified probability","Roche","Total Antibody","Low","Journal Article (Peer-Reviewed)","Zhenyu He","Chinese Academy of Medical Sciences & Peking Union Medical College","https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext?dgcid=raven_jbs_etoc_email","Verified",0.064,0.074,1.0,1.0,"","CN","CN-42"
"2021-03-25","210119_Kaliningrad_RussianAcademyOfSciences_overall","Herd immunity of sars-CoV-2 among the population of Kalinigrad region amid the COVID-19 epidemic","2021-01-19","Regional","Russian Federation","Russian Federation; Kaliningrad Region","2020-08-03","2020-08-07","Household and community samples","Multiple groups",2939.0,0.502,"Stratified probability","FBSI"" State Research Center for Applied Microbiology and Biotechnology","IgG","Moderate","Journal Article (Peer-Reviewed)","A Yu Popova","The Russian Academy of Sciences","http://dx.doi.org/10.22625/2072-6732-2020-12-5-62-71","Verified",0.49,0.511,"","","","RU","RU-KGD"
"2021-03-25","210119_Lacashire_PublicHealthEngland_overall","Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys high throughput immunoassay","2021-01-19","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Lacashire","2020-06-03","2020-06-04","Essential non-healthcare workers","Adults (18-64 years)",195.0,0.092,"Convenience","Roche","Total Antibody","High","Journal Article (Peer-Reviewed)","Ranya Mulchandani","Public Health England","http://dx.doi.org/10.1016/j.jcv.2021.104739","Verified","","","","","","GB","GB-ENG"
"2021-03-25","210224_NortheastItaly_PaduaUniversityHospital_HCW","A longitudinal study of healthcare workers surveillance during the ongoing COVID-19 Epidemics in Italy: is SARS-CoV-2 still a threat for the Health-care System?","2021-02-24","Local","Italy","Italy; Veneto Region; Padua","2020-04-08","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",344.0,0.078,"Convenience","Snibe Diagnostic","IgG; IgM","High","Preprint","F Barbaro","Padua University Hospital","https://doi.org/10.1101/2021.02.23.21249481","Verified","","",0.912,0.973,"","IT","IT-34"
"2021-03-25","210323_Estonia_UniversityOfTartu_Stage15_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","Estonia","Estonia","2021-03-11","2021-03-22","Household and community samples","Multiple groups",2382.0,0.214,"Stratified probability","Synlab","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.198,0.231,"","","","EE",""
"2021-03-26","210202_UK_SalfordRoyalNHS_primary","Investigating the Utility of COVID-19 Antibody Testing in End-Stage Renal Disease Patients Receiving Haemodialysis: A Cohort Study in the United Kingdom","2021-02-02","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-03-15","2020-10-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",237.0,0.051,"Convenience","SNIBE and Siemens","IgG","High","Preprint","Olivia Wickens","Salford Royal NHS","https://www.researchsquare.com/article/rs-154513/v1","Verified","","","","","","GB",""
"2021-03-26","210212_Dublin_RotundaHospital","Persistence of SARS-CoV-2 antibodies and symptoms in an Irish Healthcare Worker (HCW) setting: Results of the CAST Study","2021-02-12","Local","Ireland","Ireland; Leinster; Dublin","2020-05-12","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",51.0,0.04,"Convenience","Trinity Biotech","IgG","High","Preprint","Joanna Griffin","Rotunda Hospital","https://www.medrxiv.org/content/10.1101/2021.02.10.20248323v1.full-text","Verified","","",0.959,1.0,"","IE","IE-L"
"2021-03-27","120301_RhodeIsland_CDC","Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020","2021-03-01","Regional","United States of America","United States of America; Rhode Island","2020-07-17","2020-08-28","Health care workers and caregivers","Multiple groups",9863.0,0.046,"Convenience","ORTHO Clinical Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Lara Akinbami","Centers for Disease Control","https://dx.doi.org/10.3201/eid2703.204508","Verified",0.042,0.05,0.9,1.0,"","US","US-RI"
"2021-03-27","201020_DipartimentoOncologicoAziendaUslToscanaCentroFirenze_Florence","Sars-cov-2 screening and monitoring in cancer patients: Azienda USL toscana centro oncology department experience","2020-10-20","Local","Italy","Italy; Tuscany; Florence","2020-05-11","2020-05-17","Patients seeking care for non-COVID-19 reasons","Multiple groups",1145.0,0.023,"Sequential","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Francesca Martella","Azienda Usl Toscana Centro Oncology","http://dx.doi.org/10.1177/0300891620953388","Verified","","","","","","IT","IT-52"
"2021-03-27","201020_Milan_UniversitàdegliStudidiMilano_Patients1_Overall","Incidence of sars-cov-2 infection in patients with active cancer: Mono-institutional series of a comprehensive cancer institution in lombardy during the covid-19 pandemic (Niguarda Cancer Center, Milano, Italy)","2020-10-20","Local","Italy","Italy; Lombardy; Milan","2020-04-15","2020-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",42.0,0.095,"Unclear","Abbott Laboratories, Diasorin","IgG","Unclear","Journal Article (Peer-Reviewed)","Andrea Sartore Bianchi","Università degli Studi di Milano","http://dx.doi.org/10.1177/0300891620953388","Verified","","","","","","IT","IT-25"
"2021-03-27","210116_SaoPaulo_UniversityOfSãoPaulo_overall_IgG","The ""false-positive"" conundrum: IgA reference level overestimates the seroprevalence of antibodies to SARS-CoV-2","2021-01-16","Local","Brazil","Brazil; Sao Paulo; Sao Paulo","2020-05-20","2020-05-22","Multiple populations","Multiple groups",938.0,0.058,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Bruno Caramelli","University of São Paulo","https://dx.doi.org/10.7189/jogh.11.05001","Verified","","","","","","BR","BR-SP"
"2021-03-27","210127_Nice_UniversitéCôted'Azur","Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study","2021-01-27","Local","France","France; Provence-Alpes-Côte d'Azur; Nice","2020-04-15","2020-05-26","Health care workers and caregivers","Adults (18-64 years)",196.0,0.15,"Convenience","EUROIMMUN","IgA; IgG","High","Journal Article (Peer-Reviewed)","Marion Cremoni","Université Côte d'Azur","https://dx.doi.org/10.3389/fmed.2020.608804","Verified","","",1.0,"","","FR","FR-PAC"
"2021-03-27","210208_Chicago_NorthwesternUniversity_overall","Symptoms of COVID-19 infection and magnitude of antibody response in a large community-based study","2021-02-08","Local","United States of America","United States of America; Illinois; Chicago","2020-06-24","2020-11-11","Household and community samples","Multiple groups",3365.0,0.178,"Self-referral","N/A - in-house","IgG","High","Preprint","Thomas McDade","Northwestern University","https://www.medrxiv.org/content/10.1101/2021.02.04.21251170v1","Verified","","","","","","US","US-IL"
"2021-03-27","210209_Sergipe_FederalUniversityofSergipe","Seroprevalence of SARS-CoV-2 antibodies in low-income university students","2021-02-09","Regional","Brazil","Brazil; Sergipe; Aracaji, Itabaiana, Lagarto, Larangeiras, Nossa Senhora da Gloria, Sao Cristovao","2020-09-15","2020-10-06","Students and Daycares","Adults (18-64 years)",276.0,0.225,"Convenience","iChroma II, BioSys + Kovalent","IgG; IgM","High","Journal Article (Peer-Reviewed)","Adriano Antunes de Souza Araujo","Federal University of Sergipe","https://dx.doi.org/10.17179/excli2021-3459","Verified",0.179,0.277,0.958,0.97,"","BR","BR-SE"
"2021-03-27","210212_Ischgl_MedicalUniversityofInnsbruck_overall","Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: Development of a prediction model based on data from Ischgl, Austria","2021-02-12","Local","Austria","Austria; Tyrol; Ischgl","2020-04-21","2020-04-27","Household and community samples","Multiple groups",451.0,0.437,"Entire sample","1) Euroimmun; 2)Abbott","IgG; IgA","High","Journal Article (Peer-Reviewed)","Jens Lehmann","Medical University of Innsbruck","https://dx.doi.org/10.1017/S0950268821000418","Verified","","","","","","AT","AT-7"
"2021-03-27","210212_Oxford_UniversityofOxford","Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic","2021-02-12","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-04-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",404.0,0.03,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Colleen GC McGregor","University of Oxford","https://dx.doi.org/10.1136/gutjnl-2021-324116","Verified","","","","","","GB",""
"2021-03-27","210215_USA_SpaceX_overall","Discrete SARS-CoV-2 antibody titers track with functional humoral stability","2021-02-15","Local","United States of America","United States of America; Multiple; Multiple","2020-04-01","2020-06-10","Non-essential workers and unemployed persons","Adults (18-64 years)",4300.0,0.028,"Convenience","Author designed","IgG","Unclear","Journal Article (Peer-Reviewed)","Yannic Bartsch","Ragon Institute of MGH, MIT and Harvard","https://dx.doi.org/10.1038/s41467-021-21336-8","Verified","","",0.995,"","","US",""
"2021-03-27","210216_Alicante_UniversityofAlicante_overall_PopAdj_TestAdj","Seroprevalence study and cross-sectional survey on COVID-19 for a plan to reopen the university of alicante (Spain)","2021-02-16","Local","Spain","Spain; Alicante; Alicante","2020-07-06","2020-07-22","Non-essential workers and unemployed persons","Adults (18-64 years)",1479.0,0.029,"Stratified probability","Cellex Inc., Durham, NC, USA","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Jose Tuells","University of Alicante","http://dx.doi.org/10.3390/ijerph18041908","Verified",0.021,0.037,0.878,0.999,"","ES","ES-VC"
"2021-03-27","210220_Lazio_ UniversitàCattolicadelSacroCuore_Overall","Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients","2021-02-20","Local","Italy","Italy; Lazio; Rome","2020-05-25","2020-08-10","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",202.0,0.015,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Fabio Del Zompo","Università Cattolica del Sacro Cuore","https://dx.doi.org/10.1016/j.dld.2021.02.015","Verified","","","","","","IT","IT-62"
"2021-03-27","210221_Iowa_UniversityofIowa","SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal Outcomes","2021-02-21","Local","United States of America","United States of America; Iowa","2020-05-01","2020-09-22","Pregnant or parturient women","Adults (18-64 years)",1000.0,0.058,"Sequential","DiaSorin; Roche","IgG","Moderate","Journal Article (Peer-Reviewed)","Haley Steffen","University of Iowa","https://dx.doi.org/10.1055/s-0041-1723938","Verified","","","","","","US","US-IA"
"2021-03-27","210225_CapeTown_StellenboschUniversity_Overall","Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa","2021-02-25","Local","South Africa","South Africa","2020-08-17","2020-09-04","Essential non-healthcare workers","Adults (18-64 years)",405.0,0.237,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Jane Shaw","Stellenbosch University","https://dx.doi.org/10.1371/journal.pone.0247852","Verified","","","",0.985,"","ZA",""
"2021-03-27","210226_California_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Local","United States of America","United States of America; California","2020-03-23","2020-08-14","Residual sera","Multiple groups",4980.0,0.019,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-CA"
"2021-03-27","210226_Connecticut_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Connecticut","2020-03-23","2020-08-14","Residual sera","Multiple groups",8929.0,0.057,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-CT"
"2021-03-27","210226_Florida_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Florida","2020-03-23","2020-08-14","Residual sera","Multiple groups",7787.0,0.048,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-FL"
"2021-03-27","210226_Louisiana_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Louisiana","2020-03-23","2020-08-14","Residual sera","Multiple groups",2849.0,0.077,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-LA"
"2021-03-27","210226_Minnesota_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Minnesota; Minneapolis, St. Paul, St. Cloud","2020-03-23","2020-08-14","Residual sera","Multiple groups",7944.0,0.049,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-MN"
"2021-03-27","210226_Missouri_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Missouri","2020-03-23","2020-08-14","Residual sera","Multiple groups",9356.0,0.025,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-MO"
"2021-03-27","210226_NewYork_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Local","United States of America","United States of America; New York; New York City","2020-03-23","2020-08-14","Residual sera","Multiple groups",7746.0,0.172,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-NY"
"2021-03-27","210226_Pennsylvania_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Local","United States of America","United States of America; Pennsylvania; Philadelphia","2020-03-23","2020-08-14","Residual sera","Multiple groups",8657.0,0.043,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-PA"
"2021-03-27","210226_Utah_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Utah","2020-03-23","2020-08-14","Residual sera","Multiple groups",8769.0,0.027,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-UT"
"2021-03-27","210226_Washington_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America","United States of America; Washington","2020-03-23","2020-08-14","Residual sera","Multiple groups",7544.0,0.02,"Stratified probability","In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","","",0.96,0.993,"","US","US-WA"
"2021-03-27","210920_Serdivan_SakaryaUniversity","COVID-19 prevalence and oncologic outcomes of asymptomatic patients with active cancer who received chemotherapy","2021-01-15","Local","Turkey","Turkey; Sakarya; Serdivan","2020-04-07","2020-05-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",198.0,0.035,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cemil Bilir","Sakarya University","http://dx.doi.org/10.19193/0393-6384_2021_1_103","Verified","","","","","","TR","TR-54"
"2021-03-28","210117_OrangeCounty_HoagMemorialHospitalPresbyterian_First_responders","Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers","2021-01-17","Local","United States of America","United States of America; California","2020-07-15","2020-08-15","Essential non-healthcare workers","Adults (18-64 years)",92.0,0.044,"Convenience","Ortho Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Michael Brant Zawadzki","Hoag Memorial Hospital Presbyterian","https://dx.doi.org/10.1093/ofid/ofab015","Verified",0.012,0.108,0.936,1.0,"","US","US-CA"
"2021-03-28","210117_OrangeCounty_HoagMemorialHospitalPresbyterian_HCW","Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers","2021-01-17","Local","United States of America","United States of America; California","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",2754.0,0.028,"Convenience","Ortho Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Michael Brant Zawadzki","Hoag Memorial Hospital Presbyterian","https://dx.doi.org/10.1093/ofid/ofab015","Verified",0.022,0.034,0.936,1.0,"","US","US-CA"
"2021-03-28","210204_OrangeCounty_UniversityofCaliforniaIrvine_Overall_PopTestAdj","Estimated Seroprevalence of SARS-CoV-2 Antibodies Among Adults in Orange County, California","2021-02-04","Local","United States of America","United States of America; California","2020-07-10","2020-08-16","Household and community samples","Multiple groups",2979.0,0.113,"Stratified probability","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Tim Bruckner","University of California Irvine","https://dx.doi.org/10.1038/s41598-021-82662-x","Verified",0.081,0.132,0.94,1.0,"","US","US-CA"
"2021-03-28","210213_Makkah_KingAbdulazizUniversity_HCW","Seroprevalence of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Healthcare Workers in Makkah, Saudi Arabia","2021-02-13","Local","Saudi Arabia","Saudi Arabia; Mecca Province; Makkah (Mecca)","2020-06-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",204.0,0.063,"Convenience","In-House; MN assay unclear (GeurtsvanKessel et al., 2020; Kohmeret al., 2021; Lisboa Bastos et al., 2020).","IgG","High","Journal Article (Peer-Reviewed)","Waleed Ahmed","King Abdulaziz University","https://www.sciencedirect.com/science/article/pii/S1018364721000276?via%3Dihub","Verified","","","","","","SA","SA-02"
"2021-03-28","210222_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj","COVID-19 Antibody Seroprevalence in Santa Clara County, California","2021-02-22","Local","United States of America","United States of America; California","2020-04-03","2020-04-04","Household and community samples","Multiple groups",3328.0,0.028,"Stratified non-probability","Premier Biotech","IgG; IgM","High","Journal Article (Peer-Reviewed)","Eran Bendavid","Stanford University School of Medicine","https://dx.doi.org/10.1093/ije/dyab010","Verified",0.013,0.042,0.856,0.995,"","US","US-CA"
"2021-03-29","210317_UniversidadDeLosAndes_UniversidadDeLosAndes_overall","Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogotá Colombia","2021-03-17","Local","Colombia","Colombia; Capital District Cundinamarca; Bogotá","2020-11-23","2020-12-06","Essential non-healthcare workers","Adults (18-64 years)",237.0,0.135,"Convenience","Abbott","IgG","High","Preprint","John M Gonzalez","Universidad de Los Andes","https://www.medrxiv.org/content/10.1101/2021.03.15.21253609v1","Verified","","","","","","CO","CO-DC"
"2021-03-30","210212_Gurugram_Medanta-TheMedicity","Is Covid-19 seroprevalence different in health care workers as per their risk of exposure? A study from a tertiary care hospital in National Capital Region of India","2021-02-12","Local","India","India; Haryana; Gurugram","2021-01-12","2021-02-13","Health care workers and caregivers","Adults (18-64 years)",3258.0,0.462,"Convenience","DiaSorin","IgG","High","Preprint","Sushila Kataria","Madanta- The Medicity","https://www.medrxiv.org/content/10.1101/2021.02.10.21251543v1","Verified",0.444,0.479,"","","","IN","IN-HR"
"2021-03-30","210309_Massachusetts_UniversityofMassachusetts-Amherst_LocalPop_Primary","Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study","2021-03-09","Local","United States of America","United States of America; Massachusetts ; Amherst","2020-07-15","2020-08-15","Non-essential workers and unemployed persons","Multiple groups",292.0,0.04,"Simplified probability","NR","IgG","High","Preprint","Teah Snyder","University of Massachusetts-Amherst","https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf","Verified",0.016,0.065,"","","","US","US-MA"
"2021-03-30","210309_Massachusetts_UniversityofMassachusetts-Amherst_Undergrad_Primary","Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study","2021-03-09","Local","United States of America","United States of America; Massachusetts ; Amherst","2020-07-15","2020-08-15","Multiple populations","Multiple groups",779.0,0.053,"Stratified probability","NR","IgG","High","Preprint","Teah Snyder","University of Massachusetts-Amherst","https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf","Verified",0.031,0.075,"","","","US","US-MA"
"2021-03-30","210311_Vellore_UniversityOfEdinburgh_CommunitySurvey1_overall","The Burden of COVID-19 Infection in a Rural Tamil Nadu Community","2021-03-11","Local","India","India; Tamil Nadu","2020-07-06","2020-08-20","Household and community samples","Multiple groups",501.0,0.022,"Simplified probability","1) Roche; 2) Siemens","IgG","Moderate","Preprint","Rita Isaac","University of Edinburgh","https://www.researchsquare.com/article/rs-289385/v1","Verified",0.008,0.034,"","","","IN","IN-TN"
"2021-03-30","210311_Vellore_UniversityOfEdinburgh_CommunitySurvey2_overall","The Burden of COVID-19 Infection in a Rural Tamil Nadu Community","2021-03-11","Local","India","India; Tamil Nadu","2020-11-06","2020-11-20","Household and community samples","Multiple groups",200.0,0.22,"Simplified probability","1) Roche; 2) Siemens","IgG","Moderate","Preprint","Rita Isaac","University of Edinburgh","https://www.researchsquare.com/article/rs-289385/v1","Verified",0.163,0.277,"","","","IN","IN-TN"
"2021-03-31","210212_Nancy_UniversitéDeLorraine_overall","Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France","2021-02-12","Local","France","France","2020-06-26","2020-07-24","Household and community samples","Multiple groups",2006.0,0.025,"Stratified probability","1) BioRad; 2) Biosynex; 3)Euroimmun","Total Antibody; IgM; IgG; IgA","Low","Preprint","Anne Gegout petit","Université de Lorraine","10.1101/2021.02.10.21250862","Verified",0.018,0.033,"","","","FR",""
"2021-03-31","210223_Barcelona_UniversitatDeBarcelona_primary","Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19","2021-02-23","Local","Spain","Spain","2020-09-29","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",507.0,0.164,"Simplified probability","N/A - in house","IgA; IgG; IgM","Moderate","Preprint","Natalia Ortega","Universitat de Barcelona","https://www.medrxiv.org/content/10.1101/2021.02.22.21252150v1.full-text","Verified",0.133,0.199,0.958,1.0,"","ES",""
"2021-03-31","210303_Lodi_IRCCSPoliclinico_overall_CLIA","Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area","2021-03-03","Local","Italy","Italy; Lombardy region; Lodi","2020-03-18","2020-06-24","Blood donors","Multiple groups",1922.0,0.197,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Irene Cassaniti","IRCCS Policlinico","https://dx.doi.org/10.1016/j.cmi.2021.01.030","Verified","","","","","","IT","IT-25"
"2021-03-31","210303_London_NorthMiddlesexUniversityHospitalNHSTrust_Overall","Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital","2021-03-03","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-04","2020-07-03","Health care workers and caregivers","Adults (18-64 years)",3285.0,0.357,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Emily Martin","North Middlesex University Hospital NHS Trust","https://dx.doi.org/10.1016/j.jinf.2021.02.027","Verified","","","","","","GB","GB-ENG"
"2021-03-31","210312_Cincinnati_UniversityOfCincinnati_overall","Seroprevalence of SARS-CoV-2 Infection in Cincinnati Ohio USA from August to December 2020","2021-03-12","Local","United States of America","United States of America; Ohio; Greater Cincinnati Metropolitan Area","2020-08-13","2020-12-08","Blood donors","Multiple groups",9550.0,0.084,"Simplified probability","N/A - in house","IgG","Moderate","Preprint","Greg Davis","University of Cincinnati","10.1101/2021.03.11.21253263","Verified","","","","","","US","US-OH"
"2021-03-31","210312_Strasbourg_UniversityHospitalStrasbourg_overall","Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients","2021-03-12","Local","France","France","2021-02-18","2021-02-25","Patients seeking care for non-COVID-19 reasons","Multiple groups",241.0,0.108,"Unclear","Abbott","IgG","High","Preprint","Ilies Benotmane","University Hospital, Strasbourg","https://www.medrxiv.org/content/10.1101/2021.03.08.21252741v1.full-text","Verified","","","","","","FR",""
"2021-04-01","210131_NorthernVirginia_InovaChildren’sHospital_primary","SARS-CoV-2 Seroepidemiology in Children and Adolescents","2021-01-31","Local","United States of America","United States of America; Virginia; Northern Virginia","2020-07-31","2020-10-13","Multiple general populations","Children and Youth (0-17 years)",1038.0,0.085,"Convenience","Ortho diagnostics","Total Antibody","High","Preprint","Rebecca E Levorson","Inova Children’s Hospital","https://www.medrxiv.org/content/10.1101/2021.01.28.21250466v1","Verified",0.069,0.103,"",1.0,"","US","US-VA"
"2021-04-01","210309_SkåneRegion_LundUniversity_HCWs","Association between SARS-CoV-2 and exposure risks in health care workers and university employees - a cross-sectional study","2021-03-09","Local","Sweden","Sweden; Skåne Region","2020-09-08","2020-11-10","Health care workers and caregivers","Adults (18-64 years)",271.0,0.059,"Convenience","Zeta Gene Ltd.","IgG","High","Journal Article (Peer-Reviewed)","David Nygren","Lund University","https://dx.doi.org/10.1080/23744235.2021.1892819","Verified","","","","","","SE","SE-M"
"2021-04-01","210309_SkåneRegion_LundUniversity_UniversityEmployees","Association between SARS-CoV-2 and exposure risks in health care workers and university employees - a cross-sectional study","2021-03-09","Local","Sweden","Sweden; Skåne Region; Lund","2020-09-08","2020-11-10","Non-essential workers and unemployed persons","Adults (18-64 years)",192.0,0.06,"Convenience","Zeta Gene Ltd.","IgG","High","Journal Article (Peer-Reviewed)","David Nygren","Lund University","https://dx.doi.org/10.1080/23744235.2021.1892819","Verified","","","","","","SE","SE-M"
"2021-04-01","210312_Paris_SorbonneUniversite_M3","Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris, France: the SEROCOV prospective cohort study","2021-03-12","Local","France","France","2020-06-16","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",938.0,0.13,"Convenience","Abbott","IgG","Moderate","Preprint","Pierre Hausfater","Sorbonne Universite","10.1101/2021.03.09.21253200","Verified",0.111,0.152,"","","","FR",""
"2021-04-02","210211_UnitedKingdom_ImperialCollegeNHSTrust_GlomerularDiseasePatients","Serological screening for COVID-19 in patients with glomerular disease","2021-02-11","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-05-19","2020-07-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",493.0,0.077,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Tabitha Turner Stokes","Imperial College Healthcare NHS Trust","https://dx.doi.org/10.1016/j.ekir.2021.02.006","Verified","","","","","","GB",""
"2021-04-02","210218_RhodeIsland_BrownUniversity_overall_adj","Seroprevalence of SARS-CoV-2 Antibodies in Rhode Island From a Statewide Random Sample","2021-02-18","Regional","United States of America","United States of America; Rhode Island","2020-05-05","2020-05-22","Household and community samples","Multiple groups",1032.0,0.029,"Stratified probability","Abbot","IgG","Low","Journal Article (Peer-Reviewed)","Philip A Chan","Brown University","https://dx.doi.org/10.2105/AJPH.2020.306115","Verified",0.01,0.062,0.884,0.996,"","US","US-RI"
"2021-04-02","210226_Mallorca_SonLlatzerUniversityHospital_overall","Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic","2021-02-26","Local","Spain","Spain","2020-04-28","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",2210.0,0.028,"Convenience","Abbott","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adrian Rodriguez","Son Llatzer University Hospital","https://dx.doi.org/10.1016/j.ijid.2021.02.104","Verified",0.025,0.031,0.967,0.996,"","ES",""
"2021-04-02","210309_UnitedStates_StanfordUniversity_OverallPopAdj","SARS-COV-2 antibody prevalence in patients on dialysis in the US in January 2021","2021-03-09","National","United States of America","United States of America","2021-01-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",21424.0,0.213,"Unclear","Siemens Healthineers","Total Antibody","Moderate","Preprint","Shuchi Anand","Stanford University","https://doi.org/10.1101/2021.03.07.21252786","Verified",0.203,0.223,1.0,0.998,"","US",""
"2021-04-03","210204_Milan_ FoundationIRCCS Ca'GrandaOspedaleMaggiorePoliclinico_overall_adj","Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study","2021-02-22","Local","Italy","Italy; Lombardy; Milan","2020-04-27","2020-06-12","Health care workers and caregivers","Multiple groups",4055.0,0.064,"Convenience","DiaSorin, Saluggia, Italy","IgG","Moderate","Journal Article (Peer-Reviewed)","Andrea Lombardi","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico","https://dx.doi.org/10.1136/bmjopen-2020-047216","Verified","","",0.974,0.985,"","IT","IT-25"
"2021-04-03","210312_Amsterdam_PublicHealthServiceOfAmsterdam_overall","SARS-CoV-2 antibody prevalence and determinants of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020","2021-03-12","Local","Netherlands","Netherlands","2020-06-24","2020-10-09","Household and community samples","Multiple groups",2483.0,0.091,"Stratified probability","Wantai Biological Pharmacy Enterprise Co","IgG; IgA; IgM","High","Preprint","Liza Coyer","Public Health Service of Amsterdam","10.1101/2021.03.08.21252788","Verified","","","","","","NL",""
"2021-04-03","210312_Spain_ InstitutoDeSalud CarlosIII_overall_Abbott","Evolution of antibodies against SARS-CoV-2 over seven months: experience of the Nationwide Seroprevalence ENE-COVID Study in Spain","2021-03-12","National","Spain","Spain","2020-11-16","2020-11-29","Household and community samples","Multiple groups",5827.0,0.049,"Stratified probability","Abbott","IgG","Moderate","Preprint","Mayte Perez Olmeda","Instituto de Salud Carlos III","https://www.medrxiv.org/content/10.1101/2021.03.11.21253142v1","Verified","","",0.996,1.0,"","ES",""
"2021-04-03","210321_NewYork_WeillCornellMedicine_Pediatrics","Association of Age With SARS-CoV-2 Antibody Response","2021-03-22","Local","United States of America","United States of America; New York ; New York City","2020-04-09","2020-08-31","Residual sera","Children and Youth (0-17 years)",1194.0,0.165,"Sequential","ET Healthcare; COV2T","IgG","High","Journal Article (Peer-Reviewed)","He Yang","NewYork–Presbyterian Hospital/Weill Cornell Medical Center","https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743","Verified",0.144,0.187,"","","","US","US-NY"
"2021-04-04","201020_Sondrio_AltoLario-OncologiaMedicaSondrio_Overall","Rapid serological test in the covid-19 era: Our experience","2020-10-20","Local","Italy","Italy; Lombardy; Sondrio","2020-03-01","2020-10-19","Health care workers and caregivers","Adults (18-64 years)",220.0,0.114,"Convenience","Nal Von Minden GmbH (Germany)","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","G Caponigro","ASST della Valtellina ; Alto Lario-Oncologia Medica Sondrio","http://dx.doi.org/10.1177/0300891620953388","Verified","","",0.941,0.992,"","IT","IT-25"
"2021-04-04","201105_London_ImperialCollegeLondon","Prevalence of SARS-CoV-2 infection in patients with chronic myeloidleukemia","2020-11-05","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-01","2020-07-27","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",161.0,0.112,"Convenience","Imperial College London","Total Antibody","High","Journal Article (Peer-Reviewed)","Simone Claudiani","Imperial College London","http://dx.doi.org/10.1182/blood-2020-142454","Verified","","",0.948,"","","GB","GB-ENG"
"2021-04-04","210206_YokohamaCity_YokohamaCityUniversity","SARS-CoV-2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in COVID-19 endemic areas: prospective cross-sectional study in Japan","2021-02-06","Local","Japan","Japan; Kanagawa Prefecture; Yokohama City","2020-06-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",432.0,0.039,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Shigeta Miyake","Yokohama City University","http://dx.doi.org/10.1111/den.13945","Verified","","","","","","JP","JP-14"
"2021-04-04","210321_NewYork_WeillCornellMedicine_Adults","Association of Age With SARS-CoV-2 Antibody Response","2021-03-22","Local","United States of America","United States of America; New York ; New York City","2020-04-09","2020-08-31","Residual sera","Multiple groups",30232.0,0.186,"Sequential","ET Healthcare; COV2T","IgG","High","Journal Article (Peer-Reviewed)","He Yang","NewYork–Presbyterian Hospital/Weill Cornell Medical Center","https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743","Verified",0.182,0.191,"","","","US","US-NY"
"2021-04-05","210116_Philadelphia_UniversityofPennsylvania_Overall","SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy","2021-01-16","Local","United States of America","United States of America; Pennsylvania; Philadelphia","2020-05-21","2020-10-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",124.0,0.016,"Sequential","N/A - In house","IgG; IgM","High","Preprint","Lova Sun","University of Pennsylvania","https://dx.doi.org/10.1101/2021.01.15.21249810","Verified","","","","","","US","US-PA"
"2021-04-05","210202_Turin_UniversityofTurin_Overall","Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery","2021-02-02","Local","Italy","Italy; Piedmont; Turin","2020-04-15","2020-06-15","Pregnant or parturient women","Adults (18-64 years)",164.0,0.098,"Sequential","Boditech Med Inc, Gang-won-do, Korea; Diasorin, Italy","IgG; IgM; Neutralizing","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","https://dx.doi.org/10.1016/j.jri.2021.103285","Verified","","","","","","IT","IT-21"
"2021-04-05","210206_France_ParisUniversity_ELISA","Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based ""CONSTANCES"" cohort","2021-02-06","National","France","France","2019-11-04","2020-03-16","Residual sera","Multiple groups",9144.0,0.039,"Simplified probability","EUROIMMUN","IgG","Moderate","Journal Article (Peer-Reviewed)","Fabrice Carrat","Paris University","http://dx.doi.org/10.1007/s10654-020-00716-2","Unverified","","","",1.0,"","FR",""
"2021-04-05","210206_France_ParisUniversity_ELISA+NT","Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based ""CONSTANCES"" cohort","2021-02-06","National","France","France","2019-11-04","2020-03-16","Residual sera","Multiple groups",9144.0,0.005,"Simplified probability","EUROIMMUN; In-House ;  - Paris University","Neutralizing ; IgG","Moderate","Journal Article (Peer-Reviewed)","Fabrice Carrat","Paris University","http://dx.doi.org/10.1007/s10654-020-00716-2","Verified","","","",1.0,"","FR",""
"2021-04-05","210210_London_KingsCollegeLondon","Indicators of past COVID-19 infection status: Findings from a large occupational cohort of staff and postgraduate research students from a UK university","2021-02-10","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-01","2020-06-30","Multiple populations","Adults (18-64 years)",1882.0,0.07,"Convenience","Sure Screen Diagnostics","IgG; IgM","High","Preprint","Katrina Davis","King's College London","https://www.medrxiv.org/content/10.1101/2020.12.07.20245183v2","Verified","","",0.94,0.963,"","GB","GB-ENG"
"2021-04-05","210401_Ranong_ChulalongkornUniversity","Seroprevalence of hospital staff in a province with zero COVID-19 cases","2021-04-01","Local","Thailand","Thailand; Ranong","2020-04-17","2020-05-17","Health care workers and caregivers","Adults (18-64 years)",844.0,0.008,"Convenience","Baiya Phytopharm, Thailand","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Tanawin Nopsopon","Chulalongkorn University","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238088","Unverified",0.004,0.017,0.941,0.98,"","TH","TH-85"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Apr_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-04-06","2020-04-17","Blood donors","Multiple groups",829.0,0.05,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.029,0.074,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Aug_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-08-08","2020-08-19","Blood donors","Multiple groups",881.0,0.456,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.411,0.501,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Feb_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-02-07","2020-02-13","Blood donors","Multiple groups",821.0,0.004,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.0,0.033,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Jul_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-07-06","2020-07-15","Blood donors","Multiple groups",1147.0,0.49,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.442,0.536,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Jun_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-06-05","2020-06-15","Blood donors","Multiple groups",911.0,0.554,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.507,0.601,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Mar_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-03-06","2020-03-12","Blood donors","Multiple groups",832.0,0.0,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.0,0.008,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_May_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-05-05","2020-05-14","Blood donors","Multiple groups",901.0,0.434,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.384,0.486,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Oct_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-10-10","2020-10-17","Blood donors","Multiple groups",882.0,0.446,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.393,0.5,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Sept_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Amazonas; Manaus","2020-09-05","2020-09-14","Blood donors","Multiple groups",868.0,0.473,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.421,0.525,0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Apr_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-04-08","2020-04-30","Blood donors","Multiple groups",900.0,0.04,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.018,0.066,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Aug_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-08-10","2020-08-29","Blood donors","Multiple groups",906.0,0.155,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.123,0.182,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_DonorsTestOverall","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-07-01","2020-07-31","Blood donors","Multiple groups",1000.0,0.133,"Unclear","Abbott Laboratories; Roche Diagnostics","IgG","Unclear","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","","","","","","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Feb_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-02-08","2020-02-29","Blood donors","Multiple groups",799.0,0.01,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.0,0.029,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Jul_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-07-13","2020-07-25","Blood donors","Multiple groups",879.0,0.106,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.081,0.135,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Jun_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-06-08","2020-06-20","Blood donors","Multiple groups",880.0,0.131,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.103,0.163,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Mar_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-03-09","2020-03-21","Blood donors","Multiple groups",2454.0,0.028,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.018,0.039,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_May_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-05-08","2020-05-21","Blood donors","Multiple groups",826.0,0.047,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.026,0.073,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Oct_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-10-12","2020-10-24","Blood donors","Multiple groups",877.0,0.182,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.15,0.217,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Sept_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil","Brazil; Sao Paulo State; Sao Paulo","2020-09-07","2020-09-29","Blood donors","Multiple groups",933.0,0.151,"Sequential","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified",0.123,0.182,0.922,0.961,"","BR","BR-SP"
"2021-04-07","210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_BloodDonors","Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama","2021-03-02","Local","Panama","Panama","2020-04-30","2020-07-07","Blood donors","Multiple groups",255.0,0.133,"Convenience","Dr. Chong Li’s group from Institute of Biophysics, Chinese Academy of Science","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alcibiades Villarreal","Instituto de Investigaciones Científicas y; Servicios de Alta Tecnología","https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full","Verified","","",0.87,0.989,"","PA",""
"2021-04-07","210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_HCWs","Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama","2021-03-02","Local","Panama","Panama","2020-04-30","2020-07-07","Health care workers and caregivers","Multiple groups",351.0,0.128,"Unclear","Dr. Chong Li’s group from Institute of Biophysics, Chinese Academy of Science","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alcibiades Villarreal","Instituto de Investigaciones Científicas y; Servicios de Alta Tecnología","https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full","Verified","","",0.87,0.989,"","PA",""
"2021-04-08","200825_Wuhan_ChineseCenterforDiseaseControlandPrevention_primary","Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China: a cross-sectional study","2020-08-25","Local","China","China; Hubei; Wuhan","2020-03-25","2020-04-28","Household and community samples","Multiple groups",18712.0,0.033,"Self-referral","Innovita","IgG; IgM","Moderate","Preprint","Ruijie Ling","Chinese Center for Disease Control and Prevention","https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v3","Verified",0.03,0.035,0.895,0.99,"","CN","CN-42"
"2021-04-08","200826_Veneto_UniversityHospitalOfPadova","SARS-CoV-2 serosurvey in health care workers of the Veneto Region","2020-08-26","Regional","Italy","Italy; Veneto","2020-02-22","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",8285.0,0.046,"Unclear","SNIBE – Shenzhen New Industries Biomedical Engineering Co.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mario Plebani","University Hospital Of Padova","https://www.degruyter.com/document/doi/10.1515/cclm-2020-1236/html","Verified",0.041,0.05,0.73,0.98,"","IT","IT-34"
"2021-04-08","200901_Seattle_FredHutchinsonCancerResearchCenter_Overall","Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak","2020-09-01","Local","United States of America","United States of America; Washington; Seattle","2020-03-03","2020-04-24","Residual sera","Children and Youth (0-17 years)",1076.0,0.009,"Convenience","N/A, Abbott","IgG","High","Journal Article (Peer-Reviewed)","Adam S Dingens","Fred Hutchinson Cancer Research Center","https://www.nature.com/articles/s41467-020-18178-1","Verified","","","","","","US","US-WA"
"2021-04-08","2010330_Bolinas_UniversityofCalifornia_Abbott+ELISA","Universal polymerase chain reaction and antibody testing demonstrate little to no transmission of severe acute respiratory syndrome coronavirus 2 in a rural community","2020-10-30","Local","United States of America","United States of America; California; Bolinas","2020-04-20","2020-04-24","Household and community samples","Multiple groups",1880.0,0.0,"Self-referral","Abbott Laboratories; University of California","IgG","Moderate","Journal Article (Peer-Reviewed)","Ayesha Appa","University of California San Francisco","http://dx.doi.org/10.1093/ofid/ofaa531","Verified","","","","","","US","US-CA"
"2021-04-08","201216_Heidelberg_UniversityHospitalHeidelberg_Overall","SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study","2020-12-16","Local","Germany","Germany; Baden-Württemberg; Heidelberg","2020-05-05","2020-08-06","Patients seeking care for non-COVID-19 reasons","Multiple groups",219.0,0.032,"Sequential","EUROIMMUN™","IgG","High","Journal Article (Peer-Reviewed)","Conrad Rauber","University Hospital Heidelberg","https://www.sciencedirect.com/science/article/abs/pii/S0041134520329043?via%3Dihub","Verified","","",0.946,0.998,"","DE","DE-BW"
"2021-04-09","201111_Srinagar_GovernmentMedicalCollegeSrinagar","Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India – A cross-sectional study","2020-11-11","Regional","India","India; Srinagar; District Srinagar","2020-07-01","2020-07-15","Residual sera","Multiple groups",2906.0,0.036,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","S Muhammad Salim Khan","Government Medical College Srinagar","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239303","Verified",0.029,0.043,1.0,0.996,"","IN","IN-JK"
"2021-04-09","210203_HeinsbergDistrict_UniversityHospitalDusseldorf_NeutralizationAssay","Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting","2021-02-03","Local","Germany","Germany","2020-04-09","2020-04-09","Contacts of COVID patients","Multiple groups",42.0,0.619,"Convenience","NR","IgG; IgA","High","Journal Article (Peer-Reviewed)","Lisa Muller","University Hospital Dusseldorf","https://dx.doi.org/10.1007/s10096-021-04169-7","Verified","","","","","","DE",""
"2021-04-09","210223_France_MontpellierUniversity_NursingHomeResidents","Atypical symptoms, SARS-CoV-2 test results, and immunization rates in 456 residents from eight nursing homes facing a COVID-19 outbreak","2021-02-23","Regional","France","France; Occitanie","2020-04-21","2020-07-29","Assisted living and long-term care facilities","Seniors (65+ years)",456.0,0.307,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Hubert Blain","Montpellier University","https://dx.doi.org/10.1093/ageing/afab050","Verified","","","","","","FR","FR-OCC"
"2021-04-09","210224_USA_NationalInstitutesofHealth_primary","Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection","2021-02-24","National","United States of America","United States of America","2020-01-01","2020-08-26","Residual sera","Multiple groups",3257478.0,0.116,"Convenience","NR","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Raymond Harvey","National Institutes of Health","https://dx.doi.org/10.1001/jamainternmed.2021.0366","Verified","","","","","","US",""
"2021-04-09","210226_Turin_UniversityofTurin_Pharmacists","Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence","2021-02-26","Regional","Italy","Italy; Turin","2020-07-01","2020-07-31","Essential non-healthcare workers","Adults (18-64 years)",286.0,0.035,"Self-referral","Prima Lab","IgG; IgM","High","Journal Article (Peer-Reviewed)","Francesca Baratta","University of Turin","https://dx.doi.org/10.3390/ijerph18052302","Verified","","",1.0,0.98,"","IT","IT-21"
"2021-04-09","210305_EssexCounty_RutgersUniversity_overall_unadj","Self-reported symptoms, self-reported viral testing result and seroprevalence of SARS CoV-2 among a community sample in Essex County New Jersey: A brief report","2021-03-05","Local","United States of America","United States of America; New Jersey","2020-09-15","2020-12-22","Household and community samples","Multiple groups",924.0,0.09,"Simplified probability","Wang et al.","IgG","Moderate","Preprint","Henry F Raymond","Rutgers University","10.1101/2021.03.02.21252766","Verified","","","","","","US","US-NJ"
"2021-04-09","210312_Atlanta_EmoryUniversitySchoolOfMedicine_Overall","Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers","2021-03-12","Local","United States of America","United States of America; Georgia; Atlanta","2020-04-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",642.0,0.04,"Convenience","Emory University - In-House, Suthar et al., 2020.","IgG","High","Journal Article (Peer-Reviewed)","Claudia Morris","Emory University School of Medicine","https://dx.doi.org/10.1016/j.ijid.2021.03.017","Verified","","","","","","US","US-GA"
"2021-04-09","210322_TheUnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust_Overall","Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab","2021-03-22","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-09-22","2020-12-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",6935.0,0.043,"Sequential","Roche","Not reported","Moderate","Journal Article (Peer-Reviewed)","Nicholas Kennedy","Royal Devon and Exeter NHS Foundation Trust","https://dx.doi.org/10.1136/gutjnl-2021-324388","Verified",0.038,0.048,"","","","GB",""
"2021-04-09","210324_NorthernItaly_UniversitàDegliStudiDelPiemonteOrientale_HCW","High seroprevalence of sars-cov-2 among healthcare workers in a north italy hospital","2021-03-24","Local","Italy","Italy; Piedmont; Vercelli","2020-05-08","2020-06-03","Health care workers and caregivers","Adults (18-64 years)",2250.0,0.171,"Convenience","DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Chiara Airoldi","Università degli Studi del Piemonte Orientale","http://dx.doi.org/10.3390/ijerph18073343","Verified",0.156,0.187,0.979,0.985,"","IT","IT-21"
"2021-04-09","210325_Rome_UniversityofRomeTorVergata_IBDPatients","Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease","2021-03-25","Local","Italy","Italy","2020-05-27","2020-07-21","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",218.0,0.014,"Convenience","Abbott Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Ludovica Scucchi","University of Rome Tor Vergata","https://www.europeanreview.org/wp/wp-content/uploads/2418-2424.pdf","Verified","","","","","","IT",""
"2021-04-09","210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_December_AnaesthesiaHCW","Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India","2021-03-26","Local","India","India","2020-12-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",164.0,0.384,"Unclear","Abbott Laboratories","IgG","High","Preprint","Debaprasad Parai","ICMR-Regional Medical Research Centre (Government of India)","https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2","Verified",0.309,0.463,1.0,0.996,"","IN",""
"2021-04-09","210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_September_AnaesthesiaHCW","Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India","2021-03-26","Local","India","India","2020-09-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",128.0,0.125,"Unclear","Abbott Laboratories","IgG","High","Preprint","Debaprasad Parai","ICMR-Regional Medical Research Centre (Government of India)","https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2","Verified",0.073,0.195,1.0,0.996,"","IN",""
"2021-04-09","210326_Duhok_UniversityOfDuhok_Overall","COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study","2021-03-26","Local","Iraq","Iraq","2021-01-10","2021-01-30","Household and community samples","Multiple groups",743.0,0.626,"Stratified probability","Roche","IgG","Moderate","Preprint","Nawfal Hussein","University of Duhok","10.1101/2021.03.23.21254169","Verified","","","","","","IQ",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c1_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-03-30","2020-04-05","Residual sera","Multiple groups",3910.0,0.018,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.01,0.026,0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c2_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-04-20","2020-04-26","Residual sera","Multiple groups",3397.0,0.052,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.042,0.064,0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c3_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-05-18","2020-05-25","Residual sera","Multiple groups",3242.0,0.062,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.05,0.073,0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c4_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-06-08","2020-06-13","Residual sera","Multiple groups",2960.0,0.047,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.036,0.058,0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c5_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-06-29","2020-07-04","Residual sera","Multiple groups",3023.0,0.037,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.026,0.047,0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c6_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-09-07","2020-09-12","Residual sera","Multiple groups",3047.0,0.033,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.023,0.043,0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c7_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","Belgium","2020-10-12","2020-10-17","Residual sera","Multiple groups",2966.0,0.042,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified",0.031,0.052,0.849,0.987,"","BE",""
"2021-04-10","210101_Pakistan_ColSultan’sLab_Overall","A Single-centre Study of COVID-19 antibody","2021-01-01","Local","Pakistan","Pakistan; NR; NR","2020-06-13","2020-07-08","Residual sera","Multiple groups",453.0,0.638,"Self-referral","Roche Holding AG","Not reported","High","Journal Article (Peer-Reviewed)","Sidra Ghazanfer","Col Sultan’s Lab","https://dx.doi.org/10.29271/jcpsp.2021.01.S55","Verified","","","","","","PK",""
"2021-04-10","210212_London_RoyalFreeHospital","Transmission of infection among health care personnel performing surgical tracheostomies on COVID-19 patients","2021-02-12","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-03-26","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",43.0,0.186,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Natarajan Angamuthu","Royal Free Hospital","https://dx.doi.org/10.1016/j.surge.2021.01.007","Verified","","","","","","GB",""
"2021-04-10","210302_Vietnam_UniversitatsklinikumTubingen_HCW_ELISA_TotalAb","Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam","2021-03-02","Local","Viet Nam","Viet Nam; Red River Delta; Hanoi","2020-03-01","2021-01-08","Health care workers and caregivers","Adults (18-64 years)",1065.0,0.006,"Unclear","WANTAI Biological Pharmacy, Beijing, China","Total Antibody","High","Journal Article (Peer-Reviewed)","Le Huu Song","Universitätsklinikum Tübingen","https://dx.doi.org/10.1016/j.lanwpc.2021.100113","Verified","","","","","","VN",""
"2021-04-10","210302_Vietnam_UniversitatsklinikumTubingen_patients_ELISA_TotalAb","Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam","2021-03-02","Local","Viet Nam","Viet Nam; Red River Delta; Hanoi","2020-03-01","2021-01-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",288.0,0.0,"Unclear","WANTAI Biological Pharmacy, Beijing, China","Total Antibody","High","Journal Article (Peer-Reviewed)","Le Huu Song","Universitätsklinikum Tübingen","https://dx.doi.org/10.1016/j.lanwpc.2021.100113","Verified","","","","","","VN",""
"2021-04-10","210331_Lima_PeruvianMinistryOfHealth_Overall_PopAdj_TestAdj","SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru","2021-03-31","Local","Peru","Peru; Lima and Callao; Lima metropolitan area","2020-06-28","2020-07-09","Household and community samples","Multiple groups",3212.0,0.208,"Stratified probability","SD BIOSENSOR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Mary F Reyes Vega","Peruvian Ministry of Health","https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00081-X/fulltext#%20","Verified",0.172,0.235,0.969,0.962,"","PE","PE-LIM"
"2021-04-11","200920_Tokyo_NationalCenterForGlobalHealthAndMedicine_Overall","Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers","2020-09-09","Local","Japan","Japan","2020-02-14","2020-04-03","Health care workers and caregivers","Adults (18-64 years)",49.0,0.0,"Convenience","N/A - in house","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tetsuya Suzuki","National Center for Global Health and Medicine","http://dx.doi.org/10.1016/j.jiac.2020.09.006","Verified","","","","","","JP",""
"2021-04-11","210315_Vancouver_BCChildren’sHospitalResearchInstitute_OverallPrimary","A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2","2021-03-15","Local","Canada","Canada; British Columbia; Vancouver","2020-05-17","2020-06-19","Household and community samples","Adults (18-64 years)",276.0,0.006,"Convenience","1) Meso Scale Diagnostics ; 2) Ortho-Clinical Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Abdelilah Majdoubi","BC Children’s Hospital Research Institute","https://dx.doi.org/10.1172/jci.insight.146316","Verified",0.0,0.027,"","","","CA","CA-BC"
"2021-04-11","210330_ Aichi_JapanMinistryOfHealth3_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan","Japan; Aichi Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",2960.0,0.007,"Unclear","Not reported","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","","","","","","JP","JP-23"
"2021-04-11","210330_ Fukuoka_JapanMinistryOfHealth5_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan","Japan; Fukuoka Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",3078.0,0.004,"Unclear","Not reported","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","","","","","","JP","JP-40"
"2021-04-11","210330_Miyagi_JapanMinistryOfHealth4_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan","Japan; Miyagi Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",2860.0,0.001,"Unclear","Not reported","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","","","","","","JP","JP-04"
"2021-04-11","210330_Osaka_JapanMinistryOfHealth2_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan","Japan; Osaka Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",2746.0,0.007,"Unclear","Not reported","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","","","","","","JP","JP-27"
"2021-04-11","210330_Tokyo_JapanMinistryOfHealth1_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan","Japan; Tokyo Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",3399.0,0.014,"Unclear","Not reported","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","","","","","","JP","JP-13"
"2021-04-11","210401_London_PublicHealthEngland_Overall","Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK","2021-04-01","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-03-30","2020-07-21","Health care workers and caregivers","Multiple groups",1069.0,0.29,"Unclear","Roche","IgG; IgM; IgA","Unclear","Journal Article (Peer-Reviewed)","Madhumita Shrotri","Public Health England","https://dx.doi.org/10.3201/eid2704.204554","Verified",0.26,0.32,"","","","GB",""
"2021-04-12","201105_Italy_UniversityofVerona_overall_unadj","Serological prevalence of SARS-CoV-2 infection among chronicmyeloid leukemia patients undergoing tyrosine kinase inhibitortreatment in italy (COVID-19-hem study)","2020-11-05","National","Italy","Italy; Veneto, Lazio and Friuli-Venezia Giulia","2020-05-18","2020-07-29","Patients seeking care for non-COVID-19 reasons","Multiple groups",339.0,0.015,"Sequential","Menarini Diagnostics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Massimiliano Bonifacio","University of Verona","http://dx.doi.org/10.1182/blood-2020-140032","Verified","","","","","","IT",""
"2021-04-12","210302_London_UniversityCollegeLondon_HCW_Overall","Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS-CoV-2 infection","2021-03-02","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-23","2020-08-17","Health care workers and caregivers","Adults (18-64 years)",729.0,0.215,"Convenience","1) Euroimmun; 2) Roche","IgG; IgM","High","Journal Article (Peer-Reviewed)","Charlotte Manisty","University College London","https://dx.doi.org/10.1016/j.ebiom.2021.103259","Unverified","","","","","","GB","GB-ENG"
"2021-04-12","210302_Shenzhen_ChineseAcademyofMedicalSciences2_overall_adj","The prevalence of antibodies to SARS-CoV-2 among blood donors in China","2021-03-02","Local","China","China","2020-01-15","2020-04-15","Blood donors","Multiple groups",6810.0,0.0,"Convenience","Not reported","IgG; Total Antibody; IgM","Moderate","Journal Article (Peer-Reviewed)","Le Chang","Chinese Academy of Medical Sciences","https://dx.doi.org/10.1038/s41467-021-21503-x","Unverified",0.0,0.003,"","","","CN",""
"2021-04-12","210302_Shijiazhuang_ChineseAcademyofMedicalSciences3_overall_adj","The prevalence of antibodies to SARS-CoV-2 among blood donors in China","2021-03-02","Local","China","China; Hebei Province; Shijiazhuang","2020-01-15","2020-04-15","Blood donors","Adults (18-64 years)",13540.0,0.0,"Convenience","Not reported","IgG; Total Antibody; IgM","Moderate","Journal Article (Peer-Reviewed)","Le Chang","Chinese Academy of Medical Sciences","https://dx.doi.org/10.1038/s41467-021-21503-x","Verified",0.0,0.002,"","","","CN","CN-13"
"2021-04-12","210302_Wuhan_ChineseAcademyofMedicalSciences1_overall_adj","The prevalence of antibodies to SARS-CoV-2 among blood donors in China","2021-03-02","Local","China","China; Hubei Province; Wuhan","2020-01-15","2020-04-15","Blood donors","Adults (18-64 years)",17794.0,0.027,"Convenience","Not reported","IgG; Total Antibody; IgM","Moderate","Journal Article (Peer-Reviewed)","Le Chang","Chinese Academy of Medical Sciences","https://dx.doi.org/10.1038/s41467-021-21503-x","Verified",0.022,0.031,"","","","CN","CN-42"
"2021-04-13","210118_Nouakchott_CentreHospitalierNationalDeNouakchott_Overall","Serological tests for SARS-CoV-2 in a health workers population in Nouakchott-Mauritania","2021-01-18","Local","Mauritania","Mauritania","2020-05-05","2020-05-27","Health care workers and caregivers","Adults (18-64 years)",835.0,0.017,"Convenience","Biotime","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mohamed Lemine Ould Salem","Centre Hospitalier National de Nouakchott","http://dx.doi.org/10.11604/pamj.2021.38.55.24259","Verified","","",0.964,0.987,"","MR",""
"2021-04-13","210125_TerreRoveresche_UniversityOfUrbinoCarloBo_Overall","Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection in an Italian cohort in Marche Region, Italy","2021-01-25","Local","Italy","Italy; Le Marche Region; Municipality of Terre Roveresche","2020-03-15","2020-06-15","Household and community samples","Multiple groups",341.0,0.144,"Convenience","Diagnostic Bioprobes Srl","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mauro De Santi","University of Urbino Carlo Bo","https://dx.doi.org/10.23750/abm.v92i1.10847","Verified","","","","","","IT","IT-57"
"2021-04-14","210411_India_BanarasHinduUniversity_Overall","Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations","2021-04-11","National","India","India","2020-09-15","2020-12-15","Household and community samples","Adults (18-64 years)",2301.0,0.306,"Simplified probability","Biosense Technologies","IgM; IgA; IgG; Total Antibody","Moderate","Preprint","Prajjval Singh","Banaras Hindu University","https://www.medrxiv.org/content/10.1101/2021.02.05.21251118v2","Unverified",0.287,0.325,1.0,0.99,"","IN",""
"2021-04-15","210127_Bukavu_CliniqueSaint-LucDeBukavu_Overall","Seroprevalence of SARS-CoV-2 antibodies among travellers and workers screened at the saint luc clinic in Bukavu, a city in eastern democratic Republic of the Congo, from may to august 2020","2021-01-27","Local","Democratic Republic of the Congo","Democratic Republic of the Congo","2020-05-15","2020-08-30","Multiple populations","Multiple groups",684.0,0.408,"Self-referral","Cellex","IgG; IgM","High","Journal Article (Peer-Reviewed)","Philippe Bianga Katchunga","Clinique Saint-Luc de Bukavu","https://www.panafrican-med-journal.com/content/article/38/93/full/","Verified","","",0.938,0.96,"","CD",""
"2021-04-15","210202_Delhi_DelhiGovernment","After Delhi's 5th serosurvey, health minister Jain says don’t let guard down","2021-02-02","Local","India","India","2021-01-15","2021-01-23","Household and community samples","Multiple groups",28000.0,0.561,"Unclear","NR","Not reported","Unclear","News and Media","Mallika Soni","Delhi Government","https://www.hindustantimes.com/india-news/after-5th-serosurvey-health-minister-jain-says-don-t-let-your-guard-down-101612264692531.html","Verified","","","","","","IN",""
"2021-04-15","210208_Kenya_KEMRI-WellcomeTrust_Kilifi_Overall_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","Kenya","Kenya; Kilifi; Kilifi","2020-11-01","2020-11-24","Pregnant or parturient women","Adults (18-64 years)",154.0,0.11,"Sequential","N/A - in house","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified",0.062,0.167,0.927,0.99,"","KE","KE-14"
"2021-04-15","210208_Kenya_KEMRI-WellcomeTrust_Nairobi_Overall_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","Kenya","Kenya; Nairobi; Nairobi","2020-07-30","2020-08-25","Pregnant or parturient women","Adults (18-64 years)",196.0,0.499,"Sequential","N/A - in house","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified",0.427,0.58,0.927,0.99,"","KE","KE-30"
"2021-04-15","210215_Patna_AllIndiaInstituteOfMedicalSciences_Overall","Seroprevalence of igg against sars-cov-2 and its determinants among healthcare workers of a covid-19 dedicated hospital of India","2021-02-15","Local","India","India; Bihar; Patna","2020-09-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",919.0,0.133,"Convenience","ADVIA Centaur","IgG","High","Journal Article (Peer-Reviewed)","Mala Mahto","All India Institute of Medical Sciences","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010601/","Verified",0.112,0.156,1.0,0.998,"","IN","IN-BR"
"2021-04-15","210225_Brescia_UniversityofBrescia_HCW","Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy","2021-02-25","Local","Italy","Italy; Lombardy; Brescia","2020-04-26","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1893.0,0.229,"Convenience","DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Agnese Comelli","University of Brescia","https://dx.doi.org/10.3390/microorganisms9030488","Verified","","",0.957,0.985,"","IT","IT-25"
"2021-04-15","210226_WestMidlands_BirminghamCommunityHealthcareTrust_Baseline","Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals","2021-02-26","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1507.0,0.163,"Convenience","The Binding Site (TBS), Birmingham","IgG; IgM; IgA","Moderate","Preprint","Adrian Shields","Birmingham Community Healthcare Trust","10.1101/2021.02.24.21252368","Verified","","",0.986,0.983,"","GB",""
"2021-04-15","210316_Sussex_UniversityofSussex_AbbottWSHT","Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers","2021-03-16","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; West Sussex","2020-05-19","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",12388.0,0.079,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Alyss Robinson","University of Sussex","https://dx.doi.org/10.7861/clinmed.2020.1007","Verified","","",1.0,0.996,"","GB","GB-ENG"
"2021-04-15","210316_Sussex_UniversityofSussex_RocheBSUH","Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers","2021-03-16","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Brighton and Sussex","2020-05-19","2020-09-29","Health care workers and caregivers","Adults (18-64 years)",14473.0,0.13,"Convenience","Roche Diagnostics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alyss Robinson","University of Sussex","https://dx.doi.org/10.7861/clinmed.2020.1007","Verified","","",0.995,0.998,"","GB","GB-ENG"
"2021-04-15","210318_IvoryCoast_CentreHospitalierRegionald’Orleans_Overall","SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers","2021-03-18","National","Côte d'Ivoire","Côte d'Ivoire","2020-07-15","2020-10-13","Essential non-healthcare workers","Adults (18-64 years)",1687.0,0.251,"Convenience","AAZ LMB, Boulogne Billanco","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Jean Milleliri","Centre Hospitalier Regional d’Orleans","https://dx.doi.org/10.4269/ajtmh.21-0081","Unverified","","",1.0,1.0,"","CI",""
"2021-04-16","201217_Honduras_ColegioMédico_OverallGenpop","Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras wth no reports of active cases, COVID-19, June 16-23, 2020","2020-12-17","National","Honduras","Honduras","2020-06-16","2020-06-23","Household and community samples","Multiple groups",792.0,0.062,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mario Rene Mejia Nunez","Colegio Médico","https://revistas.ucr.ac.cr/index.php/psm/article/view/43261/46175","Verified","","",0.934,0.977,"","HN",""
"2021-04-16","210217_Shiraz_ShirazUniversityOfMedicalSciences_Overall","Prevalence of anti-sars-cov-2 antibody in hospital staff in double-center setting: A preliminary report of a cohort study from Iran","2021-02-17","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Fars; Shiraz City","2020-07-13","2020-08-05","Health care workers and caregivers","Multiple groups",494.0,0.059,"Convenience","Pishtaz Co","IgG","High","Journal Article (Peer-Reviewed)","Kamran Bagheri Lankarani","Shiraz University of Medical Sciences","http://dx.doi.org/10.5812/semj.112681","Verified","","","","","","IR","IR-14"
"2021-04-16","210302_NewYork_RenaissanceStonyBrookSchoolofMedicine","Prevalence of IgM and IgG antibodies to SARS-CoV-2 in health care workers at a tertiary care New York hospital during the Spring COVID-19 surge","2021-03-02","Local","United States of America","United States of America; New York","2020-04-02","2020-04-18","Health care workers and caregivers","Adults (18-64 years)",474.0,0.169,"Convenience","Chembio Diagnostics, Inc Medford, New York, USA","IgG; IgM","High","Journal Article (Peer-Reviewed)","Lilian Talbot","Renaissance Stony Brook School of Medicine","https://dx.doi.org/10.1186/s13741-021-00177-5","Verified",0.136,0.206,0.843,0.889,"","US","US-NY"
"2021-04-16","210309_Qatar_HamadMedicalCorporation_CemetaryWorkers","SARS-CoV-2 Infection in Mortuary and Cemetery Workers","2021-03-09","Local","Qatar","Qatar; NR; NR","2020-09-01","2020-09-01","Essential non-healthcare workers","Adults (18-64 years)",64.0,0.344,"Convenience","Roche, Switzerland","Not reported","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","http://dx.doi.org/10.1016/j.ijid.2021.03.012","Verified","","","","","","QA",""
"2021-04-16","210309_Qatar_HamadMedicalCorporation_MortuaryWorkers","SARS-CoV-2 Infection in Mortuary and Cemetery Workers","2021-03-09","Local","Qatar","Qatar; NR; NR","2020-09-17","2020-09-17","Essential non-healthcare workers","Adults (18-64 years)",32.0,0.25,"Convenience","Roche, Switzerland","Not reported","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","http://dx.doi.org/10.1016/j.ijid.2021.03.012","Verified","","","","","","QA",""
"2021-04-16","210310_Bavaria_BrandenburgMedicalSchoolTheodorFontane","Risk to Radiology Staff for Occupational COVID-19 Infection in a High-Risk and a Low-Risk Region in Germany: Lessons from the ""First Wave""","2021-03-10","Local","Germany","Germany; Bavaria; Wieden","2020-07-17","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1838.0,0.151,"Convenience","Roche Diagnostics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Thomas Finkenzeller","Brandenburg Medical School Theodor Fontane","https://dx.doi.org/10.1055/a-1393-6668","Verified",0.134,0.167,"","","","DE","DE-BY"
"2021-04-16","210310_Brandenburg_BrandenburgMedicalSchoolTheodorFontane","Risk to Radiology Staff for Occupational COVID-19 Infection in a High-Risk and a Low-Risk Region in Germany: Lessons from the ""First Wave""","2021-03-10","Local","Germany","Germany; Brandenburg; NR","2020-07-17","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",585.0,0.021,"Convenience","EUROIMMUN","IgG; IgA","High","Journal Article (Peer-Reviewed)","Thomas Finkenzeller","Brandenburg Medical School Theodor Fontane","https://dx.doi.org/10.1055/a-1393-6668","Verified",0.012,0.038,"","","","DE","DE-BB"
"2021-04-16","210331_Bulawayo_UniversityofEdinburgh_Primary","SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe","2021-03-31","Regional","Zimbabwe","Zimbabwe; Bulawayo","2020-06-09","2020-06-22","Health care workers and caregivers","Multiple groups",635.0,0.089,"Self-referral","Wuhan UNscience Biotechnology Companies","IgG; IgM","High","Journal Article (Peer-Reviewed)","Simbarashe Rusakaniko","University of Edinburgh","https://dx.doi.org/10.1371/journal.pntd.0009254","Verified",0.069,0.115,0.985,0.882,"","ZW","ZW-BU"
"2021-04-16","210417_Leicestershire_UniversityofLeicester_Diasorin+Siemens","Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale","2021-03-17","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; NR","2019-10-01","2020-03-31","Residual sera","Multiple groups",428.0,0.0,"Simplified probability","Diasorin Ltd.; Siemens","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Paul William Bird","University of Leicester","https://dx.doi.org/10.1016/j.jinf.2021.03.007","Unverified","","","","","","GB","GB-ENG"
"2021-04-17","210224_Castiglioned'Adda_UniversityofMilan_Overall","Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy","2021-02-24","Local","Italy","Italy; Lombardy; Castiglione D’Adda","2020-05-18","2020-06-07","Household and community samples","Multiple groups",4143.0,0.222,"Entire sample","Prisma Lab","IgG","Low","Journal Article (Peer-Reviewed)","Gabriele Pagani","University of Milan","https://dx.doi.org/10.1371/journal.pone.0246513","Verified","","",1.0,0.96,"","IT","IT-25"
"2021-04-17","210226_UniversityOfTurin_Turin","Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study","2021-02-26","Local","Italy","Italy; Piedmont; Turin","2020-04-16","2020-06-22","Pregnant or parturient women","Adults (18-64 years)",164.0,0.097,"Convenience","Boditech Med Inc, Gang-won-do, Korea","IgG; IgM","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","https://dx.doi.org/10.3390/diagnostics11030398","Verified","","","","","","IT","IT-21"
"2021-04-17","210301_Ahmedabad_SmtNHLMunicipalMedicalCollege_Overall","Prevalence of seropositivity to sars-cov-2 among health care workers in tertiary covid-19 hospital, ahmedabad, gujarat","2021-03-01","Local","India","India; Gujarat; Ahmedabad","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1333.0,0.278,"Unclear","Siemens","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jemil Makadia","Smt NHL Municipal Medical College","http://dx.doi.org/10.7860/JCDR/2021/46817.14599","Verified","","",1.0,0.998,"","IN","IN-GJ"
"2021-04-17","210303_Turkey_UniversityofHealthSciences_Overall","Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey","2021-03-03","National","Turkey","Turkey; Marmara; Istanbul and Kocaeli","2020-05-30","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",813.0,0.027,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Gizem Alkurt","University of Health Sciences","https://dx.doi.org/10.1371/journal.pone.0247865","Verified","","","","","","TR",""
"2021-04-17","210311_USA_IgenomixUSAandCanada_Overall","SARS-CoV-2 immunity, infective and naive incidence in fertility clinics after lockdown","2021-03-11","National","United States of America","United States of America; Utah, Massachuetts; Boston","2020-06-18","2020-07-30","Multiple populations","Adults (18-64 years)",337.0,0.015,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Russel Foulk","Igenomix USA and Canada","https://dx.doi.org/10.1016/j.ajog.2021.03.008","Verified","","","","","","US",""
"2021-04-17","210317_Boston_HarvardMedicalSchool_Primary","SARS-CoV-2 antibody seroprevalence after the first wave among workers at a community healthcare system in the Greater Boston area","2021-03-17","Local","United States of America","United States of America; Massachusetts; Boston","2020-06-16","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",433.0,0.113,"Self-referral","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lou Ann Bruno-Murtha","Harvard Medical School","https://dx.doi.org/10.1080/20477724.2021.1901041","Verified","","",0.8,0.995,"","US","US-MA"
"2021-04-17","210323_Surrey_RoyalHollowayUniversityofLondon","SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital","2021-03-23","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Chertsey","2020-10-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",3119.0,0.196,"Convenience","Abbott Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Gie Ken Dror","Royal Holloway University of London","https://dx.doi.org/10.7861/clinmed.2020-1096","Verified","","",0.825,0.95,"","GB","GB-ENG"
"2021-04-17","210329_PortoAlegre_UniversidadeFederaldeCienciasdaSaudedePortoAlegre_HCW_July","Prevalence of COVID-19 in healthcare professionals working in hospital emergencies during first wave peak in 2020, Porto Alegre - Brazil","2021-03-29","Local","Brazil","Brazil; Rio Grande do Sul; Porto Alegre","2020-07-20","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",1163.0,0.055,"Unclear","Biosensor","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Ana Dubiela","Universidade Federal de Ciencias da Saude de Porto Alegre","https://dx.doi.org/10.1017/ice.2021.139","Verified","","",0.943,0.951,"","BR","BR-RS"
"2021-04-18","201217_UnitedStates_UniversityofIowa","Diagnosed and Undiagnosed COVID-19 in US Emergency Department Health Care Personnel: A Cross-sectional Analysis","2020-12-17","National","United States of America","United States of America","2020-05-13","2020-07-08","Health care workers and caregivers","Multiple groups",1606.0,0.017,"Stratified non-probability","Abbott Laboratories, Chicago, IL; EUROIMMUN","IgG","Moderate","Journal Article (Peer-Reviewed)","Nicholas M Mohr","University of Iowa","http://dx.doi.org/10.1016/j.annemergmed.2020.12.007","Verified","","","","","","US",""
"2021-04-18","210223_Regensberg_HospitalStHedwigOfTheOrderOfStJohn_IgG+","Peripartal anti-SARS-CoV-2-IgA/IgG in asymptomatic pregnant women during regional SARS-CoV-2-outbreak","2021-02-23","Local","Germany","Germany; Bavaria; Regensberg","2020-04-09","2020-04-30","Pregnant or parturient women","Adults (18-64 years)",151.0,0.02,"Sequential","EUROIMMUN AG, Lübeck,; Germany","IgG","High","Journal Article (Peer-Reviewed)","Sebastian Hausler","Hospital St Hedwig of the Order of St John","https://dx.doi.org/10.1515/jpm-2021-0001","Verified","","","","","","DE","DE-BY"
"2021-04-18","210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Patients_Overall","Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study","2021-02-27","Local","France","France","2020-05-25","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",1011.0,0.017,"Convenience","Roche Diagnostics","IgG; IgM; IgA; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sylvain Ladoire","Centre Georges Francois Leclerc","https://dx.doi.org/10.1016/j.ejca.2021.02.027","Verified","","",1.0,0.998,"","FR",""
"2021-04-18","210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Staff_Overall","Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study","2021-02-27","Local","France","France","2020-05-11","2020-05-25","Health care workers and caregivers","Adults (18-64 years)",663.0,0.018,"Convenience","Roche Diagnostics","IgG; IgM; IgA; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sylvain Ladoire","Centre Georges Francois Leclerc","https://dx.doi.org/10.1016/j.ejca.2021.02.027","Verified","","",1.0,0.998,"","FR",""
"2021-04-18","210311_NewDelhi_AllIndiaInstituteOfMedicalSciences_Overall","Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation","2021-03-11","Local","India","India","2020-04-15","2020-07-15","Blood donors","Adults (18-64 years)",1191.0,0.095,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Hem Chandra Pandey","All India Institute of Medical Sciences","https://dx.doi.org/10.1016/j.transci.2021.103118","Verified","","","","","","IN",""
"2021-04-18","210321_KlangValley_MalaysianMinistryofHealth_HCW","Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia","2021-03-21","Local","Malaysia","Malaysia; Klang Valley","2020-04-13","2020-05-12","Health care workers and caregivers","Adults (18-64 years)",400.0,0.0,"Self-referral","GenScript Biotech","Not reported","High","Journal Article (Peer-Reviewed)","Yuan Liang Woon","Malaysian Ministry of Health","https://dx.doi.org/10.1016/j.lanwpc.2021.100123","Verified",0.0,0.0,0.913,1.0,"","MY",""
"2021-04-18","210322_GrandEst_StrasbourgUniversityHospital_KidneyTransplantPatients","SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a ""High Risk"" Zone","2021-03-22","Local","France","France; Grand Est","","2020-09-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",780.0,0.062,"Convenience","Abbott Laboratories, Euroimmun, Roche Diagnostic, Orient Gene Biotech, Biosynex, BioMérieux, SNIBE - Shenzhen New Industries Biomedical Engineering, Bio‐Rad","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sophie Caillard","Strasbourg University Hospital","https://dx.doi.org/10.1097/TP.0000000000003766","Verified","","","","","","FR","FR-GES"
"2021-04-18","210324_SaoPaulo_UniversityofSaoPaulo_overall","SARS-Cov-2 seroprevalence and risk factors among Health Care Workers: estimating the risk of COVID-19 dedicated units","2021-03-24","Local","Brazil","Brazil; Sao Paulo; Sao Paulo","2020-06-17","2020-07-08","Health care workers and caregivers","Adults (18-64 years)",1996.0,0.055,"Convenience","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Maura Salaroli de Oliveira","University of São Paulo","https://dx.doi.org/10.1016/j.ajic.2021.03.010","Verified","","",0.95,1.0,"","BR","BR-SP"
"2021-04-18","210402_Cairo_CairoUniversity_HCW","Asymptomatic SARS-CoV-2 infection among healthcare workers in a non-COVID-19 Teaching University Hospital","2021-04-02","Local","Egypt","Egypt","2020-05-05","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",455.0,0.079,"Convenience","SD-Biosensor; YHLO Biotech","IgG","High","Journal Article (Peer-Reviewed)","Ahmed Mukhtar","Cairo University","https://dx.doi.org/10.4081/jphr.2021.2102","Verified",0.058,0.108,"","","","EG",""
"2021-04-19","201125_Washington_GeorgeWashingtonUniversity_hcw","COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic","2021-02-01","Local","United States of America","United States of America; District of Columbia; Washington","2020-05-26","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",138.0,0.051,"Convenience","1. Biolidics; 2. Author","IgG; IgM","High","Journal Article (Peer-Reviewed)","Eric Murakami","George Washington University","https://pubmed.ncbi.nlm.nih.gov/33340874/","Verified","","","","","","US","US-DC"
"2021-04-19","210212_London_UniversityofOxford_Overall","Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic","2021-02-12","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-04-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",236.0,0.085,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Colleen GC McGregor","University of Oxford","https://dx.doi.org/10.1136/gutjnl-2021-324116","Verified","","","","","","GB",""
"2021-04-19","210308_ZhongnanHospital_Wuhan","Safety and Effectiveness of Orthopaedic Medical Staff in Providing Support in Combating the COVID-19 Pandemic: A Retrospective Investigation from Wuhan, China","2021-03-08","Local","China","China; Hubei; Wuhan","2020-01-01","2020-04-08","Health care workers and caregivers","Adults (18-64 years)",112.0,0.0,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yin-xian Wen","Zhongnan Hospital of Wuhan University","https://dx.doi.org/10.1111/os.12898","Verified","","","","","","CN","CN-42"
"2021-04-19","210419_Fribourg_UniversitédeFribourg_Overall_TestPopAdj","Corona Immunitas Fribourg Immunité de la population Episode 2/2021","2021-04-01","Regional","Switzerland","Switzerland; Canton of Fribourg","2020-11-30","2021-02-05","Household and community samples","Multiple groups",449.0,0.19,"Simplified probability","N/A - Institution designed","IgG","Moderate","Institutional Report","Emna El May","Université de Fribourg","https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2021-PopHealthLab-Corona-Immunitas-E2.pdf","Verified",0.15,0.23,0.966,0.997,"","CH","CH-FR"
"2021-04-20","201020_Milan_UniversitàdegliStudidiMilano_Physicians2_Overall","Incidence of sars-cov-2 infection in patients with active cancer: Mono-institutional series of a comprehensive cancer institution in lombardy during the covid-19 pandemic (Niguarda Cancer Center, Milano, Italy)","2020-10-20","Local","Italy","Italy; Lombardy; Milan","2020-04-15","2020-05-15","Health care workers and caregivers","Multiple groups",34.0,0.059,"Convenience","Abbott Laboratories, Diasorin","IgG","Unclear","Journal Article (Peer-Reviewed)","Andrea Sartore Bianchi","Università degli Studi di Milano","http://dx.doi.org/10.1177/0300891620953388","Verified","","","","","","IT","IT-25"
"2021-04-21","200721_Lodi_A.S.S.T.Lodi_HCW_overall","SARS-CoV-2 Antibody Prevalence in Health Care Workers of Lodi Hospital, the COVID-19 Italian Epicentre","2020-07-21","Local","Italy","Italy; Lombardy Region","2020-04-23","2020-05-05","Health care workers and caregivers","Adults (18-64 years)",2415.0,0.168,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Alessandro  Baracco","A.S.S.T. Lodi","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227","Verified","","","","","","IT","IT-25"
"2021-04-21","200721_Lodi_A.S.S.T.Lodi_genpop","SARS-CoV-2 Antibody Prevalence in Health Care Workers of Lodi Hospital, the COVID-19 Italian Epicentre","2020-07-21","Local","Italy","Italy; Lombardy region; Lodi","2020-04-23","2020-05-05","Household and community samples","Multiple groups",1792.0,0.298,"Simplified probability","DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Alessandro  Baracco","A.S.S.T.Lodi","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227","Verified","","","","","","IT","IT-25"
"2021-04-21","200828_VillaAzul_MinisterioDeSaludDeLaProvinciaDeBuenosAires_overall","Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina","2020-08-28","Local","Argentina","Argentina; Buenos Aires; Quilmes","2020-07-15","2020-07-16","Household and community samples","Multiple groups",284.0,0.148,"Stratified non-probability","COVIDAR","IgG","Moderate","Preprint","Laura Munoz","Ministerio de Salud de la Provincia de Buenos Aires","https://preprints.scielo.org/index.php/scielo/preprint/view/1147","Verified",0.111,0.195,0.95,1.0,"","AR","AR-B"
"2021-04-21","201113_London_ImperialCollegeLondon_KidneyTransplantPatients copy","Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening","2020-11-13","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-01","2020-07-03","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",855.0,0.081,"Sequential","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Michelle Willicombe","Imperial College London","https://dx.doi.org/10.1097/TP.0000000000003526","Verified",0.064,0.101,0.684,1.0,"","GB","GB-ENG"
"2021-04-21","210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAires","SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SEROEPIDEMIOLOGY STUDY IN ARGENTINIAN SLUM","2021-01-21","Local","Argentina","Argentina; Buenos Aires; Buenos Aires","2020-06-10","2020-06-26","Persons living in slums","Multiple groups",873.0,0.534,"Simplified probability","Laboratio Lemos","IgG","Moderate","Journal Article (Peer-Reviewed)","Silvana Figar","Ministry of Health of the City of Buenos Aires","https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf","Verified",0.528,0.541,0.9,1.0,"","AR","AR-B"
"2021-04-21","210227_Belgium_AntwerpUniversityHospital_HCW_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","Belgium","2020-03-24","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",92.0,0.12,"Convenience","DiaSorin, Saluggia, Italy","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","","","","","","BE",""
"2021-04-21","210227_Belgium_AntwerpUniversityHospital_PediatricCancer_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","Belgium","2020-03-24","2020-05-31","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",11.0,0.091,"Sequential","DiaSorin, Saluggia, Italy","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","","","","","","BE",""
"2021-04-21","210309_Benevento_UniversitàdegliStudidelSannio_Overall","Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy","2021-03-09","Local","Italy","Italy; Campania; NR","2020-09-01","2020-09-30","Household and community samples","Seniors (65+ years)",1383.0,0.047,"Convenience","LEPU MEDICAL TECHNOLOGY Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Immacolata Polvere","Università degli Studi del Sannio","https://dx.doi.org/10.3390/diagnostics11030483","Verified","","",0.986,0.976,"","IT","IT-72"
"2021-04-21","210316_Lancashire_LancashireTeachingHospitalsNHSTrust_OverallHCW","Seroprevalence of SARS-CoV-2 infection in healthcare workers in a large teaching hospital in the North West of England: a period prevalence survey","2021-03-16","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; Chorley, Preston, South Ribble","2020-05-29","2020-07-04","Health care workers and caregivers","Adults (18-64 years)",4474.0,0.174,"Convenience","Roche Diagnostics","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Robert Shorten","Lancashire Teaching Hospitals NHS Foundation Trust","https://dx.doi.org/10.1136/bmjopen-2020-045384","Verified","","",0.92,1.0,"","GB","GB-ENG"
"2021-04-21","210404_Marche_UniversitàPolitecnicadelleMarche_ConfirmationAssay","Seroprevalence of sars-cov-2-specific antibodies in cancer patients undergoing active systemic treatment: A single-center experience from the marche region, italy","2021-04-04","Local","Italy","Italy; Marche; Ancona","2020-07-01","2020-10-26","Patients seeking care for non-COVID-19 reasons","Multiple groups",949.0,0.007,"Sequential","Zhejiang Orient Gene Biotech; Shenzen YHLO BioTech Co. Ltd.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luca Cantini","Università Politecnica delle Marche","http://dx.doi.org/10.3390/jcm10071503","Verified","","","","","","IT","IT-57"
"2021-04-21","210420_Estonia_UniversityOfTartu_Stage16_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","Estonia","Estonia","2021-04-08","2021-04-19","Household and community samples","Multiple groups",2491.0,0.359,"Stratified probability","Synlab","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.34,0.378,"","","","EE",""
"2021-04-22","200727_Japan_HealthandWelfareDepartment_primary","About  the results of the antibody prevalence survey against the new coronavirus at  medical institutions in the prefecture","2020-07-27","Regional","Japan","Japan; prefecture 3","2020-06-15","2020-06-28","Residual sera","Multiple groups",3000.0,0.0,"Convenience","NR","IgG","Unclear","News and Media","Okuda","Health and Welfare Department","http://wave.pref.wakayama.lg.jp/news/kensei/shiryo.php?sid=31587","Verified","","","","","","JP",""
"2021-04-22","200930_Scotland_PublicHealthScotland_ResidualSera_Overall_UnAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 30 Sept 2020","2020-09-30","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-04-20","2020-08-09","Residual sera","Multiple groups",9802.0,0.049,"Stratified non-probability","Not reported","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/","Verified","","",0.875,0.986,"","GB","GB-SCT"
"2021-04-22","201017_Ujjain_TheTimesOfIndia_primary","11.9%  seroprevalence in Ujjain, finds survey","2020-09-17","Regional","India","India; Madhya Pradesh","2020-08-27","2020-08-30","Household and community samples","Multiple groups",3000.0,0.119,"Unclear","NR","Not reported","Unclear","News and Media","Amarjeet Singh","The Times of India","https://timesofindia.indiatimes.com/city/bhopal/11-9-seroprevalence-in-ujjain-finds-survey/articleshow/78159395.cms","Verified","","","","","","IN","IN-MP"
"2021-04-22","201103_Haryan_TheHindu_primary","6% rise in seropositivity among Delhi’s neighbours","2020-11-03","Regional","India","India; Haryan","2020-10-18","2020-10-24","Household and community samples","Multiple groups",16477.0,0.148,"Stratified probability","NR","Not reported","Unclear","News and Media","Ashok Kumar","Unclear","https://www.thehindu.com/news/cities/Delhi/6-rise-in-seropositivity-among-delhis-neighbours/article33006634.ece","Verified","","","","","","IN","IN-HR"
"2021-04-22","201215_CiudaddelEste_MinisteriodeSaludPública_primary","30% of those tested in the East had Covid","2020-12-15","Local","Paraguay","Paraguay","2020-11-29","2020-12-15","Household and community samples","Multiple groups",1675.0,0.3,"Unclear","NR","Not reported","Unclear","News and Media","Not reported","Ministerio de Salud Pública","https://www.ultimahora.com/el-30-testeados-el-este-tuvieron-covid-n2918654.html","Verified","","","","","","PY",""
"2021-04-22","210111_Burlington_UniversityOfVermont_overall","Jobs, Housing, and Mask Wearing: Cross-Sectional Study of Risk Factors for COVID-19","2021-01-11","Local","United States of America","United States of America; Vermont; Burlington","2020-06-25","2020-06-28","Household and community samples","Multiple groups",454.0,0.022,"Stratified probability","1) N/A - in house","IgG","High","Journal Article (Peer-Reviewed)","Eline M van den Broek Altenburg","University of Vermont","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800904/","Verified",0.008,0.036,"","","","US","US-VT"
"2021-04-22","210305_Mississippi_CDCCOVID-19ResponseTeam_Overall","Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020","2021-03-05","Regional","United States of America","United States of America; Mississippi","2020-05-17","2020-09-19","Residual sera","Children and Youth (0-17 years)",1603.0,0.109,"Sequential","Ortho Clinical Diagnostics; In-House (CDC)","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Charlotte Hobbs","CDC COVID-19 Response Team","https://dx.doi.org/10.15585/mmwr.mm7009a4","Unverified",0.094,0.124,"","","","US","US-MS"
"2021-04-22","210312_NorthCarolina_WakeForestBaptistHealth","Analysis of Accumulated SARS-CoV-2 Seroconversion in North Carolina: The COVID-19 Community Research Partnership","2021-03-12","Regional","United States of America","United States of America; North Carolina","2020-04-16","2020-12-20","Household and community samples","Adults (18-64 years)",17688.0,0.326,"Stratified non-probability","Syntron Bioresearch Inc;  Innovita Biological Technology Co","IgM; IgG","Moderate","Preprint","John Williamson","Wake Forest Baptist Health","https://www.medrxiv.org/content/10.1101/2021.03.11.21253226v1","Verified",0.284,0.35,"","","","US","US-NC"
"2021-04-23","200602_Biguacu_SecretariaMunicipaldeSaude_primary","Check out a study on the Covid-19 pandemic in Biguaçu in graphs","2020-06-02","Local","Brazil","Brazil","2020-05-30","2020-05-30","Household and community samples","Multiple groups",217.0,0.004,"Stratified probability","NR","Not reported","Unclear","News and Media","Ozias Alves Jr","Secretaria Municipal de Saude","http://jbfoco.com.br/2020/06/confira-um-estudo-sobre-a-pandemia-de-covid-19-em-biguacu-em-graficos/","Verified","","","","","","BR",""
"2021-04-23","200929_Ticino_InstituteofPublicHealth_primary","Corona Immunitas Ticino, the first results are in","2020-09-29","Local","Switzerland","Switzerland","2020-07-01","2020-07-31","Household and community samples","Adults (18-64 years)",647.0,0.11,"Simplified probability","Centre Hospitalier Universitaire Vaudois (CHUV) in collaboration with the Swiss Federal Institute of Technology in Lausanne (EFPL) and the Swiss Centre for Vaccine Research.","Not reported","Unclear","News and Media","Universita della Svizzera Italiana","The Institute of Public Health on the Università della Svizzera italiana","https://www.biomed.usi.ch/en/feeds/8913","Verified","","","","","","CH",""
"2021-04-23","201008_BneiBrak_CentralBureauofStatistics_primary","Antibody Tests  Show a Third in Israeli ultra-Orthodox Hot Spot Had Coronavirus","2020-10-08","Local","Israel","Israel","2020-06-15","2020-08-15","Household and community samples","Multiple groups",3500.0,0.146,"Stratified probability","NR","Not reported","Moderate","News and Media","Aaron Rabinowitz","The Central Bureau of Statistics","https://www.haaretz.com/israel-news/.premium-antibody-tests-30-percent-of-bnei-brak-residents-have-been-infected-with-covid-1.9217689","Verified","","","","","","IL",""
"2021-04-23","210303_MontereyCounty_UniversityofCaliforniaBerkeley_Overall","Prevalence and Clinical Profile of Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Farmworkers, California, June-November 2020.","2021-03-03","Local","United States of America","United States of America; California","2020-07-16","2020-11-30","Essential non-healthcare workers","Adults (18-64 years)",1058.0,0.19,"Self-referral","Authors","IgG","High","Journal Article (Peer-Reviewed)","Joseph Lewnard","University of California, Berkeley","https://dx.doi.org/10.3201/eid2705.204949","Verified","","","","","","US","US-CA"
"2021-04-23","210316_Spain_HospitalUniversitarioPuertadeHierro_LymphomaPatients","Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)","2021-03-16","National","Spain","Spain","2020-05-22","2020-06-11","Patients seeking care for non-COVID-19 reasons","Multiple groups",150.0,0.06,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Fernando Franco","Hospital Universitario Puerta de Hierro","https://dx.doi.org/10.3390/curroncol28020118","Unverified","","","","","","ES",""
"2021-04-23","210319_Geneva_GenevaUniversityHospitals_HospitalEmployees","SARS-CoV-2 seroconversion and occupational exposure of employees at a Swiss university hospital: a large longitudinal cohort study","2021-03-19","Local","Switzerland","Switzerland","2020-03-30","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",3421.0,0.079,"Convenience","EUROIMMUN; Roche Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Romain Martischang","Geneva University Hospitals","https://dx.doi.org/10.1017/ice.2021.117","Unverified",0.07,0.088,"","","","CH",""
"2021-04-23","210326_RiodeJaneiro_InstitutoD’OrdePesquisaeEnsino","Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report","2021-03-26","Local","Brazil","Brazil; Rio de Janeiro; Rio de Janeiro","2020-06-30","2020-08-28","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",114.0,0.307,"Sequential","Beijing LEPU-Medical Technology","IgG; IgM","High","Journal Article (Peer-Reviewed)","Thais Cleto Yamane","Instituto D’Or de Pesquisa e Ensino","https://dx.doi.org/10.1007/s00431-021-04044-9","Unverified","","",0.66,0.97,"","BR","BR-RJ"
"2021-04-23","210409_Vienna_MedicalUniversityofVienna","COVID-19 serology in nephrology healthcare workers","2021-04-09","Local","Austria","Austria; Vienna; Vienna","2020-03-22","2020-03-31","Health care workers and caregivers","Adults (18-64 years)",235.0,0.255,"Convenience","ImmunoDiagnostics,; HongKong","IgG; IgM","High","Journal Article (Peer-Reviewed)","Thomas Reiter","Medical University of Vienna","https://dx.doi.org/10.1007/s00508-021-01848-5","Unverified",0.204,0.315,"","","","AT","AT-9"
"2021-04-24","210324_Milan_UniversityofMilan_UniversityEmployees","Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: the UNICORN study","2021-03-24","Local","Italy","Italy","2020-05-13","2020-06-23","Non-essential workers and unemployed persons","Multiple groups",1826.0,0.113,"Convenience","Sino Biological, Beijing, China","IgG","High","Journal Article (Peer-Reviewed)","Gregorio Milani","University of Milan","https://dx.doi.org/10.1136/bmjopen-2020-046800","Unverified","","",0.857,0.981,"","IT",""
"2021-04-24","210402_Switzerland_UniversitàdellaSvizzeraItaliana_overall","Seroprevalence of anti-SARS-CoV-2 IgG among adolescents at military fitness-for-duty evaluation","2021-04-02","Regional","Switzerland","Switzerland; Southern Switzerland","2020-07-15","2020-12-15","Household and community samples","Adults (18-64 years)",301.0,0.033,"Sequential","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Elena Giuliano","Università della Svizzera Italiana","https://dx.doi.org/10.1136/bmjmilitary-2021-001828","Verified","","","","","","CH",""
"2021-04-24","210408_Germany_HeinrichHeineUniversityDuesseldorf_Physicians","Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV)","2021-04-08","National","Germany","Germany","2020-06-16","2020-07-02","Health care workers and caregivers","Adults (18-64 years)",516.0,0.031,"Convenience","Roche Diagnostics GmbH, Mannheim,; Germany","Total Antibody","High","Journal Article (Peer-Reviewed)","Detlef Kindgen Milles","Heinrich-Heine University Duesseldorf","https://dx.doi.org/10.1371/journal.pone.0248813","Unverified","","","","","","DE",""
"2021-04-25","210401_Madrid_HospitalUniversitarioRamonyCajal_HCW","SARS-CoV-2 Antibodies and utility of point of care testing in Health Care Workers from a Spanish University Hospital in Madrid","2021-04-01","Local","Spain","Spain","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",5875.0,0.231,"Convenience","Hangzhou ALLTEST; Biotech Co. Ltd, Hangzhou, China; Vircell Spain S.L.U., Granada, Spain","IgG","Unclear","Journal Article (Peer-Reviewed)","Mario Rodriguez Dominguez","Hospital Universitario Ramon y Cajal","https://dx.doi.org/10.1016/j.cmi.2021.03.018","Unverified",0.221,0.243,"","","","ES",""
"2021-04-26","200820_Punjab_PunjabSeroSurvey_genpop","Punjab Sero-survey Report: 27.7% people in containment zones have antibodies against Covid","2020-08-20","Regional","India","India; Punjab","2020-08-01","2020-08-17","Household and community samples","Multiple groups",1250.0,0.277,"Simplified probability","NR","IgM; IgG","Unclear","News and Media","Express News Service","NR","https://indianexpress.com/article/india/punjab-sero-survey-report-27-7-people-in-containment-zones-have-antibodies-against-covid-6563226/","Verified","","","","","","IN","IN-PB"
"2021-04-26","200901_Aurangabad_GovernmentMedicalSchool_overall","SEROPREVALENCE OF COVID-19 IN AURANGABAD DISTRICT","2020-09-01","Local","India","India; Maharashtra","2020-08-10","2020-08-19","Household and community samples","Multiple groups",6571.0,0.058,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","J V Dixit","Government Medical School, Aurangabad","https://ijcrt.org/papers/IJCRT2009467.pdf","Verified","","","","","","IN","IN-MH"
"2021-04-26","200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 1","COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context","2020-09-28","Local","Brazil","Brazil; São Paulo state; Baixada Santista","2020-04-29","2020-05-01","Household and community samples","Multiple groups",2314.0,0.014,"Stratified probability","Wondfo","Total Antibody","High","Preprint","Arthur Chioro","Baixada Santista Metropolitan Region","https://preprints.scielo.org/index.php/scielo/preprint/view/1270","Verified","","","","","","BR","BR-SP"
"2021-04-26","200929_Atahualpa_UniversidadPeruanaCayetanoHeredia_overall","Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort study","2020-09-29","Local","Ecuador","Ecuador","2020-06-25","2020-06-30","Household and community samples","Adults (18-64 years)",362.0,0.077,"Simplified probability","BIOHIT Health Care","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar H Del Brutto","Universidad Peruana Cayetano Heredia","https://www.tandfonline.com/doi/full/10.1080/20477724.2020.1826152","Verified","","","","","","EC",""
"2021-04-26","200929_Benghazi_TheCenterOfInfectiousDiseases-Benghazi_overall","Population-Based Random Survey for detection of COVID-19 Infection and Seroprevalence in Benghazi- Libya May/2020","2020-09-29","Local","Libya","Libya","2020-05-02","2020-05-07","Household and community samples","Multiple groups",600.0,0.0,"Stratified probability","Biotest","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Amal A Elfakhri","The Center of Infectious Diseases- Benghazi","https://preventive-medicine.imedpub.com/populationbased-random-survey-for-detection-of-covid19-infection-and-seroprevalence-in-benghazi-libya-may2020.pdf","Verified","","",0.817,0.967,"","LY",""
"2021-04-26","201117_Gangelt_UniversityofBonn_ v3_overall_TestAdj_IgG","Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany","2020-11-17","Local","Germany","Germany; Heinsberg; Gangelt","2020-03-31","2020-04-06","Household and community samples","Multiple groups",919.0,0.141,"Simplified probability","EUROIMMUN","IgG","Moderate","Journal Article (Peer-Reviewed)","Hendrik Streeck","University of Bonn","https://www.nature.com/articles/s41467-020-19509-y","Verified",0.112,0.173,0.909,0.991,"ELISA","DE","DE-NW"
"2021-04-26","20201231_Moscow_MoscowResearchInstituteofEpidemiologyAndMicrobiology_Overall","The structure of seroprevalence to the SARS-COV-2 virus among residents of the Moscow region during the period of epidemic incidence of COVID-19","2020-10-14","Regional","Russian Federation","Russian Federation; Central Russia; Moscow Region","2020-06-22","2020-07-11","Household and community samples","Multiple groups",2688.0,0.21,"Simplified probability","FBSI ""State scientific center for applied microbiology and biotechnology""","IgG","Unclear","Journal Article (Peer-Reviewed)","A Popova","Moscow Research Insistute of Epidemiology and Microbiology named after V.I G.N Gabrichevsky","http://dx.doi.org/10.20953/1729-9225-2020-4-17-26","Verified","","","","","","RU",""
"2021-04-27","200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 2","COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context","2020-09-28","Local","Brazil","Brazil; São Paulo state; Baixada Santista","2020-05-13","2020-05-15","Household and community samples","Multiple groups",2415.0,0.022,"Stratified probability","Wondfo","Total Antibody","High","Preprint","Arthur Chioro","Baixada Santista Metropolitan Region","https://preprints.scielo.org/index.php/scielo/preprint/view/1270","Verified","","","","","","BR","BR-SP"
"2021-04-27","201027_FernandoNoronha_UniversidadeFederaldoCeará","Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil","2020-10-27","Local","Brazil","Brazil; State of Pernambuco; Fernando de Noronha","2020-05-22","2020-05-31","Household and community samples","Multiple groups",904.0,0.043,"Simplified probability","Guangzhou Wondfo Biotech Co., Ltd.","IgG; IgM","Moderate","Preprint","Mozart Julio Tabosa Sales","Universidade Federal do Ceará","https://www.medrxiv.org/content/10.1101/2020.10.22.20216010v1.full-text","Verified",0.032,0.059,"","","","BR","BR-PE"
"2021-04-27","210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseIII","RÉSULTATS DE L'ÉTUDE - CORONA IMMUNITAS","2021-03-31","Regional","Switzerland","Switzerland; Canton of Neuchâtel","2020-12-23","2021-03-17","Household and community samples","Multiple groups",559.0,0.22,"Stratified probability","CHUV, the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Swiss Vaccine Center","IgG; IgA","Moderate","News and Media","Republique et Canton de Neuchatel","École suisse de santé publique","https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx","Verified",0.179,0.263,0.966,0.997,"","CH","CH-NE"
"2021-04-27","210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseII_overall","RÉSULTATS DE L'ÉTUDE - CORONA IMMUNITAS","2021-03-31","Regional","Switzerland","Switzerland; Canton of Neuchâtel","2020-08-21","2020-10-29","Household and community samples","Multiple groups",381.0,0.049,"Stratified probability","CHUV, the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Swiss Vaccine Center","IgG; IgA","Moderate","News and Media","Republique et Canton de Neuchatel","École suisse de santé publique","https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx","Verified",0.024,0.081,0.966,0.997,"","CH","CH-NE"
"2021-04-27","210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_IgG","Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran","2021-03-01","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); Tehran Province; Tehran","2020-04-04","2020-04-06","Multiple general populations","Multiple groups",2021.0,0.144,"Unclear","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Sahar Mortezagholi","Shahid Beheshti University Of Medical Sciences","https://dx.doi.org/10.22034/iji.2021.88168.1851","Unverified","","","","","","IR","IR-07"
"2021-04-27","210303_Jabalpur_NationalCentreForDiseaseControl_TestPopAdj","Cross-sectional Study on Sero-Prevalence of SARS-CoV-2 Infection in Jabalpur, Madhya Pradesh, India","2021-03-31","Local","India","India; Madya Pradesh; Jabalpur","2020-12-11","2020-12-21","Household and community samples","Multiple groups",9279.0,0.294,"Stratified probability","ICMR","IgG","Low","Journal Article (Peer-Reviewed)","Sudarshan Ramaswamy","National Centre for Disease Control","https://web.archive.org/web/20210410213821/http://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/536","Verified",0.284,0.304,0.924,0.979,"","IN","IN-MP"
"2021-04-29","200604_Goiania_CityOfGoiania_overall","Survey shows that 1% of the;   population has already had Covid-19 in Goiânia","2020-06-04","Local","Brazil","Brazil; Goiás; Goiania","2020-05-30","2020-05-30","Household and community samples","Multiple groups",2400.0,0.008,"Simplified probability","NR","Not reported","Unclear","News and Media","Mauro Junio","City of Goiania","https://www.goiania.go.gov.br/inquerito-aponta-que-1-das-pessoas-ja-tiveram-covid-19-em-goiania/","Verified","","","","","","BR","BR-GO"
"2021-04-29","210108_CapeVerde_MestreEmSaúdeEDesenvolvimento_overall","Sero-Epidemiological Survey and Profile of SARS-CoV-2 Infection in Cape Verde","2021-01-08","National","Cabo Verde","Cabo Verde","2020-06-26","2020-07-04","Household and community samples","Multiple groups",5348.0,0.004,"Stratified probability","Guangzhou Wondfo Biotech Co","IgG; IgM","Moderate","Preprint","Lara Ferrero Gomez","Mestre em Saúde e Desenvolvimento","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3762489","Verified","","",0.864,0.996,"","CV",""
"2021-04-30","200707_Jersey_StatisticsJersey_Round3_TestAdj_PopAdj","SARS-CoV-2: Prevalence of antibodies in Jersey Community Survey - Round 3","2020-07-07","National","Jersey","Jersey","2020-06-21","2020-06-27","Household and community samples","Multiple groups",1386.0,0.04,"Simplified probability","DNA World / CTK Biotech","IgG; IgM","Low","Institutional Report","Statistics Jersey","Statistics Jersey","https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200707%20SJ.pdf","Verified",0.028,0.052,0.9,0.994,"","JE",""
"2021-04-30","200828_CendeadeCizur_ISGlobal_primary","Coronavirus: New Seroprevalence Data for a Municipality in Navarra, Spain","2020-08-28","Local","Spain","Spain; Navarra; Cendea de Cizur","2020-06-01","2020-06-30","Household and community samples","Multiple groups",728.0,0.079,"Unclear","NR","IgA; IgG; IgM","Unclear","News and Media","Barcelona Institute for Global Health","ISGlobla","https://www.isglobal.org/en_GB/-/coronavirus-nuevos-datos-de-seroprevalencia-para-un-municipio-en-navarra","Verified","","","","","","ES","ES-NC"
"2021-04-30","201211_BadFeilnbach_RobertKochInstitute_primary","Corona monitoring locally - First key data for Bad Feilnbach","2020-12-11","Local","Germany","Germany","2020-06-23","2020-07-04","Household and community samples","Multiple groups",2152.0,0.091,"Simplified probability","NR","IgG","Moderate","News and Media","Robert Koch Institute","Robert Koch Institute","https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html","Verified","","",0.883,0.994,"","DE",""
"2021-04-30","210212_Hiroshima_HiroshimaUniversity_overall","About the result of the 2nd new coronavirus antibody prevalence survey","2021-02-12","Regional","Japan","Japan; Hiroshima Prefecture; Hiroshima, Fukuyama, Miyoshi, and Higashi-Hiroshima","2020-10-15","2020-11-15","Household and community samples","Multiple groups",2396.0,0.002,"Simplified probability","Roche","Not reported","High","Institutional Report","Prefecture of Hiroshima","Hiroshima University","https://www.chugoku-np.co.jp/local/news/article.php?comment_id=726622&comment_sub_id=0&category_id=256","Verified","","","","","","JP","JP-34"
"2021-04-30","210305_Illinois-Wisconsin_AdvocateAuroraHealth","Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System","2021-03-05","Regional","United States of America","United States of America; Illinois, Wisconsin (Midwest)","2020-06-08","2020-07-10","Health care workers and caregivers","Multiple groups",16233.0,0.038,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Veronica Fitzpatrick","Advocate Aurora Health","https://dx.doi.org/10.1177/0033354921999168","Unverified","","",0.987,0.992,"","US",""
"2021-04-30","210310_UnitedStatesofAmerica_EmoryUniversity","Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel","2021-03-10","Regional","United States of America","United States of America; Georgia, Maryland, Illinois; Atlanta, Baltimore, Chicago","2020-04-19","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",24749.0,0.044,"Convenience","Abbott, author-made, Euroimmun, Ortho Clinical","IgG","Moderate","Journal Article (Peer-Reviewed)","Jesse Jacob","Emory University","https://dx.doi.org/10.1001/jamanetworkopen.2021.1283","Unverified",0.041,0.046,"","","","US",""
"2021-04-30","210331_Naples_IstitutoNazionaleTumori_CancerPatients","Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis","2021-03-31","Local","Italy","Italy","2020-03-30","2020-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",885.0,0.054,"Convenience","Lepu Medical Technology – Beijing – Co., Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Isgro","Istituto Nazionale Tumori","https://dx.doi.org/10.1186/s12967-021-02798-2","Verified","","","","","","IT",""
"2021-04-30","210331_Naples_IstitutoNazionaleTumori_HCWs","Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis","2021-03-31","Local","Italy","Italy","2020-03-30","2020-05-15","Health care workers and caregivers","Multiple groups",1050.0,0.046,"Convenience","Lepu Medical Technology – Beijing – Co., Ltd","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Isgro","Istituto Nazionale Tumori","https://dx.doi.org/10.1186/s12967-021-02798-2","Verified",0.033,0.059,"","","","IT",""
"2021-05-02","200923_Ecuador_UniversidadCatólicaDelEcuador_Patients","Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Ecuadorian Population","2020-09-23","National","Ecuador","Ecuador","2020-05-12","2020-07-20","Household and community samples","Multiple groups",11540.0,0.19,"Self-referral","NovaTec Inmundiagnostica GmbH","IgG","High","Journal Article (Peer-Reviewed)","Camilo Zurita Salinas","Universidad Católica Del Ecuador","https://www.researchgate.net/publication/344477310_SEROPREVALENCE_OF_ANTI-SARS-COV-2_IGG_ANTIBODIES_IN_ECUADORIAN_POPULATION","Verified","","","","","","EC",""
"2021-05-02","201023_Khartoum_FederalMinistryofHealthSudan","Sudan FETP Conducts Targeted Testing for COVID-19 in Khartoum State","2020-10-23","Regional","Sudan","Sudan; Khartoum","2020-05-22","2020-07-05","Household and community samples","Multiple groups",967.0,0.183,"Unclear","NR","Not reported","Unclear","News and Media","William McCollum","Federal Ministry of Health (MOH) in Sudan","https://www.tephinet.org/sudan-fetp-conducts-targeted-testing-for-covid-19-in-khartoum-state","Verified","","","","","","SD","SD-KH"
"2021-05-02","201220_Afghanistan_UnitedStatesAirForce","Using serosurveillance for SARS-CoV-2 to conserve PCR tests in a resource constrained combat environment","2020-12-31","Local","Afghanistan","Afghanistan; NR; NR","2020-04-17","2020-06-01","Essential non-healthcare workers","Adults (18-64 years)",1957.0,0.019,"Unclear","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Brian White","United States Air Force","http://dx.doi.org/10.1093/ofid/ofaa439.666","Verified","","","","","","AF",""
"2021-05-02","210225_Florida_FloridaDepartmentOfHealth_overall","SARS-COV-2 ANTIBODY PREVALENCE AMONG HEALTHCARE WORKERS AND FIRST RESPONDERS, FLORIDA, MAY-JUNE 2020","2021-04-12","Regional","United States of America","United States of America; Florida","2020-05-06","2020-06-03","Health care workers and caregivers","Multiple groups",5776.0,0.041,"Convenience","Cellex Inc","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","James Matthias","Florida Department of Health","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040388/","Verified",0.026,0.082,0.938,0.96,"","US","US-FL"
"2021-05-02","210302_Dresden_TechnischeUniversitätDresden","Lower Household Transmission Rates of SARS-CoV-2 from Children Compared to Adults - Results from the FamilyCoviDD19-Study","2021-03-02","Local","Germany","Germany; Saxony; Dresden","2020-06-15","2021-01-15","Contacts of COVID patients","Multiple groups",248.0,0.343,"Sequential","Diasorin ; Abbott; Euroimmun","IgG","High","Preprint","Lukas Galow","Technische Universität Dresden","10.2139/ssrn.3790443","Unverified","","","","","","DE","DE-SN"
"2021-05-02","210330_Zambia_ZambiaMinistryofHealth_HCW","Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020","2021-03-30","National","Zambia","Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi, Pooled","2020-07-02","2020-07-31","Health care workers and caregivers","Multiple groups",575.0,0.022,"Stratified non-probability","PerkinElmer, Waltham, Massachusetts","IgG","Moderate","Journal Article (Peer-Reviewed)","Sombo Fwoloshi","Zambia Ministry of Health","https://dx.doi.org/10.1093/cid/ciab273","Unverified",0.005,0.039,0.9,1.0,"","ZM",""
"2021-05-02","210331_SchleswigHolstein_RuhrUniversityBochum_HCW","Half Year Longitudinal Seroprevalence of SARS-CoV-2-antibodies and Rule Compliance in German Hospital Employees","2021-03-31","Local","Germany","Germany; Schleswig-Holstein","2020-04-14","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",268.0,0.008,"Convenience","Euroimmun, Abbott, DiaSorin","IgG","High","Preprint","Jonas Herzberg","Ruhr University Bochum","https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1","Unverified","","","","","","DE","DE-SH"
"2021-05-02","210401_Warsaw_Children’sMemorialHealthInstitute_HCW","Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland","2021-04-01","Local","Poland","Poland","2020-07-01","2020-08-09","Health care workers and caregivers","Adults (18-64 years)",1879.0,0.008,"Convenience","Abbot","IgG","Moderate","Journal Article (Peer-Reviewed)","Beata Kasztelewicz","Children’s Memorial Health Institute","https://dx.doi.org/10.1371/journal.pone.0249550","Unverified","","",0.99,1.0,"","PL",""
"2021-05-02","210402_Italy_FondazioneIstitutoStomatologicoItaliano_DentalStaff","SARS-CoV-2 Infection among the Dental Staff from Lombardy Region, Italy","2021-04-02","National","Italy","Italy; Como, Lecco, Monza-Brianza, Sondrio, Varese, Bergamo, Brescia  Cremona, Lodi, Mantova, Pavia, Milan","2020-05-28","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",499.0,0.108,"Convenience","KHB, Shanghai, China","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Silvano Gallus","Fondazione Istituto Stomatologico Italiano","http://dx.doi.org/10.3390/ijerph18073711","Unverified","","",0.951,0.993,"","IT",""
"2021-05-02","210405_California_StanfordUniversitySchoolofMedicine_overall","SARS-CoV-2 IgG Seropositivity and Acute Asymptomatic Infection Rate Among Firefighter First Responders in an Early Outbreak County in California","2021-05-06","Local","United States of America","United States of America; California","2020-06-15","2020-08-15","Essential non-healthcare workers","Adults (18-64 years)",983.0,0.025,"Convenience","Abbott Architect","IgG","Moderate","Journal Article (Peer-Reviewed)","Jennifer Newberry","Stanford University","http://dx.doi.org/10.1080/10903127.2021.1912227","Verified",0.016,0.037,"","","","US","US-CA"
"2021-05-02","210412_Stockholm_KarolinskaInstitutet_hcw","SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden","2021-04-12","Local","Sweden","Sweden; Södermanland and Uppland; Stockholm","2020-05-11","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",403.0,0.201,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","S Hassan","Karolinska Institutet","https://dx.doi.org/10.1111/joim.13274","Verified","","",0.992,0.998,"","SE","SE-AB"
"2021-05-02","211231_Denver_DenverPublicHealth","SARS-Cov-2 RNA and antibodies among people experiencing homelessness and staying in shelters or outdoor encampments in Denver, Colorado, May-July 2020","2020-12-20","Local","United States of America","United States of America; Colorado; Denver","2020-06-02","2020-07-28","Persons experiencing homelessness","Adults (18-64 years)",334.0,0.167,"Convenience","NR","Not reported","Unclear","Journal Article (Peer-Reviewed)","David McCormick","Denver Public Health","http://dx.doi.org/10.1093/ofid/ofaa515.1909","Verified","","","","","","US","US-CO"
"2021-05-03","200527_RioGrandeDoSul_FederalUniversityOfPelotas_overall","Fourth stage of research shows;   stability in the total number of coronavirus","2020-05-27","Regional","Brazil","Brazil; Rio Grande do Sul","2020-05-23","2020-05-25","Household and community samples","Multiple groups",4500.0,0.002,"Unclear","NR","Not reported","Unclear","News and Media","Governo do Estato do Rio Grande do Sul","Governo do Estato do Rio Grande do Sul","https://estado.rs.gov.br/quarta-etapa-de-pesquisa-aponta-estabilidade-no-total-de-infectados-por-coronavirus-no-rs","Verified",0.001,0.003,"","","","BR","BR-RS"
"2021-05-03","200629_Goiania_CityOfGoiania_overall","Research shows that 31,838,000;   people have already been infected with COVID-19 in Goiânia","2020-06-29","Local","Brazil","Brazil; Goiás; Goiania","2020-06-10","2020-06-10","Household and community samples","Multiple groups",2628.0,0.021,"Simplified probability","NR","Not reported","Unclear","News and Media","City of Goiania","Municipal Health Department of the City of Goiania","https://www.goiania.go.gov.br/pesquisa-aponta-que-31-838-mil-pessoas-ja-foram-infectadas-por-covid-19-em-goiania/","Verified","","","","","","BR","BR-GO"
"2021-05-03","210317_Sweden_TheSwedishPublicHealthAgency_BloodDonors_overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2)","2021-03-17","National","Sweden","Sweden; Regions of: Jämtland-Härjedalen, Jönköping, Kalmar,; Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro","2020-11-23","2020-12-04","Blood donors","Multiple groups",3183.0,0.07,"Convenience","Sci Life Lab / KTH","Not reported","Unclear","Institutional Report","Swedish Public Health Agency","The Swedish Public Health Agency (Folkhälsomyndigheten)","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf","Verified",0.058,0.085,0.994,0.989,"","SE",""
"2021-05-03","210415_NewYork_NewYorkUniversity_hcw","Seroepidemiology among Employees of New York City Health and Hospitals during the First Wave of the SARS-CoV-2 Epidemic","2021-04-15","Local","United States of America","United States of America; New York ; New York","2020-04-30","2020-06-30","Health care workers and caregivers","Multiple groups",727.0,0.294,"Convenience","NR","Not reported","High","Preprint","Alexander Bryan","New York University","https://www.medrxiv.org/content/10.1101/2021.04.12.21255344v1","Verified","","","","","","US","US-NY"
"2021-05-04","201204_SantaClara_O’ConnorHospital_Overall","Effectiveness of an infection prevention strategy to limit exposure of high-risk patients to COVID-19 in a hospital-based subacute unit: a descriptive report","2020-12-04","Local","United States of America","United States of America; California; San Jose","2020-05-06","2020-05-06","Patients seeking care for non-COVID-19 reasons","Multiple groups",24.0,0.0,"Convenience","Poway, CA, USA","IgG; IgM","High","Journal Article (Peer-Reviewed)","Brian D McBeth","O'Connor Hospital","https://dx.doi.org/10.1177/1757177420976814","Unverified","","","","","","US","US-CA"
"2021-05-05","200501_SanMiguelCounty_UnitedBiomedical_overall","San Miguel County, CO IgG Antibody Tests","2020-05-01","Local","United States of America","United States of America; Colorado","2020-03-26","2020-04-15","Household and community samples","Multiple groups",5283.0,0.005,"Entire sample","NR","IgG","Moderate","Institutional Report","San Miguel County","United Biomedical Group","https://www.sanmiguelcountyco.gov/DocumentCenter/View/5717/San-Miguel-County-IgG-Antibody-Test-Statistics-and-Demographics-PDF","Verified","","","","","","US","US-CO"
"2021-05-05","200626_BomJesus_InstitutoPiaunienseDeOpiniaoPubilca_overall","Pesquisa Sobre Status Sorológico da População Quanto a Infecção por SARS‐COV‐2 em Situação de Pandemia","2020-06-26","Local","Brazil","Brazil; Piauí; Bom Jesus","2020-06-24","2020-06-26","Household and community samples","Multiple groups",200.0,0.08,"Simplified probability","NR","IgG; IgM","High","Institutional Report","Instituto Piauniense de Opiniao Publica","Instituto Piauniense de Opinião Pública","https://portalpontox.com/wp-content/uploads/2020/06/PESQUISA-BOM-JESUS-COVID-24a26-06.2020.pdf","Verified","","","","","","BR","BR-PI"
"2021-05-05","200831_KingCounty_UniversityOfWashington_overall","King County, Washington Anti-SARS-CoV-2 Seroprevalence Survey, August 2020","2020-08-31","Local","United States of America","United States of America; Washington","2020-08-08","2020-08-29","Household and community samples","Multiple groups",1364.0,0.039,"Stratified probability","1) Bio-Rad 2) EuroImmun","IgG; IgM; IgA","Moderate","Institutional Report","Karen Cowgill","University of Washington","https://www.kingcounty.gov/depts/health/covid-19/data/~/media/depts/health/communicable-diseases/documents/C19/serosurvey-report-covid19.ashx https://kingcounty.gov/depts/health/covid-19/seroprevalence.aspx https://www.kingcounty.gov/depts/health/covid-19/seroprevalence-study.aspx page 9: http://www.co.cowlitz.wa.us/DocumentCenter/View/20793/8122020-Cowlitz-County-COVID-update-to-Board-of-County-Commissioners","Verified",0.024,0.06,0.829,1.0,"","US","US-WA"
"2021-05-05","201231_SanDiego_UniversityofCaliforniaSanDiegoHealth_HCW","Asymptomatic healthcare worker COVID-19 testing program","2020-12-31","Local","United States of America","United States of America; California; San Diego","2020-04-22","2020-06-02","Health care workers and caregivers","Adults (18-64 years)",5589.0,0.01,"Convenience","Diazyme Laboratories","IgG","High","Journal Article (Peer-Reviewed)","Lucy E Horton","University of California San Diego Health","http://dx.doi.org/10.1093/ofid/ofaa439.630","Verified","","","","","","US","US-CA"
"2021-05-05","201231_WestVirginia_WestVirginiaUniversityMedicine_HCW","Serum IgG antibody testing against severe acute respiratory syndrome coronavirus 2 in healthcare workers","2020-12-31","Local","United States of America","United States of America; West Virginia; Morgantown","2020-05-26","2020-06-05","Health care workers and caregivers","Adults (18-64 years)",1042.0,0.009,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Joy J Juskowich","West Virginia University Medicine","http://dx.doi.org/10.1093/ofid/ofaa439.694","Verified","","","","","","US","US-WV"
"2021-05-05","210101_MurmanskRegion_StPetersburgPasteurInstitute_Overall","Humoral immunity to SARS-CoV-2 in the population of the Murmansk region against the background of the incidence of COVID-19","2021-01-01","Regional","Russian Federation","Russian Federation; Murmansk Region","2020-08-03","2020-08-11","Household and community samples","Multiple groups",3117.0,0.312,"Stratified probability","FBSI State Scientific Center Applied Microbiology and Biotechnology","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St. Petersburg Pasteur Institute","https://hiv.bmoc-spb.ru/jour/article/view/605#","Verified",0.304,0.32,"","","","RU","RU-MUR"
"2021-05-05","210320_Japan_NationalCenterForGlobalHealthAndMedicine","Evaluation of serum antibodies against SARSâ€CoVâ€2 in healthcare workers who participated in the operation of charter flights for the evacuation of Japanese residents from Hubei Province","2021-03-20","National","Japan","Japan","2020-02-14","2020-03-13","Health care workers and caregivers","Adults (18-64 years)",10.0,0.0,"Convenience","NR","Not reported","High","Preprint","Tetsuya Suzuki","National Center for Global Health and Medicine","10.1101/https://www.medrxiv.org/content/10.1101/2021.03.17.21251964v1","Unverified","","","","","","JP",""
"2021-05-06","200812_Cajamar_MunicipalSecretariatOfCajamar_overall","Department of Health releases;   balance sheet of active search for antibodies to Sars-Cov-2","2020-08-12","Local","Brazil","Brazil; São Paulo; Municipality of Cajamar","2020-07-21","2020-07-27","Household and community samples","Multiple groups",1015.0,0.04,"Convenience","Not reported","Not reported","High","News and Media","Municipal Secretariat of Cajamar","Municipal Secretariat of Cajamar","https://cajamar.sp.gov.br/noticias/2020/08/12/secretaria-de-saude-divulga-balanco-da-pesquisa-de-busca-ativa-de-anticorpos-para-sars-cov-2/","Verified","","","","","","BR","BR-SP"
"2021-05-06","200831_Mumbai_NITI-Aayog_HCW","SARS-CoV2 Serological Survey in Mumbai by NITI-BMC-TIFR: Preliminary Report of Round-2","2020-08-31","Local","India","India","2020-08-16","2020-08-29","Health care workers and caregivers","Adults (18-64 years)",728.0,0.273,"Unclear","Abbott","IgG","Unclear","Institutional Report","Ullas Kolthur Seetharam","NITI-Aayog","https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf","Verified",0.241,0.306,0.93,1.0,"","IN",""
"2021-05-06","200831_Mumbai_NITI-Aayog_Non-Slum_overall","SARS-CoV2 Serological Survey in Mumbai by NITI-BMC-TIFR: Preliminary Report of Round-2","2020-08-31","Local","India","India","2020-08-16","2020-08-29","Household and community samples","Multiple groups",2176.0,0.175,"Stratified probability","Abbott","IgG","Low","Institutional Report","Ullas Kolthur Seetharam","NITI-Aayog","https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf","Verified",0.159,0.191,0.93,1.0,"","IN",""
"2021-05-06","200831_Mumbai_NITI-Aayog_Slums_overall","SARS-CoV2 Serological Survey in Mumbai by NITI-BMC-TIFR: Preliminary Report of Round-2","2020-08-31","Local","India","India","2020-08-16","2020-08-29","Persons living in slums","Multiple groups",3024.0,0.449,"Stratified probability","Abbott","IgG","Low","Institutional Report","Ullas Kolthur Seetharam","NITI-Aayog","https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf","Verified",0.432,0.467,0.93,1.0,"","IN",""
"2021-05-06","201231_LosAngeles_UniversityofCaliforniaLosAngeles","Lack of SARS-CoV-2 antibody seroconversion after prompt identification and cohorting of sentinel SARS-CoV-2-positive residents in a skilled nursing facility","2020-12-31","Local","United States of America","United States of America; California; Los Angeles","2020-06-01","2020-06-15","Assisted living and long-term care facilities","Adults (18-64 years)",121.0,0.016,"Convenience","DiaSorin","IgG","High","Presentation or Conference","Debika Bhattacharya","University of California Los Angeles","https://academic.oup.com/ofid/article/7/Supplement_1/S165/6058251","Unverified","","","","","","US","US-CA"
"2021-05-06","210415_France_InstitutPasteur_HighSchool1_overall","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France","France; Hauts-de-France","2020-03-30","2020-04-04","Students and Daycares","Multiple groups",664.0,0.251,"Convenience","Institut Pasteur","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","","",0.994,0.99,"","FR","FR-HDF"
"2021-05-06","210415_France_InstitutPasteur_PrimarySchool2_overall","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France","France; Hauts-de-France","2020-04-28","2020-04-30","Students and Daycares","Multiple groups",1340.0,0.104,"Convenience","Institut Pasteur","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","","",0.994,0.99,"","FR","FR-HDF"
"2021-05-07","210408_Germany_BundeswehrInstituteofMicrobiology_overall","Sars-cov-2 seroprevalence among health care workers-a voluntary screening study in a regional medical center in southern germany","2021-04-08","Local","Germany","Germany","2020-04-02","2020-04-08","Health care workers and caregivers","Adults (18-64 years)",198.0,0.035,"Convenience","Euroimmun","IgG; IgA","High","Journal Article (Peer-Reviewed)","Katharina Muller","Bundeswehr Institute of Microbiology","http://dx.doi.org/10.3390/ijerph18083910","Verified","","","","","","DE",""
"2021-05-08","201231_Charleston_MedicalUniversityofSouthCarolina","Point-of-care, in-home SARS-CoV-2 IgG antibody testing to assess seroprevalence in at-risk health care workers","2020-12-31","Local","United States of America","United States of America; South Carolina ; Charleston","2020-04-14","2020-05-06","Health care workers and caregivers","Adults (18-64 years)",439.0,0.014,"Convenience","RayBiotech","IgG","High","Presentation or Conference","Eric G Meissner","Medical University of South Carolina","http://dx.doi.org/10.1093/ofid/ofaa439.653","Unverified","","",0.76,0.95,"","US","US-SC"
"2021-05-09","210312_UnitedStatesOlympicandParalympicTrainingfacilities_MassachusettsGeneralHospital","Resumption of Sport at the United States Olympic and Paralympic Training Facilities During the COVID-19 Pandemic","2021-03-12","National","United States of America","United States of America; Colorado; Colorado Springs","2020-07-01","2020-07-31","Non-essential workers and unemployed persons","Adults (18-64 years)",301.0,0.036,"Convenience","Not reported","Not reported","Unclear","Journal Article (Peer-Reviewed)","Ankit B Shah","Massachusetts General Hospital","https://dx.doi.org/10.1177/19417381211002761","Unverified","","","","","","US","US-CO"
"2021-05-10","20210226_Zurich_UniversityofZurich_carehomeworkers","Zurich studies on the seroprevalence of home and home staff as well as on the immune response and long-term consequences in those who tested positive for corona","2021-02-26","Regional","Switzerland","Switzerland; Canton of Zurich","2020-09-09","2020-10-23","Health care workers and caregivers","Adults (18-64 years)",296.0,0.149,"Convenience","NR","Not reported","Unclear","Institutional Report","Canton Zurich","University of Zurich","https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html","Unverified","","","","","","CH","CH-ZH"
"2021-05-10","20210226_Zurich_UniversityofZurich_spitexworkers","Zurich studies on the seroprevalence of home and home staff as well as on the immune response and long-term consequences in those who tested positive for corona","2021-02-26","Regional","Switzerland","Switzerland; Canton of Zurich","2020-09-09","2020-10-23","Health care workers and caregivers","Adults (18-64 years)",131.0,0.038,"Convenience","NR","Not reported","Unclear","Institutional Report","Canton Zurich","University of Zurich","https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html","Unverified","","","","","","CH","CH-ZH"
"2021-05-10","210208_Paris_JeanVerdierHospital_DaycareStaff2_Overall_TestAdj","SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study","2021-02-08","National","France","France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","2020-06-04","2020-07-03","Essential non-healthcare workers","Adults (18-64 years)",197.0,0.068,"Convenience","Biosynex","IgM; IgG","High","Journal Article (Peer-Reviewed)","Eric Lachassinne","Jean Verdier Hospital","https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext","Verified",0.032,0.115,0.918,0.992,"","FR",""
"2021-05-10","210208_Paris_JeanVerdierHospital_HCW3_Overall_TestAdj","SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study","2021-02-08","National","France","France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","2020-06-04","2020-07-03","Health care workers and caregivers","Adults (18-64 years)",164.0,0.05,"Unclear","Biosynex","IgM; IgG","High","Journal Article (Peer-Reviewed)","Eric Lachassinne","Jean Verdier Hospital","https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext","Verified",0.016,0.098,0.918,0.992,"","FR",""
"2021-05-10","210309_HarrisCounty_HarrisCountyPublicHealth_genpop","Harris County Public Health announces initial results of COVID-19 antibody project","2021-03-09","Local","United States of America","United States of America; Texas","2020-11-15","2020-12-15","Household and community samples","Multiple groups",646.0,0.16,"Simplified probability","NR","Not reported","Unclear","News and Media","Harris County Public Health","Harris County Public Health","https://publichealth.harriscountytx.gov/Portals/27/Documents/HCPH%20Antibody%20Results%20NR.pdf?ver=ZkoB5qeX0P1G--8gfGH8fg%3d%3d","Verified","","","","","","US","US-TX"
"2021-05-10","210311_Egypt_CenterofScientificExcellenceforInfluenzaViruses_October3","Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort.","2021-03-11","National","Egypt","Egypt; Sharkiyah Governorate, Gharbiyah Governorate, Kafr El Sheikh Governorate, Qalyubiyah Governorate, Fayyoum Governorate","2020-10-01","2020-10-31","Household and community samples","Multiple groups",1260.0,0.348,"Simplified probability","N/A - Author Designed","Neutralizing","Unclear","Journal Article (Peer-Reviewed)","Mokhtar R Gomaa","Center of Scientific Excellence for Influenza Viruses","https://dx.doi.org/10.1371/journal.ppat.1009413","Verified","","","","","","EG",""
"2021-05-10","210316_Netherlands_SanquinResearch_blooddonors","Low awareness of past SARS-CoV-2 infection in healthy plasma donors","2021-03-16","National","Netherlands","Netherlands","2020-05-11","2020-05-18","Blood donors","Multiple groups",3676.0,0.065,"Entire sample","Wantai Biological Pharmacy Enterprise Co.","Not reported","Moderate","Journal Article (Peer-Reviewed)","Katj van den HUrk","Sanquin Research","https://dx.doi.org/10.1016/j.xcrm.2021.100222","Verified","","",0.987,0.996,"","NL",""
"2021-05-10","210427_Germany_HelmholtzCentreForInfectionResearch","SARS-CoV-2 Seroprevalence in Germany - A Population Based Sequential Study in Five Regions","2021-04-27","National","Germany","Germany","2020-07-15","2020-12-15","Household and community samples","Multiple groups",13405.0,0.02,"Stratified probability","Euroimmun","IgG","Moderate","Preprint","Daniela Gornyk","Helmholtz Centre for Infection Research","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3834300","Verified","","","","","","DE",""
"2021-05-11","200831_Limeira_LimeriaCityHall_overall","Study suggests that almost;   36,000 residents of Limeira had covid-19","2020-08-31","Local","Brazil","Brazil; São Paulo; Limeira","2020-08-24","2020-08-29","Household and community samples","Multiple groups",1291.0,0.146,"Simplified probability","NR","IgG; IgM","High","News and Media","Redacao Educadora","Limeira City Hall","https://elimeira.com.br/noticias/limeira/estudo-sugere-que-quase-36-mil-moradores-de-limeira-tiveram-covid-19/","Verified",0.119,0.173,"","","","BR","BR-SP"
"2021-05-11","210308_Berlin_UniversitatmedizinBerlin","Sars-cov-2 infection, risk perception, behaviour and preventive measures at schools in berlin, germany, during the early post-lockdown phase: A cross-sectional study","2021-03-08","Local","Germany","Germany","2020-06-11","2020-06-19","Multiple populations","Multiple groups",527.0,0.013,"Stratified non-probability","Euroimmun AG","IgG","High","Journal Article (Peer-Reviewed)","Franziska Hommes","Universitatmedizin Berlin","http://dx.doi.org/10.3390/ijerph18052739","Unverified","","","","","","DE",""
"2021-05-11","210312_Lima_InstitutoNacionalDeSalud_Overall","Household transmission of SARS-CoV-2 (COVID-19) in Lima, Peru","2021-03-12","Local","Peru","Peru","2020-04-23","2020-05-02","Contacts of COVID patients","Multiple groups",236.0,0.53,"Stratified non-probability","Core Technology Co., Beijing, China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yolanda Angulo Bazan","Instituto Nacional de Salud","https://dx.doi.org/10.1590/0102-311X00238720","Verified","","",0.976,1.0,"","PE",""
"2021-05-12","210320_GardenaValley_HospitalOfBolzano_PopAdj_TestAdj","Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley","2021-03-20","Local","Italy","Italy","2020-05-26","2020-06-08","Household and community samples","Multiple groups",2106.0,0.269,"Stratified probability","Abbott","IgG","Low","Preprint","Roberto Melotti","Hospital of Bolzano","10.1101/2021.03.19.21253883","Verified",0.252,0.286,0.969,0.999,"","IT",""
"2021-05-13","200803_Italy_InstitutoNazionaleDiStatistica_overall","FIRST RESULTS OF THE SEROPREVALENCE SURVEY ON SARS-CoV-2","2020-08-03","National","Italy","Italy","2020-05-25","2020-07-15","Household and community samples","Multiple groups",64660.0,0.025,"Stratified probability","NR","IgG","Moderate","Institutional Report","Instituto Nazionale di Statistica","The Institute for National Statistics","https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf","Verified",0.023,0.026,"","","","IT",""
"2021-05-13","201216_Utsunomiya_TokyoMedicalandDentalUniversity_PopAdj","Seroprevalence of SARS‐CoV‐2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020","2020-12-16","Local","Japan","Japan; Tochigi Prefecture; Utsunomiya City","2020-06-14","2020-07-05","Household and community samples","Multiple groups",742.0,0.012,"Simplified probability","Shenzhen YHLO Biotech Co","IgG","Low","Journal Article (Peer-Reviewed)","Nobutoshi Nawa","Tokyo Medical and Dental University","https://onlinelibrary.wiley.com/doi/full/10.1002/jgf2.408","Verified",0.002,0.023,0.973,0.963,"","JP","JP-09"
"2021-05-13","210118_Lithuania_210118_Lithuania_LithuanianUniversityofHealthSciences_TestAdj","SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey","2021-01-18","National","Lithuania","Lithuania; Vilnius County, Kaunas county, Klaipėda County, Tauragė County, Utena county; ; Vilnius, Kaunas, Klaipėda","2020-08-10","2020-09-10","Household and community samples","Multiple groups",3089.0,0.014,"Simplified probability","AMP Diagnostics","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Kastytis Smigelskas","Lithuanian University of Health Sciences","https://www.journals.vu.lt/AML/article/view/22344","Verified",0.009,0.02,0.92,0.994,"","LT",""
"2021-05-13","210210_Joinville_CityHallofJoinville_PopAdj","Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil","2021-02-10","Local","Brazil","Brazil; Santa Catarina; Joinville","2020-06-15","2020-08-07","Household and community samples","Multiple groups",4403.0,0.048,"Stratified probability","Celer","IgG; IgM","Moderate","Preprint","Henrique Diegoli","City Hall of Joinville","https://www.medrxiv.org/content/10.1101/2021.02.08.21251009v1.full","Verified","","",0.864,0.996,"","BR","BR-SC"
"2021-05-13","210315_FukuokaCity_KanenokumaHospital_Residents","Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan","2021-03-15","Local","Japan","Japan","2020-04-23","2020-06-15","Assisted living and long-term care facilities","Seniors (65+ years)",76.0,0.079,"Convenience","Abbott","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yong Chong","Kanenokuma Hospital","https://dx.doi.org/10.1186/s12879-021-05972-5","Verified","","","","","","JP",""
"2021-05-13","210315_FukuokaCity_KanenokumaHospital_Staff","Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan","2021-03-15","Local","Japan","Japan","2020-04-23","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",40.0,0.0,"Convenience","Abbott","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yong Chong","Kanenokuma Hospital","https://dx.doi.org/10.1186/s12879-021-05972-5","Verified","","","","","","JP",""
"2021-05-13","210322_England_PublicHealthEnglandColindale_Overall","Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers","2021-03-22","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London, Wythenshawe, Porton","2020-03-23","2020-11-18","Multiple populations","Adults (18-64 years)",2246.0,0.118,"Convenience","Euroimmun; Roche; Abbott; Author-designed","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Robert Harris","Public Health England Colindale","https://dx.doi.org/10.1016/j.jinf.2021.03.015","Unverified","","","","","","GB","GB-ENG"
"2021-05-13","210405_Japan_SOUSEIKAI_Overall","Sars-cov-2 seroprevalence among healthcare workers in general hospitals and clinics in Japan","2021-04-05","Local","Japan","Japan; Fukuoka, Kumamoto, Tokyo","2020-08-15","2020-10-15","Health care workers and caregivers","Multiple groups",2160.0,0.017,"Convenience","INNOVITA Biological Technol-ogy Co., Ltd., Tangshan, China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Tatsuya Yoshihara","SOUSEIKAI Medical Group","http://dx.doi.org/10.3390/ijerph18073786","Verified","","",0.873,1.0,"","JP",""
"2021-05-13","210427_Bhubaneswar_IndianCouncilOfMedicalResearch_overall","Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from 3 rounds of community surveys","2021-04-27","Local","India","India; Odisha; Bhubaneswar","2020-09-01","2020-09-30","Household and community samples","Multiple groups",1403.0,0.49,"Stratified probability","Roche","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","Indian Council of Medical Research","https://www.cambridge.org/core/journals/epidemiology-and-infection/article/seroprevalence-of-sarscov2-in-bhubaneswar-india-findings-from-3-rounds-of-community-surveys/29A7905F297A1EFA68749AC3C6383300","Verified",0.464,0.517,"","","","IN","IN-OR"
"2021-05-13","211006_Goiânia_MunicipalityofGoiâniaHealthDepartment","Population Survey helps identify areas of higher concentration of Covid-19","2020-10-06","Local","Brazil","Brazil; Goiás","2020-09-19","2020-09-19","Household and community samples","Multiple groups",2436.0,0.14,"Unclear","Nr","IgG","High","News and Media","Prefeitura De Goiania","Health Department of the Municipality of Goiânia","https://www.goiania.go.gov.br/inquerito-populacional-ajuda-identificar-areas-de-maior-concentracao-da-covid-19/","Verified","","","","","","BR","BR-GO"
"2021-05-14","201011_Assam_Srijanasom_overall","Assam’s sero-survey found 23.7;   per cent Seroprevalence in the state","2020-10-11","Regional","India","India; Assam","2020-08-23","2020-09-26","Household and community samples","Multiple groups",2390.0,0.237,"Unclear","NR","IgG","Unclear","News and Media","Bikash Singh","Srijanasom","https://economictimes.indiatimes.com/news/politics-and-nation/assams-sero-survey-found-23-7-per-cent-seroprevalence-in-the-state/articleshow/78606153.cms","Verified","","","","","","IN","IN-AS"
"2021-05-14","210302_Athens_NationalandKapodistrianUniversityofAthens_PopTestAdj","Sars-cov-2 infection is asymptomatic in nearly half of adults with robust anti-spike protein receptor-binding domain antibody response","2021-03-02","Local","Greece","Greece; Attica; Athens","2020-06-15","2020-11-15","Non-essential workers and unemployed persons","Multiple groups",4996.0,0.016,"Simplified probability","Roche Diagnostics","IgG; IgA; IgM","Low","Journal Article (Peer-Reviewed)","Ourania Tsitsilonis","National and Kapodistrian University of Athens","http://dx.doi.org/10.3390/vaccines9030207","Verified",0.009,0.025,1.0,0.998,"","GR","GR-I"
"2021-05-14","210315_Thuringia_ThuringiaClinic_COVIDStaff_overall","Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and ""Covid-19"" wards.","2021-03-15","Local","Germany","Germany; Thuringia; Saalfeld/Saale","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",18.0,0.056,"Convenience","EUROIMMUN™","IgG","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000382","Verified","","","",0.985,"","DE","DE-TH"
"2021-05-14","210315_Thuringia_ThuringiaClinic_ICU_Overall","Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and ""Covid-19"" wards.","2021-03-15","Local","Germany","Germany; Thuringia; Saalfeld/Saale","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",50.0,0.0,"Convenience","EUROIMMUN™","IgG; IgA","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000382","Verified","","","","","","DE","DE-TH"
"2021-05-14","210320_Cogne_UniversitàDiTorino_genpop_overall","The effects of physical distancing and lockdown to restrain SARS-CoV-2 outbreak in the Italian Municipality of Cogne","2021-03-20","Local","Italy","Italy; Valle D'Aosta; Cogne","2020-06-04","2020-06-05","Household and community samples","Multiple groups",857.0,0.034,"Entire sample","YHLO","IgG; IgM","Low","Preprint","F Truc","Università di Torino","https://www.medrxiv.org/content/10.1101/2021.03.19.21253962v1.full-text","Verified","","","","","","IT","IT-23"
"2021-05-14","210331_Poznań_PolishAcademyofSciences_Primary","Prevalence of anti-SARS-CoV-2 antibodies in Poznan Poland, after the first wave of the COVID-19 pandemic","2021-03-31","Local","Poland","Poland; Greater Poland; Poznań","2020-07-15","2020-09-15","Household and community samples","Multiple groups",1500.0,0.009,"Simplified probability","EuroImmun; Polycheck","IgG","Moderate","Preprint","Dagny Lorent","Polish Academy of Sciences","https://www.medrxiv.org/content/10.1101/2021.03.29.21254544v1.full","Verified",0.006,0.016,"","","","PL","PL-30"
"2021-05-14","210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_Households_TestAdj.","Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study","2021-04-24","Regional","United Arab Emirates","United Arab Emirates; Emirate of Abu Dhabi; Abu Dhabi, Al Ain, Al Dhafra","2020-07-19","2020-08-14","Household and community samples","Multiple groups",8831.0,0.104,"Stratified probability","Roche Diagnostics USA- Roche Elecsys® Anti-SARS-CoV-2 assay; Diasorin-LIAISON® SARS-CoV-2 S1/S2 IgG assay","IgG","Low","Journal Article (Peer-Reviewed)","Ahmed R Alsuwaidi","Abu Dhabi Public Health Center","https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207","Unverified",0.095,0.114,0.974,0.985,"","AE","AE-AZ"
"2021-05-14","210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_LabourCamps_TestAdj.","Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study","2021-04-24","Regional","United Arab Emirates","United Arab Emirates; Emirate of Abu Dhabi; Abu Dhabi, Al Ain, Al Dhafra","2020-07-19","2020-08-14","Essential non-healthcare workers","Multiple groups",4855.0,0.686,"Stratified probability","Roche Diagnostics USA- Roche Elecsys® Anti-SARS-CoV-2 assay; Diasorin-LIAISON® SARS-CoV-2 S1/S2 IgG assay","IgG","Moderate","Journal Article (Peer-Reviewed)","Ahmed R Alsuwaidi","Abu Dhabi Public Health Center","https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207","Unverified",0.617,0.747,0.974,0.985,"","AE","AE-AZ"
"2021-05-14","210429_Munich_GermanResearchCenterForEnvironmentalHealth_overall_popadj_testadj","From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)","2021-04-29","Local","Germany","Germany","2020-11-02","2021-01-31","Household and community samples","Multiple groups",4433.0,0.036,"Simplified probability","Roche","Not reported","Low","Preprint","Katja Radon","German Research Center for Environmental Health","https://www.medrxiv.org/content/10.1101/2021.04.27.21256133v1","Verified",0.029,0.043,0.992,0.987,"","DE",""
"2021-05-16","201215_Straubing_RobertKochInstitut_ELISA_poptestadj","Corona monitoring locally -;   Key data for Straubing","2020-12-15","Local","Germany","Germany; Bavaria; Straubing","2020-09-08","2020-09-26","Household and community samples","Multiple groups",2361.0,0.017,"Simplified probability","Euroimmun","IgG","Moderate","News and Media","Robert Koch Institute","Robert Koch Institute","https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html","Verified","","",0.883,0.994,"","DE","DE-BY"
"2021-05-16","210324_Morioka_IwatePrefecturalCentralHospital_hcw","Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020","2021-03-24","Local","Japan","Japan; Tonoku; Morioka","2020-05-18","2020-05-19","Health care workers and caregivers","Adults (18-64 years)",1404.0,0.0,"Convenience","Abbott Laboratories, Abbott Park; Roche Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Akihiro Nakamura","Iwate Prefectural Central Hospital","https://onlinelibrary.wiley.com/doi/10.1002/jmv.26962","Verified","","","","","","JP",""
"2021-05-17","200814_Pakistan_GetzPharma_Overall","Sero-prevalence findings from metropoles in Pakistan: implications for assessing COVID-19 prevalence and case-fatality within a dense, urban working population","2020-08-14","Regional","Pakistan","Pakistan; NR; Karachi, Lahore, Multan, Peshawar and Quetta","","2020-07-06","Household and community samples","Adults (18-64 years)",24210.0,0.175,"Simplified probability","Getz Pharma (inferred)","IgG; IgM","Moderate","Preprint","Wajiha Javed","Getz Pharma","https://www.medrxiv.org/content/10.1101/2020.08.13.20173914v1","Verified","","","","","","PK",""
"2021-05-17","201210_MatoGrosso_StateUniversityOfMatoGrosso","Unemat coordinates study on;   health conditions of MT population during pandemic","2020-12-20","Regional","Brazil","Brazil; Mato Grosso; Água Boa, Alta Floresta, Barra do Garças, Cáceres, Cuiabá, Juína, Rondonópolis, Sinop, Tangará da Serra and Várzea Grande","2020-09-16","2020-10-15","Household and community samples","Multiple groups",4206.0,0.125,"Simplified probability","NR","IgG","High","News and Media","Lygia Lima","State University of Mato Gross","http://www.mt.gov.br/-/16042707-unemat-coordena-estudo-sobre-condicoes-de-saude-da-populacao-de-mt-durante-pandemia","Unverified","","","","","","BR","BR-MT"
"2021-05-17","201221_London_PublicHealthEngland_overall_unadj","Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation.","2020-12-21","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-05-05","2020-05-05","Multiple populations","Adults (18-64 years)",193.0,0.13,"Convenience","NA - in house","IgG","High","Journal Article (Peer-Reviewed)","Hannah Taylor","Public Health England","https://dx.doi.org/10.1016/j.lanepe.2020.100015","Verified","","","","","","GB",""
"2021-05-17","201225_Seattle_UniversityofWashington_GenPop_ELISA+Neutralizaion","SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing","2020-12-25","Local","United States of America","United States of America; Washington; Seattle","2020-03-26","2020-04-15","Household and community samples","Multiple groups",100.0,0.04,"Simplified probability","In-House (University of Washington) and Abbott","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Jennifer Rathe","University of Washington","http://dx.doi.org/10.1093/infdis/jiaa797","Verified","","","","","","US","US-WA"
"2021-05-17","210122_BuenosAires_GovernmentOfTheProvinceOfBuenosAires","ONLY 13 PERCENT OF THE;   NEIGHBOURS OF 30 PEOPLE'S NEIGHBOURHOODS OF THE AMBA HAD CORONAVIRUS","2021-01-22","Local","Argentina","Argentina; Buenos Aires; Metropolitan Area of Buenos Aires","2020-07-15","2020-12-15","Household and community samples","Multiple groups",9000.0,0.13,"Unclear","NR","Not reported","High","News and Media","Government of the Province of Buenos Aires","Government of the Province of Buenos Aires","https://www.gba.gob.ar/saludprovincia/noticias/s%C3%B3lo_el_13_por_ciento_de_los_vecinos_y_vecinas_de_30_barrios_populares_del","Unverified","","","","","","AR","AR-B"
"2021-05-17","210220_Dresden_DresdenUniversityOfTechnology_December","SARS-CoV-2 transmissions in students and teachers: Seroprevalence follow-up study in a German secondary school in November and December 2020","2021-03-24","Local","Germany","Germany; Saxony; Dresden","2020-12-10","2020-12-11","Students and Daycares","Multiple groups",237.0,0.068,"Convenience","DiaSorin; Abbott; Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Jakob Armann","Dresden University of Technology","http://dx.doi.org/10.1136/bmjpo-2021-001036","Unverified",0.038,0.101,"","","","DE","DE-SN"
"2021-05-17","210301_Uzbekistan_ResearchInstituteofVirology","FORMATION of HERD IMMUNITY to SARS-CoV-2 in the REGIONS of UZBEKISTAN","2021-03-01","National","Uzbekistan","Uzbekistan","2020-08-27","2020-09-11","Residual sera","Multiple groups",86879.0,0.231,"Convenience","Wantai","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","R A Rakhimov","Research Institute of Virology","https://ejmcm.com/article_9453.html","Unverified",0.23,0.232,"","","","UZ",""
"2021-05-17","210310_Ankara_HacettepeUniversity_Overall","SARS-CoV-2;   Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data;   From A University Hospital in Turkey","2021-03-10","Local","Turkey","Turkey; Central Anatolia; Ankara","2020-03-24","2020-09-10","Health care workers and caregivers","Adults (18-64 years)",774.0,0.074,"Unclear","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Adem Ozdemir","Hacettepe University","http://www.mikrobiyolbul.org/linkout.aspx?pmid=33882653","Verified","","","","","","TR",""
"2021-05-17","210317_Bavaria_LudwigMaximiliansUniversityMunich_Overall","[Pandemic management in a psychiatric care hospital : SARS-CoV-2 antibody tests as a tool for risk estimation].","2021-03-17","Local","Germany","Germany; Bavaria; Wasserburg","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",1342.0,0.088,"Convenience","Roche GmbH","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","M Rentrop","Ludwig Maximilians University Munich","https://dx.doi.org/10.1007/s00115-021-01101-4","Verified","","",1.0,0.998,"","DE","DE-BY"
"2021-05-17","210317_Bolzano_HospitalofBolzano","Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.","2021-03-17","Local","Italy","Italy; Trentino-Alto Adige/Südtirol; Bolzano","2020-10-29","2020-12-28","Residual sera","Multiple groups",3033.0,0.345,"Sequential","Roche Diagnostics","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Thomas Mueller","Hospital of Bolzano","https://dx.doi.org/10.1016/j.cca.2021.03.007","Verified","","","","","","IT","IT-32"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase1East_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan","Pakistan; Karachi; District East","2020-04-15","2020-04-25","Household and community samples","Multiple groups",500.0,0.004,"Simplified probability","Roche Diagnostics","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified",0.0,0.013,1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase1Malir_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan","Pakistan; Karachi; District Malir","2020-04-15","2020-04-25","Household and community samples","Multiple groups",500.0,0.002,"Simplified probability","Roche Diagnostics","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified",0.0,0.007,1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase2East_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan","Pakistan; Karachi; District East","2020-06-25","2020-07-11","Household and community samples","Multiple groups",500.0,0.151,"Simplified probability","Roche Diagnostics","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified",0.094,0.217,1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase2Malir_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan","Pakistan; Karachi; District Malir","2020-06-25","2020-07-11","Household and community samples","Multiple groups",504.0,0.087,"Simplified probability","Roche Diagnostics","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified",0.051,0.131,1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase3East_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan","Pakistan; Karachi; District East","2020-08-17","2020-08-22","Household and community samples","Multiple groups",500.0,0.215,"Simplified probability","Roche Diagnostics","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified",0.156,0.28,1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase3Malir_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan","Pakistan; Karachi; District Malir","2020-08-17","2020-08-22","Household and community samples","Multiple groups",501.0,0.128,"Simplified probability","Roche Diagnostics","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified",0.083,0.177,1.0,0.998,"","PK","PK-SD"
"2021-05-17","210331_Bergen_UniversityOfBergen_overall_unadj","Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study.","2021-03-31","Local","Norway","Norway","2020-02-28","2020-04-04","Contacts of COVID patients","Multiple groups",179.0,0.45,"Convenience","N/A - in house","IgG","Moderate","Journal Article (Peer-Reviewed)","Kanika Kuwelker","University of Bergen","https://dx.doi.org/10.1016/j.lanepe.2020.100014","Verified",0.38,0.53,"","","","NO",""
"2021-05-17","210404_Vienna_MedicalUniversityofVienna_Overall_2months","A longitudinal seroprevalence study evaluating infection control and prevention strategies at a large tertiary care center with low covid-19 incidence","2021-04-15","Local","Austria","Austria; Vienna; Vienna","2020-04-01","2020-06-01","Health care workers and caregivers","Adults (18-64 years)",553.0,0.015,"Convenience","Abott Architect i2000","IgG","High","Journal Article (Peer-Reviewed)","Lorenz Schubert","Medical University of Vienna","http://dx.doi.org/10.3390/ijerph18084201","Verified","","","","","","AT","AT-9"
"2021-05-17","210422_RioGrandeDoSul_SantaCasaDeMisericordiaDePortoAlegre_police","COVID-19 seroprevalence in military police force, Southern Brazil","2021-04-22","Regional","Brazil","Brazil; Rio Grande do Sul State; Porto Alegre, Caxias do Sul, Canoas, Pelotas, Santa Maria, Passo Fundo, Uruguaiana, Santa Cruz do Sul, Ijui, and Lajeado","2020-07-23","2020-07-25","Essential non-healthcare workers","Adults (18-64 years)",1592.0,0.033,"Stratified probability","EUROIMMUN®","IgG; IgA","Moderate","Journal Article (Peer-Reviewed)","Alessandro Pasqualotto","Molecular Biology Laboratory at Santa Casa de Misericordia de Porto Alegre","https://dx.doi.org/10.1371/journal.pone.0249672","Verified","","","","","","BR","BR-RS"
"2021-05-17","210424_SouthKorea_KoreaAssociationofHealthPromotion_Primary","Nationwide;   seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in;   South Korea: a cross-sectional study","2021-04-24","National","Republic of Korea","Republic of Korea; N/A; Seoul (Dongbu), Chuncheon, Chungju, Daegu (Dong-gu), Daegu (Buk-gu), Ulsan, Busan, Changwon, Kwangju, Jeonju, Daejeon, Suwon, Seoul (Kangnam), Incheon, Seoul (Seobu), Jeju","2020-09-24","2020-12-09","Residual sera","Multiple groups",4085.0,0.004,"Stratified probability","Roche Elecsys, Mannheim, Germany","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Eun Hee Nah","Korea Association of Health Promotion","https://bmjopen.bmj.com/content/11/4/e049837.abstract","Unverified",0.002,0.006,0.995,0.998,"","KR",""
"2021-05-17","210426_Portugal_DepartmentofEpidemiologyandInfectiousDiseasesoftheNationalInstitutesofHealth","The second national serological survey showed that 15.5% of the Portuguese population has antibodies against SARS-CoV-2","2021-04-26","National","Portugal","Portugal","2021-02-02","2021-03-31","Household and community samples","Multiple groups",8463.0,0.155,"Convenience","Unclear","IgG; IgM","Unclear","News and Media","Pedro Simas","Department of Epidemiology and Infectious Diseases of the National Institutes of Health (INSA)","https://newsline.news/the-second-national-serological-survey-showed-that-15-5-of-the-portuguese-population-has-antibodies-against-sars-cov-2/","Verified","","","","","","PT",""
"2021-05-17","210427_NewYorkCity_AlbertEinsteinCollegeofMedicine","COVID‐19 in heart transplant recipients—A seroprevalence survey","2021-04-27","Local","United States of America","United States of America; New York state; New York City","2020-06-01","2020-08-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",232.0,0.134,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Snehal R Patel","Albert Einstein College of Medicine","https://onlinelibrary.wiley.com/doi/10.1111/ctr.14329","Unverified","","","","","","US","US-NY"
"2021-05-17","210428_ChungbukProvince_ChungbukNationalUniversity_NonEpicenter_OverallAdj","Differences;   in seroprevalence between epicenter and non-epicenter areas of the COVID-19;   outbreak in South Korea","2021-04-28","Local","Republic of Korea","Republic of Korea; Chungbuk Province","2020-05-01","2020-07-17","Residual sera","Multiple groups",3981.0,0.009,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hye Won Jeong","Chungbuk National University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/","Verified",0.007,0.011,0.995,1.0,"","KR","KR-43"
"2021-05-17","210428_DaeguCity_ChungbukNationalUniversity_Epicenter_OverallAdj","Differences;   in seroprevalence between epicenter and non-epicenter areas of the COVID-19;   outbreak in South Korea","2021-04-28","Local","Republic of Korea","Republic of Korea; North Gyeongsang Province; Daegu","2020-05-01","2020-07-17","Residual sera","Multiple groups",3268.0,0.013,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hye Won Jeong","Chungbuk National University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/","Verified",0.01,0.015,0.995,1.0,"","KR","KR-47"
"2021-05-18","200808_Lima_NationalMaternalPerinatalInstitute_overall","SARS-COVID-19 antibodies in pregnant women at a level III hospital in Peru","2020-08-08","Local","Peru","Peru; Lima Province; Lima","2020-04-15","2020-05-15","Pregnant or parturient women","Adults (18-64 years)",2419.0,0.07,"Sequential","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Enrique Guevara Rios","National Maternal Perinatal; Institut","http://www.scielo.org.pe/scielo.php?pid=S2304-51322020000300002&script=sci_abstract&tlng=en","Verified",0.061,0.081,0.976,0.988,"","PE","PE-LMA"
"2021-05-18","201007_Turin_UniversityofTurin_primary","Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients","2021-04-01","Local","Italy","Italy","2020-02-22","2020-05-21","Pregnant or parturient women","Adults (18-64 years)",225.0,0.093,"Convenience","Boditech, DiaSorin","IgG; IgM","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","http://dx.doi.org/10.1016/j.ajog.2020.10.005","Verified","","","","","","IT",""
"2021-05-18","201021_RepublicOfTartarstan_SaintPetersburgPasteurInstitute_overall","Distribution of SARS-CоV-2 seroprevalence among residents of the Republic of Tatarstan during the COVID-19 epidemic period","2020-10-21","Regional","Russian Federation","Russian Federation; Republic of Tartarstan","2020-09-20","2020-09-27","Household and community samples","Multiple groups",2946.0,0.313,"Simplified probability","FBSI ""State National Research Center for Applied Microbiology; gii and biotechnology ""Rospotrebnadzor.","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Yu Popova","Saint Petersburg Pasteur Institute","https://microbiol.elpub.ru/jour/article/view/940?locale=en_US","Verified","","","","","","RU","RU-TA"
"2021-05-18","210104_Louisville_UniversityOfLouisville","COVID-19 rates continue to;   increase, with highest rates among 18-34-year-olds","2021-01-04","Regional","United States of America","United States of America; Kentucky; Louisville","2020-12-10","2020-12-14","Household and community samples","Multiple groups",700.0,0.112,"Simplified probability","NR","Not reported","Unclear","News and Media","Betty Coffman","University of Louisville","https://www.uoflnews.com/post/uofltoday/covid-19-rates-continue-to-increase-with-highest-rates-among-18-34-year-olds/","Unverified","","","","","","US","US-KY"
"2021-05-18","210203_Ticino_UniversitàdellaSvizzeraitaliana_primary","Corona Immunitas Ticino: together to react - here are the results of the  second phase of serological tests","2021-02-03","Regional","Italy","Switzerland; Ticino","2020-11-01","2021-01-13","Household and community samples","Multiple groups",1463.0,0.16,"Simplified probability","NR","Not reported","Unclear","News and Media","Institute of Public Health of the Universita della Svizzera italiana","Università della Svizzera italiana","https://www.biomed.usi.ch/it/feeds/9035","Verified","","","","","","CH","CH-TI"
"2021-05-18","210217_Berlin-Mitte_RobertKochInstit_ELISA_testadj_popadj","Corona monitoring locally -;   Key data for Berlin-Mitte","2021-02-17","Local","Germany","Germany; Berlin; Berlin-Mitte","2020-11-17","2020-12-05","Household and community samples","Multiple groups",2287.0,0.044,"Simplified probability","Euroimmun","IgG","Moderate","News and Media","Robert Koch Institut","Robert Koch Institut","https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html","Verified","","","","","","DE","DE-BE"
"2021-05-18","210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_firstwave_primary","Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.","2021-04-01","Local","Spain","Spain","2020-03-15","2020-06-30","Residual sera","Multiple groups",968.0,0.126,"Sequential","N/A","Not reported","Moderate","Journal Article (Peer-Reviewed)","Vicente Soriano","UNIR Health Sciences School and Medical Centre","https://dx.doi.org/10.1016/j.ijid.2021.02.115","Verified","","","","","","ES",""
"2021-05-18","210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_secondwave_primary","Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.","2021-04-01","Local","Spain","Spain","2020-09-15","2020-12-24","Residual sera","Multiple groups",601.0,0.077,"Sequential","N/A","Not reported","Moderate","Journal Article (Peer-Reviewed)","Vicente Soriano","UNIR Health Sciences School and Medical Centre","https://dx.doi.org/10.1016/j.ijid.2021.02.115","Verified","","","","","","ES",""
"2021-05-18","210312_Venice_TheVenetoEyeBankFoundation","Corneal transplantation during the COVID-19 pandemic: An operational guide.","2021-03-27","Local","Italy","Italy; Veneto region; Venice","2020-03-15","2020-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",30.0,0.033,"Sequential","Snibe","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonella Franch","The Veneto Eye Bank Foundation","https://dx.doi.org/10.1177/11206721211006565","Verified","","","","","","IT","IT-34"
"2021-05-18","210315_NewMexico_DiaSorinInc_overall_unadj","Evaluation of the automated LIAISON SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies","2021-03-15","Regional","United States of America","United States of America; New Mexico","2020-09-01","2020-09-30","Residual sera","Multiple groups",1931.0,0.02,"Sequential","1) DiaSorin; 2) Beckman","IgG","High","Journal Article (Peer-Reviewed)","Fabrizio Bonelli","Dia Sorin Inc","http://dx.doi.org/10.1515/cclm-2021-0023","Verified","","","","","","US","US-NM"
"2021-05-18","210315_NewYork_DiaSorinInc_overall_unadj","Evaluation of the automated LIAISON SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies","2021-03-15","Regional","United States of America","United States of America; New York","2020-09-01","2020-09-30","Residual sera","Multiple groups",1491.0,0.244,"Sequential","1) DiaSorin; 2) Siemens","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Fabrizio Bonelli","Dia Sorin Inc","http://dx.doi.org/10.1515/cclm-2021-0023","Verified","","","","","","US","US-NY"
"2021-05-18","210317_SilesianVoivodeship_JanKochanowskiUniversity","Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?.","2021-03-17","Regional","Poland","Poland; Silesian Voivodeship","2020-05-15","2020-06-15","Non-essential workers and unemployed persons","Adults (18-64 years)",516.0,0.019,"Convenience","Vazyme","IgG; IgM","High","Journal Article (Peer-Reviewed)","Rafal Krygier","Jan Kochanowski University","https://dx.doi.org/10.13075/ijomeh.1896.01756","Verified","","","","","","PL","PL-24"
"2021-05-18","210326_Norway_ArcticUniversityOfNorway_PopAdj_TestAdj","Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period","2021-03-26","National","Norway","Norway","2020-11-25","2021-02-15","Household and community samples","Multiple groups",27700.0,0.009,"Stratified probability","Euroimmun","IgG","Low","Preprint","Erik Anda","Arctic University of Norway","https://www.medrxiv.org/content/10.1101/2021.03.23.21253730v1","Verified",0.007,0.01,"","","","NO",""
"2021-05-18","210401_Colorado_AnschutzMedicalCampus_primary","Development and validation of a multiplex microsphere immunoassay using dried blood spots for SARS-CoV-2 seroprevalence: application in first responders in Colorado, USA.","2021-04-01","Local","United States of America","United States of America; Colorado; Aurora","2020-07-01","2020-08-31","Essential non-healthcare workers","Adults (18-64 years)",264.0,0.042,"Convenience","N/A -Author designed","IgG","High","Journal Article (Peer-Reviewed)","Jonathan S Schultz","Anschutz Medical Campus","https://dx.doi.org/10.1128/JCM.00290-21","Verified","","","","","","US","US-CO"
"2021-05-18","210415_Belgium_UniversiteCatholiquedeLouvain_T4_overall","A longitudinal, 3-month serologic assessment of sars-cov-2 infections in a belgian hemodialysis facility","2021-04-15","Local","Belgium","Belgium; Brussels; Brussels","2020-07-07","2020-07-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",96.0,0.083,"Convenience","Roche Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Laura Labriola","University Catholique de Louvain","http://dx.doi.org/10.2215/CJN.12490720","Verified","","","","","","BE","BE-BRU"
"2021-05-18","210429_SanFrancisco_UniversityOfCaliforniaSanFrancisco_HIV1_TestAdj","SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","2021-04-29","Local","United States of America","United States of America; California; San Francisco","2020-08-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",955.0,0.037,"Sequential","ET HealthCare","IgG","High","Journal Article (Peer-Reviewed)","Matthew A Spinelli","University of California San Francisco","https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00072-2/fulltext","Unverified",0.024,0.05,0.89,1.0,"","US","US-CA"
"2021-05-18","210502_SergipeState_FederalUniversityofSergipe","Seroprevalence;   of SARS-CoV-2 antibodies in broadcast media workers","2021-05-02","Regional","Brazil","Brazil; Sergipe; N/A","2020-12-01","2020-12-20","Essential non-healthcare workers","Adults (18-64 years)",113.0,0.247,"Convenience","NR","IgG; IgM","High","Preprint","Paulo Ricardo Martins Filho","Federal University of Sergipe, Aracaju","https://www.medrxiv.org/content/10.1101/2021.04.29.21256360v1","Unverified",0.177,0.335,"","","","BR","BR-SE"
"2021-05-18","210506_EastJava_KobeUniversity","Seroepidemiological;   study of SARS-CoV-2 infection in East Java, Indonesia","2021-05-06","Regional","Indonesia","Indonesia; East Java; Surabaya, Jombang","2020-06-15","2020-12-15","Household and community samples","Multiple groups",1819.0,0.114,"Convenience","Nanjing Vazyme Medical Technology","IgG","Moderate","Journal Article (Peer-Reviewed)","Ni Luh Ayu Megasari","Kobe University","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251234","Verified","","",0.915,0.97,"","ID","ID-JI"
"2021-05-19","200801_Afghanistan_AfghanistanMinistryofPublicHealth","Prevalence of COVID-19 and its Related Deaths in Afghanistan: A Nationwide, Population-Based Seroepidemiological Study July 202","2020-08-01","National","Afghanistan","Afghanistan; NR; NR","2020-06-01","2020-06-15","Household and community samples","Multiple groups",9514.0,0.315,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Sayed Ataullah Saeedzai","Afghanistan Ministry of Public Health","https://moph.gov.af/sites/default/files/2020-08/Final%20COVID-19%20Survey%20English%20Report.pdf","Verified","","","","","","AF",""
"2021-05-19","201228_Moscow_SaintPetersburgPasteurInstitute_primary","Collective immunity to SARS-COV-2 of moscow residents during the COVID-19 epidemic period","2021-04-06","Local","Russian Federation","Russian Federation","2020-07-01","2020-07-30","Household and community samples","Multiple groups",2688.0,0.221,"Simplified probability","FBIS SRCAMB","IgG","Moderate","Journal Article (Peer-Reviewed)","Popova A Yu","Saint-Petersburg Pasteur Institute","http://dx.doi.org/10.20953/1729-9225-2020-4-8-16","Verified","","","","","","RU",""
"2021-05-19","210315_SanFranciscoBayArea_StanfordUniversity_overall_unadj","Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results.","2021-03-15","Local","United States of America","United States of America; California","2020-08-03","2020-08-15","Residual sera","Multiple groups",1080.0,0.107,"Convenience","1) Abbott; 2) EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","Hannah Wang","Stanford University","https://dx.doi.org/10.1093/clinchem/hvab045","Verified","","","","","","US","US-CA"
"2021-05-19","210320_Ahmedabad_AMCMETMedicalCollege_Overall","Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases.","2021-03-20","Local","India","India; Gujarat; Ahmedabad","2020-08-17","2020-08-31","Contacts of COVID patients","Multiple groups",3973.0,0.319,"Stratified non-probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","AMC MET Medical College","https://pubmed.ncbi.nlm.nih.gov/33753682/","Verified",0.305,0.334,0.924,0.979,"","IN","IN-GJ"
"2021-05-19","210330_NorthCarolina_UniversityOfNorthCarolina_Cohort1_PopTestAdj","Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period","2021-03-30","Regional","United States of America","United States of America; North Carolina","2020-04-19","2020-06-13","Residual sera","Multiple groups",3463.0,0.029,"Convenience","Author designed","IgG","Moderate","Preprint","Cesar Lopez","University of North Carolina","https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2","Verified",0.017,0.043,0.98,1.0,"","US","US-NC"
"2021-05-19","210330_NorthCarolina_UniversityOfNorthCarolina_Cohort2_PopTestAdj","Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period","2021-03-30","Regional","United States of America","United States of America; North Carolina","2020-06-14","2020-08-08","Residual sera","Multiple groups",3528.0,0.088,"Convenience","Author designed","IgG","Moderate","Preprint","Cesar Lopez","University of North Carolina","https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2","Verified",0.071,0.106,0.98,1.0,"","US","US-NC"
"2021-05-19","210330_NorthCarolina_UniversityOfNorthCarolina_Cohort3_PopTestAdj","Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period","2021-03-30","Regional","United States of America","United States of America; North Carolina","2020-08-09","2020-10-03","Residual sera","Multiple groups",2633.0,0.091,"Convenience","Author designed","IgG","Moderate","Preprint","Cesar Lopez","University of North Carolina","https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2","Verified",0.072,0.111,0.98,1.0,"","US","US-NC"
"2021-05-19","210401_Denmark_SlagelseSygehus_blooddonors_primary","Prevalence of SARS-CoV-2-Antibodies in Danish Children and Adults","2021-04-01","Regional","Denmark","Denmark; Capital Region and Region Zealand","2020-06-22","2020-07-03","Blood donors","Adults (18-64 years)",750.0,0.02,"Simplified probability","Zhuhai, Guangdon, China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maren J H Rytter","Slagelse Sygehus","http://dx.doi.org/10.1097/INF.0000000000003048","Verified",0.011,0.033,0.93,0.98,"","DK","DK-84"
"2021-05-19","210401_Denmark_SlagelseSygehus_children_primary","Prevalence of SARS-CoV-2-Antibodies in Danish Children and Adults","2021-04-01","Regional","Denmark","Denmark; Capital Region and Region Zealand","2020-06-22","2020-07-03","Residual sera","Children and Youth (0-17 years)",1033.0,0.016,"Convenience","Zhuhai, Guangdon, China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maren J H Rytter","Slagelse Sygehus","http://dx.doi.org/10.1097/INF.0000000000003048","Verified",0.01,0.026,0.93,0.98,"","DK","DK-84"
"2021-05-19","210401_Srinagar_GovernmentMedicalCollegeSrinagar_Primary","Seroprevalence of SARS CoV 2 specific Ig G antibodies in District Srinagar, Kashmir: a population based study","2021-04-01","Local","India","India; Kashmir; Srinagar","2020-10-17","2020-10-20","Household and community samples","Multiple groups",2418.0,0.406,"Stratified probability","Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Taha Ayub","Government Medical College Srinagar","https://www.ijcmph.com/index.php/ijcmph/article/view/7827","Verified",0.387,0.426,1.0,0.996,"","IN","IN-JK"
"2021-05-19","210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_firstwave_primary","A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave.","2021-04-02","Regional","Germany","Germany; Bavaria","2020-01-15","2020-08-15","Household and community samples","Children and Youth (0-17 years)",15523.0,0.007,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Markus Hippich","German Research Center for Environmental Health","https://dx.doi.org/10.1016/j.medj.2021.03.019","Verified",0.006,0.008,"","","","DE","DE-BY"
"2021-05-19","210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_secondwave_primary","A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave.","2021-04-02","Regional","Germany","Germany; Bavaria","2020-09-15","2021-02-15","Household and community samples","Children and Youth (0-17 years)",11380.0,0.039,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Markus Hippich","German Research Center for Environmental Health","https://dx.doi.org/10.1016/j.medj.2021.03.019","Verified",0.036,0.043,"","","","DE","DE-BY"
"2021-05-19","210403_Mainz_JohannesGutenbergUniversity_overall_unadj","Covid-19-importance for patients on the waiting list and after kidney transplantation-a single center evaluation in 2020-2021","2021-04-03","Local","Germany","Germany; Rhineland-Palatinate; Mainz","2020-01-01","2021-02-28","Patients seeking care for non-COVID-19 reasons","Multiple groups",248.0,0.052,"Convenience","Abbott","IgG; IgM","High","Journal Article (Peer-Reviewed)","Simone C Boedecker","Johannes Gutenberg University","http://dx.doi.org/10.3390/pathogens10040429","Verified","","","","","","DE","DE-RP"
"2021-05-19","210404_Tirschenreuth_ FriedrichAlexanderUniversity_primary","Estimates and determinants of SARS-CoV-2 seroprevalence and infection fatality ratio using latent class analysis: the population-based Tirschenreuth study in the hardest-hit German county in spring 2020","2021-04-04","Local","Germany","Germany; Bavaria","2020-06-28","2020-07-10","Household and community samples","Multiple groups",4201.0,0.086,"Simplified probability","Shenzhen Yhlo Biotech Co , Roche Diagnostics","IgG","Moderate","Preprint","Ralf Wagner","Friedrich-Alexander University","https://www.medrxiv.org/content/10.1101/2021.03.29.21254343v1","Verified","","","","","","DE","DE-BY"
"2021-05-19","210406_Lambayeque_UniversidadParticulardeChiclayo_PopTestAdj","SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020","2021-04-06","Regional","Peru","Peru; Lambayeque Province","2020-06-24","2020-07-10","Household and community samples","Multiple groups",2010.0,0.295,"Stratified probability","Core Technology","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Cristian Diaz Velez","Universidad Particular de Chiclayo","https://dx.doi.org/10.7717/peerj.11210","Verified",0.276,0.315,0.66,0.97,"","PE","PE-LAM"
"2021-05-19","210408_Taiwan_NationalChengKungUniversityHospital_overall","A seroprevalence study of COVID-19 at a campus in southern Taiwan","2021-04-08","National","China","China; Taiwan","2020-08-15","2020-09-13","Residual sera","Adults (18-64 years)",969.0,0.0,"Convenience","Roche Diagnostics Basel, Switzerland","Total Antibody","High","Journal Article (Peer-Reviewed)","Ming Chi Li","National Cheng Kung University Hospital","https://dx.doi.org/10.1016/j.jmii.2021.03.018","Unverified","","","","","","CN",""
"2021-05-19","210412_ValMesolcina_UniversitàdellaSvizzeraItaliana_HCW","SARS-CoV-2 Ig G among Healthcare Workers and the General Population.","2021-04-12","Local","Switzerland","Switzerland; Grisons; NR","2020-05-15","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",289.0,0.159,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Gregorio Milani","Università della Svizzera Italiana","https://dx.doi.org/10.3390/pathogens10040465","Verified","","","","","","CH","CH-GR"
"2021-05-19","210412_ValMesolcina_UniversitàdellaSvizzeraItaliana__Genpop","SARS-CoV-2 Ig G among Healthcare Workers and the General Population.","2021-04-12","Local","Switzerland","Switzerland; Grisons; NR","2020-05-15","2020-05-31","Household and community samples","Multiple groups",423.0,0.026,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Gregorio Milani","Università della Svizzera Italiana","https://dx.doi.org/10.3390/pathogens10040465","Verified","","","","","","CH","CH-GR"
"2021-05-19","210413_Melbourne_EasternHealth_OverallHCW","SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia.","2021-08-01","Local","Australia","Australia; Victoria; Melbourne","2020-11-09","2020-12-04","Health care workers and caregivers","Multiple groups",736.0,0.022,"Convenience","Roche Diagnostics; NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jillian SY Lau","Eastern Health","https://dx.doi.org/10.1016/j.idh.2021.03.004","Verified","","","","","","AU","AU-VIC"
"2021-05-19","210413_NewOrleans_OchsnerClinicFoundation_HospitalStaff","The Surgeon’s Risk of SARS-CoV-2 Infection During the Initial Peak of the COVID-19 Pandemic in New Orleans","2021-04-13","Local","United States of America","United States of America; Louisiana; New Orleans","2020-04-22","2020-05-01","Health care workers and caregivers","Adults (18-64 years)",13343.0,0.08,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Tung Vu","Ochsner Clinic Foundation","https://journals.sagepub.com/doi/10.1177/00031348211011090","Unverified",0.075,0.085,"","","","US","US-LA"
"2021-05-19","210413_NewOrleans_OchsnerClinicFoundation_Surgeons","The Surgeon’s Risk of SARS-CoV-2 Infection During the Initial Peak of the COVID-19 Pandemic in New Orleans","2021-04-13","Local","United States of America","United States of America; Louisiana; New Orleans","2020-03-01","2020-04-22","Health care workers and caregivers","Adults (18-64 years)",105.0,0.019,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Tung Vu","Ochsner Clinic Foundation","https://journals.sagepub.com/doi/10.1177/00031348211011090","Unverified",0.002,0.067,"","","","US","US-LA"
"2021-05-19","210413_Tabriz_TabrizUniversityOfMedicalSciences_overall_unadj_IgG_anti-S","Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation.","2021-04-13","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of)","2020-04-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",609.0,0.061,"Unclear","N/A - institution designed","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mohammad Sadegh Soltani Zangbar","Tabriz University of Medical Sciences","https://dx.doi.org/10.1016/j.genrep.2021.101140","Verified","","",0.938,0.98,"","IR",""
"2021-05-19","210415_Mexico_InstitutodeSaludparaelBienestar_Overall","SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020.","2021-04-15","National","Mexico","Mexico; NR; NR","2020-02-10","2020-12-31","Residual sera","Multiple groups",24273.0,0.159,"Stratified non-probability","DiaSorin; Genscript","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Jose Munoz-Medina","Instituto de Salud para el Bienestar","https://dx.doi.org/10.3390/microorganisms9040850","Verified","","","","","","MX",""
"2021-05-19","210419_Lublin_MedicalUniversityofLublin_HealthyControls","Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study.","2021-04-19","Local","Poland","Poland; Lublin Voivodeship; Lublin","2020-06-01","2020-09-30","Household and community samples","Children and Youth (0-17 years)",32.0,0.063,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Violetta Opoka Winiarska","Medical University of Lublin","https://dx.doi.org/10.3390/jcm10081771","Verified","","","",0.919,"","PL","PL-06"
"2021-05-19","210419_Lublin_MedicalUniversityofLublin_JIA","Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study.","2021-04-19","Local","Poland","Poland; Lublin Voivodeship; Lublin","2020-06-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",62.0,0.048,"Sequential","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Violetta Opoka Winiarska","Medical University of Lublin","https://dx.doi.org/10.3390/jcm10081771","Verified","","","",0.919,"","PL","PL-06"
"2021-05-19","210419_Philadelphia_UniversityofPennsylvania","Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity","2021-04-19","Local","United States of America","United States of America; Pennsylvania; ; Philadelphia","2020-04-13","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",2043.0,0.02,"Convenience","In-House (University of Pennsylvania)","IgG; IgM","Moderate","Preprint","Sigrid Gouma","University of Pennsylvania","https://www.medrxiv.org/content/10.1101/2021.04.12.21255324v1.full-text","Unverified","","","","","","US","US-PA"
"2021-05-19","210419_Sergipe_UniversidadeFederalDeSergipe_Stage1_overall_unadj","Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Resultados da Terceira Fase: 18 de fevereiro a 30 de março de 2021.","2021-04-19","Regional","Brazil","Brazil; Sergipe","2020-07-01","2020-07-31","Household and community samples","Multiple groups",5615.0,0.093,"Stratified probability","1) Kovalent; 2) iChroma II, BioSys + Kovalent","IgG; IgM","Moderate","Institutional Report","Adriano Araujo","The Federal Univeristy of Sergipe","https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021","Unverified",0.085,0.101,"","","","BR","BR-SE"
"2021-05-19","210419_Sergipe_UniversidadeFederalDeSergipe_Stage2_overall_unadj copy","Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Resultados da Terceira Fase: 18 de fevereiro a 30 de março de 2021.","2021-04-19","Regional","Brazil","Brazil; Sergipe","2020-08-11","2020-11-17","Household and community samples","Multiple groups",5405.0,0.079,"Stratified probability","1) Kovalent; 2) iChroma II, BioSys + Kovalent","IgG; IgM","Moderate","Institutional Report","Adriano Araujo","The Federal Univeristy of Sergipe","https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021","Unverified",0.068,0.091,"","","","BR","BR-SE"
"2021-05-19","210419_Sergipe_UniversidadeFederalDeSergipe_Stage3_overall_unadj copy","Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Resultados da Terceira Fase: 18 de fevereiro a 30 de março de 2021.","2021-04-19","Regional","Brazil","Brazil; Sergipe","2021-02-18","2021-03-30","Household and community samples","Multiple groups",5527.0,0.154,"Stratified probability","1) Kovalent; 2) iChroma II, BioSys + Kovalent","IgG; IgM","Moderate","Institutional Report","Adriano Araujo","The Federal Univeristy of Sergipe","https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021","Unverified",0.145,0.164,"","","","BR","BR-SE"
"2021-05-19","210419_Wuhan_ChineseAcademyofSciences","Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.","2021-04-19","Local","China","China; Hubei; Wuhan","2020-05-30","2020-06-12","Essential non-healthcare workers","Adults (18-64 years)",508.0,0.059,"Unclear","In-House (Chinese Academy of Sciences)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yong Yang","Chinese Academy of Sciences","https://dx.doi.org/10.1080/22221751.2021.1919032","Verified","","","","","","CN","CN-42"
"2021-05-19","210420_Libreville_CentreHospitalierUniversitaire(CHU)‐Mère‐Enfant_overall_unadj","Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!.","2021-04-20","Local","Gabon","Gabon","2020-07-15","2020-10-15","Residual sera","Multiple groups",1495.0,0.362,"Convenience","1) Roche; 2) Biomerieux","IgG; IgM","High","Journal Article (Peer-Reviewed)","Amandine Mveang Nzoghe","Centre Hospitalier Universitaire (CHU) ‐ Mère‐ Enfant","https://dx.doi.org/10.1186/s13104-021-05570-3","Verified","","","","","","GA",""
"2021-05-19","210421_Pakistan_MemorialCancerHospitalandResearchCenter_overall","Seroprevalence of SARS-CoV-2 Antibodies Among Health Care Personnel at a Health Care System in Pakistan","2021-04-21","Local","Pakistan","Pakistan; Punjab; Lahore","2020-07-29","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",2162.0,0.396,"Convenience","Roche Diagnostics International Ltd","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Salma Abbas","Shaukat Khanum Memorial Cancer Hospital and Research Centre","https://dx.doi.org/10.1177/10105395211011010","Verified","","","","","","PK","PK-PB"
"2021-05-19","210422_Orlando_JohnsHopkinsUniversity","SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.","2021-04-22","Local","United States of America","United States of America; Florida; Orlando","2020-06-11","2020-10-19","Non-essential workers and unemployed persons","Adults (18-64 years)",3648.0,0.009,"Convenience","Siemens; Abbott Laboratories; Ortho-Clinical Diagnostics; Roche Diagnostics","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Christina Mack","Johns Hopkins University School of Medicine","https://dx.doi.org/10.1001/jamainternmed.2021.2114","Verified","","","","","","US","US-FL"
"2021-05-19","210423_Connecticut_YaleUniversity","Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel","2021-04-23","Regional","United States of America","United States of America; Connecticut","2020-04-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",995.0,0.103,"Self-referral","NR","IgG","High","Preprint","Joseph Zell","Yale University","https://www.medrxiv.org/content/10.1101/2021.04.21.21255881v1","Verified","","","","","","US","US-CT"
"2021-05-19","210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Kalulushi1_HCW","Comparable;   exposure to SARS-CoV-2 in young children and healthcare workers in Zambia","2021-05-06","Local","Zambia","Zambia; Copperbelt Province ; Kalulushi","2020-08-01","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",237.0,0.08,"Convenience","N/A- author designed","IgG","High","Preprint","Natasha Makabilo Laban","Centre for Infectious Disease Research in Zambia","https://wellcomeopenresearch.org/articles/6-97/v1","Verified","","","","","","ZM","ZM-08"
"2021-05-19","210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Lusaka2_Infants","Comparable;   exposure to SARS-CoV-2 in young children and healthcare workers in Zambia","2021-05-06","Local","Zambia","Zambia; Lusaka Province; Lusaka","2020-08-15","2020-12-15","Household and community samples","Children and Youth (0-17 years)",150.0,0.06,"Convenience","N/A- author designed","IgG","High","Preprint","Natasha Makabilo Laban","Centre for Infectious Disease Research in Zambia","https://wellcomeopenresearch.org/articles/6-97/v1","Verified","","","","","","ZM","ZM-09"
"2021-05-19","210519_Rochester_MayoClinic_primary","Providing safe care for patients in the coronavirus disease 2019 (COVID-19) era: A case series evaluating risk for hospital-associated COVID-19.","2021-04-05","Local","United States of America","United States of America; Minesota; Rochester","2020-05-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",1339.0,0.019,"Convenience","EUROIMMUN, Ortho-Clinical Diagnostics, Roche diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Elizabeth B Habermann","Mayo Clinic","https://dx.doi.org/10.1017/ice.2021.38","Verified","","","","","","US","US-MN"
"2021-05-20","200515_Regensburg_UniversityOfRegensburg","Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.","2020-05-15","Local","Germany","Germany; Bavaria; Regensburg","2020-03-01","2020-03-31","Health care workers and caregivers","Adults (18-64 years)",201.0,0.204,"Convenience","EUROIMMUN AG","IgG; IgA","High","Journal Article (Peer-Reviewed)","Susanne Brandstetter","University of Regensburg","https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.13278?af=R","Unverified","","","","","","DE","DE-BY"
"2021-05-20","200821_Campinas_CampinasMunicipalHealthDepartment","Campinas City Hall presents;   second Covid-19 Serological Survey","2020-08-21","Local","Brazil","Brazil; Sao Paulo; Campinas","2020-08-03","2020-08-15","Household and community samples","Multiple groups",1876.0,0.037,"Simplified probability","NR","Not reported","High","News and Media","Campinas City Hall","Campinas Municipal Health Department","https://covid-19.campinas.sp.gov.br/prefeitura-de-campinas-apresenta-segundo-inqu-rito-sorol-gico-da-covid-19","Verified","","","","","","BR","BR-SP"
"2021-05-20","200930_Karachi_NationalInstituteOfBloodDiseasesAndBoneMarrowTransplantation","is karachi knocking at herd immunity? a possible reason for decline in sars-cov-2 infections","2020-09-30","Local","Pakistan","Pakistan; Sindh; Kararchi","2020-08-30","2020-09-12","Household and community samples","Adults (18-64 years)",2404.0,0.55,"Convenience","Roche diagnostics International Ltd","IgG; IgM; IgA","High","Preprint","Faiza Rezwan","National Institute of Blood Diseases and Bone Marrow Transplantation","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3700931","Unverified","","","","","","PK","PK-SD"
"2021-05-20","200930_Kerala_GovernmentOfKerala_August","ICMR Sero Surveillance 2nd Round-Kerala","2020-09-30","Regional","India","India; Kerala; Ernakulam, Palakkad, Thrissur","2020-08-24","2020-08-26","Household and community samples","Multiple groups",1281.0,0.008,"Unclear","Not reported","Not reported","Unclear","Institutional Report","Government of Kerala","Indian Medical Research Council","https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf","Verified","","","","","","IN","IN-KL"
"2021-05-20","200930_Kerala_GovernmentOfKerala_May","ICMR Sero Surveillance 2nd Round-Kerala","2020-09-30","Regional","India","India; Kerala; Ernakulam, Palakkad, Thrissur","2020-05-18","2020-05-23","Household and community samples","Multiple groups",1193.0,0.003,"Unclear","Not reported","Not reported","Unclear","Institutional Report","Government of Kerala","Indian Medical Research Council","https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf","Verified","","","","","","IN","IN-KL"
"2021-05-20","201110_Maranhao_UniversidadeFederaldoMaranhao_Phase2_OverallPopAdj","Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, Brasil Relatório Final de Pesquisa Fase II","2020-11-10","Regional","Brazil","Brazil; Maranhão","2020-10-19","2020-10-30","Household and community samples","Multiple groups",4563.0,0.381,"Stratified probability","Roche","Total Antibody","Moderate","Institutional Report","Antonio da Silva","Universidade Federal do Maranhao","https://www.saude.ma.gov.br/wp-content/uploads/2020/11/Inquerito-Sorologico-Maranhao-Fase-2.pdf","Verified",0.348,0.414,"","","","BR","BR-MA"
"2021-05-20","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Household and community samples","Multiple groups",9756.0,0.014,"Stratified probability","Qingdao Hightop Biotech","IgG; IgM","Moderate","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","","","","","","MZ","MZ-B"
"2021-05-20","201202_Utah_UniversityofUtah_Phase1BCache_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America","United States of America; Utah; NR","2020-05-01","2020-07-01","Household and community samples","Multiple groups",1622.0,0.023,"Simplified probability","NR","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified",0.007,0.057,0.83,0.996,"","US","US-UT"
"2021-05-20","201202_Utah_UniversityofUtah_Phase1BWashington_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America","United States of America; Utah; NR","2020-05-01","2020-07-01","Household and community samples","Multiple groups",1594.0,0.005,"Simplified probability","NR","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified",0.0,0.016,0.83,0.996,"","US","US-UT"
"2021-05-20","201202_Utah_UniversityofUtah_Phase1BWeber_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America","United States of America; Utah; NR","2020-05-01","2020-07-01","Household and community samples","Multiple groups",1211.0,0.014,"Simplified probability","NR","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified",0.003,0.037,0.83,0.996,"","US","US-UT"
"2021-05-20","201202_Utah_UniversityofUtah_Phase2Prelim_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America","United States of America; Utah; NR","2020-07-07","2020-08-15","Household and community samples","Multiple groups",1622.0,0.028,"Simplified probability","NR","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified",0.01,0.064,0.83,0.996,"","US","US-UT"
"2021-05-20","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Overall","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Household and community samples","Multiple groups",1360.0,0.025,"Stratified probability","Qingdao Hightop biotech","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-05-20","210101_Montpellier_UniversityHospitalMontpellier_HCW","Increased risks of SARS-CoV-2 nosocomial acquisition in highrisk COVID-19 units justify personal protective equipment: a cross-sectional study","2020-10-30","Local","France","France","2020-04-21","2020-06-03","Health care workers and caregivers","Adults (18-64 years)",647.0,0.02,"Unclear","ID.Vet","IgG","Unclear","Journal Article (Peer-Reviewed)","Marie Bistoquet","University Hospital Montpellier","https://www.journalofhospitalinfection.com/article/S0195-6701(20)30505-3/fulltext","Verified",0.009,0.031,"","","","FR",""
"2021-05-20","210111_SanFrancisco_UniversityofCalifornia_EDproviders","Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers","2021-01-11","Local","United States of America","United States of America; California; San Francisco","2020-09-01","2020-10-15","Health care workers and caregivers","Adults (18-64 years)",139.0,0.029,"Convenience","Abbott Laboratories; Diasorin Inc","IgG","High","Journal Article (Peer-Reviewed)","Ralph Wang","University of California","https://dx.doi.org/10.1016/j.annemergmed.2021.01.010","Verified",0.008,0.072,"","","","US","US-CA"
"2021-05-20","210305_Stockholm_Västerås_primary","No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study","2021-03-05","Local","Sweden","Sweden","2020-06-04","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",70.0,0.043,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Elisabet Granstam","Västerås","https://bmjophth.bmj.com/content/6/1/e000616","Verified","","",1.0,0.996,"","SE",""
"2021-05-20","210309_Texas_UTSouthwesternMedicalCenter_Dallas_overall_unadj","DFW COVID-19 Prevlance Study Update for Dallas & Tarrant Counties – March 2021","2021-03-09","Local","United States of America","United States of America","2020-08-15","2021-02-15","Household and community samples","Multiple groups",11580.0,0.072,"Self-referral","NR","Not reported","High","Institutional Report","UT Southwestern Medical Center","UT Southwestern Medical Center","https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf","Verified","","","","","","US",""
"2021-05-20","210309_Texas_UTSouthwesternMedicalCenter_Employees_overall_unadj","DFW COVID-19 Prevlance Study Update for Dallas & Tarrant Counties – March 2021","2021-03-09","Local","United States of America","United States of America","2020-08-15","2021-02-15","Essential non-healthcare workers","Multiple groups",4098.0,0.052,"Self-referral","NR","Not reported","High","Institutional Report","UT Southwestern Medical Center","UT Southwestern Medical Center","https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf","Verified","","","","","","US",""
"2021-05-20","210309_Texas_UTSouthwesternMedicalCenter_Tarrant_overall_unadj","DFW COVID-19 Prevlance Study Update for Dallas & Tarrant Counties – March 2021","2021-03-09","Local","United States of America","United States of America","2020-08-15","2021-02-15","Household and community samples","Multiple groups",5697.0,0.085,"Self-referral","NR","Not reported","High","Institutional Report","UT Southwestern Medical Center","UT Southwestern Medical Center","https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf","Verified","","","","","","US",""
"2021-05-20","210407_Slovenia_UniversityofLjubljana_FirstRound_GenPop_ElecsysTestAdj","Seroprevalence of SARS-CoV-2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned","2021-04-07","National","Slovenia","Slovenia","2020-04-20","2020-05-01","Household and community samples","Multiple groups",1316.0,0.009,"Simplified probability","Roche Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Mario Poljak","University of Ljubljana","https://dx.doi.org/10.1016/j.cmi.2021.03.009","Verified",0.004,0.014,"","","","SI",""
"2021-05-20","210415_Croatia_ChildrensHospitalZagreb_timepoint1_primary","Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia","2021-04-15","Local","Croatia","Croatia","2020-05-13","2020-05-29","Residual sera","Children and Youth (0-17 years)",240.0,0.029,"Convenience","Vircell, Granada, Spain","IgA; IgM; IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Jasna Lenicek Krleza","Children's Hospital Zagreb","https://dx.doi.org/10.11613/BM.2021.020706","Verified","","","","","","HR",""
"2021-05-20","210415_Croatia_ChildrensHospitalZagreb_timepoint2_primary","Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia","2021-04-15","Local","Croatia","Croatia","2020-10-24","2020-11-23","Residual sera","Children and Youth (0-17 years)",308.0,0.084,"Convenience","Roche Cobas Elecysis","IgG; IgM; Neutralizing","High","Journal Article (Peer-Reviewed)","Jasna Lenicek Krleza","Children's Hospital Zagreb","https://dx.doi.org/10.11613/BM.2021.020706","Verified","","","","","","HR",""
"2021-05-20","210419_Milwakee_UniversityOfWisconsin","Seroprevalence of SARS-CoV-2 Antibody in Echocardiography and Stress Laboratory","2021-04-19","Local","United States of America","United States of America; Wisconsin; Milwaukee","2020-06-15","2020-07-03","Health care workers and caregivers","Adults (18-64 years)",43.0,0.07,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Renuka Jain","University of Wisconsin","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060043/","Verified",0.02,0.2,"",0.992,"","US","US-WI"
"2021-05-20","210419_NewZealand_UniversityOfAuckland_BloodDonors","Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand","2021-04-19","National","New Zealand","New Zealand","2020-12-03","2021-01-06","Blood donors","Adults (18-64 years)",9806.0,0.001,"Sequential","Euroimmun; GenScript; NA - Author Designed","IgG","Moderate","Preprint","Lauren Carlton","University of Auckland","https://www.medrxiv.org/content/10.1101/2021.04.12.21255282v1","Verified",0.001,0.001,0.817,1.0,"","NZ",""
"2021-05-20","210419_Turin_AziendaOspedalieraOrdineMauriziano_Primary","Risk factors of SARS‐CoV‐2 seroprevalence among hospital employees in Italy: a single‐centre study","2021-04-19","Local","Italy","Italy; Piedmont; Turin","2020-05-08","2020-05-15","Health care workers and caregivers","Multiple groups",1562.0,0.098,"Convenience","DiaSorin","IgG","High","Journal Article (Peer-Reviewed)","Marco Daperno","Azienda Ospedaliera Ordine Mauriziano","https://onlinelibrary.wiley.com/doi/10.1111/imj.15201","Verified","","",0.841,0.937,"","IT","IT-21"
"2021-05-20","210420_Foggia_UniversityOfFoggia","Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy","2021-04-20","Local","Italy","Italy; Apulia; Foggia","2020-03-15","2020-06-15","Blood donors","Adults (18-64 years)",1797.0,0.01,"Sequential","Ortho Clinical Diagnostics","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Mariantonietta Di Stefano","University of Foggia","https://www.karger.com/Article/Abstract/515258","Verified","","","","","","IT","IT-75"
"2021-05-20","210420_Singapore_NationalUniversityOfSingapore_Community_TestAdj","Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population","2021-04-20","National","Singapore","Singapore","2020-11-15","2020-12-15","Household and community samples","Multiple groups",937.0,0.002,"Convenience","GenScript","Neutralizing","High","Preprint","Hannah E Clapham","National University of Singapore","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194","Verified",0.0,0.007,0.803,0.993,"","SG",""
"2021-05-20","210420_Singapore_NationalUniversityOfSingapore_MigrantWorkers_TestAdj","Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population","2021-04-20","Local","Singapore","Singapore","2020-05-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",478.0,0.638,"Simplified probability","GenScript","Neutralizing","High","Preprint","Hannah E Clapham","National University of Singapore","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194","Verified",0.579,0.703,0.803,0.993,"","SG",""
"2021-05-20","210421_Israel_MinistryofHealth_genpop_primary","Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel","2021-04-21","National","Israel","Israel","2020-06-28","2020-09-14","Household and community samples","Multiple groups",54357.0,0.046,"Convenience","Abbott and DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Shay Reicher","Ministry of Health","https://dx.doi.org/10.1007/s10654-021-00749-1","Verified",0.044,0.048,"","","","IL",""
"2021-05-20","210421_Lima_HarvardMedicalSchool_BusDepot2","Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.","2021-04-21","Local","Peru","Peru; Lima Province; Lima","2020-06-05","2020-07-18","Essential non-healthcare workers","Adults (18-64 years)",477.0,0.363,"Convenience","SD Biosensor, Suwon, Korea","IgG; IgM","High","Journal Article (Peer-Reviewed)","Marco Tovar","Harvard Medical School","https://dx.doi.org/10.1093/cid/ciab323","Unverified","","",0.9,0.99,"","PE","PE-LMA"
"2021-05-20","210421_Lima_HarvardMedicalSchool_Market1","Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.","2021-04-21","Local","Peru","Peru; Lima Province; Lima","2020-06-05","2020-07-18","Essential non-healthcare workers","Adults (18-64 years)",1285.0,0.45,"Convenience","SD Biosensor, Suwon, Korea","IgG; IgM","High","Journal Article (Peer-Reviewed)","Marco Tovar","Harvard Medical School","https://dx.doi.org/10.1093/cid/ciab323","Unverified","","",0.9,0.99,"","PE","PE-LMA"
"2021-05-20","210421_London_DMGDental-MaterialGesellschaftmbH_overall_unadj","COVID-19 testing in a UK dental practice - results of a pilot study.","2021-04-21","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",14.0,0.214,"Convenience","SureScreen Diagnostics","IgG; IgM","High","Journal Article (Peer-Reviewed)","Linda Greenwall","DMG Dental-Material Gesellschaft mbH","https://dx.doi.org/10.1038/s41415-021-2849-7","Verified","","","","","","GB","GB-ENG"
"2021-05-20","210422_Brandenburg_MedicalSchoolTheodorFontane_followup_primary","Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study.","2021-04-22","Regional","Germany","Germany; Brandenburg; Brandenburg/Havel, Neuruppin","2020-05-31","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",811.0,0.022,"Convenience","Medizinische Labordiagnostika","IgG","High","Journal Article (Peer-Reviewed)","Mark Reinwald","Brandenburg Medical School Theodor Fontane","https://dx.doi.org/10.3390/healthcare9050498","Verified","","",0.95,0.962,"","DE","DE-BB"
"2021-05-20","210423_Blackpool_NHSFoundationTrust_primaryAbbott","EXPRESS: Comparison of four high throughput, automated immunoassays for the detection of SARS-CoV-2 antibodies.","2021-04-23","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-08-01","2020-08-31","Residual sera","Multiple groups",225.0,0.053,"Convenience","Abbott Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Jane Oakey","NHS Foundation Trust","https://dx.doi.org/10.1177/00045632211015711","Verified","","",1.0,"","","GB",""
"2021-05-20","210423_Monterrey_UniversidadAutónomaDeNuevoLeón","Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients.","2021-04-23","Local","Mexico","Mexico; Nuevo Leon; Monterrey","2020-05-22","2020-05-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",154.0,0.117,"Sequential","Healgen","IgG; IgM","High","Journal Article (Peer-Reviewed)","Giovanna Yazmin Arteaga Muller","Universidad Autónoma de Nuevo León","https://dx.doi.org/10.1007/s11255-021-02852-4","Unverified","","",0.901,0.985,"","MX","MX-NLE"
"2021-05-20","210425_Essen_UniversityHospitalEssen","SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study.","2021-04-25","Local","Germany","Germany; North Rhine-Westphalia; Essen","2020-10-01","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",315.0,0.051,"Convenience","Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Johannes Korth","University Hospital Essen","https://dx.doi.org/10.3390/ijerph18094540","Verified","","",0.944,0.996,"","DE","DE-NW"
"2021-05-21","200617_Norbotten_UmeaUniversity_overall","The seroprevalence of covid-19 antibodies in Norrbotten County, Sweden","2020-06-17","Regional","Sweden","Sweden; Norbotten; Piteå, Luleå/Boden, Gällivare, Kalix, Kiruna","2020-05-25","2020-06-05","Household and community samples","Multiple groups",425.0,0.019,"Simplified probability","1)Abbott; 2)Euroimmun","IgG","Moderate","Institutional Report","Mats Eliasson","Umea University","https://web.archive.org/web/20200623000020/https://www.norrbotten.se/publika/lg/kom/Corona/Rapport%20-%20förekomst%20av%20antikroppar/Förekomst%20av%20antikroppar%20mot%20covid-19%20i%20Norrbottens%20befolkning%20maj%202020%20-%20Region%20Norrbotten%20rapport%20200618.pdf","Verified",0.008,0.037,"","","","SE","SE-BD"
"2021-05-21","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Household and community samples","Multiple groups",1769.0,0.05,"Stratified probability","STANDARD Q","IgG; IgM","Moderate","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.04,0.06,"","","","MZ","MZ-N"
"2021-05-21","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Household and community samples","Multiple groups",4717.0,0.038,"Stratified probability","Abbott","IgG; IgM","Moderate","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-05-21","200901_Loreto_HospitalRegionaldeLoreto_primary","Seroprevalence of COVID-19 in workers in a hospital in the Peruvian Amazon","2020-09-01","Local","Peru","Peru","2020-05-19","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",1147.0,0.583,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ricci Alonso Chafloque Vasquez","Hospital Regional de Loreto","https://amp.cmp.org.pe/index.php/AMP/article/view/1050","Verified","","","","","","PE",""
"2021-05-21","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Household and community samples","Multiple groups",1946.0,0.007,"Stratified probability","QINGDAO HIGHTOP Biotech","IgG; IgM","Moderate","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","","","","","","MZ","MZ-T"
"2021-05-21","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Household and community samples","Multiple groups",5069.0,0.025,"Stratified probability","Abbott","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","","","","","","MZ","MZ-Q"
"2021-05-21","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Household and community samples","Multiple groups",4940.0,0.052,"Stratified probability","Abbott","IgG; IgM","Moderate","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","","","","","","MZ","MZ-S"
"2021-05-21","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Household and community samples","Multiple groups",1635.0,0.003,"Stratified probability","QINGDAO HIGHTOP Biotech","IgG; IgM","Moderate","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","","","","","","MZ","MZ-A"
"2021-05-21","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Household and community samples","Multiple groups",5394.0,0.036,"Stratified probability","Abbott","IgG; IgM","Moderate","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","","","","","","MZ","MZ-MPM"
"2021-05-21","201123_PuertoRico_PuertoRicoPublicHealthTrust_Primary","Resultados Primera Fase Proyecto CASPER - Primer Estudio de Seroprevalencia de COVID-19 en Puerto Rico","2020-11-23","National","Puerto Rico","Puerto Rico","2020-11-20","2020-11-23","Household and community samples","Multiple groups",1816.0,0.028,"Stratified probability","NR","IgM; IgG","High","Institutional Report","Puerto Rico Public Health Trust","Puerto Rico Public Health Trust","https://sites.google.com/view/casperpr/análisis-y-resultados?authuser=0","Verified","","","","","","PR",""
"2021-05-21","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Household and community samples","Multiple groups",2451.0,0.053,"Stratified probability","Abbott","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-05-21","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Household and community samples","Multiple groups",4932.0,0.037,"Stratified probability","Abbott","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-05-21","201211_Austria_StatistikAustria_overall_PopAdj","COVID-19 Prävalenz und Seroprävalenz","2020-12-11","National","Austria","Austria","2020-11-12","2020-11-14","Household and community samples","Multiple groups",2229.0,0.047,"Simplified probability","NR","Not reported","Moderate","Institutional Report","Statistik Austria","StatistikAustria","http://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&dDocName=124957","Unverified",0.038,0.056,"","","","AT",""
"2021-05-21","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Household and community samples","Multiple groups",3974.0,0.055,"Stratified probability","QINGDAO HIGHTOP Biotech","IgG; IgM","Moderate","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-05-21","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Household and community samples","Multiple groups",1577.0,0.074,"Stratified probability","QINGDAO HIGHTOP Biotech","IgG; IgM","Moderate","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-05-21","201221_Lombardy_ATSMilan_cohabitants","SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians","2020-12-21","Regional","Italy","Italy; Lombardy","2020-04-01","2020-04-30","Family of essential workers","Adults (18-64 years)",755.0,0.244,"Convenience","ACRO BIOTECH, Inc","IgG","High","Journal Article (Peer-Reviewed)","Rinaldo Missaglia","University of Milano-Bicocca","https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0","Verified","","",0.96,0.792,"","IT","IT-25"
"2021-05-21","201221_Lombardy_ATSMilan_peds","SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians","2020-12-21","Regional","Italy","Italy; Lombardy","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",377.0,0.149,"Convenience","ACRO BIOTECH, Inc","IgG","High","Journal Article (Peer-Reviewed)","Rinaldo Missaglia","University of Milano-Bicocca","https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0","Verified","","",0.96,0.792,"","IT","IT-25"
"2021-05-21","201221_Lombardy_ATSMilan_staff","SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians","2020-12-21","Regional","Italy","Italy; Lombardy","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",108.0,0.157,"Convenience","ACRO BIOTECH, Inc","IgG","High","Journal Article (Peer-Reviewed)","Rinaldo Missaglia","University of Milano-Bicocca","https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0","Verified","","",0.96,0.792,"","IT","IT-25"
"2021-05-21","201230_ArgentinaHurlingham_UniversidadNacionalHurlingham","Se presentaron los resultados del estudio de seroprevalencia de COVID-19 que realizó la Universidad en el Municipio de Hurlingham","2020-12-30","Local","Argentina","Argentina; Buenos Aires; Buenos Aires","2020-12-01","2020-12-30","Household and community samples","Multiple groups",1182.0,0.121,"Stratified probability","Molecular Virology Laboratory of the Leloir Institute Foundation","IgG","High","Institutional Report","Universidad Nacional De Hurlingham","Universidad Nacional De Hurlingham","http://www.unahur.edu.ar/es/se-presentaron-los-resultados-del-estudio-de-seroprevalencia-de-covid-19-que-realizo-la-universidad","Verified",0.1,0.142,"","","","AR","AR-B"
"2021-05-21","210112_PlacerCounty_StanfordUniversity","CA-FACTS Seroprevalence for SARS- CoV-2 in Placer County","2021-01-12","Local","United States of America","United States of America; California","2020-11-01","2020-11-30","Household and community samples","Multiple groups",810.0,0.023,"Simplified probability","Not reported","Not reported","High","Institutional Report","Julie Parsonnet","Stanford University","https://www.placer.ca.gov/DocumentCenter/View/49523/2021-011221-PowerPoint-Item-02A","Verified","","","","","","US","US-CA"
"2021-05-21","210113_SaoPaulo_CidadeDeSaoPaolo_2021_Phase1_overall","Novo inquérito sorológico 2021 - fase 1","2021-01-13","Local","","Brazil; Sao Paulo; Sao Paulo","2021-01-05","2021-01-07","Household and community samples","Multiple groups",1960.0,0.141,"Simplified probability","Wondfo","IgG; IgM","Moderate","Institutional Report","City of Sao Paulo","Cidade de São Paulo","http://www.capital.sp.gov.br/arquivos/pdf/2021/coletiva_saude_14-01.pdf","Verified",0.117,0.168,0.979,"","","BR","BR-SP"
"2021-05-21","210121_Abuja_MolecularPathologyInstituteEnugu","Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria","2021-01-21","Local","Nigeria","Nigeria; NR; Abuja, Enugu","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",113.0,0.42,"Convenience","NOVA TECH Germany","IgG","High","Preprint","Ijeoma Ifeorah","Molecular Pathology Institute","https://www.researchsquare.com/article/rs-151037/v1","Unverified",0.34,0.52,1.0,1.0,"","NG",""
"2021-05-21","210204_SaoPaulo_CityOfSaoPaulo_2021_Phase2","inquérito sorológico adultos (>18) para sars-cov-2 evolução da prevalência da infecção no msp 2021 - resultado da fase 2 de 2021","2021-02-04","Local","Brazil","Brazil; Sao Paulo; Sao Paulo","2021-01-07","2021-01-21","Household and community samples","Multiple groups",1841.0,0.139,"Simplified probability","Wondfo","IgG; IgM","High","Institutional Report","City of Sao Paulo","City of Sao Paulo","http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-02_2021.pdf/view","Verified",0.117,0.164,0.979,"","","BR","BR-SP"
"2021-05-21","210321_Jamshedpur_TataMainHospital_OverallHCW","Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity","2021-03-21","Local","India","India; Jharkhand; Jamshedpur","2020-10-07","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",2110.0,0.438,"Convenience","Beckman Coulter Inc.","IgG","Moderate","Journal Article (Peer-Reviewed)","Minakshi Mishra","Tata Main Hospital","https://pubmed.ncbi.nlm.nih.gov/33898113/","Verified","","",1.0,0.986,"","IN","IN-JH"
"2021-05-21","210323_Tabriz_TabrizUniversityofMedicalSciences","Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients.","2021-03-23","Local","Iran (Islamic Republic of)","Iran (Islamic Republic of); East Azerbaijan Province; Tabriz","2020-06-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",288.0,0.101,"Sequential","In-House (assembled from Florian Krammer et al.)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jalal Etemadi","Tabriz University of Medical Sciences","https://dx.doi.org/10.1080/08820139.2021.1899202","Verified","","",0.93,0.98,"","IR","IR-01"
"2021-05-21","210415_KentCounty_UniversityofMichigan_S1","Health Care Acquired COVID-19 is Less Symptomatic than Community Acquired Disease Among Healthcare Workers.","2021-04-15","Local","United States of America","United States of America; Michigan; NR","2020-08-17","2020-09-04","Health care workers and caregivers","Adults (18-64 years)",1385.0,0.019,"Convenience","Siemens; bioMerieux","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jeffrey Fletcher","University of Michigan","https://dx.doi.org/10.1017/ice.2021.167","Verified",0.012,0.026,"","","","US","US-MI"
"2021-05-21","210415_KentCounty_UniversityofMichigan_S2","Health Care Acquired COVID-19 is Less Symptomatic than Community Acquired Disease Among Healthcare Workers.","2021-04-15","Local","United States of America","United States of America; Michigan; NR","2020-12-02","2020-12-23","Health care workers and caregivers","Adults (18-64 years)",1445.0,0.137,"Convenience","Siemens; bioMerieux","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jeffrey Fletcher","University of Michigan","https://dx.doi.org/10.1017/ice.2021.167","Verified",0.119,0.155,"","","","US","US-MI"
"2021-05-21","210420_Bytom1_UniversityofOpole","SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.","2021-04-20","Local","Poland","Poland; Silesian; Bytom","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",90.0,0.1,"Convenience","Euroimmun Medizinische Labordiagnostik [Anti-SARS-CoV-2 ELISA (IgG)","IgG","High","Journal Article (Peer-Reviewed)","Rafal Jakub Buldak","University of Opole","https://dx.doi.org/10.3390/ijerph18084376","Unverified","","","",0.99,"","PL","PL-24"
"2021-05-21","210420_MiasteczkoSlaskie2_UniversityofOpole","SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.","2021-04-20","Local","Poland","Poland; Silesian; Miasteczko Slaskie","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",25.0,0.04,"Convenience","Euroimmun Medizinische Labordiagnostik [Anti-SARS-CoV-2 ELISA (IgG)","IgG","High","Journal Article (Peer-Reviewed)","Rafal Jakub Buldak","University of Opole","https://dx.doi.org/10.3390/ijerph18084376","Unverified","","","",0.99,"","PL","PL-24"
"2021-05-21","210420_Opole3_UniversityofOpole","SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.","2021-04-20","Local","Poland","Poland; Opole; Opole","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",84.0,0.012,"Convenience","Euroimmun Medizinische Labordiagnostik [Anti-SARS-CoV-2 ELISA (IgG)","IgG","High","Journal Article (Peer-Reviewed)","Rafal Jakub Buldak","University of Opole","https://dx.doi.org/10.3390/ijerph18084376","Unverified","","","",0.99,"","PL","PL-16"
"2021-05-21","210425_Florence_UniversityofFlorence_BloodDonors","SARS-CoV-2 was already circulating in Italy, in early December 2019","2021-04-25","Local","Italy","Italy; Tuscany; Florence","2020-01-22","2020-03-09","Blood donors","Multiple groups",56.0,0.036,"Sequential","CHIL; MP Biomedicals","IgG","High","Journal Article (Peer-Reviewed)","Laura Gragnani","University of Florence","https://dx.doi.org/10.26355/eurrev_202104_25746","Verified","","","","","","IT","IT-52"
"2021-05-21","210425_Florence_UniversityofFlorence_HP","SARS-CoV-2 was already circulating in Italy, in early December 2019","2021-04-25","Local","Italy","Italy; Tuscany; Florence","2019-11-04","2020-03-09","Patients seeking care for non-COVID-19 reasons","Multiple groups",234.0,0.043,"Sequential","CHIL; MP Biomedicals","IgG","High","Journal Article (Peer-Reviewed)","Laura Gragnani","University of Florence","https://dx.doi.org/10.26355/eurrev_202104_25746","Verified","","","","","","IT","IT-52"
"2021-05-21","210427_Cuenca_UniversityOfAntwerp_overall_UnAdj","Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study","2021-04-27","Local","Ecuador","Ecuador; Azuay","2020-08-11","2020-11-01","Household and community samples","Multiple groups",2457.0,0.132,"Stratified probability","SD BIOSNSOR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","David Acurio Paez","University of Antwerp","https://www.mdpi.com/1660-4601/18/9/4657","Verified","","",0.879,0.943,"","EC","EC-A"
"2021-05-21","210428_Austria_HanuschHospital","Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe.","2021-04-28","National","Austria","Austria","2020-07-01","2020-07-31","Non-essential workers and unemployed persons","Adults (18-64 years)",7858.0,0.011,"Convenience","Abbott Rapid Diagnostics; In-House (Hanusch Hospital)","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Johann Bartko","Hanusch Hospital","https://dx.doi.org/10.3390/jcm10091909","Verified",0.009,0.014,"","","","AT",""
"2021-05-21","210429_Johannesburg_NationalHealthLaboratoryService_PopTestAdj_Primary","Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020","2021-04-29","Local","South Africa","South Africa; Gauteng; Johannesburg","2020-08-01","2020-10-31","Residual sera","Multiple groups",4393.0,0.273,"Simplified probability","Roche Diagnostics","IgM; IgG","Moderate","Preprint","Jaya George","National Health Laboratory Service","https://www.medrxiv.org/content/10.1101/2021.04.27.21256099v1","Verified",0.238,0.299,"","","","ZA","ZA-GT"
"2021-05-21","210429_Phoenix_VincereCancerCenter_December_IgG_Unadj","COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020.","2021-04-29","Regional","United States of America","United States of America; Arizona; Phoenix Metropolitan Area","2020-12-05","2020-12-11","Household and community samples","Multiple groups",3038.0,0.165,"Self-referral","Assure","IgG","High","Journal Article (Peer-Reviewed)","Christine Lau","Vincere Cancer Center,","https://dx.doi.org/10.1007/s10900-021-00991-4","Verified","","",1.0,0.988,"","US","US-AZ"
"2021-05-21","210429_Phoenix_VincereCancerCenter_November_IgG_Unadj","COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020.","2021-04-29","Regional","United States of America","United States of America; Arizona; Phoenix Metropolitan Area","2020-11-07","2020-11-13","Household and community samples","Multiple groups",2037.0,0.166,"Self-referral","Assure","IgG","High","Journal Article (Peer-Reviewed)","Christine Lau","Vincere Cancer Center,","https://dx.doi.org/10.1007/s10900-021-00991-4","Verified","","",1.0,0.988,"","US","US-AZ"
"2021-05-21","210429_Phoenix_VincereCancerCenter_October_IgG_Unadj","COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020.","2021-04-29","Regional","United States of America","United States of America; Arizona; Phoenix Metropolitan Area","2020-10-10","2020-10-16","Household and community samples","Multiple groups",1635.0,0.087,"Self-referral","Assure","IgG","High","Journal Article (Peer-Reviewed)","Christine Lau","Vincere Cancer Center,","https://dx.doi.org/10.1007/s10900-021-00991-4","Verified","","",1.0,0.988,"","US","US-AZ"
"2021-05-21","210501_CastillaYLeon_CentroDeHemoterapiaYHemodonación","Sustained;   seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood;   donors","2021-05-01","National","Spain","Spain; Castilla y Leon","2019-07-15","2020-10-15","Blood donors","Multiple groups",9886.0,0.067,"Simplified probability","Elecsys®","Total Antibody","Moderate","Preprint","Carmen Martin","Centro de Hemoterapia y Hemodonación de Castilla y León","https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1","Verified","","","","","","ES","ES-CL"
"2021-05-22","201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_firstfase_primary","Avaliação da prevalência de marcadores virológicos e sorológicos da infecção pelo SARS-CoV-2 na população de Pitangueiras-SP: inquérito epidemiológico populacional","2020-12-11","Local","Brazil","Brazil","2020-08-24","2020-08-29","Household and community samples","Multiple groups",150.0,0.017,"Stratified probability","NR","IgG; IgM","Moderate","Institutional Report","Ana Celeste Crotti Peixoto","Prefeitura Municipal de Pitangueiras","https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf","Unverified",0.005,0.029,"","","","BR",""
"2021-05-22","201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_secondfase_primary","Avaliação da prevalência de marcadores virológicos e sorológicos da infecção pelo SARS-CoV-2 na população de Pitangueiras-SP: inquérito epidemiológico populacional","2020-12-11","Local","Brazil","Brazil","2020-09-24","2020-09-29","Household and community samples","Multiple groups",125.0,0.08,"Stratified probability","NR","IgG; IgM","Moderate","Institutional Report","Ana Celeste Crotti Peixoto","Prefeitura Municipal de Pitangueiras","https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf","Unverified","","","","","","BR",""
"2021-05-22","210215_Chile_UniversityOfChile_HCW","SARS-CoV-2 Antibody Prevalence Among 85,529 Healthcare Workers Following the First Wave of COVID-19 in Chile","2021-02-15","National","Chile","Chile","2020-09-11","2020-10-24","Health care workers and caregivers","Multiple groups",85528.0,0.072,"Entire sample","Zhukai Livzon Diagnostic Inc. China","IgG; IgM","Low","Preprint","Marcela Zuniga","Universidad de Chile","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3785998","Verified","","",0.958,1.0,"","CL",""
"2021-05-22","210301_Madrid_HospitalUniversitarioLaPaz_primary","Low rate of SARS-CoV-2 infection in picu workers caring for COVID-19 adults and children","2021-03-01","Local","Spain","Spain","2020-03-15","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",105.0,0.057,"Convenience","nr","Not reported","High","Journal Article (Peer-Reviewed)","G Santos Simarro","Hospital Universitario La Paz","http://dx.doi.org/10.1097/01.pcc.0000741352.50491.98","Verified","","","","","","ES",""
"2021-05-22","210312_SouthAfrica_NationalHealthLaboratoryService_overall_Unadj","COVID-19 SEROPREVALENCE DURING THE SECOND WAVE OF THE PANDEMIC IN THREE DISTRICTS OF SOUTH AFRICA - PRELIMINARY FINDINGS","2021-03-12","National","South Africa","South Africa; Western Cape Province, KwaZulu-Natal Province, North West Province; Mitchell’s Plain, Pietermaritzburg, and Klerksdorp","2020-11-23","2021-01-31","Household and community samples","Multiple groups",927.0,0.358,"Simplified probability","Beijing Wantai Biological Pharmacy Enterprise","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sue Aitken","National Health Laboratory Service","https://www.nicd.ac.za/wp-content/uploads/2021/03/COVID-19-Special-Public-Health-Surveillance-Bulletin-9-12-March-2021_.pdf","Verified","","",0.967,0.975,"","ZA",""
"2021-05-22","210324_India_UniversityofToronto_genpop_overall_unadj","SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020","2021-03-24","National","India","India; Maharashtra, West Bengal, Tamil Nadu, Karnataka, Gujarat, Rajasthan, Bihar, Andhra Pradesh; Mumbia, Delhi, Kolkata, Chennai, Bangalore, Ahmedabad, Pune, Surat, Jaipur, Nagpur, Coimbatore, Visakhapatnam","2020-06-12","2020-12-31","Household and community samples","Multiple groups",448518.0,0.31,"Self-referral","Abbott; Roche","IgG; Total Antibody","Moderate","Preprint","Arokiaswamy Velumani","University of Toronto","10.1101/2021.03.19.21253429","Verified","","","","","","IN",""
"2021-05-22","210324_UniversiteCatholiquedeLouvain_Piedmont_workers","Diagnostic value of igm and igg detection in covid-19 diagnosis by the mobile laboratory b-life: A massive testing strategy in the piedmont region","2021-03-24","Regional","Italy","Italy; PIedmont","2020-06-20","2020-07-23","Multiple populations","Multiple groups",6033.0,0.048,"Convenience","ZenTech","IgM; IgG","High","Journal Article (Peer-Reviewed)","Omar Nyabi","Université Catholique de Louvain","http://dx.doi.org/10.3390/ijerph18073372","Verified","","","","","","IT","IT-21"
"2021-05-22","210404_Nepal_GovernmentOfNepal_overall_PopAdj","ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION","2021-04-04","National","Nepal","Nepal","2020-10-09","2020-10-22","Household and community samples","Multiple groups",3040.0,0.144,"Stratified probability","Beijing Wantai Biological Pharmacy","Total Antibody","Low","Institutional Report","Government of Nepal","Government of Nepal","https://mohp.gov.np/attachments/article/708/First%20Sero-prevalence_final_report_04-04-2021.pdf","Verified",0.118,0.17,0.967,0.975,"","NP",""
"2021-05-22","210408_London_St.Thomas’NHSFoundationTrust_Primary","IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis.","2021-04-08","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-07-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",681.0,0.186,"Convenience","DiaSorin, Saluggia, Italy","IgG","High","Journal Article (Peer-Reviewed)","Caroline Dudreuilh","St. Thomas’ NHS Foundation Trust","https://dx.doi.org/10.1016/j.ekir.2021.03.900","Verified","","",0.974,"","","GB",""
"2021-05-22","210409_Bonn_UniversityOfBonn_RhinelandStudy1_overall_Unadj_ELISA","Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany","2021-04-09","Local","Germany","Germany; North Rhine-Westphalia; Bonn","2020-04-24","2020-06-30","Household and community samples","Multiple groups",4755.0,0.01,"Convenience","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","N Ahmad Aziz","University of Bonn","https://dx.doi.org/10.1038/s41467-021-22351-5","Verified",0.007,0.013,0.944,0.996,"","DE","DE-NW"
"2021-05-22","210409_Bonn_UniversityOfBonn_Voluntary2_overall_Unadj_ELISA","Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany","2021-04-09","Local","Germany","Germany; North Rhine-Westphalia; Bonn","2020-04-24","2020-06-30","Household and community samples","Multiple groups",360.0,0.019,"Self-referral","EUROIMMUN","IgG","High","Journal Article (Peer-Reviewed)","N Ahmad Aziz","University of Bonn","https://dx.doi.org/10.1038/s41467-021-22351-5","Verified",0.008,0.044,0.944,0.996,"","DE","DE-NW"
"2021-05-22","210409_England_PublicHealthEngland","SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).","2021-04-09","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-06-18","2020-12-31","Health care workers and caregivers","Multiple groups",25661.0,0.294,"Convenience","NR","Not reported","Unclear","Journal Article (Peer-Reviewed)","Victoria Jane Hall","Public Health England","https://dx.doi.org/10.1016/S0140-6736(21)00675-9","Verified","","","","","","GB",""
"2021-05-22","210409_NewYorkCity_NYCdepthealth_overall","Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020","2021-04-09","Local","United States of America","United States of America; New York; New York","2020-05-13","2020-07-21","Household and community samples","Multiple groups",45367.0,0.236,"Convenience","DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Preeti Pathela","New York City Department of Health and Mental Hygiene","https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab200/6219118","Verified",0.232,0.24,0.976,0.993,"","US","US-NY"
"2021-05-22","210412_NewYork_CityUniversityofNewYork_Primary","The emergence, surge and subsequent wave of the SARS-CoV-2 pandemic in New York metropolitan area: The view from a major region-wide urgent care provider","2021-04-12","Regional","United States of America","United States of America; New York ; New York City; Bronx; Brooklyn; Long Island; Manhatten; Metro North; Queens; Staten Island","2020-03-08","2021-01-01","Household and community samples","Multiple groups",693205.0,0.216,"Sequential","NR","IgG","High","Preprint","Madhura S Rane","City University of New York","https://www.medrxiv.org/content/10.1101/2021.04.06.21255009v3","Verified",0.215,0.217,"","","","US","US-NY"
"2021-05-22","210412_TelAviv_TelAvivUniversity","Prevalence of COVID-19 and Seroprevalence to SARS-CoV-2 in a Rheumatologic Patients Population from a Tertiary Referral Clinic in Israel.","2021-04-12","Local","Israel","Israel","2020-05-01","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",242.0,0.021,"Sequential","EUROIMMUN (Medizinische Labordiagnostika AG)","IgG; IgA","High","Journal Article (Peer-Reviewed)","Tali Eviatar","Tel Aviv University","https://dx.doi.org/10.1111/imj.15202","Verified","","",1.0,0.985,"","IL",""
"2021-05-22","210415_Campania_UniversityofNapoli","Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence.","2021-04-15","Regional","Italy","Italy; Campania","2020-05-11","2020-05-18","Household and community samples","Multiple groups",388.0,0.018,"Simplified probability","NovaTec GmbH, Germany","IgG","High","Journal Article (Peer-Reviewed)","Valeria Caturano","University of Napoli","https://dx.doi.org/10.1186/s12879-021-06054-2","Verified",0.007,0.029,0.949,0.962,"","IT","IT-72"
"2021-05-22","210415_MadridZaragoza_GeneralUniversityHospital_pregnant","Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing","2021-04-15","Local","Spain","Spain; NA & Zaragoza; Madrid & Zaragoza","2020-03-31","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",1211.0,0.05,"Unclear","Author developed","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Ricardo Saviron Cornudella","University of Zaragoza","http://dx.doi.org/10.1016/j.lfs.2021.119200","Verified","","","","","","ES","ES-AR"
"2021-05-22","210416_Itabaianinha_FederalUniversityofSergipe_ControlCohort2","Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.","2021-04-16","Local","Brazil","Brazil; Sergipe; Itabaianinha","2020-10-01","2020-10-03","Patients seeking care for non-COVID-19 reasons","Multiple groups",27.0,0.185,"Convenience","Boditech Med Inc., South Korea","IgG; IgM","High","Journal Article (Peer-Reviewed)","Manuela A Melo","Federal University of Sergipe, Aracaju","https://dx.doi.org/10.1007/s12020-021-02728-8","Unverified","","",0.958,0.97,"","BR","BR-SE"
"2021-05-22","210416_Itabaianinha_FederalUniversityofSergipe_IGHDCohort1","Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.","2021-04-16","Local","Brazil","Brazil; Sergipe; Itabaianinha","2020-10-01","2020-10-03","Household and community samples","Multiple groups",27.0,0.037,"Convenience","Boditech Med Inc., South Korea","IgG; IgM","High","Journal Article (Peer-Reviewed)","Manuela A Melo","Federal University of Sergipe, Aracaju","https://dx.doi.org/10.1007/s12020-021-02728-8","Unverified","","",0.958,0.97,"","BR","BR-SE"
"2021-05-22","210416_Safed_ZivMedicalCentre_overall_unadj","SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021: Implications for vaccination policy","2021-04-16","Local","Israel","Israel","2020-12-15","2021-03-15","Health care workers and caregivers","Adults (18-64 years)",725.0,0.034,"Convenience","1) Abbott; 2) DiaSorin","IgG","High","Preprint","Kamal Abu Jabal","Ziv Medical Centre","10.1101/2021.04.11.21255273","Verified","","","","","","IL",""
"2021-05-22","210416_Tokyo_JuntendoUniversity_HCW_Overall_testadj","SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo","2021-04-16","Local","Japan","Japan; Kantō; Tokyo","2020-07-06","2020-08-21","Health care workers and caregivers","Multiple groups",4147.0,0.004,"Convenience","Roche Diagnostics","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Hiroshi Fukuda","Juntendo Univesity","https://dx.doi.org/10.1038/s41598-021-87688-9","Verified",0.002,0.006,1.0,0.998,"","JP",""
"2021-05-22","210421_Wuhan_WuhanUniversity_overall","SARS-CoV-2;   Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020","2021-04-21","Local","China","China; Hubei; Wuhan","2020-04-23","2020-05-24","Household and community samples","Multiple groups",35326.0,0.038,"Convenience","Vazyme, Nanjing China; YHLO Biotech,; Shenzhen, China","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Huan Han","Wuhan University","https://pubmed.ncbi.nlm.nih.gov/33883260/","Verified",0.036,0.04,"","","","CN","CN-42"
"2021-05-22","210425_Bucaramanga_FundaciónCardiovascularDeColombia_overall_popadj_testadj","Seroprevalence of sars-cov-2 infection among occupational groups from the bucaramanga metropolitan area, Colombia","2021-04-15","Local","Colombia","Colombia","2020-09-28","2020-12-24","Essential non-healthcare workers","Adults (18-64 years)",7045.0,0.195,"Stratified probability","Abbot","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Claudia Colmenares-Mejia","Fundación Cardiovascular de Colombia","http://dx.doi.org/10.3390/ijerph18084172","Verified",0.186,0.204,0.852,0.973,"","CO",""
"2021-05-22","210429_Germany_BoehringerIngelheim_primary","Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company","2021-04-29","National","Germany","Germany","2020-04-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",121.0,0.016,"Convenience","Euroimmun AG, L€ubeck, Germany","IgG","High","Journal Article (Peer-Reviewed)","Petra C Moroni Zentgraf","Boehringer Ingelheim","https://dx.doi.org/10.1080/03007995.2021.1914943","Verified","","",0.55,1.0,"","DE",""
"2021-05-22","210429_Mali_UniversityofSciences_Visit2_Overall_adj","Rapidly;   increasing SARS-CoV-2 seroprevalence and limited clinical disease in three;   Malian communities: a prospective cohort study","2021-04-29","Local","Mali","Mali","2020-12-14","2021-01-29","Household and community samples","Multiple groups",2353.0,0.547,"Convenience","MRTC/DEAP Immunology Laboratory","IgG","Moderate","Preprint","Issaka Sagara","University of Sciences","https://www.medrxiv.org/content/10.1101/2021.04.26.21256016v1","Verified",0.444,0.65,0.739,0.994,"","ML",""
"2021-05-22","210429_SouthernItaly_UniversityofCampania","Seroprevalence;   of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy","2021-04-29","Regional","Italy","Italy; Southern Italy; Caserta, Naples","2020-09-21","2020-12-31","Multiple populations","Multiple groups",2394.0,0.058,"Convenience","Ortho-Clinical; Diagnostics, Abbott Diagnostics, DiaSorin","Total Antibody","High","Journal Article (Peer-Reviewed)","Francesco Napolitano","University of Campania","https://www.mdpi.com/1660-4601/18/9/4761","Unverified","","","","","","IT",""
"2021-05-22","210501_Ahmedabad_MunicipalMedicalCollege_Genpop_primary","Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad","2021-05-01","Local","India","India","2020-10-15","2020-10-31","Household and community samples","Multiple groups",17009.0,0.242,"Convenience","Zydus Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://www.nepjol.info/index.php/AJMS/article/view/35099","Verified",0.236,0.249,0.924,0.979,"","IN",""
"2021-05-22","210501_SãoPaulo_Ipec_overall_Unadj","SoroEpi MSP – Inquéritos soroepidemiológicos seriados para monitorar a prevalência da  infecção por SARS-CoV-2 no Município de São Paulo, SP, Brasil: Fase 6","2021-05-01","Local","Brazil","Brazil; São Paulo; São Paulo","2021-04-22","2021-05-01","Household and community samples","Multiple groups",1187.0,0.416,"Stratified probability","1) Abbott; 2) Roche","IgG; IgM","Moderate","Institutional Report","Beatriz Tess","Inteligência em Pesquisa e Consultoria","https://www.monitoramentocovid19.org/resultados","Verified","","","","","","BR","BR-SP"
"2021-05-22","210507_Salamanca_UniversityofSalamanca","Seroprevalence;   of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the;   University of Salamanca: The DIANCUSAL Study","2021-05-07","Local","Spain","Spain; Province of Salamanca; Salamanca","2020-07-15","2020-10-15","Non-essential workers and unemployed persons","Multiple groups",8197.0,0.082,"Convenience","Diasorin","IgG; IgM","High","Preprint","Vicente Santiago Belen","University of Salamanca","https://www.researchsquare.com/article/rs-489321/v1","Unverified","","","","","","ES","ES-CL"
"2021-05-22","210602_Dublin_UniversityCollegeDublin_overall_Unadj","EXPRESS: Performance characteristics of five SARS-CoV-2 serological assays: clinical utility in healthcare workers.","2021-06-02","Local","Ireland","Ireland; Leinster; Dublin","2020-06-15","2020-09-15","Multiple populations","Adults (18-64 years)",109.0,0.009,"Unclear","1) Roche; 2) Euroimmun; 3) Euroimmun; 4) Fortress Diagnostics; 5) DIAsource","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Emma Heffernan","University College Dublin","https://dx.doi.org/10.1177/00045632211012728","Verified","","","","","","IE","IE-L"
"2021-05-23","201226_Scotland_UniversityofGlasgow_overall_unaj","Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting","2020-12-26","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland; Greater Glasgow area","2020-03-16","2020-05-24","Residual sera","Multiple groups",6635.0,0.078,"Simplified probability","N/A - in house","IgG","Moderate","Journal Article (Peer-Reviewed)","Ellen C Hughes","University of Glasgow","http://dx.doi.org/10.1093/infdis/jiaa788","Verified",0.072,0.085,0.953,0.972,"","GB","GB-SCT"
"2021-05-23","210223_Osaka_KyotoUniversity_RLA_Overall","Radioligand Assay-Based Detection of Antibodies against; SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan","2021-02-23","Local","Japan","Japan; Honshu; Osaka","2020-07-08","2020-07-22","Health care workers and caregivers","Adults (18-64 years)",1000.0,0.004,"Convenience","N/A - In-House","IgG","High","Journal Article (Peer-Reviewed)","Hidenori Matsunaga","Kyoto University","https://www.mdpi.com/1999-4915/13/2/347","Verified","","","","","","JP",""
"2021-05-23","210316_UK_OfficeForNationalStatistics_England_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2021-02-04","2021-03-03","Household and community samples","Multiple groups",34623.0,0.346,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified",0.34,0.353,0.99,0.991,"","GB","GB-ENG"
"2021-05-23","210316_UK_OfficeForNationalStatistics_NorthernIreland_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2021-02-04","2021-03-03","Household and community samples","Multiple groups",632.0,0.312,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified",0.273,0.352,0.99,0.991,"","GB","GB-NIR"
"2021-05-23","210316_UK_OfficeForNationalStatistics_Scotland_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-04","2021-03-03","Household and community samples","Multiple groups",2737.0,0.223,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified",0.206,0.241,0.99,0.991,"","GB","GB-SCT"
"2021-05-23","210316_UK_OfficeForNationalStatistics_Wales_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; Wales","2021-02-04","2021-03-03","Household and community samples","Multiple groups",1224.0,0.305,"Stratified probability","University of Oxford","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified",0.275,0.336,0.99,0.991,"","GB","GB-WLS"
"2021-05-23","210317_NewYorkCity_IcahnSchoolOfMedicine","Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics","2021-03-17","Local","United States of America","United States of America; New York; Mount Sinai","2020-05-26","2020-07-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",383.0,0.104,"Convenience","N/A - author designed","Not reported","High","Preprint","Serre Yu Wong","Icahn School Of Medicine","https://www.medrxiv.org/content/10.1101/2021.03.15.21253615v1","Verified","","","","","","US","US-NY"
"2021-05-23","210324_London_ImperialCollegeLondon_Overall","Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection","2021-03-24","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England; London","2020-02-24","2021-01-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",301.0,0.429,"Unclear","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Candice L Clarke","Imperial College London","https://dx.doi.org/10.1016/j.kint.2021.03.009","Verified","","","","","","GB","GB-ENG"
"2021-05-23","210330_Munich_UniversityHospitalLMUMunich_TestAdj","Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich","2021-03-30","Local","Germany","Germany; Bavaria; Munich","2020-04-05","2020-06-12","Household and community samples","Multiple groups",5313.0,0.018,"Stratified probability","Roche","Total Antibody","Low","Journal Article (Peer-Reviewed)","Michael Pritsch","University Hospital LMU Munich","https://dx.doi.org/10.3390/ijerph18073572","Verified",0.013,0.024,0.886,0.997,"","DE","DE-BY"
"2021-05-23","210415_ParrisIsland_IchanSchoolofMedicine","SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study","2021-04-15","Local","United States of America","United States of America; South Carolina; Port Royal","2020-05-11","2020-11-02","Essential non-healthcare workers","Adults (18-64 years)",3076.0,0.073,"Convenience","Author designed","IgG","High","Journal Article (Peer-Reviewed)","Andrew G Letizia","Icahn School of Medicine at Mount Sinai","https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext","Verified","","","",1.0,"","US","US-SC"
"2021-05-23","210418_Delhi_CouncilofScientificandIndustrialResearchInstituteofGenomicsandIntegrativeBiology_HCW","Effect Monitoring and Insights from Vaccination program of Healthcare Workforce from a tertiary level hospital in India against SARS-CoV-2","2021-04-18","Regional","India","India; Delhi","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",307.0,0.42,"Convenience","Roche Diagnostics","Not reported","High","Preprint","Rajat Ujjainia","Council of Scientific and Industrial Research Institute of Genomics and Integrative Biology","https://www.medrxiv.org/content/10.1101/2021.02.28.21252621v3","Unverified","","","","","","IN","IN-DL"
"2021-05-23","210420_Barcelona_CIBERESP","Antibody Conversion rates to SARS-CoV-2 in Saliva from Children Attending Summer Schools in Barcelona, Spain","2021-04-20","Local","Spain","Spain","2020-06-29","2020-07-31","Students and Daycares","Multiple groups",1518.0,0.032,"Convenience","Luminex Corporation","IgG; IgM; IgA","High","Preprint","Carlota Dobano","Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Públic","10.1101/2021.04.20.440593","Unverified","","","","","","ES",""
"2021-05-23","210421_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj","Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya","2021-04-24","National","Kenya","Kenya; Central, Coastal, Western","2020-07-30","2020-12-04","Health care workers and caregivers","Adults (18-64 years)",684.0,0.208,"Convenience","Krammer","IgG","Moderate","Journal Article (Peer-Reviewed)","Anthony Etyang","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1093/cid/ciab346","Verified",0.175,0.244,0.927,0.99,"","KE",""
"2021-05-23","210428_NewYorkCity_NewYorkBloodCenter_Ortho+Neut","Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”","2021-04-28","Local","United States of America","United States of America; New York; New York City","2020-06-15","2020-07-15","Blood donors","Multiple groups",1000.0,0.09,"Sequential","Ortho Clinical Diagnostics, Vyriad IMMUNO-COV","Total Antibody; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Daniel Jin","New York Blood Centre","https://dx.doi.org/10.1371/journal.pone.0250319","Verified","","","","","","US","US-NY"
"2021-05-23","210501_Qatar_CornellUniversity","Herd;   Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in;   10 Communities, Qatar","2021-05-01","National","Qatar","Qatar","2020-06-21","2020-09-09","Essential non-healthcare workers","Adults (18-64 years)",4970.0,0.644,"Convenience","Roche Diagnostics","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Andrew Jeremijenko","Cornell University","https://wwwnc.cdc.gov/eid/article/27/5/20-4365_article","Unverified",0.63,0.657,0.995,0.998,"","QA",""
"2021-05-24","210227_Belgium_AntwerpUniversityHospital_AdultCancer_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","Belgium","2020-03-24","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",827.0,0.062,"Sequential","DiaSorin, Saluggia, Italy","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","","","","","","BE",""
"2021-05-24","210227_Belgium_AntwerpUniversityHospital_Adult_nonCancer_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","Belgium","2020-03-24","2020-05-31","Residual sera","Multiple groups",90.0,0.056,"Sequential","DiaSorin, Saluggia, Italy","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","","","","","","BE",""
"2021-05-24","210331_SchleswigHolstein_RuhrUniversityBochum_NonHCW","Half Year Longitudinal Seroprevalence of SARS-CoV-2-antibodies and Rule Compliance in German Hospital Employees","2021-03-31","Local","Germany","Germany; Schleswig-Holstein","2020-04-14","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",138.0,0.007,"Convenience","Euroimmun, Abbott, DiaSorin","IgG","High","Preprint","Jonas Herzberg","Ruhr University Bochum","https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1","Unverified","","","","","","DE","DE-SH"
"2021-05-25","210417_Itami_ItamiCityHospital","Challenges and responses of elective orthopaedic surgery during the second wave of COVID-19.","2021-04-17","Local","Japan","Japan; Kansai; Itami","2020-05-15","2020-11-20","Residual sera","Multiple groups",592.0,0.022,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Tsuyoshi Nakai","Itami City Hospital","https://dx.doi.org/10.1016/j.jos.2021.02.017","Unverified","","","","","","JP",""
"2021-05-25","210422_Illinois+Wisconsin_AdvocateAuroraHealth_Overall","Incidence of COVID-19 recurrence among large cohort of healthcare employees.","2021-04-22","Regional","United States of America","United States of America; Illinois, Wisconsin","2020-06-08","2020-07-10","Health care workers and caregivers","Multiple groups",14921.0,0.036,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Fitzpatrick Veronica","Advocate Aurora Health","https://dx.doi.org/10.1016/j.annepidem.2021.04.005","Verified","","",0.987,0.992,"","US",""
"2021-05-25","210427_Turkey_SakaryaUniversity_Overall","Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study.","2021-04-27","Local","Turkey","Turkey","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",2988.0,0.036,"Entire sample","Hotgen Biotech","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Aziz Ogutlu","Sakarya University","https://dx.doi.org/10.1186/s12941-021-00436-9","Verified","","","","","","TR",""
"2021-05-25","210430_Amsterdam_AmsterdamUniversityMedicalCenter","SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort.","2021-04-30","Local","Netherlands","Netherlands; North Holland; Amsterdam","2020-07-31","2020-12-18","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",546.0,0.117,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Zoe van Kempen","Amsterdam University Medical Center","https://dx.doi.org/10.1001/jamaneurol.2021.1364","Unverified","","",0.981,0.995,"","NL","NL-NH"
"2021-05-25","210501_UnitedStates_MayoClinic","Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center.","2021-03-26","Regional","United States of America","United States of America; Minnesota, Wisconsin, Florida, Arizona, Iowa; Rochester","2020-06-15","2020-08-08","Health care workers and caregivers","Multiple groups",29606.0,0.006,"Convenience","Euroimmun, Roche, Ortho-Clinical Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Rickey Carter","The Mayo Clinic","https://dx.doi.org/10.1016/j.mayocp.2021.03.015","Verified",0.005,0.007,"","","","US",""
"2021-05-25","210512_Denmark_CopenhagenUniversityHospital_PEH1_Overall","SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study","2021-05-12","National","Denmark","Denmark; Central, North, Capital, South;  Copenhagen, Aarhus, Aalborg and Odense","2020-11-02","2020-11-20","Persons experiencing homelessness","Adults (18-64 years)",628.0,0.068,"Convenience","CTK Biotech","IgG; IgM","Moderate","Preprint","Alexandra R Rothlin Eriksen","Copenhagen University Hospital","https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2","Verified","","",0.969,0.994,"","DK",""
"2021-05-25","210512_Denmark_CopenhagenUniversityHospital_ShelterWorkers2_Overall","SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study","2021-05-12","National","Denmark","Denmark; Central, North, Capital, South;  Copenhagen, Aarhus, Aalborg and Odense","2020-11-02","2020-11-20","Essential non-healthcare workers","Adults (18-64 years)",191.0,0.063,"Convenience","CTK Biotech","IgG; IgM","High","Preprint","Alexandra R Rothlin Eriksen","Copenhagen University Hospital","https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2","Verified","","",0.969,0.994,"","DK",""
"2021-05-26","210420_Kashmir_GovernmentMedicalCollege","SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.","2021-04-20","Regional","India","India; Kashmir","2020-06-15","2020-06-29","Health care workers and caregivers","Multiple groups",2905.0,0.025,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Muhammad Salim Khan","Government Medical College","https://dx.doi.org/10.12788/jhm.3609","Unverified",0.02,0.031,1.0,0.99,"","IN","IN-JK"
"2021-05-26","210420_NewYorkCity_BronxCareHealthSystem","SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.","2021-04-20","Local","United States of America","United States of America; New York State; New York City","2020-05-18","2020-06-26","Health care workers and caregivers","Multiple groups",2749.0,0.302,"Convenience","Roche","Not reported","High","Journal Article (Peer-Reviewed)","Murli U Purswani","BronxCare Health System","https://dx.doi.org/10.12788/jhm.3627","Unverified",0.29,0.32,0.971,1.0,"","US","US-NY"
"2021-05-27","201202_Rome_UniversitàCattolicaDelSacroCuore_overall","No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy","2020-12-02","Local","Italy","Italy; Lazio; Rome","2019-12-01","2020-02-29","Patients seeking care for non-COVID-19 reasons","Multiple groups",451.0,0.0,"Convenience","1) DiaPro; 2) Eagle Bioscience","IgG","High","Journal Article (Peer-Reviewed)","Francesca Lombardi","Università Cattolica del Sacro Cuore","http://dx.doi.org/10.1016/j.cmi.2020.11.026","Verified",0.0,0.0,"","","","IT","IT-62"
"2021-05-27","201205_Maryland_MarylandDepartmentOfHealth_overall","Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Status in Decedents Undergoing Forensic Postmortem Examination in Maryland, May 24 to June 30, 2020","2020-12-15","Regional","United States of America","United States of America; Maryland","2020-05-24","2020-06-30","Residual sera","Multiple groups",500.0,0.1,"Sequential","Hangzhou Biotest Bioctech Co.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Keri N Althoff","The Maryland Department of Health","https://dx.doi.org/10.1093/ofid/ofaa611","Unverified","","",0.95,1.0,"","US","US-MD"
"2021-05-27","210420_Iran_TehranUniversityOfMedicalSciences","SARS-CoV-2 serological assay and viral testing: a report of professional football setting.","2021-04-20","National","Iran (Islamic Republic of)","Iran (Islamic Republic of)","2020-09-15","2020-10-15","Non-essential workers and unemployed persons","Adults (18-64 years)",1243.0,0.179,"Entire sample","Pishtaxz Teb Diagnostics","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Bahar Hassanmirzaei","Tehran University of Medical Sciences","https://dx.doi.org/10.1136/postgradmedj-2021-140176","Verified",0.158,0.201,0.794,0.973,"","IR",""
"2021-05-27","210426_England_CambridgeUniversityHospitalsNHS","SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic","2021-04-24","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",434.0,0.078,"Convenience","Abbexa","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","DM Favara","Cambridge University Hospitals NHS Foundation Trust","https://dx.doi.org/10.1016/j.clon.2021.04.005","Unverified","","",0.985,0.979,"","GB","GB-ENG"
"2021-05-27","210427_Connecticut_HartfordHealthcare_overall","Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.","2021-04-27","Regional","United States of America","United States of America; Connecticut; Hartford","2020-05-11","2020-08-16","Health care workers and caregivers","Multiple groups",6863.0,0.063,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Pavlos Papasavas","Hartford Healthcare","https://dx.doi.org/10.1016/j.jhin.2021.04.021","Verified",0.057,0.069,1.0,0.996,"","US","US-CT"
"2021-05-27","210429_Fortaleza_StateUniversityofCearáCampusdoItaperi_Overall","Prevalence of COVID-19 in children, adolescents, and adults in remote education situation in the city of Fortaleza - Brazil.","2021-05-01","Local","Brazil","Brazil; Ceará; Fortaleza","2020-11-09","2020-12-09","Multiple populations","Multiple groups",1559.0,0.267,"Simplified probability","Beijing Lepu Medical Technology Co., Ltd.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Valdester Cavalcante Pinto Junior","State University of Ceará, Campus do Itaperi","https://dx.doi.org/10.1016/j.ijid.2021.04.086","Verified","","",0.989,0.976,"","BR","BR-CE"
"2021-05-27","210506_Boston_BostonMedicalCenter_Overall","Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.","2021-05-06","Local","United States of America","United States of America; Massachusetts; Boston","2020-07-13","2020-07-26","Health care workers and caregivers","Multiple groups",1743.0,0.054,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Yachana Kataria","Boston Medical Center","https://dx.doi.org/10.1038/s41598-021-89107-5","Verified","","","","","","US","US-MA"
"2021-05-27","210521_Bengaluru_BangaloreMedicalCollege","One in five has antibodies against Covid in slums in Bengalu: Study","2021-05-21","Local","India","India; Karnataka; Bangalore","2021-04-15","2021-04-22","Persons living in slums","Multiple groups",728.0,0.203,"Convenience","NR","Not reported","High","News and Media","Ranganath TS","Bangalore Medical College and Research Institute","https://timesofindia.indiatimes.com/city/bengaluru/one-in-five-has-antibodies-against-covid-in-slums-in-bengaluru-study/articleshow/82825325.cms","Unverified","","","","","","IN","IN-KA"
"2021-05-27","210522_UK_UniversityCollegeLondon_overall","Household overcrowding and risk of SARS-CoV-2: analysis of the Virus Watch prospective community cohort study in England and Wales","2021-05-22","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England and Wales","2021-02-01","2021-05-03","Household and community samples","Multiple groups",10330.0,0.082,"Convenience","Roche","Total Antibody","Moderate","Preprint","Robert W Aldridge","University College London","https://www.medrxiv.org/content/10.1101/2021.05.10.21256912v2","Verified","","","","","","GB","GB-ENG"
"2021-05-28","210118_Hangzhou_ZhejiangUniversitySchoolofMedicine_Overall","Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.","2021-01-18","Local","China","China; Zhejiang; Hangzhou","2020-04-24","2020-05-08","Multiple populations","Multiple groups",16043.0,0.005,"Convenience","Livzon, Zhuhai, Guangzhou, China; Vazyme, Nanjing, Jiangsu, China)","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jun Huang","Zhejiang University School of Medicine","https://dx.doi.org/10.21037/atm-20-7163","Verified","","","","","","CN","CN-33"
"2021-05-28","210415_Poland_MedicalUniversityOfSilesiaInKatowice_Overall","Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland.","2021-04-21","Regional","Poland","Poland; Silesian Voivodeship; Katowice, Gliwice, Sosnowiec","2020-10-15","2020-11-15","Household and community samples","Multiple groups",5479.0,0.229,"Self-referral","EUROIMMUN POLSKA Sp. z o.o.","IgG","High","Journal Article (Peer-Reviewed)","Małgorzata Kowalska","Medical University of SilesiaIn Katowice","https://dx.doi.org/10.3390/vaccines9050415","Verified","","","","","","PL","PL-24"
"2021-05-28","210428_Europe_SorbonneUniversité_2Île-de-France","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","France","France; Île-de-France","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",593.0,0.071,"Convenience","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","","","","","","FR","FR-IDF"
"2021-05-28","210501_Rome_SapienzaUniversity","Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab.","2021-05-01","Local","Italy","Italy; Lazio; Rome","2020-05-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",17377.0,0.012,"Convenience","DiaSorin; Roche Diagnostics","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Guido Antonelli","Sapienza University","https://dx.doi.org/10.1016/S2666-5247(21)00083-5","Verified","","","","","","IT","IT-62"
"2021-05-28","210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareResidents1","The Demography and Characteristic of SARS-CoV-2 Sero-positive Residents and Staff of Nursing Homes for Older Adults in the Community of Madrid: the SeroSOS Study.","2021-05-04","Local","Spain","Spain","2020-07-07","2020-10-23","Assisted living and long-term care facilities","Seniors (65+ years)",9332.0,0.554,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Francisco Javier Candel","Hospital General Universitario La Paz","https://dx.doi.org/10.1093/ageing/afab096","Verified",0.544,0.564,1.0,0.996,"","ES",""
"2021-05-28","210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareWorkers2","The Demography and Characteristic of SARS-CoV-2 Sero-positive Residents and Staff of Nursing Homes for Older Adults in the Community of Madrid: the SeroSOS Study.","2021-05-04","Local","Spain","Spain","2020-07-07","2020-10-23","Health care workers and caregivers","Adults (18-64 years)",10614.0,0.315,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Francisco Javier Candel","Hospital General Universitario La Paz","https://dx.doi.org/10.1093/ageing/afab096","Verified",0.306,0.324,1.0,0.996,"","ES",""
"2021-05-28","210506_Berlin_FreieUniversitätBerlin","SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany - a cross sectional study.","2021-05-06","Local","Germany","Germany; Berlin; Berlin","2020-09-28","2020-10-02","Students and Daycares","Multiple groups",720.0,0.001,"Convenience","Euroimmun AG, Lübeck, Germany","IgG","High","Journal Article (Peer-Reviewed)","Marlene Thielecke","Freie Universität Berlin","https://dx.doi.org/10.1093/eurpub/ckab079","Unverified","","","","","","DE","DE-BE"
"2021-05-28","210506_Gabon_CHUMèreEnfantFondationJeanneEbori","Dynamic and features of SARS-CoV-2 infection in Gabon.","2021-05-06","National","Gabon","Gabon","2020-03-15","2020-08-15","Contacts of COVID patients","Multiple groups",319.0,0.55,"Convenience","Roche; bioMerieux","Not reported","Unclear","Journal Article (Peer-Reviewed)","Amandine Mveang Nzoghe","CHU Mère Enfant Fondation Jeanne Ebori","https://dx.doi.org/10.1038/s41598-021-87043-y","Verified","","","","","","GA",""
"2021-05-28","210507_Ethiopia_EthiopianPublicHealthInstitute_AddisAbaba","Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic","2021-05-07","Local","Ethiopia","Ethiopia; Oromia Region; Addis Ababa","2020-07-22","2020-09-02","Household and community samples","Multiple groups",956.0,0.035,"Stratified probability","Core Technology Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saro Abdella","Ethiopian Public Health Institute","http://dx.doi.org/10.1016/j.eclinm.2021.100880","Verified",0.017,0.054,0.69,0.97,"","ET","ET-OR"
"2021-05-28","210507_Ethiopia_EthiopianPublicHealthInstitute_JimmaRegion","Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic","2021-05-07","Local","Ethiopia","Ethiopia; Oromia Region; Jimma","2020-07-22","2020-09-02","Household and community samples","Multiple groups",900.0,0.006,"Stratified probability","Core Technology Co.","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saro Abdella","Ethiopian Public Health Institute","http://dx.doi.org/10.1016/j.eclinm.2021.100880","Verified",0.001,0.018,0.69,0.97,"","ET","ET-OR"
"2021-05-28","210508_NorthCarolina_FirstHealthoftheCarolinas_Overall","SARS-CoV2 Antibody Positivity Rates and Employee Expectations of Positivity Rates among Health Care Workers at a Community Hospital in North Carolina.","2021-05-08","Regional","United States of America","United States of America; North Carolina","2020-06-10","2020-07-17","Health care workers and caregivers","Multiple groups",2076.0,0.03,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","GS Arnoczy","FirstHealth of the Carolinas","https://dx.doi.org/10.1016/j.ajic.2021.04.086","Unverified",0.019,0.033,"","","","US","US-NC"
"2021-05-28","210512_Vienna_LudwigBoltzmannInstituteForLungHealth_overall","Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown.","2021-05-12","Local","Austria","Austria","2020-04-20","2020-05-20","Household and community samples","Multiple groups",12419.0,0.013,"Stratified probability","1) Roche ; 2) N/A - in house ; 3) Euroimmun","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Marie Kathrin Breyer","Ludwig Boltzmann Institute for Lung Health","https://dx.doi.org/10.1038/s41598-021-89711-5","Verified","","","","","","AT",""
"2021-05-28","210513_Ulm_UlmUniversity_Overall","Longitudinal SARS-CoV-2 infection study at Ulm University: Test and hygiene concepts for classroom teaching during the pandemic in medical school","2021-05-13","Local","Germany","Germany; Baden-Württemberg; Ulm","2020-11-15","2021-03-07","Multiple populations","Adults (18-64 years)",818.0,0.145,"Convenience","Roche Diagnostics","IgG; IgM; IgA","Moderate","Preprint","Michael Schon","Ulm University","https://www.medrxiv.org/content/10.1101/2021.05.04.21256382v2.full-text","Unverified","","",0.988,1.0,"","DE","DE-BW"
"2021-05-28","210514_Madrid_HospitalUniversitarioLaPaz","Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases. Cross-sectional study from a reference centre in Spain","2021-05-14","Local","Spain","Spain; Madrid; Madrid","2020-09-15","2021-02-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",105.0,0.2,"Convenience","NR","IgG","High","Preprint","Clara Udaondo","Hospital Universitario La Paz","https://www.researchsquare.com/article/rs-505561/v1","Verified","","","","","","ES","ES-MD"
"2021-05-28","210518_Stockholm_KarolinskaInstitutet","Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden","2021-05-18","Local","Sweden","Sweden; Uppland; Stockholm","2020-03-14","2021-02-28","Multiple general populations","Adults (18-64 years)",5100.0,0.192,"Simplified probability","NR; In house","IgG","Moderate","Journal Article (Peer-Reviewed)","Xaquin Castro Dopico","Karolinska Institutet","https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13304","Verified",0.151,0.244,"","","","SE","SE-AB"
"2021-05-29","210318_Sarajevo_InternationalBurchUniversity_DrAbdulahNakasGeneralHospital1_overall","Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report.","2021-03-18","Local","Bosnia and Herzegovina","Bosnia and Herzegovina","2020-04-15","2020-05-15","Residual sera","Multiple groups",1720.0,0.034,"Convenience","Artron","IgG; IgM","High","Journal Article (Peer-Reviewed)","Adna Asic","International Burch University","https://dx.doi.org/10.5114/aoms/134143","Verified","","","","","","BA",""
"2021-05-29","210318_Sarajevo_InternationalBurchUniversity_EurofarmCentreLaboratory2_overall","Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report.","2021-03-18","Local","Bosnia and Herzegovina","Bosnia and Herzegovina","2020-04-21","2020-07-17","Residual sera","Multiple groups",1121.0,0.043,"Convenience","Dynamiker Biotechnology Co.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Adna Asic","International Burch University","https://dx.doi.org/10.5114/aoms/134143","Verified","","","","","","BA",""
"2021-05-29","210504_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM","Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study.","2021-05-04","Local","Italy","Italy; Sardinia; Cagliari","2020-09-01","2020-12-10","Patients seeking care for non-COVID-19 reasons","Multiple groups",121.0,0.107,"Convenience","Snibe","IgG; IgM","High","Journal Article (Peer-Reviewed)","Federico Cappellacci","University of Cagliari","https://dx.doi.org/10.1016/j.amsu.2021.102375","Verified","","","","","","IT","IT-88"
"2021-05-29","210505_Johannesburg_UniversityoftheWitwatersrand","SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study.","2021-05-05","Local","South Africa","South Africa; Gauteng Province; Johannesburg","2020-04-22","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",395.0,0.413,"Convenience","In-House: University of the Witwatersrand","IgG","High","Journal Article (Peer-Reviewed)","Marta Nunes","University of the Witwatersrand","https://dx.doi.org/10.1093/cid/ciab398","Verified","","",1.0,1.0,"","ZA","ZA-GT"
"2021-05-29","210507_Stockholm_KarolinskaUniversityHospital","SARS-CoV-2 Infections Among Healthcare Workers Outside Hospitals","2021-05-07","Local","Sweden","Sweden; Uppland; Stockholm","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",839.0,0.12,"Convenience","NR","IgG","Moderate","Preprint","Maria Froberg","Karolinska University Hospital","https://www.researchsquare.com/article/rs-493146/v1","Verified","","",0.992,0.998,"","SE","SE-AB"
"2021-05-29","210513_Lyon_CentreHospitalierSaintJosephSaintLuc","Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital.","2021-05-13","Local","France","France; Auvergne-Rhône-Alpes; Lyon","2020-06-08","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",971.0,0.09,"Convenience","Roche Diagnostic","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Emmanuel Vivier","Centre Hospitalier Saint Joseph Saint Luc","https://dx.doi.org/10.1186/s13613-021-00868-8","Verified",0.088,0.092,0.99,0.99,"","FR","FR-ARA"
"2021-05-29","210527_Estonia_UniversityOfTartu_Stage17_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","Estonia","Estonia","2021-05-13","2021-05-24","Household and community samples","Multiple groups",2290.0,0.495,"Stratified probability","Synlab","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.475,0.516,"","","","EE",""
"2021-05-30","210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_Dallas1","Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST).","2021-04-13","Local","United States of America","United States of America; Texas; Dallas","2020-03-01","2021-03-31","Residual sera","Multiple groups",2533.0,0.389,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Madhusudhanan Narasimhan","University of Texas Southwestern Medical Center","https://dx.doi.org/10.3390/vaccines9040376","Unverified","","","","","","US","US-TX"
"2021-05-30","210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_DallasFortWorth2","Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST).","2021-04-13","Local","United States of America","United States of America; Texas; Dallas-Fort Worth","2020-06-01","2021-02-28","Residual sera","Multiple groups",21101.0,0.071,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Madhusudhanan Narasimhan","University of Texas Southwestern Medical Center","https://dx.doi.org/10.3390/vaccines9040376","Unverified","","","","","","US","US-TX"
"2021-05-30","210428_Europe_SorbonneUniversité_1Nordrhein-Westfalen","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Germany","Germany; Nordrhein-Westfalen","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",624.0,0.008,"Convenience","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","","","","","","DE","DE-NW"
"2021-05-30","210428_Europe_SorbonneUniversité_3Centro","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Portugal","Portugal; Região do Centro","2020-07-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",526.0,0.011,"Convenience","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","","","","","","PT",""
"2021-05-30","210428_Europe_SorbonneUniversité_5EmiliaRomagna","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Italy","Italy; Emilia Romagna","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",522.0,0.015,"Convenience","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","","","","","","IT","IT-45"
"2021-05-30","210430_Tokyo_NationalCenterForGlobalHealthAndMedicine_Primary","Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan.","2021-04-30","Local","Japan","Japan; Tokyo Prefecture; Tokyo","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1228.0,0.001,"Convenience","Abbott","IgG","Moderate","Journal Article (Peer-Reviewed)","Shohei Yamamoto","National Center for Global Health and Medicine","https://dx.doi.org/10.35772/ghm.2021.01022","Verified",0.0,0.005,1.0,0.999,"","JP","JP-13"
"2021-05-30","210506_Luanda_InstitutoNacionaldeInvestigaçãoemSaúde_IgG","Serological identification of past and recent SARS-CoV-2 infection through antibody screening in Luanda, Angola.","2021-05-06","Local","Angola","Angola; Luanda Province; NR","2020-07-15","2020-09-15","Residual sera","Multiple groups",660.0,0.011,"Convenience","bioMérieux SA","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cruz Sebastiao","Instituto Nacional de Investigação em Saúde","https://dx.doi.org/10.1002/hsr2.280","Verified","","","","","","AO","AO-LUA"
"2021-05-30","210510_Denmark_CopenhagenUniversityHospital_BloodDonorsOverall","Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark","2021-05-10","National","Denmark","Denmark","2021-01-08","2021-01-31","Blood donors","Multiple groups",22677.0,0.058,"Entire sample","Beijing Wantai Biological Pharmacy Enterprise","Not reported","Moderate","Preprint","Kamille Fogh","Copenhagen University Hospital","https://doi.org/10.1101/2021.05.07.21256725","Verified","","","","","","DK",""
"2021-05-30","210510_Denmark_CopenhagenUniversityHospital_SHOverall","Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark","2021-05-10","National","Denmark","Denmark","2021-01-08","2021-01-31","Household and community samples","Multiple groups",13279.0,0.173,"Stratified non-probability","CTK Biotech inc","IgG; IgM","Moderate","Preprint","Kamille Fogh","Copenhagen University Hospital","https://doi.org/10.1101/2021.05.07.21256725","Verified","","",0.9,1.0,"","DK",""
"2021-05-30","210518_Sergipe_FederalUniversityofSergipe_overall","Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.","2021-05-18","Regional","Brazil","Brazil; Sergipe","2020-07-01","2020-07-31","Household and community samples","Multiple groups",5615.0,0.093,"Stratified probability","Guangzhou Wondfo Biotech Co., Ltd.; BioSys + Kovalent","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Adriano Antunes de Souza Araújo","Federal University of Sergipe","https://dx.doi.org/10.1017/S0950268821001163","Verified",0.085,0.101,"","","","BR","BR-SE"
"2021-05-31","210409_NewDelhi_MaulanaAzadMedicalCollege","Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India.","2021-04-09","Local","India","India; National Capital Territory of Delhi; New Delhi","2020-08-15","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",1401.0,0.121,"Convenience","ICMR-NIV","IgG","Moderate","Journal Article (Peer-Reviewed)","Pragya Sharma","Maulana Azad Medical College","https://dx.doi.org/10.24171/j.phrp.2021.12.2.06","Verified",0.104,0.138,0.924,0.979,"","IN","IN-DL"
"2021-05-31","210427_Oman_Directorate-GeneralforDiseasesSurveillanceandControl_Primary","The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study.","2021-04-27","Regional","Oman","Oman; Al Dakhilia, North Batinah, and South Batinah goveronates","2020-09-14","2020-09-28","Health care workers and caregivers","Adults (18-64 years)",1078.0,0.21,"Stratified probability","DiaSorin","IgG","Moderate","Journal Article (Peer-Reviewed)","Amal Al Maani","Directorate-General for Diseases Surveillance and Control","https://dx.doi.org/10.1016/j.ijid.2021.04.071","Verified","","","","","","OM",""
"2021-05-31","210428_Europe_SorbonneUniversité_4ComunidaddeMadrid","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Spain","Spain; Comunidad de Madrid","2020-07-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",524.0,0.134,"Convenience","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","","","","","","ES","ES-MD"
"2021-05-31","210428_Europe_SorbonneUniversité_6London","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; London; London","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",239.0,0.146,"Convenience","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","","","","","","GB","GB-ENG"
"2021-05-31","210510_Cantabria_UniversityofCantabria_Overall","Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home.","2021-05-10","Regional","Spain","Spain; Cantabria; NR","2020-04-27","2020-05-29","Household and community samples","Multiple groups",1022.0,0.031,"Stratified probability","Hangzhou Clongene Biotech Co., Ltd., China","IgG","Low","Journal Article (Peer-Reviewed)","Paula Iruzubieta","University of Cantabria","https://dx.doi.org/10.1038/s41598-021-89236-x","Verified",0.022,0.044,0.974,0.989,"","ES","ES-CB"
"2021-05-31","210511_SkåneUniversityHospital_LundUniversity_HCW","Post-outbreak serological screening for SARS-CoV-2 infection in healthcare workers at a Swedish University Hospital","2021-05-11","Local","Sweden","Sweden","2020-08-01","2020-08-22","Health care workers and caregivers","Adults (18-64 years)",107.0,0.355,"Convenience","ZetaGene","IgG; IgM","High","Journal Article (Peer-Reviewed)","Rasmus Strand","Lund University","https://dx.doi.org/10.1080/23744235.2021.1925739","Verified","","",0.95,0.97,"","SE",""
"2021-06-01","210413_Tubingen_EberhardKarlsUniversitatTubingen","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre","2021-04-13","Local","Germany","Germany; Baden-Württemberg; Tubingen","2020-05-01","2020-05-01","Essential non-healthcare workers","Adults (18-64 years)",318.0,0.028,"Convenience","Roche Diagnostics, Siemens Healthcare Diagnostics, Mediagnost","Not reported","High","Journal Article (Peer-Reviewed)","Focke Ziemssen","Eberhard Karls Universitat Tubingen","https://bmjophth.bmj.com/content/bmjophth/6/1/e000688.full.pdf","Unverified",0.015,0.053,"","","","DE","DE-BW"
"2021-06-01","210427_EastLondon_QueenMaryUniversityofLondon","Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK.","2021-04-27","Local","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-06-15","2020-08-15","Health care workers and caregivers","Multiple groups",2001.0,0.253,"Convenience","Panbio Abbott; Abbott; Roche","IgG; IgM","High","Journal Article (Peer-Reviewed)","Naheed Choudhry","Queen Mary University of London","https://dx.doi.org/10.3389/fmed.2021.642723","Unverified","","","","","","GB",""
"2021-06-01","210430_Baltimore_JohnsHopkinsUniversity_Overall","Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department.","2021-04-30","Local","United States of America","United States of America; Maryland; Baltimore","2020-03-16","2020-05-31","Residual sera","Multiple groups",3255.0,0.035,"Sequential","1) Euroimmun; 2) Hangzhou Biotest Biotech Co.","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oliver Laeyendecker","Johns Hopkins University","https://dx.doi.org/10.1016/j.ajem.2021.04.081","Verified",0.029,0.042,0.84,1.0,"","US","US-MD"
"2021-06-01","210518_Mid-WestIreland_UniversityofLimerick_Staff1","Seroprevalence study of SARS-CoV-2 infection in General Practice in Ireland.","2021-05-18","Regional","Ireland","Ireland; Munster","2020-06-15","2020-07-10","Health care workers and caregivers","Multiple groups",172.0,0.111,"Convenience","Maccura Biotechnology Ltd, Chengdu, China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Michael Edmund O'Callaghan","University of Limerick","https://dx.doi.org/10.3399/BJGPO.2021.0038","Unverified",0.04,0.19,"","","","IE","IE-M"
"2021-06-02","200515_Tokyo_UniversityOfTokyo","About antibody positive rate test results in Tokyo","2020-05-15","Local","Japan","Japan; Tokyo Prefecture; Tokyo","2020-05-01","2020-05-02","Residual sera","Multiple groups",500.0,0.006,"Convenience","JSR Corporation","IgG; IgM","High","Presentation or Conference","Tatsuhiko Kodama","University of Tokyo","https://www.rcast.u-tokyo.ac.jp/ja/news/release/20200515.html","Verified","","","","","","JP","JP-13"
"2021-06-02","210403_Majadahonda_HospitalUniversitarioPuertaDeHierro_overall_Unadj","Impact of COVID-19 pandemic on patients and health professionals of a radiation oncology department at a Spanish tertiary hospital","2021-04-03","Local","Spain","Spain","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",50.0,0.12,"Convenience","Vircell","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jesus Romero","Hospital Universitario Puerta de Hierro","10.5603/RPOR.a2021.0036","Unverified","","","","","","ES",""
"2021-06-02","210427_Juba_WorldHealthOrganization_Overall_PopTestAdj","Seroprevalence of severe acute respiratory syndrome coronavirus 2 IgG in Juba, South Sudan, 2020","2021-04-27","Local","South Sudan","South Sudan; Central Equatoria; Juba","2020-08-10","2020-09-11","Household and community samples","Multiple groups",2214.0,0.383,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Kirsten E Wiens","World Health Organization","https://dx.doi.org/10.3201/eid2706.210568","Verified","","",0.655,1.0,"","SS",""
"2021-06-02","210512_Lübeck_UniversityofLübeck_TotalStudy","Cohort-based surveillance of SARS-CoV2 transmission mirrors infection rates at the population level a one-year longitudinal study","2021-05-12","Local","Germany","Germany","2020-05-06","2021-02-01","Household and community samples","Multiple groups",3051.0,0.034,"Self-referral","EUROIMMUN","IgG","High","Preprint","Christine Klein","University of Lübeck","https://www.medrxiv.org/content/10.1101/2021.05.10.21256966v1.full-text","Verified","","","","","","DE",""
"2021-06-02","210518_Mid-WestIreland_UniversityofLimerick_Patients2","Seroprevalence study of SARS-CoV-2 infection in General Practice in Ireland.","2021-05-18","Regional","Ireland","Ireland; Munster","2020-06-15","2020-07-10","Health care workers and caregivers","Multiple groups",799.0,0.126,"Convenience","Maccura Biotechnology Ltd, Chengdu, China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Michael Edmund O'Callaghan","University of Limerick","https://dx.doi.org/10.3399/BJGPO.2021.0038","Unverified",0.08,0.17,"","","","IE","IE-M"
"2021-06-03","210430_UnitedStates_MedicalUniversityofSouthCarolina","Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients.","2021-04-30","Regional","United States of America","United States of America; South Carolina, North Carolina, Georgia","2020-05-15","2020-07-15","Blood donors","Multiple groups",60835.0,0.026,"Sequential","In-House (Medical University of South Carolina); Genscript","IgG; Neutralizing ; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Connor Dwyer","Medical University of South Carolina","https://dx.doi.org/10.1016/j.isci.2021.102489","Verified","","","","","","US",""
"2021-06-03","210508_Ahmedabad_GujaratUniversity","SARS-CoV2 IgG antibody: Seroprevalence among health care workers.","2021-05-08","Local","India","India; Gujarat; Ahmedabad","2020-08-15","2020-08-31","Health care workers and caregivers","Multiple groups",1710.0,0.236,"Convenience","Zydus Diagnostics","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Gujarat University","https://dx.doi.org/10.1016/j.cegh.2021.100766","Unverified",0.217,0.257,0.924,0.979,"","IN","IN-GJ"
"2021-06-03","210517_Quebec_Héma-Québec_PopAdj","SARS-CoV-2 seroprevalence among blood donors in Quebec, and analysis of symptoms associated with seropositivity: a nested case-control study.","2021-05-17","Regional","Canada","Canada; Québec","2020-05-25","2020-07-09","Blood donors","Adults (18-64 years)",7691.0,0.022,"Convenience","NA- author designed","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Antoine Lewin","Héma-Québec","https://dx.doi.org/10.17269/s41997-021-00531-6","Verified",0.019,0.026,0.989,0.985,"","CA","CA-QC"
"2021-06-03","210519_UnitedStates_QuestDiagnostics","Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults.","2021-05-19","National","United States of America","United States of America","2020-08-15","2020-11-15","Non-essential workers and unemployed persons","Adults (18-64 years)",18148.0,0.05,"Convenience","Ortho Clinical Diagnostics; Abbott Laboratories","IgG","Moderate","Journal Article (Peer-Reviewed)","Yonghong Li","Quest Diagnostics","https://dx.doi.org/10.1001/jamanetworkopen.2021.11634","Verified","","","","","","US",""
"2021-06-04","210316_MetropolitanDetroit_HenryFordHealthSystem","SARS-CoV-2 RT-PCR positivity and antibody prevalence among asymptomatic hospital-based health care workers.","2021-03-16","Local","United States of America","United States of America; Michigan; Detroit","2020-06-17","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",374.0,0.024,"Simplified probability","Beckman Coulter","IgG","Moderate","Journal Article (Peer-Reviewed)","Christine C Johnson","Henry Ford Health System","https://dx.doi.org/10.1016/j.jcv.2021.104794","Unverified",0.013,0.045,"","","","US","US-MI"
"2021-06-04","210512_Canada_UniversityofAlberta_April1","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard","2021-05-12","National","Canada","Canada","2020-04-01","2020-04-30","Blood donors","Adults (18-64 years)",8999.0,0.031,"Convenience","N/A- author designed","IgG","High","Preprint","Sahar Saeed","University of Alberta","https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1","Unverified","","",0.891,"","","CA",""
"2021-06-04","210512_Canada_UniversityofAlberta_September2","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard","2021-05-12","National","Canada","Canada","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",8999.0,0.027,"Simplified probability","N/A- author designed","IgG","Moderate","Preprint","Sahar Saeed","University of Alberta","https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1","Unverified","","",0.891,0.982,"","CA",""
"2021-06-05","210226_Vorarlberg_VorarlberbInstituteForVascularInvestigationAndTreatment_overall","SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021","2021-02-26","Regional","Austria","Austria; Vorarlberg","2020-06-26","2021-01-20","Health care workers and caregivers","Adults (18-64 years)",395.0,0.18,"Convenience","Technoclone","IgG","High","Preprint","Michele Atzl","Vorarlberg Institute for Vascular Investigation and Treatment","https://www.medrxiv.org/content/10.1101/2021.02.19.21252045v2","Verified","","","","","","AT","AT-8"
"2021-06-05","210504_Texas_UniversityofTexasSouthwestern","Front line provider risk for SARS-CoV- 2 over time in an urban county","2021-05-04","Local","United States of America","United States of America; Texas; Dallas","2020-06-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",549.0,0.033,"Self-referral","Abbott","IgG","High","Presentation or Conference","Gilberto Salazar","University of Texas Southwestern","http://dx.doi.org/10.1111/acem.14249","Verified","","","","","","US","US-TX"
"2021-06-05","210510_Paris_GroupeHospitalierNordEssonneLongjumeau","Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children.","2021-05-10","Local","France","France; Île-de-France; Paris","2020-05-08","2020-07-27","Contacts of COVID patients","Multiple groups",120.0,0.39,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Lorelei Charbonnier","Groupe Hospitalier Nord Essonne Longjumeau","https://dx.doi.org/10.3389/fped.2021.638502","Unverified","","",1.0,1.0,"","FR","FR-IDF"
"2021-06-05","210510_UK_PublicHealthEngland_Primary_RocheS","Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021","2021-05-10","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2021-02-22","2021-03-21","Blood donors","Multiple groups",7720.0,0.464,"Convenience","Roche","Not reported","Moderate","Journal Article (Peer-Reviewed)","Heather J Whitaker","Public Health England","http://dx.doi.org/10.1016/j.jinf.2021.04.037","Verified",0.454,0.475,0.97,0.998,"","GB",""
"2021-06-05","210525_UnitedStates_RutgersUniversity_Primary","A Nationwide Survey of COVID-19 Testing in LGBTQ+ Populations in the United States.","2021-05-25","National","United States of America","United States of America","2020-05-07","2020-07-31","Household and community samples","Multiple groups",124.0,0.363,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Richard Martino","Rutgers University","https://dx.doi.org/10.1177/00333549211018190","Verified","","","","","","US",""
"2021-06-05","210601_Providence_BrownUniversity","Seroprevalence of SARS-CoV-2 among Internal Medicine Residents at a Major Academic Medicine Residency Program.","2021-06-01","Local","United States of America","United States of America; Rhode Island; Providence","2020-06-08","2020-06-23","Health care workers and caregivers","Adults (18-64 years)",101.0,0.029,"Convenience","Abbott, Lake Forest, IL","IgG","High","Journal Article (Peer-Reviewed)","Matthew Murphy","Brown University","http://rimed.org/rimedicaljournal/2021/06/2021-06-20-contribution-murphy.pdf","Verified","","","","","","US","US-RI"
"2021-06-06","201216_Mexico_GovernmentOfMexico_overall","Secretaría de Salud presenta resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19","2020-12-16","National","Mexico","Mexico","2020-08-15","2020-11-15","Household and community samples","Multiple groups",7098.0,0.25,"Unclear","NR","Not reported","Unclear","News and Media","Secretaria de Salud","Government of Mexico","https://www.gob.mx/salud/prensa/255-secretaria-de-salud-presenta-resultados-preliminares-de-la-encuesta-nacional-de-salud-y-nutricion-covid-19?idiom=es","Verified","","","","","","MX",""
"2021-06-06","20210524_NCGM_Japan_hcw","Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.","2021-05-24","Regional","Japan","Japan","2020-10-01","2020-12-31","Essential non-healthcare workers","Adults (18-64 years)",2563.0,0.007,"Convenience","Abbott; Roche; EUROIMMUN","IgG","Unclear","Journal Article (Peer-Reviewed)","Shohei Yamamoto","The National Center for Global Health and Medicine (NCGM)","https://dx.doi.org/10.1016/j.jinf.2021.05.017","Unverified",0.004,0.011,"","","","JP",""
"2021-06-06","210319_Ecuador_ InstitutoEcuatorianodeEnfermedadesDigestivas","Rapid covid-19 antibodies screening testing combined with clinical evaluation for resuming activities in the endoscopy unit: A single-center experience","2021-03-19","Local","Ecuador","Ecuador; Guayas; Guayaquil","2020-04-15","2020-05-22","Residual sera","Adults (18-64 years)",127.0,0.071,"Convenience","Not reported","IgM","High","Journal Article (Peer-Reviewed)","C Robles Medranda","Instituto Ecuatoriano de Enfermedades Digestivas","http://dx.doi.org/10.1055/s-0041-1724977","Verified","","","","","","EC","EC-G"
"2021-06-06","210408_Malegaon_MunicipalCorporationofMalegaon_genpop_overall","Seroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra.","2021-04-08","Local","India","India","2020-07-25","2020-08-20","Household and community samples","Multiple groups",336.0,0.4,"Stratified non-probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Pallavi Saple","The Municipality of Malegaon","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140273/","Verified",0.35,0.45,0.93,1.0,"","IN",""
"2021-06-06","210521_Zurich_UniversityofZurich_overall","Long-term symptoms after SARS-CoV-2 infection in school children: population-based cohort with 6-months follow-up. Short Report","2021-05-21","Local","Switzerland","Switzerland","2020-06-15","2021-04-15","Students and Daycares","Children and Youth (0-17 years)",1355.0,0.08,"Simplified probability","Institute of Medical Virology, University of ZUrich","IgG; IgM; IgA","Moderate","Preprint","Thomas Radtke","University of Zurich","https://www.medrxiv.org/content/10.1101/2021.05.16.21257255v2","Unverified","","",0.943,0.99,"","CH",""
"2021-06-06","210526_Chile_UniversidadDelDesarrollo_Overall2_Overall","Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.","2021-05-26","Local","Chile","Chile; Santiago; Santiago","2020-04-27","2020-07-31","Health care workers and caregivers","Multiple groups",446.0,0.24,"Convenience","Vircell, Euroimmun","IgG","High","Journal Article (Peer-Reviewed)","Mirentxu Iruretagoyena","Universidad del Desarrollo","https://dx.doi.org/10.1186/s12879-021-06208-2","Verified",0.202,0.283,"","","","CL",""
"2021-06-06","210526_HospitalUniversitarioFundacionJimenezDiaz_Madrid_hcw","Serological study of healthcare workers in four different hospitals in Madrid (Spain) with no previous history of COVID-19.","2021-05-26","Local","Spain","Spain","2020-04-06","2020-04-25","Health care workers and caregivers","Multiple groups",5995.0,0.162,"Convenience","Biozek Medical","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Fabian Vazquez Rivas","Fundación Jiménez Díaz University Hospital","https://dx.doi.org/10.1136/oemed-2020-107001","Unverified","","","","","","ES",""
"2021-06-06","210901_LimaPeru_HospitalNacionalDocenteMadreNinoSanBartolome_primary","Gestation in times of COVID-19 pandemic. Hospital nacional docente Madre Nino San Bartolome, Lima, Peru","2020-09-01","Local","Peru","Peru","2020-04-15","2020-07-15","Pregnant or parturient women","Adults (18-64 years)",1869.0,0.185,"Sequential","Not reported","IgG; IgM","High","Journal Article (Peer-Reviewed)","Edy Martin Vera Loyola","Hospital Nacional Docente Madre Nino San Bartolome","http://www.spog.org.pe/web/revista/index.php/RPGO/article/download/2265/pdf","Verified","","","","","","PE",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_Austria3","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","Austria","Austria","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",72.0,0.028,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified",0.008,0.096,1.0,0.996,"","AT",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_Denmark4","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","Denmark","Denmark","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",34.0,0.029,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified",0.005,0.149,1.0,0.996,"","DK",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_Germany2","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","Germany","Germany","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",137.0,0.029,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified",0.011,0.073,1.0,0.996,"","DE",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_UK1","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",311.0,0.068,"Convenience","Abbott","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified",0.045,0.101,1.0,0.996,"","GB",""
"2021-06-07","210408_Indore_NationalCentreforDiseaseControl_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020.","2021-04-08","Local","India","India; Madhya Pradesh; Indore","2020-08-11","2020-08-23","Household and community samples","Multiple groups",7103.0,0.078,"Stratified probability","Indian Council of Medical Research","IgG","Low","Journal Article (Peer-Reviewed)","Salil Sakalle","National Centre for Disease Control","https://dx.doi.org/10.4103/jfmpc.jfmpc_2015_20","Unverified",0.071,0.084,0.921,0.977,"","IN","IN-MP"
"2021-06-07","210429_Indianapolis_IndianaUniversity_overall","Placement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical Residents.","2021-04-29","Local","United States of America","United States of America; Indiana; Indianapolis","2020-05-18","2020-05-22","Health care workers and caregivers","Adults (18-64 years)",44.0,0.273,"Convenience","Abnova","IgG; IgM","High","Journal Article (Peer-Reviewed)","Timothy Crisci","Indiana Univeristy","https://dx.doi.org/10.3389/fped.2021.633082","Verified","","","","","","US","US-IN"
"2021-06-07","210503_USA_HIV_ClinicalReferenceLaboratory","HIV and the Seroprevalence of SARS-CoV-2","2021-05-03","National","United States of America","United States of America","2020-01-01","2021-03-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1191.0,0.128,"Convenience","Roche","Total Antibody","Moderate","Preprint","Robert Stout","Clinical Reference Laboratory","10.1101/2021.04.29.21256302","Verified","","",0.995,0.998,"","US",""
"2021-06-07","210504_DallasTexas_UniversityofTexasSouthwestern","Childcare providers anxiety levels and SARS-CoV- 2 testing","2021-05-04","Local","United States of America","United States of America","2020-10-01","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",37.0,0.0,"Convenience","Abbot","IgG","High","Journal Article (Peer-Reviewed)","Lauren Diercks","University of Texas Southwestern","http://dx.doi.org/10.1111/acem.14249","Unverified","","","","","","US",""
"2021-06-07","210504_Okinawa_OkinawaInstituteOfScienceAndTechnology","COVID-19 serological survey using micro blood sampling.","2021-05-04","Local","Japan","Japan; Okinawa Prefecture; Okinawa","2020-08-01","2020-08-31","Multiple populations","Adults (18-64 years)",675.0,0.0,"Convenience","N/A - institution designed","Not reported","Moderate","Journal Article (Peer-Reviewed)","Melissa M Matthews","Okinawa Institute of Science and Technology","https://dx.doi.org/10.1038/s41598-021-88850-z","Verified","","",0.925,1.0,"ELISA","JP","JP-47"
"2021-06-07","210513_Greece_UniversityThessaly_TestPopAdj","Repeated Leftover Serosurvey of SARS-CoV-2 IgG Antibodies in Greece, May to August 2020.","2021-05-13","National","Greece","Greece","2020-05-01","2020-08-31","Household and community samples","Multiple groups",20110.0,0.002,"Stratified probability","Abbott","IgG","Low","Journal Article (Peer-Reviewed)","Zacharoula Bogogiannidou","University of Thessaly","https://dx.doi.org/10.3390/vaccines9050504","Unverified",0.001,0.003,0.84,0.997,"","GR",""
"2021-06-07","210518_UK_UniversityCollegeLondon_overall","Occupation, Work-Related Contact, and SARS-CoV-2 Anti-Nucleocapsid Serological Status: Findings from the Virus Watch prospective cohort study","2021-05-18","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England and Wales","2021-02-01","2021-04-28","Household and community samples","Adults (18-64 years)",3761.0,0.116,"Convenience","Roche","Total Antibody","High","Preprint","Sarah Beale","University College London","10.1101/2021.05.13.21257161","Verified","","","","","","GB","GB-ENG"
"2021-06-07","210521_France_SantePubliqueFrance_April2_Overall_PopAdj_TestAdj","Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.","2021-05-21","National","France","France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","2020-04-06","2020-04-12","Residual sera","Multiple groups",3595.0,0.041,"Stratified probability","N/A - Author Designed","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Stephane Le Vu","Santé publique France","https://dx.doi.org/10.1038/s41467-021-23233-6","Verified",0.033,0.05,1.0,1.0,"","FR",""
"2021-06-07","210521_France_SantePubliqueFrance_March1_Overall_PopAdj_TestAdj","Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.","2021-05-21","National","France","France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","2020-03-09","2020-03-15","Residual sera","Multiple groups",3834.0,0.004,"Stratified probability","N/A - Author Designed","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Stephane Le Vu","Santé publique France","https://dx.doi.org/10.1038/s41467-021-23233-6","Verified",0.0,0.009,1.0,1.0,"","FR",""
"2021-06-07","210521_France_SantePubliqueFrance_May3_Overall_PopAdj_TestAdj","Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.","2021-05-21","National","France","France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","2020-05-11","2020-05-17","Residual sera","Multiple groups",3592.0,0.049,"Stratified probability","N/A - Author Designed","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Stephane Le Vu","Santé publique France","https://dx.doi.org/10.1038/s41467-021-23233-6","Verified",0.04,0.059,1.0,1.0,"","FR",""
"2021-06-07","210523_Istanbul_KocUniversity","Predictors of SARS CoV-2 Infection Among Healthcare Workers: The Impact of Community-Hospital Gradient","2021-05-23","Regional","Turkey","Turkey; Marmara; Istanbul","2020-05-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",1732.0,0.15,"Convenience","Roche","IgG; IgM; IgA","High","Preprint","Fatihan Pınarlık","Koc University","10.1101/2021.05.20.21257518","Unverified","","","","","","TR",""
"2021-06-07","210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Residents1","Seroprevalence of SARS-CoV-2 Among Skilled Nursing Facility Residents and Staff Members - Los Angeles County, August-September 2020.","2021-05-24","Regional","United States of America","United States of America; California","2020-08-18","2020-09-24","Patients seeking care for non-COVID-19 reasons","Multiple groups",1806.0,0.25,"Convenience","Abbott, Diasorin","IgG","High","Journal Article (Peer-Reviewed)","Jason H Malenfant","Los Angeles County Department of Public Health","https://dx.doi.org/10.1093/infdis/jiab281","Unverified","","","","","","US","US-CA"
"2021-06-07","210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Staff2","Seroprevalence of SARS-CoV-2 Among Skilled Nursing Facility Residents and Staff Members - Los Angeles County, August-September 2020.","2021-05-24","Regional","United States of America","United States of America; California","2020-08-18","2020-09-24","Health care workers and caregivers","Multiple groups",856.0,0.4,"Convenience","Abbott, Diasorin","IgG","High","Journal Article (Peer-Reviewed)","Jason H Malenfant","Los Angeles County Department of Public Health","https://dx.doi.org/10.1093/infdis/jiab281","Unverified","","","","","","US","US-CA"
"2021-06-07","210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_July1_overall","Seroprevalence of SARS-CoV-2 antibodies in South Korea.","2021-05-24","National","Democratic People's Republic of Korea","Republic of Korea","2020-04-21","2020-06-16","Residual sera","Multiple groups",1500.0,0.0,"Convenience","N/A - in house","Neutralizing","High","Journal Article (Peer-Reviewed)","Kwangmin Lee","Korea Disease Control and Prevention Agency","https://dx.doi.org/10.1007/s42952-021-00131-7","Verified","","",0.933,0.971,"","KR",""
"2021-06-07","210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_November3_TestAdj","Seroprevalence of SARS-CoV-2 antibodies in South Korea.","2021-05-24","National","Democratic People's Republic of Korea","Republic of Korea","2020-08-14","2020-10-31","Residual sera","Multiple groups",1379.0,0.006,"Convenience","N/A - in house","Neutralizing","High","Journal Article (Peer-Reviewed)","Kwangmin Lee","Korea Disease Control and Prevention Agency","https://dx.doi.org/10.1007/s42952-021-00131-7","Verified","","",0.933,0.971,"","KR",""
"2021-06-07","210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_September2","Seroprevalence of SARS-CoV-2 antibodies in South Korea.","2021-05-24","National","Democratic People's Republic of Korea","Republic of Korea","2020-06-10","2020-08-13","Residual sera","Multiple groups",1440.0,0.001,"Convenience","N/A - in house","Neutralizing","High","Journal Article (Peer-Reviewed)","Kwangmin Lee","Korea Disease Control and Prevention Agency","https://dx.doi.org/10.1007/s42952-021-00131-7","Verified","","",0.933,0.971,"","KR",""
"2021-06-07","210525_Pakistan_RiphahInternationalUniversity","SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?.","2021-05-25","National","Pakistan","Pakistan","2020-07-15","2020-07-31","Household and community samples","Multiple groups",15390.0,0.424,"Stratified probability","Roche","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Mohsina Haq","Riphah International University","https://dx.doi.org/10.1007/s15010-021-01629-2","Verified",0.415,0.431,0.988,1.0,"","PK",""
"2021-06-07","210526_Ireland_TrinityCollege","SARS-CoV-2 Antibody Testing in Healthcare Workers: a comparison of the clinical performance of three commercially available antibody assays","2021-05-26","Regional","Ireland","Ireland","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",5787.0,0.095,"Convenience","Roche","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Niamh Allen","Trinity College, University of Dublin","https://europepmc.org/article/PPR/PPR347943","Unverified","","",1.0,0.998,"","IE",""
"2021-06-07","210527_NewYorkCity_NewYorkUniversityGrossmanSchoolofMedicine_primary","Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.","2021-05-27","Local","United States of America","United States of America; New York; New York City","2020-04-29","2021-02-09","Patients seeking care for non-COVID-19 reasons","Multiple groups",329.0,0.16,"Convenience","NA","IgG","High","Journal Article (Peer-Reviewed)","Amit Saxena","New York University Grossman School of Medicine","https://dx.doi.org/10.1016/S2665-9913(21)00114-4","Unverified","","","","","","US","US-NY"
"2021-06-07","210528_Tokyo_NationalCancerCenterHospital_HCW_primary","Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.","2021-05-28","Local","Japan","Japan","2020-09-01","2020-10-30","Health care workers and caregivers","Multiple groups",1190.0,0.007,"Convenience","N/A- Author designed","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shu Yazaki","National Cancer Center Hospital","https://dx.doi.org/10.1001/jamaoncol.2021.2159","Unverified",0.003,0.013,"","","","JP",""
"2021-06-07","210528_Tokyo_NationalCancerCenterHospital_patients_primary","Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.","2021-05-28","Local","Japan","Japan","2020-08-03","2020-08-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",500.0,0.01,"Convenience","N/A- Author designed","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shu Yazaki","National Cancer Center Hospital","https://dx.doi.org/10.1001/jamaoncol.2021.2159","Unverified",0.003,0.023,"","","","JP",""
"2021-06-07","210531_Denmark_AarhusUniversity_BloodDonors2","Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with Systemic Lupus Erythematosus or Rheumatoid arthritis.","2021-05-31","National","Denmark","Denmark","2020-06-08","2020-06-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",513.0,0.019,"Convenience","Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Christian Ammitzboll","Aarhus University","https://dx.doi.org/10.1002/acr.24716","Unverified","","",0.967,0.995,"","DK",""
"2021-06-07","210531_Denmark_AarhusUniversity_CRDPatients1","Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with Systemic Lupus Erythematosus or Rheumatoid arthritis.","2021-05-31","National","Denmark","Denmark","2020-06-08","2020-06-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",365.0,0.003,"Convenience","Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China","Total Antibody","High","Journal Article (Peer-Reviewed)","Christian Ammitzboll","Aarhus University","https://dx.doi.org/10.1002/acr.24716","Unverified","","",0.967,0.995,"","DK",""
"2021-06-07","210531_Marseille_HôpitauxdeMarseille","Seroprevalence of SARS-CoV-2 Antibodies Among Homeless People Living Rough, in Shelters and Squats: A Large Population-Based Study in France","2021-05-31","Local","France","France; Provence-Alpes-Côte d'Azur; Marseille","2020-06-01","2020-08-05","Persons experiencing homelessness","Adults (18-64 years)",1156.0,0.056,"Convenience","Biosynex","IgG; IgM","Moderate","Preprint","Sandrine Loubiere","Hôpitaux de Marseille","https://europepmc.org/article/PPR/PPR350578","Unverified",0.029,0.072,1.0,0.995,"","FR","FR-PAC"
"2021-06-07","210602_SouthEastAsia_MaulanaAzadMedicalCollege","SARS-CoV-2 Immunoglobulin g (IgG) Kinetics in Healthcare Workers and Their Close Contacts Reduced Risk of Re-infection: South-East Asian Region","2021-06-02","Local","India","India","2020-06-22","2020-12-22","Contacts of COVID patients","Multiple groups",166.0,0.373,"Convenience","Erba Mannheim and Calbiotech","IgG","High","Preprint","Mradul Kumar Daga","Maulana Azad Medical College","https://www.researchsquare.com/article/rs-540165/v1","Unverified","","","","","","IN",""
"2021-06-07","210602_UK_dental_UniversityBirmingham_Follow-up","COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals.","2021-06-02","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; West midlands","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",944.0,0.514,"Convenience","Development; of this assay was undertaken by the authors at the University of Birmingham in collaboration; with The Binding Site.","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","A M Shields","University of Birmingham","https://dx.doi.org/10.1177/00220345211020270","Unverified","","",0.986,0.983,"","GB","GB-ENG"
"2021-06-07","210603_UnitedStates_EmoryUniversity","Us population-based survey of vaccine willingness and sars-cov- 2 antibody prevalence","2021-06-03","National","United States of America","United States of America; NR; NR","2020-08-09","2020-12-08","Household and community samples","Multiple groups",1454.0,0.047,"Simplified probability","NR","Not reported","Unclear","Presentation or Conference","Aaron Siegler","Emory University","https://www.croiconference.org/abstract/us-population-based-survey-of-vaccine-willingness-and-sars-cov-2-antibody-prevalence/","Verified","","","","","","US",""
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Brno/South Moravian Region","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Regional","Czechia","Czechia; Brno / South Moravian","2020-04-23","2020-05-01","Household and community samples","Multiple groups",5049.0,0.001,"Stratified non-probability","Fortress","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified",0.0,0.002,0.95,1.0,"","CZ","CZ-JM"
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litomerice","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Local","Czechia","Czechia","2020-04-23","2020-05-01","Household and community samples","Multiple groups",3106.0,0.002,"Stratified non-probability","Fortress","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified",0.001,0.004,0.95,1.0,"","CZ",""
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litovel_Unicov","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Local","Czechia","Czechia","2020-04-23","2020-05-01","Household and community samples","Multiple groups",2409.0,0.018,"Stratified non-probability","Fortress","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified",0.012,0.023,0.95,1.0,"","CZ",""
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Olomouc/Olomouckykraj","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Regional","Czechia","Czechia; Olomouc / Olomouc","2020-04-23","2020-05-01","Household and community samples","Multiple groups",6686.0,0.007,"Stratified non-probability","Fortress","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified",0.005,0.009,0.95,1.0,"","CZ","CZ-712"
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Prague","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Local","Czechia","Czechia","2020-04-23","2020-05-01","Household and community samples","Multiple groups",5021.0,0.002,"Stratified non-probability","Fortress","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified",0.0,0.003,0.95,1.0,"","CZ",""
"2021-06-08","210323_Budel_MaastrichtUniversity_Overall","[Experiences of (care) professionals during a COVID-19 outbreak and results of serological tests in the staff of a heavily affected nursing home.].","2021-03-23","Local","Netherlands","Netherlands; North Brabant; Budel","2020-06-04","2020-06-16","Health care workers and caregivers","Adults (18-64 years)",240.0,0.392,"Convenience","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Joyce Heffels","Maastricht University","https://dx.doi.org/10.36613/tgg.1875-6832/2021.01.01","Verified","","",0.961,0.98,"","NL","NL-NB"
"2021-06-08","210416_Jordan_KingHusseinCancerCenter_Grp1_June","Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic","2021-04-19","National","Jordan","Jordan; North, Center, South","2020-01-15","2020-06-15","Blood donors","Adults (18-64 years)",736.0,0.0,"Sequential","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Maher Sughayer","King Hussein Cancer Center","http://dx.doi.org/10.1016/j.ijid.2021.04.059","Verified",0.0,0.005,1.0,0.998,"","JO",""
"2021-06-08","210416_Jordan_KingHusseinCancerCenter_Grp2_September","Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic","2021-04-19","National","Jordan","Jordan; North, Center, South","2020-09-01","2020-09-15","Blood donors","Adults (18-64 years)",348.0,0.0,"Sequential","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Maher Sughayer","King Hussein Cancer Center","http://dx.doi.org/10.1016/j.ijid.2021.04.059","Verified",0.0,0.005,1.0,0.998,"","JO",""
"2021-06-08","210416_Jordan_KingHusseinCancerCenter_Grp3_January_TestAdj","Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic","2021-04-19","National","Jordan","Jordan; North, Center, South","2021-01-28","2021-02-05","Blood donors","Adults (18-64 years)",292.0,0.273,"Sequential","Roche Diagnostics","Total Antibody","High","Journal Article (Peer-Reviewed)","Maher Sughayer","King Hussein Cancer Center","http://dx.doi.org/10.1016/j.ijid.2021.04.059","Verified",0.225,0.329,1.0,0.998,"","JO",""
"2021-06-08","210427_Sweden_SwedishPublicHealthAgency_Outpatients_10_Week48-49_Overall","Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården (Delrapport 1)","2021-04-27","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-11-23","2020-12-04","Residual sera","Multiple groups",4500.0,0.079,"Stratified probability","Sci LifeLab / KTH","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Unverified",0.068,0.092,0.994,"","","SE",""
"2021-06-08","210427_Sweden_SwedishPublicHealthAgency_Outpatients_11_Week9-10_2021_Overall","Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården (Delrapport 1)","2021-04-27","National","Sweden","Sweden; Jönköping, Kalmar, Skåne,Stockholm, Uppsala, Västerbotten, Västra Götaland, Örebo","2021-03-01","2021-03-12","Residual sera","Multiple groups",4749.0,0.207,"Stratified probability","Sci LifeLab / KTH","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Unverified",0.194,0.221,0.994,"","","SE",""
"2021-06-08","210427_Sweden_SwedishPublicHealthAgency_Outpatients_9_Week42-43_Overall","Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården (Delrapport 1)","2021-04-27","National","Sweden","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-10-12","2020-10-23","Residual sera","Multiple groups",4500.0,0.067,"Stratified probability","Sci LifeLab / KTH","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Unverified",0.057,0.078,0.994,"","","SE",""
"2021-06-08","210502_England_ImperialCollegeLondon_TestPopAdj","Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults.","2021-05-02","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-20","2020-09-28","Household and community samples","Multiple groups",365104.0,0.049,"Stratified probability","Fortress Diagnostics","IgG","Low","Journal Article (Peer-Reviewed)","Helen Ward","Imperial College London","https://dx.doi.org/10.1016/j.lanepe.2021.100098","Unverified",0.048,0.05,0.844,0.986,"","GB","GB-ENG"
"2021-06-08","210510_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report May 10, 2021 Report #7: January 2021 Survey","2021-05-10","National","Canada","Canada","2021-01-01","2021-01-27","Blood donors","Multiple groups",33400.0,0.028,"Sequential","Roche","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.026,0.03,0.988,0.996,"","CA",""
"2021-06-08","210521_Karnataka_IndianInstituteOfPublicHealth_Primary","The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India","2021-05-21","Regional","India","India; Karnataka","2020-09-03","2020-09-16","Household and community samples","Multiple groups",15624.0,0.168,"Stratified probability","Zydus Cadila","IgG","Low","Journal Article (Peer-Reviewed)","Giridhara Babu","Indian Institute of Public Health","http://dx.doi.org/10.1016/j.ijid.2021.05.043","Verified",0.155,0.181,0.921,0.977,"","IN","IN-KA"
"2021-06-08","210528_Bari_IRCCSIstitutoTumoriGiovanniPaoloII_Baseline","Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological Test.","2021-05-28","Local","Italy","Italy; Puglia; Bari","2020-03-26","2020-03-31","Health care workers and caregivers","Multiple groups",606.0,0.011,"Convenience","VivaChek Biotech, Hangzhou, China","IgG; IgM","High","Journal Article (Peer-Reviewed)","Angelo Virgilio Paradiso","IRCCS Istituto Tumori “Giovanni Paolo II”","https://dx.doi.org/10.3390/diagnostics11060975","Unverified","","","","","","IT","IT-75"
"2021-06-15","210518_Taiwan_NationalTaiwanUniversity_GroupH1","Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.","2021-05-18","National","","China; Taiwan; Taipei, Zhubei","2020-06-25","2020-07-29","Health care workers and caregivers","Adults (18-64 years)",464.0,0.0,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Wen Pin Tseng","National Taiwan University","https://dx.doi.org/10.3389/fimmu.2021.626609","Unverified",0.0,0.008,"","","","CN",""
"2021-06-16","210505_Brussels_CliniquesUniversitairesSaint-Luc","Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity","2021-05-05","Local","","Belgium; Brussels-Capital; City of Brussels","2020-06-19","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",3255.0,0.078,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Anais Scohy","Cliniques universitaires Saint-Luc","http://dx.doi.org/10.1016/j.diagmicrobio.2021.115414","Unverified","","",1.0,0.95,"","BE","BE-BRU"
"2021-06-16","210518_Taiwan_NationalTaiwanUniversity_GroupC2","Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.","2021-05-18","National","","China; Taiwan; Taipei, Zhubei","2020-06-25","2020-07-29","Health care workers and caregivers","Adults (18-64 years)",1142.0,0.001,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Wen Pin Tseng","Researchers at the National Taiwan University studied symptomatic patients with frontline healthcare workers (n=464) and found a stringently judged seroprevalence of 0%.","https://dx.doi.org/10.3389/fimmu.2021.626609","Unverified",0.0,0.005,"","","","CN",""
"2021-06-16","210530_Cameroon_UniversityofYaoundé_primary","Serologic Response to SARS-CoV-2 in an African Population.","2021-05-30","Regional","","Cameroon","2020-06-15","2020-08-15","Multiple populations","Multiple groups",999.0,0.32,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Karl Njuwa Fai","University of Yaoundé","https://dx.doi.org/10.1016/j.sciaf.2021.e00802","Unverified",0.27,0.35,"","","","CM",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoApril_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-04-01","2020-04-30","Blood donors","Adults (18-64 years)",157.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-08-01","2020-08-30","Blood donors","Adults (18-64 years)",432.0,0.413,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.411,0.415,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",428.0,0.354,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.352,0.356,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",308.0,0.028,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.027,0.029,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMarch_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-03-01","2020-03-30","Blood donors","Adults (18-64 years)",496.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMay_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-05-01","2020-05-31","Blood donors","Adults (18-64 years)",598.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",502.0,0.38,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.379,0.382,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",495.0,0.432,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.43,0.434,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",481.0,0.435,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.433,0.438,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",227.0,0.492,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.489,0.495,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",182.0,0.512,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.508,0.516,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",82.0,0.437,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.431,0.443,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",282.0,0.233,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.231,0.235,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",199.0,0.33,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.326,0.333,0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",213.0,0.362,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.359,0.365,0.926,0.996,"","MG",""
"2021-06-16","210604_Qatar_CornellUniversity_Overall1","Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.","2021-06-04","National","","Qatar","2020-07-26","2020-09-09","Non-essential workers and unemployed persons","Adults (18-64 years)",394.0,0.465,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gheyath K Nasrallah","Cornell University","https://dx.doi.org/10.1038/s41598-021-91235-x","Verified",0.416,0.514,"","","","QA",""
"2021-06-17","201708_Pune_AshokaUniversity_primary","First sero survey shows extensive spread of Covid-19: From 36.1% to 65.4% in selected areas sampled in Pune","2020-08-17","Local","India","India; Maharashtra; Pune","2020-07-20","2020-08-05","Household and community samples","Multiple groups",1664.0,0.515,"Stratified probability","NR","IgG","Unclear","News and Media","Anuradha Mascarenhas","Ashoka University","https://indianexpress.com/article/cities/pune/first-sero-survey-shows-extensive-spread-of-covid-19-from-36-1-to-65-4-in-selected-areas-sampled-in-pune-6558853/","Unverified","","","","","","IN","IN-MH"
"2021-06-17","210508_SouthDakota_SouthDakotaStateUniversity_Phase3","Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers","2021-06-08","Regional","","United States of America; South Dakota, Minnesota","2020-10-16","2020-12-22","Health care workers and caregivers","Adults (18-64 years)",7.0,0.148,"Convenience","NR","IgG; IgM; IgA","High","Preprint","Jordan Neises","South Dakota State University","https://www.medrxiv.org/content/10.1101/2021.06.07.21258375v1","Unverified","","","","","","US",""
"2021-06-17","210529_Pakistan_CombinedMilitaryHospitalKharianMedicalCollege","Seroprevalence of COVID-19 and associated factors in a medical institution in Pakistan.","2021-05-29","National","","Pakistan","2020-09-01","2020-09-30","Non-essential workers and unemployed persons","Multiple groups",442.0,0.17,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Iffat Naiyar","Combined Military Hospital Kharian Medical College","https://dx.doi.org/10.1016/j.jtumed.2021.04.004","Unverified","","",0.958,0.967,"","PK",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",120.0,0.104,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.102,0.106,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-07-01","2020-07-30","Blood donors","Adults (18-64 years)",142.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",129.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",172.0,0.162,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.16,0.164,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",152.0,0.187,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.185,0.189,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",173.0,0.219,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.216,0.221,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",107.0,0.445,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.441,0.448,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",98.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.001,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",50.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",30.0,0.215,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.209,0.22,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",26.0,0.296,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.289,0.302,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",53.0,0.26,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.259,0.261,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",167.0,0.079,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.077,0.081,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",147.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.0,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",87.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.0,0.001,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",199.0,0.235,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.232,0.238,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",139.0,0.277,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.273,0.28,0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",185.0,0.242,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified",0.239,0.244,0.926,0.996,"","MG",""
"2021-06-17","210605_Kinshasa_InstitutNationaldeRechercheBiomédicale_primary","High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey.","2021-06-05","Local","","Democratic Republic of the Congo","2020-10-22","2020-11-08","Household and community samples","Multiple groups",1080.0,0.166,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Antoine N Nkuba","Institut National de Recherche Biomédicale","https://dx.doi.org/10.1093/cid/ciab515","Verified",0.14,0.195,1.0,0.997,"","CD",""
"2021-06-17","210609_SouthBrazil_UniversidadeFederaldoParaná","SARS-CoV-2 in asymptomatic pregnant women in South Brazil: RT-PCR and serological detection.","2021-06-09","Regional","","Brazil; Mato Grosso do Sul; Curitiba","2020-09-15","2020-10-15","Pregnant or parturient women","Adults (18-64 years)",195.0,0.087,"Convenience","NR","IgG; IgM","High","Preprint","Jullie Anne Chiste","Complexo Hospital de Clínicas da Universidade Federal do Paraná","https://dx.doi.org/10.1515/jpm-2021-0173","Unverified","","","","","","BR","BR-MS"
"2021-06-17","210611_Quebec_Héma-Québec_overall_PopAdj","Phase 2 de l’étude sur la séroprévalence des anticorps dirigés contre le SRAS-CoV-2 au Québec","2021-06-11","Regional","","Canada; Québec","2021-01-25","2021-04-22","Blood donors","Multiple groups",7924.0,0.147,"Sequential","NR","Not reported","Moderate","Institutional Report","Hema-Quebec","Héma-Québec","https://www.hema-quebec.qc.ca/userfiles/file/coronavirus/COVID-rapport-final-ph2-11-06-2021.pdf","Verified",0.138,0.156,0.989,0.985,"","CA","CA-QC"
"2021-06-18","210225_England_ImperialCollegeLondon_Round5_overall_Primary","REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England","2021-02-25","National","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2021-01-25","2021-02-08","Household and community samples","Multiple groups",155172.0,0.139,"Stratified probability","Fortress Diagnostics","IgG","Low","Institutional Report","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1","Verified",0.137,0.141,0.844,0.986,"","GB","GB-ENG"
"2021-06-18","210607_LosAngeles_UniversityofSouthernCalifornia","SARS-CoV-2 Seroprevalence Among Firefighters in Los Angeles, California","2021-06-07","Local","","United States of America; California; Los Angeles","2020-10-20","2020-10-28","Essential non-healthcare workers","Adults (18-64 years)",686.0,0.089,"Convenience","NR","IgG; IgM","High","Preprint","Karen Mulligan","University of Southern California","10.1101/2021.06.03.21258299","Unverified","","","","","","US","US-CA"
"2021-06-19","210608_Warsaw_CentralClinicalHospitalOfTheMinistryOfInterior","Dynamics of humoral response to coronavirus antigens among employees of COVID-dedicated hospital: an observational study.","2021-06-08","Local","","Poland; Mazovia; Warsaw","2020-04-21","2020-07-20","Health care workers and caregivers","Adults (18-64 years)",1572.0,0.227,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Radosław Rzeplinski","Central Clinical Hospital of the Ministry of Interior and Administration","https://dx.doi.org/10.20452/pamw.16025","Unverified","","","","","","PL","PL-14"
"2021-06-20","210409_OrangeCounty_UniversityofCaliforniaIrvine_Primary","Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.","2021-04-09","Local","","United States of America; California; Orange County","2020-04-14","2020-05-13","Health care workers and caregivers","Adults (18-64 years)",143.0,0.105,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Theodore W. Heyming","University of California Irvine","https://dx.doi.org/10.5811/westjem.2021.1.50058","Verified","","",1.0,0.838,"","US","US-CA"
"2021-06-20","210518_NewZealand_SouthernCommunityLaboratories_MostAdj","SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020.","2021-05-18","Regional","","New Zealand; Southern Region","2020-06-04","2020-08-04","Contacts of COVID patients","Multiple groups",1127.0,0.008,"Convenience","NR","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Alyson Craigie","Southern Community Laboratories","https://dx.doi.org/10.1016/j.pathol.2021.04.001","Verified",0.004,0.015,"","","","NZ",""
"2021-06-20","210527_Austria_UniversitätsklinikfürInnereMedizinII_HCWs_PeriodB","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers and an unselected all comer patient population","2021-05-27","Local","","Austria; NR; Vienna","2020-09-08","2021-02-22","Health care workers and caregivers","Adults (18-64 years)",498.0,0.072,"Convenience","NR","Total Antibody","Unclear","Presentation or Conference","M. Riesenhuber","Universitätsklinik für Innere; Medizin II","https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf","Verified",0.053,0.098,"","","","AT",""
"2021-06-20","210527_Austria_UniversitätsklinikfürInnereMedizinII_Patients","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers and an unselected all comer patient population","2021-05-27","Local","","Austria; NR; Vienna","2020-08-24","2021-02-22","Residual sera","Multiple groups",6092.0,0.057,"Sequential","NR","Total Antibody","Unclear","Presentation or Conference","M. Riesenhuber","Universitätsklinik für Innere Medizin II","https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf","Verified","","","","","","AT",""
"2021-06-20","210611_Cordoba_UniversidadNacionaldeColombia_Primary","Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department.","2021-06-11","Regional","","Colombia; Cordoba","2020-03-15","2020-10-02","Household and community samples","Multiple groups",2447.0,0.408,"Stratified probability","NR","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Nelson Alvis Guzma","Universidad de Cordoba","https://dx.doi.org/10.1016/j.ijid.2021.06.018","Verified","","",0.93,0.95,"","CO","CO-COR"
"2021-06-20","210614_Barcelona_HospitalUniversitariValld’Hebron","Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.","2021-06-14","Local","","Spain; Province of Barcelona; Barcelona","2020-05-10","2020-10-26","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",294.0,0.031,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Isabel Campos-Varela","Hospital Universitari Vall d’Hebron","https://dx.doi.org/10.1111/tri.13946","Verified","","","","","","ES","ES-CT"
"2021-06-20","210614_Verona_UniversityofVerona","Sars-cov-2 infection in health workers: Analysis from verona sieroepid study during the pre-vaccination era","2021-06-14","Local","Italy","Italy; Province of Verona; Verona","2020-04-28","2020-07-20","Health care workers and caregivers","Adults (18-64 years)",5299.0,0.06,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Stefano Porru","University of Verona","http://dx.doi.org/10.3390/ijerph18126446","Unverified",0.053,0.066,"","","","IT","IT-34"
"2021-06-21","210501_Poltava_UkranianMedicalStomatologicalAcademy_IgG2","EPIDEMIOLOGICAL DATA ON THE DETECTION OF IMMUNOGLOBULINS OF CLASS IGM, IGG TO SARS-COV-2 AMONG POPULATION OF POLTAVA REGION.","2021-05-01","Local","","Ukraine; Poltava Oblast; Poltava","2020-07-15","2020-12-15","Household and community samples","Multiple groups",468.0,0.477,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Alla Marchenko","Ukranian Medical Stomatological Academy","https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf","Verified","","","","","","UA","UA-53"
"2021-06-21","210501_Poltava_UkranianMedicalStomatologicalAcademy_IgM1","EPIDEMIOLOGICAL DATA ON THE DETECTION OF IMMUNOGLOBULINS OF CLASS IGM, IGG TO SARS-COV-2 AMONG POPULATION OF POLTAVA REGION.","2021-05-01","Local","","Ukraine; Poltava Oblast; Poltava","2020-07-15","2020-12-15","Household and community samples","Multiple groups",2375.0,0.057,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Alla Marchenko","Ukranian Medical Stomatological Academy","https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf","Verified","","","","","","UA","UA-53"
"2021-06-21","210503_USA_IndianaUniversity_Primary","A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students.","2021-06-07","Local","","United States of America; Indiada","2020-09-08","2020-09-30","Students and Daycares","Adults (18-64 years)",1076.0,0.046,"Simplified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Sina Kianersi","Indiana University School of Public Health-Bloomington","https://dx.doi.org/10.1016/j.jadohealth.2021.05.003","Unverified",0.033,0.058,"","","","US","US-IN"
"2021-06-21","210505_Trieste_ItalianNationalInstituteOfHealth","Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study.","2021-06-05","Regional","","Italy; NR; Trieste","2021-01-05","2021-01-31","Blood donors","Children and Youth (0-17 years)",169.0,0.095,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Manola Comar","Italian National Institute of Health","https://dx.doi.org/10.1186/s13052-021-01074-9","Unverified","","","","","","IT",""
"2021-06-21","210602_USA_MontantaStateUniversity_Primary","Titers, prevalence, and duration of sars-cov-2 antibodies in a local covid-19 outbreak and following vaccination","2021-06-02","Local","","United States of America; Montana; Bozeman","2020-04-15","2020-11-15","Blood donors","Adults (18-64 years)",168.0,0.19,"Self-referral","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jodi Hedges","Montana State University","http://dx.doi.org/10.3390/vaccines9060587","Unverified","","","","","","US","US-MT"
"2021-06-21","210607_EastScotland_UniversityofDundee_Control2","The protective effect of sars-cov-2 antibodies in scottish healthcare workers","2021-06-07","Regional","","United Kingdom of Great Britain and Northern Ireland; Scotland; Dundee","2020-05-28","2020-09-02","Residual sera","Multiple groups",231.0,0.048,"Sequential","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Hani Abo-Leyah","University of Dundee","http://dx.doi.org/10.1183/23120541.00080-2021","Verified","","",0.95,"","","GB","GB-SCT"
"2021-06-21","210607_EastScotland_UniversityofDundee_HCW1","The protective effect of sars-cov-2 antibodies in scottish healthcare workers","2021-06-07","Regional","","United Kingdom of Great Britain and Northern Ireland; Scotland; Dundee","2020-05-28","2020-09-02","Health care workers and caregivers","Adults (18-64 years)",2063.0,0.145,"Convenience","NR","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Hani Abo-Leyah","University of Dundee","http://dx.doi.org/10.1183/23120541.00080-2021","Verified","","",0.95,"","","GB","GB-SCT"
"2021-06-21","210607_Italy_UniversityofMilan_Cohabitants3","Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.","2021-06-07","National","","Italy","2020-07-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",271.0,0.03,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","William Morello","University of Milan","https://dx.doi.org/10.2215/CJN.00330121","Unverified","","","","","","IT",""
"2021-06-21","210607_Italy_UniversityofMilan_Patients1","Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.","2021-06-07","National","","Italy","2020-07-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",178.0,0.017,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","William Morello","University of Milan","https://dx.doi.org/10.2215/CJN.00330121","Unverified","","","","","","IT",""
"2021-06-21","210607_Italy_UniversityofMilan_Siblings2","Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.","2021-06-07","National","","Italy","2020-07-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",90.0,0.07,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","William Morello","University of Milan","https://dx.doi.org/10.2215/CJN.00330121","Unverified","","","","","","IT",""
"2021-06-21","210608_Tokyo_BostonChildrensHospital_August19-September2","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-08-19","2020-09-02","Non-essential workers and unemployed persons","Adults (18-64 years)",62.0,0.468,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_August5-August18","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-08-05","2020-08-18","Non-essential workers and unemployed persons","Adults (18-64 years)",115.0,0.417,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_July22-August4","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-07-22","2020-08-04","Non-essential workers and unemployed persons","Adults (18-64 years)",175.0,0.389,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_July8-July21","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-07-08","2020-07-21","Non-essential workers and unemployed persons","Adults (18-64 years)",256.0,0.371,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_June10-June23","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-06-10","2020-06-23","Non-essential workers and unemployed persons","Adults (18-64 years)",119.0,0.05,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_June24-July7","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-06-24","2020-07-07","Non-essential workers and unemployed persons","Adults (18-64 years)",187.0,0.257,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_May26-June9","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","","Japan; Tokyo Prefecture; Tokyo","2020-05-26","2020-06-09","Non-essential workers and unemployed persons","Adults (18-64 years)",51.0,0.059,"Convenience","NR","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","","","","","JP","JP-13"
"2021-06-21","210609_CentralDenmarkRegion_AarhusUniversity","Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.","2021-06-09","Regional","","Denmark; Central Denmark Region","2020-05-18","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",11138.0,0.04,"Convenience","NR","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Kathrine Agergard Kaspersen","Aarhus University","https://dx.doi.org/10.1016/j.ijid.2021.06.017","Unverified","","",0.967,0.995,"","DK","DK-82"
"2021-06-21","210610_Lombardy_HumanitasUniversity_HCW_overall","SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy.","2021-06-10","Regional","","Italy; Lombardy ; Milan, Rozzano, Varese, Castellanza and Bergamo","2020-04-28","2020-05-16","Health care workers and caregivers","Multiple groups",3985.0,0.13,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Teresa Sandri","Humanitas University","https://dx.doi.org/10.1038/s41598-021-91773-4","Verified","","",0.904,0.985,"","IT","IT-25"
"2021-06-21","210610_Vietnam_TheUniversityOfSydney_GenPop1_overall","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","National","","Viet Nam; Hanoi Capital, Quang Nam Province, Da Nang Province; Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang","2020-09-04","2020-11-23","Household and community samples","Multiple groups",3034.0,0.004,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","",0.968,0.998,"","VN",""
"2021-06-21","210610_Vietnam_TheUniversityOfSydney_HCW2_overall","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","Local","","Viet Nam; Da Nang","2020-11-24","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",148.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","",0.968,0.998,"","VN","VN-DN"
"2021-06-21","210611_SanFrancisco_UniversityofCaliforniaSanFrancisco_mostadj","Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.","2021-06-11","Local","","United States of America; California; San Francisco","2020-03-28","2020-06-26","Residual sera","Multiple groups",4735.0,0.042,"Stratified non-probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Isobel Routledge","University of California San Francisco","https://dx.doi.org/10.1038/s41467-021-23651-6","Verified",0.021,0.063,0.937,0.996,"","US","US-CA"
"2021-06-22","210604_NewYorkCity_NewYorkCityDepartmentOfHealthAndMentalHygiene_Overall","Prevalence of SARS-CoV-2 antibodies in New York City adults, June-October, 2020: a population-based survey.","2021-06-04","Local","","United States of America; New York State; New York City","2020-06-01","2020-10-09","Household and community samples","Multiple groups",1074.0,0.243,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jannae Parrott","New York City Department of Health and Mental Hygiene","https://dx.doi.org/10.1093/infdis/jiab296","Verified",0.207,0.283,0.976,0.993,"","US","US-NY"
"2021-06-22","210607_NuevoLeon_HealthServicesOfTheStateOfNuevoLeon_Overall","Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico","2021-06-07","Regional","","Mexico; Nuevo Leon","2020-08-15","2020-11-15","Household and community samples","Multiple groups",4495.0,0.271,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Edgar Rodriguez-Vidales","Health Services of the State of Nuevo Leon","https://dx.doi.org/10.1002/jmv.27131","Verified",0.258,0.284,"","","","MX","MX-NLE"
"2021-06-22","210610_Saxony_TechnischeUniversitätDresden_Students_SeptOct_2_overall","SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools.","2021-06-10","Regional","","Germany; Saxony","2020-09-15","2020-10-13","Students and Daycares","Children and Youth (0-17 years)",1334.0,0.008,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carolin Kirsten","Technische Universität Dresden","https://dx.doi.org/10.1136/bmjopen-2021-049876","Unverified","","","","","","DE","DE-SN"
"2021-06-22","210610_Saxony_TechnischeUniversitätDresden_Teachers_SeptOct_4_overall","SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools.","2021-06-10","Regional","","Germany; Saxony","2020-09-15","2020-10-13","Essential non-healthcare workers","Adults (18-64 years)",445.0,0.002,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Carolin Kirsten","Technische Universität Dresden","https://dx.doi.org/10.1136/bmjopen-2021-049876","Unverified","","","","","","DE","DE-SN"
"2021-06-22","210610_USA_BostonHeartDiagnostics","Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging","2021-06-10","National","","United States of America","2020-04-06","2020-12-01","Residual sera","Multiple groups",81624.0,0.052,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Ernst J. Schaefer","Boston Heart Diagnostics","http://dx.doi.org/10.1371/journal.pone.0252818","Unverified","","",0.984,0.974,"","US",""
"2021-06-22","210615_USA_JohnsHopkinsUniversity","Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020.","2021-06-15","National","","United States of America","2020-01-02","2020-03-18","Household and community samples","Multiple groups",24079.0,0.0,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Keri Althoff","Johns Hopkins University","https://dx.doi.org/10.1093/cid/ciab519","Verified","","",0.907,1.0,"","US",""
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_Agartala5","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","","India; Tripura; Agartala","2021-03-26","2021-06-01","Household and community samples","Multiple groups",1001.0,0.519,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","",0.944,1.0,"","IN","IN-TR"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_Bhubaneswar3","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","","India; Odisha; Bhubaneswar","2021-03-22","2021-05-07","Household and community samples","Multiple groups",1000.0,0.526,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","",0.944,1.0,"","IN","IN-OR"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_DelhiRural2","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","","India; Haryana; ; Faridabad","2021-04-12","2021-05-22","Household and community samples","Multiple groups",1059.0,0.593,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","",0.944,1.0,"","IN","IN-HR"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_DelhiUrban1","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","","India; National Capital Territory of Delhi; New Delhi","2021-03-15","2021-03-31","Household and community samples","Multiple groups",1001.0,0.747,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","",0.944,1.0,"","IN","IN-DL"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_Gorakhpur4","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","","India; Uttar Pradesh; Gorakhpur","2021-04-22","2021-06-10","Household and community samples","Multiple groups",448.0,0.879,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","",0.944,1.0,"","IN","IN-UP"
"2021-06-23","200826_Andhra_CollegeOfVeterinary Sciences_Anantapur2","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.167,"Unclear","NR","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","","","","","IN","IN-AP"
"2021-06-23","200826_Andhra_CollegeOfVeterinary Sciences_EastGodavari3","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.144,"Unclear","NR","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","","","","","IN","IN-AP"
"2021-06-23","200826_Andhra_CollegeOfVeterinary Sciences_Nellore4","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.082,"Unclear","NR","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","","","","","IN","IN-AP"
"2021-06-23","200826_Andhra_CollegeOfVeterinarySciences_Krishna1","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.217,"Unclear","NR","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","","","","","IN","IN-AP"
"2021-06-23","200903_Ahmedabad_AhmedabadMunicipalCorporation","Second survey in Ahmedabad: Sero-positivity up by 5.6 per cent since June, no herd immunity yet","2020-09-03","Local","","India; Gujarat; Ahmedabad","2020-08-15","2020-08-29","Household and community samples","Multiple groups",10310.0,0.232,"Unclear","NR","Not reported","High","News and Media","Express News Service","Ahmedabad Municipal Corporation","https://indianexpress.com/article/cities/ahmedabad/second-survey-in-ahmedabad-sero-positivity-up-by-5-6-per-cent-since-june-no-herd-immunity-yet-6580951/","Unverified","","","","","","IN","IN-GJ"
"2021-06-23","210201_Yamagata_YamagataUniversity_Overall","Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020.","2021-02-01","Local","","Japan; Yamagata prefecture; Yamagata","2020-06-01","2020-06-04","Residual sera","Multiple groups",1009.0,0.005,"Sequential","NR","Total Antibody","High","Institutional Report","Keita Morikane","Yamagata University","https://dx.doi.org/10.5365/wpsar.2020.11.3.012","Verified",0.001,0.009,"",0.998,"","JP","JP-06"
"2021-06-23","210208_Kenya_KEMRI-WellcomeTrust_KilifiOct_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","","Kenya; NR; Kilifi","2020-10-01","2020-10-31","Pregnant or parturient women","Adults (18-64 years)",183.0,0.015,"Sequential","NR","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified",0.001,0.041,0.927,0.99,"","KE",""
"2021-06-23","210208_Kenya_KEMRI-WellcomeTrust_KilifiSept_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","","Kenya","2020-09-18","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",82.0,0.013,"Sequential","NR","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified",0.0,0.047,0.927,0.99,"","KE",""
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Non-essential workers and unemployed persons","Adults (18-64 years)",369.0,0.054,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenseForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Essential non-healthcare workers","Adults (18-64 years)",513.0,0.037,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DisplacedPeople","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Persons experiencing homelessness","Multiple groups",66.0,0.061,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Fishermen","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Non-essential workers and unemployed persons","Adults (18-64 years)",80.0,0.05,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_HealthProfessionals","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",506.0,0.055,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Essential non-healthcare workers","Adults (18-64 years)",248.0,0.048,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Vendors/Merchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Non-essential workers and unemployed persons","Adults (18-64 years)",928.0,0.065,"Convenience","Qingdao Hightop biotech","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","","","","","","MZ","MZ-P"
"2021-06-28","210622_Estonia_UniversityOfTartu_Stage18_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","","Estonia","2021-06-10","2021-06-21","Household and community samples","Multiple groups",2330.0,0.679,"Stratified probability","NR","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.66,0.698,"","","","EE",""
"2021-06-29","210525_Paris_SamusocialDeParis_Residents_Overall","Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020)","2021-05-25","Local","","France; Ile de France; Paris","2020-03-01","2020-05-31","Persons experiencing homelessness","Multiple groups",96.0,0.698,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maya Husain","Samusocial de Paris","http://dx.doi.org/10.1016/j.cmi.2021.05.039","Unverified","","",0.96,0.993,"","FR","FR-IDF"
"2021-06-29","210525_Paris_SamusocialDeParis_Staff_Overall","Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020)","2021-05-25","Local","","France; Ile de France; Paris","2020-03-01","2020-05-31","Essential non-healthcare workers","Multiple groups",81.0,0.185,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maya Husain","Samusocial de Paris","http://dx.doi.org/10.1016/j.cmi.2021.05.039","Unverified","","",0.96,0.993,"","FR","FR-IDF"
"2021-06-29","210531_Madrid_CentroDeTransfusiónDeLaComunidadDeMadrid_overall","Anti SARS-CoV-2 antibodies prevalence in Madrid blood donors prior to first outbreak","2021-05-31","Local","","Spain","2020-01-01","2020-03-22","Blood donors","Multiple groups",2419.0,0.001,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","R. Alenda","Centro de Transfusión de la Comunidad de Madrid","http://dx.doi.org/10.1111/vox.13117","Verified","","","","","","ES",""
"2021-06-29","210601_Chennai_GovernmentKilpaukMedicalCollege","Evaluation of IgG antibody response to severe acute respiratory syndrome Coronavirus-2 in healthcare workers in a tertiary care centre, Chennai, India","2021-06-01","Local","","India; Tamil Nadu; Chennai","2020-04-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",45.0,0.267,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Therese Dhason","Government Kilpauk Medical College","http://dx.doi.org/10.7860/JCDR/2021/48889.14995","Unverified","","","","","","IN","IN-TN"
"2021-06-29","210606_Pennsylvania_UniversityOfPittsburgh_Fall1_overall","A cross-sectional study of sars-cov-2 seroprevalence between fall 2020 and february 2021 in allegheny county, western pennsylvania, usa","2021-06-06","Regional","","United States of America; Pennsylvania","2020-09-21","2020-11-04","Multiple general populations","Multiple groups",199.0,0.02,"Convenience","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Lingqing Xu","University of Pittsburgh","http://dx.doi.org/10.3390/pathogens10060710","Verified",0.01,0.05,"","","","US","US-PA"
"2021-06-29","210606_Pennsylvania_UniversityOfPittsburgh_Feb2","A cross-sectional study of sars-cov-2 seroprevalence between fall 2020 and february 2021 in allegheny county, western pennsylvania, usa","2021-06-06","Local","","United States of America; Pennsylvania; Pittsburgh","2021-02-01","2021-02-05","Residual sera","Multiple groups",194.0,0.165,"Sequential","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Lingqing Xu","University of Pittsburgh","http://dx.doi.org/10.3390/pathogens10060710","Verified",0.12,0.22,"","","","US","US-PA"
"2021-06-29","210622_UnitedStatesOfAmerica_NationalInstitutesOfHealth_PopAdj","Undiagnosed SARS-CoV-2 Seropositivity During the First Six Months of the COVID-19 Pandemic in the United States.","2021-06-22","National","","United States of America","2020-04-01","2020-08-04","Household and community samples","Multiple groups",8058.0,0.046,"Stratified non-probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Heather Kalish","National Institutes of Health","https://dx.doi.org/10.1126/scitranslmed.abh3826","Unverified",0.026,0.065,"","","","US",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Dec2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2019-12-01","2019-12-31","Residual sera","Multiple groups",147.0,0.075,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Feb2020","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2020-02-01","2020-03-10","Residual sera","Multiple groups",105.0,0.2,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Jan2020","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2020-01-01","2020-01-31","Residual sera","Multiple groups",106.0,0.028,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Nov2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2019-11-01","2019-11-30","Residual sera","Multiple groups",273.0,0.095,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Oct2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2019-10-01","2019-10-31","Residual sera","Multiple groups",166.0,0.163,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Sept2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","Italy","2019-09-01","2019-09-30","Residual sera","Multiple groups",162.0,0.142,"Sequential","Mazzini et al","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","","",0.857,0.981,"","IT",""
"2021-06-30","210302_Vietnam_UniversitatsklinikumTubingen_patients_RDT","Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam","2021-03-02","Local","Viet Nam","Viet Nam; Red River Delta; Hanoi","2020-03-01","2021-01-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",288.0,0.0,"Unclear","WANTAI Biological Pharmacy, Beijing, China","Total Antibody","High","Journal Article (Peer-Reviewed)","Le Huu Song","Universitätsklinikum Tübingen","https://dx.doi.org/10.1016/j.lanwpc.2021.100113","Verified","","","","","","VN",""
"2021-06-30","210604_Nancy_UniversiteDeLorraine_Overall_PopAdj","Seroprevalence of sars-cov-2, symptom profiles and sero-neutralization in a suburban area, france","2021-06-04","Local","","France; Grand Est; Nancy","2020-06-26","2020-07-24","Household and community samples","Multiple groups",2006.0,0.025,"Convenience","NR","IgG; IgM; IgA; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Anne Petit","Université de Lorraine","http://dx.doi.org/10.3390/v13061076","Verified",0.018,0.033,"","","","FR","FR-GES"
"2021-06-30","210608_Geneva_UniversityOfGeneva_overall","Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland","2021-06-08","Regional","","Switzerland; Canton of Geneva","2020-05-18","2020-09-18","Essential non-healthcare workers","Adults (18-64 years)",10513.0,0.098,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Silvia Stringhini","The University of Geneva","http://dx.doi.org/10.1038/s41467-021-23796-4","Unverified","","","","","","CH","CH-GE"
"2021-06-30","210608_SouthWestOfIreland_CorkUniversityHospital","Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland","2021-06-08","Regional","","Ireland; Munster; Cork","2020-05-27","2020-07-07","Health care workers and caregivers","Adults (18-64 years)",404.0,0.015,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Eamonn Faller","Cork University Hospital","http://dx.doi.org/10.1136/bmjopen-2021-051415","Unverified","","","","","","IE","IE-M"
"2021-06-30","210612_Tokyo_TheUniversityOfTokyo_overall","Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).","2021-06-12","Local","","Japan","2020-06-11","2020-10-28","Multiple populations","Multiple groups",6609.0,0.005,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Akihisa Mitani","The University of Tokyo","https://dx.doi.org/10.1016/j.jiac.2021.06.008","Verified","","","","","","JP",""
"2021-06-30","210618_Sweden_PublicHealthAgencyOfSweden","Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection","2021-06-18","National","","Sweden","2020-10-30","2020-12-08","Household and community samples","Multiple groups",324.0,0.086,"Convenience","NR","IgG","High","Preprint","Thomas Akerlund","Public Health Agency of Sweden","https://www.medrxiv.org/content/10.1101/2021.06.16.21258960v1.full-text","Unverified","","",0.997,1.0,"","SE",""
"2021-06-30","210618_Vancouver_UniversityOfBritishColumbia_BloodDonors_TestAdj","SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada","2021-06-18","Local","","Canada; British Columbia; Vancouver","2021-01-01","2021-01-31","Blood donors","Adults (18-64 years)",2502.0,0.023,"Convenience","NR","IgG; IgM; IgA","High","Preprint","David Goldfarb","University of British Columbia","10.1101/2021.06.16.21258861","Unverified",0.017,0.03,"","","","CA","CA-BC"
"2021-06-30","210618_Vancouver_UniversityOfBritishColumbia_TestAdj","SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada","2021-06-18","Local","","Canada; British Columbia; Vancouver","2021-02-10","2021-05-15","Essential non-healthcare workers","Adults (18-64 years)",1556.0,0.023,"Self-referral","NR","IgG; IgM; IgA","Moderate","Preprint","David Goldfarb","University of British Columbia","10.1101/2021.06.16.21258861","Unverified",0.016,0.032,"","","","CA","CA-BC"
"2021-06-30","210620_Delhi_AllIndiaInstituteOfMedicalScience","Seroprevalence of COVID-19 in HIV Population","2021-06-20","Local","","India","2020-09-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",164.0,0.14,"Convenience","NR","IgG","High","Preprint","Shivdas Rajaram Naik","All India Institute Of Medical Science","https://www.medrxiv.org/content/10.1101/2021.06.17.21259066v1.full-text","Verified",0.091,0.203,0.94,1.0,"","IN",""
"2021-06-30","210621_Jacksonville_MayoClinic","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers in a surgical environment.","2021-06-21","Local","","United States of America; Florida; Jacksonville","2020-05-06","2020-07-01","Health care workers and caregivers","Adults (18-64 years)",292.0,0.027,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Martin L.De Ruyter","Mayo Clinic","https://dx.doi.org/10.1093/bjs/znab109","Unverified",0.012,0.053,1.0,1.0,"","US","US-FL"
"2021-06-30","210625_Osaka_ ToyonakaMunicipalHospital_Overall","Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.","2021-06-25","Local","","Japan; Osaka Prefecture; Osaka","2020-06-12","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",925.0,0.004,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Tsutomu Nishida","Toyonaka Municipal Hospital","https://dx.doi.org/10.1097/MD.0000000000026433","Verified",0.002,0.011,1.0,0.996,"","JP","JP-27"
"2021-07-01","210525_London_PublicHealthEngland_Week18_Euroimmun_Primary","Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.","2021-05-25","Local","","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-01","2020-05-03","Blood donors","Multiple groups",974.0,0.149,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Gayatri Amirthalingam","Public Health England","https://dx.doi.org/10.3201/eid2707.203167","Verified",0.121,0.18,0.825,0.991,"","GB","GB-ENG"
"2021-07-01","210531_Skopje_InstituteForTransfusionMedicine","Seroprevalence of SARS-CoV-2 among blood donors","2021-05-31","Local","","North Macedonia; Skopje; Skopje","2020-11-15","2021-03-15","Blood donors","Multiple groups",9773.0,0.25,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Tatjana Makarovska Bojadjieva","Institute for Transfusion Medicine","http://dx.doi.org/10.1111/vox.13117","Verified","","","","","","MK","MK-"
"2021-07-01","210615_Nashville_VanderbiltUniversityMedicalCenter_FollowUp2_Overall","Low in-school COVID-19 transmission and asymptomatic infection despite high community prevalence.","2021-06-15","Local","","United States of America; Tennessee; Nashville","2021-01-27","2021-01-27","Essential non-healthcare workers","Adults (18-64 years)",34.0,0.147,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Sophie E. Katz","Vanderbilt University Medical Center","https://dx.doi.org/10.1016/j.jpeds.2021.06.015","Verified","","","","","","US","US-TN"
"2021-07-01","210617_Barcelona_UniversitatDeBarcelona_Overall_PopAdj","Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain","2021-06-17","Local","","Spain; Catalonia; Barcelona","2020-12-14","2021-02-25","Multiple populations","Adults (18-64 years)",2775.0,0.142,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Sebastian Videla","Universitat de Barcelona","http://dx.doi.org/10.3390/ijerph18126526","Verified","","","","","","ES","ES-CT"
"2021-07-02","210621_Portugal_LosAlamosNationalLaboratory_overall_PopAdj_TestAdj","Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic","2021-06-21","National","","Portugal","2021-03-01","2021-03-17","Household and community samples","Multiple groups",2435.0,0.173,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Luisa Canto e Castro","Los Alamos National Laboratory","https://europepmc.org/article/PPR/PPR359402","Verified",0.158,0.188,0.981,0.999,"","PT",""
"2021-07-05","210212_Kaunas_LithuanianUniversityOfHealthSciences_HidradenitisSuppurativa","SARS-CoV-2 seroprevalence in patients with hidradenitis suppurativa in Lithuania","2021-02-12","Local","","Lithuania","2020-08-12","2020-12-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",26.0,0.077,"Convenience","NR","IgG; IgM","High","Presentation or Conference","Vaiva Jariene","Lithuanian University of Health Sciences","https://www.researchgate.net/publication/349992124_SARS-CoV-2_Seroprevalence_in_Patients_with_Hidradenitis_Suppurativa_in_Lithuania","Verified",0.021,0.241,"","","","LT",""
"2021-07-05","210414_Holyoke_CityofHolyoke_Overall_PopAdj","City of Holyoke Serosurvey Report","2021-06-23","Local","United States of America","United States of America; Massachusetts; Holyoke","2020-11-05","2021-01-31","Household and community samples","Multiple groups",328.0,0.139,"Simplified probability","NR","IgM; IgG","Moderate","Institutional Report","City of Holyoke","City of Holyoke","https://www.holyoke.org/documents/city-of-holyoke-serosurvey-report/","Verified",0.078,0.218,"","","","US","US-MA"
"2021-07-05","210603_Italy_UniversityHospitalCittaDellaSalute_Healthcare","Prevalence, persistence, and factors associated with sars-cov-2 igg seropositivity in a large cohort of healthcare workers in a tertiary care university hospital in northern italy","2021-06-03","Local","","Italy; Piedmont; Turin","2020-05-04","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",8769.0,0.076,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gitana Scozzari","University Hospital Città Della Salute e Della Scienza di Torino","http://dx.doi.org/10.3390/v13061064","Unverified",0.071,0.082,"","","","IT","IT-21"
"2021-07-05","210603_Italy_UniversityHospitalCittaDellaSalute_University","Prevalence, persistence, and factors associated with sars-cov-2 igg seropositivity in a large cohort of healthcare workers in a tertiary care university hospital in northern italy","2021-06-03","Local","","Italy; Piedmont; Turin","2020-06-29","2020-07-29","Non-essential workers and unemployed persons","Adults (18-64 years)",1185.0,0.033,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gitana Scozzari","University Hospital Città Della Salute e Della Scienza di Torino","http://dx.doi.org/10.3390/v13061064","Unverified",0.024,0.045,"","","","IT","IT-21"
"2021-07-05","210615_SantaFe_UniversidadNacionalDelLitoral_genpop_overall","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","2021-06-15","Local","","Argentina","2020-07-01","2020-11-30","Multiple general populations","Multiple groups",3000.0,0.088,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Luz Maria Rodeles","Universidad Nacional del Litoral","https://dx.doi.org/10.26633/RPSP.2021.66","Unverified","","",0.967,1.0,"","AR",""
"2021-07-05","210623_KathmanduValley_NepalHealthResearchCouncil_TestAdj","Seroprevalence of COVID-19 among health workers in the Kathmandu valley, Nepal (SEVID-KaV): a longitudinal cohort study","2021-06-23","Regional","","Nepal; Bagmati Pradesh Province; Kathmandu Valley","2020-12-03","2020-12-25","Health care workers and caregivers","Adults (18-64 years)",800.0,0.39,"Stratified probability","NR","IgG","Moderate","Preprint","Kiran Raj Pandey","Nepal Health Research Council","10.21203/rs.3.rs-626260/v1","Unverified",0.291,0.439,0.893,0.992,"","NP",""
"2021-07-05","210629_Belgium_Sciensano_Dec25","Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.","2021-06-29","National","","Belgium","2020-12-25","2020-12-25","Health care workers and caregivers","Adults (18-64 years)",308.0,0.197,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Laure Mortgat","Sciensano","https://dx.doi.org/10.1136/bmjopen-2021-050824","Unverified",0.12,0.306,0.93,0.99,"","BE",""
"2021-07-05","210630_Dublin_TrinityCollegeDublin_Overall","High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital.","2021-06-30","Local","","Ireland","2020-07-15","2020-10-15","Health care workers and caregivers","Adults (18-64 years)",1176.0,0.179,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Ann Leonard","Trinity College Dublin","https://dx.doi.org/10.1007/s11845-021-02690-4","Verified","","",0.861,1.0,"","IE",""
"2021-07-06","210602_UnitedStates_TranslationalPulmonaryAndImmunologyResearchCenter_Overall","Immune response to sars-cov-2 in an asymptomatic pediatric allergic cohort","2021-06-02","National","","United States of America","2020-02-01","2020-04-20","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",172.0,0.04,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Nathan Marsteller","Translational Pulmonary and Immunology Research Center","http://dx.doi.org/10.3390/antib10020022","Verified","","","","","","US",""
"2021-07-06","210605_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_Overall","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","2021-06-05","Local","","Iran (Islamic Republic of); Tehran; Tehran","2020-06-15","2020-07-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",168.0,0.173,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maliheh Arab","Shahid Beheshti University of Medical Sciences","https://dx.doi.org/10.31557/APJCP.2021.22.6.1667","Unverified","","",1.0,"","","IR","IR-07"
"2021-07-06","210610_Cairo_CairoUniversity_GenPop2_overall_TotalAbCLIA","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","2021-06-10","Local","","Egypt","2020-06-01","2020-06-14","Household and community samples","Adults (18-64 years)",725.0,0.294,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sherief Musa","Cairo University","https://dx.doi.org/10.1016/j.jiph.2021.06.001","Verified","","",0.9,1.0,"","EG",""
"2021-07-06","210610_Cairo_CairoUniversity_HCW1_overall","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","2021-06-10","Local","","Egypt","2020-06-01","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",386.0,0.158,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Sherief Musa","Cairo University","https://dx.doi.org/10.1016/j.jiph.2021.06.001","Verified","","",0.9,1.0,"","EG",""
"2021-07-06","210611_Padova_UniversityOfPadova_HCW_Overall","SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology.","2021-06-11","Local","","Italy; Province of Padova; Padova","2020-06-01","2020-08-07","Health care workers and caregivers","Multiple groups",95.0,0.084,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Augusta Ortolan","University of Padova","https://dx.doi.org/10.3389/fimmu.2021.682850","Unverified","","","","","","IT","IT-34"
"2021-07-06","210611_Padova_UniversityOfPadova_SpAPatients_Overall","SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology.","2021-06-11","Local","","Italy; Province of Padova; Padova","2020-06-01","2020-08-07","Patients seeking care for non-COVID-19 reasons","Multiple groups",200.0,0.125,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Augusta Ortolan","University of Padova","https://dx.doi.org/10.3389/fimmu.2021.682850","Unverified","","","","","","IT","IT-34"
"2021-07-06","210617_Stockholm_KTHRoyalInstituteofTechnology","Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.","2021-06-17","Local","","Sweden","2020-04-15","2020-05-15","Household and community samples","Multiple groups",878.0,0.125,"Simplified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Niclas Roxhed","KTH Royal Institute of Technology","https://dx.doi.org/10.1038/s41467-021-23893-4","Verified",0.103,0.147,1.0,0.96,"","SE",""
"2021-07-06","210618_Bonn_BonnUniversityHospital_primary","SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study).","2021-06-18","Local","","Germany","2020-12-15","2021-01-15","Health care workers and caregivers","Multiple groups",118.0,0.14,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Kathrin van Bremen","Bonn University Hospital","https://dx.doi.org/10.1007/s15010-021-01641-6","Unverified","","",0.995,0.995,"","DE",""
"2021-07-06","210621_SaintPetersburg_EuropeanUniversity_ELISA_Overall_PopTestAdj","Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study.","2021-06-21","Local","","Russian Federation; Northwestern; Saint Petersburg","2020-05-27","2020-06-26","Household and community samples","Multiple groups",988.0,0.091,"Simplified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Anton Barchuk","European University at St. Petersburg","https://dx.doi.org/10.1038/s41598-021-92206-y","Verified",0.072,0.109,0.996,1.0,"","RU",""
"2021-07-06","210622_Madrid_HospitalCentralDeLaDefensaGomezUlla","SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.","2021-06-22","Local","","Spain","2020-04-27","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",2781.0,0.162,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Maria Simon Sacristan","Hospital Central de la Defensa Gómez Ulla","https://dx.doi.org/10.1007/s00284-021-02541-6","Unverified","","","","","","ES",""
"2021-07-06","210623_Marseille_Aix-MarseilleUniversity","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: a mixed-methods exploratory analysis.","2021-06-23","Local","","France; Provence; Marseille","2020-06-01","2020-07-31","Health care workers and caregivers","Multiple groups",99.0,0.061,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Emilie Mosnier","Aix-Marseille University","https://dx.doi.org/10.1016/j.puhip.2021.100154","Verified","","","","","","FR",""
"2021-07-06","210624_Brazil_UniversidadeFederalDePelotas_overall","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","2021-06-24","National","","Brazil","2020-06-21","2020-06-24","Household and community samples","Multiple groups",31869.0,0.027,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Ana M. B. Menezes","Universidade Federal de Pelotas","https://dx.doi.org/10.1038/s41598-021-92775-y","Verified","","",0.848,1.0,"","BR",""
"2021-07-06","210625_Ekaterinburg_DentalCollegeYamunanagar","Do aspirating systems have a role in preventing COVID-19 transmission among dental healthcare workers?.","2021-06-25","Local","","Russian Federation; Ural; Ekaterinburg","2020-05-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",157.0,0.121,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Neeraj Gugnani","Dental College Yamunanagar","https://dx.doi.org/10.1038/s41432-021-0171-5","Unverified","","","","","","RU",""
"2021-07-06","210625_Wroclaw_RegionalSpecialistHospitalInWrocław_overall","Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021","2021-06-25","Local","","Poland; Silesia; Wroclaw","2021-05-15","2021-05-22","Household and community samples","Multiple groups",501.0,0.591,"Unclear","NR","IgG; IgA","High","Preprint","Wiktoria Budziar","Regional Specialist Hospital in Wrocław","10.1101/2021.06.22.21258711","Verified","","","","","","PL","PL-24"
"2021-07-06","210629_Cordoba_ColombiaUniversidadDeCordoba_Overall","SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.","2021-06-29","Regional","","Colombia; Cordoba Department","2020-07-15","2020-11-15","Household and community samples","Multiple groups",2564.0,0.408,"Stratified non-probability","NR","IgA; IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Evelin Garay","Colombia-Universidad de Cordoba","https://dx.doi.org/10.1093/trstmh/trab094","Verified","","","","","","CO","CO-COR"
"2021-07-06","210629_StPetersburg_Saint-PetersburgStateUniversityHospital_overall","Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.","2021-06-29","Local","","Russian Federation","2020-05-27","2021-03-19","Non-essential workers and unemployed persons","Adults (18-64 years)",180.0,0.156,"Unclear","NR","IgA","Unclear","Journal Article (Peer-Reviewed)","Andrei Ivanov","B.P.Konstantinov St Petersburg Nuclear Physics Institute","https://dx.doi.org/10.1002/jmv.27166","Verified","","","","","","RU",""
"2021-07-06","210630_Porto_UniversidadeDoPorto_primary","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","2021-06-30","Local","","Portugal; Norte; Porto","2020-05-21","2020-07-31","Essential non-healthcare workers","Multiple groups",4592.0,0.025,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Paula Meireles","Universidade do Porto","https://dx.doi.org/10.1136/oemed-2021-107519","Verified",0.001,0.053,"","","","PT",""
"2021-07-07","201010_Taipei_TaipeiVeteransGeneralHospital_popadj","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","2020-10-10","Local","","China","2020-05-25","2020-07-08","Residual sera","Multiple groups",14765.0,0.0,"Sequential","NR","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Hsiang-Ling Ho","Taipei Veterans General Hospital","https://dx.doi.org/10.1016/j.lanwpc.2020.100041","Verified",0.0,0.001,"","","","CN",""
"2021-07-07","201207_Ticino_UniversitaDellaSvizzeraItaliana","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","2020-12-17","Regional","","Switzerland; Canton of Ticino","2020-04-16","2020-04-30","Health care workers and caregivers","Multiple groups",4726.0,0.096,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Luca Piccoli","Università della Svizzera italiana","https://dx.doi.org/10.1016/j.lanepe.2020.100013","Unverified","","","","","","CH",""
"2021-07-07","210607_Iran_TehranUniversityofMedicalSciences_Primary","Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme","2021-06-07","National","","Iran (Islamic Republic of)","2020-08-03","2020-10-31","Household and community samples","Multiple groups",11256.0,0.142,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Kazem Khalagi","Tehran University of Medical Sciences","http://dx.doi.org/10.1016/j.cmi.2021.06.002","Verified",0.133,0.152,0.74,0.98,"","IR",""
"2021-07-07","210609_Chelyabinsk_SouthUralStateUniversity_HighRisk_testadj","Seroprevalence of sars-cov-2 antibodies in symptomatic individuals is higher than in persons who are at increased risk exposure: The results of the single-center, prospective, cross-sectional study","2021-06-09","Local","","Russian Federation","2020-09-28","2020-12-30","Health care workers and caregivers","Adults (18-64 years)",1091.0,0.172,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alexandr Zurochka","South Ural State University","http://dx.doi.org/10.3390/vaccines9060627","Unverified",0.172,0.173,"","","","RU",""
"2021-07-07","210618_LosAngeles_UniversityCaliforniaLosAngeles","Sars-cov-2 infection detection by pcr and serologic testing in clinical practice","2021-06-18","Local","","United States of America; California; Los Angeles","","2020-08-10","Residual sera","Multiple groups",3075.0,0.088,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Douglas Murad","University of California Los Angeles","http://dx.doi.org/10.1128/JCM.00431-21","Verified","","","","","","US","US-CA"
"2021-07-07","210619_Tokyo_KeioUniversityHealthCenter","SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.","2021-06-19","Local","","Japan","2020-08-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",2320.0,0.009,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Tomoyasu Nishimura","Keio University Health Center","https://dx.doi.org/10.2169/internalmedicine.7033-21","Verified",0.005,0.013,"","","","JP",""
"2021-07-07","210621_Geneva_GenevaUniversityHospitals_overall","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic","2021-06-21","Local","","Switzerland","2020-06-01","2020-06-30","Residual sera","Multiple groups",1167.0,0.059,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Stephanie Baggio","Geneva University Hospitals","http://dx.doi.org/10.1016/j.ypmed.2021.106696","Verified",0.047,0.074,"","","","CH",""
"2021-07-07","210625_Germany_RobertKochInstitute_overall","Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort","2021-06-25","National","","Germany","2020-10-15","2021-02-15","Household and community samples","Multiple groups",15122.0,0.013,"Simplified probability","NR","IgG","Moderate","Preprint","Jens Hoebel","German Institute for Economic Research","https://www.medrxiv.org/content/10.1101/2021.06.21.21259001v1.full-text","Verified","","","","","","DE",""
"2021-07-07","210625_Kenya_KEMRI-WellcomeTrustResearchProgramme_overall_adj","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","2021-06-25","National","","Kenya","2020-04-30","2020-09-30","Blood donors","Adults (18-64 years)",9922.0,0.079,"Sequential","NR","IgG","Low","Journal Article (Peer-Reviewed)","Ifedayo M. O. Adetifa","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1038/s41467-021-24062-3","Verified",0.067,0.09,0.927,0.99,"","KE",""
"2021-07-07","210626_Leicester_UniversityOfLeicester","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the UK.","2021-06-26","Local","","United Kingdom of Great Britain and Northern Ireland; England; Leicester","2020-03-16","2020-06-03","Household and community samples","Multiple groups",1779.0,0.114,"Simplified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Paul William Bird","University of Leicester","https://dx.doi.org/10.1002/jmv.27162","Verified","","",0.97,0.989,"","GB","GB-ENG"
"2021-07-07","210626_Spain_HospitalGregorioMaranon_popadj","Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.","2021-06-26","National","","Spain","2020-04-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1076.0,0.081,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Juan Berenguer","Hospital Gregorio Maranon","https://dx.doi.org/10.1016/j.cmi.2021.06.023","Verified",0.065,0.1,"","","","ES",""
"2021-07-07","210628_Jeddah_KingAbdulazizUniversity","Prevalence of COVID-19 antibodies among operating room and critical care staff at a tertiary teaching hospital: A cross-sectional study.","2021-06-28","Local","","Saudi Arabia; Mecca; Jeddah","2020-08-09","2020-11-02","Health care workers and caregivers","Adults (18-64 years)",319.0,0.122,"Convenience","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Sara Farsi","King Abdulaziz University","https://dx.doi.org/10.15537/smj.2021.42.7.20210348","Verified","","","","","","SA","SA-02"
"2021-07-07","210630_Hwaseong_DongtanSacredHeartHospital","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","2021-06-30","Local","","Republic of Korea; Gyeonggi; Hwaseong","2021-03-04","2021-03-12","Health care workers and caregivers","Adults (18-64 years)",298.0,0.0,"Convenience","NR","IgG; IgM; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Seri Jeong","Dongtan Sacred Heart Hospital","https://dx.doi.org/10.1128/JCM.01105-21","Unverified","","",0.954,0.908,"","KR","KR-41"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Non-essential workers and unemployed persons","Multiple groups",188.0,0.069,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","","","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Essential non-healthcare workers","Multiple groups",324.0,0.028,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","","","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Health care workers and caregivers","Multiple groups",787.0,0.039,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","","","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Essential non-healthcare workers","Multiple groups",473.0,0.087,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","","","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Non-essential workers and unemployed persons","Multiple groups",1585.0,0.083,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","","","","","","MZ","MZ-S"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Non-essential workers and unemployed persons","Adults (18-64 years)",250.0,0.05,"Convenience","STANDARD Q","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.02,0.07,"","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1427.0,0.07,"Convenience","STANDARD Q","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.06,0.09,"","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_MerchantsVendors","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Non-essential workers and unemployed persons","Adults (18-64 years)",1493.0,0.1,"Convenience","STANDARD Q","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.08,0.11,"","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Essential non-healthcare workers","Adults (18-64 years)",564.0,0.06,"Convenience","STANDARD Q","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.04,0.08,"","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Refugees","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Persons experiencing homelessness","Multiple groups",221.0,0.06,"Convenience","STANDARD Q","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.02,0.08,"","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Essential non-healthcare workers","Adults (18-64 years)",554.0,0.03,"Convenience","STANDARD Q","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified",0.01,0.04,"","","","MZ","MZ-N"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Non-essential workers and unemployed persons","Adults (18-64 years)",172.0,0.047,"Convenience","Qingdao Hightop Biotech","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","","","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Essential non-healthcare workers","Adults (18-64 years)",407.0,0.049,"Convenience","Qingdao Hightop Biotech","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","","","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Health care workers and caregivers","Adults (18-64 years)",380.0,0.013,"Convenience","Qingdao Hightop Biotech","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","","","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Essential non-healthcare workers","Adults (18-64 years)",287.0,0.01,"Convenience","Qingdao Hightop Biotech","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","","","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Non-essential workers and unemployed persons","Adults (18-64 years)",643.0,0.019,"Convenience","Qingdao Hightop Biotech","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","","","","","","MZ","MZ-B"
"2021-07-12","210626_Torno_SaccoUniversityHospital_Residents1","Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out.","2021-06-26","Local","","Italy; Lombardy; Torno","2020-06-01","2020-06-22","Assisted living and long-term care facilities","Seniors (65+ years)",74.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Mario Tagliabue","Sacco University Hospital","https://dx.doi.org/10.1016/j.pmedr.2021.101471","Unverified","","","","","","IT","IT-25"
"2021-07-12","210626_Torno_SaccoUniversityHospital_Staff2","Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out.","2021-06-26","Local","","Italy; Lombardy; Torno","2020-06-01","2020-06-22","Health care workers and caregivers","Adults (18-64 years)",51.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Mario Tagliabue","Sacco University Hospital","https://dx.doi.org/10.1016/j.pmedr.2021.101471","Unverified","","","","","","IT","IT-25"
"2021-07-12","210628_Lombardy_UniversityofPavia_patients_primary","A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects.","2021-06-28","Local","","Italy","2020-05-15","2020-05-31","Assisted living and long-term care facilities","Adults (18-64 years)",36.0,0.361,"Convenience","NR","IgA; IgG","High","Journal Article (Peer-Reviewed)","Natascia Brondino","University of Pavia","https://dx.doi.org/10.3390/brainsci11070860","Unverified","","",0.97,0.86,"","IT",""
"2021-07-12","210628_Lombardy_UniversityofPavia_staff_primary","A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects.","2021-06-28","Local","","Italy","2020-05-15","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",35.0,0.343,"Convenience","NR","IgA; IgG","High","Journal Article (Peer-Reviewed)","Natascia Brondino","University of Pavia","https://dx.doi.org/10.3390/brainsci11070860","Unverified","","",0.97,0.86,"","IT",""
"2021-07-12","210630_RioDeJaneiro_HospitalFederaldosServidoresdoEstado","Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders.","2021-06-30","Local","","Brazil","2020-04-13","2020-06-17","Pregnant or parturient women","Adults (18-64 years)",115.0,0.235,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Maria de Lourdes Benamor Teixeira","Hospital Federaldo dos Servidores do Estado","https://dx.doi.org/10.3390/v13071277","Verified","","","","","","BR",""
"2021-07-12","210701_Prague_InstituteForClinicalAndExperimentalMedicine_HCWs","Humoral Response To SARS-CoV-2 Is Well-Preserved And Symptom-Dependent In Kidney Transplant Recipients.","2021-07-01","Local","","Czechia","2020-10-01","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",512.0,0.119,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Maria Magicova","Institute for Clinical and Experimental Medicine","https://dx.doi.org/10.1111/ajt.16746","Unverified","","",0.912,0.902,"","CZ",""
"2021-07-12","210701_Prague_InstituteForClinicalAndExperimentalMedicine_Patients","Humoral Response To SARS-CoV-2 Is Well-Preserved And Symptom-Dependent In Kidney Transplant Recipients.","2021-07-01","Local","","Czechia","2020-10-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",1002.0,0.068,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Maria Magicova","Institute for Clinical and Experimental Medicine","https://dx.doi.org/10.1111/ajt.16746","Unverified","","",0.912,0.902,"","CZ",""
"2021-07-12","210703_Melbourne_RoyalChildrensHospital_Primary","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.","2021-07-03","Local","","Australia","2020-10-21","2020-10-30","Health care workers and caregivers","Adults (18-64 years)",318.0,0.0,"Convenience","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Jane Tuckerman","Royal Children's Hospital","https://dx.doi.org/10.1111/jpc.15585","Verified","","","","","","AU",""
"2021-07-12","210703_Rome_FondazionePoliclinicoUniversitario_Primary","Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.","2021-07-03","Local","","Italy","2020-03-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1106.0,0.007,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Francesca Lombardi","Fondazione Policlinico Universitario","https://dx.doi.org/10.3390/diagnostics11071154","Unverified","","","","","","IT",""
"2021-07-13","210430_AghiaSophiaChildrensHospital_Athens_HCW","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","2021-07-05","Local","","Greece; Atica; Athens","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1216.0,0.007,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Elizabeth‑Barbara Tatsi","The ""Aghia Sophia"" Children's Hospital","https://dx.doi.org/10.1007/s15010-021-01653-2","Verified","","","","","","GR","GR-I"
"2021-07-13","210620_Croatia_CroatianInstituteOfPublicHealth_FirstWave_Overall","SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.","2021-06-20","National","","Croatia","2020-05-15","2020-07-15","Multiple general populations","Multiple groups",1088.0,0.022,"Convenience","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tatjana Vilibic-Cavlek","Croatian Institute of Public Health","https://dx.doi.org/10.3390/pathogens10060774","Verified",0.014,0.033,"","","","HR",""
"2021-07-13","210620_Croatia_CroatianInstituteOfPublicHealth_SecondWave_Overall","SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.","2021-06-20","National","","Croatia","2020-12-15","2021-02-15","Multiple general populations","Multiple groups",1436.0,0.251,"Convenience","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tatjana Vilibic-Cavlek","Croatian Institute of Public Health","https://dx.doi.org/10.3390/pathogens10060774","Verified",0.228,0.274,"","","","HR",""
"2021-07-13","210702_USA_DaVitaClinicalResearch","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","2021-07-02","National","","United States of America; California, Connecticut, Minnesota, Nevada, New York, Ohio, Texas, Virginia, and Wisconsin","2020-07-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",2337.0,0.095,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Dena Cohen","DaVita Clinical Research","https://dx.doi.org/10.1681/ASN.2021030387","Verified","","","","","","US",""
"2021-07-13","210705_Lausanne_UniversityOfLausanne_Overall","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","2021-07-05","Local","","Switzerland","2020-05-18","2020-06-12","Health care workers and caregivers","Multiple groups",1874.0,0.1,"Stratified non-probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Sylvain Meylan","Lausanne University Hospital and University of Lausanne","https://dx.doi.org/10.1136/bmjopen-2021-049232","Unverified",0.087,0.115,0.97,0.98,"","CH",""
"2021-07-13","210705_SierraLeone_HarvardMedicalSchool_WeightedOverall","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","2021-07-05","National","","Sierra Leone","2021-03-01","2021-03-31","Household and community samples","Multiple groups",1893.0,0.026,"Stratified probability","NR","IgG; IgM","Low","Preprint","Mohamed Bailor Barrie","Harvard Medical School","https://dx.doi.org/10.1101/2021.06.27.21259271","Unverified",0.019,0.034,1.0,1.0,"","SL",""
"2021-07-13","210706_France_InstitutdeCancérologiedel’Ouest_HCW_primary","Anosmia but not ageusia as a covid-19-related symptom among cancer patients-first results from the papesco-19 cohort study","2021-07-06","Regional","","France; Western France, Eastern France, Central France","2020-07-17","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",940.0,0.078,"Self-referral","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ke Zhou","Institut de Cancérologie de l’Ouest","http://dx.doi.org/10.3390/cancers13143389","Unverified","","",1.0,0.953,"","FR",""
"2021-07-13","210706_France_InstitutdeCancérologiedel’Ouest_patients_primary","Anosmia but not ageusia as a covid-19-related symptom among cancer patients-first results from the papesco-19 cohort study","2021-07-06","Regional","","France; Western France, Eastern France, Central France","2020-07-17","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",878.0,0.067,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ke Zhou","Institut de Cancérologie de l’Ouest","http://dx.doi.org/10.3390/cancers13143389","Unverified","","",1.0,0.953,"","FR",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase1_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","","Ghana; Greater Acra Region, Central Region, Eastern Region, Upper East Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2020-07-27","2020-09-14","Multiple general populations","Multiple groups",1305.0,0.19,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","",0.66,0.94,"","GH",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase2_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","","Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2020-10-01","2020-10-31","Multiple general populations","Multiple groups",395.0,0.152,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","",0.66,0.94,"","GH",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase3_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","","Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2020-12-01","2020-12-31","Multiple general populations","Multiple groups",393.0,0.097,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","",0.66,0.94,"","GH",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase4_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","","Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2021-02-01","2021-02-28","Multiple general populations","Multiple groups",636.0,0.228,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","",0.66,0.94,"","GH",""
"2021-07-13","210706_Kathmandu_ManmohanMemorialMedicalCollege_primary","ANTI - SARS-CoV-2 ANTIBODY SCREENING IN HEALTH CARE WORKERS AND ITS CORRELATION WITH CLINICAL PRESENTATION","2021-07-06","Local","","Nepal","2020-11-15","2021-01-15","Health care workers and caregivers","Adults (18-64 years)",185.0,0.222,"Convenience","NR","IgM; IgG","High","Preprint","Suraj Aryal","Manmohan Memorial Medical College","https://www.medrxiv.org/content/10.1101/2021.07.01.21259884v1.full-text","Verified","","","","","","NP",""
"2021-07-13","210706_SouthAfrica_SouthAfricanNationalBloodService_Overall_PopAdj","Prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa during the period January-May 2021","2021-07-06","National","","South Africa","2021-01-15","2021-05-15","Blood donors","Multiple groups",16762.0,0.474,"Sequential","NR","Total Antibody","Low","Preprint","Marion Vermeulen","South African National Blood Service","https://assets.researchsquare.com/files/rs-690372/v2_covered.pdf?c=1627923426","Verified",0.462,0.486,1.0,0.995,"","ZA",""
"2021-07-13","210707_Monrovia_OakCrestInstituteOfScience_Overall","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","2021-07-07","Local","","United States of America; California; Monrovia","2020-03-27","2020-05-26","Non-essential workers and unemployed persons","Adults (18-64 years)",33.0,0.061,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Manjula Gunawardana","Oak Crest Institute of Science","https://dx.doi.org/10.1128/mSphere.00542-21","Verified","","","","","","US","US-CA"
"2021-07-14","210309_Madrid_FundacionRenalInigoAlvarezDeToledo","Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study.","2021-03-09","Local","","Spain","2020-03-01","2020-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",672.0,0.15,"Convenience","NR","IgM; IgA","High","Journal Article (Peer-Reviewed)","Roberto Alcazar Arroyo","Fundación Renal Íñigo Álvarez de Toledo","https://dx.doi.org/10.1093/ckj/sfab048","Unverified","","",0.88,0.99,"","ES",""
"2021-07-14","210518_Paris_HopitalBichat-ClaudeBernard","Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.","2021-05-18","Local","","France","2020-05-12","2020-06-02","Health care workers and caregivers","Adults (18-64 years)",72.0,0.153,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Charlotte Charpentier","Hopital Bichat-Claude Bernard","https://dx.doi.org/10.1016/j.diagmicrobio.2021.115430","Unverified",0.069,0.237,"","","","FR",""
"2021-07-14","210624_Modiin_IsraelMinistryOfHealth_Primary","SARS-CoV-2 outbreak in a synagogue community: Longevity and strength of anti-SARS-CoV-2 IgG responses","2021-06-24","Local","","Israel","2020-09-01","2020-09-30","Household and community samples","Multiple groups",283.0,0.166,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Yael Gozlan","Israel Ministry of Health","http://dx.doi.org/10.1017/S0950268821001369","Verified","","","","","","IL",""
"2021-07-14","210701_Heilbronn_SLKClinicsHeilbronn_Primary","Assessment of sars-cov-2 infection among healthcare workers of a german covid-19 treatment center","2021-07-01","Local","","Germany; Baden-Württemberg; Heilbronn","2020-07-01","2020-07-21","Health care workers and caregivers","Multiple groups",3066.0,0.031,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lionel Larribere","SLK Clinics Heilbronn","http://dx.doi.org/10.3390/ijerph18137057","Verified","","",1.0,"","","DE","DE-BW"
"2021-07-14","210701_RioDeJaneiro_OswaldoCruzFoundation_Primarysam","SARS-CoV-2 infection dynamics in children and household contacts in a slum in Rio de Janeiro","2021-07-01","Local","","Brazil; Rio de Janeiro; Rio de Janeiro","2020-05-18","2020-09-24","Multiple general populations","Multiple groups",515.0,0.293,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Pamella Lugon","Oswaldo Cruz Foundation","https://europepmc.org/article/MED/33863845","Verified","","","","","","BR","BR-RJ"
"2021-07-14","210702_RibeiraoPreto_UniversidadedeSãoPaulo_Followup","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirao Preto, Southeast Brazil: an epidemiological survey.","2021-07-02","Local","","Brazil; São Paulo; Ribeirão Preto (RP)","2020-06-11","2020-06-14","Household and community samples","Multiple groups",646.0,0.028,"Stratified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Edson Zangiacomi Martinez","Universidade de São Paulo","https://dx.doi.org/10.1590/0037-8682-0210-2021","Verified","","",0.864,0.996,"","BR","BR-SP"
"2021-07-14","210703_Atlanta_CentersForDiseaseControlAndPrevention","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","2021-07-03","Local","","United States of America; Georgia; Atlanta","2020-08-31","2020-11-23","Residual sera","Multiple groups",592.0,0.179,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Talya Shragai","United States Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/infdis/jiab349","Verified","","","","","","US","US-GA"
"2021-07-14","210707_Dublin_StJames'sHospital","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","2021-07-07","Local","","Ireland; Leinster; Dublin","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",49.0,0.29,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Colm Kerr","St. James’s Hospital","https://dx.doi.org/10.1007/s11845-021-02700-5","Unverified","","","","","","IE","IE-L"
"2021-07-15","210616_Lisbon_ UniversidadeNOVAdeLisboa_primary","Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.","2021-06-16","Local","","Portugal","2020-06-15","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",1624.0,0.031,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","David G. Lopes","Universidade NOVA de Lisboa","https://dx.doi.org/10.3389/fpubh.2021.689919","Unverified","","",0.947,0.995,"","PT",""
"2021-07-16","210702_Ohio_UniversityHospitalsClevelandMedicalCenter_Overall","SARS-CoV-2 Seroprevalence among First Responders in Northeastern Ohio","2021-07-02","Regional","","United States of America; Northeastern Ohio","2020-05-22","2020-09-15","Essential non-healthcare workers","Multiple groups",3080.0,0.024,"Convenience","NR","IgG","Moderate","Preprint","Xiaochun Zhang","University Hospitals Cleveland Medical Center","https://www.medrxiv.org/content/10.1101/2021.06.27.21259432v1.full-text","Unverified","","",1.0,0.996,"","US",""
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Non-essential workers and unemployed persons","Adults (18-64 years)",404.0,0.005,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","","","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Health care workers and caregivers","Adults (18-64 years)",569.0,0.007,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","","","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Essential non-healthcare workers","Adults (18-64 years)",554.0,0.029,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","","","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Essential non-healthcare workers","Adults (18-64 years)",334.0,0.015,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","","","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Non-essential workers and unemployed persons","Adults (18-64 years)",1556.0,0.008,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","","","","","","MZ","MZ-T"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",200.0,0.01,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","","","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",390.0,0.031,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","","","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Health care workers and caregivers","Adults (18-64 years)",543.0,0.037,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","","","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",367.0,0.074,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","","","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",1123.0,0.016,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","","","","","","MZ","MZ-Q"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Non-essential workers and unemployed persons","Adults (18-64 years)",122.0,0.0,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","","","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Health care workers and caregivers","Adults (18-64 years)",454.0,0.018,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","","","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Essential non-healthcare workers","Adults (18-64 years)",471.0,0.015,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","","","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Essential non-healthcare workers","Adults (18-64 years)",230.0,0.004,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","","","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Non-essential workers and unemployed persons","Adults (18-64 years)",871.0,0.002,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","","","","","","MZ","MZ-A"
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Airport&PortWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",362.0,0.033,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",595.0,0.045,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Health care workers and caregivers","Adults (18-64 years)",1443.0,0.026,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_NursingHomeWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Health care workers and caregivers","Adults (18-64 years)",85.0,0.012,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",559.0,0.039,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",623.0,0.022,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","Mozambique","2020-08-03","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",1246.0,0.052,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","","","","","","MZ",""
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Non-essential workers and unemployed persons","Adults (18-64 years)",323.0,0.059,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","","","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",793.0,0.039,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","","","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",456.0,0.044,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","","","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",282.0,0.032,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","","","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Non-essential workers and unemployed persons","Adults (18-64 years)",1288.0,0.05,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","","","","","","MZ","MZ-MPM"
"2021-07-18","210604_RepublicOfSrpska_InstituteforTransfusionMedicine_Primary","Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: A 30-day survey","2021-06-04","National","","Bosnia and Herzegovina; Republic of Srpska","2020-06-17","2020-07-16","Blood donors","Adults (18-64 years)",807.0,0.027,"Unclear","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Gordana Guzijan","Institute for Transfusion Medicine of the Republic of Srpska","http://dx.doi.org/10.2298/VSP200122059G","Verified","","","","","","BA",""
"2021-07-18","210616_LomaLinda_LomaLindaUniversityChildren'sHospital_Overall","COVID-19 diagnosis and testing in pediatric heart transplant recipients.","2021-06-16","Local","","United States of America; California; Loma Linda","2020-03-15","2021-03-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",146.0,0.062,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Matthew J. Bock","Loma Linda University Children's Hospital","https://dx.doi.org/10.1016/j.healun.2021.06.009","Verified","","","","","","US","US-CA"
"2021-07-18","210709_Dublin_HSENationalDrugTreatmentCentre_overall","A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment.","2021-07-09","Local","","Ireland","2020-07-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",103.0,0.019,"Convenience","NR","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Fiona Fenton","HSE National Drug Treatment Centre","https://dx.doi.org/10.1007/s11845-021-02660-w","Unverified","","","","","","IE",""
"2021-07-18","210714_Baden-Württemberg_UlmUniversityHospital_Employees2_overall","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","2021-07-14","Local","","Germany; Baden-Württemberg; Alb-Danube district and Ulm","2020-07-27","2020-08-25","Health care workers and caregivers","Adults (18-64 years)",394.0,0.002,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Lukas Perkhofer","Ulm University Hospital","https://dx.doi.org/10.1007/s00391-021-01931-6","Unverified","","","","","","DE","DE-BW"
"2021-07-18","210714_Baden-Württemberg_UlmUniversityHospital_Residents1_overall","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","2021-07-14","Local","","Germany; Baden-Württemberg; Alb-Danube district and Ulm","2020-07-27","2020-08-25","Assisted living and long-term care facilities","Multiple groups",100.0,0.01,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Lukas Perkhofer","Ulm University Hospital","https://dx.doi.org/10.1007/s00391-021-01931-6","Unverified","","","","","","DE","DE-BW"
"2021-07-19","210614_Fukushima_HirataCentralHospital_May_CLIA_IgG","Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.","2021-06-14","Local","","Japan; Fukushima; Ishikawa District","2020-05-08","2020-05-28","Health care workers and caregivers","Multiple groups",515.0,0.01,"Entire sample","NR","IgG","Low","Journal Article (Peer-Reviewed)","Yurie Kobashi","Hirata Central Hospital","https://dx.doi.org/10.1016/j.intimp.2021.107884","Unverified",0.003,0.022,0.973,0.963,"","JP","JP-07"
"2021-07-19","210614_Fukushima_HirataCentralHospital_Oct_CLIA_IgG","Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.","2021-06-14","Local","","Japan; Fukushima; Ishikawa District","2020-10-05","2020-10-23","Health care workers and caregivers","Multiple groups",515.0,0.004,"Entire sample","NR","IgG","Low","Journal Article (Peer-Reviewed)","Yurie Kobashi","Hirata Central Hospital","https://dx.doi.org/10.1016/j.intimp.2021.107884","Unverified",0.0,0.014,0.973,0.963,"","JP","JP-07"
"2021-07-19","210625_Emilia-Romagna_UniversityofMilan_primary","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","2021-06-25","Regional","","Italy; Calerno, Parma, Spilamberto","2020-06-01","2020-06-30","Essential non-healthcare workers","Adults (18-64 years)",815.0,0.038,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Susanna Esposito","University of Milan","https://dx.doi.org/10.3389/fpubh.2021.628098","Unverified","","","","","","IT",""
"2021-07-19","210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_MiscarriagePatients","Did the SARS-CoV-2 effect pregnancy complications?","2021-07-06","Local","","Turkey","2020-06-01","2020-07-31","Pregnant or parturient women","Adults (18-64 years)",230.0,0.0,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ozge Yucel Celik","Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital","https://dx.doi.org/10.5603/GP.a2021.0134","Verified","","","","","","TR",""
"2021-07-19","210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_PROMPatients","Did the SARS-CoV-2 effect pregnancy complications?","2021-07-06","Local","","Turkey","2020-06-01","2020-07-31","Pregnant or parturient women","Adults (18-64 years)",205.0,0.029,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ozge Yucel Celik","Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital","https://dx.doi.org/10.5603/GP.a2021.0134","Verified","","","","","","TR",""
"2021-07-19","210706_Ethiopia_ArmauerHansenResearchInstitute_HCW","High Seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers","2021-07-06","National","","Ethiopia; Oromiya, Sidama, Amhara; Addis Ababa","2020-12-15","2021-02-14","Health care workers and caregivers","Adults (18-64 years)",1997.0,0.396,"Self-referral","NR","IgG","High","Preprint","Tesfaye Gelanew","Armauer Hansen Research Institute","10.1101/2021.07.01.21259687","Unverified",0.374,0.417,1.0,0.977,"","ET",""
"2021-07-19","210707_UnitedStates_NationalInstitutesOfHealth_Overall","Undiagnosed sars-cov-2 seropositivity during the first 6 months of the covid-19 pandemic in the united states","2021-07-07","National","","United States of America","2020-04-01","2020-08-04","Household and community samples","Multiple groups",8058.0,0.046,"Stratified non-probability","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Heather Kalish","National Institutes of Health","http://dx.doi.org/10.1126/scitranslmed.abh3826","Verified",0.026,0.065,"","","","US",""
"2021-07-19","210710_EthiopiaDireDawa_JimmaUniversityInstituteofHealth_Primary","Seroprevalence of SARS-CoV-2 antibody among individuals aged above 15 years and residing in congregate settings in Dire Dawa city administration, Ethiopia.","2021-07-10","Local","","Ethiopia","2020-06-15","2020-07-30","Household and community samples","Multiple groups",684.0,0.032,"Simplified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Tamrat Shaweno","Jimma University Institute of Health","https://dx.doi.org/10.1186/s41182-021-00347-7","Verified",0.02,0.048,1.0,0.996,"","ET",""
"2021-07-19","210710_SouthIndia_AravindEyeHospital_Primary","Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India.","2021-07-10","Regional","","India; South India","2020-08-19","2020-08-28","Health care workers and caregivers","Multiple groups",1313.0,0.158,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","RajapandianSiva Ganesa Karthikeyan","Aravind Eye Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.06.014","Unverified","","",0.921,0.997,"","IN",""
"2021-07-19","210710_USA_EmoryUniversity_overall_PopAdj_TestAdj","SARS-CoV-2 cumulative incidence, United States, August-December 2020.","2021-07-10","National","","United States of America","2020-08-09","2020-12-08","Household and community samples","Multiple groups",4654.0,0.047,"Stratified probability","NR","Total Antibody","Low","Journal Article (Peer-Reviewed)","Patrick Sean Sullivan","Emory University","https://dx.doi.org/10.1093/cid/ciab626","Verified",0.033,0.061,0.98,0.993,"","US",""
"2021-07-19","210714_Thailand_MinistryOfPublicHealthThailand_Overall","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","2021-07-14","National","","Thailand; Eastern, Western, Central Thailand","2021-01-18","2021-03-05","Health care workers and caregivers","Adults (18-64 years)",600.0,0.002,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Wanitchaya Kittikraisak","Ministry of Public Health, Thailand","https://dx.doi.org/10.1371/journal.pone.0254563","Unverified","","","","","","TH",""
"2021-07-19","210715_Egypt_NationalResearchCentre_Primary","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","2021-07-15","Local","","Egypt","2020-08-15","2020-10-15","Multiple general populations","Multiple groups",888.0,0.3,"Convenience","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Amira S. El Rifay","National Research Centre","https://dx.doi.org/10.1111/irv.12889","Unverified","","","","","","EG",""
"2021-07-20","201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Adults2","Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain","2020-11-20","Local","","Spain","2020-04-28","2020-06-03","Household and community samples","Multiple groups",412.0,0.187,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pedro Brotons","University Hospital Sant Joan de Deu Barcelona","http://dx.doi.org/10.1093/cid/ciaa1721","Unverified",0.15,0.228,"","","","ES",""
"2021-07-20","201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Children1","Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain","2020-11-20","Local","","Spain","2020-04-28","2020-06-03","Household and community samples","Multiple groups",672.0,0.176,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pedro Brotons","University Hospital Sant Joan de Deu Barcelona","http://dx.doi.org/10.1093/cid/ciaa1721","Unverified",0.148,0.207,"","","","ES",""
"2021-07-20","210312_SaoPaulo_CityOfSaoPaulo_2021_Phase4_overall","inquérito sorológico adultos (>18)para sars-cov-2 - resultado da fase 4 de 2021","2021-03-12","Local","","Brazil; São Paulo; São Paulo","2021-02-16","2021-02-18","Household and community samples","Multiple groups",1793.0,0.25,"Simplified probability","NR","IgG; IgM","High","Institutional Report","City of Sao Paulo","City of São Paulo","http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-04_2021.pdf/","Verified",0.217,0.287,"","","","BR","BR-SP"
"2021-07-20","210624_Israel_TelAvivUniversity_overall","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","2021-06-24","National","","Israel","2020-04-15","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",874.0,0.011,"Convenience","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Khitam Muhsen","Tel Aviv University","https://dx.doi.org/10.3389/fmed.2021.689994","Verified",0.006,0.021,"","","","IL",""
"2021-07-20","210713_Strasbourg_HôpitauxUniversitairesdeStrasbourg_primary","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","2021-07-13","Local","","France","2020-05-18","2020-07-02","Patients seeking care for non-COVID-19 reasons","Multiple groups",469.0,0.066,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Renaud Felten","Hôpitaux Universitaires de Strasbourg studied patienst with rare autoimmune diseases (n=469) and found a seroprevalence of 6.6%","https://dx.doi.org/10.1186/s13075-021-02565-0","Unverified","","","","","","FR",""
"2021-07-20","210714_Iran_TarbiatModaresUniversity_primary","SARS-CoV-2 seroprevalence in asymptomatic or mild symptomatic people and symptomatic patients with negative PCR results: The hidden perspective in epidemiological reports","2021-07-14","National","","Iran (Islamic Republic of)","2020-05-30","2020-06-17","Multiple populations","Multiple groups",716.0,0.173,"Unclear","NR","IgG","High","Preprint","Nazila Hajiahmadi","Tarbiat Modares University","10.1101/2021.07.11.21260336","Unverified",0.088,0.258,0.941,0.983,"","IR",""
"2021-07-20","210716_Foggia_UniversityHospitalOfFoggia_May-Sept1_Primary","Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders","2021-07-16","Local","","Italy; Foggia; Foggia","2020-05-01","2020-09-30","Blood donors","Multiple groups",4018.0,0.005,"Sequential","NR","IgA; IgM; IgG","High","Preprint","Francescopaolo Antonucci","University Hospital “Riuniti” of Foggia","10.1101/2021.07.12.21260358","Verified",0.0,0.005,"","","","IT","IT-75"
"2021-07-20","210716_Foggia_UniversityHospitalOfFoggia_Oct-Mar2_Primary","Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders","2021-07-16","Local","","Italy; Foggia; Foggia","2020-10-01","2021-03-31","Blood donors","Multiple groups",4165.0,0.119,"Sequential","NR","IgA; IgM; IgG","High","Preprint","Francescopaolo Antonucci","University Hospital “Riuniti” of Foggia","10.1101/2021.07.12.21260358","Verified","","","","","","IT","IT-75"
"2021-07-20","210724_Brescia-Lombardy_UniversityOfBrescia_Residents1","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","2021-07-24","Local","","Italy; Province of Brescia; Brescia","2020-05-19","2020-06-30","Assisted living and long-term care facilities","Multiple groups",246.0,0.24,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonella Savio","University Of Brescia","https://dx.doi.org/10.3389/fpubh.2021.649524","Unverified","","",0.976,1.0,"","IT","IT-25"
"2021-07-20","210724_Brescia-Lombardy_UniversityOfBrescia_Staff2","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","2021-07-24","Local","","Italy; Province of Brescia; Brescia","2020-04-23","2020-05-14","Health care workers and caregivers","Multiple groups",286.0,0.168,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonella Savio","University Of Brescia","https://dx.doi.org/10.3389/fpubh.2021.649524","Unverified","","",0.976,1.0,"","IT","IT-25"
"2021-07-21","210618_Brazil_UniversidadeFederaldePelotas_primary","COVID-19 and social distancing among children and adolescents in Brazil.","2021-06-18","National","","Brazil","2020-05-14","2020-06-23","Household and community samples","Multiple groups",89362.0,0.023,"Stratified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Fernando C Barros","Universidade Federal de Pelotas","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225319/","Verified","","",0.848,0.99,"","BR",""
"2021-07-21","210706_Lombardy_BrunoKesslerFoundation_HCW","Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.","2021-07-06","Regional","","Italy; Lombardy region","2020-04-01","2020-06-26","Health care workers and caregivers","Multiple groups",82961.0,0.122,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Piero Poletti","Bruno Kessler Foundation","https://dx.doi.org/10.1001/jamanetworkopen.2021.15699","Unverified",0.12,0.124,0.944,0.983,"","IT","IT-25"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_LFIA_September4_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","","Serbia; Vojvodina","2020-09-17","2020-09-30","Household and community samples","Multiple groups",1041.0,0.146,"Stratified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified",0.125,0.168,0.873,1.0,"","RS","RS-VO"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_Unadj_April1_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","","Serbia; Vojvodina","2020-04-17","2020-04-30","Household and community samples","Multiple groups",1267.0,0.026,"Stratified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified",0.018,0.036,0.873,1.0,"","RS","RS-VO"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_Unadj_June3_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","","Serbia; Vojvodina","2020-06-17","2020-06-30","Household and community samples","Multiple groups",1014.0,0.061,"Stratified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified",0.047,0.078,0.873,1.0,"","RS","RS-VO"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_Unadj_May2_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","","Serbia; Vojvodina","2020-05-18","2020-05-31","Household and community samples","Multiple groups",1068.0,0.039,"Stratified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified",0.028,0.053,0.873,1.0,"","RS","RS-VO"
"2021-07-21","210710_Athens_UniversityofGeorgia_PopTestAdj","Prevalence of previous infection with SARS-CoV-2 and persistent symptoms at a large university","2021-07-10","Local","","United States of America; Georgia; Athens","2021-01-22","2021-03-22","Students and Daycares","Adults (18-64 years)",432.0,0.41,"Convenience","NR","IgA","Moderate","Preprint","Mark H Ebell","University of Georgia","https://www.medrxiv.org/content/10.1101/2021.07.08.21260201v1","Unverified",0.314,0.507,0.889,0.889,"","US","US-GA"
"2021-07-21","210712_UnitedStates_StanfordUniversity_Overall","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","2021-07-12","National","","United States of America","2021-01-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",21464.0,0.187,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Shuchi Anand","Stanford University","https://dx.doi.org/10.1001/jamanetworkopen.2021.16572","Unverified",0.181,0.192,1.0,0.998,"","US",""
"2021-07-21","210713_England_DepartmentofHealthandSocialCare","National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.","2021-07-13","Regional","","United Kingdom of Great Britain and Northern Ireland; England; NR","2020-05-26","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",1146310.0,0.163,"Convenience","NR","IgM; IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Cordelia Coltart","Department of Health and Social Care","https://dx.doi.org/10.1136/bmjopen-2021-049703","Unverified",0.162,0.164,"","","","GB","GB-ENG"
"2021-07-22","210316_England_PublicHealthEngland_Round1_Staff_Primary","SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.","2021-06-01","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-19","Essential non-healthcare workers","Adults (18-64 years)",1379.0,0.151,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Shamez Ladhani","Public Health England","https://dx.doi.org/10.1016/S2352-4642(21)00061-4","Verified",0.119,0.189,"","","","GB","GB-ENG"
"2021-07-22","210316_England_PublicHealthEngland_Round1_Students_Primary","SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.","2021-06-01","Regional","The United Kingdom","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-19","Students and Daycares","Children and Youth (0-17 years)",816.0,0.112,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Shamez Ladhani","Public Health England","https://dx.doi.org/10.1016/S2352-4642(21)00061-4","Verified",0.079,0.151,"","","","GB","GB-ENG"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",145.0,0.075,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Essential non-healthcare workers","Adults (18-64 years)",67.0,0.104,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Health care workers and caregivers","Adults (18-64 years)",165.0,0.103,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Essential non-healthcare workers","Adults (18-64 years)",112.0,0.161,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",472.0,0.068,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Non-essential workers and unemployed persons","Adults (18-64 years)",272.0,0.033,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Essential non-healthcare workers","Adults (18-64 years)",116.0,0.017,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Health care workers and caregivers","Adults (18-64 years)",281.0,0.057,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Essential non-healthcare workers","Adults (18-64 years)",209.0,0.038,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Non-essential workers and unemployed persons","Adults (18-64 years)",460.0,0.059,"Convenience","Abbott","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","","","","","","MZ","MZ-G"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",255.0,0.035,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_DefenceForcesy","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Essential non-healthcare workers","Multiple groups",174.0,0.092,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Health care workers and caregivers","Adults (18-64 years)",342.0,0.02,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Essential non-healthcare workers","Adults (18-64 years)",153.0,0.046,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",1001.0,0.045,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Non-essential workers and unemployed persons","Adults (18-64 years)",128.0,0.109,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Essential non-healthcare workers","Adults (18-64 years)",116.0,0.181,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Health care workers and caregivers","Adults (18-64 years)",131.0,0.061,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Essential non-healthcare workers","Adults (18-64 years)",34.0,0.059,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Vendors/Merchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Non-essential workers and unemployed persons","Adults (18-64 years)",517.0,0.089,"Convenience","QINGDAO HIGHTOP Biotech","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","","","","","","MZ","MZ-I"
"2021-07-26","210719_Arkansas_UniversityOfArkansasForMedicalSciences_1_Overall","Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas","2021-07-19","Regional","","United States of America; Arkansas; Little Rock, Springdale, Pine Bluff","2020-08-15","2020-09-05","Residual sera","Multiple groups",1301.0,0.026,"Convenience","NR","IgG","Moderate","Preprint","Joshua Kennedy","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1","Verified",0.017,0.035,"","","","US","US-AR"
"2021-07-26","210719_Arkansas_UniversityOfArkansasForMedicalSciences_2_Overall","Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas","2021-07-19","Regional","","United States of America; Arkansas; Little Rock, Springdale, Pine Bluff, Fort Smith","2020-09-12","2020-10-24","Residual sera","Multiple groups",2098.0,0.041,"Convenience","NR","IgG","Moderate","Preprint","Joshua Kennedy","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1","Verified",0.031,0.051,"","","","US","US-AR"
"2021-07-26","210719_Arkansas_UniversityOfArkansasForMedicalSciences_3_Overall","Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas","2021-07-19","Regional","","United States of America; Arkansas; Little Rock, Springdale, Pine Bluff, Fort Smith","2020-11-07","2020-12-19","Residual sera","Multiple groups",2405.0,0.074,"Convenience","NR","IgG","Moderate","Preprint","Joshua Kennedy","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1","Verified",0.06,0.087,"","","","US","US-AR"
"2021-07-26","210721_India_IndianCouncilOfMedicalResearch_genpop_overall","Antibodies in 68% Indians","2021-07-21","National","","India","2021-06-20","2021-07-10","Household and community samples","Multiple groups",28975.0,0.676,"Simplified probability","NR","IgG","Unclear","News and Media","Rhythma Kaul","Indian Council of Medical Research","https://www.hindustantimes.com/india-news/antibodies-in-68-indians-101626804217418.html","Verified","","","","","","IN",""
"2021-07-27","210720_LongIsland_StonyBrookUniversity_Totaladj","COVID-19 cumulative incidence, asymptomatic infections, and fatality in Long Island, NY, January-August 2020: A cohort of World Trade Center responders.","2021-07-20","Local","","United States of America; New York; Long Island","2020-03-25","2020-09-18","Household and community samples","Multiple groups",1042.0,0.213,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Olga Morozova","Stony Brook University","https://dx.doi.org/10.1371/journal.pone.0254713","Verified",0.195,0.232,0.934,1.0,"","US","US-NY"
"2021-07-27","210721_Nancy_CHRUNancy_Primary","SARS-CoV-2 seroprevalence among Laboratory staff: Safe handling of COVID-19 samples.","2021-07-21","Local","","France","2020-04-01","2020-04-30","Health care workers and caregivers","Multiple groups",396.0,0.023,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","C Hartard","Nancy University Hospital","https://dx.doi.org/10.1017/ice.2021.334","Unverified","","","","","","FR",""
"2021-07-27","210722_Wuhan_HospitalofHubeiProvince_HCW_primary","Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.","2021-07-22","Local","","China; Hubei; Wuhan","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",385.0,0.018,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Hongwen Ma","Hospital of Hubei Province","https://dx.doi.org/10.1007/s12026-021-09213-4","Verified","","","","","","CN","CN-42"
"2021-07-27","210722_Wuhan_HospitalofHubeiProvince_partners_primary","Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.","2021-07-22","Local","","China; Hubei; Wuhan","2020-04-01","2020-12-30","Multiple general populations","Adults (18-64 years)",15671.0,0.007,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Hongwen Ma","Hospital of Hubei Province","https://dx.doi.org/10.1007/s12026-021-09213-4","Verified","","","","","","CN","CN-42"
"2021-07-27","210722_Wuhan_HospitalofHubeiProvince_pregnant_primary","Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.","2021-07-22","Local","","China; Hubei; Wuhan","2020-04-01","2020-12-30","Pregnant or parturient women","Adults (18-64 years)",15953.0,0.007,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Hongwen Ma","Hospital of Hubei Province","https://dx.doi.org/10.1007/s12026-021-09213-4","Verified","","","","","","CN","CN-42"
"2021-07-27","210801_Zambia_USCDC_Outpatient_Primary_Adj","SARS-CoV-2 Prevalence among Outpatients during Community Transmission, Zambia, July 2020.","2021-08-01","National","","Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi; NR","2020-07-02","2020-07-31","Residual sera","Multiple groups",1657.0,0.082,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Jonas Z Hines","US Centers for Disease Control and Prevention","https://wwwnc.cdc.gov/eid/article/27/8/21-0502_article","Verified",0.051,0.114,0.657,1.0,"","ZM",""
"2021-07-28","200720_Sweden_TheSwedishPublicHealthAgency_Primary","Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021","2021-07-20","National","","Sweden","2021-04-26","2021-05-09","Blood donors","Multiple groups",2860.0,0.328,"Self-referral","NR","IgG","Moderate","Institutional Report","Swedish Public Health Agency","The Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/45eafde72689438a8a21efa93a5591a4/forekomsten-antikroppar-mot-sars-cov-2.pdf","Unverified",0.306,0.351,"","","","SE",""
"2021-07-28","210601_England_UniversityCollegeLondon_residents_primary","Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study","2021-06-01","Regional","","United Kingdom of Great Britain and Northern Ireland; England","2020-10-01","2021-02-01","Assisted living and long-term care facilities","Seniors (65+ years)",682.0,0.33,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Krutikov","University College London","https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext","Verified","","","","","","GB","GB-ENG"
"2021-07-28","210601_England_UniversityCollegeLondon_staff_primary","Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study","2021-06-01","Regional","","United Kingdom of Great Britain and Northern Ireland; England","2020-10-01","2021-02-01","Health care workers and caregivers","Adults (18-64 years)",1429.0,0.29,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Krutikov","University College London","https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext","Verified","","","","","","GB","GB-ENG"
"2021-07-28","210622_London_LondonSchoolOfHygieneAndTropicalMedicine_HCWs","Association between SARS-CoV-2 exposure and antibody status among healthcare workers in two London hospitals: a cross-sectional study","2021-06-22","Local","","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-04","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",615.0,0.407,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Admire Murongazvombo","London School Of Hygiene And Tropical Medicine","http://dx.doi.org/10.1016/j.infpip.2021.100157","Verified","","","","","","GB","GB-ENG"
"2021-07-28","210707_Istanbul_FlorenceNightingaleHospital_primary","Interventional pain management during sars-cov-2 pandemic","2021-07-07","Local","","Turkey; Marmara; Istanbul","2020-03-20","2020-06-20","Patients seeking care for non-COVID-19 reasons","Multiple groups",83.0,0.036,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Savas Comlek","Florence Nightingale Hospital","http://dx.doi.org/10.22514/sv.2021.008","Unverified","","","","","","TR",""
"2021-07-28","210713_LaoPDR_InstitutPasteurDuLaos_GeneralCommunity_Primary_Adjusted","Low seroprevalence of COVID-19 in Lao PDR, late 2020","2021-07-13","National","","Lao People's Democratic Republic; Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak","2020-08-12","2020-09-25","Household and community samples","Multiple groups",2433.0,0.052,"Stratified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Siriphone Virachith","Institut Pasteur du Laos","https://dx.doi.org/10.1016/j.lanwpc.2021.100197","Verified",0.042,0.065,"","","","LA",""
"2021-07-28","210713_LaoPDR_InstitutPasteurDuLaos_HCW_Primary_Adjusted","Low seroprevalence of COVID-19 in Lao PDR, late 2020","2021-07-13","National","","Lao People's Democratic Republic; Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak","2020-08-12","2020-09-25","Health care workers and caregivers","Adults (18-64 years)",666.0,0.02,"Convenience","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Siriphone Virachith","Institut Pasteur du Laos","https://dx.doi.org/10.1016/j.lanwpc.2021.100197","Verified",0.011,0.033,"","","","LA",""
"2021-07-28","210713_LaoPDR_InstitutPasteurDuLaos_WildlifeContacts_Primary","Low seroprevalence of COVID-19 in Lao PDR, late 2020","2021-07-13","Regional","","Lao People's Democratic Republic; Vientiane Province","2020-08-12","2020-09-25","Non-essential workers and unemployed persons","Multiple groups",74.0,0.203,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Siriphone Virachith","Institut Pasteur du Laos","https://dx.doi.org/10.1016/j.lanwpc.2021.100197","Verified",0.126,0.31,"","","","LA","LA-VI"
"2021-07-28","210719_Kanagawa_OsakaCityUniversity","Serological testing reveals the hidden COVID-19 burden among healthcare workers experiencing a SARS-CoV-2 nosocomial outbreak","2021-07-19","Local","","Japan; Kanagawa; Yokohama City","2020-06-30","2020-07-02","Health care workers and caregivers","Adults (18-64 years)",377.0,0.072,"Convenience","NR","IgG; Neutralizing ; IgM","High","Preprint","Yu Nakagama","Osaka City University","https://www.medrxiv.org/content/10.1101/2021.07.15.21260585v1.full-text","Unverified","","","","","","JP","JP-14"
"2021-07-28","210720_Italy_UniversityofGenoa","Effect of SARS-CoV-2 mRNA Vaccination in MS Patients Treated With Disease Modifying Therapies","2021-07-20","National","","Italy","2021-03-04","2021-07-09","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1022.0,0.112,"Convenience","NR","Not reported","High","Preprint","Maria Pia Sormani","University of Genoa","10.2139/ssrn.3886420","Unverified","","","","","","IT",""
"2021-07-28","210722_Kolkata_IndianStatisticalInstitute_Primary","Seroprevalence and Dynamics of anti-SARS-CoV-2 antibody among healthcare workers following ChAdOx1 nCoV-19 vaccination","2021-07-22","Local","","India; West Bengal; Kolkata","2020-11-15","2021-01-15","Health care workers and caregivers","Adults (18-64 years)",313.0,0.4,"Simplified probability","NR","Total Antibody","Moderate","Preprint","Soma Sarkar","Indian Statistical Institute","10.1101/2021.07.20.21260278","Verified","","","","","","IN","IN-WB"
"2021-07-29","210520_NorthRhine-Westphalia_RuhrUniversityBochum","COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study","2021-05-20","Local","","Germany; North Rhine-Westphalia","2020-07-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",907.0,0.014,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Anke Hildebrandt","Ruhr University Bochum","10.1016/j.ijheh.2021.113771","Unverified","","",0.99,0.99,"","DE","DE-NW"
"2021-07-29","210521_Andorra_ISGlobal_Overall","Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra","2021-05-21","National","","Andorra","2020-05-04","2020-05-28","Household and community samples","Multiple groups",72964.0,0.11,"Entire sample","NR","IgM; IgG","Low","Journal Article (Peer-Reviewed)","Cristina Royo Cebrecos","ISGlobal","https://www.sciencedirect.com/science/article/pii/S266677622100096X","Verified","","",0.92,1.0,"","AD",""
"2021-07-29","210701_LaRinconada_GrenobleAlpesUniversity_overall","High-Altitude Environment and COVID-19: SARS-CoV-2 Seropositivity in the Highest City in the World","2021-07-01","Local","","Peru; Puno; La Riconanda","2020-10-11","2020-10-18","Household and community samples","Multiple groups",159.0,0.484,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Benoit Champigneulle","Grenoble Alpes University","http://dx.doi.org/10.1089/ham.2021.0020","Verified",0.405,0.564,1.0,1.0,"","PE","PE-PUN"
"2021-07-29","210708_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_PopAdjusted","Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.","2021-07-08","Local","","United Kingdom of Great Britain and Northern Ireland; England; Sheffield","2020-05-15","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",1275.0,0.231,"Convenience","NR","IgG; IgA","High","Preprint","David Hodgson","Sheffield Teaching Hospitals NHS Foundation Trust","https://dx.doi.org/10.1101/2021.07.07.21260151","Unverified",0.141,0.333,0.995,0.996,"","GB","GB-ENG"
"2021-07-29","210710_Jordan_WorldHealthOrganization_August2020_","A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan","2021-07-10","National","","Jordan","2020-08-01","2020-08-31","Household and community samples","Multiple groups",4704.0,0.003,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saverio Bellizzi","World Health Organization","http://dx.doi.org/10.1016/j.onehlt.2021.100292","Verified",0.002,0.004,"","","","JO",""
"2021-07-29","210710_Jordan_WorldHealthOrganization_January2021","A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan","2021-07-10","National","","Jordan","2020-12-27","2021-01-06","Household and community samples","Multiple groups",5044.0,0.342,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saverio Bellizzi","World Health Organization","http://dx.doi.org/10.1016/j.onehlt.2021.100292","Verified",0.338,0.346,"","","","JO",""
"2021-07-29","210710_Jordan_WorldHealthOrganization_October2020","A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan","2021-07-10","National","","Jordan","2020-10-01","2020-10-31","Household and community samples","Multiple groups",5470.0,0.07,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saverio Bellizzi","World Health Organization","http://dx.doi.org/10.1016/j.onehlt.2021.100292","Verified",0.068,0.072,"","","","JO",""
"2021-07-29","210719_Brussels_UniversitéLibredeBruxelles","Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.","2021-07-19","Local","","Belgium; NR; Brussels","2020-03-15","2021-02-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",75.0,0.2,"Sequential","NR","Not reported","High","Journal Article (Peer-Reviewed)","Anissa Messaaoui","Université Libre de Bruxelles","https://dx.doi.org/10.1515/jpem-2021-0289","Unverified","","","","","","BE",""
"2021-07-29","210722_Hyderabad_CSIR-CentreForCellularAndMolecularBiology_Primary","SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021","2021-07-22","Local","","India; Telangana; Hyderabad","2021-01-08","2021-01-24","Household and community samples","Multiple groups",9363.0,0.542,"Simplified probability","NR","Total Antibody","High","Preprint","Avula Laxmaiah","CSIR-CentreForCellularAndMolecularBiology","10.1101/2021.07.18.21260555","Verified",0.532,0.552,"","","","IN","IN-TG"
"2021-07-29","210722_Kerala_GovernmentMedicalCollegeThiruvananthapuram_TestAdj","Prevalence of SARS CoV-2 infection among Health Care Workers of a hybrid tertiary COVID 19 hospital in Kerala","2021-07-22","Local","","India; Kerala; Thiruvananthapuram","2021-01-08","2021-01-19","Health care workers and caregivers","Adults (18-64 years)",940.0,0.212,"Stratified probability","NR","IgG","Moderate","Preprint","S J Jessy","Government Medical College Thiruvananthapuram","10.1101/2021.07.19.21260792","Unverified","","",0.9,1.0,"","IN","IN-KL"
"2021-07-31","210706_Canada_StatisticsCanada_Overall","Study reveals children and youth had highest rates of SARS-CoV-2 infection in Canada before third wave","2021-07-06","National","","Canada","2020-11-15","2021-04-15","Household and community samples","Multiple groups",11124.0,0.036,"Stratified probability","NR","Not reported","Moderate","News and Media","Statistics Canada","Statistics Canada","https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310081801","Verified",0.026,0.042,"","","","CA",""
"2021-08-01","210527_NewYorkCity_HospitalForSpecialSurgery_overall","Coronavirus Disease 2019 Exposure in Surgeons and Anesthesiologists at a New York City Specialty Hospital; A Cross-Sectional Study of Symptoms and SARS-CoV-2 Antibody Status","2021-05-27","Local","","United States of America; New York; New York City","2020-05-06","2020-06-05","Health care workers and caregivers","Adults (18-64 years)",143.0,0.098,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ellen Soffin","Hospital for Special Surgery","http://dx.doi.org/10.1097/JOM.0000000000002182","Verified","","","","","","US","US-NY"
"2021-08-01","210722_Belgium_UniversityOfNamur_overall","Antibody titres decline 3-month post-vaccination with BNT162b2","2021-07-22","National","","Belgium","2021-01-16","2021-02-15","Health care workers and caregivers","Multiple groups",200.0,0.29,"Unclear","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Julien Favresse","University of Namur","http://dx.doi.org/10.1080/22221751.2021.1953403","Verified","","","","","","BE",""
"2021-08-02","201029_Madrid_HospitalUniversitarioPríncipedeAsturias","Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hospital workers in a severely affected institution in Madrid, Spain: A surveillance cross-sectional study","2020-10-29","Local","","Spain; NR; Madrid","2020-05-01","2020-05-30","Health care workers and caregivers","Adults (18-64 years)",2424.0,0.224,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Felipe Perez Garcia","Hospital Universitario Príncipe de Asturias","http://dx.doi.org/10.1017/ice.2020.1303","Verified","","",0.88,1.0,"","ES",""
"2021-08-02","210522_Adana_AdanaDr.TurgutNoyanTeachingandResearchHospital","Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic","2021-05-22","Local","","Turkey; Mediterranean Region; Adana","2020-05-18","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",572.0,0.037,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Hatice Hale GUMUS","Adana Dr. Turgut Noyan Teaching and Research Hospital","http://mikrobiyolbul.org/managete/fu_folder/2021-03/357-373%20Hatice%20Hale%20Gumus.pdf","Unverified","","","","","","TR",""
"2021-08-02","210629_SaoPaulo_UniversidadeFederaldeSãoPaulo_Overall","Lower seroprevalence for SARS-CoV-2-specific antibodies among kidney transplant recipients compared to the general population in the city of Sao Paulo, Brazil.","2021-07-29","Local","","Brazil","2020-09-01","2020-09-25","Patients seeking care for non-COVID-19 reasons","Multiple groups",416.0,0.082,"Convenience","NR","IgG","High","Preprint","Marina P Cristelli","Universidade Federal de São Paulo","https://dx.doi.org/10.1111/tid.13706","Unverified","","","","","","BR",""
"2021-08-02","210720_Jeddah_KingAbdulazizUniversity_Overall","Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia","2021-07-20","Local","","Saudi Arabia","2020-06-29","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",693.0,0.322,"Convenience","NR","Neutralizing ; IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Rowa Alhabbab","King Abdulaziz University","10.3390/v13071413","Verified",0.288,0.358,"","","","SA",""
"2021-08-02","210721_FortCollins_ColoradoStateUniversity","Association Between COVID-19 Exposure and Self-reported Compliance With Public Health Guidelines Among Essential Employees at an Institution of Higher Education in the US.","2021-07-21","Local","","United States of America; Colorado; Fort Collins","2020-07-13","2020-09-02","Essential non-healthcare workers","Adults (18-64 years)",508.0,0.004,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Tracy Nelson","Colorado State University","https://dx.doi.org/10.1001/jamanetworkopen.2021.16543","Unverified",0.001,0.014,"","","","US","US-CO"
"2021-08-02","210723_France_InstitutPasteur_overall_Luminex+Neut","Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.","2021-07-23","National","","France","2020-02-15","2020-08-15","Residual sera","Multiple groups",2399.0,0.053,"Convenience","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tom Woudenberg","Institut Pasteur","https://dx.doi.org/10.1016/j.ebiom.2021.103495","Verified","","","","","","FR",""
"2021-08-02","210727_Modena_UniversityofModenaandReggioEmilia_Overall","Frequency of anti-sars-cov-2 antibodies in various occupational sectors in an industrialized area of northern italy from may to october 2020","2021-07-27","Regional","","Italy; Modena","2020-05-18","2020-10-05","Essential non-healthcare workers","Adults (18-64 years)",246608.0,0.005,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alberto Modenese","University of Modena and Reggio Emilia","http://dx.doi.org/10.3390/ijerph18157948","Unverified","","","","","","IT","IT-45"
"2021-08-02","210728_Amsterdam_AmsterdamUniversityMedicalCenters_COVIDCare3","Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.","2021-07-28","Local","","Netherlands","2020-03-23","2020-06-25","Health care workers and caregivers","Adults (18-64 years)",439.0,0.132,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Jonne Sikkens","Amsterdam University Medical Centers","https://dx.doi.org/10.1001/jamanetworkopen.2021.18554","Verified",0.099,0.164,0.852,0.993,"","NL",""
"2021-08-02","210728_Amsterdam_AmsterdamUniversityMedicalCenters_NoPatientCare1","Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.","2021-07-28","Local","","Netherlands","2020-03-23","2020-06-25","Health care workers and caregivers","Adults (18-64 years)",198.0,0.036,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Jonne Sikkens","Amsterdam University Medical Centers","https://dx.doi.org/10.1001/jamanetworkopen.2021.18554","Verified",0.009,0.061,0.852,0.993,"","NL",""
"2021-08-02","210728_Amsterdam_AmsterdamUniversityMedicalCenters_NonCOVIDCare2","Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.","2021-07-28","Local","","Netherlands","2020-06-25","2020-06-25","Health care workers and caregivers","Adults (18-64 years)",164.0,0.067,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Jonne Sikkens","Amsterdam University Medical Centers","https://dx.doi.org/10.1001/jamanetworkopen.2021.18554","Verified",0.028,0.105,0.852,0.993,"","NL",""
"2021-08-02","210728_Grisons_KantonsspitalGraubunden_followup_HCW","Healthcare Institutions’ Recommendation Regarding the Use of FFP-2 Masks and SARS-Cov-2 Seropositivity Among Healthcare Workers – A Multicenter Longitudinal Cohort Study","2021-07-28","Regional","","Switzerland; Grisons","2021-01-04","2021-02-19","Health care workers and caregivers","Multiple groups",2315.0,0.162,"Convenience","NR","Not reported","High","Preprint","Katarzyna Szajek","Kantonsspital Graubunden","https://www.researchsquare.com/article/rs-722792/v1","Verified","","",1.0,0.998,"","CH","CH-GR"
"2021-08-03","210715_Cairo_Ain-ShamsUniversity_TestAdj","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital","2021-07-15","Local","","Egypt; Cairo Governate; Cairo","2020-05-05","2020-10-31","Residual sera","Multiple groups",2927.0,0.298,"Sequential","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Samia Girgis","Ain-Shams University","http://dx.doi.org/10.1371/journal.pone.0254581","Unverified",0.282,0.315,1.0,0.998,"","EG",""
"2021-08-03","210715_Israel_ShaareZedekMedicalCenter_Primary","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population","2021-07-15","Local","","Israel","2020-10-18","2021-01-12","Residual sera","Children and Youth (0-17 years)",1138.0,0.1,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Adin Breuer","Shaare Zedek Medical Center","http://dx.doi.org/10.1111/apa.16031","Verified","","","","","","IL",""
"2021-08-03","210715_USA_GeorgeWashingtonUniversity_Overall","Association of varying clinical manifestations and positive anti-SARS-CoV-2 IgG antibodies: a cross-sectional observational study.","2021-07-15","Regional","","United States of America; California, Connecticut, Michigan, New Jersey, New York","2020-05-14","2020-05-30","Household and community samples","Multiple groups",6665.0,0.3,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Jonathan Silverberg","George Washington University","https://dx.doi.org/10.1016/j.jaip.2021.06.046","Verified","","","","","","US",""
"2021-08-03","210719_AnambraState_StateMinistryOfHealth_testadj","Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria","2021-07-19","Regional","","Nigeria; Anambra State","2020-12-08","2020-12-15","Household and community samples","Multiple groups",3142.0,0.161,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","OgoChukwu Vincent Okpala","Anambra State Ministry of Health","https://www.sciencedirect.com/science/article/pii/S1201971221005968","Verified","","",0.98,0.99,"","NG","NG-AN"
"2021-08-03","210722_Lyon_UniversitéClaudeBernardLyon1_overall","Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.","2021-07-22","Local","","France","2020-05-10","2020-06-28","Health care workers and caregivers","Adults (18-64 years)",190.0,0.037,"Convenience","NR","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Antonin Bal","Université Claude Bernard Lyon 1","https://dx.doi.org/10.1038/s41598-021-93828-y","Verified","","","","","","FR",""
"2021-08-03","210726_Chapecó_CommunityUniversityOfChapecóRegion_Primary","Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil","2021-07-26","Local","","Brazil; Santa Catarina; Chapecó","2020-06-15","2020-08-15","Household and community samples","Multiple groups",2179.0,0.006,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maria Silva","Community University of Chapecó Region","https://rsdjournal.org/index.php/rsd/article/view/17996/16175","Verified","","",0.86,0.99,"","BR","BR-SC"
"2021-08-03","210726_Dagahaley_MédecinsSansFrontières_FamilyMembers","Seroprevalence of SARS-CoV-2 Antibodies and Retrospective Mortality in a Refugee Camp, Dagahaley, Kenya","2021-07-26","Local","","Kenya; NR; Dagahaley camp, Daadab Refugee Complex","2021-03-01","2021-04-14","Multiple populations","Multiple groups",587.0,0.092,"Convenience","NR","IgG; IgM","Moderate","Preprint","Etienne Gignoux","Médicins Sans Frontières","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538","Unverified","","",0.958,0.981,"","KE",""
"2021-08-03","210726_Dagahaley_MédecinsSansFrontières_Patients_Overall","Seroprevalence of SARS-CoV-2 Antibodies and Retrospective Mortality in a Refugee Camp, Dagahaley, Kenya","2021-07-26","Local","","Kenya; NR; Dagahaley camp, Daadab Refugee Complex","2021-03-01","2021-04-14","Multiple populations","Multiple groups",619.0,0.069,"Sequential","NR","IgG; IgM","Moderate","Preprint","Etienne Gignoux","Médicins Sans Frontières","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538","Unverified","","",0.958,0.981,"","KE",""
"2021-08-03","210726_Zurich_UniversityofZurich_Adults_Overall","Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.","2021-07-26","Local","","Switzerland; Zurich; Zurich","2020-06-16","2020-07-09","Household and community samples","Adults (18-64 years)",857.0,0.036,"Simplified probability","NR","IgG; IgA","Low","Journal Article (Peer-Reviewed)","Agne Ulyte","University of Zurich","https://dx.doi.org/10.1136/bmjopen-2020-047483","Verified",0.017,0.054,0.983,0.984,"","CH","CH-ZH"
"2021-08-03","210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_HCW_Unadj","The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.","2021-07-27","Local","","Romania","2020-05-17","2020-12-01","Health care workers and caregivers","Adults (18-64 years)",30.0,0.233,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Corina Manolea","Carol Davila University of Medicine and Pharmacy","https://dx.doi.org/10.1093/hropen/hoab028","Unverified","","","","","","RO",""
"2021-08-03","210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_Patients_Unadj","The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.","2021-07-27","Local","","Romania","2020-05-17","2020-12-01","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",516.0,0.068,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Corina Manolea","Carol Davila University of Medicine and Pharmacy","https://dx.doi.org/10.1093/hropen/hoab028","Unverified","","","","","","RO",""
"2021-08-03","210727_UK_UniversityHospitalSouthampton_Primary","Immunocompromised Children and Young People Are at No Increased Risk of Severe COVID-19","2021-07-27","National","","United Kingdom of Great Britain and Northern Ireland","2021-02-15","2021-03-15","Residual sera","Children and Youth (0-17 years)",478.0,0.098,"Simplified probability","NR","IgG","High","Preprint","H Chappell","University Hospital Southampton","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893560","Verified","","","","","","GB",""
"2021-08-04","201214_UnitedKingdom_UniversityOfSouthamptonSchoolOfMedicine","Investigations, actions and learning from an outbreak of SARS-CoV-2 infection among healthcare workers in the United Kingdom.","2020-12-14","National","","United Kingdom of Great Britain and Northern Ireland","2020-05-13","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",135.0,0.13,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Kordo Saeed","University of Southampton School of Medicine","https://dx.doi.org/10.1177/1757177420976798","Unverified","","","","","","GB",""
"2021-08-04","210702_Ahmedabad_AMC-MET-MedicalCollege_Primary","Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city.","2021-07-02","Local","","India; Gujarat; Ahmedabad","2020-08-15","2020-08-31","Household and community samples","Multiple groups",10310.0,0.232,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","AMC MET Medical College","https://dx.doi.org/10.4103/jfmpc.jfmpc_2062_20","Verified",0.224,0.241,"","","","IN","IN-GJ"
"2021-08-04","210702_Jaipur_AllIndiaInstituteOfMedicalSciences_2","COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India.","2021-07-02","Local","","India; Rajasthan; Jaipur","2020-08-04","2020-08-04","Essential non-healthcare workers","Adults (18-64 years)",41.0,0.136,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Vidhi Jain","All India Institute Of Medical Sciences","https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20","Unverified","","","","","","IN","IN-RJ"
"2021-08-04","210702_Jodhpur_AllIndiaInstituteOfMedicalSciences_1","COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India.","2021-07-02","Local","","India; Rajasthan; Jodhpur","2020-07-28","2020-07-28","Essential non-healthcare workers","Adults (18-64 years)",22.0,0.024,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Vidhi Jain","All India Institute Of Medical Sciences","https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20","Unverified","","","","","","IN","IN-RJ"
"2021-08-04","210706_London_LondonSchoolofHygiene&TropicalMedicine","SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study","2021-07-06","Local","","United Kingdom of Great Britain and Northern Ireland; England; London","2020-10-19","2020-12-07","Household and community samples","Multiple groups",1242.0,0.643,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Katherine Gaskell","London School of Hygiene & Tropical Medicine","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/","Verified",0.616,0.67,0.962,0.974,"","GB","GB-ENG"
"2021-08-04","210718_England_ImperialCollegeLondon_Round6","Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study","2021-07-18","National","","United Kingdom of Great Britain and Northern Ireland","2021-05-12","2021-05-25","Household and community samples","Multiple groups",207337.0,0.611,"Stratified probability","NR","IgG","Low","Preprint","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2021.07.14.21260497v1","Unverified",0.609,0.614,0.844,0.986,"","GB",""
"2021-08-04","210720_Bangkok_ChulalongkornUniversity","Potential applications of the rapid COVID-19 antibody test kit screening in comparison to the RT-PCR in patients and personnel at the Department of Obstetrics and Gynecology","2021-07-20","Local","","Thailand","2020-08-15","2021-01-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",210.0,0.01,"Unclear","NR","IgG; IgM","High","Preprint","Amarin Narkwichean","Chulalongkorn University","https://www.medrxiv.org/content/10.1101/2021.07.16.21259725v1.full-text","Unverified","","",0.887,0.906,"","TH",""
"2021-08-04","210720_Sitakunda_JohnsHopkinsBloombergSchoolofPublicHealth_Adj","SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021","2021-07-20","Local","","Bangladesh; NR; Chattogram","2021-03-27","2021-04-13","Household and community samples","Multiple groups",664.0,0.631,"Stratified probability","NR","Total Antibody","Low","Preprint","Taufiqur Rahman Bhuiyan","Johns Hopkins Bloomberg School of Public Health","https://www.medrxiv.org/content/10.1101/2021.07.16.21260611v1.full-text","Unverified",0.562,0.698,0.873,0.991,"","BD",""
"2021-08-04","210727_Tokyo_MusashinoRed CrossHospital_Baseline","The dynamics of quantitative SARS-CoV-2 anti-spike IgG response to BNT162b2 vaccination.","2021-07-27","Local","","Japan","2021-03-15","2021-05-15","Essential non-healthcare workers","Multiple groups",59.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Shun Kaneko","Musashino Red Cross Hospital","https://dx.doi.org/10.1002/jmv.27231","Unverified","","",1.0,0.996,"","JP",""
"2021-08-04","210728_NewYorkCity_WeillCornellMedicine_overall","SARS-CoV-2 Antibody Response in Patients Undergoing Kidney Transplantation","2021-07-28","Local","","United States of America; New York ; New York City","2020-05-28","2020-12-12","Patients seeking care for non-COVID-19 reasons","Multiple groups",72.0,0.319,"Sequential","NR","IgG","High","Preprint","Michelle Lubetzky","Weill Cornell Medicine","https://www.medrxiv.org/content/10.1101/2021.07.25.21261066v1.full-text","Verified","","","","","","US","US-NY"
"2021-08-05","210326_Vaud_UniversityofLausanne_CloseContactsOutsideHousehold2_Overall_ClusterAdj","Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.","2021-03-26","Regional","","Switzerland; Vaud","2020-05-04","2020-06-27","Contacts of COVID patients","Multiple groups",69.0,0.19,"Simplified probability","Lausanne University Hospital, Switzerland","IgG","High","Journal Article (Peer-Reviewed)","Julien Dupraz","University of Lausanne","https://dx.doi.org/10.1093/ofid/ofab149","Verified",0.1,0.332,0.967,0.992,"","CH","CH-VD"
"2021-08-05","210326_Vaud_UniversityofLausanne_Household1_Overall_ClusterAdj","Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.","2021-03-26","Regional","","Switzerland; Vaud","2020-05-04","2020-06-27","Contacts of COVID patients","Multiple groups",302.0,0.572,"Simplified probability","Lausanne University Hospital, Switzerland","IgG","Moderate","Journal Article (Peer-Reviewed)","Julien Dupraz","University of Lausanne","https://dx.doi.org/10.1093/ofid/ofab149","Verified",0.495,0.643,0.967,0.992,"","CH","CH-VD"
"2021-08-05","210407_Slovenia_UniversityofLjubljana_SecondRound_Nov","Seroprevalence of SARS-CoV-2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned","2021-04-07","National","Slovenia","Slovenia","2020-10-17","2020-11-10","Household and community samples","Multiple groups",1211.0,0.043,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Mario Poljak","University of Ljubljana","https://dx.doi.org/10.1016/j.cmi.2021.03.009","Verified",0.032,0.055,"","","","SI",""
"2021-08-10","210614_Gothenburg_TheSwedishPublicHealthAgency_Primary","Förekomsten av antikroppar mot SARS-CoV-2 bland äldre i Göteborg 1-16 mars 2021","2021-06-14","Local","","Sweden","2021-03-01","2021-03-16","Blood donors","Seniors (65+ years)",724.0,0.069,"Self-referral","NR","IgG","High","Institutional Report","Swedish Public Health Agency","The Public Health Agency of Sweden, University of Gothenburg, Sahlgrenska University Hospital and Region Västra Götaland","https://www.folkhalsomyndigheten.se/contentassets/eee8b4f90ef24a18b2a65865341710e1/forekomsten-antikroppar-sars-cov-2-aldre-goteborg.pdf","Unverified",0.053,0.09,"","","","SE",""
"2021-08-10","210706_Italy_FondazioneIRCCSPoliclinicoSanMatteo_Primary","Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study","2021-07-06","Regional","","Italy; Pavia, Lecco, Piacenza","2020-04-29","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",9610.0,0.152,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Francesca Rovida","Fondazione IRCCS Policlinico San Matteo","http://dx.doi.org/10.1016/j.ijid.2021.07.003","Verified","","","","","","IT",""
"2021-08-10","210729_Mariana+OuroPreto_FederalUniversityOfOuro","COVID-Inconfidentes - SARS-CoV-2 seroprevalence in two Brazilian urban areas during the pandemic first wave: study protocol and initial results","2021-07-29","Local","","Brazil; Minas Gerais; Mariana, OuroPreto","2020-10-15","2020-12-15","Household and community samples","Multiple groups",1762.0,0.055,"Convenience","NR","IgG; IgM","High","Preprint","Adriana Lucia Meireles","Federal University of Ouro","https://preprints.scielo.org/index.php/scielo/preprint/view/2720","Unverified","","",0.864,0.996,"","BR","BR-MG"
"2021-08-10","210731_Caracas_UniversidadCentraldeVenezuela","IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.","2021-07-31","Local","","Venezuela (Bolivarian Republic of)","2021-02-01","2021-02-06","Health care workers and caregivers","Multiple groups",86.0,0.314,"Simplified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Franklin Claro","Universidad Central de Venezuela","https://dx.doi.org/10.1016/j.ijid.2021.07.070","Verified","","","","","","VE",""
"2021-08-10","210801_Riyadh_KingSaudUniversity_Primary","Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.","2021-08-01","Local","","Saudi Arabia","2020-11-22","2020-12-17","Blood donors","Adults (18-64 years)",515.0,0.122,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Mohammed F. Alosaimi","King Saud University","https://dx.doi.org/10.15537/smj.2021.42.8.20210238","Verified","","",1.0,0.996,"","SA",""
"2021-08-10","210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Adults","Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021.","2021-08-04","Local","","United States of America; Missouri; St Louis","2020-07-25","2020-07-31","Residual sera","Multiple groups",506.0,0.045,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Brittany K. Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.00450-21","Verified",0.021,0.069,0.982,0.987,"","US","US-MO"
"2021-08-10","210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Children","Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021.","2021-08-04","Local","","United States of America; Missouri; St Louis","2020-07-22","2020-08-16","Residual sera","Children and Youth (0-17 years)",546.0,0.052,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Brittany K. Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.00450-21","Verified",0.028,0.077,0.982,0.987,"","US","US-MO"
"2021-08-10","210805_Bloomington_IndianaUniversity","High-risk alcohol consumption may increase the risk of SARS-CoV-2 seroconversion: a prospective seroepidemiologic cohort study among American college students","2021-08-05","Local","","United States of America; Indiana; Bloomington","2020-09-28","2020-11-23","Students and Daycares","Adults (18-64 years)",808.0,0.05,"Simplified probability","NR","IgG; IgM","High","Preprint","Sina Kianersi","Indiana University","10.1101/2021.08.03.21261444","Verified","","",0.64,1.0,"","US","US-IN"
"2021-08-10","210805_Varmland_CentreforClinicalResearchandEducation_primary","Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.","2021-08-05","Regional","","Sweden; Varmland","2020-06-20","2020-10-12","Health care workers and caregivers","Multiple groups",4955.0,0.057,"Entire sample","NR","IgG","High","Journal Article (Peer-Reviewed)","Lukas Frans Ocias","Centre for Clinical Research and Education of Varmland","https://dx.doi.org/10.1080/23744235.2021.1959949","Unverified","","",0.97,0.995,"","SE","SE-S"
"2021-08-11","210721_Pune_ArmedForcesMedicalCollege","Estimating the proportion and IgG antibody response to SARS-CoV-2 in individuals joining a central educational institute from different parts of India by Enzyme-linked immunosorbent assay (ELISA) based serology.","2021-07-27","Local","","India; Maharashtra; Pune","2020-06-16","2020-08-16","Non-essential workers and unemployed persons","Adults (18-64 years)",413.0,0.075,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Sourav Sen","Armed Forces Medical College","https://dx.doi.org/10.1016/j.mjafi.2021.02.008","Unverified",0.053,0.104,0.98,0.99,"","IN","IN-MH"
"2021-08-11","210802_Calgary_UniversityofCalgary","Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study.","2021-08-02","Local","","Canada; Alberta; Calgary","2020-10-15","2021-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",279.0,0.011,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Gilaad Kaplan","University of Calgary","https://dx.doi.org/10.1136/gutjnl-2021-325238","Verified",0.002,0.031,0.95,0.99,"","CA","CA-AB"
"2021-08-11","210803_Mainz_UniversityMedicalCentreOfMainz_Adj","An Epidemiological Cohort Study of SARS-CoV-2 and COVID-19 in German Healthcare Workers ‚Äì Interim Analysis after Six Months of Follow-up","2021-08-03","Local","","Germany; Rhineland-Palatinate; Mainz","2020-08-15","2020-10-15","Health care workers and caregivers","Adults (18-64 years)",3664.0,0.019,"Convenience","NR","IgG; IgM","High","Preprint","Stephan Gehring","University Medical Centre of Mainz","https://www.researchsquare.com/article/rs-688656/v1","Unverified",0.014,0.025,"","","","DE","DE-RP"
"2021-08-11","210805_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round2_PopTestAdj","COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020 - April, 2021","2021-08-05","Local","","Russian Federation; Northwestern Region; Saint Petersburg","2020-07-20","2020-08-08","Household and community samples","Multiple groups",474.0,0.133,"Simplified probability","NR","Total Antibody","Low","Preprint","Anton Barchuk","Smorodinova Research Institute of Influenza","https://www.medrxiv.org/content/10.1101/2021.07.31.21261428v2","Verified",0.099,0.166,0.92,1.0,"","RU",""
"2021-08-11","210805_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round3_PopTestAdj","COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020 - April, 2021","2021-08-05","Local","","Russian Federation; Northwestern Region; Saint Petersburg","2020-10-12","2020-12-06","Household and community samples","Multiple groups",1322.0,0.229,"Simplified probability","NR","Total Antibody","Low","Preprint","Anton Barchuk","Smorodinova Research Institute of Influenza","https://www.medrxiv.org/content/10.1101/2021.07.31.21261428v2","Verified",0.203,0.255,0.92,1.0,"","RU",""
"2021-08-12","210701_Kerala_ JubileeMissionMedicalCollegeandResearchInstitute_primary","Serosurveillance of SARS-CoV-2 among the healthcare workers of a tertiary care teaching institution during the post lockdown phase in Central Kerala, India","2021-07-01","Local","","India","2020-12-20","2020-12-30","Health care workers and caregivers","Adults (18-64 years)",423.0,0.088,"Stratified non-probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Aboobacker Mohamed Rafi","Jubilee Mission Medical College and Research Institute","https://www.jcdr.net/articles/PDF/15154/48703_CE[Ra1]_F(SL)_PF1(AG_OM)_PFA(KM_AnK)%20PB(AG_AnK)_PN(KM).pdf","Unverified",0.062,0.119,0.9,1.0,"","IN",""
"2021-08-12","210726_India_ArmedForcesMedicalCollege","Seropositivity of severe acute respiratory syndrome coronavirus 2 infection among healthcare workers of the Armed Forces medical services, India: A multicentric study.","2021-07-26","National","","India","2020-08-21","2020-11-20","Health care workers and caregivers","Adults (18-64 years)",3253.0,0.197,"Simplified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Subhadeep Ghosh","Armed Forces Medical College","https://dx.doi.org/10.1016/j.mjafi.2021.03.020","Unverified",0.185,0.217,0.924,0.979,"","IN",""
"2021-08-13","210501_Ahmedabad_MunicipalMedicalCollege_ContactCases","Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad","2021-05-01","Local","India","India","2020-10-15","2020-10-31","Contacts of COVID patients","Multiple groups",2038.0,0.26,"Convenience","Zydus Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://www.nepjol.info/index.php/AJMS/article/view/35099","Verified","","",0.924,0.979,"","IN",""
"2021-08-13","210501_Ahmedabad_MunicipalMedicalCollege_HCW","Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad","2021-05-01","Local","India","India","2020-10-15","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",1737.0,0.208,"Convenience","Zydus Diagnostics","IgG","High","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://www.nepjol.info/index.php/AJMS/article/view/35099","Verified","","",0.924,0.979,"","IN",""
"2021-08-13","210801_Aracuja_FederalUniversityofSergipe_Overall_IgG","Estimated SARS-CoV-2 infection and seroprevalence in firefighters from a Northeastern Brazilian state: A cross-sectional study","2021-08-01","Local","","Brazil; Sergipe; Aracuja","2021-01-01","2021-01-31","Essential non-healthcare workers","Adults (18-64 years)",123.0,0.26,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Lysandro Borges","Federal University of Sergipe","http://dx.doi.org/10.3390/ijerph18158148","Verified","","",0.958,0.97,"","BR","BR-SE"
"2021-08-15","210708_Philadelphia_UniversityofPennsylvania","Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration","2021-07-08","Local","","United States of America; Pennsylvania; Philadelphia","2020-04-13","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",2043.0,0.02,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Sigrid Gouma","University of Pennsylvania","http://dx.doi.org/10.1172/jci.insight.150449","Unverified","","","","","","US","US-PA"
"2021-08-15","210801_Phoenix_DignityHealthResearchInstitute","32 Decay of Anti-SARS-CoV-2 Nucleocapsid IgG in Seropositive Health Care Workers Over Time","2021-08-01","Local","","United States of America; Arizona; Phoenix","2020-06-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",1358.0,0.214,"Convenience","NR","IgG","High","Presentation or Conference","B. Tiffany","Dignity Health Research Institute","http://dx.doi.org/10.1016/j.annemergmed.2021.07.033","Unverified","","","","","","US","US-AZ"
"2021-08-16","210810_Bern_UniversityofBern_primary","A multidimensional cross-sectional analysis of COVID-19 seroprevalence among a police officer cohort: The PoliCOV-19 study","2021-08-10","Local","","Switzerland","2021-02-09","2021-03-09","Essential non-healthcare workers","Adults (18-64 years)",978.0,0.129,"Convenience","NR","IgG; IgM; IgA","High","Preprint","Parham Sendi","University of Bern","10.1101/2021.08.09.21261789","Verified","","","","","","CH",""
"2021-08-16","210810_CzechRepublic_MasarykUniversity_overallAdj","Dynamics of Seroconversion of Anti-Sars-Cov-2 Igg Antibodies in the Czech Unvaccinated Population: Nationwide Prospective Seroconversion (Proseco) Study","2021-08-10","National","","Czechia","2020-10-01","2021-03-31","Multiple general populations","Multiple groups",30054.0,0.464,"Convenience","NR","IgG","Moderate","Preprint","Pavel PIler","Masaryk University","10.2139/ssrn.3902465","Verified",0.458,0.47,"","","","CZ",""
"2021-08-16","210810_Odisha_IndianCouncilofMedicalResearch_primary","Antibodies Against SARS-CoV-2 among High-Risk Groups: Findings from Serosurveys in 6 Urban Areas of Odisha, India","2021-08-10","Regional","","India; Odisha","2020-07-15","2020-11-15","Multiple populations","Multiple groups",5434.0,0.349,"Convenience","NR","IgG","High","Preprint","Srikanta Kanungo","Indian Council of Medical Research","https://www.researchsquare.com/article/rs-664559/v1","Verified",0.336,0.362,"","","","IN","IN-OR"
"2021-08-16","210811_Munich_LudwigMaximiliansUniversitatMunich_overall","In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.","2021-08-11","Local","Germany","Germany","2020-05-27","2020-08-12","Health care workers and caregivers","Adults (18-64 years)",7554.0,0.022,"Convenience","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Paul Wratil","Ludwig Maximilians UNiversitat Munich (LMU Munich)","https://dx.doi.org/10.1007/s15010-021-01672-z","Unverified",0.019,0.026,"","","","DE",""
"2021-08-16","210811_UnitedStates_NationalInstitutesOfHealth_Primary","SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States","2021-08-11","National","","United States of America","2020-04-15","2020-10-15","Residual sera","Multiple groups",2542.0,0.079,"Convenience","NR","IgG; IgM","High","Preprint","Tran B Ngo","National Institutes of Health","https://www.medrxiv.org/content/10.1101/2021.08.10.21261849v1","Verified",0.069,0.09,1.0,1.0,"","US",""
"2021-08-17","210709_Dubai_DubaiHealthAuthority_Overall","Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors","2021-07-09","Local","","United Arab Emirates; NR; Dubai","2020-08-15","2020-12-15","Blood donors","Adults (18-64 years)",1418.0,0.135,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","May Raouf","Dubai Health Authority","http://dx.doi.org/10.1159/000517456","Unverified","","",0.968,0.996,"","AE",""
"2021-08-17","210726_Corsica_UniversitédeCorse_Overall_PopTestAdj","Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People.","2021-07-26","Regional","","France; Corsica","2020-11-06","2021-02-12","Residual sera","Multiple groups",4505.0,0.087,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Lisandru Capai","Université de Corse","https://dx.doi.org/10.3389/fpubh.2021.715192","Verified","","",0.903,0.998,"","FR","FR-COR"
"2021-08-17","210726_Florence_MeyerChildren'sUniversityHospital","Surveillance on Healthcare Workers During the First Wave of SARS-CoV-2 Pandemic in Italy: The Experience of a Tertiary Care Pediatric Hospital.","2021-07-26","Local","","Italy; Tuscany; ; Florence","2020-04-02","2020-05-06","Health care workers and caregivers","Adults (18-64 years)",1502.0,0.028,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Valentina Guarnieri","Meyer Children's University Hospital","https://dx.doi.org/10.3389/fpubh.2021.644702","Unverified","","","","","","IT","IT-52"
"2021-08-17","210727_California_EmoryUniversity_primary","SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California.","2021-07-27","Regional","","United States of America; California","2020-08-15","2020-12-15","Household and community samples","Multiple groups",983.0,0.045,"Simplified probability","NR","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Katherine Lamba","Emory University","https://dx.doi.org/10.1093/ofid/ofab379","Verified",0.028,0.074,0.922,0.996,"","US","US-CA"
"2021-08-17","210727_FrenchAlps_AnnecyGenevoisHospital","Effect of professional and extra-professional exposure on seroprevalence of SARS-CoV-2 infection among healthcare workers of the French alps: A multicentric cross-sectional study","2021-07-27","Regional","","France; French Alps Region; NR","2020-06-27","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",3454.0,0.05,"Convenience","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Virginie Vitrat","Annecy Genevois Hospital","http://dx.doi.org/10.3390/vaccines9080824","Verified",0.043,0.058,"","","","FR",""
"2021-08-17","210729_SãoPaulo_HospitalIsraelitaAlbertEinstein_Adj","A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil","2021-07-29","Local","","Brazil; São Paulo State; ; São Paulo","2020-09-15","2020-12-15","Household and community samples","Multiple groups",272.0,0.452,"Simplified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Joao Luiz Miraglia","Hospital Israelita Albert Einstein","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255412","Verified",0.394,0.51,"","","","BR","BR-SP"
"2021-08-17","210730_USA_AmericanRedCross_overall","Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.","2021-07-30","National","","United States of America","2020-06-15","2020-11-30","Blood donors","Multiple groups",1531221.0,0.042,"Sequential","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Roger Dodd","American Red Cross","https://dx.doi.org/10.1016/j.tmrv.2021.07.001","Verified","","",1.0,1.0,"","US",""
"2021-08-17","210803_Brasilia_UniversidadedeBrasilia_OverallCLIA","SARS-CoV-2 Seroprevalence and Accuracy Diagnostic Evaluation During a Covid-19 Outbreak in a Major Penitentiary Complex in Brazil, June-July 2020: A Population-Based Study","2021-08-03","Local","","Brazil; Federal District; Brasilia","2020-06-17","2020-07-22","Persons who are incarcerated","Adults (18-64 years)",455.0,0.811,"Simplified probability","NR","IgG; IgM","Moderate","Preprint","Fernando Gouvea-Reis","Universidade de Brasília","https://doi.org/10.2139/ssrn.3898505","Verified",0.744,0.878,"","","","BR","BR-DF"
"2021-08-17","210806_Columbus_OhioStateUniversityCollegeofMedicine","Decline in Sars-CoV-2 antibodies over 6 month follow up in Obstetrical Healthcare workers.","2021-08-06","Local","","United States of America; Ohio; Columbus","2020-09-18","2020-09-25","Health care workers and caregivers","Adults (18-64 years)",126.0,0.214,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Miranda Kiefer","Ohio State University College of Medicine","https://dx.doi.org/10.1111/aji.13490","Unverified","","","","","","US","US-OH"
"2021-08-17","210806_Rishikesh_AllIndiaInstituteofMedicalSciences","Seroprevalence of Antibodies against SARS COV- 2 among Health Care Workers at Tertiary Care Hospital, Uttarakhand: A Retrospective study","2021-08-06","Local","","India; Uttarakhand; Rishikesh","2020-07-15","2020-08-14","Health care workers and caregivers","Adults (18-64 years)",704.0,0.02,"Convenience","NR","IgM; IgG","High","Preprint","Amit Saini","All India Institute of Medical Sciences","https://www.researchsquare.com/article/rs-783686/v1","Unverified","","","","","","IN","IN-UL"
"2021-08-17","210807_SanDiego&Tijuana_UniversityofCalifornia","Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region","2021-08-07","Local","","United States of America; California; San-Diego","2020-10-20","2021-06-16","Multiple populations","Adults (18-64 years)",386.0,0.363,"Convenience","NR","IgG; IgM","High","Preprint","Steffanie Strathdee","University of California","https://www.medrxiv.org/content/10.1101/2021.08.05.21261671v1.full-text","Verified",0.315,0.411,"","","","US","US-CA"
"2021-08-17","210807_Texas_UniversityofTexas","Estimation of Total Immunity to SARS-CoV-2 in Texas","2021-08-07","Regional","","United States of America; Texas; NR","2020-10-01","2021-07-04","Multiple populations","Multiple groups",14899.0,0.353,"Convenience","NR","Not reported","High","Preprint","Stacia Desantis","University of Texas","https://www.medrxiv.org/content/10.1101/2021.08.05.21261610v1.full-text","Verified",0.337,0.369,0.995,0.998,"","US","US-TX"
"2021-08-17","210808_Birmingham_UniversityHospitalsBirmingham_primary","Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.","2021-08-02","Local","","United Kingdom of Great Britain and Northern Ireland","2020-03-15","2020-07-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",990.0,0.259,"Convenience","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Gemma D. Banham","University Hospitals Birmingham","https://dx.doi.org/10.1681/ASN.2021020188","Verified","","","","","","GB",""
"2021-08-17","210809_Chicago_NorthwesternUniversity","Serologic Status and SARS CoV-2 Infection over 6-Months of Follow-Up in Healthcare Workers in Chicago: A Cohort Study.","2021-08-09","Local","United States of America","United States of America; Illinois; Chicago","2020-11-09","2021-01-08","Health care workers and caregivers","Adults (18-64 years)",4947.0,0.084,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","John Wilkins","Northwestern University","https://dx.doi.org/10.1017/ice.2021.367","Unverified","","",1.0,0.996,"","US","US-IL"
"2021-08-17","210810_Antwerp_UniversityOfAntwerp","SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.","2021-08-10","Local","","Belgium; Antwerp Province; Antwerp","2020-06-09","2020-06-29","Health care workers and caregivers","Multiple groups",5233.0,0.076,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Reinout Naesens","University Of Antwerp","https://dx.doi.org/10.1017/S0950268821001497","Unverified",0.069,0.083,0.95,0.99,"","BE",""
"2021-08-18","210528_Spain_InstitutodeInvestigacionesBiomédicasdeMálaga_Overall","Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients (p): SOLID study","2021-05-28","National","","Spain","2020-04-21","2020-06-03","Patients seeking care for non-COVID-19 reasons","Multiple groups",1500.0,0.085,"Unclear","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Mariano Provencio","Instituto de Investigaciones Biomédicas de Málaga (IBIMA)","https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.8531","Verified",0.072,0.101,"","","","ES",""
"2021-08-18","210609_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report June 9, 2021 Report #8: March 2021 Survey Tracking seroprevalence in the vaccine era","2021-06-09","National","","Canada","2021-02-27","2021-03-13","Blood donors","Multiple groups",16873.0,0.098,"Sequential","Roche","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.094,0.103,0.988,0.996,"","CA",""
"2021-08-18","210630_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report June 30, 2021 Report #9: April 2021 Survey Tracking seroprevalence in the vaccine era","2021-06-30","National","","Canada","2021-04-13","2021-04-30","Blood donors","Multiple groups",16931.0,0.269,"Sequential","Roche","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.262,0.276,0.988,0.996,"","CA",""
"2021-08-18","210727_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report July 27, 2021 Report #10: May 2021 Survey Tracking seroprevalence in the vaccine era","2021-07-27","National","","Canada","2021-05-08","2021-06-04","Blood donors","Multiple groups",17001.0,0.639,"Sequential","Roche","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.632,0.646,0.988,0.996,"","CA",""
"2021-08-18","210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Primary","Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021.","2021-08-04","Local","","United States of America; Missouri; St Louis","2020-07-22","2020-08-16","Residual sera","Multiple groups",1052.0,0.059,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Brittany K. Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.00450-21","Verified","","",0.982,0.987,"","US","US-MO"
"2021-08-18","210808_North-WesternItaly_UniversitàDelPiemonteOrientale","Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy.","2021-08-08","Regional","","Italy","2020-04-28","2020-08-07","Essential non-healthcare workers","Multiple groups",23568.0,0.05,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Chiara Airoldi","Università del Piemonte Orientale","https://dx.doi.org/10.1093/annweh/wxab062","Unverified",0.047,0.052,0.933,1.0,"","IT",""
"2021-08-18","210811_Karnataka_IndianInstituteofPublicHealth_Overall_PopTestAdj","Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India","2021-08-11","Regional","","India; Karnataka","2021-01-25","2021-02-18","Multiple populations","Multiple groups",41228.0,0.156,"Stratified probability","Zydus-Cadila","IgG","Moderate","Preprint","Rajagopal Padma","Indian Institute of Public Health","https://www.medrxiv.org/content/10.1101/2021.08.10.21261842v1","Unverified",0.149,0.163,0.924,0.979,"","IN","IN-KA"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave1_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-04-02","2020-05-06","Residual sera","Children and Youth (0-17 years)",316.0,0.086,"Sequential","NR","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified",0.051,0.121,0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave2_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-06-06","2020-08-10","Residual sera","Children and Youth (0-17 years)",300.0,0.098,"Sequential","NR","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified",0.061,0.136,0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave3_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-09-08","2020-10-17","Residual sera","Children and Youth (0-17 years)",594.0,0.169,"Sequential","NR","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified",0.133,0.206,0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave4_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-11-07","2020-12-17","Residual sera","Children and Youth (0-17 years)",600.0,0.125,"Sequential","NR","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified",0.096,0.155,0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave5_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2021-04-05","2021-04-28","Residual sera","Children and Youth (0-17 years)",590.0,0.242,"Sequential","NR","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified",0.201,0.282,0.946,1.0,"","US","US-AR"
"2021-08-23","210813_Denmark_CopenhagenUniversityHospital_Primary","Testing Denmark: A Danish nationwide surveillance study of COVID-19","2021-08-13","National","","Denmark","2020-10-02","2020-10-11","Household and community samples","Multiple groups",318552.0,0.008,"Simplified probability","NR","IgG; IgM","Moderate","Preprint","Kamille Fogh","Copenhagen University Hospital","https://www.medrxiv.org/content/10.1101/2021.08.10.21261777v1","Verified","","",0.933,0.982,"","DK",""
"2021-08-24","210519_Lombardy_ASSTGaetanoPini-CTOInstitute","Seroprevalence of anti-SARS-CoV-2 antibodies in rheumatic patients treated with biological and targeted therapy living in lombardy, Italy (mainstream project)","2021-05-19","Regional","Argentina","Italy; Lombardy","2020-05-04","2020-06-16","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",300.0,0.186,"Unclear","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ennio Giulio Favalli","The ASST Gaetano Pini-CTO; Institute","http://dx.doi.org/10.1136/annrheumdis-2021-eular.594","Verified",0.146,0.234,"","","","IT","IT-25"
"2021-08-24","210612_Kenya_KEMRI-WellcomeTrustResearchProgramme_PrimaryTestAdj","Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence among Truck Drivers and Assistants in Kenya","2021-06-12","Regional","","Kenya; Western Province, Coast Province ; Magarini, Busia, Malaba","2020-09-30","2020-10-23","Essential non-healthcare workers","Adults (18-64 years)",830.0,0.423,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Eunice Kagucia","KEMRI-Wellcome Trust Research Programme","http://dx.doi.org/10.1093/ofid/ofab314","Verified",0.384,0.463,0.93,0.99,"","KE",""
"2021-08-24","210801_Europe_UniversityHospitalsPitiéSalpêtrière_Primary","SARS-CoV-2 outbreak in autoimmune diseases: The euro-covimid study","2021-08-01","National","","France","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",3028.0,0.055,"Unclear","NR","Not reported","High","Presentation or Conference","D Saadoun","University Hospitals Pitié Salpêtrière","http://dx.doi.org/10.1136/annrheumdis-2021-eular.3368","Unverified","","","","","","FR",""
"2021-08-24","210802_Riyadh_KingSaudUniversity_Primary","Risk factors and predictors that influence SARS-Cov-2 IgG positivity","2021-08-02","Local","","Saudi Arabia; Riyadh Province; Riyadh","2020-11-22","2020-12-17","Blood donors","Multiple groups",515.0,0.122,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Mohammed Alosaimi","King Saud University","http://dx.doi.org/10.15537/SMJ.2021.42.8.20210238","Verified","","",1.0,0.996,"","SA","SA-01"
"2021-08-24","210813_Brazil_FederalUniversityofOuroPreto_Town1","Logistics workers are a key factor for SARS-CoV-2 spread in Brazilian small towns: case-control study.","2021-08-13","Local","","Brazil; Minas Gerais; Nepomuceno","2020-05-30","2020-05-31","Household and community samples","Multiple groups",400.0,0.005,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Breno Bernardes-Souza","Federal University of Ouro Preto","https://dx.doi.org/10.2196/30406","Verified",0.001,0.018,0.95,1.0,"","BR","BR-MG"
"2021-08-24","210813_Brazil_FederalUniversityofOuroPreto_Town2","Logistics workers are a key factor for SARS-CoV-2 spread in Brazilian small towns: case-control study.","2021-08-13","Local","","Brazil; Minas Gerais; Carmópolis","2020-06-27","2020-06-28","Household and community samples","Multiple groups",400.0,0.018,"Stratified probability","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Breno Bernardes-Souza","Federal University of Ouro Preto","https://dx.doi.org/10.2196/30406","Verified",0.008,0.036,0.95,1.0,"","BR","BR-MG"
"2021-08-24","210813_Geneva_GenevaUniversityHospital_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland","2021-08-13","Local","","Switzerland","2021-06-01","2021-07-07","Household and community samples","Multiple groups",3355.0,0.299,"Stratified probability","NR","Total Antibody","Low","Preprint","Silvia Stringhini","Geneva University Hospital","https://www.medrxiv.org/content/10.1101/2021.08.12.21261929v1","Verified",0.28,0.319,"","","","CH",""
"2021-08-24","210816_Pakistan_ChughtaiInstituteofPathology_Primary","Seroprevalence of COVID-19 IgG antibodies among healthcare workers of Pakistan: a cross-sectional study assessing exposure to COVID-19 and identification of high-risk subgroups.","2021-08-16","National","","Pakistan","2021-07-01","2021-07-20","Health care workers and caregivers","Adults (18-64 years)",15000.0,0.33,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hijab Batool","Chughtai Institute of Pathology","https://dx.doi.org/10.1136/bmjopen-2020-046276","Unverified","","",0.996,0.967,"","PK",""
"2021-08-24","210817_Senegal_UniversityGastonBerger_Primary","Prevalence of SARS-CoV-2 Antibodies in Hemodialysis Patients in Senegal: A Multicenter Cross-Sectional Study","2021-08-17","National","","Senegal","2020-06-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",303.0,0.212,"Simplified probability","NR","IgM; IgG","Moderate","Preprint","Sidy Mohamed Seck","University Gaston Berger","https://www.researchsquare.com/article/rs-660094/v1","Unverified",0.167,0.261,"","","","SN",""
"2021-08-24","210818_Jordan_KingHusseinCancerCenter_Primary","A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity?","2021-08-18","National","","Jordan","2021-06-01","2021-06-30","Blood donors","Adults (18-64 years)",536.0,0.744,"Sequential","NR","Total Antibody","High","Preprint","Maher Sughayer","King Hussein Cancer Center","https://www.medrxiv.org/content/10.1101/2021.08.15.21261584v1.full-text","Verified","","",0.988,1.0,"","JO",""
"2021-08-25","200821_UniversityOfCalifornia_SanFrancisco","Community transmission of severe acute respiratory syndrome coronavirus 2 disproportionately affects the latinx population during shelter-in-place in san francisco","2020-08-21","Local","","United States of America; California; San Francisco","2020-04-25","2020-04-28","Household and community samples","Multiple groups",3861.0,0.031,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gabriel Chamie","University of California, San Francisco","http://dx.doi.org/10.1093/cid/ciaa1234","Unverified",0.025,0.039,"","","","US","US-CA"
"2021-08-25","201105_Detroit_OaklandUniversity_TestAdjustment","Coronavirus disease 2019 (covid-19) seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking","2020-11-05","Local","","United States of America; Michigan; Detroit","2020-04-13","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",20614.0,0.081,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Matthew Sims","Oakland University","http://dx.doi.org/10.1093/cid/ciaa1684","Verified",0.068,0.089,0.981,0.993,"","US","US-MI"
"2021-08-25","210805_Estonia_TartuUniversityHospital_Saaremaa_overall_testadj","Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).","2021-09-07","Local","","Estonia","2020-05-08","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",954.0,0.067,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Piia Jogi","University of Tartu","https://dx.doi.org/10.1016/j.vaccine.2021.07.093","Verified",0.05,0.084,"","","","EE",""
"2021-08-25","210805_Estonia_TartuUniversityHospital_Tallinn_overall_testadj","Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).","2021-09-07","Local","","Estonia","2020-05-08","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",1006.0,0.015,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Piia Jogi","University of Tartu","https://dx.doi.org/10.1016/j.vaccine.2021.07.093","Verified",0.006,0.024,"","","","EE",""
"2021-08-25","210806_Barcelona_InstitutdeRecercaSantJoandeDéu","COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era.","2021-08-06","Local","","Spain; Catalonia; Barcelona","2020-06-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",65.0,0.107,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Angela Deya-Martinez","Institut de Recerca Sant Joan de Déu","https://dx.doi.org/10.1016/j.clim.2021.108821","Unverified",0.07,0.13,"","","","ES","ES-CT"
"2021-08-25","210813_NewJersey_RutgersUniversity","Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study.","2021-08-13","Local","","United States of America; New Jersey; Newark, New Brunswick, Piscataway","2020-03-24","2020-09-22","Health care workers and caregivers","Adults (18-64 years)",831.0,0.1,"Convenience","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Daniel Horton","Rutgers University","https://dx.doi.org/10.1093/infdis/jiab411","Unverified","","",0.943,0.997,"","US","US-NJ"
"2021-08-25","210817_Seville_HospitalUniversitarioVirgendeValme_HIV","Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic.","2021-08-17","Local","","Spain; Andalusia; Seville","2020-02-09","2021-03-04","Patients seeking care for non-COVID-19 reasons","Multiple groups",707.0,0.075,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Marta Fernandez-Fuertes","Hospital Universitario Virgen de Valme","https://dx.doi.org/10.1111/tbed.14293","Unverified","","",0.995,0.998,"","ES","ES-AN"
"2021-08-28","210811_Ischgl_MedicalUniversityOfInnsbruck","Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl","2021-08-01","Local","","Austria; Tyrol; Ischgl","2020-11-02","2020-11-08","Household and community samples","Adults (18-64 years)",801.0,0.454,"Convenience","NR","IgG; IgA","Moderate","Journal Article (Peer-Reviewed)","Wegene Borena","Medical University Of Innsbruck","https://dx.doi.org/10.1016/j.ebiom.2021.103534","Verified",0.42,0.49,"","","","AT","AT-7"
"2021-08-29","210810_SaoPaulo_UniversidadedeSaoPaulo_Primary","Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of Sao Paulo, Brazil.","2021-08-10","Regional","","Brazil","2020-05-04","2020-05-12","Multiple general populations","Multiple groups",463.0,0.06,"Stratified non-probability","NR","IgG; IgM; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Beatriz Tess","Universidade de Sao Paulo","https://dx.doi.org/10.1016/j.bjid.2021.101604","Verified",0.039,0.083,"","","","BR",""
"2021-08-29","210812_MexicoCity_InstitutoNacionaldeRehabilitacion_Overall","Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a ""non-COVID"" hospital in Mexico City","2021-08-12","Local","","Mexico","2020-08-10","2020-09-09","Health care workers and caregivers","Multiple groups",299.0,0.13,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Esteban Cruz-Arenas","Nacional de Rehabilitacion hospital","http://dx.doi.org/10.1371/journal.pone.0255916","Unverified","","",0.946,0.998,"","MX",""
"2021-08-29","210818_Mongomery_WestVirginiaUniversity","Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital.","2021-08-18","Local","","United States of America; West Virginia; Montgomery","2020-09-10","2020-09-10","Hospital visitors","Multiple groups",150.0,0.1,"Convenience","NR","IgG","High","Preprint","Alexander Horspool","West Virginia University","https://dx.doi.org/10.1101/2021.08.16.21262128","Unverified","","","","","","US","US-WV"
"2021-08-30","210729_NorthernVirginia_InovaHeartandVascularInstitute_Community4_Primary","Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States.","2021-07-29","Regional","","United States of America; Virginia","2020-06-01","2020-08-14","Household and community samples","Multiple groups",949.0,0.045,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Abdulla Damluji","Inova Heart and Vascular Institute","https://dx.doi.org/10.1016/j.lana.2021.100030","Unverified","","","","","","US","US-VA"
"2021-08-30","210729_NorthernVirginia_InovaHeartandVascularInstitute_HCWOctoberNovember3_Primary","Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States.","2021-07-29","Regional","","United States of America; Virginia","2020-04-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",1323.0,0.048,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Abdulla Damluji","Inova Heart and Vascular Institute","https://dx.doi.org/10.1016/j.lana.2021.100030","Unverified","","","","","","US","US-VA"
"2021-08-30","210815_ Czechia_GENNETImmunologyLaboratory_Primary","COVID-19-free workplace: Measuring the level of antibodies against coronavirus as a basis for testing strategy in companies.","2021-08-15","Local","","Czechia","2020-03-28","2021-03-28","Health care workers and caregivers","Adults (18-64 years)",182.0,0.357,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Zuzana Kratka","GENNET Immunology Laboratory","https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2021-4-5/download?hl=cs","Unverified","","","","","","CZ",""
"2021-08-30","210816_Iran_HighInstituteForResearchEducationInTransfusionMedicine_Primary","Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors.","2021-08-21","National","","Iran (Islamic Republic of)","2020-05-18","2020-05-27","Blood donors","Multiple groups",1339.0,0.121,"Stratified non-probability","NR","IgM; IgG","Moderate","Preprint","Ali Arabkhazaeli","High Institute for Research and Education in Transfusion Medicine","https://dx.doi.org/10.1016/j.tracli.2021.08.008","Verified",0.103,0.138,0.85,1.0,"","IR",""
"2021-08-30","210816_Kuwait_MinistryofHealth_primary","Factors associated with SARS-CoV-2 infection amongst healthcare workers in a COVID-19 designated hospital","2021-08-16","National","","Kuwait","2020-08-15","2020-10-15","Health care workers and caregivers","Multiple groups",847.0,0.205,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","SarahAl Youha","Ministry of Health","http://dx.doi.org/10.1016/j.jiph.2021.08.012","Unverified","","","","","","KW",""
"2021-08-30","210819_NewYork_ColumbiaUniversityIrvingMedicalCenter_Overall","Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control.","2021-08-19","Local","","United States of America; New York","2021-01-03","2021-01-21","Household and community samples","Multiple groups",474.0,0.679,"Simplified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Alan Werzberger","Columbia University Irving Medical Center","https://dx.doi.org/10.1016/j.ajic.2021.08.015","Verified","","","","","","US","US-NY"
"2021-08-30","210820_Maryland_UniversityofMaryland","COVID-19 symptoms, patient contacts, PCR-positivity and seropositivity among healthcare personnel in a Maryland healthcare system.","2021-08-20","Local","","United States of America; Maryland","2020-06-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",778.0,0.026,"Self-referral","NR","Not reported","High","Journal Article (Peer-Reviewed)","Lyndsay O'Hara","University of Maryland","https://dx.doi.org/10.1017/ice.2021.373","Unverified","","","","","","US","US-MD"
"2021-08-30","210825_RhodeIsland_LindsleyFKimballResearchInstitute_CLIA_OverallAdj","Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.","2021-08-25","Regional","","United States of America; Rhode Island","2020-04-27","2020-05-11","Blood donors","Multiple groups",1996.0,0.006,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Daniel Nesbitt","Lindsley F Kimball Research Institute","https://dx.doi.org/10.1186/s12879-021-06438-4","Verified",0.002,0.011,"","","","US","US-RI"
"2021-08-31","210728_HavlickuvBrod_CharlesUniversity_Overall","What is the immunity of high school students to coronavirus?.","2021-07-28","Local","","Czechia; Vysočina; Havlíčkův Brod","2021-06-08","2021-06-21","Students and Daycares","Children and Youth (0-17 years)",196.0,0.459,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Vaclav Fejt","Charles University (Univerzity Karlovy)","https://www.prolekare.cz/en/journals/journal-of-czech-physicians/2021-4-5/what-is-the-immunity-of-high-school-students-to-coronavirus-127893","Unverified",0.388,0.532,0.981,0.996,"","CZ","CZ-VY"
"2021-08-31","210806_China_FudanUniversity_OcularSurfaceDisease_Overall","Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study.","2021-08-06","National","","China","2020-05-15","2021-03-15","Representative patient population","Multiple groups",1755.0,0.023,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shengjie Li","Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care","https://dx.doi.org/10.3389/fimmu.2021.695428","Unverified","","","","","","CN",""
"2021-08-31","210812_Amiens_UniversitéPicardieJules-Verne_LTC","[Covid-19 serology in nursing home and long-term care: prevalence of seroconversion in the Amiens-Picardie University Hospital].","2021-08-12","Local","","France; Hauts-de-France  ; Amiens","2020-06-15","2020-06-16","Assisted living and long-term care facilities","Seniors (65+ years)",114.0,0.456,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Julien Moyet","Université Picardie Jules-Verne","https://www.jle.com/10.1684/pnv.2021.0952","Unverified","","","","","","FR","FR-HDF"
"2021-08-31","210812_Amiens_UniversitéPicardieJules-Verne_NH","[Covid-19 serology in nursing home and long-term care: prevalence of seroconversion in the Amiens-Picardie University Hospital].","2021-08-12","Local","","France; Hauts-de-France  ; Amiens","2020-06-15","2020-06-16","Assisted living and long-term care facilities","Seniors (65+ years)",107.0,0.887,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Julien Moyet","Université Picardie Jules-Verne","https://www.jle.com/10.1684/pnv.2021.0952","Unverified","","","","","","FR","FR-HDF"
"2021-08-31","210813_Madurai_UniversityOfCaliforniaBerkeley_Primary","SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study","2021-08-13","Local","","India; Tami Nadu; Madurai","2020-10-19","2020-11-05","Household and community samples","Multiple groups",1140.0,0.402,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ramanan Laxminarayan","University of California Berkeley","https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00393-5/fulltext","Verified",0.359,0.447,0.93,0.929,"","IN",""
"2021-08-31","210819_England_UniversityofBirmingham_Overall","Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.","2021-08-19","National","","United Kingdom of Great Britain and Northern Ireland; England","2020-12-11","2020-12-18","Assisted living and long-term care facilities","Adults (18-64 years)",124.0,0.24,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gokhan Tut","University of Birmingham","https://dx.doi.org/10.1016/S2666-7568(21)00168-9","Unverified","","","","","","GB","GB-ENG"
"2021-08-31","210819_RussianFederation_StPetersburgPasteurInstitute_Overall","Sars-cov-2 seroprevalence structure of the russian population during the covid-19 pandemic","2021-08-19","National","","Russian Federation","2020-06-15","2020-12-31","Household and community samples","Multiple groups",74158.0,0.192,"Unclear","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Anna Popova","Saint Petersburg Pasteur Institute","http://dx.doi.org/10.3390/v13081648","Unverified",0.189,0.195,"","","","RU",""
"2021-08-31","210820_Hamburg_UniversitätHamburg_primary","Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany.","2021-08-20","Local","","Germany","2020-08-19","2020-09-18","Health care workers and caregivers","Multiple groups",619.0,0.003,"Stratified non-probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Marietta Neumann","Universität Hamburg","https://dx.doi.org/10.1007/s12519-021-00447-8","Verified",0.0,0.012,0.946,0.998,"","DE",""
"2021-08-31","210820_Poland_CentralClinicalHospitaloftheMinistryoftheInteriorandAdministration","Social distancing during covid-19 pandemic among inflammatory bowel disease patients","2021-08-20","National","","Poland; Masovian Voivodeship, Greater Poland Voivodeship, Łódź Voivodeship; Warsaw, Poznań, Łódź","2020-05-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",473.0,0.093,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Michal Lodyga","Central Clinical Hospital of the Ministry of the Interior and Administration","http://dx.doi.org/10.3390/jcm10163689","Unverified","","",0.88,0.99,"","PL",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_August_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","","Denmark","2020-08-15","2020-09-30","Household and community samples","Multiple groups",11478.0,0.02,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified",0.017,0.024,0.967,0.995,"","DK",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_December_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","","Denmark","2020-12-01","2020-12-31","Household and community samples","Multiple groups",4044.0,0.043,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified",0.034,0.051,0.967,0.995,"","DK",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_May_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","","Denmark","2020-05-05","2020-05-15","Household and community samples","Multiple groups",2512.0,0.015,"Simplified probability","NR","Total Antibody","Low","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified",0.009,0.021,0.967,0.995,"","DK",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_October_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","","Denmark","2020-10-01","2020-11-30","Household and community samples","Multiple groups",9654.0,0.024,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified",0.019,0.028,0.967,0.995,"","DK",""
"2021-08-31","210823_Madrid_HospitalUniversitarioPuertadeHierroMajadahonda_HCW","SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.","2021-08-23","Local","","Spain; Communidad de Madrid; Madrid","2020-04-24","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",4324.0,0.166,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mireia Cantero","Hospital Universitario Puerta de Hierro Majadahonda","https://dx.doi.org/10.1080/23744235.2021.1963468","Unverified",0.155,0.177,"","","","ES",""
"2021-08-31","210825_OrangeCounty_UniversityofCaliforniaIrvine","SARS-CoV-2 antibody seroprevalence among firefighters in Orange County, California.","2021-08-25","Local","","United States of America; California; NR","2020-10-05","2020-10-23","Essential non-healthcare workers","Adults (18-64 years)",923.0,0.054,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Veronica Vieira","University of California Irvine","https://dx.doi.org/10.1136/oemed-2021-107461","Unverified","","",0.996,1.0,"","US","US-CA"
"2021-08-31","210827_Birjand_BirjandUniversityOfMedicalSciences","The high level of adherence of personal protective equipment in health care workers efficiently protects them from COVID-19 infection.","2021-08-27","Local","","Iran (Islamic Republic of); South Khorasan Province; Birjand","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",137.0,0.051,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Malihe Zangoue","Birjand University Of MedicalSciences","https://dx.doi.org/10.3233/WOR-210634","Verified","","",0.941,0.983,"","IR","IR-29"
"2021-09-01","210806_China_FudanUniversity_NoOcularDisease_Overall","Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study.","2021-08-06","National","","China","2020-05-15","2021-03-15","Residual sera","Multiple groups",5852.0,0.009,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Shengjie Li","Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care","https://dx.doi.org/10.3389/fimmu.2021.695428","Unverified","","","","","","CN",""
"2021-09-01","210806_China_FudanUniversity_NoOcularSurfaceDisease_Overall","Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study.","2021-08-06","National","","China","2020-05-15","2021-03-15","Representative patient population","Multiple groups",12550.0,0.007,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shengjie Li","Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care","https://dx.doi.org/10.3389/fimmu.2021.695428","Unverified","","","","","","CN",""
"2021-09-01","210811_England_OfficeForNationalStatistics_Round6_StaffPrimary","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Essential non-healthcare workers","Adults (18-64 years)",832.0,0.252,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified",0.197,0.312,0.972,0.998,"","GB","GB-ENG"
"2021-09-01","210811_England_OfficeForNationalStatistics_Round6_StaffSecondary","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Essential non-healthcare workers","Adults (18-64 years)",1574.0,0.234,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified",0.207,0.262,0.972,0.998,"","GB","GB-ENG"
"2021-09-01","210819_CityofGuadalupe_UniversidadAutónomadeNuevoLeón_Overall","Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.","2021-08-19","Local","","Mexico; Nuevo Leon; Guadalupe","2020-07-09","2020-07-23","Multiple populations","Multiple groups",3268.0,0.059,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cristina Diaz‑Salazar","Universidad Autonoma de Nuevo Leon","https://dx.doi.org/10.1186/s12879-021-06550-5","Verified",0.051,0.068,0.995,0.998,"","MX","MX-NLE"
"2021-09-03","210429_Houston_HoustonHealthDepartment_MultipleTest_Primary","Population-Based Estimates of SARS-CoV-2 Seroprevalence in Houston, TX as of September 2020","2021-04-29","Local","United States of America","United States of America; Texas; Houston","2020-09-01","2020-09-19","Household and community samples","Multiple groups",685.0,0.115,"Stratified probability","NR","IgG; IgM; IgA","Low","Journal Article (Peer-Reviewed)","Elaine Symanski","Houston Health Department","https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab203/6258999","Verified","","","","","","US","US-TX"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_1_June_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-06-01","2020-06-05","Residual sera","Multiple groups",8442.0,0.009,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.009,0.009,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_2_July_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-07-06","2020-07-10","Residual sera","Multiple groups",13175.0,0.009,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.009,0.009,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_3_August_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-08-04","2020-08-11","Residual sera","Multiple groups",12284.0,0.012,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.012,0.012,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_4_September_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-09-07","2020-09-11","Residual sera","Multiple groups",12006.0,0.01,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.01,0.01,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_5_October_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-10-05","2020-10-09","Residual sera","Multiple groups",13490.0,0.012,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.012,0.012,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_6_November_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-11-09","2020-11-13","Residual sera","Multiple groups",11471.0,0.016,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.016,0.016,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_7_December_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2020-12-07","2020-12-10","Residual sera","Multiple groups",12076.0,0.025,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.025,0.025,"","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_8_January_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","","Canada; Alberta","2021-01-11","2021-01-14","Residual sera","Multiple groups",11094.0,0.046,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified",0.046,0.046,"","","","CA","CA-AB"
"2021-09-04","210518_Odisha_ICMR-RegionalMedicalResearchCentre_BAM_GenderAdj","Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.","2021-05-18","Local","India","India; Odisha; Berhampur","2020-08-01","2020-08-31","Household and community samples","Multiple groups",1375.0,0.311,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1038/s41598-021-89877-y","Verified",0.287,0.337,"","","","IN","IN-OR"
"2021-09-04","210518_Odisha_ICMR-RegionalMedicalResearchCentre_BBS_GenderAdj","Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.","2021-05-18","Local","India","India; Odisha; Bhubaneswar","2020-08-01","2020-08-31","Household and community samples","Multiple groups",1319.0,0.052,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1038/s41598-021-89877-y","Verified",0.041,0.066,"","","","IN","IN-OR"
"2021-09-04","210518_Odisha_ICMR-RegionalMedicalResearchCentre_RKL_GenderADj","Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.","2021-05-18","Local","India","India; Odisha; Rourkela","2020-08-01","2020-08-31","Household and community samples","Multiple groups",1452.0,0.246,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1038/s41598-021-89877-y","Verified",0.224,0.269,"","","","IN","IN-OR"
"2021-09-06","210829_Delhi_CouncilOfScientificAndIndustrialResearch_overall","27% reinfected during 4th wave in Delhi, says study","2021-08-29","Local","","India","2021-05-15","2021-06-15","Multiple populations","Multiple groups",846.0,0.87,"Convenience","NR","Not reported","Unclear","News and Media","Anonna Dutt","Council Of Scientific And Industrial Research (CSIR)","https://www.hindustantimes.com/india-news/covid-crisis-one-in-four-patients-in-delhi-were-reinfected-during-the-second-wave-says-preprint-study-101630175376759-amp.html","Unverified","","","","","","IN",""
"2021-09-07","210502_Qatar_CornellUniversity_Primary","SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.","2021-05-02","National","","Qatar","2020-07-26","2020-09-09","Essential non-healthcare workers","Multiple groups",2641.0,0.553,"Stratified probability","NR","Not reported","Low","Journal Article (Peer-Reviewed)","Mohamed Al-Thani","Cornell University","https://academic.oup.com/ofid/article/8/8/ofab221/6261968","Unverified",0.533,0.573,"","","","QA",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","","Germany","2020-11-02","2020-11-16","Household and community samples","Multiple groups",576.0,0.014,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified",0.006,0.027,"","","","DE",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_PrimaryStudent_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","","Germany","2020-11-02","2020-11-16","Students and Daycares","Children and Youth (0-17 years)",174.0,0.011,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified","","","","","","DE",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_SecondaryStudent_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","","Germany","2020-11-02","2020-11-16","Students and Daycares","Children and Youth (0-17 years)",173.0,0.029,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified","","","","","","DE",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_Staff_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","","Germany","2020-11-02","2020-11-16","Essential non-healthcare workers","Adults (18-64 years)",141.0,0.014,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified",0.002,0.05,"","","","DE",""
"2021-09-07","210826_Borriana_PublicHealthCenterOfCastellon_PrimaryIgG","Mass gathering events and COVID-19 transmission in Borriana (Spain): A retrospective cohort study","2021-08-26","Local","","Spain; Castellon; Borriana","2020-06-23","2020-06-27","Household and community samples","Multiple groups",997.0,0.51,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Salvador Domenech Montoliu","Public Health Center of Castellon","http://dx.doi.org/10.1371/journal.pone.0256747","Verified","","","","","","ES",""
"2021-09-07","210827_Linkoping_LinkopingUniversity_Overall","SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic","2021-08-27","Local","","Sweden; Ostergotland; Linkoping","2020-03-15","2021-01-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",100.0,0.36,"Sequential","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Johanna Sjowall","Linkoping University","https://www.frontiersin.org/articles/10.3389/fimmu.2021.724047/full","Unverified","","","","","","SE","SE-E"
"2021-09-07","210830_Nepal_MinistryofHealthandPopulation_Overall","Over two-thirds population has Covid-19 antibodies, seroprevalence study shows","2021-08-30","National","","Nepal","2021-07-05","2021-08-14","Household and community samples","Multiple groups",13161.0,0.686,"Simplified probability","NR","Not reported","Unclear","News and Media","Shuvam Dhungana","Ministry of Health and Population","https://kathmandupost.com/health/2021/08/30/over-two-thirds-population-has-covid-19-antibodies-seroprevalence-study-shows","Verified","","","","","","NP",""
"2021-09-07","210831_Italy_UniversityofVerona_Overall","The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.","2021-08-31","National","","Italy; Veneto, Friuli-Venezia Giulia, and Lazio","2020-05-18","2020-11-03","Patients seeking care for non-COVID-19 reasons","Multiple groups",564.0,0.02,"Sequential","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Massimiliano Bonifacio","University of Verona","https://dx.doi.org/10.1002/cam4.4179","Unverified",0.011,0.035,"",1.0,"","IT",""
"2021-09-07","210901_Dusseldorf_HeinrichHeineUniversityDusseldorf","High rate of clinically unrecognized SARS-CoV-2 infections in pediatric palliative care patients.","2021-09-01","Local","","Germany; North Rhine-Westphalia; Dusseldorf","2020-12-17","2021-02-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",39.0,0.256,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Benedikt Botticher","Heinrich Heine University","https://dx.doi.org/10.1007/s00431-021-04242-5","Verified","","","","","","DE","DE-NW"
"2021-09-07","210901_Utah_UniversityofUtah_genpop_popadj_testadj","Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.","2021-09-01","Regional","","United States of America; Utah","2020-05-04","2020-06-30","Household and community samples","Multiple groups",8108.0,0.008,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Matthew Samore","University of Utah","https://wwwnc.cdc.gov/eid/article/27/11/20-4435_article","Verified",0.001,0.016,0.864,0.996,"","US","US-UT"
"2021-09-08","210221_UnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust","Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients.","2021-09-02","National","","United Kingdom of Great Britain and Northern Ireland","2020-01-29","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",13509.0,0.031,"Sequential","NR","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Neil Chanchlani","Royal Devon And Exeter NHS Foundation Trust","https://dx.doi.org/10.1093/ecco-jcc/jjab153","Unverified","","",0.995,0.998,"","GB",""
"2021-09-08","210616_Austria_UniversityHospitalOfSalzburg_Overall","Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors.","2021-06-16","National","","Austria","2020-06-05","2020-12-04","Blood donors","Multiple groups",20228.0,0.025,"Convenience","NR","Total Antibody","Low","Journal Article (Peer-Reviewed)","Lisa Weidner","University Hospital of Salzburg","https://dx.doi.org/10.1007/s15010-021-01639-0","Verified","","",1.0,0.998,"","AT",""
"2021-09-08","210617_Campinas_UniversityOfCampinas","Low SARS-CoV-2 seroprevalence in a cohort of Brazilian sickle cell disease patients: Possible effects of emphasis on social isolation for a population initially considered to be at very high risk","2021-06-17","Regional","","Brazil; Sao Paulo; Campinas","2020-08-15","2021-01-15","Representative patient population","Multiple groups",135.0,0.11,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Luiza Francisco Trafane","University of Campinas","https://onlinelibrary.wiley.com/doi/10.1002/jha2.254","Verified","","","","","","BR","BR-SP"
"2021-09-08","210719_Vo_UniversityOfPadova_Overall_Adj","SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'.","2021-07-19","Local","","Italy; Padova; Vo","2020-05-01","2020-05-31","Household and community samples","Multiple groups",2602.0,0.035,"Entire sample","NR","IgG","Low","Journal Article (Peer-Reviewed)","Ilaria Dorigatti","University of Padova","https://dx.doi.org/10.1038/s41467-021-24622-7","Verified",0.028,0.043,"","","","IT","IT-34"
"2021-09-08","210825_London_NHSFoundationTrust_Overall","SARS-CoV-2 antibody seroprevalence among people living with HIV","2021-08-25","Local","","United Kingdom of Great Britain and Northern Ireland","2020-08-01","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",1621.0,0.092,"Sequential","NR","Not reported","Unclear","Presentation or Conference","Venkateshwaran Sivaraj","Guy's and St Thomas' NHS Foundation Trust","https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.13131","Unverified","","","","","","GB",""
"2021-09-08","210830_Conneticut_YaleUniversity","Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel.","2021-08-30","Regional","","United States of America; Connecticut","2021-04-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",988.0,0.104,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Joseph Zell","Yale University","https://dx.doi.org/10.1371/journal.pone.0251114","Unverified","","",0.995,0.998,"","US","US-CT"
"2021-09-09","210629_RioGrandedoSul_UniversidadeFederaldePelotas_Primary","Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants.","2021-06-29","Regional","","Brazil; Rio Grande do Sul","2020-04-11","2020-09-06","Household and community samples","Multiple groups",35611.0,0.006,"Stratified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Pedro C. Hallal","Universidade Federal de Pelotas","https://dx.doi.org/10.2105/AJPH.2021.306351","Verified","","",0.848,1.0,"","BR","BR-RS"
"2021-09-09","210820_ Weißenkirchen_DanubePrivateUniversity","Longitudinal monitoring of SARS-CoV-2-specific immune responses","2021-08-20","Local","","Austria; Lower Austria; Weißenkirchen in der Wachau","2021-02-13","2021-02-13","Household and community samples","Multiple groups",552.0,0.25,"Convenience","NR","IgG","High","Preprint","Heike Rebholz","Danube Private University","https://doi.org/10.1101/2021.08.14.21262042","Verified","","","","","","AT","AT-3"
"2021-09-09","210902_Kenya_KEMRI-WellcomeTrustResearchProgramme_OverallPopAndTestAdjusted","Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.","2021-09-02","National","","Kenya","2021-01-03","2021-03-15","Blood donors","Multiple groups",3018.0,0.485,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Sophie Uyoga","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1001/jama.2021.15265","Verified",0.452,0.521,0.927,0.99,"","KE",""
"2021-09-10","210901_Kentucky_UniversityofKentucky_Primary","Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center - An assessment of occupational infection risk.","2021-09-01","Local","","United States of America; Kentucky; Lexington","2020-06-22","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",322.0,0.016,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Derek Forster","University of Kentucky","https://dx.doi.org/10.1016/j.ajic.2021.04.005","Unverified",0.007,0.037,1.0,0.996,"","US","US-KY"
"2021-09-11","200925_Stockholm_TheStockholmRegion","25 september: Lägesrapport om arbetet med det nya coronaviruset","2020-09-25","Local","","Sweden","2020-06-15","2020-09-20","Household and community samples","Multiple groups",483345.0,0.152,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/25-september-lagesrapport-om-arbetet-med-det-nya-coronaviruset/","Verified","","","","","","SE",""
"2021-09-11","200929_Stockholm_TheStockholmRegion","29 september: Lägesrapport om covid-19","2020-09-29","Local","","Sweden","2020-09-21","2020-09-27","Household and community samples","Multiple groups",9648.0,0.143,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/29-september-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-09-12","210731_Greece_NationalandKapodistrianUniversityofAthens_Primary","Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece.","2021-07-31","National","","Greece","2020-06-01","2020-07-09","Health care workers and caregivers","Adults (18-64 years)",57418.0,0.007,"Self-referral","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Petros Galanis","National and Kapodistrian University of Athens","https://dx.doi.org/10.1016/j.puhe.2021.07.029","Unverified","","",1.0,0.996,"","GR",""
"2021-09-13","201006_Stockholm_TheStockholmRegion","6 oktober: Lägesrapport om covid-19","2020-10-06","Local","","Sweden","2020-09-28","2020-10-04","Household and community samples","Multiple groups",11670.0,0.154,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/6-oktober-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-09-13","210529_Yokohama_YokohamaDai-ichiHospital","Assessment of sars-cov-2 antibodies in patients on hemodialysis","2021-05-29","Local","","Japan","2020-08-01","2020-12-14","Patients seeking care for non-COVID-19 reasons","Multiple groups",55.0,0.036,"Sequential","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Takayasu Taira","Yokohama Dai-ichi Hospital","http://dx.doi.org/10.1093/ndt/gfab098.0019","Unverified","","","","","","JP",""
"2021-09-13","210701_India_IndianCouncilOfMedicalResearch_GenPop_TestPopAdj","SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021","2021-07-01","National","India","India","2020-12-18","2021-01-06","Household and community samples","Multiple groups",28598.0,0.241,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Manoj V Murhekar","Indian Council of Medical Research","http://dx.doi.org/10.1016/j.ijid.2021.05.040","Verified",0.23,0.253,"","","","IN",""
"2021-09-13","210701_India_IndianCouncilOfMedicalResearch_HCWs_TestPopAdj","SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021","2021-07-01","National","India","India","2020-12-18","2021-01-06","Health care workers and caregivers","Multiple groups",7385.0,0.256,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Manoj V Murhekar","Indian Council of Medical Research","http://dx.doi.org/10.1016/j.ijid.2021.05.040","Verified",0.235,0.278,1.0,0.999,"","IN",""
"2021-09-13","210821_Stockholm_KarolinskaUniversityHospital_Overall","Differences in risk for SARS-CoV-2 infection among healthcare workers","2021-08-21","Local","Sweden","Sweden; Sodermanland and Uppland; Stockholm","2020-04-23","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",12928.0,0.115,"Convenience","N/A - in house","IgG","Moderate","Journal Article (Peer-Reviewed)","Klara Miriam Elfstrom","Karolinska University Hospital","https://dx.doi.org/10.1016/j.pmedr.2021.101518","Verified","","",0.994,0.991,"","SE","SE-AB"
"2021-09-13","210827_Italy_AOUCittàdellaSaluteedellaScienzadiTorino","SCREENING FOR SARS-CoV-2 NEUTRALIZING ANTIBODIES IN CIRRHOTIC PATIENTS WAITING FOR LIVER TRANSPLANTATION: IMPACT ON DONOR POOL EXPANSION","2021-08-27","Local","","Italy; Piedmont; Turin","2020-11-25","2021-02-12","Patients seeking care for non-COVID-19 reasons","Multiple groups",98.0,0.224,"Convenience","NR","IgG","Moderate","Presentation or Conference","Margherita Saracco","AOU Citta della Salute e della Scienza di Torino","https://onlinelibrary.wiley.com/doi/10.1111/tri.13944","Unverified","","","","","","IT","IT-21"
"2021-09-13","210901_Riyadh_KingSaudbinAbdulazizUniversity","Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.","2021-09-01","Local","","Saudi Arabia; Riyadh Province; Riyadh City","2020-07-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",420.0,0.148,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Fayhan Alroqi","King Saudbin Abdulaziz University for Health Sciences","https://dx.doi.org/10.1016/j.jiph.2021.08.029","Unverified",0.115,0.185,0.944,0.996,"","SA","SA-01"
"2021-09-13","210901_WesternKenya_WalterReedArmyInstituteofResearch_overall","SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020.","2021-09-01","Regional","","Kenya; Western Region; Kisumu, Kericho","2020-01-01","2020-03-19","Residual sera","Adults (18-64 years)",582.0,0.033,"Convenience","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Trevor Crowell","Walter Reed Army Institute of Research","https://dx.doi.org/10.1097/QAD.0000000000003054","Verified","","","","","","KE",""
"2021-09-13","210903_SouthAfrica_UniversityoftheWitwatersrand_Rural_Date5_Overall_Adj","SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.","2021-09-03","Local","","South Africa; Mpumalanga Province; Bushbuckridge Municipality","2021-03-22","2021-04-11","Household and community samples","Multiple groups",587.0,0.26,"Simplified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Jackie Kleynhans","University of the Witwatersrand","https://dx.doi.org/10.3201/eid2712.211465","Verified",0.22,0.29,0.995,0.998,"","ZA","ZA-MP"
"2021-09-13","210903_SouthAfrica_UniversityoftheWitwatersrand_Urban_Date5_Overall_Adj","SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.","2021-09-03","Local","","South Africa; North West Province; Matlosana Municipality","2021-03-22","2021-04-11","Household and community samples","Multiple groups",510.0,0.41,"Simplified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Jackie Kleynhans","University of the Witwatersrand","https://dx.doi.org/10.3201/eid2712.211465","Verified",0.37,0.45,0.995,0.998,"","ZA","ZA-NW"
"2021-09-13","210909_SouthWales_CwmTafMorgannwgUniversityHealthBoard_Overall","SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study","2021-09-09","Regional","","United Kingdom of Great Britain and Northern Ireland; Wales","2020-09-15","2020-10-27","Non-essential workers and unemployed persons","Multiple groups",991.0,0.07,"Convenience","NR","IgG; IgM","High","Preprint","Alice Puchades","Cwm Taf Morgannwg University Health Board","https://www.researchsquare.com/article/rs-850315/v1","Unverified","","",0.96,0.955,"","GB","GB-WLS"
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_HCW_primary","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","","Belgium","2020-05-06","2020-05-10","Health care workers and caregivers","Multiple groups",785.0,0.084,"Convenience","NR","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_14-16april","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","","Belgium","2020-04-14","2020-04-16","Blood donors","Multiple groups",900.0,0.048,"Convenience","NR","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_27-29April","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","","Belgium","2020-04-27","2020-04-29","Blood donors","Multiple groups",900.0,0.047,"Convenience","NR","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_march_primary","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","","Belgium","2020-03-30","2020-03-30","Blood donors","Multiple groups",584.0,0.013,"Convenience","NR","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_may_primary","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","","Belgium","2020-05-11","2020-05-13","Blood donors","Multiple groups",900.0,0.047,"Convenience","NR","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","","","","","BE",""
"2021-09-14","210529_NewYorkCity_RenalResearchInstitute_Primary","Prevalence and persistence of covid-19 antibodies in New York City hemodialysis clinic","2021-05-29","Local","","United States of America; New York; New York City","2020-06-10","2020-07-13","Patients seeking care for non-COVID-19 reasons","Multiple groups",429.0,0.303,"Convenience","NR","IgG","Unclear","Presentation or Conference","Ohnmar Thwin","Renal Research Institute","http://dx.doi.org/10.1093/ndt/gfab100.002","Unverified","","",1.0,0.98,"","US","US-NY"
"2021-09-14","210719_Sweden_SwedishPublicHealthAgency_Outpatients_Week21-22_Primary","Påvisning av antikroppar mot SARS-CoV-2 i blodprov från öppenvården","2021-07-19","National","","Sweden","2021-05-24","2021-06-04","Residual sera","Multiple groups",3949.0,0.522,"Stratified non-probability","NR","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf","Verified",0.504,0.54,0.989,0.994,"","SE",""
"2021-09-14","210726_Dresden_TechnischeUniversitatDresden_200715-201115_Adults","Prevalence and Transmission of Severe Acute Respiratory Syndrome Coronavirus Type 2 in Childcare Facilities: A Longitudinal Study","2021-07-26","Local","","Germany; Saxony; Dresden","2020-07-15","2020-11-15","Multiple populations","Multiple groups",350.0,0.006,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Luise Haag","Technische Universitat Dresden","http://dx.doi.org/10.1016/j.jpeds.2021.07.054","Unverified","","","","","","DE","DE-SN"
"2021-09-14","210726_Dresden_TechnischeUniversitatDresden_201116-210131_Adults","Prevalence and Transmission of Severe Acute Respiratory Syndrome Coronavirus Type 2 in Childcare Facilities: A Longitudinal Study","2021-07-26","Local","","Germany; Saxony; Dresden","2020-07-16","2021-01-31","Multiple populations","Multiple groups",424.0,0.113,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Luise Haag","Technische Universitat Dresden\","http://dx.doi.org/10.1016/j.jpeds.2021.07.054","Unverified","","","","","","DE","DE-SN"
"2021-09-14","210802_Delhi_ DirectorateGeneralHealthServices_Aug1_PopTestAdj","The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.","2021-08-02","Regional","India","India; NCT Delhi","2020-08-01","2020-08-07","Household and community samples","Multiple groups",14779.0,0.284,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Nandini Sharma","Government of National Capital Territory of Delhi","https://dx.doi.org/10.1093/trstmh/trab109","Verified",0.276,0.291,0.921,0.977,"","IN","IN-DL"
"2021-09-14","210802_Delhi_ DirectorateGeneralHealthServices_Oct3_PopTestAdj","The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.","2021-08-02","Regional","India","India; NCT Delhi","2020-10-15","2020-10-21","Household and community samples","Multiple groups",14905.0,0.247,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Nandini Sharma","Government of National Capital Territory of Delhi","https://dx.doi.org/10.1093/trstmh/trab109","Verified",0.24,0.254,0.991,0.993,"","IN","IN-DL"
"2021-09-14","210802_Delhi_ DirectorateGeneralHealthServices_Sept2_PopTestAdj","The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.","2021-08-02","Regional","India","India; NCT Delhi","2020-09-01","2020-09-07","Household and community samples","Multiple groups",16953.0,0.241,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Nandini Sharma","Government of National Capital Territory of Delhi","https://dx.doi.org/10.1093/trstmh/trab109","Verified",0.234,0.247,0.991,0.993,"","IN","IN-DL"
"2021-09-14","210902_Manaus_InstitutoNacionaldePesquisasdaAmazônia_overall","Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.","2021-09-02","Local","","Brazil; Amazonas; Manaus","2020-10-10","2020-11-14","Household and community samples","Multiple groups",280.0,0.646,"Sequential","NR","IgA; IgG","Moderate","Journal Article (Peer-Reviewed)","Gemilson Soares Pontes","Instituto Nacional de Pesquisas da Amazônia","https://www.nature.com/articles/s41598-021-96843-1","Verified",0.59,0.703,"","","","BR","BR-AM"
"2021-09-14","210902_Milan_UniversityofMilan_January2021","Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?","2021-09-02","Local","","Italy; Lombardy; Milan","2021-01-01","2021-01-31","Students and Daycares","Children and Youth (0-17 years)",1109.0,0.125,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Lucia Barcellini","University of Milan","http://dx.doi.org/10.1371/journal.pone.0257046","Unverified",0.106,0.146,0.96,1.0,"","IT","IT-25"
"2021-09-14","210902_Milan_UniversityofMilan_September2020","Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?","2021-09-02","Local","","Italy; Lombardy; Milan","2020-09-01","2020-09-30","Students and Daycares","Children and Youth (0-17 years)",1109.0,0.028,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Lucia Barcellini","University of Milan","http://dx.doi.org/10.1371/journal.pone.0257046","Unverified",0.019,0.039,0.96,1.0,"","IT","IT-25"
"2021-09-14","210906_Strasbourg_CHUdeStrasbourg_Overall","High SARS-CoV-2 seroconversion rate among geriatric staff from Strasbourg University Hospitals.","2021-09-06","Local","","France; Grand Est; Strasbourg","2020-06-22","2020-11-01","Health care workers and caregivers","Adults (18-64 years)",5694.0,0.085,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Baptiste Panaget","Centres Hospitaliers et Universitaires de Strasbourg","https://dx.doi.org/10.1017/ice.2021.402","Unverified","","",0.93,0.99,"","FR","FR-GES"
"2021-09-15","210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_Baseline_Overall","Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance","2021-07-06","Local","","Switzerland","2020-04-15","2020-07-15","Multiple populations","Multiple groups",187.0,0.123,"Simplified probability","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Javier Perez Saez","Johns Hopkins Bloomberg School of Public Health","https://doi.org/10.1016/j.cmi.2021.06.040","Unverified","","","","","","CH",""
"2021-09-15","210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_FollowUp_Overall","Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance","2021-07-06","Local","","Switzerland","2020-11-01","2020-11-30","Multiple populations","Multiple groups",187.0,0.273,"Simplified probability","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Javier Perez Saez","Johns Hopkins Bloomberg School of Public Health","https://doi.org/10.1016/j.cmi.2021.06.040","Unverified","","","","","","CH",""
"2021-09-15","210728_Stockholm_TheSwedishPublicHealthAgency","Undersökning av immunologiskt svar mot SARS-CoV-2 hos barn, unga och skolpersonal","2021-07-28","Local","","Sweden; Södermanland, Uppland; Stockholm","2020-11-15","2020-12-15","Essential non-healthcare workers","Adults (18-64 years)",49.0,0.367,"Unclear","NR","Not reported","High","Institutional Report","Swedish Public Health Agency","The Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/u/undersokning-av-immunologiskt-svar-mot-sars-cov-2-hos-barn-unga-och-skolpersonal/","Unverified","","","","","","SE","SE-AB"
"2021-09-15","210801_India_SevenHillsDedicatedCovidHospital","Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.","2021-08-01","Local","","India; Maharashtra; Mumbai","2020-12-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",1005.0,0.123,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Chavhan Santosh","Seven Hills Dedicated Covid Hospital","https://europepmc.org/article/med/34472805","Unverified","","","","","","IN","IN-MH"
"2021-09-15","210812_NorthCarolina_UniversityOfNorthCarolina","Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color","2021-08-12","Regional","","United States of America; North Carolina","2020-04-15","2020-10-15","Household and community samples","Multiple groups",103.0,0.28,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Carla Cerami","University of North Carolina","http://dx.doi.org/10.1093/cid/ciab701","Verified","","","","","","US","US-NC"
"2021-09-15","210820_Solothurn_UniversityofBern_Primary","Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.","2021-08-20","Regional","","Switzerland; Canton of Solothurn","2020-06-01","2020-07-01","Health care workers and caregivers","Adults (18-64 years)",357.0,0.034,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Kathrin Zurcher","University of Bern","https://dx.doi.org/10.4414/SMW.2021.w30021","Unverified",0.017,0.058,"","","","CH","CH-SO"
"2021-09-15","210827_Flanders_UniversityofAntwerp_December","Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium.","2021-08-27","Regional","","Belgium; Flanders","2020-12-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",698.0,0.134,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Joachim Marien","University of Antwerp","https://dx.doi.org/10.1093/fampra/cmab094","Unverified",0.108,0.164,"",0.99,"","BE","BE-VLG"
"2021-09-16","210830_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report August 30, 2021 Report #11: June 2021 Survey Tracking seroprevalence in the vaccine era","2021-08-30","National","","Canada","2021-06-14","2021-06-29","Blood donors","Multiple groups",16884.0,0.908,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.903,0.912,0.988,0.996,"","CA",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W16","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-04-12","2020-04-18","Household and community samples","Adults (18-64 years)",362.0,0.003,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.016,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W17","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-04-19","2020-04-25","Household and community samples","Adults (18-64 years)",674.0,0.003,"Simplified probability","NR","IgG; Neutralizing","Moderate","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.001,0.011,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W18","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-04-26","2020-05-02","Household and community samples","Adults (18-64 years)",426.0,0.005,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.001,0.017,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W19","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-05-03","2020-05-09","Household and community samples","Adults (18-64 years)",514.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.007,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W20","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-05-10","2020-05-16","Household and community samples","Adults (18-64 years)",401.0,0.002,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.014,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W21","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-05-17","2020-05-23","Household and community samples","Adults (18-64 years)",210.0,0.005,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.001,0.026,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W22","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-05-24","2020-05-30","Household and community samples","Adults (18-64 years)",178.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.021,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W23","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-05-31","2020-06-06","Household and community samples","Adults (18-64 years)",214.0,0.005,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.001,0.026,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W24","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-06-07","2020-06-13","Household and community samples","Adults (18-64 years)",174.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.022,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W25","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-06-14","2020-06-20","Household and community samples","Adults (18-64 years)",78.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.047,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W26","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-06-21","2020-06-27","Household and community samples","Adults (18-64 years)",32.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.107,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W27","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-06-28","2020-07-04","Household and community samples","Adults (18-64 years)",85.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.043,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W28","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-07-05","2020-07-11","Household and community samples","Adults (18-64 years)",51.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.07,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W29","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-07-12","2020-07-18","Household and community samples","Adults (18-64 years)",7.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.354,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W30","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-07-19","2020-07-25","Household and community samples","Adults (18-64 years)",9.0,0.111,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.02,0.435,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W31","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-07-26","2020-08-01","Household and community samples","Adults (18-64 years)",75.0,0.013,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.002,0.072,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W32","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-08-02","2020-08-08","Household and community samples","Adults (18-64 years)",49.0,0.02,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.004,0.107,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W33","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-08-09","2020-08-15","Household and community samples","Adults (18-64 years)",64.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.057,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W34","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-08-16","2020-08-22","Household and community samples","Adults (18-64 years)",63.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.058,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W35","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-08-23","2020-08-29","Household and community samples","Adults (18-64 years)",48.0,0.021,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.004,0.109,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W36","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-08-30","2020-09-05","Household and community samples","Adults (18-64 years)",63.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.058,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W37","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-09-06","2020-09-12","Household and community samples","Adults (18-64 years)",54.0,0.0,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.066,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W38","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-09-13","2020-09-19","Household and community samples","Adults (18-64 years)",48.0,0.021,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.004,0.109,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W39","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-09-20","2020-09-26","Household and community samples","Adults (18-64 years)",56.0,0.018,"Simplified probability","NR","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.003,0.094,"","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W40","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-09-27","2020-10-03","Household and community samples","Adults (18-64 years)",60.0,0.017,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.003,0.089,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W41","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-10-04","2020-10-10","Household and community samples","Adults (18-64 years)",51.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.07,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W42","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-10-11","2020-10-17","Household and community samples","Adults (18-64 years)",59.0,0.017,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.003,0.09,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W43","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-10-18","2020-10-24","Household and community samples","Adults (18-64 years)",55.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.065,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W44","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-10-25","2020-10-31","Household and community samples","Adults (18-64 years)",56.0,0.018,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.003,0.094,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W45","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-11-01","2020-11-07","Household and community samples","Adults (18-64 years)",55.0,0.054,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.019,0.148,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W46","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-11-08","2020-11-14","Household and community samples","Adults (18-64 years)",52.0,0.019,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.003,0.101,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W47","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-11-15","2020-11-21","Household and community samples","Adults (18-64 years)",64.0,0.031,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.009,0.107,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W48","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-11-22","2020-11-28","Household and community samples","Adults (18-64 years)",85.0,0.035,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.012,0.099,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W49","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-11-29","2020-12-05","Household and community samples","Adults (18-64 years)",80.0,0.025,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.007,0.087,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W50","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-12-06","2020-12-12","Household and community samples","Adults (18-64 years)",106.0,0.009,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.002,0.052,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W51","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-12-13","2020-12-19","Household and community samples","Adults (18-64 years)",115.0,0.009,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.002,0.048,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W52","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-12-20","2020-12-26","Household and community samples","Adults (18-64 years)",65.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.056,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W53","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2020-12-27","2021-01-02","Household and community samples","Adults (18-64 years)",26.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.129,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W01","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-01-03","2021-01-09","Household and community samples","Adults (18-64 years)",12.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.242,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W02","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-01-10","2021-01-16","Household and community samples","Adults (18-64 years)",6.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.39,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W03","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-01-17","2021-01-23","Household and community samples","Adults (18-64 years)",5.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.435,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W04","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-01-24","2021-01-30","Household and community samples","Adults (18-64 years)",30.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.114,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W05","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-01-31","2021-02-06","Household and community samples","Adults (18-64 years)",110.0,0.027,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.009,0.077,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W06","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-02-07","2021-02-13","Household and community samples","Adults (18-64 years)",111.0,0.054,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.025,0.113,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W07","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-02-14","2021-02-20","Household and community samples","Adults (18-64 years)",69.0,0.072,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.031,0.159,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W08","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-02-21","2021-02-27","Household and community samples","Adults (18-64 years)",123.0,0.065,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.033,0.123,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W09","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-02-28","2021-03-06","Household and community samples","Adults (18-64 years)",132.0,0.023,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.008,0.065,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W10","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-03-07","2021-03-13","Household and community samples","Adults (18-64 years)",64.0,0.031,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.009,0.107,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W11","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-03-14","2021-03-20","Household and community samples","Adults (18-64 years)",104.0,0.067,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.033,0.132,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W12","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-03-21","2021-03-27","Household and community samples","Adults (18-64 years)",73.0,0.106,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.067,0.202,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W13","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-03-28","2021-04-03","Household and community samples","Adults (18-64 years)",60.0,0.083,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.036,0.181,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W14","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-04-04","2021-04-10","Household and community samples","Adults (18-64 years)",59.0,0.068,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.027,0.162,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W15","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-04-11","2021-04-17","Household and community samples","Adults (18-64 years)",29.0,0.138,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.055,0.306,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W16","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-04-18","2021-04-24","Household and community samples","Adults (18-64 years)",102.0,0.186,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.123,0.273,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W17","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-04-25","2021-05-01","Household and community samples","Adults (18-64 years)",109.0,0.229,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.16,0.317,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W18","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-05-02","2021-05-08","Household and community samples","Adults (18-64 years)",74.0,0.284,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.194,0.395,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W19","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-05-09","2021-05-15","Household and community samples","Adults (18-64 years)",52.0,0.269,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.168,0.404,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W20","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-05-16","2021-05-22","Household and community samples","Adults (18-64 years)",86.0,0.442,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.342,0.547,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W21","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-05-23","2021-05-29","Household and community samples","Adults (18-64 years)",93.0,0.495,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.395,0.594,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W22","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-05-30","2021-06-05","Household and community samples","Adults (18-64 years)",39.0,0.487,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.339,0.638,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W23","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-06-06","2021-06-12","Household and community samples","Adults (18-64 years)",68.0,0.603,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.484,0.711,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W24","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-06-13","2021-06-19","Household and community samples","Adults (18-64 years)",47.0,0.574,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.433,0.705,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W25","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-06-20","2021-06-26","Household and community samples","Adults (18-64 years)",44.0,0.727,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.582,0.807,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W26","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-06-27","2021-07-03","Household and community samples","Adults (18-64 years)",48.0,0.688,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.547,0.8,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W27","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-07-04","2021-07-10","Household and community samples","Adults (18-64 years)",12.0,0.583,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.32,0.807,1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W28","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-07-11","2021-07-17","Household and community samples","Adults (18-64 years)",2.0,1.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.342,1.0,1.0,1.0,"","FI",""
"2021-09-21","210815_Ethiopia_FederalMinistryofHealth_Overall_Adjusted","Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020","2021-08-15","National","","Ethiopia","2020-06-24","2020-07-08","Household and community samples","Multiple groups",16932.0,0.035,"Simplified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Enyew Birru Tadesse","Federal Ministry of Health","http://dx.doi.org/10.1016/j.ijid.2021.08.028","Verified",0.032,0.038,0.545,1.0,"","ET",""
"2021-09-21","210818_NewYork_SunRiverHealth","Covid-19 Sero-Prevalence and Risk Factors in a Sample of Community Health Center Employees in New York State","2021-08-18","Regional","","United States of America; New York","2020-07-15","2020-09-15","Health care workers and caregivers","Multiple groups",325.0,0.154,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Anne Kauffman Nolon","Sun River Health","http://dx.doi.org/10.1097/JOM.0000000000002357","Unverified","","","","","","US","US-NY"
"2021-09-21","210819_Managua_UniversityOfMichiganAnnArbor_Primary_PopAdj","Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection","2021-08-19","Local","","Nicaragua","2020-10-15","2020-11-15","Household and community samples","Multiple groups",1995.0,0.575,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Hannah E. Maier","University of Michigan, Ann Arbor","http://dx.doi.org/10.1093/cid/ciab717","Verified","","","","","","NI",""
"2021-09-21","210827_Belgium_UniversityofLiegeHospital_Overall","Systematic screening for SARS-CoV-2 S1/S2 antibodies helps to better assess the real incidence of COVID-19 in kidney transplant recipients","2021-08-27","National","","Belgium","2020-03-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",525.0,0.027,"Unclear","NR","IgG","Unclear","Presentation or Conference","Louis Firket","University of Liege Hospital","http://dx.doi.org/10.1111/tri.13944","Unverified","","","","","","BE",""
"2021-09-21","210827_Modena_UniversityofModenaandReggioEmilia_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies in the Northern Italy population before the COVID-19 second wave.","2021-08-27","Local","","Italy; Province of Modena; Modena","2020-06-01","2020-09-25","Multiple populations","Multiple groups",7561.0,0.047,"Self-referral","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Nausicaa Berselli","University of Modena and Reggio Emilia","https://dx.doi.org/10.13075/ijomeh.1896.01826","Unverified",0.042,0.052,"","","","IT","IT-45"
"2021-09-21","210910_Kazakhstan_KaragandaMedicalUniversity","Seroprevalence of anti-SARS-CoV-2 IgG and IgA antibodies before the launch of COVID-19 vaccination in Kazakhstan","2021-09-10","Local","","Kazakhstan; Karaganda; Karaganda","2021-04-01","2021-05-31","Non-essential workers and unemployed persons","Adults (18-64 years)",98.0,0.347,"Convenience","NR","IgA; IgG","High","Preprint","Irina Kadyrova","Karaganda Medical University","https://www.medrxiv.org/content/10.1101/2021.09.03.21262885v1.full-text","Unverified","","","","","","KZ","KZ-KAR"
"2021-09-21","210913_Belém_UniversidadeFederaldoPará","Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belem, Para, Amazonia, Brazil.","2021-09-13","Local","","Brazil; Pará State; Belém","2020-09-15","2021-01-15","Household and community samples","Multiple groups",101.0,0.832,"Entire sample","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hilton Pereira da Silva","Universidade Federal do Pará","https://dx.doi.org/10.1186/s12889-021-11696-7","Unverified","","","","","","BR","BR-PA"
"2021-09-21","210913_Delhi_MaulanaAzadMedicalCollege_PopTestAdj","Second wave of the Covid-19 pandemic in Delhi, India: high seroprevalence not a deterrent?","2021-09-13","Regional","","India; Delhi","2021-01-11","2021-01-22","Household and community samples","Multiple groups",27436.0,0.561,"Stratified probability","NR","IgG","Low","Preprint","Nandini Sharma","Maulana Azad Medical College","10.1101/2021.09.09.21263331","Verified",0.555,0.568,0.9,1.0,"","IN","IN-DL"
"2021-09-21","210913_Syria_ArabInternationalUniversity_Overall","Seropositivity of anti-SARS-CoV-2 IgG antibodies among asymptomatic and pauci-symptomatic students and staff at the Arab International University, Syria: a snapshot after a year of pandemic","2021-09-13","Local","","Syrian Arab Republic; Daraa Governorate; Ghabaghib","2021-02-17","2021-03-31","Household and community samples","Multiple groups",94.0,0.638,"Convenience","NR","IgG","High","Preprint","Wafika Zarzour","Arab International University","https://www.researchsquare.com/article/rs-885678/v1","Verified","","","","","","SY","SY-DR"
"2021-09-21","210914_Estonia_UniversityofTartu_overall","Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination.","2021-09-14","National","","Estonia","2021-02-08","2021-03-25","Residual sera","Multiple groups",2517.0,0.201,"Stratified non-probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Hiie Soeorg","University of Tartu","https://dx.doi.org/10.1080/23744235.2021.1974540","Verified",0.185,0.217,"","","","EE",""
"2021-09-21","210914_Louisville_UniversityofLouisville_July2020","Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky.","2021-09-14","Local","","United States of America; Kentucky; Louisville","2020-07-06","2020-07-20","Health care workers and caregivers","Adults (18-64 years)",915.0,0.023,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Krystal Hamorsky","University of Louisville","https://dx.doi.org/10.1038/s41598-021-97423-z","Unverified","","","","","","US","US-KY"
"2021-09-21","210915_Monterey_UniversityofCalifornia_Primary","Risk Factors Associated With SARS-CoV-2 Infection Among Farmworkers in Monterey County, California.","2021-09-15","Regional","","United States of America; California","2020-07-16","2020-11-30","Essential non-healthcare workers","Adults (18-64 years)",1058.0,0.19,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ana M. Mora","Universityof California,Berkeley","https://dx.doi.org/10.1001/jamanetworkopen.2021.24116","Unverified","","","","","","US","US-CA"
"2021-09-21","211001_Antananarivo_InstitutPasteurdeMadagascar_6March2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","","Madagascar","2021-03-01","2021-03-31","Blood donors","Adults (18-64 years)",497.0,0.499,"Sequential","NR","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified",0.455,0.543,1.0,0.944,"","MG",""
"2021-09-21","211001_Antananarivo_InstitutPasteurdeMadagascar_8May2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","","Madagascar","2021-05-01","2021-05-26","Blood donors","Adults (18-64 years)",500.0,0.648,"Sequential","NR","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified",0.561,0.726,1.0,0.944,"","MG",""
"2021-09-22","210616_Texas_UniversityofTexasatHouston_Overall","Estimated Prevalence of SARS-CoV-2 Antibodies in the Texas Pediatric Population, 2021","2021-06-16","Regional","","United States of America; Texas","2021-01-01","2021-06-01","Household and community samples","Children and Youth (0-17 years)",503.0,0.387,"Convenience","NR","IgM; IgA; IgG","Moderate","Preprint","Sarah Messiah","University of Texas at Houston","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3868061","Verified",0.345,0.431,0.995,0.998,"","US","US-TX"
"2021-09-22","210915_Netherlands_UniversityofAmsterdam_Wantai_Overall","Saliva SARS-CoV-2 Antibody Prevalence in Children.","2021-09-15","Local","","Netherlands; North Holland; Amsterdam","2020-04-12","2020-10-02","Residual sera","Children and Youth (0-17 years)",487.0,0.033,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Maya Keuning","University of Amsterdam","https://dx.doi.org/10.1128/Spectrum.00731-21","Verified",0.019,0.053,0.967,0.975,"","NL","NL-NH"
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_3December2020","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","","Madagascar","2020-12-01","2020-12-31","Blood donors","Adults (18-64 years)",177.0,0.22,"Sequential","NR","IgG","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified",0.166,0.287,"","","","MG",""
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_4January2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","","Madagascar","2021-01-01","2021-01-31","Blood donors","Adults (18-64 years)",389.0,0.447,"Sequential","NR","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified",0.399,0.497,1.0,0.944,"","MG",""
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_5February2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","","Madagascar","2021-02-01","2021-02-28","Blood donors","Adults (18-64 years)",319.0,0.505,"Sequential","NR","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Unverified",0.45,0.559,1.0,0.944,"","MG",""
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_7April2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","","Madagascar","2021-04-01","2021-04-30","Blood donors","Adults (18-64 years)",493.0,0.584,"Sequential","NR","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Unverified",0.54,0.627,1.0,0.944,"","MG",""
"2021-09-23","210909_Chile_UniversidaddeChile","Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.","2021-09-09","National","","Chile","2021-03-12","2021-07-02","Household and community samples","Multiple groups",54261.0,0.528,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Denis Saure","Universidad de Chile","https://dx.doi.org/10.1016/S1473-3099(21)00479-5","Unverified","","","","","","CL",""
"2021-09-23","210910_SouthWales_PublicHealthWales","The protective effect of previous COVID-19 infection in a high-prevalence hospital setting.","2021-09-10","Regional","","United Kingdom of Great Britain and Northern Ireland; Wales","2020-06-02","2020-07-07","Health care workers and caregivers","Adults (18-64 years)",276.0,0.388,"Convenience","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Favian Narrainen","Public Health Wales Microbiology","https://dx.doi.org/10.7861/clinmed.2021-0225","Unverified","","","","","","GB","GB-WLS"
"2021-09-24","210413_Verona_UniversityofVerona_IgAorIgG_Overall","SARS-CoV-2 infection: A potential trigger of inflammatory neurological disorders","2021-04-13","Local","","Italy","2020-03-01","2020-08-31","Residual sera","Multiple groups",332.0,0.078,"Convenience","NR","IgG; IgA","High","Presentation or Conference","Cecilia Zivelonghi","University of Verona","https://n.neurology.org/content/96/15_Supplement/4295","Unverified","","","","","","IT",""
"2021-09-24","210729_SouthernUSA_WalterReedArmyInstituteOfResearch_Timepoint3","Serological and RT-PCR Surveillance for COVID-19 in an Asymptomatic US Army Trainee Population.","2021-07-29","Local","","United States of America; Southern United States; NR","2020-11-18","2021-01-03","Essential non-healthcare workers","Adults (18-64 years)",1211.0,0.095,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Shilpa Hakre","Walter Reed Army Institute of Research","https://dx.doi.org/10.1093/ofid/ofab407","Unverified",0.079,0.112,"","","","US",""
"2021-09-24","210826_Dublin_MaterMisericordiaeUniversityHospital","Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.","2021-08-26","Local","","Ireland","2020-06-24","2020-07-06","Multiple populations","Multiple groups",157.0,0.064,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Brendan O'Kelly","Mater Misericordiae University Hospital","https://dx.doi.org/10.3389/fmed.2021.642318","Unverified","","","","","","IE",""
"2021-09-24","210903_Maharashtra_ICMR-NationalInstituteOfImmunohematology","Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection.","2021-09-03","Regional","","India; Maharashtra; Dombivli","2020-07-21","2020-08-03","Health care workers and caregivers","Adults (18-64 years)",500.0,0.11,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Reetika Malik Yadav","ICMR-National Institute of Immunohematology","https://dx.doi.org/10.2991/jegh.k.210518.001","Unverified","","","","","","IN","IN-MH"
"2021-09-24","210918_Chandigarh_GovernmentMedicalCollegeandHospital_overall","Sero survey: 80% of Chandigarh’s adults have Covid antibodies","2021-09-18","Local","","India; Punjab; Chandigarh","2021-07-01","2021-07-31","Household and community samples","Adults (18-64 years)",1200.0,0.802,"Simplified probability","NR","Not reported","Unclear","News and Media","Hindustan Times Correspondent","Government Medical College and Hospital","https://www.hindustantimes.com/cities/chandigarh-news/sero-survey-80-of-chandigarh-s-adults-have-covid-antibodies-101631914347989.html","Verified","","","","","","IN","IN-PB"
"2021-09-27","201013_Stockholm_TheStockholmRegion","13 oktober: Lägesrapport om covid-19","2020-10-13","Local","","Sweden","2020-10-05","2020-10-11","Household and community samples","Multiple groups",11065.0,0.152,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/13-oktober-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-09-27","201020_Stockholm_TheStockholmRegion","20 oktober: Lägesrapport om covid-19","2020-10-20","Local","","Sweden","2020-10-12","2020-10-18","Household and community samples","Multiple groups",10297.0,0.154,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/20-oktober-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-09-27","201027_Stockholm_TheStockholmRegion","27 oktober: Lägesrapport om covid-19","2020-10-27","Local","","Sweden","2020-10-19","2020-10-25","Household and community samples","Multiple groups",8941.0,0.206,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/27-oktober-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-09-27","210908_Italy_UniversityofFlorence_Players","Soccer in the time of COVID-19: One year report from an Italian top league club, March 2020 - February 2021","2021-09-08","Local","","Italy","2020-05-14","2020-05-15","Non-essential workers and unemployed persons","Adults (18-64 years)",27.0,0.67,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Michele Spinicci","University of Florence","http://dx.doi.org/10.1017/S0950268821002065","Unverified","","","","","","IT",""
"2021-09-27","210908_Italy_UniversityofFlorence_Staff","Soccer in the time of COVID-19: One year report from an Italian top league club, March 2020 - February 2021","2021-09-08","Local","","Italy","2020-05-14","2020-05-15","Non-essential workers and unemployed persons","Adults (18-64 years)",26.0,0.65,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Michele Spinicci","University of Florence","http://dx.doi.org/10.1017/S0950268821002065","Unverified","","","","","","IT",""
"2021-09-27","210920_Dublin_UniversityCollegeDublin_overall","Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study.","2021-09-20","Local","","United Kingdom of Great Britain and Northern Ireland; Ireland; Dublin","2020-05-04","2020-05-15","Pregnant or parturient women","Adults (18-64 years)",598.0,0.017,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Kate Glennon","University College Dublin","https://dx.doi.org/10.1371/journal.pone.0253090","Verified",0.008,0.031,"","","","GB",""
"2021-09-27","211103_Stockholm_TheStockholmRegion","3 november: Lägesrapport om covid-19","2020-11-03","Local","","Sweden","2020-10-26","2020-11-01","Household and community samples","Multiple groups",9580.0,0.217,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/3-november-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-09-28","210826_FaroeIslands_UniversityoftheFaroeIslands_TestAdjusted","Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020","2021-08-26","National","","Faroe Islands","2020-05-01","2020-09-15","Contacts of COVID patients","Multiple groups",584.0,0.053,"Entire sample","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Maria Petersen","University of the Faroe Islands","https://wwwnc.cdc.gov/eid/article/27/11/20-4948_article","Unverified",0.035,0.075,0.967,0.995,"","FO",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_1-6","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Children and Youth (0-17 years)",55.0,0.109,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.041,0.169,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_14-17","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Children and Youth (0-17 years)",182.0,0.176,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.123,0.239,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_18-29","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",399.0,0.055,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.035,0.082,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_30-39","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",388.0,0.049,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.03,0.08,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_40-49","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",391.0,0.097,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.07,0.131,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_50-59","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",409.0,0.076,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.052,0.106,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_60-69","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Multiple groups",376.0,0.08,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.054,0.112,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_7-13","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Children and Youth (0-17 years)",151.0,0.086,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.047,0.143,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_70+","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Seniors (65+ years)",377.0,0.148,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.114,0.188,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_Overall","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Multiple groups",2728.0,0.091,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.08,0.102,"","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase2-Stage3_Overall","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Multiple groups",1651.0,0.31,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified",0.288,0.333,"","","","RU",""
"2021-09-28","210901_Petropolis_SociedadeFrancoBrasileiradeOncologia_baseline","1603P SARS-CoV-2 seroconversion among oncology healthcare workers in Brazil","2021-09-01","Local","","Brazil","2020-04-09","2020-04-29","Health care workers and caregivers","Adults (18-64 years)",60.0,0.05,"Convenience","NR","IgG; IgM","High","Presentation or Conference","Carla Ismael","Sociedade Franco Brasileira de Oncologia (SFBO)","http://dx.doi.org/10.1016/j.annonc.2021.08.1596","Unverified","","","","","","BR",""
"2021-09-28","210901_Petropolis_SociedadeFrancoBrasileiradeOncologia_followup","1603P SARS-CoV-2 seroconversion among oncology healthcare workers in Brazil","2021-09-01","Local","","Brazil","2020-11-05","2020-12-28","Health care workers and caregivers","Adults (18-64 years)",60.0,0.1,"Convenience","NR","IgG","High","Presentation or Conference","Carla Ismael","Sociedade Franco Brasileira de Oncologia (SFBO)","http://dx.doi.org/10.1016/j.annonc.2021.08.1596","Unverified","","","","","","BR",""
"2021-09-28","210914_Denmark_OdenseUniversityTestAdj","SARS-CoV-2 seroprevalence among 7,950 health-care workers in the Region of Southern Denmark. (THEIJID-D-21-01420R1).","2021-09-14","Regional","","Denmark; Region of Southern Denmark","2020-05-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",7950.0,0.014,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Sebastian von Huth","Odense University","https://dx.doi.org/10.1016/j.ijid.2021.09.023","Unverified",0.01,0.018,0.78,0.993,"","DK","DK-83"
"2021-09-28","210915_Wuhan_HubeiProvincialHospital_AgeSexAdj","Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.","2021-09-15","Local","","China; Hubei; Wuhan","2020-03-25","2020-04-28","Multiple populations","Multiple groups",18712.0,0.032,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","LING Rui Jie","Hubei Provincial Hospital","https://dx.doi.org/10.3967/bes2021.103","Verified",0.029,0.034,"","","","CN","CN-42"
"2021-09-28","210916_Augsburg_UniversityHospitalofAugsburg_HCW","Evaluation of the ESGE recommendations for COVID-19 pre-endoscopy risk-stratification in a high-volume center in Germany.","2021-09-16","Local","","Germany; Bavaria; Augsburg","2020-12-24","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",43.0,0.023,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Stephan Zellmer","University Hospital of Augsburg","https://dx.doi.org/10.1055/a-1526-1169","Unverified","","","","","","DE","DE-BY"
"2021-09-28","210916_MexicoCity_UniversidadNacionalAutónomaDeMéxico_Primary","SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.","2021-09-16","Local","","Mexico","2020-09-21","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",169.0,0.207,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Fatima Sofía Magana-Guerrero","Universidad Nacional Autónoma De México","https://dx.doi.org/10.1080/09286586.2021.1974493","Unverified","","","","","","MX",""
"2021-09-28","210920_Genoa_UniversitàdegliStudidiGenova_overall","Incidence and Immunomic Features of Apyretic COVID-19 in Patients Affected by Solid Tumors: A Prospective Cohort Study","2021-09-20","Local","","Italy; Liguria; Genoa","2020-04-14","2020-08-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",446.0,0.031,"Convenience","NR","IgG; IgM","High","Preprint","Francesco Ravera","Università degli Studi di Genova","https://www.researchsquare.com/article/rs-864803/v1","Unverified","","","","","","IT","IT-42"
"2021-09-28","210921_Andorra_HospitalNostraSenyoradeMeritxell_November","1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study)","2021-09-21","Local","","Andorra","2020-11-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",156.0,0.064,"Convenience","NR","Not reported","High","Presentation or Conference","C Royo-Cebrecos","Hospital Nostra Senyora de Meritxell","http://dx.doi.org/10.1016/j.annonc.2021.08.1594","Unverified","","","","","","AD",""
"2021-09-28","210922_Flanders_GhentUniversity_residents","Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.","2021-09-22","Regional","","Belgium; Flanders; Wingene, Liedekerke, Assenede, Wetteren","2020-08-01","2020-08-31","Assisted living and long-term care facilities","Seniors (65+ years)",199.0,0.302,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Eline Meyers","Ghent University","https://dx.doi.org/10.1128/Spectrum.00178-21","Unverified","","","","","","BE","BE-VLG"
"2021-09-28","210922_Flanders_GhentUniversity_staff","Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.","2021-09-22","Regional","","Belgium; Flanders; Wingene, Liedekerke, Assenede, Wetteren","2020-08-01","2020-08-31","Assisted living and long-term care facilities","Adults (18-64 years)",241.0,0.286,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Eline Meyers","Ghent University","https://dx.doi.org/10.1128/Spectrum.00178-21","Unverified","","","","","","BE","BE-VLG"
"2021-09-29","210610_Vietnam_TheUniversityOfSydney_GenPop1_Female","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","National","","Viet Nam; Hanoi Capital, Quang Nam Province, Da Nang Province; Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang","2020-09-04","2020-11-23","Household and community samples","Multiple groups",1410.0,0.005,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","",0.968,0.998,"","VN",""
"2021-09-29","210610_Vietnam_TheUniversityOfSydney_GenPop1_Male","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","National","","Viet Nam; Hanoi Capital, Quang Nam Province, Da Nang Province; Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang","2020-09-04","2020-11-23","Household and community samples","Multiple groups",1624.0,0.004,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","",0.968,0.998,"","VN",""
"2021-09-29","210731_Wisconsin_CentersforDiseaseControlandPrevention_1September","Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti-SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September-November 2020.","2021-07-31","Regional","","United States of America; Wisconsin","2020-09-01","2020-09-04","Students and Daycares","Adults (18-64 years)",517.0,0.041,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hannah Segaloff","Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/ofid/ofab405","Unverified","","","","","","US","US-WI"
"2021-09-29","210731_Wisconsin_CentersforDiseaseControlandPrevention_2November","Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti-SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September-November 2020.","2021-07-31","Regional","","United States of America; Wisconsin","2020-11-09","2020-11-13","Students and Daycares","Adults (18-64 years)",413.0,0.186,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hannah Segaloff","Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/ofid/ofab405","Unverified","","","","","","US","US-WI"
"2021-09-29","210901_Switzerland_KantonsspitalStGallen","Anti-S1 antibodies after vaccination with anti SARS-CoV-2 mRNA vaccines in patients with rheumatoid arthritis differ in magnitude and kinetics from healthy controls: Results from a prospective, observational controlled study","2021-09-01","Local","","Switzerland; St. Gallen; St. Gallen","2021-01-10","2021-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",77.0,0.052,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Andrea Rubbert-Roth","Kantonsspital St. Gallen","https://smw.ch/article/doi/SMW.2021.w30056","Unverified","","","","","","CH",""
"2021-09-29","210903_Grisons_CantonalHospitalGrisons","Seroconversion for SARS-COV-2 in health care workers after the first and the second wave of COVID-19 in the canton of Grisons in Switzerland","2021-09-03","Regional","","Switzerland; Canton of Grisons","2020-06-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",5109.0,0.093,"Convenience","NR","Not reported","High","Presentation or Conference","Katarzyna Szajek","Cantonal Hospital Grisons","https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf","Unverified","","","","","","CH",""
"2021-09-29","210917_Gussago_FondazionePoliambulanzaHospital","Antibody response after bnt162b2 vaccination in healthcare workers previously exposed and not exposed to sars-cov-2","2021-09-17","Local","","Italy; Brescia; Gussago","2021-01-01","2021-04-01","Health care workers and caregivers","Adults (18-64 years)",337.0,0.38,"Unclear","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Marcello Salvaggio","Fondazione Poliambulanza Hospital","http://dx.doi.org/10.3390/jcm10184204","Unverified","","","","","","IT","IT-25"
"2021-09-29","210921_USA_CityUniversityofNewYork_Overall","Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA-the CHASING COVID Cohort study.","2021-09-21","National","","United States of America","2020-05-15","2020-08-15","Household and community samples","Multiple groups",4459.0,0.068,"Convenience","NR","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","McKaylee Robertson","City University of New York","https://dx.doi.org/10.1136/bmjopen-2021-048778","Verified",0.061,0.076,1.0,1.0,"","US",""
"2021-10-04","201110_Stockholm_TheStockholmRegion","10 november: Lägesrapport om covid-19","2020-11-10","Local","","Sweden","2020-11-02","2020-11-08","Household and community samples","Multiple groups",11500.0,0.259,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/10-november-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-04","201117_Stockholm_TheStockholmRegion","17 november: Lägesrapport om covid-19","2020-11-17","Local","","Sweden","2020-11-09","2020-11-15","Household and community samples","Multiple groups",13273.0,0.278,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/17-november-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-04","201124_Stockholm_TheStockholmRegion","24 november: Lägesrapport om covid-19","2020-11-24","Local","","Sweden","2020-11-16","2020-11-22","Household and community samples","Multiple groups",15474.0,0.314,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/24-november-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-04","201201_Stockholm_TheStockholmRegion","1 december: Lägesrapport om covid-19","2020-12-01","Local","","Sweden","2020-11-23","2020-11-29","Household and community samples","Multiple groups",16389.0,0.336,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/1-december-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-04","201208_Stockholm_TheStockholmRegion","8 december: Lägesrapport om covid-19","2020-12-08","Local","","Sweden","2020-11-30","2020-12-06","Household and community samples","Multiple groups",16943.0,0.367,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/8-december-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-04","210926_RiodeJaneiro_OswaldoCruzFoundation_Primary","P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL","2021-09-26","Local","","Brazil; Rio de Janeiro; Rio de Janeiro","2020-01-07","2021-01-11","Pregnant or parturient women","Adults (18-64 years)",31.0,0.194,"Unclear","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Alanna Calheiros Santos","Oswaldo Cruz Foundation","http://dx.doi.org/10.1016/j.aohep.2021.100450","Verified","","","","","","BR","BR-RJ"
"2021-10-05","210902_USA_VitalantResearchInstitute_202007_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2020-07-01","2020-07-31","Blood donors","Multiple groups",116513.0,0.037,"Simplified probability","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.034,0.04,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202008_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2020-08-01","2020-08-31","Blood donors","Multiple groups",123200.0,0.048,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.046,0.051,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202009_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2020-09-01","2020-09-30","Blood donors","Multiple groups",131052.0,0.05,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.048,0.053,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202010_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2020-10-01","2020-10-31","Blood donors","Multiple groups",131731.0,0.059,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.057,0.062,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202011_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2020-11-01","2020-11-30","Blood donors","Multiple groups",134061.0,0.082,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.079,0.085,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202012_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2020-12-01","2020-12-31","Blood donors","Multiple groups",135026.0,0.119,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.115,0.122,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202101_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2021-01-01","2021-01-31","Blood donors","Multiple groups",134632.0,0.205,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.202,0.209,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202102_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2021-02-01","2021-02-28","Blood donors","Multiple groups",133288.0,0.335,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.331,0.339,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202103_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2021-03-01","2021-03-31","Blood donors","Multiple groups",134557.0,0.492,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.487,0.496,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202104_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2021-04-01","2021-04-30","Blood donors","Multiple groups",134510.0,0.714,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.711,0.718,"","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202105_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","","United States of America","2021-05-01","2021-05-31","Blood donors","Multiple groups",134949.0,0.833,"Simplified probability","","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified",0.829,0.837,"","","","US",""
"2021-10-05","210909_Milan_FondazioneIRCCSCa’GrandaOspedaleMaggiorePoliclinico","Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area.","2021-09-09","Local","","Italy","2020-04-20","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",109.0,0.184,"Convenience","NR","IgG; IgA","High","Journal Article (Peer-Reviewed)","Luca Elli","Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico","https://dx.doi.org/10.1016/j.dld.2021.08.027","Unverified","","","","","","IT",""
"2021-10-05","210913_UnitedStates_AirForceResearchLaboratory","COVID-19 Seroprevalence and Active Infection in an Asymptomatic Population.","2021-09-13","Local","","United States of America; Ohio","2020-07-23","2020-10-23","Household and community samples","Multiple groups",582.0,0.031,"Convenience","NR","IgM; IgG; IgA","High","Journal Article (Peer-Reviewed)","Amy Breedon","Air Force Research Laboratory, Wright-Patterson Air Force Base","https://dx.doi.org/10.3389/fmed.2021.749732","Verified","","","","","","US","US-OH"
"2021-10-05","210919_India_TataMainHospital_Jul2021_Primary","Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India.","2021-09-19","Local","","India; Jharkhand","2021-07-01","2021-07-31","Multiple populations","Multiple groups",4575.0,0.75,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Deb Sanjay Nag","Tata Main Hospital","https://dx.doi.org/10.7759/cureus.18097","Verified","","",1.0,1.0,"","IN","IN-JH"
"2021-10-05","210920_Egypt_AssiutUniversity_Overall","Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt.","2021-09-20","National","","Egypt; Ash Sharqiyah, Asyut; Zagazig, Assiut","2020-10-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",82.0,0.463,"Unclear","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Rehab El-Sokkary","Assiut University","https://dx.doi.org/10.1016/j.jiph.2021.09.011","Unverified","","","","","","EG",""
"2021-10-05","210920_Peru_UniversidadAndinadelCusco_OverallPopAdj","SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study","2021-09-20","Regional","","Peru; Cusco Region","2020-09-12","2020-09-27","Household and community samples","Multiple groups",1924.0,0.331,"Simplified probability","NR","Total Antibody","Low","Journal Article (Peer-Reviewed)","Charles Huamani","Universidad Andina del Cusco","http://dx.doi.org/10.7717/peerj.12149","Verified",0.301,0.364,0.967,0.986,"","PE","PE-CUS"
"2021-10-05","210922_EspiritoSanto_LaboratoriodeEpidemiologia_Overall","COVID-19 in children, adolescents and young adults: a cross-sectional study in Espirito Santo, Brazil, 2020.","2021-09-22","Regional","","Brazil; Espirito Santo; Colatina, Linhares, São Mateus, Afonso Cláudio, Nova Venécia, Cachoeiro de Itapemirim, Alegre, Vila Velha, Cariacica, Serra, Vitória","2020-05-10","2020-06-21","Household and community samples","Children and Youth (0-17 years)",1693.0,0.061,"Stratified probability","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Ethel Leonor Noia Maciel","Laboratorio de Epidemiologia","https://dx.doi.org/10.1590/S1679-49742021000400001","Verified","","",0.864,0.996,"","BR","BR-ES"
"2021-10-05","210922_Madinah_TaibahUniversity_children1_primary","Assessment of SARS-CoV-2 anti-spike IgG antibody in women and children in Madinah, Saudi Arabia: A single-center study","2021-09-22","Local","","Saudi Arabia","2021-01-15","2021-04-15","Residual sera","Children and Youth (0-17 years)",332.0,0.587,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Waleed Mahallawi","Taibah University","http://dx.doi.org/10.3390/ijerph18199971","Verified","","",0.987,0.984,"","SA",""
"2021-10-05","210922_Madinah_TaibahUniversity_women2","Assessment of SARS-CoV-2 anti-spike IgG antibody in women and children in Madinah, Saudi Arabia: A single-center study","2021-09-22","Local","","Saudi Arabia","2021-01-15","2021-04-15","Residual sera","Adults (18-64 years)",247.0,0.502,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Waleed Mahallawi","Taibah University","http://dx.doi.org/10.3390/ijerph18199971","Verified","","",0.987,0.984,"","SA",""
"2021-10-05","210922_PimpriChinchwad_DrDYPatilVidyapeeth_Overall","Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity?.","2021-09-22","Local","","India; Maharashtra; Pimpri-Chinchwad","2020-10-07","2020-10-17","Household and community samples","Multiple groups",5000.0,0.34,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Amitav Banerjee","Dr. D. Y. Patil Medical College, Hospital and Research Centre","https://www.ijph.in/article.asp?issn=0019-557X;year=2021;volume=65;issue=3;spage=256;epage=260;aulast=Banerjee","Verified",0.313,0.368,0.927,0.999,"","IN","IN-MH"
"2021-10-05","210923_Kashmir_GovernmentMedicalCollegeSrinagar_PopAndTestAdjusted","Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.","2021-09-23","Regional","","India; Kashmir","2020-10-17","2020-11-04","Household and community samples","Multiple groups",6230.0,0.367,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Muhammad Khan","Government Medical College Srinagar","https://dx.doi.org/10.1136/bmjopen-2021-053791","Verified",0.343,0.392,1.0,0.996,"","IN","IN-JK"
"2021-10-05","210929_Islamabad_NationalInstituteofHealth_Overall","Prevalence of SARS-CoV-2: An age-stratified, population-based, seroepidemiological survey in Islamabad, Pakistan","2021-09-29","Local","","Pakistan; Islamabad Capital Territory; Islamabad","2020-06-01","2020-06-30","Household and community samples","Multiple groups",6333.0,0.163,"Stratified probability","NR","IgG; IgM","Moderate","Preprint","Mirza Amir Baig","National Institute of Health","https://www.medrxiv.org/content/10.1101/2021.09.27.21264003v1.article-info","Verified","","","","","","PK","PK-IS"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-05_to_2020-06_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","","Iran (Islamic Republic of); Tehran; Tehran","2020-05-01","2020-06-30","Household and community samples","Multiple groups",573.0,0.098,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-07_to_2020-08_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","","Iran (Islamic Republic of); Tehran; Tehran","2020-07-01","2020-08-31","Household and community samples","Multiple groups",1221.0,0.204,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-09_to_2020-10_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","","Iran (Islamic Republic of); Tehran; Tehran","2020-09-01","2020-10-31","Household and community samples","Multiple groups",1387.0,0.337,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-11_to_2020-12_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","","Iran (Islamic Republic of); Tehran; Tehran","2020-11-01","2020-12-31","Household and community samples","Multiple groups",1074.0,0.458,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2021-01_to_2021-02_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","","Iran (Islamic Republic of); Tehran; Tehran","2021-01-01","2021-02-28","Household and community samples","Multiple groups",294.0,0.36,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2021-03_to_2021-04_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","","Iran (Islamic Republic of); Tehran; Tehran","2021-03-01","2021-04-30","Household and community samples","Multiple groups",367.0,0.251,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","",0.941,0.983,"","IR","IR-07"
"2021-10-06","210920_France_ToulouseUniversityHospital","Antibody titers and protection against a SARS-CoV-2 infection.","2021-09-21","National","","France","2020-06-10","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",8758.0,0.032,"Unclear","NR","Total Antibody","Unclear","Journal Article (Peer-Reviewed)","Chloe Dimeglio","Tolouse University Hospital","https://dx.doi.org/10.1016/j.jinf.2021.09.013","Verified","","","","","","FR",""
"2021-10-06","210924_BneiBrak_MayaneiHayeshuaMedicalCenter_primary","Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy.","2021-09-24","Local","","Israel; Tel Aviv District; Bnei Brak","2021-02-28","2021-03-08","Pregnant or parturient women","Adults (18-64 years)",21.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Lior Kashani-Ligumsky","Mayanei Hayeshua Medical Center","https://dx.doi.org/10.1038/s41372-021-01216-1","Unverified","","","","","","IL","IL-TA"
"2021-10-06","210927_AbuDhabi_SEHAAbuDhabiHealthServicesCompany","An Analysis Of Antibody Responses And Clinical Sequalae Of The Sinopharm HB02 COVID19 Vaccine In Dialysis Patients In The UAE.","2021-09-27","Local","","United Arab Emirates","2021-01-25","2021-03-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",446.0,0.17,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Stephen Holt","SEHA Abu Dhabi Health Services Company","https://dx.doi.org/10.1111/nep.13980","Unverified","","","","","","AE",""
"2021-10-06","210928_HyogoPrefecture_KobeUniversity_Primary_NAntigens","Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021a","2021-09-28","Local","","Japan","2021-07-19","2021-08-06","Residual sera","Multiple groups",1000.0,0.021,"Convenience","NR","Not reported","Moderate","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2021.09.26.21264129v1.full-text","Verified","","","","","","JP",""
"2021-10-06","210928_HyogoPrefecture_KobeUniversity_Primary_SAntigens","Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021a","2021-09-28","Local","","Japan","2021-07-19","2021-08-06","Residual sera","Multiple groups",1000.0,0.387,"Convenience","NR","IgG","Moderate","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2021.09.26.21264129v1.full-text","Verified","","","","","","JP",""
"2021-10-06","210929_Atahualpa_StonyBrookUniversity_April2021_primary","Body Composition in Community-Dwelling Older Adults Before and After SARS-CoV-2 Infection: A Longitudinal Prospective Study in a Rural Village Struck by the Pandemic.","2021-09-29","Local","","Ecuador","2021-04-01","2021-04-30","Household and community samples","Multiple groups",277.0,0.632,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Stony Brook University","https://dx.doi.org/10.1177/21501327211047781","Verified","","","","","","EC",""
"2021-10-06","210929_CasolaDiNapoli_UniversityOfSalerno_Overall","Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: a cohort study.","2021-09-29","Local","","Italy; Naples; City of Napoli","2020-06-25","2020-07-12","Household and community samples","Multiple groups",2738.0,0.014,"Self-referral","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Carmine Coppola","University of Salerno","https://dx.doi.org/10.1111/jvh.13623","Verified","","","","","","IT","IT-72"
"2021-10-07","210901_China_SouthernMedicalUniversity_GuangdongHCW4","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","","China; Guangdong; Guangzhou, Foshan","2020-03-01","2020-03-15","Health care workers and caregivers","Adults (18-64 years)",260.0,0.012,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","",0.83,1.0,"","CN","CN-44"
"2021-10-07","210901_China_SouthernMedicalUniversity_GuangdongPatients2","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","","China; Guangdong; Guangzhou and Foshan","2020-03-01","2020-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",563.0,0.028,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","",0.83,1.0,"","CN","CN-44"
"2021-10-07","210901_China_SouthernMedicalUniversity_HubeiHCW3","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","","China; Hubei province; Honghu and Jingzhou","2020-03-01","2020-03-15","Health care workers and caregivers","Adults (18-64 years)",2945.0,0.012,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","",0.83,1.0,"","CN","CN-42"
"2021-10-07","210901_China_SouthernMedicalUniversity_HubeiPatients1","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","","China; Hubei province; Honghu and Jingzhou","2020-03-01","2020-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",978.0,0.036,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","",0.83,1.0,"","CN","CN-42"
"2021-10-07","210924_Michigan_UniversityOfMichigan_AfterDec14_Overall","Understanding the patterns of serological testing for covid-19 pre-and post-vaccination rollout in michigan","2021-09-24","Local","","United States of America; Michigan","2020-12-14","2021-05-03","Household and community samples","Multiple groups",2024.0,0.362,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zhangchen Zhao","University of Michigan","http://dx.doi.org/10.3390/jcm10194341","Verified","","","","","","US","US-MI"
"2021-10-07","210924_Michigan_UniversityOfMichigan_BeforeDec14_Overall","Understanding the patterns of serological testing for covid-19 pre-and post-vaccination rollout in michigan","2021-09-24","Local","","United States of America; Michigan","2020-04-27","2020-12-13","Household and community samples","Multiple groups",8026.0,0.092,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Zhangchen Zhao","University of Michigan","http://dx.doi.org/10.3390/jcm10194341","Verified","","","","","","US","US-MI"
"2021-10-12","210902_Nairobi_WashingtonStateUniversity_TestAdjPopAdj","High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya","2021-09-02","Local","","Kenya","2020-11-02","2020-11-23","Household and community samples","Multiple groups",1164.0,0.347,"Simplified probability","NR","IgM; IgG","Low","Journal Article (Peer-Reviewed)","Isaac Ngere","Washington State University","https://dx.doi.org/10.1016/j.ijid.2021.08.062","Verified",0.318,0.376,0.944,1.0,"","KE",""
"2021-10-12","210905_Razarbag_BRACUniversity_GroupII_Overall","Assessment of a rapid pan-antibody dot test for detection of antibodies against SARS-CoV-2","2021-09-05","Local","","Bangladesh; Dhaka District; Dhaka","2020-05-15","2020-06-15","Residual sera","Multiple groups",100.0,0.2,"Stratified non-probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Md Ahsanul Haq","BRAC University","http://dx.doi.org/10.3329/BJMS.V20I5.55407","Verified","","","",0.96,"","BD",""
"2021-10-12","210925_Hamburg_UniversityMedicalCenterHamburg-Eppendorf","Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.","2021-09-25","Local","","Germany","2021-05-11","2021-05-31","Health care workers and caregivers","Adults (18-64 years)",872.0,0.927,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Thomas Theo Brehm","the University Medical Center Hamburg-Eppendorf","https://dx.doi.org/10.1016/j.ijheh.2021.113851","Unverified","","",0.998,1.0,"","DE",""
"2021-10-12","210927_Hanoi_NationalCenterforGlobalHealthandMedicine_primary","Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam.","2021-09-27","Local","","Viet Nam","2020-06-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",1243.0,0.002,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Shoko Matsumoto","National Center for Global Health and Medicine","https://dx.doi.org/10.1007/s10461-021-03464-w","Unverified","","","","","","VN",""
"2021-10-12","210929_England_PublicHealthEngland_Overall","Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England.","2021-09-29","National","","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-07-23","Students and Daycares","Multiple groups",2179.0,0.14,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Georgina Ireland","Public Health England","https://dx.doi.org/10.1016/j.eclinm.2021.101150","Unverified","","","","","","GB","GB-ENG"
"2021-10-12","211001_UnitedStates_OchsnerHealth","Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients.","2021-10-01","Local","","United States of America; Louisiana; New Orleans","2020-03-01","2020-05-01","Multiple populations","Adults (18-64 years)",13343.0,0.08,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Edmond Kabagambe","Ochsner Health","https://dx.doi.org/10.1016/j.amjms.2021.09.006","Unverified",0.075,0.084,1.0,0.996,"","US","US-LA"
"2021-10-12","211002_UnitedStates_CohenChildrensMedicalCenter","Seroprevalence and Clinical Outcomes of SARS-CoV-2 in Paediatric Patients with Rheumatic Disease.","2021-10-02","Local","","United States of America; New York; New York City","2020-05-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",262.0,0.13,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Heather Walters","Cohen Children’s Medical Center,","https://dx.doi.org/10.1093/rheumatology/keab730","Unverified","","","","","","US","US-NY"
"2021-10-12","211004_Lombardy_UniversityOfPavia","SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red Zone.","2021-10-04","Regional","","Italy; Lombardy","2020-06-15","2021-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",93.0,0.13,"Unclear","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Syed M A Ahmed","University Of Pavia","https://dx.doi.org/10.1111/jdv.17721","Unverified","","","","","","IT","IT-25"
"2021-10-12","211005_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall","Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study.","2021-10-05","Local","","India; Delhi; New Delhi","2020-01-01","2021-02-26","Household and community samples","Adults (18-64 years)",352.0,0.452,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Alpesh Goyal","All India Institute of Medical Sciences","https://dx.doi.org/10.1007/s13300-021-01158-z","Unverified","","",0.974,0.985,"","IN","IN-DL"
"2021-10-12","211006_Israel_IsraelInstituteforBiologicalResearch","A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.","2021-10-06","National","","Israel","2020-04-24","2020-04-24","Household and community samples","Multiple groups",146.0,0.0,"Convenience","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Morly Fisher","Israel Institute for Biological Research","https://dx.doi.org/10.1128/Spectrum.00870-21","Verified","","",0.982,1.0,"","IL",""
"2021-10-13","210901_Potheri_SRMInstituteofScienceandTechnology_Group1_Overall","COVID-19 seroprevalence study in asymptomatic healthcare workers, at a tertiary healthcare centre, India","2021-09-01","Local","","India; Tamil Nadu; Potheri","2021-01-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",82.0,0.098,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Bhuvanamha Ramamurthy","SRM Institute of Science and Technology","https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422","Unverified","","","","","","IN","IN-TN"
"2021-10-13","210901_Potheri_SRMInstituteofScienceandTechnology_Group2_Overall","COVID-19 seroprevalence study in asymptomatic healthcare workers, at a tertiary healthcare centre, India","2021-09-01","Local","","India; Tamil Nadu; Potheri","2021-01-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",46.0,0.13,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Bhuvanamha Ramamurthy","SRM Institute of Science and Technology","https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422","Unverified","","","","","","IN","IN-TN"
"2021-10-13","210927_Karachi_AgaKhanUniversityandHospital_primary","Increasing IgG antibodies to SARS-CoV-2 in asymptomatic blood donors through the second COVID-19 wave in Karachi associated with exposure and immunity in the population","2021-09-27","Local","","Pakistan","2020-12-15","2021-02-14","Blood donors","Multiple groups",558.0,0.534,"Convenience","NR","IgG","High","Preprint","Muhammad Hasan","The Aga Khan University and Hospital","https://www.researchsquare.com/article/rs-941908/v1","Verified","","","","","","PK",""
"2021-10-13","211001_Colombia_MedicalMissionInstitute_Overall","Direct and indirect proof of sars-cov-2 infections in indigenous wiwa communities in north-eastern colombia-a cross-sectional assessment providing preliminary surveillance data","2021-10-01","Regional","","Colombia; Department of Cesar, Department of La Guajira; San Juan, Sabana de Higuieron, Piñoncito, Ahuyamal, Surimena, Tezhumake, Valledupar, La Junta, Atanquez, Los Corazones, Patillal, Siminke and Vereda Platanal.","2021-03-28","2021-04-26","Household and community samples","Multiple groups",452.0,0.277,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gustavo Concha","Medical Mission Institute","http://dx.doi.org/10.3390/vaccines9101120","Verified","","","",1.0,"","CO",""
"2021-10-13","211001_Estonia_UniversityOfTartu_Stage20_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","","Estonia","2021-09-15","2021-09-27","Household and community samples","Multiple groups",2302.0,0.767,"Stratified probability","NR","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.749,0.784,"","","","EE",""
"2021-10-13","211003_MinneapolisStPaul_UniversityofMinnesota_OverallTestAdjusted","SARS-CoV-2 Seroprevalence among Healthcare Workers","2021-10-03","Local","","United States of America; Minnesota ; Minneapolis, Saint Paul","2020-12-18","2021-02-15","Health care workers and caregivers","Multiple groups",423.0,0.183,"Convenience","NR","IgG","Moderate","Preprint","Talia Wiggen","University of Minnesota","https://www.medrxiv.org/content/10.1101/2021.10.02.21264468v1","Unverified","","",0.97,1.0,"","US","US-MN"
"2021-10-13","211006_Yaoundé_HopitalCentraldeYaounde_PopTestAdj_Overall","SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon.","2021-10-06","Local","","Cameroon; Centre; Yaoundé","2020-10-14","2020-11-26","Household and community samples","Multiple groups",971.0,0.292,"Simplified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Kene Nwosu","Hopital Central de Yaounde","https://dx.doi.org/10.1038/s41467-021-25946-0","Verified",0.238,0.349,0.915,0.935,"","CM","CM-CE"
"2021-10-13","211007_Palestine_PalestinianNationalInstituteofPublicHealth_Gaza_Overall","Sero Prevalence of COVID-19 in Palestine in 2020","2021-10-07","Regional","","occupied Palestinian territory - including east Jerusalem; Gaza; N/A","2020-12-01","2020-12-31","Household and community samples","Multiple groups",2904.0,0.4,"Stratified probability","NR","IgG","Moderate","Preprint","I Rayan","Palestinian National Institute of Public Health","https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1","Verified","","",0.988,1.0,"","PS","PS-GZZ"
"2021-10-13","211007_Palestine_PalestinianNationalInstituteofPublicHealth_WestBank_Overall","Sero Prevalence of COVID-19 in Palestine in 2020","2021-10-07","Regional","","occupied Palestinian territory - including east Jerusalem; West Bank; N/A","2020-12-01","2020-12-31","Household and community samples","Multiple groups",4356.0,0.38,"Stratified probability","NR","IgG","Moderate","Preprint","I Rayan","Palestinian National Institute of Public Health","https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1","Verified","","",0.988,1.0,"","PS","PS-WBK"
"2021-10-14","201215_Stockholm_TheStockholmRegion","15 december: Lägesrapport om covid-19","2020-12-15","Local","","Sweden","2020-12-07","2020-12-13","Household and community samples","Multiple groups",20466.0,0.39,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/15-december-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-14","201222_Stockholm_TheStockholmRegion","22 december: Lägesrapport om covid-19","2020-12-22","Local","","Sweden","2020-12-14","2020-12-20","Household and community samples","Multiple groups",23466.0,0.381,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/22-december-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-14","201229_Stockholm_TheStockholmRegion","29 december: Lägesrapport om covid-19","2020-12-29","Local","","Sweden","2020-12-21","2020-12-27","Household and community samples","Multiple groups",17624.0,0.378,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/29-december-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-14","210106_UnitedKingdom_OxfordUniversity","The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers","2021-01-06","National","","United Kingdom of Great Britain and Northern Ireland","2020-04-23","2020-10-20","Health care workers and caregivers","Multiple groups",3217.0,0.16,"Convenience","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Sheila F Lumley","Oxford University","https://academic.oup.com/cid/article/73/3/e699/6064824","Unverified","","","","","","GB",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle1_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","","Oman","2020-07-12","2020-07-23","Household and community samples","Multiple groups",4210.0,0.055,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified",0.048,0.062,"","","","OM",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle2_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","","Oman","2020-08-16","2020-08-27","Household and community samples","Multiple groups",4403.0,0.097,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified",0.085,0.11,"","","","OM",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle3_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","","Oman","2020-09-13","2020-09-24","Household and community samples","Multiple groups",4780.0,0.164,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified",0.145,0.184,"","","","OM",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle4_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","","Oman","2020-11-08","2020-11-19","Household and community samples","Multiple groups",4064.0,0.22,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified",0.196,0.246,"","","","OM",""
"2021-10-14","210930_Qatar_HamadMedicalCorporation_Primary","Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system","2021-09-30","National","","Qatar","2020-03-01","2020-10-31","Multiple populations","Multiple groups",12126.0,0.177,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","http://dx.doi.org/10.1371/journal.pone.0257845","Unverified","","","","","","QA",""
"2021-10-14","211002_NewYork_NorthShoreUniversityHospital_Delivery","Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation.","2021-10-02","Local","","United States of America; New York","2020-10-15","2020-11-15","Pregnant or parturient women","Adults (18-64 years)",149.0,0.141,"Sequential","NR","IgG","High","Preprint","Cara Staszewski","North Shore University Hospital","https://dx.doi.org/10.1016/j.ajog.2021.09.037","Verified","","","","","","US","US-NY"
"2021-10-14","211005_Munich_LMUMunich_TestAdjusted","SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort","2021-10-05","Local","","Germany; Bavaria; Munich","2020-05-14","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",509.0,0.013,"Convenience","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Katharina Eisenhut","LMU Munich","https://dx.doi.org/10.1007/s00415-021-10818-w","Unverified",0.005,0.024,"","","","DE","DE-BY"
"2021-10-14","211006_Italy_IRCCSOrthopedicInstituteGaleazzi_IOG-CSS","Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.","2021-10-06","National","","Italy; Lombardy, Apulia; Milan, San Giovanni Rotondo","2021-01-04","2021-02-12","Health care workers and caregivers","Multiple groups",950.0,0.184,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Davide Ferrari","IRCCS Orthopedic Institute Galeazzi","https://dx.doi.org/10.1515/cclm-2021-0364","Unverified","","",1.0,0.999,"","IT",""
"2021-10-14","211006_Italy_IRCCSOrthopedicInstituteGaleazzi_OSR","Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.","2021-10-06","Local","","Italy; Lombardy; Milan","2021-01-04","2021-02-12","Health care workers and caregivers","Multiple groups",3340.0,0.091,"Unclear","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Davide Ferrari","IRCCS Orthopedic Institute Galeazzi","https://dx.doi.org/10.1515/cclm-2021-0364","Unverified","","","","","","IT","IT-25"
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W29","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-07-18","2021-07-24","Household and community samples","Adults (18-64 years)",2.0,1.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.342,1.0,1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W30","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-07-25","2021-07-31","Household and community samples","Adults (18-64 years)",11.0,0.818,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.523,0.949,1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W31","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-08-01","2021-08-07","Household and community samples","Adults (18-64 years)",42.0,0.929,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.81,0.975,1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W32","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-08-08","2021-08-14","Household and community samples","Adults (18-64 years)",25.0,0.84,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.654,0.936,1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W33","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-08-15","2021-08-21","Household and community samples","Adults (18-64 years)",7.0,0.857,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.487,0.974,1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W34","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-08-22","2021-08-28","Household and community samples","Adults (18-64 years)",8.0,0.75,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.409,0.928,1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W35","THL serological population study of the coronavirus epidemic","2021-10-07","National","","Finland","2021-08-29","2021-09-04","Household and community samples","Adults (18-64 years)",1.0,0.0,"Simplified probability","NR","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified",0.0,0.794,1.0,1.0,"","FI",""
"2021-10-18","210105_Stockholm_TheStockholmRegion","5 januari: Lägesrapport om covid-19","2021-01-05","Local","","Sweden","2020-12-28","2021-01-03","Household and community samples","Multiple groups",15061.0,0.424,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/5-januari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-18","210112_Stockholm_TheStockholmRegion","12 januari: Lägesrapport om covid-19","2021-01-12","Local","","Sweden","2021-01-04","2021-01-10","Household and community samples","Multiple groups",10378.0,0.428,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/12-januari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-18","210119_Stockholm_TheStockholmRegion","19 januari: Lägesrapport om covid-19","2021-01-19","Local","","Sweden","2021-01-11","2021-01-17","Household and community samples","Multiple groups",18544.0,0.453,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/19-januari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-18","210126_Stockholm_TheStockholmRegion","26 januari: Lägesrapport om covid-19","2021-01-26","Local","","Sweden","2021-01-18","2021-01-24","Household and community samples","Multiple groups",15498.0,0.444,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/26-januari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-18","210202_Stockholm_TheStockholmRegion","2 februari: Lägesrapport om covid-19","2021-02-02","Local","","Sweden","2021-01-25","2021-01-31","Household and community samples","Multiple groups",11749.0,0.457,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/2-februari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-10-18","211012_NortheastPortugal_FernandoPessoaUniversity_Overall","Pre-vaccination immune response to COVID-19 in a population in Northeast Portugal.","2021-10-12","National","","Portugal","2020-04-15","2021-02-15","Household and community samples","Multiple groups",358.0,0.304,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Mary Duro","Fernando Pessoa University","https://dx.doi.org/10.1007/s11845-021-02799-6","Verified","","","","","","PT",""
"2021-10-19","210917_Lakewood_JointBaseLewisMcChord_Overall","COVID-19 Antibody Prevalence From July to September 2020: One Army Infantry Brigade's Experience","2021-09-17","Local","","United States of America; Washington; Lakewood","2020-06-15","2020-09-15","Essential non-healthcare workers","Adults (18-64 years)",264.0,0.004,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Alex Koo","Joint Base Lewis McChord","https://pubmed.ncbi.nlm.nih.gov/34529807/","Unverified","","","","","","US","US-WA"
"2021-10-19","211001_NewYorkCity_NorthShoreUniversityHospital_Overall","THE CLINICAL IMPACT OF COVID-19 ON CYSTIC FIBROSIS PATIENTS IN NEW YORK","2021-10-01","Local","","United States of America; New York; New York City","2020-03-01","2020-08-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",812.0,0.023,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Janice Wang","North Shore University Hospital","http://dx.doi.org/10.1016/j.chest.2021.07.1326","Unverified","","","","","","US","US-NY"
"2021-10-19","211006_Babahoyo_WayneStateUniversity","Seroprevalence of SARS-CoV-2 immunoglobulins in pregnant women and neonatal cord blood from a highly impacted region.","2021-10-06","Local","","Ecuador; Los Ríos; Babahoyo","2020-09-03","2021-01-31","Pregnant or parturient women","Multiple groups",100.0,0.32,"Unclear","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Hector Zambrano","Wayne State University","https://dx.doi.org/10.1016/j.placenta.2021.10.001","Unverified","","","","","","EC","EC-R"
"2021-10-19","211008_NorthBrabant_RegionalPublicHealthServiceofWestBrabant_Overall","SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: baseline data from the prospective COco-study.","2021-10-08","Regional","","Netherlands; North Brabant","2020-06-01","2020-07-14","Non-essential workers and unemployed persons","Multiple groups",497.0,0.113,"Convenience","NR","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Dymphie Mioch","Regional Public Health Service of West-Brabant","https://dx.doi.org/10.1016/j.pmedr.2021.101594","Unverified","","",0.96,0.99,"","NL","NL-NB"
"2021-10-19","211008_Palestine_An-NajahNationalUniversity_Overall","Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study.","2021-10-08","Regional","","occupied Palestinian territory - including east Jerusalem; West Bank","2020-11-01","2020-12-31","Residual sera","Multiple groups",1269.0,0.24,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Beesan Maraqa","An-Najah National University","https://dx.doi.org/10.1371/journal.pone.0258255","Verified",0.217,0.265,"","","","PS","PS-WBK"
"2021-10-19","211009_UnitedStates_AmericanRedCross_Overall_S1","Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 - June 2021.","2021-10-09","National","","United States of America","2020-06-15","2021-06-25","Blood donors","Multiple groups",1567446.0,0.601,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Roger Dodd","American Red Cross","https://dx.doi.org/10.1093/infdis/jiab514","Verified","","","","","","US",""
"2021-10-19","211011_Kerala_KeralaGovernment_Primary","82% adults in state have Covid-19 antibodies, says latest serosurvey in Kerala","2021-10-11","Regional","","India; Kerala","2021-07-04","2021-08-07","Household and community samples","Multiple groups",13000.0,0.826,"Unclear","NR","Not reported","Unclear","News and Media","Hindustan Times","Kerala Government","https://www.hindustantimes.com/india-news/82-adults-in-state-have-covid-19-antibodies-says-latest-serosurvey-in-kerala-101633964468707.html","Verified","","","","","","IN","IN-KL"
"2021-10-19","211011_NewYork_ChildrensHospitalAtMontefiore","COVID-19 infection in pediatric solid organ transplant patients.","2021-10-11","Local","","United States of America; New York; New York","2020-04-15","2020-12-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",108.0,0.111,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Neha Bansal","Childrens Hospital at Montefiore","https://dx.doi.org/10.1111/petr.14156","Unverified","","","",1.0,"","US","US-NY"
"2021-10-19","211011_NorthRhineWestphalia_UniversityofDuisburgEssen_Overall","Discrepancy between frequent occurrence of COVID-19-like symptoms and low seroconversion rates among healthcare workers.","2021-10-11","Regional","","Germany; North Rhine-Westphalia","2020-06-01","2020-07-31","Health care workers and caregivers","Multiple groups",861.0,0.008,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Dorothea Dehnen","University of Duisburg-Essen","https://dx.doi.org/10.1002/jmv.27385","Unverified","","","","","","DE","DE-NW"
"2021-10-19","211011_SaitamaCity_JichiMedicalUniversity_cohort_HCW_primary","Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.","2021-10-11","Local","","Japan; Saitama Prefecture; Saitama City","2020-05-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",116.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Hiroshi Hori","Jichi Medical University","https://dx.doi.org/10.1371/journal.pone.0257513","Unverified","","",1.0,0.998,"","JP","JP-11"
"2021-10-19","211011_SaitamaCity_JichiMedicalUniversity_crosssectional_HCW","Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.","2021-10-11","Local","","Japan; Saitama Prefecture; Saitama City","2020-07-05","2020-07-19","Health care workers and caregivers","Adults (18-64 years)",607.0,0.002,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Hiroshi Hori","Jichi Medical University","https://dx.doi.org/10.1371/journal.pone.0257513","Unverified",0.0,0.011,"","","","JP","JP-11"
"2021-10-19","211012_Colorado_UniversityofColorado_Followup_TestAdjusted","Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.","2021-10-12","Regional","","United States of America; Colorado","2020-05-15","2021-03-15","Essential non-healthcare workers","Adults (18-64 years)",783.0,0.2,"Convenience","NR","IgG; IgA","Moderate","Journal Article (Peer-Reviewed)","Brian Montague","University of Colorado","https://dx.doi.org/10.1093/infdis/jiab524","Unverified","","","","","","US","US-CO"
"2021-10-19","211012_Ontario_TheHospitalforSickChildren_Primary","SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.","2021-10-12","Regional","","Canada; Ontario","2020-04-01","2020-11-13","Health care workers and caregivers","Adults (18-64 years)",1062.0,0.054,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Michelle Science","The Hospital for Sick Children","https://dx.doi.org/10.9778/cmajo.20210044","Unverified","","",0.9,0.98,"","CA","CA-ON"
"2021-10-20","210824_Ireland_UniversityofLimerick_HCW_TestAdjusted","SARS-CoV-2 infection in general practice in Ireland: a seroprevalence study","2021-08-24","Regional","","Ireland; Midwest Region","2020-06-15","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",171.0,0.111,"Stratified non-probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Michael O'Callaghan","University of Limerick","http://dx.doi.org/10.3399/BJGPO.2021.0038","Verified",0.042,0.186,0.71,0.98,"","IE",""
"2021-10-20","210824_Ireland_UniversityofLimerick_Patients_TestAdjusted","SARS-CoV-2 infection in general practice in Ireland: a seroprevalence study","2021-08-24","Regional","","Ireland; Midwest Region","2020-06-15","2020-07-10","Residual sera","Multiple groups",796.0,0.126,"Stratified non-probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Michael O'Callaghan","University of Limerick","http://dx.doi.org/10.3399/BJGPO.2021.0038","Verified",0.075,0.166,0.71,0.98,"","IE",""
"2021-10-20","210917_DenmarkCapitalRegion_UniversityofCopenhagen_Round3_Overall","Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers","2021-09-17","Regional","","Denmark; Capital Region of Denmark","2020-09-30","2020-10-07","Health care workers and caregivers","Adults (18-64 years)",27457.0,0.074,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kasper Iversen","University of Copenhagen","http://dx.doi.org/10.1016/j.cmi.2021.09.005","Unverified","","",0.967,0.995,"","DK","DK-84"
"2021-10-20","210929_PointAPitre_UniversityHospitalofGuadeloupe","Seroprevalence of SARS-CoV-2 IgG antibodies among workers in the University Hospital of Guadeloupe.","2021-09-29","Local","","Guadeloupe; Pointe-à-Pitre; Pointe-à-Pitre","2020-07-01","2020-10-28","Health care workers and caregivers","Adults (18-64 years)",892.0,0.05,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Vincenzo Palmeri","University Hospital of Guadeloupe","https://pubmed.ncbi.nlm.nih.gov/34625780/","Unverified",0.036,0.065,"","","","GP",""
"2021-10-20","211001_Charleston_WestVirginiaUniversity_CEW","COVID-19: ESSENTIAL WORKERS AND THE RISKS WE FACE","2021-10-01","Local","","United States of America; West Virginia; Charleston","2020-09-15","2020-12-15","Essential non-healthcare workers","Adults (18-64 years)",623.0,0.058,"Unclear","NR","IgG","Unclear","Presentation or Conference","Syed Mahmood","West Virginia University","https://www.sciencedirect.com/science/article/pii/S0012369221020201","Unverified","","","","","","US","US-WV"
"2021-10-20","211001_Charleston_WestVirginiaUniversity_HCW","COVID-19: ESSENTIAL WORKERS AND THE RISKS WE FACE","2021-10-01","Local","","United States of America; West Virginia; Charleston","2020-09-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",458.0,0.1,"Unclear","NR","IgG","Unclear","Presentation or Conference","Syed Mahmood","West Virginia University","https://www.sciencedirect.com/science/article/pii/S0012369221020201","Unverified","","","","","","US","US-WV"
"2021-10-20","211011_SanSiro_ASSTFatebenefratelliSacco_primary","Differences in the prevalence of sars-cov-2 infection and access to care between italians and non-italians in a social-housing neighbourhood of milan, italy","2021-10-11","Local","","Italy; Lombardy; Milan","2020-12-23","2021-02-19","Household and community samples","Multiple groups",2044.0,0.112,"Self-referral","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Gabriele Pagani","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.3390/ijerph182010621","Unverified","","","","","","IT","IT-25"
"2021-10-20","211012_Germany_UniversitätWürzburg_Overall","[Seroprevalence of COVID-19 and Psychosocial Effects in the General Population: Results of the STAAB-COVID-One Program].","2021-10-12","Local","","Germany; Bavaria; Würzburg","2020-06-01","2020-10-31","Household and community samples","Multiple groups",3034.0,0.011,"Stratified non-probability","NR","IgA; IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Felizitas Eichner","Universität Würzburg","https://dx.doi.org/10.1055/a-1630-7601","Verified",0.007,0.015,"","","","DE","DE-BY"
"2021-10-20","211013_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report October 13, 2021 Report #12: July 2021 Survey Tracking Seroprevalence in the Vaccine Era","2021-10-13","National","","Canada","2021-07-14","2021-07-23","Blood donors","Multiple groups",8457.0,0.947,"Sequential","","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.942,0.952,0.988,0.996,"","CA",""
"2021-10-20","211014_Milan_UniversitàdegliStudidiMilano_Primary","Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors.","2021-10-14","Local","","Italy","2020-07-01","2021-02-23","Blood donors","Multiple groups",10680.0,0.059,"Sequential","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luca Valenti","Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano","https://dx.doi.org/10.1111/trf.16693","Verified","","","","","","IT",""
"2021-10-22","210801_SouthBronx_MountSinai_primary","Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms","2021-08-01","Local","","United States of America; New York; New York City","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",501.0,0.284,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Juan Manuel Carreno","Icahn School of Medicine at Mount Sinai","https://www.cell.com/iscience/fulltext/S2589-0042(21)00905-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004221009056%3Fshowall%3Dtrue","Unverified","","",0.95,1.0,"","US","US-NY"
"2021-10-24","201223_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 23 Dec 2020","2020-12-23","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-10-26","2020-11-29","Blood donors","Multiple groups",2499.0,0.063,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/","Verified",0.046,0.089,0.84,1.0,"","GB","GB-SCT"
"2021-10-24","201223_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 23 Dec 2020","2020-12-23","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-10-26","2020-11-29","Residual sera","Multiple groups",3638.0,0.068,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/","Verified",0.057,0.077,0.875,0.986,"","GB","GB-SCT"
"2021-10-24","210602_Croatia_UniversityofZagreb","Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.","2021-06-02","Local","","Croatia","2020-09-07","2020-11-27","Patients seeking care for non-COVID-19 reasons","Multiple groups",512.0,0.201,"Entire sample","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Mrzljak","University of Zagreb","https://dx.doi.org/10.11613/BM.2021.030901","Unverified",0.164,0.263,"","","","HR",""
"2021-10-24","211014_Marseille_AixMarseilleUniversity","COVID-19 outbreak among French firefighters, Marseille, France, 2020.","2021-10-14","Local","","France","2020-04-02","2020-04-06","Essential non-healthcare workers","Adults (18-64 years)",85.0,0.259,"Entire sample","NR","Neutralizing","High","Journal Article (Peer-Reviewed)","Guillaume Durand","Aix Marseille University","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.41.2001676","Unverified","","","","","","FR",""
"2021-10-25","210827_Bhubaneswar_AllIndiaInstituteOfMedicalSciences_Primary","Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in a teaching hospital in Eastern India.","2021-08-27","Local","","India; Odisha; Bhubaneswar","2020-08-01","2020-08-08","Health care workers and caregivers","Adults (18-64 years)",821.0,0.039,"Simplified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mishra Baijayantimala","All India Institute of Medical Sciences (AIIMS)","https://dx.doi.org/10.4103/jfmpc.jfmpc_2486_20","Unverified",0.026,0.051,0.991,0.951,"","IN","IN-OR"
"2021-10-25","211013_Odisha_GovernmentofIndia_Primary","Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection.","2021-10-13","Regional","","India; Odisha","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",134.0,0.41,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Debaprasad Parai","Government of India","https://dx.doi.org/10.1016/j.tmaid.2021.102170","Unverified","","","","","","IN","IN-OR"
"2021-10-25","211015_Jerusalem_ShaareZedekMedicalCenter","COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response.","2021-10-15","Local","","Israel; Jerusalem District; Jerusalem","2020-12-01","2021-02-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",249.0,0.181,"Entire sample","NR","IgG","Low","Journal Article (Peer-Reviewed)","Jenny Weinbrand-Goichberg","Shaare Zedek Medical Centre (SZMC)","https://dx.doi.org/10.1007/s40620-021-01171-2","Unverified","","","","","","IL","IL-JM"
"2021-10-25","211018_UnitedKingdom_QueenMaryUniversityofLondon_Overall","Determinants of Pre-Vaccination Antibody Responses to SARS-CoV-2: A Population-Based Longitudinal Study (COVIDENCE UK)","2021-10-18","National","","United Kingdom of Great Britain and Northern Ireland","2020-11-06","2021-04-18","Household and community samples","Multiple groups",11130.0,0.152,"Convenience","NR","Total Antibody","Moderate","Preprint","Mohammad Talaei","Queen Mary University of London","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3944582","Verified","","",0.986,0.983,"","GB",""
"2021-10-26","210127_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 Jan 2021","2021-01-27","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-30","2021-01-03","Blood donors","Multiple groups",2499.0,0.059,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/","Verified",0.044,0.071,0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210127_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 Jan 2021","2021-01-27","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-30","2021-01-03","Residual sera","Multiple groups",3485.0,0.096,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/","Verified",0.084,0.108,0.875,0.986,"","GB","GB-SCT"
"2021-10-26","210303_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 03 March 2021","2021-03-03","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-01-04","2021-02-07","Blood donors","Multiple groups",2497.0,0.152,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/","Verified",0.134,0.176,0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210303_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 03 March 2021","2021-03-03","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-01-04","2021-02-07","Residual sera","Multiple groups",3606.0,0.125,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/","Verified",0.112,0.138,0.875,0.986,"","GB","GB-SCT"
"2021-10-26","210407_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 07 April 2021","2021-04-07","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-08","2021-03-14","Blood donors","Multiple groups",2492.0,0.252,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/","Verified",0.225,0.279,0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210407_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 07 April 2021","2021-04-07","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-08","2021-03-14","Pregnant or parturient women","Adults (18-64 years)",3355.0,0.096,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/","Verified",0.085,0.107,0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210407_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 07 April 2021","2021-04-07","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-08","2021-03-14","Residual sera","Multiple groups",3436.0,0.237,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/","Verified",0.221,0.255,0.875,0.986,"","GB","GB-SCT"
"2021-10-26","210512_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 12 May 2021","2021-05-12","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-03-15","2021-04-18","Blood donors","Multiple groups",2493.0,0.466,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/","Verified",0.44,0.489,0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210512_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 12 May 2021","2021-05-12","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-03-15","2021-04-18","Pregnant or parturient women","Adults (18-64 years)",3326.0,0.125,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/","Verified",0.112,0.138,0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210512_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 12 May 2021","2021-05-12","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-12","2021-04-18","Residual sera","Multiple groups",708.0,0.438,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/","Verified",0.402,0.474,0.973,0.996,"","GB","GB-SCT"
"2021-10-26","210616_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 16 Jun 2021","2021-06-16","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-19","2021-05-23","Blood donors","Multiple groups",2494.0,0.663,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/","Verified",0.638,0.684,0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210616_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 16 Jun 2021","2021-06-16","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-19","2021-05-23","Pregnant or parturient women","Adults (18-64 years)",3333.0,0.108,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/","Verified",0.097,0.12,0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210616_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 16 Jun 2021","2021-06-16","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-19","2021-05-23","Residual sera","Multiple groups",3589.0,0.486,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/","Verified",0.47,0.503,0.973,0.996,"","GB","GB-SCT"
"2021-10-26","210825_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 August 2021","2021-08-25","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-06-28","2021-08-01","Blood donors","Multiple groups",2493.0,0.995,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/","Verified",0.984,1.0,0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210825_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 August 2021","2021-08-25","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-06-28","2021-08-01","Pregnant or parturient women","Adults (18-64 years)",2990.0,0.138,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/","Verified",0.124,0.152,0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210825_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 August 2021","2021-08-25","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-06-28","2021-08-01","Residual sera","Multiple groups",3427.0,0.729,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/","Verified",0.714,0.744,0.973,0.996,"","GB","GB-SCT"
"2021-10-26","211001_Italy_UniversityofUrbino","Prevalence of sars-cov-2 infection in the workplace: results of a year of investigation in the marche nord companies","2021-10-01","Regional","","Italy; Marche","2020-05-15","2021-04-15","Non-essential workers and unemployed persons","Adults (18-64 years)",10000.0,0.052,"Convenience","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Chiara Orlandi","University of Urbino","http://dx.doi.org/10.23750/abm.v92iS6.12238","Unverified","","","","","","IT","IT-57"
"2021-10-26","211013_Cuttack_SriramChandraBhanjaMedicalCollegeandHospital_Primary","SARS COV-2- IgG antibodies in blood donors in pandemic - a game changer for policy makers.","2021-10-13","Local","","India; Odisha; ; Cuttack","2020-11-01","2021-01-31","Blood donors","Adults (18-64 years)",1032.0,0.359,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Smita Mahapatra","Sriram Chandra Bhanja Medical College and Hospital","https://dx.doi.org/10.1016/j.tracli.2021.10.004","Verified","","","","","","IN","IN-OR"
"2021-10-26","211018_WRNMMC_UniformedServicesUniversity","Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers","2021-10-18","Local","","United States of America; Maryland; Bethesda","2021-02-01","2021-08-15","Health care workers and caregivers","Adults (18-64 years)",17.0,0.235,"Convenience","NR","IgG","High","Preprint","Eric Laing","Uniformed Services University","https://www.medrxiv.org/content/10.1101/2021.10.16.21265087v1","Unverified","","",0.94,1.0,"","US","US-MD"
"2021-10-26","211020_Avon_UniversityOfBristol_G0_Overall","The Avon Longitudinal Study of Parents and Children - A resource for COVID-19 research: Antibody testing results, April ‚Äì June 2021","2021-10-20","Local","","United Kingdom of Great Britain and Northern Ireland","2021-04-08","2021-06-28","Household and community samples","Adults (18-64 years)",2555.0,0.964,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Daniel Major-Smith","University of Bristol","https://wellcomeopenresearch.org/articles/6-283","Verified","","",0.988,1.0,"","GB",""
"2021-10-26","211020_Avon_UniversityOfBristol_G1_Overall","The Avon Longitudinal Study of Parents and Children - A resource for COVID-19 research: Antibody testing results, April ‚Äì June 2021","2021-10-20","Local","","United Kingdom of Great Britain and Northern Ireland","2021-04-08","2021-06-28","Household and community samples","Adults (18-64 years)",1686.0,0.42,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Daniel Major-Smith","University of Bristol","https://wellcomeopenresearch.org/articles/6-283","Verified","","",0.988,1.0,"","GB",""
"2021-10-27","210930_Konya_NecmettinErbakanUniversityMeramFacultyofMedicine_Primary","COVID-19 seroprevalance in a university hospital health workers","2021-09-30","Local","","Turkey","2020-06-01","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",741.0,0.17,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Gokce Kader Arslan","Necmettin Erbakan University Meram Faculty of Medicine","http://dx.doi.org/10.5578/FLORA.20219706","Unverified","","","","","","TR",""
"2021-10-27","211012_Essen_EssenUniversityHospital_overall","[SARS-CoV-2 IgG seroprevalence in personnel of the extraclinical fight against the COVID-19 pandemic].","2021-10-12","Local","","Germany","2020-05-28","2020-05-29","Essential non-healthcare workers","Adults (18-64 years)",729.0,0.008,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Bastian Brune","Essen University Hospital","https://dx.doi.org/10.1007/s10049-021-00948-z","Unverified","","","",0.958,"","DE",""
"2021-10-27","211018_UniversityofPorto_UniversityofPorto_Overall_TestAdj","The SARS-CoV-2 infection among students in the University of Porto: a cross-sectional study","2021-10-18","Local","","Portugal; Norte; Porto","2020-09-24","2020-12-15","Students and Daycares","Multiple groups",6512.0,0.079,"Convenience","NR","IgM; IgG","Moderate","Preprint","Paula Meireles","University of Porto","https://www.medrxiv.org/content/10.1101/2021.10.14.21264978v1","Unverified",0.049,0.111,"","","","PT",""
"2021-10-28","211018_Porto_UniversidadedoPorto","Incidence of SARS-CoV-2 infection in a cohort of workers from the University of Porto","2021-10-18","Local","","Portugal; Porto District; Porto","2020-11-27","2021-01-29","Non-essential workers and unemployed persons","Multiple groups",1891.0,0.107,"Self-referral","NR","IgG; IgM","Moderate","Preprint","Joana Costa","Universidade do Porto","10.1101/2021.10.14.21264980","Unverified","","",0.945,0.957,"","PT","PT-13"
"2021-10-29","210127_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 Jan 2021","2021-01-27","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-30","2021-01-03","Pregnant or parturient women","Adults (18-64 years)",3052.0,0.058,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/","Verified",0.05,0.068,0.923,1.0,"","GB","GB-SCT"
"2021-10-29","210303_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 03 March 2021","2021-03-03","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-01-04","2021-02-07","Pregnant or parturient women","Adults (18-64 years)",3478.0,0.075,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/","Verified",0.066,0.085,0.923,1.0,"","GB","GB-SCT"
"2021-10-31","211013_SarajevoCanton_PublicHealthInstitute_Overall","Study of SARS-CoV-2 Seroprevalence in Canton Sarajevo","2021-10-13","Local","Bosnia and Herzegovina","Bosnia and Herzegovina","2021-01-05","2021-03-20","Multiple populations","Multiple groups",3650.0,0.273,"Convenience","NR","IgG","Moderate","Institutional Report","Anes Joguncic","Public Health Institute","","Unverified","","","","","","BA",""
"2021-11-01","211101_Thrace_UniversityGeneralHospitalOfAlexandroupolis_Primary","Prevalence of anti-SARS-CoV-2 IgG antibodies in a group of patients, a control group, and healthcare workers of thrace area in Greece, by the use of two distinct methods","2021-11-01","Regional","","Greece; Thrace","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",1036.0,0.006,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Theocharis Konstantinidis","University General Hospital of Alexandroupolis","http://dx.doi.org/10.18683/germs.2021.1274","Unverified","","","","","","GR",""
"2021-11-02","210906_NashikCity_GovernmentMedicalCollege_NonSlums_Overall","Seroprevalence of COVID-19 in a City in India: A Community-based Cross-Sectional Study","2021-09-06","Local","","India; Maharashtra ; Nashik","2021-01-09","2021-01-11","Household and community samples","Multiple groups",1629.0,0.381,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Bapusaheb Nagargoje","Government Medical College","https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html","Verified",0.358,0.405,"","","","IN","IN-MH"
"2021-11-02","210906_NashikCity_GovernmentMedicalCollege_Slums_Overall","Seroprevalence of COVID-19 in a City in India: A Community-based Cross-Sectional Study","2021-09-06","Local","","India; Maharashtra ; Nashik","2021-01-09","2021-01-11","Household and community samples","Multiple groups",726.0,0.427,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Bapusaheb Nagargoje","Government Medical College","https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html","Verified",0.391,0.464,"","","","IN","IN-MH"
"2021-11-02","210915_Oman_ArmedForcesHospital_HCW_overall","Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman.","2021-09-15","Local","","Oman","2020-12-09","2020-12-24","Health care workers and caregivers","Adults (18-64 years)",1111.0,0.336,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Khalid Al-Naamani","Armed Forces Hospital","https://dx.doi.org/10.1016/j.jiph.2021.09.006","Unverified","","",0.988,1.0,"","OM",""
"2021-11-02","211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_HCW_overall","A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.","2021-10-01","Local","","Italy; Verona; Negrar di Valpolicella","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",2209.0,0.13,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Mirko Di Ruscio","IRCCS Sacro Cuore Don Calabria Hospital","https://dx.doi.org/10.3390/medicina57101048","Unverified","","","","","","IT","IT-34"
"2021-11-02","211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_IBDpatients","A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.","2021-10-01","Local","","Italy; Verona; Negrar di Valpolicella","2020-12-07","2021-01-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",386.0,0.104,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Mirko Di Ruscio","IRCCS Sacro Cuore Don Calabria Hospital","https://dx.doi.org/10.3390/medicina57101048","Unverified","","","","","","IT","IT-34"
"2021-11-02","211004_Bavaria_UniversityofRegensburg_ELISA-ELECSYS-Neutralization","Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children","2021-10-04","Regional","","Germany; Bavaria; Tirschenreuth, Regensburg city and county, and Oberbayern/ alpine region","2020-05-22","2020-07-22","Multiple general populations","Children and Youth (0-17 years)",2832.0,0.048,"Simplified probability","NR","IgG; IgM; IgA; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Otto Laub","University of Regensburg","http://dx.doi.org/10.3389/fped.2021.678937","Verified","","","","","","DE","DE-BY"
"2021-11-02","211021_OrangeCounty_Children’sHospitalofOrangeCounty_Overall","SARS-CoV-2 Serology Testing in an Asymptomatic, At-Risk Population: Methods, Results, Pitfalls.","2021-10-21","Local","","United States of America; California; NA","2020-05-14","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",282.0,0.003,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Theodore Heyming","Children’s Hospital of Orange County","https://dx.doi.org/10.3390/idr13040082","Unverified","","","","","","US","US-CA"
"2021-11-02","211022_AlcaladeHenares_HospitalUniversitarioPríncipedeAsturias_primary","[SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.].","2021-10-22","Local","","Spain; Madrid; Alcala de Henares","2020-05-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1339.0,0.226,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Felipe Perez Garcia","Hospital Universitario Príncipede Asturias","https://pubmed.ncbi.nlm.nih.gov/34675168/","Unverified","","","","","","ES","ES-MD"
"2021-11-02","211022_Guilan_GuilanUniversityofMedical Sciences","High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran.","2021-10-22","Local","","Iran (Islamic Republic of); Guilan; Rasht","2020-04-15","2020-05-15","Health care workers and caregivers","Multiple groups",503.0,0.39,"Simplified probability","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Heydar Balou","Guilan University of Medical Sciences","https://dx.doi.org/10.1155/2021/9081491","Unverified",0.348,0.433,0.941,"","","IR","IR-19"
"2021-11-02","211025_Baden-Württemberg_HeidelbergUniversityHospital_overall","Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May-August 2020.","2021-10-25","Regional","","Germany; Baden-Württemberg; Alb-Donau, Breisgau-Hochschwarzwald, Heidelberg/Rhein-Neckar, Karlsruhe, Mannheim, Neckar-Odenwald, Reutlingen, and Tübingen","2020-05-11","2020-08-01","Contacts of COVID patients","Multiple groups",1220.0,0.328,"Convenience","NR","IgG; IgM; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Maximilian Stich","Heidelberg University Hospital","https://wwwnc.cdc.gov/eid/article/27/12/21-0978_article","Unverified","","","","","","DE","DE-BW"
"2021-11-02","211025_Ynysmaerdy _CardiffUniversity","A cluster of children with facial nerve palsy in a high prevalence area for COVID-19.","2021-10-25","Local","","United Kingdom of Great Britain and Northern Ireland; South Wales;  Ynysmaerdy","2020-06-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",5.0,0.0,"Entire sample","NR","Not reported","High","Journal Article (Peer-Reviewed)","David Barron","Cardiff University","https://dx.doi.org/10.1186/s12887-021-02831-9","Verified","","","","","","GB",""
"2021-11-02","211026_Iran_NeyshaburUniversityofMedicalSciences_Overall","Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after one year of the COVID-19 Pandemic.","2021-10-26","National","","Iran (Islamic Republic of); Razavi Khorasan Province, Mazandaran Province; Neyshabur, Sabzevar, Babol","2021-04-01","2021-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",270.0,0.293,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Seyed Alireza Javadinia","Neyshabur University of Medical Sciences","https://dx.doi.org/10.1080/07357907.2021.1995742","Unverified","","",0.941,0.983,"","IR",""
"2021-11-03","210721_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 21 July 2021","2021-07-21","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-05-24","2021-06-27","Blood donors","Multiple groups",2494.0,0.818,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/","Verified",0.798,0.84,0.84,1.0,"","GB","GB-SCT"
"2021-11-03","210721_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 21 July 2021","2021-07-21","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-05-24","2021-06-27","Pregnant or parturient women","Adults (18-64 years)",3052.0,0.121,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/","Verified",0.108,0.135,0.923,1.0,"","GB","GB-SCT"
"2021-11-03","210721_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 21 July 2021","2021-07-21","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-05-24","2021-06-27","Residual sera","Multiple groups",3554.0,0.614,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/","Verified",0.597,0.629,0.973,0.996,"","GB","GB-SCT"
"2021-11-03","210804_Italy_UniversityofCampania_Primary","Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic.","2021-08-04","Regional","","Italy; Campania (Southern Italy)","2020-04-21","2020-06-10","Blood donors","Multiple groups",1808.0,0.008,"Sequential","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Federica Calo","University of Campania","https://dx.doi.org/10.2450/2021.0196-21","Verified","","",0.945,1.0,"","IT",""
"2021-11-03","211019_Paris_HopitalEuropeenGeorgesPompidou_Primary","No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris.","2021-10-19","Local","","France","2020-03-05","2020-12-04","Health care workers and caregivers","Adults (18-64 years)",3186.0,0.121,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Maxime Wack","Hopital Europeen Georges Pompidou","https://dx.doi.org/10.1016/j.jcv.2021.104999","Unverified",0.11,0.133,"","","","FR",""
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase1","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-06-29","2020-07-02","Household and community samples","Multiple groups",2481.0,0.097,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.079,0.118,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase10","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2021-02-02","2021-02-04","Household and community samples","Multiple groups",1742.0,0.16,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.131,0.193,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase11","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2021-02-16","2021-02-18","Household and community samples","Multiple groups",1780.0,0.25,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.217,0.287,"","","","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase2","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-07-13","2020-07-16","Household and community samples","Multiple groups",2323.0,0.111,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.096,0.129,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase3","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-07-28","2020-07-30","Household and community samples","Multiple groups",2529.0,0.109,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.092,0.129,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase4","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-08-11","2020-08-13","Household and community samples","Multiple groups",2447.0,0.11,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.09,0.133,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase5","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-08-25","2020-08-27","Household and community samples","Multiple groups",2225.0,0.139,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.118,0.162,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase6","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-09-08","2020-09-10","Household and community samples","Multiple groups",2125.0,0.119,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.1,0.141,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase7","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-09-22","2020-09-24","Household and community samples","Multiple groups",2012.0,0.136,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.116,0.158,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase8","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2021-01-05","2021-01-07","Household and community samples","Multiple groups",1908.0,0.141,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.117,0.168,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase9","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2021-01-19","2021-01-21","Household and community samples","Multiple groups",1795.0,0.139,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.117,0.164,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Pilot","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","","Brazil; Greater São Paulo","2020-06-10","2020-06-17","Household and community samples","Multiple groups",2645.0,0.095,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","José Olimpio Moura de Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Verified",0.079,0.114,0.848,0.99,"","BR","BR-SP"
"2021-11-03","211023_Sweden_KarolinskaInstitutet_Overall","SARS-CoV-2 specific B- and T-cell immunity in a population-based study of young Swedish adults.","2021-10-23","National","","Sweden","2020-10-06","2021-06-23","Household and community samples","Adults (18-64 years)",977.0,0.284,"Convenience","NR","IgA; IgM; IgG","High","Journal Article (Peer-Reviewed)","Sophia Bjorkander","Karolinska Institutet","https://www.sciencedirect.com/science/article/pii/S0091674921016262","Unverified","","","","","","SE",""
"2021-11-03","211025_Estonia_UniversityOfTartu_Stage21_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","","Estonia","2021-10-13","2021-10-25","Household and community samples","Multiple groups",2312.0,0.764,"Stratified probability","NR","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.743,0.784,"","","","EE",""
"2021-11-03","211026_Betim_EscoladeSaúdePúblicadeBetim_Survey1","Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil","2021-10-26","Local","","Brazil; Minas Gerais; Betim","2020-06-03","2020-06-05","Household and community samples","Multiple groups",1079.0,0.003,"Stratified probability","NR","IgG; IgM","Moderate","Preprint","Ana Silva","Escola de Saúde Pública de Betim","https://www.medrxiv.org/content/10.1101/2021.10.21.21265140v1.full-text","Verified","","",0.864,0.996,"","BR","BR-MG"
"2021-11-03","211026_Betim_EscoladeSaúdePúblicadeBetim_Survey2","Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil","2021-10-26","Local","","Brazil; Minas Gerais; Betim","2020-06-23","2020-06-25","Household and community samples","Multiple groups",1080.0,0.007,"Stratified probability","NR","IgG; IgM","Moderate","Preprint","Ana Silva","Escola de Saúde Pública de Betim","https://www.medrxiv.org/content/10.1101/2021.10.21.21265140v1.full-text","Verified","","",0.864,0.996,"","BR","BR-MG"
"2021-11-03","211026_Betim_EscoladeSaúdePúblicadeBetim_Survey3","Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil","2021-10-26","Local","","Brazil; Minas Gerais; Betim","2020-07-13","2020-07-15","Household and community samples","Multiple groups",1080.0,0.026,"Stratified probability","NR","IgG; IgM","Moderate","Preprint","Ana Silva","Escola de Saúde Pública de Betim","https://www.medrxiv.org/content/10.1101/2021.10.21.21265140v1.full-text","Verified","","",0.864,0.996,"","BR","BR-MG"
"2021-11-03","211026_France_UniversitéParisSaclay_May(Round1)_Primary","Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort â€“ EPICOV","2021-10-26","National","","France","2020-05-01","2020-05-31","Household and community samples","Multiple groups",12114.0,0.045,"Simplified probability","NR","IgG","Low","Preprint","Josiane Warszawski","Université Paris-Saclay","https://www.medrxiv.org/content/10.1101/2021.10.25.21265456v1.full-text","Verified",0.04,0.051,0.944,"","","FR",""
"2021-11-03","211026_France_UniversitéParisSaclay_November(Round2)_Primary","Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort â€“ EPICOV","2021-10-26","National","","France","2020-11-01","2020-11-30","Household and community samples","Multiple groups",63524.0,0.062,"Simplified probability","NR","IgG","Low","Preprint","Josiane Warszawski","Université Paris-Saclay","https://www.medrxiv.org/content/10.1101/2021.10.25.21265456v1.full-text","Verified",0.059,0.066,0.944,"","","FR",""
"2021-11-03","211026_Tyrol_TirolKlinikenGmbH_Abbott_Primary","Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020.","2021-10-26","Regional","","Austria; Tyrol","2020-06-08","2020-09-04","Blood donors","Multiple groups",5345.0,0.031,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anita Siller","Tirol Kliniken GmbH","https://dx.doi.org/10.1007/s00508-021-01963-3","Unverified",0.026,0.036,1.0,0.996,"","AT","AT-7"
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week21-22","Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare","2021-10-28","National","","Sweden","2021-05-24","2021-06-04","Blood donors","Multiple groups",3009.0,0.519,"Self-referral","NR","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf","Unverified",0.495,0.544,"","","","SE",""
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week38-39","Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare","2021-10-28","National","","Sweden","2021-09-20","2021-10-03","Blood donors","Multiple groups",402.0,0.968,"Self-referral","NR","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf","Unverified",0.945,0.985,"","","","SE",""
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week9-10","Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare","2021-10-28","National","","Sweden","2021-03-01","2021-03-12","Blood donors","Multiple groups",3067.0,0.224,"Self-referral","NR","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf","Unverified",0.203,0.245,"","","","SE",""
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_Outpatients_Week38-39_Primary","Påvisning av antikroppar mot SARS-CoV-2 i blodprov från öppenvården","2021-10-28","National","","Sweden","2021-09-20","2021-10-03","Residual sera","Multiple groups",2959.0,0.756,"Convenience","NR","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf","Verified",0.738,0.773,0.989,0.994,"","SE",""
"2021-11-04","210826_Nairobi_KenyaMedicalResearchInstitute_Overall_PopAdjusted","Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi","2021-08-26","Local","","Kenya; Nairobi","2020-11-27","2020-12-05","Household and community samples","Multiple groups",511.0,0.433,"Simplified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Patrick Munywoki","Kenya Medical Research Institute","https://f1000research.com/articles/10-853","Verified",0.374,0.495,0.944,1.0,"","KE","KE-30"
"2021-11-04","210927_Turkey_HacettepeUniversity_Primary","SARS-CoV-2 seropositivity among pediatric health care personnel just after the first peak of pandemic: A nationwide surveillance","2021-09-27","National","","Turkey; Middle Anatolia region; Marmara region; Aegean region; East Anatolia region; South-east Anatolian region; Black Sea region; Mediterranean region","2020-05-25","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",4927.0,0.061,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Pembe Derin Oygar","Hacettepe University","http://dx.doi.org/10.1016/j.ijid.2021.09.054","Unverified","","","","","","TR",""
"2021-11-04","211018_Venlo_VieCuriMedicalCentre_Overall","SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: A cross-sectional study","2021-10-18","Local","","Netherlands; Limburg; Venlo","2020-06-22","2020-07-03","Health care workers and caregivers","Multiple groups",2507.0,0.211,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Maud Bouwman","VieCuri Medical Centre","http://dx.doi.org/10.1136/bmjopen-2021-051573","Unverified","","",0.975,0.996,"","NL","NL-LI"
"2021-11-04","211020_NewDelhi_ SirGangaRamHospital_Overall","A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.","2021-10-20","Local","","India","2020-09-18","2020-09-24","Health care workers and caregivers","Multiple groups",1033.0,0.258,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Chand Wattal","Sir Ganga Ram Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.09.011","Unverified","","","","","","IN",""
"2021-11-04","211021_Spain_AlcalaUniversity_Students_Overall","High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcala, Spain: Contributing Factors.","2021-10-21","Regional","","Spain; Community of Madrid, Community of Castilla-La Mancha; Madrid, Guadalajara","2020-06-08","2020-06-16","Students and Daycares","Adults (18-64 years)",507.0,0.172,"Stratified probability","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ramon Perez-Tanoira","Alcala University","https://dx.doi.org/10.2147/IJGM.S332803","Unverified","","","","","","ES",""
"2021-11-04","211022_Switzerland_CantonalHospitalStGallen","Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection â€“ results of a prospective multicenter cohort","2021-10-22","National","","Switzerland","2021-01-15","2021-02-15","Health care workers and caregivers","Multiple groups",3334.0,0.203,"Convenience","NR","Total Antibody","Moderate","Preprint","Carol Strahm","Cantonal Hospital St Gallen","https://www.medrxiv.org/content/10.1101/2021.10.19.21265187v1.full-text","Unverified","","",0.88,0.99,"","CH",""
"2021-11-04","211023_Peru_GermanCentreforInfectionResearch_CLIAandNeutralization","High SARS-CoV-2 seroprevalence in rural Peru, 2021; a cross-sectional population-based study","2021-10-23","Regional","","Peru; San Martin","2021-03-01","2021-03-31","Household and community samples","Multiple groups",563.0,0.59,"Simplified probability","NR","IgG; Neutralizing","Moderate","Preprint","Andres Moreira-Soto","German Centre for Infection Research","https://www.medrxiv.org/content/10.1101/2021.10.19.21265219v1.full-text","Verified",0.55,0.63,"","","","PE","PE-SAM"
"2021-11-04","211026_NewYorkCity_MountSinaiHealthSystem_Phase2_Overall_Spike","Longitudinal humoral antibody response to SARS-CoV-2 infection among healthcare workers in a New York City hospital.","2021-10-26","Local","","United States of America; New York; New York","2020-08-15","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",176.0,0.386,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Vidya Menon","Mount Sinai Health System","https://dx.doi.org/10.1136/bmjopen-2021-051045","Unverified","","",0.94,1.0,"","US","US-NY"
"2021-11-04","211101_Ethiopia_UniversityofMunich_AddisAbaba_AddisKetema_Round3","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","","Ethiopia","2021-04-08","2021-04-10","Household and community samples","Multiple groups",176.0,0.727,"Convenience","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Verified",0.659,0.791,1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_AddisAbaba_Yeka_Round3","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","","Ethiopia","2021-04-01","2021-04-03","Household and community samples","Multiple groups",188.0,0.548,"Convenience","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Verified",0.477,0.619,1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_HCW_AddisAbaba_Round3","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","","Ethiopia","2021-01-19","2021-03-12","Health care workers and caregivers","Adults (18-64 years)",121.0,0.537,"Unclear","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Verified",0.448,0.625,1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_HCW_Jimma_Round3","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","","Ethiopia","2021-01-05","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",372.0,0.561,"Unclear","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Verified",0.511,0.611,1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_JimmaRural_Round3","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","","Ethiopia","2021-02-04","2021-03-16","Household and community samples","Multiple groups",100.0,0.31,"Convenience","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Verified",0.223,0.403,1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_JimmaUrban_Round3","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","","Ethiopia","2021-02-02","2021-03-15","Household and community samples","Multiple groups",166.0,0.452,"Convenience","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Verified",0.377,0.527,1.0,0.998,"","ET",""
"2021-11-05","211014_Delhi_InstituteofLiverandBiliarySciences_Primary","SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread.","2021-10-14","Local","","India","2020-09-24","2020-10-31","Blood donors","Adults (18-64 years)",1066.0,0.276,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Pratibha Kale","Institute of Liver and Biliary Sciences","https://dx.doi.org/10.1016/j.transci.2021.103293","Verified","","","","","","IN",""
"2021-11-05","211022_Belgium_UniversitéLibreDeBruxelles","SARS-CoV-2 seroprevalence in children and their family members, July-October 2020, Brussels.","2021-10-22","National","","Belgium","2020-07-01","2020-10-31","Students and Daycares","Children and Youth (0-17 years)",112.0,0.125,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Lorraine Dethioux","Université Libre de Bruxelles","https://dx.doi.org/10.1007/s00431-021-04284-9","Unverified","","","","","","BE",""
"2021-11-05","211101_Manaus_UniversidadeFederaldoAmazona_Primary","High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.","2021-11-01","Local","","Brazil; Amazonas; Manaus","2020-08-20","2020-11-20","Household and community samples","Multiple groups",1631.0,0.131,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Pritesh Lalwani","Universidade Federal do Amazonas","https://dx.doi.org/10.1016/S2214-109X(21)00355-7","Verified",0.115,0.148,0.943,0.97,"","BR","BR-AM"
"2021-11-08","201027_Vermont_UniversityOfVermont_Staff_Primary","SARS CoV-2 seroprevalence in a US school district during COVID-19.","2021-10-27","Local","","United States of America; Vermont","2020-12-02","2020-12-19","Students and Daycares","Adults (18-64 years)",336.0,0.046,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Sean S M Bullis","University of Vermont","https://dx.doi.org/10.1136/bmjpo-2021-001259","Unverified",0.025,0.077,0.95,0.99,"","US","US-VT"
"2021-11-08","201027_Vermont_UniversityOfVermont_Student_Primary","SARS CoV-2 seroprevalence in a US school district during COVID-19.","2021-10-27","Local","","United States of America; Vermont","2020-12-02","2020-12-19","Students and Daycares","Children and Youth (0-17 years)",196.0,0.049,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Sean S M Bullis","University of Vermont","https://dx.doi.org/10.1136/bmjpo-2021-001259","Unverified",0.02,0.093,0.95,0.99,"","US","US-VT"
"2021-11-08","211021_Spain_AlcalaUniversity_AdminStaff_Overall","High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcala, Spain: Contributing Factors.","2021-10-21","Regional","","Spain; Community of Madrid, Community of Castilla-La Mancha; Madrid, Guadalajara","2020-06-08","2020-06-16","Essential non-healthcare workers","Multiple groups",66.0,0.136,"Stratified probability","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ramon Perez-Tanoira","Alcala University","https://dx.doi.org/10.2147/IJGM.S332803","Unverified","","","","","","ES",""
"2021-11-08","211021_Spain_AlcalaUniversity_TeachingStaff_Overall","High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcala, Spain: Contributing Factors.","2021-10-21","Regional","","Spain; Community of Madrid, Community of Castilla-La Mancha; Madrid, Guadalajara","2020-06-08","2020-06-16","Essential non-healthcare workers","Multiple groups",132.0,0.258,"Stratified probability","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ramon Perez-Tanoira","Alcala University","https://dx.doi.org/10.2147/IJGM.S332803","Unverified","","","","","","ES",""
"2021-11-08","211103_NewYorkCity_NewYorkCityHealthandHospitals_Overall","Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.","2021-11-03","Local","","United States of America; New York ; New York","2020-04-30","2020-06-30","Health care workers and caregivers","Multiple groups",727.0,0.294,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Alexander Bryan","New York City Health and hospitals","https://dx.doi.org/10.1136/bmjopen-2021-053158","Unverified","","","","","","US","US-NY"
"2021-11-09","210917_Senegal_InstitutPasteurdeDakar_Overall_PopandTestAdj","Seroprevalence of Anti-SARS-CoV-2 Antibodies in Senegal: A National Population-Based Cross-Sectional Survey, between October and November 2020","2021-09-17","National","","Senegal","2020-10-25","2020-11-26","Household and community samples","Multiple groups",1422.0,0.284,"Stratified probability","NR","Total Antibody","Low","Preprint","Cheikh Talla","Institut Pasteur de Dakar","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3925475","Verified",0.261,0.308,"","","","SN",""
"2021-11-09","211002_Madrid_HospitalLaPaz_Overall","Serum prevalence of SARS-COv2 antibodies in patients with inflammatory bowel disease before vaccination","2021-10-02","Local","","Spain; Community of Madrid; Madrid","2021-02-26","2021-03-26","Patients seeking care for non-COVID-19 reasons","Multiple groups",338.0,0.186,"Convenience","NR","IgG","High","Presentation or Conference","M. Hernandez Perez","Hospital La Paz","http://dx.doi.org/10.1002/ueg2.12144","Unverified","","","","","","ES","ES-MD"
"2021-11-09","211015_JordanUniversityOfScienceAndTechnology_Primary","Prevalence of COVID-19 among blood donors: The Jordan University of Science and Technology experience.","2021-10-15","Local","","Jordan","2020-09-15","2021-01-15","Blood donors","Adults (18-64 years)",1000.0,0.145,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Ziad Elnasser","Jordan University of Science and Technology","https://dx.doi.org/10.1097/MD.0000000000027537","Verified","","","","","","JO",""
"2021-11-09","211019_Qatar_PrimaryHealthCareCorporation_Timepoint1","Antibody Response to SARS-CoV-2: A Cohort Study in Qatar's Primary Care Settings","2021-10-19","National","","Qatar","2020-07-01","2020-07-31","Household and community samples","Multiple groups",943.0,0.12,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Mohamed Syed","Primary Health Care Corporation (PHCC)","https://journals.sagepub.com/doi/full/10.1177/21501327211050569","Verified","","","","","","QA",""
"2021-11-09","211019_Qatar_PrimaryHealthCareCorporation_Timepoint2","Antibody Response to SARS-CoV-2: A Cohort Study in Qatar's Primary Care Settings","2021-10-19","National","","Qatar","2020-10-01","2020-10-31","Household and community samples","Multiple groups",943.0,0.172,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Mohamed Syed","Primary Health Care Corporation (PHCC)","https://journals.sagepub.com/doi/full/10.1177/21501327211050569","Verified","","","","","","QA",""
"2021-11-09","211023_Harare_BiomedicalResearchandTrainingInstituteHarare_February2021_Overall","Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.","2021-10-23","Local","","Zimbabwe; Harare; Harare","2021-02-10","2021-04-17","Household and community samples","Multiple groups",1530.0,0.53,"Simplified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Arun Fryatt","Biomedical Research and Training Institute","https://dx.doi.org/10.1016/j.eclinm.2021.101172","Verified",0.496,0.564,0.992,0.986,"","ZW","ZW-HA"
"2021-11-09","211023_Harare_BiomedicalResearchandTrainingInstituteHarare_November2020_Overall","Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.","2021-10-23","Local","","Zimbabwe; Harare; Harare","2020-11-20","2020-12-20","Household and community samples","Multiple groups",620.0,0.19,"Simplified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Arun Fryatt","Biomedical Research and Training Institute","https://dx.doi.org/10.1016/j.eclinm.2021.101172","Verified",0.151,0.235,0.992,0.986,"","ZW","ZW-HA"
"2021-11-09","211027_Amazon_UniversidaddeCórdoba_Primary","High prevalence of SARS-CoV-2 in an indigenous community of the Colombian amazon region","2021-10-27","Local","","Colombia; Columbian Amazon; Mitú","2020-12-01","2020-12-31","Household and community samples","Multiple groups",589.0,0.576,"Unclear","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Hector Serrano-Coll","Universidad de Córdoba","http://dx.doi.org/10.3390/tropicalmed6040191","Verified","","",0.901,0.992,"","CO",""
"2021-11-09","211028_UniversityHospitalofTrieste_University of Trieste","Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers' serum for COVID-19 screening.","2021-10-28","Local","","Italy; Northeast Italy; Trieste","2020-05-15","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",389.0,0.347,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Francesca Filon","University of Trieste","https://dx.doi.org/10.23749/mdl.v112i5.11798","Unverified","","","","","","IT",""
"2021-11-09","211029_Delhi_MaulanaAzadMedicalCollege","Covid antibodies found in 97% of Delhi residents","2021-10-29","Local","","India","2020-09-24","2021-10-09","Household and community samples","Multiple groups",28000.0,0.97,"Stratified probability","NR","Not reported","Moderate","News and Media","The Times of India","Maulana Azad Medical College","https://timesofindia.indiatimes.com/city/delhi/covid-antibodies-found-in-97-of-delhi-residents/articleshow/87350053.cms","Unverified","","","","","","IN",""
"2021-11-09","211030_Massachusetts_UniversityofMassachusetts","Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens","2021-10-30","Regional","","United States of America; Massachusetts","2019-11-15","2020-12-15","Perinatal","Children and Youth (0-17 years)",72117.0,0.018,"Convenience","NR","IgG","Unclear","Preprint","Kevin Ma","University of Massachusetts","https://www.medrxiv.org/content/10.1101/2021.10.29.21265678v1.full-text","Unverified","","","","","","US","US-MA"
"2021-11-09","211101_Riyadh_PrinceSultanMilitaryMedicalCity_Primary","SARS-CoV-2 seroprevalence among healthcare workers from a tertiary care center in Riyadh, Saudi Arabia.","2021-11-01","Local","","Saudi Arabia","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",188.0,0.032,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Abeer M. Albaadani","Prince Sultan Military Medical City","https://dx.doi.org/10.15537/smj.2021.42.11.20210391","Unverified","","","","","","SA",""
"2021-11-10","210804_Cambridge_RoyalPapworthHospitalNHSTrust_HCW","Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19.","2021-08-04","Local","","United Kingdom of Great Britain and Northern Ireland; England; Cambridge","2020-04-20","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",498.0,0.14,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Helen Baxendale","Cambridge University Hospitals NHS Foundation Trust","https://dx.doi.org/10.2478/jccm-2021-0018","Unverified","","",0.97,1.0,"","GB","GB-ENG"
"2021-11-10","210811_England_OfficeForNationalStatistics_Round6_StudentsPrimary3_PopAdj_TestAdj","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Students and Daycares","Children and Youth (0-17 years)",3798.0,0.112,"Stratified probability","NR","IgG","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified",0.089,0.139,0.8,0.99,"","GB","GB-ENG"
"2021-11-10","210811_England_OfficeForNationalStatistics_Round6_StudentsSecondary4_TestAdj_PopAdj","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Students and Daycares","Children and Youth (0-17 years)",6927.0,0.13,"Stratified probability","NR","IgG","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified",0.116,0.144,0.8,0.99,"","GB","GB-ENG"
"2021-11-10","210930_UnitedKingdom_QueensUniversityBelfast_Round2_overall","Seroprevalence and kinetics of SARS-CoV-2 antibodies in children in the UK: A prospective multicentre cohort study","2021-09-30","National","","United Kingdom of Great Britain and Northern Ireland; England, Northern Ireland, Wales, Scotland; London, Belfast, Cardiff, Glasgow, Manchester","2020-06-16","2020-06-30","Family of essential workers","Children and Youth (0-17 years)",849.0,0.077,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Cathal Roarty","Queens University Belfast","http://dx.doi.org/10.1136/archdischild-2021-rcpch.65","Unverified",0.06,0.096,"","","","GB",""
"2021-11-10","211021_France_UNIVIsanté","[Seroprevalence, risk factors and clinical presentation after the first wave of COVID-19 in nursing homes of the UNIVI group: The SEROCOVID study].","2021-10-21","National","","France","2020-08-31","2020-10-16","Assisted living and long-term care facilities","Seniors (65+ years)",1141.0,0.144,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Marc Harboun","UNIVI santé","https://dx.doi.org/10.1016/j.revmed.2021.10.330","Unverified",0.124,0.164,"","","","FR",""
"2021-11-10","211029_Jatni_ICMRRegionalMedicalResearchCentre","Investigating immunological interaction between lymphatic filariasis and COVID-19 infection: a preliminary evidence.","2021-10-29","Local","","India; Odisha; Jatni","2021-01-15","2021-02-15","Household and community samples","Multiple groups",174.0,0.425,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Abhinav Sinha","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1080/21645515.2021.1989925","Unverified","","",0.98,0.98,"","IN","IN-OR"
"2021-11-10","211029_Thailand_ChulalongkornUniversity_overall_popadj","COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: a cross-sectional study.","2021-10-29","National","","Thailand; Northern Region, Northeastern Region, Central Region, Eastern Region, Southern Region","2020-04-06","2020-06-26","Multiple populations","Adults (18-64 years)",857.0,0.063,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Tanawin Nopsopon","Chulalongkorn University","https://dx.doi.org/10.1136/bmjopen-2020-046676","Unverified","","",0.941,0.98,"","TH",""
"2021-11-10","211030_Aichi_NationalCenterforGeriatricsandGerontology_Primary","Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.","2021-10-30","Regional","","Japan; Aichi Prefecture","2021-06-01","2021-06-30","Health care workers and caregivers","Adults (18-64 years)",556.0,0.937,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Akihiko Nishikimi","National Center for Geriatrics and Gerontology","https://dx.doi.org/10.1016/j.jinf.2021.10.021","Unverified","","","","","","JP","JP-23"
"2021-11-10","211030_UnitedKingdom_QueensUniversityBelfast","Symptoms of SARS-CoV-2 infection in the UK paediatric population","2021-09-30","Regional","","United Kingdom of Great Britain and Northern Ireland; Northern Ireland, Scotland, Wales, England; Belfast, Glasgow, Cardiff, Manchester,; London","2020-04-16","2020-07-03","Household and community samples","Children and Youth (0-17 years)",992.0,0.068,"Unclear","NR","IgG; Not reported","Unclear","Presentation or Conference","Claire McGinn","Queens University Belfast","http://dx.doi.org/10.1136/archdischild-2021-rcpch.135","Unverified","","","","","","GB",""
"2021-11-10","211102_Guatemala_UnidadNacionaldeOftalmología_HCW","SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.","2021-11-02","Local","","Guatemala","2020-11-25","2020-11-25","Health care workers and caregivers","Adults (18-64 years)",94.0,0.18,"Convenience","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Pamela Davila Siliezar","Unidad Nacional de Oftalmología","https://dx.doi.org/10.1080/07853890.2021.1993325","Unverified","","",1.0,0.998,"","GT",""
"2021-11-10","211102_Luanda_UniversidadeAgostinhoNeto_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola.","2021-11-02","Local","","Angola; NR; Luanda","2019-12-15","2020-09-15","Blood donors","Adults (18-64 years)",343.0,0.047,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cruz Sebastiao","Instituto Nacional de Investigação em Saúde","https://dx.doi.org/10.1186/s12879-021-06814-0","Verified","","","","","","AO",""
"2021-11-10","211103_Catalonia_BarcelonaInstituteForGlobalHealth_adults_popadj","Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.","2021-11-03","Regional","","Spain; Catalonia","2020-06-30","2020-11-15","Household and community samples","Multiple groups",4740.0,0.153,"Convenience","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Marianna Karachaliou","Barcelona Institute For Global Health","https://dx.doi.org/10.1038/s41598-021-00807-4","Verified","","",0.958,1.0,"","ES","ES-CT"
"2021-11-10","211103_Madrid_LaPazUniversityHospitalInstituteforHealthResearch_Overall_Testadj","SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown.","2021-11-03","Local","","Spain; Community of Madrid; Madrid","2020-04-15","2020-06-15","Multiple populations","Multiple groups",449.0,0.337,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Patricia Torres Martinez","La Paz University Hospital Institute for Health Research","https://dx.doi.org/10.1038/s41598-021-00990-4","Unverified",0.293,0.382,1.0,0.98,"","ES","ES-MD"
"2021-11-10","211103_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 Nov 2021","2021-11-03","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-09-06","2021-10-10","Blood donors","Multiple groups",2494.0,0.997,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/","Verified",0.993,1.0,0.84,1.0,"","GB","GB-SCT"
"2021-11-10","211103_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 Nov 2021","2021-11-03","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-09-06","2021-10-10","Pregnant or parturient women","Adults (18-64 years)",3023.0,0.197,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/","Verified",0.18,0.213,0.923,1.0,"","GB","GB-SCT"
"2021-11-10","211103_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 Nov 2021","2021-11-03","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-09-06","2021-10-10","Residual sera","Multiple groups",3132.0,0.776,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/","Verified",0.759,0.793,0.973,0.996,"","GB","GB-SCT"
"2021-11-10","211104_Bronx_MontefioreMedicalCenter","Prevalence and dynamics of SARS-CoV-2 nucleocapsid IGG in kidney transplant recipients","2021-11-04","Local","","United States of America; New York; New York","2021-05-03","2021-05-05","Patients seeking care for non-COVID-19 reasons","Multiple groups",1164.0,0.171,"Unclear","NR","IgG","Unclear","Presentation or Conference","Yorg Azzi","Montefiore Medical Center","http://dx.doi.org/10.1681/asn.2020030362","Unverified","","","","","","US","US-NY"
"2021-11-10","211104_Ireland_St.James’sHospital_Primary","Prevalence of Antibodies to SARS-CoV-2 following natural infection and vaccination in Irish Hospital Healthcare Workers; changing epidemiology as the pandemic progresses","2021-11-04","National","","Ireland","2021-04-19","2021-04-28","Health care workers and caregivers","Multiple groups",5085.0,0.18,"Self-referral","NR","Total Antibody","Moderate","Preprint","Niamh Allen","St. James's Hospital","https://www.medrxiv.org/content/10.1101/2021.11.04.21265921v1.full-text","Unverified",0.17,0.19,"","","","IE",""
"2021-11-11","210523_Qatar_CornellUniversity_Overall_PopTestAdj","SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals","2021-05-23","National","","Qatar","2020-05-12","2020-09-09","Residual sera","Multiple groups",112941.0,0.148,"Sequential","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Peter Coyle","Cornell University","http://dx.doi.org/10.1016/j.isci.2021.102646","Verified","","",0.995,0.998,"","QA",""
"2021-11-11","210604_NewYorkCity_LiveOnNY","Covid studies in 208 patients with consent for donation","2021-06-04","Local","","United States of America; New York; New York City","2020-03-16","2020-12-02","Patients seeking care for non-COVID-19 reasons","Multiple groups",208.0,0.034,"Unclear","NR","Not reported","Unclear","Presentation or Conference","Amy Friedman","LiveOnNY","https://atcmeetingabstracts.com/abstract/covid-studies-in-208-patients-with-consent-for-donation/","Unverified","","","","","","US","US-NY"
"2021-11-11","210605_Bronx_MontefioreMedicalCenter","Prevalence and dynamics of SARS-CoV-2 IGG in kidney transplant recipients","2021-06-05","Local","","United States of America; New York; New York","2020-05-03","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",1042.0,0.157,"Unclear","NR","IgG","Unclear","Presentation or Conference","Yorg Azzi","Montefiore Medical Center","https://atcmeetingabstracts.com/abstract/prevalence-and-dynamics-of-sars-cov-2-igg-in-kidney-transplant-recipients/","Unverified","","","","","","US","US-NY"
"2021-11-11","211026_UttarPrasesh_GovernmentofUttarPradesh_primary","Understanding the Prevalence and Geographic Heterogeneity of SARS-CoV-2 Infection: Findings of the First Serosurvey in Uttar Pradesh, India.","2021-10-26","Regional","","India; Uttar Pradesh","2020-09-04","2020-09-10","Household and community samples","Multiple groups",16012.0,0.222,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Vasanthakumar Namasivayam","Government of Uttar Pradesh","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546397/","Verified",0.215,0.229,0.924,0.979,"","IN","IN-UP"
"2021-11-11","211029_Ecuador_UniversidadEspirituSanto","Factors Associated With a Persistent Seronegative Status 1 Year After a SARS-CoV-2 Massive Infection Outbreak in Community Dwellers Living in Rural Ecuador: A Prospective Population-based Study.","2021-10-29","Local","","Ecuador; Santa Elena Province; Atahualpa","2020-05-01","2021-04-30","Household and community samples","Adults (18-64 years)",673.0,0.637,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Universidad Espíritu Santo","https://dx.doi.org/10.1177/21501327211054989","Verified","","",0.975,1.0,"","EC","EC-SE"
"2021-11-11","211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGNSN","Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitoria (Espirito Santo).","2021-10-29","Regional","","Brazil; Espírito Santo; Vitória","2020-06-22","2020-06-26","Persons living in slums","Multiple groups",733.0,0.102,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Ethel Leonor Noia Maciel","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210048","Unverified",0.08,0.125,0.864,0.976,"","BR","BR-ES"
"2021-11-11","211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGSN","Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitoria (Espirito Santo).","2021-10-29","Regional","","Brazil; Espírito Santo; Vitória","2020-06-22","2020-06-26","Household and community samples","Multiple groups",714.0,0.121,"Stratified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ethel Leonor Noia Maciel","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210048","Unverified",0.096,0.145,0.864,0.976,"","BR","BR-ES"
"2021-11-11","211101_Germany_RuhrUniversityBochum","Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center.","2021-11-01","Local","","Germany","2020-08-15","2021-02-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",110.0,0.091,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oliver Overheu","Ruhr-University Bochum","https://dx.doi.org/10.1159/000520572","Unverified","","",0.995,"","","DE",""
"2021-11-12","211103_Catalonia_BarcelonaInstituteForGlobalHealth_adolescents_unadj","Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.","2021-11-03","Regional","","Spain; Catalonia","2020-06-30","2020-11-15","Household and community samples","Children and Youth (0-17 years)",260.0,0.115,"Convenience","NR","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Marianna Karachaliou","Barcelona Institute For Global Health","https://dx.doi.org/10.1038/s41598-021-00807-4","Verified","","",0.958,1.0,"","ES","ES-CT"
"2021-11-15","211030_Turkey_BiruniUniversity_AirCrew","COVID-19 seroconversion in the aircrew from Turkey.","2021-10-30","Local","","Turkey; Marmara; Istanbul","2020-12-01","2021-01-13","Essential non-healthcare workers","Adults (18-64 years)",313.0,0.46,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Mehmet Islamoglu","Biruni University","https://dx.doi.org/10.1016/j.tmaid.2021.102190","Unverified","","","","","","TR",""
"2021-11-15","211030_Turkey_BiruniUniversity_HCW","COVID-19 seroconversion in the aircrew from Turkey.","2021-10-30","Local","","Turkey; Marmara; Istanbul","2020-12-01","2021-01-13","Health care workers and caregivers","Adults (18-64 years)",451.0,0.41,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Mehmet Islamoglu","Biruni University","https://dx.doi.org/10.1016/j.tmaid.2021.102190","Unverified","","","","","","TR",""
"2021-11-15","211030_Turkey_BiruniUniversity_Other","COVID-19 seroconversion in the aircrew from Turkey.","2021-10-30","Local","","Turkey; Marmara; Istanbul","2020-12-01","2021-01-13","Residual sera","Adults (18-64 years)",4258.0,0.353,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Mehmet Islamoglu","Biruni University","https://dx.doi.org/10.1016/j.tmaid.2021.102190","Unverified","","","","","","TR",""
"2021-11-15","211108_Virginia_InovaHealthSystem","A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.","2021-11-08","Regional","","United States of America; Virginia","2020-07-31","2020-10-13","Multiple general populations","Children and Youth (0-17 years)",1038.0,0.085,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Rebecca Levorson","Inova Health System","https://dx.doi.org/10.1371/journal.pone.0259823","Verified",0.069,0.103,"","","","US","US-VA"
"2021-11-15","211109_Quebec_McGillUniversity_EDM","Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study","2021-11-09","Local","","Canada; Québec; Montréal","2021-01-19","2021-07-20","Persons who are incarcerated","Adults (18-64 years)",600.0,0.273,"Unclear","NR","IgG","Moderate","Preprint","Nadine Kronfli","McGill University","10.2139/ssrn.3959665","Unverified","","",0.998,0.995,"","CA","CA-QC"
"2021-11-15","211109_Quebec_McGillUniversity_EDRDP","Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study","2021-11-09","Local","","Canada; Québec; Montréal","2021-02-03","2021-03-24","Persons who are incarcerated","Adults (18-64 years)",300.0,0.147,"Unclear","NR","IgG","Moderate","Preprint","Nadine Kronfli","McGill University","10.2139/ssrn.3959665","Unverified","","",0.998,0.995,"","CA","CA-QC"
"2021-11-15","211109_Quebec_McGillUniversity_EDSJ","Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study","2021-11-09","Local","","Canada; Québec; Saint-Jérôme","2021-03-30","2021-09-15","Persons who are incarcerated","Adults (18-64 years)",200.0,0.19,"Unclear","NR","IgG","Moderate","Preprint","Nadine Kronfli","McGill University","10.2139/ssrn.3959665","Unverified","","",0.998,0.995,"","CA","CA-QC"
"2021-11-16","211019_Daegu_KyungpookNationalUniversity_Overall","Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.","2021-10-19","Local","","Republic of Korea","2021-01-18","2021-02-26","Health care workers and caregivers","Multiple groups",2935.0,0.004,"Convenience","NR","IgG; IgM; IgA; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Yu Kim","Kyungpook National University","https://dx.doi.org/10.3346/jkms.2021.36.e294","Unverified","","","","","","KR",""
"2021-11-16","211109_Denver_CentersforDiseaseControlandPrevention_CommunitySurvey_Overall","Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.","2021-11-09","Regional","","United States of America; Colorado; Denver","2020-07-22","2020-08-08","Household and community samples","Multiple groups",381.0,0.08,"Stratified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kiersten Kugeler","Centers for Disease Control and Prevention","https://dx.doi.org/10.1177/00333549211055137","Verified",0.039,0.157,0.932,0.99,"","US","US-CO"
"2021-11-17","210908_SanFrancisco_UniversityofCalifornia_overall","Seroprevalence of SARS-CoV-2 Among Firefighters/Paramedics in San Francisco, CA.","2021-09-08","Local","","United States of America; California; San Francisco","2020-06-15","2020-07-02","Essential non-healthcare workers","Adults (18-64 years)",1231.0,0.002,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Megan Grant","University of California","https://dx.doi.org/10.1097/JOM.0000000000002383","Unverified",0.0,0.007,"","","","US","US-CA"
"2021-11-17","211019_Geneva_GenevaUniversityHospitals_Overall_Adjusted","Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study","2021-10-19","Regional","","Switzerland; Canton of Geneva","2020-04-06","2020-06-30","Household and community samples","Multiple groups",8344.0,0.078,"Simplified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Aude Richard","Geneva University Hospitals","https://www.medrxiv.org/content/10.1101/2020.12.16.20248180v1.full-text","Verified",0.068,0.089,0.93,1.0,"","CH","CH-GE"
"2021-11-17","211019_SãoPaulo_FederalUniversityofParaná_homeless_overall","High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in Sao Paulo, Brazil","2021-10-19","Local","","Brazil; São Paulo State; São Paulo","2020-08-25","2020-08-27","Persons experiencing homelessness","Multiple groups",203.0,0.547,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anahi Chechia do Couto","Federal University of Paraná","https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754","Unverified",0.478,0.615,"","","","BR","BR-SP"
"2021-11-17","211019_SãoPaulo_FederalUniversityofParaná_workers_overall","High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in Sao Paulo, Brazil","2021-10-19","Local","","Brazil; São Paulo State; São Paulo","2020-08-25","2020-08-27","Essential non-healthcare workers","Multiple groups",87.0,0.494,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anahi Chechia do Couto","Federal University of Paraná","https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754","Unverified","","","","","","BR","BR-SP"
"2021-11-17","211021_EssexCounty_RutgersUniversity_Overall","Prevalence and Correlates of SARS CoV-2 Among a Community-Based Sample Recruited Using Randomized Venue-Based Sampling. Essex County, NJ, 2020.","2021-11-08","Local","","United States of America; New Jersey","2020-09-15","2020-12-22","Household and community samples","Multiple groups",924.0,0.09,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Henry Raymond","Rutgers University","https://dx.doi.org/10.1007/s40615-021-01175-5","Verified","","","","","","US","US-NJ"
"2021-11-17","211029_OsakaCity_OsakaCityGeneralHospital_Overall","Recent Outpatient Services in General Internal Medicine: 6.4% of Symptomatic Patients Were Post-Acute COVID-19.","2021-10-29","Local","","Japan; Osaka Prefecture; Osaka City","2020-11-01","2021-03-31","Residual sera","Multiple groups",94.0,0.064,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Yusuke Hanioka","Osaka City General Hospital","https://dx.doi.org/10.2147/IJGM.S330525","Unverified","","",0.995,0.998,"","JP","JP-27"
"2021-11-17","211105_Colombia_InstitutoNacionaldeSalud_TestAdj","Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.","2021-11-05","National","","Colombia","2020-09-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",3296.0,0.35,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jeadran Nevardo Malagon-Rojas","Instituto Nacional de Salud","https://dx.doi.org/10.1136/oemed-2021-107487","Unverified",0.33,0.37,0.86,0.99,"","CO",""
"2021-11-17","211105_SouthAfrica_NationalHealthLaboratoryService_Overall_Overall","Seroprevalence of SARS-CoV-2 after the Second Wave in South Africa in HIV-Infected and Uninfected Persons: A Cross-Sectional Household Survey, November 2020 â€“ April 2021","2021-11-05","National","","South Africa; KwaZulu-Natal, North West Province, Western Cape; Pietermaritzburg, Klerksdorp, Mitchell's Plain","2020-11-15","2021-04-15","Household and community samples","Multiple groups",7577.0,0.452,"Stratified probability","NR","Total Antibody","Moderate","Preprint","Nicole Wolter","National Health Laboratory Service","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3957112","Verified",0.437,0.467,"","","","ZA",""
"2021-11-17","211108_Colombo_UniversityofSriJayewardenepura","Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.","2021-11-08","Local","","Sri Lanka","2020-04-15","2020-05-19","Contacts of COVID patients","Multiple groups",2633.0,0.034,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Chandima Jeewandara","University of Sri Jayewardenepura","https://dx.doi.org/10.1371/journal.pone.0257548","Unverified","","","",1.0,"","LK",""
"2021-11-17","211108_France_UniversitedeParis_Overall","Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.","2021-11-08","National","","France","2020-05-15","2020-11-15","Household and community samples","Adults (18-64 years)",26823.0,0.041,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Joane Matta","Universite de Paris","https://dx.doi.org/10.1001/jamainternmed.2021.6454","Verified","","",0.87,0.975,"","FR",""
"2021-11-17","211109_EasternCape_WalterSisuluUniversity_HCW_overall","Cumulative incidence of SARS-CoV-2 and associated risk factors among healthcare workers in the Eastern Cape, South Africa","2021-11-09","Regional","","South Africa; Eastern Cape; Buffalo City, Amathole, Chris Hani, Joe Gqabi","2020-11-04","2020-12-18","Health care workers and caregivers","Multiple groups",1295.0,0.377,"Stratified non-probability","NR","IgG","Moderate","Preprint","David Stead","Walter Sisulu University","https://www.medrxiv.org/content/10.1101/2021.11.08.21265966v1.full-text","Unverified","","",1.0,0.999,"","ZA","ZA-EC"
"2021-11-18","210101_Kerala_GovernmentofKerala","ICMR - Serological Surveillance Report - Round 3","2021-01-01","Regional","","India; Kerala","2020-12-20","2020-12-30","Household and community samples","Multiple groups",1246.0,0.116,"Unclear","NR","IgG","Unclear","Institutional Report","Government of Kerala","Government of Kerala Department of Health & Family Welfare","https://health.kerala.gov.in/pdf/Technical-paper-COVID-19-Sero-Surveillance-Round-3-ICMR.pdf","Unverified",0.099,0.135,"","","","IN","IN-KL"
"2021-11-18","210601_Kerala_GovernmentofKerala","ICMR - Serological Surveillance Report - Round 4","2021-06-01","National","","India","2021-05-01","2021-05-31","Household and community samples","Multiple groups",28975.0,0.676,"Unclear","NR","IgG","Unclear","Institutional Report","Government of Kerala","Government of Kerala Department of Health & Family Welfare","https://health.kerala.gov.in/pdf/Technical_paper_COVID_19_Sero_Surveillance_Round_4_ICMR.pdf","Unverified","","","","","","IN",""
"2021-11-18","211104_OrangeCounty_UniversityofCaliforniaIrvine_1_SantaAna_Multiplex","Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.","2021-11-04","Local","","United States of America; California; Santa Ana","2020-12-01","2020-12-30","Household and community samples","Multiple groups",3347.0,0.26,"Stratified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Rafael Assis","University of California Irvine","https://dx.doi.org/10.1038/s41541-021-00396-3","Unverified","","","","","","US","US-CA"
"2021-11-18","211104_OrangeCounty_UniversityofCaliforniaIrvine_2_HCW_May_Multiplex","Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.","2021-11-04","Local","","United States of America; California; Inrvine","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1060.0,0.04,"Convenience","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Rafael Assis","University of California Irvine","https://dx.doi.org/10.1038/s41541-021-00396-3","Unverified","","","","","","US","US-CA"
"2021-11-18","211104_OrangeCounty_UniversityofCaliforniaIrvine_3_HCW_December_Multiplex","Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.","2021-11-04","Local","","United States of America; California; Irvine","2020-12-01","2020-12-30","Health care workers and caregivers","Adults (18-64 years)",313.0,0.11,"Convenience","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Rafael Assis","University of California Irvine","https://dx.doi.org/10.1038/s41541-021-00396-3","Unverified","","","","","","US","US-CA"
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time1_PopTestAdj","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","","Norway","2020-04-19","2020-05-16","Residual sera","Multiple groups",900.0,0.01,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Verified",0.001,0.024,0.86,1.0,"","NO",""
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time2_PopTestAdj","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","","Norway","2020-07-19","2020-09-12","Residual sera","Multiple groups",1812.0,0.006,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Verified",0.002,0.012,0.86,0.999,"","NO",""
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time3_PopTestAdj","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","","Norway","2020-12-27","2021-02-13","Residual sera","Multiple groups",1912.0,0.032,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Verified",0.023,0.042,0.96,0.998,"","NO",""
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time4_Primary","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","","Norway","2019-08-01","2019-08-31","Residual sera","Multiple groups",216.0,0.0,"Convenience","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Verified","","","","","","NO",""
"2021-11-18","211109_Poland_SlaskiUniwersytetMedyczny_Primary","[Infection Fatality Rate (IFR) during the course of COVID-19 pandemic in Upper Silesia Metropolitan Area (Poland) in 2020].","2021-11-09","Local","","Poland","2020-10-15","2020-11-15","Household and community samples","Multiple groups",1167.0,0.114,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jan Zejda","Slaski Uniwersytet Medyczny","https://dx.doi.org/10.13075/mp.5893.01179","Verified",0.095,0.132,0.88,0.99,"","PL",""
"2021-11-18","211110_FaroeIslands_TheFaroeseHospitalSystem_TestAdj","Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020.","2021-11-10","National","","Faroe Islands","2020-11-21","2020-11-30","Household and community samples","Multiple groups",960.0,0.004,"Simplified probability","NR","Total Antibody","Low","Journal Article (Peer-Reviewed)","Maria Skaalum Petersen","The Faroese Hospital System","https://dx.doi.org/10.3201/eid2801.210917","Verified",0.001,0.01,0.944,1.0,"","FO",""
"2021-11-18","211110_Malaysia_UniversityofMalaya_PopAdjusted","Changing predominant SARS-CoV-2 lineages drive successive COVID-19 waves in Malaysia, February 2020 to March 2021.","2021-11-10","Regional","","Malaysia; Selangor; Kuala Lumpur","2020-12-15","2021-04-15","Residual sera","Multiple groups",653.0,0.03,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","I-Ching Sam","University of Malaya","https://dx.doi.org/10.1002/jmv.27441","Verified","","",0.967,0.995,"","MY","MY-10"
"2021-11-18","211111_Australia_NSWWestmeadHospital_Primary","The utility of SARS-CoV-2-specific serology in COVID-19 diagnosis.","2021-11-11","National","","Australia; Australia (Western Australia, South Australia, Tasmania, Victoria; and the Australian Capital Territory) and countries (New Zealand)","2020-01-24","2020-07-31","Multiple populations","Multiple groups",10595.0,0.098,"Sequential","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Tasnim Hasan","New South Wales Westmead Hospital","https://dx.doi.org/10.1111/1753-6405.13155","Verified","","",0.913,0.989,"","AU",""
"2021-11-19","210930_Kerala_GovernmentOfKerala_Antenatal_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","","India; Kerala","2021-08-15","2021-09-15","Pregnant or parturient women","Adults (18-64 years)",2274.0,0.654,"Convenience","NR","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Verified",0.634,0.674,"","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Children_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Children and Youth (0-17 years)",1459.0,0.402,"Stratified probability","NR","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Verified","","","","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Coastal_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",1476.0,0.877,"Stratified probability","NR","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Verified",0.86,0.893,"","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_GenPop_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",4429.0,0.826,"Stratified probability","NR","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Verified",0.815,0.837,"","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Slum_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","","India; Kerala","2021-09-01","2021-09-30","Persons living in slums","Multiple groups",1706.0,0.853,"Stratified probability","NR","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Verified",0.836,0.87,"","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Tribal_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",1521.0,0.782,"Stratified probability","NR","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Verified","","","","","","IN","IN-KL"
"2021-11-19","211109_Denver_CentersforDiseaseControlandPrevention_ClinicalResidualSera_Overall","Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.","2021-11-09","Regional","","United States of America; Colorado","2020-07-22","2020-08-08","Residual sera","Multiple groups",1598.0,0.068,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kiersten Kugeler","Centers for Disease Control and Prevention","https://dx.doi.org/10.1177/00333549211055137","Verified",0.05,0.092,0.932,0.99,"","US","US-CO"
"2021-11-21","211112_Denmark_AarhusUniversity_2020Weeks41to44_TestAdjusted","Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark.","2021-11-12","National","","Denmark","2020-10-05","2020-11-01","Blood donors","Adults (18-64 years)",22690.0,0.021,"Entire sample","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kathrine Kaspersen","Aarhus University","https://dx.doi.org/10.1093/infdis/jiab566","Verified",0.012,0.025,0.967,0.995,"","DK",""
"2021-11-21","211112_Denmark_AarhusUniversity_2021Weeks5to8_Unadjusted","Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark.","2021-11-12","National","","Denmark","2021-02-01","2021-02-28","Blood donors","Adults (18-64 years)",20398.0,0.074,"Entire sample","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kathrine Kaspersen","Aarhus University","https://dx.doi.org/10.1093/infdis/jiab566","Verified","","",0.967,0.995,"","DK",""
"2021-11-22","210209_Stockholm_TheStockholmRegion","9 februari: Lägesrapport om covid-19","2021-02-09","Local","","Sweden","2021-02-01","2021-02-07","Household and community samples","Multiple groups",11175.0,0.447,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/9-februari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210216_Stockholm_TheStockholmRegion","16 februari: Lägesrapport om covid-19","2021-02-16","Local","","Sweden","2021-02-08","2021-02-14","Household and community samples","Multiple groups",8108.0,0.425,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/16-februari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210223_Stockholm_TheStockholmRegion","23 februari: Lägesrapport om covid-19","2021-02-23","Local","","Sweden","2021-02-15","2021-02-21","Household and community samples","Multiple groups",9024.0,0.424,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/23-februari-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210302_Stockholm_TheStockholmRegion","2 mars: Lägesrapport om covid-19","2021-03-02","Local","","Sweden","2021-02-22","2021-02-28","Household and community samples","Multiple groups",12605.0,0.409,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/2-mars-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210309_Stockholm_TheStockholmRegion","9 mars: Lägesrapport om covid-19","2021-03-09","Local","","Sweden","2021-03-01","2021-03-07","Household and community samples","Multiple groups",9237.0,0.395,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/9-mars-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210316_Stockholm_TheStockholmRegion","16 mars: Lägesrapport om covid-19","2021-03-16","Local","","Sweden","2021-03-08","2021-03-14","Household and community samples","Multiple groups",9769.0,0.398,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/16-mars-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210323_Stockholm_TheStockholmRegion","23 mars: Lägesrapport om covid-19","2021-03-23","Local","","Sweden","2021-03-15","2021-03-21","Household and community samples","Multiple groups",9040.0,0.404,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/23-mars-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210330_Stockholm_TheStockholmRegion","30 mars: Lägesrapport om covid-19","2021-03-30","Local","","Sweden","2021-03-22","2021-03-28","Household and community samples","Multiple groups",10146.0,0.409,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/30-mars-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","210406_Stockholm_TheStockholmRegion","6 april: Lägesrapport om covid-19","2021-04-06","Local","","Sweden","2021-03-29","2021-04-04","Household and community samples","Multiple groups",10419.0,0.427,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/6-april-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-11-22","211028_Italy_FondazioneIRCCS_STest","Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.","2021-10-28","Local","","Italy","2020-06-15","2020-12-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",201.0,0.144,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Anna Lia Asti","IRCCS San Matteo Hospital","https://pubmed.ncbi.nlm.nih.gov/34783351/","Unverified","","","","","","IT",""
"2021-11-22","211109_Strasbourg_StrasbourgUniversityHospitals_V0","COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.","2021-11-09","Local","","France","2020-04-06","2020-05-07","Health care workers and caregivers","Multiple groups",1497.0,0.344,"Stratified probability","NR","IgG; IgM","High","Preprint","A Velay","Strasbourg University Hospitals","https://dx.doi.org/10.1016/j.idnow.2021.11.002","Unverified","","","","","","FR",""
"2021-11-22","211113_Tokyo_TokyoMetropolitanInstituteofMedicalScience_Overall","Serologic survey of IgG against SARS-CoV-2 among hospital visitors without a history of SARS-CoV-2 infection in Tokyo, 2020-2021.","2021-11-13","Local","","Japan","2020-09-01","2021-03-31","Residual sera","Multiple groups",23234.0,0.018,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Takahiro Sanada","Tokyo Metropolitan Institute of Medical Science","https://dx.doi.org/10.2188/jea.JE20210324","Unverified",0.017,0.02,"",1.0,"","JP",""
"2021-11-22","211115_HongKong_TheChineseUniversityofHongKong_Overall_PopAdjusted","Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.","2021-11-15","National","","China; NR; NR","2020-04-21","2021-04-18","Household and community samples","Multiple groups",4198.0,0.002,"Convenience","NR","IgG; Not reported","Moderate","Journal Article (Peer-Reviewed)","Siaw Boon","The Chinese University of Hong Kong","https://dx.doi.org/10.1001/jamanetworkopen.2021.32923","Unverified",0.001,0.003,"","","","CN",""
"2021-11-23","200515_Boston_BostonPublicHealthCommission","Results released for antibody and COVID-19 testing of Boston residents","2020-05-18","Local","United States of America","United States of America; Massachusetts; Boston","","2020-05-15","Household and community samples","","","","","NR","","High","News and Media","City of Boston","Boston Public Health Commission","https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents","Unverified","","","","","","US","US-MA"
"2021-11-23","211112_FrenchGuiana_InstitutPasteurinFrenchGuiana_Overall_PopAdjusted","Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.","2021-11-12","National","","French Guiana; Cayenne, Saint-Laurent-du-Maroni; Cayenne, Matoury, Mana, Apatou, Saint-Laurent-du-Maroni, Awala-Yalimapo, Iracoubo, Sinnamary, Kourou, Macouria, Cayenne, Rémire-Montjoly, Saint-Georges, Maripasoula, Papaïchton, Grand-Santi","2020-07-15","2020-07-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",480.0,0.154,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Claude Flamand","Institut Pasteur in French Guiana","https://dx.doi.org/10.1371/journal.pntd.0009945","Verified",0.093,0.244,0.938,0.996,"","GF",""
"2021-11-23","211115_TamilNadu_GovernmentofTamilNadu_Round1_Primary","Seroprevalence in Tamil Nadu through India‚Äôs two COVID waves: Evidence on antibody decline following infection and vaccination","2021-11-15","Regional","","India; Tamil Nadu","2020-10-19","2020-11-30","Household and community samples","Multiple groups",26135.0,0.316,"Stratified probability","NR","IgG","Moderate","Preprint","T S Selvavinayagam","Government of Tamil Nadu","https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text","Unverified",0.303,0.327,"","","","IN","IN-TN"
"2021-11-23","211115_TamilNadu_GovernmentofTamilNadu_Round2_Primary","Seroprevalence in Tamil Nadu through India‚Äôs two COVID waves: Evidence on antibody decline following infection and vaccination","2021-11-15","Regional","","India; Tamil Nadu","2021-04-07","2021-04-30","Household and community samples","Multiple groups",21992.0,0.229,"Stratified probability","NR","IgG","Moderate","Preprint","T S Selvavinayagam","Government of Tamil Nadu","https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text","Unverified",0.218,0.239,"","","","IN","IN-TN"
"2021-11-23","211115_TamilNadu_GovernmentofTamilNadu_Round3_Primary","Seroprevalence in Tamil Nadu through India‚Äôs two COVID waves: Evidence on antibody decline following infection and vaccination","2021-11-15","Regional","","India; Tamil Nadu","2021-06-28","2021-07-07","Household and community samples","Multiple groups",26592.0,0.671,"Stratified probability","NR","IgG","Moderate","Preprint","T S Selvavinayagam","Government of Tamil Nadu","https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text","Unverified",0.659,0.683,"","","","IN","IN-TN"
"2021-11-23","211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_August_Overall","Prospective study on COVID-19 seroprevalence and behavioural patterns in military personnel from the Southern Brazil.","2021-11-16","Regional","","Brazil; Rio Grande do Sul","2020-08-01","2020-08-31","Essential non-healthcare workers","Multiple groups",46.0,0.023,"Stratified non-probability","NR","Not reported","High","Preprint","Sergio Renato da Rosa Decker","Universidade Federal do Rio Grande do Sul","https://dx.doi.org/10.1080/23744235.2021.1995039","Unverified",0.003,0.147,"","","","BR","BR-RS"
"2021-11-23","211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_July_Overall","Prospective study on COVID-19 seroprevalence and behavioural patterns in military personnel from the Southern Brazil.","2021-11-16","Regional","","Brazil; Rio Grande do Sul","2020-07-01","2020-07-31","Essential non-healthcare workers","Multiple groups",48.0,0.061,"Stratified non-probability","NR","Not reported","High","Preprint","Sergio Renato da Rosa Decker","Universidade Federal do Rio Grande do Sul","https://dx.doi.org/10.1080/23744235.2021.1995039","Unverified",0.019,0.177,"","","","BR","BR-RS"
"2021-11-24","210527_Krakow_JagiellonianUniversityMedicalCollege_Primary","SARS-CoV-2 infection and seroconversion in pediatric patients on biological therapy for Crohn's disease: single tertiary center experience","2021-05-27","Local","","Poland","2020-03-04","2021-03-03","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",62.0,0.306,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ruth Sladek","Jagiellonian University Medical College","https://academic.oup.com/ecco-jcc/article/15/Supplement_1/S372/6286668","Unverified","","","","","","PL",""
"2021-11-24","210930_Novara_UniversityofPiemonteOrientale_nonpregnant_overall","COVID-19 seroprevalence in a group of pregnant women compared to a group of non-pregnant women","2021-09-30","Local","","Italy; Novara; ; Novara City","2020-04-27","2020-07-01","Household and community samples","Adults (18-64 years)",588.0,0.128,"Unclear","NR","Not reported","High","Journal Article (Peer-Reviewed)","Viviana Piccirllo","University of Piemonte Orientale","http://dx.doi.org/10.1080/14767058.2021.1962370","Unverified","","","","","","IT",""
"2021-11-24","210930_Novara_UniversityofPiemonteOrientale_pregnant_overall","COVID-19 seroprevalence in a group of pregnant women compared to a group of non-pregnant women","2021-09-30","Local","","Italy; Novara; Novara City","2020-04-27","2020-07-01","Pregnant or parturient women","Adults (18-64 years)",344.0,0.026,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Viviana Piccirllo","University of Piemonte Orientale","http://dx.doi.org/10.1080/14767058.2021.1962370","Unverified","","","","","","IT",""
"2021-11-24","211110_Bangalore_BangaloreBaptistHospital_Phase1_HCW_overall","Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.","2021-11-10","Local","","India; Karnataka; Bangalore","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",211.0,0.0,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sindhulina Chandrasingh","Bangalore Baptist Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.10.006","Verified","","",0.972,0.998,"","IN","IN-KA"
"2021-11-24","211110_Bangalore_BangaloreBaptistHospital_Phase2_HCW_overall","Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.","2021-11-10","Local","","India; Karnataka; Bangalore","2020-09-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",206.0,0.092,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sindhulina Chandrasingh","Bangalore Baptist Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.10.006","Verified",0.086,0.094,0.972,0.998,"","IN","IN-KA"
"2021-11-24","211110_Karnataka_BangaloreBaptistHospital_Phase1_BloodDonors_overall","Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.","2021-11-10","Regional","","India; Karnataka","2020-05-15","2020-06-15","Blood donors","Multiple groups",210.0,0.0,"Unclear","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sindhulina Chandrasingh","Bangalore Baptist Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.10.006","Verified","","",0.972,0.998,"","IN","IN-KA"
"2021-11-24","211111_Rennes_RennesUniversityHospital_Primary","Risk factors for SARS-CoV-2 infection among health care workers","2021-11-11","Local","","France","2020-05-29","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",3234.0,0.038,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Christophe Paris","Rennes University Hospital","https://dx.doi.org/10.1016/j.ajic.2021.11.001","Unverified","","","","","","FR",""
"2021-11-24","211116_Italy_BambinoGesuChildrensHospital","SARS-COV2 Seroprevalence in a Cohort of Perinatally HIV Infected Children and Young Adults From May to December 2020 in Italy","2021-11-16","Local","","Italy","2020-05-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",85.0,0.058,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Chiara Casamento Tumeo","Bambino Gesù Children’s Hospital","https://www.researchsquare.com/article/rs-1061389/v1","Unverified","","","","","","IT",""
"2021-11-24","211117_Catalonia_BarcelonaInstituteforGlobalHealth_Overall","Ambient Air Pollution in Relation to SARS-CoV-2 Infection, Antibody Response, and COVID-19 Disease: A Cohort Study in Catalonia, Spain (COVICAT Study).","2021-11-17","Regional","","Spain; Catalonia","2020-05-17","2020-11-15","Household and community samples","Adults (18-64 years)",4103.0,0.181,"Convenience","NR","IgM; IgA; IgG","Moderate","Journal Article (Peer-Reviewed)","Manolis Kogevinas","Barcelona Institute for Global Health","https://dx.doi.org/10.1289/EHP9726","Verified","","",0.958,1.0,"","ES","ES-CT"
"2021-11-24","211118_Belgium_CliniqueNotreDamedeGrace","SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second.","2021-11-18","Local","","Belgium","2021-01-18","2021-02-08","Health care workers and caregivers","Adults (18-64 years)",189.0,0.418,"Convenience","NR","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Loris Wauthier","Clinique Notre-Dame de Grâce","https://dx.doi.org/10.1080/17843286.2021.2004349","Unverified","","","","","","BE",""
"2021-11-25","211031_Texas_UniversityOfTexas_Children2_Primary","Texas Coronavirus Antibody Response Survey October 2021","2021-10-31","Regional","","United States of America; Texas","","2021-10-04","Household and community samples","Children and Youth (0-17 years)",3889.0,0.365,"Self-referral","NR","Total Antibody","Moderate","Institutional Report","The University of Texas Health Science Center at Houston","University of Texas Health Science Center","https://sph.uth.edu/projects/texascares/docs/TexasCARES%20-%20October%20Report.pdf","Unverified",0.35,0.381,"","","","US","US-TX"
"2021-11-25","211111_Belgium_Sciensano_Residents","The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.","2021-11-11","National","","Belgium; Flanders, Wallonia, Brussels","2020-10-01","2020-12-08","Assisted living and long-term care facilities","Seniors (65+ years)",259.0,0.293,"Convenience","NR","Not reported; IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Goossens","Sciensano","https://dx.doi.org/10.1186/s13690-021-00715-z","Unverified","","","","","","BE",""
"2021-11-25","211111_Belgium_Sciensano_Staff","The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.","2021-11-11","National","","Belgium; Flanders, Wallonia, Brussels","2020-10-01","2020-12-08","Assisted living and long-term care facilities","Adults (18-64 years)",509.0,0.208,"Convenience","NR","Not reported; IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Goossens","Sciensano","https://dx.doi.org/10.1186/s13690-021-00715-z","Unverified","","","","","","BE",""
"2021-11-25","211111_Qatar_HamadMedicalCorporation_SchoolEnd","SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term.","2021-11-11","Local","","Qatar","2020-12-16","2020-12-22","Essential non-healthcare workers","Adults (18-64 years)",331.0,0.317,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","https://dx.doi.org/10.1186/s12889-021-12134-4","Unverified","","",0.995,0.998,"","QA",""
"2021-11-25","211111_UZBrussel_UZBrussel_Phase2","Fear for CoViD-19 and reluctance to work among health care workers during the epidemic, a prospective monocentric cohort study.","2021-11-11","Local","","Belgium","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",2336.0,0.079,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Marco Moretti","University Hospital Brussels","https://dx.doi.org/10.1016/j.ajic.2021.10.042","Unverified","","","","","","BE",""
"2021-11-25","211112_London_UniversityOfOxford","Tracking the Incidence and Risk Factors for Sars-Cov-2 Infection in North West London by Detection of Antibody in Historical Maternal Booking Serum Samples","2021-11-12","Local","","United Kingdom of Great Britain and Northern Ireland","2019-10-15","2020-09-15","Pregnant or parturient women","Adults (18-64 years)",11256.0,0.17,"Sequential","NR","Not reported","Moderate","Preprint","Edward Mullins","University of Oxford","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3954923","Unverified","","",0.989,0.996,"","GB",""
"2021-11-25","211115_Foggia_UniversityHospital“Ospedali Riuniti”Foggia_general_primary","Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders.","2021-11-16","Local","","Italy","2020-05-15","2021-03-15","Blood donors","Multiple groups",8183.0,0.063,"Convenience","NR","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Francescopaolo Antonucci","University Hospital “Ospedali Riuniti” Foggia","https://dx.doi.org/10.1080/23744235.2021.2003856","Verified","","","","","","IT",""
"2021-11-25","211931_Texas_UniversityOfTexas_Adults1_Primary","Texas Coronavirus Antibody Response Survey October 2021","2021-10-31","Regional","","United States of America; Texas","","2021-10-04","Household and community samples","Multiple groups",83977.0,0.231,"Self-referral","NR","Total Antibody","Moderate","Institutional Report","The University of Texas Health Science Center at Houston","University of Texas Health Science Center","https://sph.uth.edu/projects/texascares/docs/TexasCARES%20-%20October%20Report.pdf","Unverified",0.229,0.234,"","","","US","US-TX"
"2021-11-29","211120_Italy_UniversitàCattolicadelSacroCuore_Primary","Seroprevalence of sars-cov-2 in a large cohort of italian police officers","2021-11-21","National","","Italy","2020-04-15","2020-07-15","Essential non-healthcare workers","Multiple groups",10535.0,0.048,"Self-referral","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Sergio Garbarino","Università Cattolica del Sacro Cuore","http://dx.doi.org/10.3390/ijerph182212201","Unverified",0.044,0.053,"",1.0,"","IT",""
"2021-11-30","210430_StLouis_WashingtonUniversityinStLouis_Overall","Limited Diagnostic Utility of SARS-CoV2 Serologic Testing in Symptomatic PCR Negative Patients","2021-04-30","Local","","United States of America; Missouri; St. Louis","2020-08-29","2020-09-19","Residual sera","Multiple groups",393.0,0.036,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Kwaku Tawiah","Washington University in St. Louis","https://doi.org/10.1093/jalm/jfab021","Verified","","","","","","US","US-MO"
"2021-11-30","210528_Lille_OscarLambretComprehensiveCancerCenter","Very low seroprevalence of sars-cov-2 among health care personnel (HCP) in a French northern comprehensive cancer center at the end of first national containment","2021-05-28","Local","","France; Hauts-de-France; Lille","2020-05-04","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",392.0,0.018,"Convenience","NR","Not reported","High","Presentation or Conference","Philippe Doutrelant","Oscar Lambret Comprehensive Cancer Center","https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e13604","Unverified",0.007,0.036,"","","","FR","FR-HDF"
"2021-11-30","210721_France_UniversitedeParis_PREVENIR_Primary","SARS CoV-2 seroprevalence among HIV-negative participants using tenofovir/emtricitabine-based PrEP in 2020-a sub-study of PREVENIR-ANRS and SAPRIS-Sero","2021-07-21","National","","France","2020-05-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",844.0,0.103,"Unclear","NR","IgG","High","Presentation or Conference","C Delaugerre","Université de Paris","https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25755","Unverified","","","","","","FR",""
"2021-11-30","210721_France_UniversitedeParis_SAPRIS-Sero_Primary","SARS CoV-2 seroprevalence among HIV-negative participants using tenofovir/emtricitabine-based PrEP in 2020-a sub-study of PREVENIR-ANRS and SAPRIS-Sero","2021-07-21","National","","France","2020-05-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",844.0,0.092,"Unclear","NR","IgG","High","Presentation or Conference","C Delaugerre","Université de Paris","https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25755","Unverified","","","","","","FR",""
"2021-11-30","210914_Chennai_NationalInstituteofEpidemiology_Overall_PopandTestAdjusted","Monitoring the trend of SARS-CoV-2 seroprevalence in Chennai, India, July and October 2020","2021-09-14","Local","","India; Tamil Nadu; Chennai","2020-10-08","2020-10-15","Household and community samples","Multiple groups",6366.0,0.301,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Muthusamy Kumar","National Institute of Epidemiology","https://academic.oup.com/trstmh/article/115/11/1350/6370308?login=true","Verified",0.247,0.361,1.0,0.996,"","IN","IN-TN"
"2021-11-30","211001_Israel_MaccabiHealthcareServices_Overall_TestAdjusted","COVID-19 seropositive rates between the Waves, Israel","2021-10-01","National","","Israel","2020-06-28","2020-07-27","Residual sera","Multiple groups",15459.0,0.019,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anat Ekka Zohar","Maccabi Healthcare Services","https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2021&month=10&page=611","Unverified","","","","","","IL",""
"2021-11-30","211027_SicilianRegion_UniversityOfCatania_Primary","How to Prevent SARS-CoV-2 Transmission in the Agri-Food Industry during the First Pandemic Wave: Effects on Seroprevalence","2021-10-27","Local","","Italy; Sicilian","2020-04-01","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",328.0,0.0,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ermanno Vitale","University of Catania","https://www.mdpi.com/2076-3417/11/21/10051/htm","Unverified","","","","","","IT",""
"2021-11-30","211118_Delhi_RajivGandhiSuperSpecialityHospital","Evaluation of SARS-CoV-2 antibody responses in healthcare workers at a tertiary care COVID 19 dedicated hospital in Delhi.","2021-11-18","Local","","India","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",305.0,0.22,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","B.L. Sherwal","Rajiv Gandhi Super Speciality Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.11.006","Unverified","","","","","","IN",""
"2021-11-30","211119_Malawi_Malawi-Liverpool-WellcomeTrustClinicalResearchProgramme_Primary","SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021.","2021-11-19","National","","Malawi","2020-01-15","2021-07-15","Blood donors","Multiple groups",5085.0,0.276,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jonathan Mandolo","Malawi-Liverpool-Wellcome Trust Clinical Research Programme","https://dx.doi.org/10.1186/s12916-021-02187-y","Verified","","",0.97,0.98,"","MW",""
"2021-11-30","211119_RiodeJaneiro_FundaçãoOswaldoCruz_Primary","Anti-SARS-CoV-2 antibodies seroprevalence among patients submitted to treatment for tuberculosis in Rio de Janeiro, Brazil: a cross-sectional study","2021-11-19","Local","","Brazil","2020-09-01","2021-02-28","Patients seeking care for non-COVID-19 reasons","Multiple groups",83.0,0.265,"Convenience","NR","IgG; IgM","High","Preprint","Karen Gomes","Fundação Oswaldo Cruz","10.1101/2021.11.17.21266274","Unverified",0.17,0.36,"","","","BR",""
"2021-11-30","211120_ChapelHill_UniversityofNorthCarolinaatChapelHill_3Months_Primary","A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic","2021-11-20","Local","","United States of America; North Carolina; Chapel Hill","2020-07-15","2020-12-15","Multiple populations","Adults (18-64 years)",751.0,0.101,"Convenience","NR","IgG","Moderate","Preprint","Audrey Pettifor","University of North Carolina at Chapel Hill","https://www.medrxiv.org/content/10.1101/2021.11.17.21266367v1.full-text","Unverified",0.074,0.127,0.98,1.0,"","US","US-NC"
"2021-11-30","211121_Bengui_UniversityofBangui","Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic","2021-11-21","Local","","Central African Republic","2021-07-12","2021-08-20","Household and community samples","Multiple groups",799.0,0.741,"Simplified probability","NR","Total Antibody","Moderate","Preprint","Alexandre Manirakiza","University of Bangui","https://www.medrxiv.org/content/10.1101/2021.11.18.21266496v1.full-text","Unverified","","","",0.994,"","CF",""
"2021-11-30","211123_SaudiArabia_JohnsHopkinsAramcoHealthcare","Seroprevalence of Antibodies against SARS-CoV-2 Infection among Healthcare Workers at a Tertiary Hospital in Saudi Arabia","2021-11-23","Local","","Saudi Arabia; Eastern Province; Dhahran","2020-06-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",682.0,0.127,"Convenience","NR","IgG","Moderate","Preprint","Hayat Mushcab","Johns Hopkins Aramco Healthcare","10.21203/rs.3.rs-1102731/v1","Unverified","","",1.0,1.0,"","SA","SA-04"
"2021-11-30","211124_Germany_RobertKochInstitute_Primary","Germany's low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study","2021-11-24","National","","Germany","2020-10-15","2020-11-15","Household and community samples","Multiple groups",14781.0,0.013,"Stratified probability","NR","IgG","Low","Preprint","Hannelore Neuhauser","Robert Koch Institute","10.1101/2021.11.22.21266711","Unverified",0.009,0.017,0.811,0.997,"","DE",""
"2021-11-30","211124_Texas_TheUniversityofTexasHealthScienceCenter_Primary","Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents","2021-11-24","Regional","","United States of America; Texas","2020-10-15","2021-07-15","Household and community samples","Multiple groups",159.0,0.434,"Convenience","NR","Total Antibody","High","Preprint","Sarah Messiah","The University of Texas Health Science Center","10.1101/2021.11.21.21266484","Unverified","","",0.97,0.97,"","US","US-TX"
"2021-12-01","210413_Stockholm_TheStockholmRegion","13 april: Lägesrapport om covid-19","2021-04-13","Local","","Sweden","2021-04-05","2021-04-11","Household and community samples","Multiple groups",2084.0,0.509,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/13-april-lagesrapport-om-covid-19/","Verified","","","","","","SE",""
"2021-12-01","210420_Stockholm_TheStockholmRegion","20 april: Lägesrapport om covid-19","2021-04-20","Local","","Sweden","2021-04-12","2021-04-18","Household and community samples","Multiple groups",868.0,0.576,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/mall-lagesrapport-med-tabell/","Verified","","","","","","SE",""
"2021-12-01","210427_Stockholm_TheStockholmRegion","27 april: Lägesrapport om covid-19","2021-04-27","Local","","Sweden","2021-04-19","2021-04-25","Household and community samples","Multiple groups",953.0,0.615,"Unclear","NR","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/27-april-Lagesrapport-om-ovid-19/","Verified","","","","","","SE",""
"2021-12-01","211105_Mexico_InstitutoNacionaldeSaludPublica_Adolescent_Primary","Seroprevalence of SARS-CoV-2 in Mexican children and adolescents in primary and secondary education age","2021-11-05","National","","Mexico","2020-08-15","2020-11-15","Household and community samples","Children and Youth (0-17 years)",944.0,0.187,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Francisco Canto-Osorio","Instituto Nacional de Salud Públic","https://saludpublica.mx/index.php/spm/article/view/12847","Verified",0.149,0.225,0.92,0.995,"","MX",""
"2021-12-01","211105_Mexico_InstitutoNacionaldeSaludPublica_Children_Primary","Seroprevalence of SARS-CoV-2 in Mexican children and adolescents in primary and secondary education age","2021-11-05","National","","Mexico","2020-08-15","2020-11-15","Household and community samples","Children and Youth (0-17 years)",858.0,0.267,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Francisco Canto-Osorio","Instituto Nacional de Salud Públic","https://saludpublica.mx/index.php/spm/article/view/12847","Verified",0.221,0.313,0.92,0.995,"","MX",""
"2021-12-01","211109_Nayarit_AutonomousUniversityofNayarit_overall","Anti-SARS CoV-2 IgG levels in children from Nayarit, Mexico, as a biomarker of community immunity. Case study of 17 months after the COVID-19 pandemic","2021-11-09","Local","","Mexico; Nayarit; Ciudad de Tepic","2021-06-28","2021-06-28","Household and community samples","Children and Youth (0-17 years)",134.0,0.17,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Gladys Alejandra Toledo-Ibarra","Autonomous University of Nayarit","https://saludpublica.mx/index.php/spm/article/view/13128/12175","Unverified","","","","","","MX","MX-NAY"
"2021-12-01","211110_PalmBeachCounty_FloridaDepartmentofHealth_overall","SARS-CoV-2 Seroprevalence in Florida Department of Health in Palm Beach County Obstetric Clinics: A Cross-Sectional Study during the First Pandemic Surge.","2021-11-10","Local","","United States of America; Florida; Lantana, West Palm Beach, Delray Beach, Belle Glade","2020-06-29","2020-08-05","Pregnant or parturient women","Adults (18-64 years)",618.0,0.264,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Charles Gonik","Wayne State University School of Medicine","https://dx.doi.org/10.1055/s-0041-1739353","Unverified","","",1.0,0.996,"","US","US-FL"
"2021-12-01","211116_SouthAndaman_AndamanandNicobarIslandsInstituteofMedicalSciences_Overall","A seroprevalence study of Covid 19 antibody after 1st wave of the pandemic in South Andaman district, India.","2021-11-16","Local","","India; Andaman and Nicobar Islands","2020-12-15","2021-02-15","Household and community samples","Multiple groups",2400.0,0.393,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Deepak Kumar","Andaman and Nicobar Islands Institute of Medical Sciences","https://dx.doi.org/10.1016/j.cegh.2021.100901","Verified","","",0.95,0.993,"","IN","IN-AN"
"2021-12-01","211117_Norway_OsloUniversityHospital_KidneyTransplantRecipient","Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway.","2021-11-17","National","","Norway","2020-06-15","2020-10-31","Representative patient population","Multiple groups",815.0,0.0,"Convenience","NR","IgG","High","Preprint","Kjersti B. Blom","Oslo University Hospital","https://dx.doi.org/10.1016/j.xkme.2021.09.006","Unverified","","","","","","NO",""
"2021-12-01","211119_Kashmir_GovernmentMedicalCollegeSrinagarJammuKashmir_Primary","The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India-A seroepidemiological study.","2021-11-19","Regional","","India; Kashmir","2021-01-14","2021-01-17","Health care workers and caregivers","Adults (18-64 years)",2003.0,0.268,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Inaamul Haq","Government Medical College Srinagar, Jammu and Kashmir","https://dx.doi.org/10.1371/journal.pone.0259893","Unverified",0.248,0.288,1.0,0.99,"","IN","IN-JK"
"2021-12-01","211122_Germany_SaarlandUniversity_PEP/PrEP_Primary","IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.","2021-11-22","Regional","","Germany; South-west Germany","2020-04-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",50.0,0.06,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Dominic Kaddu-Mulindwa","Saarland University","https://dx.doi.org/10.1111/hiv.13207","Unverified","","","","","","DE",""
"2021-12-01","211122_Germany_SaarlandUniversity_PLWH_Primary","IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.","2021-11-22","Regional","","Germany; South-west Germany","2020-04-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",594.0,0.019,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Dominic Kaddu-Mulindwa","Saarland University","https://dx.doi.org/10.1111/hiv.13207","Unverified","","","","","","DE",""
"2021-12-01","211122_Montreal_UniversityOfMontreal","Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.","2021-11-23","Local","","Canada; Quebec; Montreal","2020-10-22","2021-03-22","Students and Daycares","Children and Youth (0-17 years)",1632.0,0.058,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Kate Zinszer","University of Montreal","https://dx.doi.org/10.1001/jamanetworkopen.2021.35975","Unverified",0.049,0.07,0.95,1.0,"","CA","CA-QC"
"2021-12-01","211122_OrangeCounty_UniversityofCalifornia_Primary","Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the community.","2021-11-22","Local","","United States of America; California","2020-05-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",654.0,0.133,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shruti Gohil","University of California","https://dx.doi.org/10.1186/s13756-021-01031-5","Unverified","","","","","","US","US-CA"
"2021-12-01","211122_SanJuandeLurigancho_InstitutodeInvestigacionNutricional_overall","SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study","2021-11-22","Local","","Peru","2020-12-09","2021-03-19","Household and community samples","Multiple groups",132.0,0.098,"Sequential","NR","IgG","High","Preprint","Claudio Lanata","Vanderbilt University and Vanderbilt University Medical Center","10.2139/ssrn.3961370","Unverified",0.054,0.162,"","","","PE",""
"2021-12-01","211123_Athens_UniversityofAthens_June_Overall","A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.","2021-11-23","Local","","Greece; Attica; Athens","2021-06-01","2021-06-22","Residual sera","Multiple groups",901.0,0.557,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Helena Maltezou","University of Athens","https://dx.doi.org/10.1002/jmv.27465","Verified","","","","","","GR","GR-I"
"2021-12-01","211123_Athens_UniversityofAthens_March_Overall","A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.","2021-11-23","Local","","Greece; Attica; Athens","2021-03-01","2021-03-22","Residual sera","Multiple groups",764.0,0.116,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Helena Maltezou","University of Athens","https://dx.doi.org/10.1002/jmv.27465","Verified","","","","","","GR","GR-I"
"2021-12-01","211123_Perpignan_PerpignanHospitalCenter_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.","2021-11-23","Local","","France; Occitanie; Perpignan","2020-06-29","2020-07-17","Household and community samples","Multiple groups",700.0,0.354,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Adeline Beaumont","Perpignan Hospital Center","https://dx.doi.org/10.1136/bmjopen-2021-053201","Unverified",0.302,0.41,0.995,0.998,"","FR","FR-OCC"
"2021-12-02","211102_Sweden_UniversityofGothenburg_BloodDonorsTP5_N+S","Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.","2021-11-02","Local","","Sweden","2021-01-12","2021-01-29","Blood donors","Multiple groups",253.0,0.119,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Emelie Marklund","University of Gothenburg","https://dx.doi.org/10.3389/fimmu.2021.750448","Verified","","","","","","SE",""
"2021-12-02","211102_Sweden_UniversityofGothenburg_HCWsTP5_N+S","Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.","2021-11-02","Local","","Sweden","2021-01-12","2021-01-29","Health care workers and caregivers","Multiple groups",280.0,0.293,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Emelie Marklund","University of Gothenburg","https://dx.doi.org/10.3389/fimmu.2021.750448","Verified","","","","","","SE",""
"2021-12-02","211112_Zurich_UniversityofZurich_T3","Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona.","2021-11-12","Regional","","Switzerland; Zurich","2021-03-15","2021-04-16","Students and Daycares","Children and Youth (0-17 years)",2450.0,0.164,"Stratified probability","NR","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Agne Ulyte","University of Zurich","https://dx.doi.org/10.4414/smw.2021.w30092","Unverified",0.121,0.195,0.982,0.994,"","CH","CH-ZH"
"2021-12-02","211116_Bratislava_SlovakAcademyOfSciences","Seroprevalence of SARS-CoV-2 IgG antibodies in the staff of the Slovak Academy of Sciences in response to COVID-19 and/or vaccination: situation in August 2021.","2021-11-16","Local","","Slovakia","2021-07-01","2021-08-15","Non-essential workers and unemployed persons","Multiple groups",1928.0,0.841,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ivana Kajanova","Slovak Academy Of Sciences","https://dx.doi.org/10.4149/av_2021_407","Unverified","","",0.944,0.996,"","SK",""
"2021-12-02","211121_NewYorkCity_ IcahnSchoolofMedicine","SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort.","2021-11-21","Local","","United States of America; New York; New York City","2020-04-20","2020-09-22","Pregnant or parturient women","Adults (18-64 years)",708.0,0.164,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Nina Molenaar","Icahn School of Medicine","https://dx.doi.org/10.1111/ppe.12812","Verified",0.137,0.193,0.95,1.0,"","US","US-NY"
"2021-12-02","211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round10_Overall","Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.","2021-11-22","Regional","","Brazil; Rio Grande do Sul","2021-04-09","2021-04-11","Household and community samples","Multiple groups",4499.0,0.182,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Aluisio Barros","Universidade Federal de Pelotas","https://www.scielosp.org/article/rsp/2021.v55/78/","Verified",0.169,0.195,0.95,0.986,"","BR","BR-RS"
"2021-12-02","211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round9_Overall","Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.","2021-11-22","Regional","","Brazil; Rio Grande do Sul","2021-02-05","2021-02-07","Household and community samples","Multiple groups",4501.0,0.1,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Aluisio Barros","Universidade Federal de Pelotas","https://www.scielosp.org/article/rsp/2021.v55/78/","Verified",0.091,0.11,0.95,0.986,"","BR","BR-RS"
"2021-12-02","211124_EastHararghe_UniversityofLondon_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance.","2021-11-24","Regional","","Ethiopia; Oromia, Harari; Haramaya, Harar","2020-04-01","2021-03-31","Pregnant or parturient women","Adults (18-64 years)",1447.0,0.057,"Simplified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Nega Assefa","The London School of Hygiene & Tropical Medicine","https://dx.doi.org/10.1136/bmjopen-2021-055834","Verified",0.046,0.07,1.0,0.988,"","ET",""
"2021-12-03","211125_France_UnitédesVirusÉmergents_Overall_PopAdjusted","Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France.","2021-11-25","National","","France; Haut de France, Normandi, Ile de France, Bretagne, Grand Est, Bourgogne France Comte, Centre val de Loire, Auvergne Rhome Alpes, Pays de Loire, Occitanie, Nouvelle Aquitaine, Provence-Alpes-Côte d'Azur","2020-05-04","2020-09-30","Household and community samples","Multiple groups",82126.0,0.051,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Fabrice Carrat","Unité des Virus Émergents","https://dx.doi.org/10.1007/s15010-021-01731-5","Verified",0.049,0.054,0.87,0.975,"","FR",""
"2021-12-06","211126_Jazan_JazanUniversity_Primary","Community-based seroprevalence of sars-cov-2 antibodies following the first wave of the covid-19 pandemic in jazan province, saudi arabia","2021-11-26","Regional","","Saudi Arabia; Jazan province","2020-08-25","2020-12-30","Household and community samples","Multiple groups",594.0,0.258,"Self-referral","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Abdulaziz Alhazmi","Jazan University","http://dx.doi.org/10.3390/ijerph182312451","Unverified",0.212,0.3,"","","","SA","SA-09"
"2021-12-06","211130_France_SorbonneParisNordUniversity_Primary","Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Sante cohort.","2021-11-30","National","","France","2020-05-15","2020-10-15","Blood donors","Multiple groups",7766.0,0.04,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Melanie Deschasaux-Tanguy","Sorbonne Paris Nord University","https://dx.doi.org/10.1186/s12916-021-02168-1","Unverified","","","","","","FR",""
"2021-12-06","211201_Veneto_MonastierDiTrevisoHospital_Primary","Epidemiological study in a small rural area of Veneto (Italian region) during Sars-Cov-2 Pandemia.","2021-12-01","Local","","Italy; Veneto","2020-05-04","2020-07-15","Household and community samples","Multiple groups",922.0,0.021,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Marco Bassanello","Monastier di Treviso Hospital","https://dx.doi.org/10.1038/s41598-021-02654-9","Unverified","","","","","","IT","IT-34"
"2021-12-06","211202_Philadelphia_UniversityofPennsylvania_Overall","Evolution of SARS-CoV-2 Seroprevalence Among Employees of a United States Academic Children's Hospital During the COVID-19 Pandemic.","2021-12-02","Local","","United States of America; Pennsylvania; Philadelphia","2020-04-20","2020-11-04","Health care workers and caregivers","Multiple groups",1740.0,0.053,"Convenience","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Brian T Fisher","University of Pennsylvania","https://dx.doi.org/10.1017/ice.2021.487","Unverified","","",1.0,0.989,"","US","US-PA"
"2021-12-07","211029_Maharashtra_ArmedForcesMedicalCollege_Primary","Impact of Safety Measures in Endoscopic Procedures in Health Care Professionals during Corona Virus Pandemic","2021-10-29","Regional","","India; Maharashtra","2020-08-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",117.0,0.325,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Harish Kumur","Armed Forces Medical College","https://www.journaljpri.com/index.php/JPRI/article/view/33074","Unverified","","","","","","IN","IN-MH"
"2021-12-07","211105_Gauteng_NationalHealthLaboratoryService_OverallFullAdjust","Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August- October 2020","2021-11-05","Regional","","South Africa; Gauteng","2020-08-01","2020-10-31","Residual sera","Multiple groups",6477.0,0.278,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya George","National Health Laboratory Service","https://doi.org/10.7196/SAMJ.2021.v111i11.15669","Unverified","","",0.93,0.99,"","ZA","ZA-GT"
"2021-12-07","211112_Ruhr_RuhrUniversityBochum_Primary","Longitudinal Rise in Seroprevalence of SARS-CoV-2 Infections in Children in Western Germany-A Blind Spot in Epidemiology?.","2021-11-12","Regional","","Germany; Ruhr; Bochum, Gütersloh, Herne","2020-06-15","2021-02-15","Residual sera","Children and Youth (0-17 years)",2145.0,0.026,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Folke Brinkmann","Ruhr University Bochum","https://dx.doi.org/10.3390/idr13040088","Verified","","","","","","DE",""
"2021-12-07","211123_Mongolia_MongolianNationalUniversityofMedicalSciences_Primary_Popadjust","SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey.","2021-11-23","National","","Mongolia","2020-10-13","2020-12-04","Household and community samples","Multiple groups",5000.0,0.014,"Stratified probability","NR","Total Antibody; IgG","Low","Journal Article (Peer-Reviewed)","Battogtokh Chimeddorj","Mongolian National University of Medical Sciences","https://dx.doi.org/10.1016/j.lanwpc.2021.100317","Verified",0.011,0.016,"","","","MN",""
"2021-12-07","211128_Prishtina_MunicipalityofPrishtina_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies among municipal staff in the municipality of Prishtina","2021-11-28","Local","","Kosovo","2020-10-01","2020-11-30","Non-essential workers and unemployed persons","Adults (18-64 years)",418.0,0.211,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Bujar Gashi","Municipality of Prishtina","http://dx.doi.org/10.3390/ijerph182312545","Unverified","","","","","","XK",""
"2021-12-08","210501_Ithaca_CornellUniversity_Primary_AntiRBD","Development of a quantitative COVID-19 Multiplex Assay and its use for serological surveillance in a low SARS-CoV-2 incidence community","2021-05-01","Local","","United States of America; New York; Ithaca","2020-06-01","2020-06-15","Household and community samples","Multiple groups",332.0,0.051,"Unclear","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Cassandra Guarino","Cornell University","https://www.jimmunol.org/content/206/1_Supplement/114.11?ct=&utm_source=TrendMD&utm_medium=cpc&utm_campaign=J_Immunol_TrendMD_1","Unverified","","","","","","US","US-NY"
"2021-12-08","211111_Brazil_UniversidadedeSantaCruzdoSul_Primary","[Social distancing as protection factor against COVID-19 in a non-metropolitan area in the State of Rio Grande do Sul, BrazilLas medidas de distanciamiento social como factor de proteccion contra la COVID-19 en el interior de Rio Grande do Sul, Brasil].","2021-11-11","Regional","","Brazil; Vale do Rio Pardo","2020-08-01","2020-10-17","Household and community samples","Multiple groups",4252.0,0.029,"Stratified probability","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Ana Schneider","Universidade de Santa Cruz do Sul","https://dx.doi.org/10.26633/RPSP.2021.145","Verified","","",0.968,0.976,"","BR",""
"2021-12-08","211118_Guangdong_GuangzhouMedicalUniversity_OverallPopAdjust","Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020.","2021-11-18","Regional","","China; Guangdong; Chaozhou,Heyuan,Jiangmen,Jieyang,Maoming,Meizhou,Qingyuan,Shantou,Shanwei,Shaoguan,Yangjiang,Yunfu,Zhanjiang,Zhaoqing,Dongguan,Foshan,Guangzhou,Huizhou,Shenzhen,Zhongshan,Zhuhai","2020-03-11","2020-06-24","Residual sera","Multiple groups",14629.0,0.002,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Cheng Xiao","Guangzhou Medical University","https://www.mdpi.com/2076-0817/10/11/1505/htm","Unverified",0.001,0.002,0.896,0.992,"","CN","CN-44"
"2021-12-09","211105_Sergipe_FederalUniversityofSergipe_Phase1_Overall","Does In-Person Visiting Affect the Number of COVID-19 Cases in Prisons?.","2021-11-05","Regional","","Brazil; Sergipe","2020-08-31","2020-09-09","Persons who are incarcerated","Multiple groups",778.0,0.32,"Simplified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lysandro Pinto Borges","Federal University of Sergipe","https://dx.doi.org/10.3390/life11111184","Unverified","","",0.97,0.99,"","BR","BR-SE"
"2021-12-09","211105_Sergipe_FederalUniversityofSergipe_Phase2","Does In-Person Visiting Affect the Number of COVID-19 Cases in Prisons?.","2021-11-05","Regional","","Brazil; Sergipe","2020-10-05","2020-10-09","Persons who are incarcerated","Multiple groups",453.0,0.196,"Simplified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lysandro Pinto Borges","Federal University of Sergipe","https://dx.doi.org/10.3390/life11111184","Unverified","","",0.97,0.99,"","BR","BR-SE"
"2021-12-09","211128_SanFrancisco_UniversityofCalifornia_Round3","Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic Studies","2021-11-28","Regional","","United States of America; California","2021-02-15","2021-04-15","Household and community samples","Multiple groups",4641.0,0.313,"Convenience","NR","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Marcus Wong","University of California","https://www.medrxiv.org/content/10.1101/2021.11.25.21266786v1.full-text","Verified","","","","","","US","US-CA"
"2021-12-09","211201_Wuhan_ZhongnanHospitalUniversityOfWuhan_IgG","Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.","2021-12-01","Local","","China; Hubei; Wuhan","2020-03-01","2020-06-30","Multiple populations","Multiple groups",21398.0,0.046,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Yufeng Shang","University of Wuhan Zhongnan Hospital","https://dx.doi.org/10.1002/jmv.27483","Unverified",0.043,0.049,"","","","CN","CN-42"
"2021-12-13","211115_Ireland_RoyalCollegeofSurgeonsinIreland","Babies born in the 1st 2020 lockdown: Early data from the CORAL study","2021-11-15","National","","Ireland","2020-03-15","2020-05-15","Perinatal","Children and Youth (0-17 years)",200.0,0.015,"Unclear","NR","Not reported","Unclear","Journal Article (Peer-Reviewed)","Marguerite Lawler","Royal College of Surgeons in Ireland","http://dx.doi.org/10.1111/all.15095","Unverified","","","","","","IE",""
"2021-12-13","211125_Ireland_IrishBloodTransfusionService_Primary","Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection.","2021-11-25","National","","Ireland","2020-02-15","2020-09-15","Blood donors","Multiple groups",8509.0,0.024,"Simplified probability","NR","IgG; IgM; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Dearbhla Butler","Irish Blood Transfusion Service","https://dx.doi.org/10.1016/j.jcv.2021.105045","Unverified",0.021,0.028,"","","","IE",""
"2021-12-13","211207_MayoClinicRochester_MayoClinic","Autoimmune Encephalitis After SARS-CoV-2 Infection Case Frequency, Findings, and Outcomes","2021-12-07","Local","","United States of America; Minnesota; Rochester","2019-11-01","2020-12-31","Residual sera","Multiple groups",556.0,0.032,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Cristina Sanchez","Mayo Clinic","http://dx.doi.org/10.1212/WNL.0000000000012931","Verified","","","","","","US","US-MN"
"2021-12-13","211208_SaudiArabia_JohnsHopkinsAramcoHealthcare_Primary","High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia.","2021-12-08","Local","","Saudi Arabia","2020-08-01","2020-08-31","Household and community samples","Multiple groups",5629.0,0.502,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Sami Almudarra","Saudi Ministry of Health","https://dx.doi.org/10.1007/s15010-021-01726-2","Unverified",0.488,0.515,"","","","SA",""
"2021-12-14","211021_Armenia_EcoSenseDiagnosticCenter","Serological investigation of covid 19 antibodies in Armenia","2021-10-21","National","","Armenia","2020-03-15","2020-12-15","Household and community samples","Multiple groups",837.0,0.253,"Self-referral","NR","IgG","High","Presentation or Conference","I Nazaryan","EcoSense Diagnostic Center","http://dx.doi.org/10.1515/cclm-2021-5027","Unverified","","","","","","AM",""
"2021-12-14","211022_Canada_UniversityofAlberta","COVID-19 infection and mental wellness in a Canadian cohort study of healthcare workers","2021-10-22","National","","Canada; British Columbia, Alberta, Ontario, and Quebec","2020-03-19","2020-09-22","Health care workers and caregivers","Adults (18-64 years)",5135.0,0.002,"Unclear","NR","Not reported","Unclear","Presentation or Conference","Nicola Cherry","University of Alberta","http://dx.doi.org/10.1136/OEM-2021-EPI.34","Unverified","","","","","","CA",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_MarApr2021","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","","Netherlands","2021-03-01","2021-04-30","Multiple populations","Multiple groups",288.0,0.122,"Convenience","NR","Total Antibody","High","Presentation or Conference","Myrthe L Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Verified","","",1.0,0.982,"","NL",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_SepOct2020","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","","Netherlands","2020-09-01","2020-10-31","Multiple populations","Multiple groups",312.0,0.067,"Convenience","NR","Total Antibody","High","Presentation or Conference","Myrthe L Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Verified","","",1.0,0.982,"","NL",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_MarApr2021","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","","Netherlands","2021-03-01","2021-04-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",202.0,0.129,"Convenience","NR","Total Antibody","High","Presentation or Conference","Myrthe L Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Verified","","",1.0,0.982,"","NL",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_SepOct2020","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","","Netherlands","2020-09-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",236.0,0.055,"Convenience","NR","Total Antibody","High","Presentation or Conference","Myrthe L Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Verified","","",1.0,0.982,"","NL",""
"2021-12-14","211029_Cairo_AinShamsUniversity","Seropositive coronavirus disease 2019 detection among apparently healthy voluntary blood donors: a preliminary step to catch asymptomatic cases as a potential viral spread route","2021-10-29","Local","","Egypt","2020-09-06","2020-10-31","Blood donors","Adults (18-64 years)",100.0,0.38,"Simplified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Sahar Abdelmaksoud","Ain-Shams University","https://www.ehj.eg.net/article.asp?issn=1110-1067;year=2021;volume=46;issue=2;spage=65;epage=69;aulast=Abdelmaksoud","Verified","","","","","","EG",""
"2021-12-14","211110_Modena_UniversityofModenaandReggioEmilia","eP034 Usefulness of serological antibodies assays to better evaluate the prevalence of SARS-CoV-2 infection in youths with type 1 diabetes","2021-11-10","Local","","Italy","2021-01-15","2021-06-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",85.0,0.153,"Unclear","NR","IgG","Unclear","Presentation or Conference","B Predieri","University of Modena and Reggio Emilia","http://dx.doi.org/10.1111/pedi.13269","Unverified","","","","","","IT",""
"2021-12-14","211112_Colombo_UniversityofSriJayewardenepura_Overall","Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka","2021-11-12","Local","","Sri Lanka; Western Province; Colombo","2021-01-15","2021-01-31","Household and community samples","Multiple groups",2547.0,0.245,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Chandima Jeewandara","University of Sri Jayewardenepura","https://www.frontiersin.org/articles/10.3389/fpubh.2021.724398/full","Unverified","","",0.98,1.0,"","LK","LK-1"
"2021-12-14","211201_GreaterLondon_PublicHealthEngland_Residents","Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.","2021-12-01","Local","","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-11","2020-07-26","Assisted living and long-term care facilities","Seniors (65+ years)",459.0,0.577,"Convenience","NR","IgG; Not reported","High","Journal Article (Peer-Reviewed)","Anna Jeffery-Smith","Public Health England","https://dx.doi.org/10.1016/S2666-7568(21)00253-1","Unverified","","","","","","GB","GB-ENG"
"2021-12-14","211201_GreaterLondon_PublicHealthEngland_Staff","Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.","2021-12-01","Local","","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-11","2020-07-26","Assisted living and long-term care facilities","Adults (18-64 years)",712.0,0.496,"Convenience","NR","IgG; Not reported","High","Journal Article (Peer-Reviewed)","Anna Jeffery-Smith","Public Health England","https://dx.doi.org/10.1016/S2666-7568(21)00253-1","Unverified","","","","","","GB","GB-ENG"
"2021-12-14","211202_Israel_Tel-AvivUniversity","Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.","2021-12-02","Local","","Israel; Tel Aviv District; Ramat Gan","2020-04-04","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",428.0,0.007,"Self-referral","NR","IgG","High","Journal Article (Peer-Reviewed)","Yaniv Lustig","Tel-Aviv University","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001690","Unverified",0.002,0.02,0.818,0.98,"","IL","IL-TA"
"2021-12-14","211202_Tehran_ImamHosseinHospital","Routine COVID-19 testing may not be necessary for most cancer patients.","2021-12-02","Local","","Iran (Islamic Republic of); Tehran; Tehran","2020-08-01","2020-10-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",107.0,0.14,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ali Motlagh","Imam Hossein Hospital","https://dx.doi.org/10.1038/s41598-021-02692-3","Unverified","","","","","","IR","IR-07"
"2021-12-14","211207_Calgary_CummingSchoolofMedicine","SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls.","2021-12-07","Local","","Canada; Alberta; Calgary","2020-01-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",173.0,0.035,"Convenience","NR","IgG; IgA","High","Journal Article (Peer-Reviewed)","Hanna Mathew","Cumming School of Medicine, University of Calgary","https://dx.doi.org/10.1177/09612033211063793","Unverified","","","","","","CA","CA-AB"
"2021-12-15","211025_Piacenza_1AUSLPiacenza","ELBA03 Efficacy and Safety of COVID-19 Vaccine in Cancer Patients","2021-10-25","Local","","Italy; Emilia-Romagna; Piacenza","2021-03-20","2021-05-29","Patients seeking care for non-COVID-19 reasons","Multiple groups",293.0,0.072,"Convenience","NR","IgG","High","Presentation or Conference","Biasini C","Azienda Unita Sanitaria Locale di Piacenza","http://dx.doi.org/10.1177/03008916211041664","Unverified","","","","","","IT","IT-45"
"2021-12-15","211111_Verona_UniversityofVerona","Inflammatory peripheral neuropathies during the covid-19 pandemic: Is there a relation?","2021-11-11","Local","","Italy; Veneto; Verona","2020-01-01","2020-12-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",49.0,0.184,"Convenience","NR","IgG; IgA","High","Presentation or Conference","M Trentinaglia","University of Verona","http://dx.doi.org/10.1111/jns.12472","Unverified","","","","","","IT","IT-34"
"2021-12-15","211202_Ireland_HealthProtectionSurveillanceCentre_Dublin_OverallWeighted","The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020.","2021-12-02","Local","","Ireland","2020-06-22","2020-07-16","Household and community samples","Multiple groups",913.0,0.031,"Simplified probability","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Heavey","Health Protection Surveillance Centre","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741","Verified",0.02,0.045,"","","","IE",""
"2021-12-15","211202_Ireland_HealthProtectionSurveillanceCentre_Sligo_OverallWeighted","The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020.","2021-12-02","Local","","Ireland","2020-06-22","2020-07-16","Household and community samples","Multiple groups",820.0,0.006,"Simplified probability","NR","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Heavey","Health Protection Surveillance Centre","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741","Verified",0.002,0.014,"","","","IE",""
"2021-12-15","211202_Israel_TelAvivUniversity_Overall","Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021.","2021-12-02","National","","Israel","2020-01-01","2021-03-31","Residual sera","Children and Youth (0-17 years)",2765.0,0.056,"Convenience","NR","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Victoria Indenbaum","Tel Aviv University","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2101040","Verified",0.048,0.066,"","","","IL",""
"2021-12-15","211207_Philadelphia_ThomasJeffersonUniversity","Comprehensive Serological Profile and Specificity of Maternal and Neonatal Cord Blood SARS CoV-2 Antibodies","2021-12-07","Local","","United States of America; Pennsylvania; Philadelphia","2020-04-01","2021-02-28","Pregnant or parturient women","Adults (18-64 years)",76.0,0.2,"Convenience","NR","IgG; IgM","High","Preprint","Rupsa Boelig","Thomas Jefferson University","https://www.medrxiv.org/content/10.1101/2021.12.06.21267328v1.full-text","Unverified","","","","","","US","US-PA"
"2021-12-15","211208_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 December 2021","2021-12-08","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-10-11","2021-11-14","Blood donors","Multiple groups",2496.0,0.998,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/","Verified",0.994,1.0,0.84,1.0,"","GB","GB-SCT"
"2021-12-15","211208_Scotland_PublicHealthScotland_PregnantWomen3_Overall_Anti-S_Unadj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 December 2021","2021-12-08","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-10-11","2021-11-14","Pregnant or parturient women","Adults (18-64 years)",2890.0,0.862,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/","Verified","","",0.923,1.0,"","GB","GB-SCT"
"2021-12-15","211208_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 December 2021","2021-12-08","National","Argentina","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-10-11","2021-11-14","Residual sera","Multiple groups",2882.0,0.805,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/","Verified",0.786,0.82,0.973,0.996,"","GB","GB-SCT"
"2021-12-15","211209_Kyrgyzstan_SaintPetersburgPasteurInstitute_Overall","SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021","2021-12-09","National","","Kyrgyzstan","2021-06-28","2021-07-03","Household and community samples","Multiple groups",9471.0,0.487,"Simplified probability","NR","IgG","Moderate","Preprint","Anna Popova","Saint Petersburg Pasteur Institute","https://www.researchsquare.com/article/rs-1138128/v1","Unverified",0.477,0.497,"","","","KG",""
"2021-12-15","211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_HCW_Primary","Prevalence of COVID-19 infection in the prison system in Espirito Santo/Brazil: persons deprived of liberty and justice workers.","2021-12-10","Regional","","Brazil; Espírito Santo","2020-08-31","2020-09-04","Health care workers and caregivers","Adults (18-64 years)",311.0,0.119,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adriana Ilha da Silva","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210053","Unverified",0.081,0.157,0.974,0.993,"","BR","BR-ES"
"2021-12-15","211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PDL_Primary","Prevalence of COVID-19 infection in the prison system in Espirito Santo/Brazil: persons deprived of liberty and justice workers.","2021-12-10","Regional","","Brazil; Espírito Santo","2020-08-31","2020-09-04","Persons who are incarcerated","Adults (18-64 years)",884.0,0.316,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adriana Ilha da Silva","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210053","Unverified",0.284,0.348,0.974,0.993,"","BR","BR-ES"
"2021-12-15","211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PrisonOfficer_Primary","Prevalence of COVID-19 infection in the prison system in Espirito Santo/Brazil: persons deprived of liberty and justice workers.","2021-12-10","Regional","","Brazil; Espírito Santo","2020-08-31","2020-09-04","Essential non-healthcare workers","Adults (18-64 years)",675.0,0.221,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adriana Ilha da Silva","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210053","Unverified",0.189,0.253,0.974,0.993,"","BR","BR-ES"
"2021-12-16","211201_Ermont_CliniqueClaudeBernard_Overall","SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers.","2021-12-01","Local","","France; Île-de-France; Ermont","2020-09-15","2020-10-15","Residual sera","Multiple groups",299.0,0.197,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Henri Boulanger","Clinique Claude Bernard","https://dx.doi.org/10.1155/2021/4747221","Unverified","","","","","","FR","FR-IDF"
"2021-12-16","211205_CaliforniaBayArea_UniversityofCalifornia_Round3_primary","Impact of individual-level characteristics and transmission mitigation behaviors on SARS-CoV-2 infection and seroprevalence in a large Northern California Bay Area cohort","2021-12-05","Regional","","United States of America; California","2021-02-11","2021-03-20","Household and community samples","Multiple groups",4608.0,0.276,"Stratified non-probability","NR","Total Antibody; IgG","Moderate","Preprint","Cameron Adams","University of California, Berkeley","https://www.medrxiv.org/content/10.1101/2021.12.02.21266871v1.full-text","Verified",0.228,0.335,"","","","US","US-CA"
"2021-12-21","211211_California_CaliforniaDepartmentofPublicHealth_Adults_S_PopAdj","CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021‚Äì July 2021","2021-12-11","Regional","","United States of America; California","2021-04-20","2021-08-01","Household and community samples","Multiple groups",7483.0,0.67,"Stratified probability","NR","Total Antibody","Low","Preprint","Megha Mehrotra","California Department of Public Health","https://www.medrxiv.org/content/10.1101/2021.12.09.21267565v1.full-text","Unverified",0.63,0.71,1.0,1.0,"","US","US-CA"
"2021-12-21","211211_California_CaliforniaDepartmentofPublicHealth_Children_S_PopAdj","CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021‚Äì July 2021","2021-12-11","Regional","","United States of America; California","2021-04-20","2021-06-16","Household and community samples","Children and Youth (0-17 years)",1375.0,0.41,"Stratified probability","NR","Total Antibody","Low","Preprint","Megha Mehrotra","California Department of Public Health","https://www.medrxiv.org/content/10.1101/2021.12.09.21267565v1.full-text","Unverified",0.35,0.47,1.0,1.0,"","US","US-CA"
"2021-12-23","211027_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report October 27, 2021 Report #13: August 2021 Survey Tracking seroprevalence in the vaccine era","2021-10-27","National","","Canada; British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador","2021-08-15","2021-08-26","Blood donors","Multiple groups",9109.0,0.961,"Sequential","","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.956,0.965,0.988,0.996,"","CA",""
"2021-12-23","211130_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report November 30th, 2021 Report #14: September 2021 Survey Tracking seroprevalence in the vaccine era","2021-11-30","National","","Canada; British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador","2021-09-14","2021-09-24","Blood donors","Multiple groups",9363.0,0.97,"Sequential","","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified",0.966,0.974,0.988,0.996,"","CA",""
"2021-12-23","211130_England_UKHSA_2020NovDec_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2020-11-01","2020-12-31","Residual sera","Children and Youth (0-17 years)",711.0,0.148,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.112,0.198,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211130_England_UKHSA_2020SepOct_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2020-09-01","2020-10-31","Residual sera","Children and Youth (0-17 years)",119.0,0.076,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.032,0.182,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211130_England_UKHSA_2021JanFeb_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-01-01","2021-02-28","Residual sera","Children and Youth (0-17 years)",970.0,0.233,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.184,0.295,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211130_England_UKHSA_2021JulAug_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-07-01","2021-08-31","Residual sera","Children and Youth (0-17 years)",685.0,0.264,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.201,0.353,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211130_England_UKHSA_2021MarApr_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-03-01","2021-04-30","Residual sera","Children and Youth (0-17 years)",925.0,0.315,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.253,0.391,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211130_England_UKHSA_2021MayJun_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-05-01","2021-06-30","Residual sera","Children and Youth (0-17 years)",1186.0,0.275,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.207,0.372,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211130_England_UKHSA_2021SepOct_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","","United Kingdom of Great Britain and Northern Ireland; England","2021-09-01","2021-10-31","Residual sera","Children and Youth (0-17 years)",600.0,0.461,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Verified",0.383,0.536,0.955,1.0,"","GB","GB-ENG"
"2021-12-23","211215_Lima_InstitutoNacionalMaternoPerinatal","Clinical and epidemiological characterization in the follow-up of newborns with COVID-19: a descriptive study.","2021-12-15","Local","","Peru","2020-06-01","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",4733.0,0.314,"Sequential","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Carmen Davila-Aliaga","Instituto Nacional Materno Perinatal","https://dx.doi.org/10.5867/medwave.2021.11.002141","Unverified","","","","","","PE",""
"2021-12-25","211211_England_UKHealthSecurityAgency_Round4_Staff_S","Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England","2021-12-11","Regional","","United Kingdom of Great Britain and Northern Ireland; England; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","2021-05-20","2021-07-14","Essential non-healthcare workers","Adults (18-64 years)",639.0,0.978,"Convenience","NR","IgG","High","Preprint","Shamez N. Ladhani","The UK Health Security Agency","https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text","Verified","","","","","","GB","GB-ENG"
"2021-12-25","211211_England_UKHealthSecurityAgency_Round4_Students_S","Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England","2021-12-11","Regional","","United Kingdom of Great Britain and Northern Ireland; England; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","2021-05-20","2021-07-14","Students and Daycares","Children and Youth (0-17 years)",655.0,0.414,"Convenience","NR","IgG","High","Preprint","Shamez N. Ladhani","The UK Health Security Agency","https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text","Verified","","","","","","GB","GB-ENG"
"2021-12-29","211210_India_ICMR_GenPop_OverallTestAdjust","Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.","2021-12-10","National","","India; Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal","2021-06-14","2021-07-06","Household and community samples","Multiple groups",28975.0,0.668,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Manoj Murhekar","Indian Council of Medical Research","https://dx.doi.org/10.1371/journal.pmed.1003877","Unverified",0.655,0.68,0.8,0.99,"","IN",""
"2021-12-29","211210_India_ICMR_HCW_OverallTestAdjust","Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.","2021-12-10","National","","India; Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal","2021-06-14","2021-07-06","Health care workers and caregivers","Multiple groups",7252.0,0.874,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Manoj Murhekar","Indian Council of Medical Research","https://dx.doi.org/10.1371/journal.pmed.1003877","Unverified",0.856,0.891,0.8,0.99,"","IN",""
"2022-01-01","211020_Leon_NationalAutonomousUniversityofNicaraguaatLeon_FebMar2021_TestAdj","Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in Leon, Nicaragua","2021-10-20","Local","","Nicaragua","2021-02-15","2021-03-15","Household and community samples","Multiple groups",1243.0,0.347,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Fredman Gonzalez","The National Autonomous University of Nicaragua at León","10.1017/s0950268821002144","Unverified",0.312,0.382,0.952,0.967,"","NI",""
"2022-01-01","211213_Quebec_InstitutNationaldeSantePubliqueduQuebec","SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.","2021-12-13","Regional","","Canada; Quebec","2020-07-06","2020-09-24","Health care workers and caregivers","Adults (18-64 years)",2056.0,0.117,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Nicholas Brousseau","Institut National de Sante Publique du Quebec","https://dx.doi.org/10.1503/cmaj.202783","Unverified","","",0.82,1.0,"","CA","CA-QC"
"2022-01-02","211108_Istanbul_UmraniyeTrainingandResearchHospital","Clinical course of COVID-19 in children with rheumatic disease under biologic therapy","2021-11-08","Local","","Turkey; Marmara; Istanbul","2020-04-01","2020-12-01","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",436.0,0.005,"Convenience","NR","Not reported","Unclear","Presentation or Conference","Ferhat Demir","Umraniye Training and Research; Hospital","https://dx.doi.org/10.1186/s12969-021-00632-z","Unverified","","","","","","TR",""
"2022-01-02","211210_Rome_UniversityofRomeTorVergata","Factors associated with pre-vaccination sars-cov-2 infection risk among hospital nurses facing covid-19 outbreak","2021-12-10","Local","","Italy","2020-03-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",918.0,0.021,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Luca Coppeta","University of Rome Tor Vergata","https://dx.doi.org/10.3390/ijerph182413053","Unverified","","",0.986,0.995,"","IT",""
"2022-01-03","211210_California_SutterHealth_Overall","COVID-19 in pregnancy by race and ethnicity: Implications for development of a vaccination strategy.","2021-12-10","Regional","","United States of America; California","2020-10-01","2020-12-31","Pregnant or parturient women","Adults (18-64 years)",4500.0,0.081,"Convenience","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Alice Pressman","Sutter Health","https://dx.doi.org/10.1177/17455065211063300","Verified","","",1.0,0.998,"","US","US-CA"
"2022-01-04","211107_India_ESICMedicalCollegeAndHospital_OverallCrude","Screening of Asymptomatic Healthcare Workers for SARS-COV-2 for Occult Infections: A Cross-Sectional Study.","2021-11-07","Local","","India; Telangana; Hyderabad","2020-10-15","2021-01-15","Health care workers and caregivers","Multiple groups",190.0,0.253,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Lakshmi Tadi","ESIC Medical College & Hospital","https://dx.doi.org/10.7759/cureus.19341","Unverified","","","","","","IN","IN-TG"
"2022-01-04","211127_Bydgoszcz_NicolausCopernicusUniversity_OverallIgG","The differences in the level of anti-sars-cov-2 antibodies after mrna vaccine between convalescent and non-previously infected people disappear after the second dose-study in healthcare workers group in Poland","2021-11-27","Local","","Poland; Kuyavian-Pomeranian; Bydgoszcz","2020-07-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",120.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Joanna Kwiecinska-Pirog","Nicolaus Copernicus University","https://dx.doi.org/10.3390/vaccines9121402","Unverified","","","","","","PL",""
"2022-01-04","211205_Tokyo_UniversityofTokyo_iFlashIgG","Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers.","2021-12-05","Local","","Japan","2020-06-11","2020-12-22","Multiple populations","Adults (18-64 years)",10039.0,0.002,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Akihisa Mitani","University of Tokyo","https://dx.doi.org/10.1016/j.jiac.2021.11.020","Unverified","","","","","","JP",""
"2022-01-04","211213_MexicoCity_INCMNSZ_FollowUp","SARS-CoV-2 Infection Rate in Patients With Cancer and Health Care Workers in a Chemoradiotherapy Unit During the Pandemic: A Prospective Cohort in Mexico.","2021-12-13","Local","","Mexico","2020-08-15","2020-09-30","Multiple populations","Multiple groups",97.0,0.072,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Monica Meneses-Medina","The National Institute of Medical Sciences and Nutrition Salvador Zubirán","https://dx.doi.org/10.1200/GO.21.00207","Unverified","","","","","","MX",""
"2022-01-06","211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_HCW","Study of features of humoral immune response to the new coronavirus infection covid-19 among healthcare workers","2021-11-01","Local","","Russian Federation; Tatarstan; Kazan","2020-06-30","2020-07-27","Health care workers and caregivers","Adults (18-64 years)",60.0,0.467,"Simplified probability","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Irina Dmitrievna Reshetnikova","Scientific Research Institutes of Rospotrebnadzor","https://dx.doi.org/10.15789/2220-7619-SOT-1587","Unverified","","","","","","RU","RU-TA"
"2022-01-06","211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_nonHCW","Study of features of humoral immune response to the new coronavirus infection covid-19 among healthcare workers","2021-11-01","Local","","Russian Federation; Tatarstan; Kazan","2020-06-30","2020-07-27","Essential non-healthcare workers","Adults (18-64 years)",61.0,0.213,"Simplified probability","NR","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Irina Dmitrievna Reshetnikova","Scientific Research Institutes of Rospotrebnadzor","https://dx.doi.org/10.15789/2220-7619-SOT-1587","Unverified","","","","","","RU","RU-TA"
"2022-01-08","200720_Guangzhou_NanfangHospital_Primary","Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemic","2020-07-20","Local","","China; Hubei; Wuhan","2020-03-20","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",943.0,0.0,"Entire sample","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Fan Fan Hou","Nanfang Hospital","https://dx.doi.org/10.1093/PCMEDI/PBAA024","Unverified","","",0.873,0.995,"","CN","CN-42"
"2022-01-08","200720_Wuhan_NanfangHospital_Primary","Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemic","2020-07-20","Local","","China; Hubei; Wuhan","2020-03-20","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",7586.0,0.032,"Entire sample","NR","IgG; IgM","","Journal Article (Peer-Reviewed)","Fan Fan Hou","Nanfang Hospital","https://dx.doi.org/10.1093/PCMEDI/PBAA024","Unverified","","",0.873,0.995,"","CN","CN-42"
"2022-01-08","211205_Jaipur_MahatmaGandhiMedicalCollege&Hospital_Overall","Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study.","2021-12-05","Local","","India; Rajasthan; Jaipur","2020-12-15","2021-01-15","Blood donors","Adults (18-64 years)",534.0,0.429,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ram Jaiswal","Mahatma Gandhi Medical College & Hospital","https://dx.doi.org/10.1016/j.transci.2021.103338","Unverified","","",0.9,1.0,"","IN","IN-RJ"
"2022-01-08","211227_Vellore_ChristianMedicalCollege_Jan2021_PopAdj","Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.","2021-12-27","Local","","India","2021-01-01","2021-01-31","Household and community samples","Multiple groups",1228.0,0.285,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Divya Dayanand","Christian Medical College","https://dx.doi.org/10.1016/j.ijid.2021.12.356","Unverified",0.223,0.337,"",0.976,"","IN",""
"2022-01-08","211227_Vellore_ChristianMedicalCollege_July2021_PopAdj","Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.","2021-12-27","Local","","India","2021-07-01","2021-07-31","Household and community samples","Multiple groups",1205.0,0.716,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Divya Dayanand","Christian Medical College","https://dx.doi.org/10.1016/j.ijid.2021.12.356","Unverified",0.628,0.805,"",0.976,"","IN",""
"2022-01-08","211228_Deskati_UniversityofThessaly_Overall","Defining antibody seroprevalence and duration of humoral responses to sars-cov-2 infection and/or vaccination in a greek community","2021-12-28","Local","","Greece; West Macedonia; Deskati","2021-06-06","2021-06-06","Household and community samples","Multiple groups",69.0,0.797,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ourania Kotsiou","University of Thessaly","https://dx.doi.org/10.3390/ijerph19010407","Unverified","","",0.999,1.0,"","GR","GR-C"
"2022-01-08","211228_Limburg_SouthLimburgPublicHealthService_Primary","Exposure Factors Associated With SARS-CoV-2 Seroprevalence During the First Eight Months of the COVID-19 Pandemic in the Netherlands: A Cross-sectional Study","2021-12-28","Regional","","Netherlands; Limburg","2020-10-28","2020-12-23","Household and community samples","Multiple groups",10001.0,0.195,"Convenience","NR","Total Antibody","High","Preprint","Demi Pagen","South Limburg Public Health Service","https://assets.researchsquare.com/files/rs-1159143/v1/ad6e3392-8480-4bf2-9e9a-37c27020976e.pdf?c=1640718437","Unverified",0.187,0.203,0.954,0.996,"","NL","NL-LI"
"2022-01-08","211228_MâncioLima_UniversityofSãoPaulo_AprtoMay2021","Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.","2021-12-28","Regional","","Brazil; Acre; Mâncio Lima","2021-04-15","2021-05-15","Household and community samples","Multiple groups",729.0,0.287,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","Vanessa Nicolete","University of São Paulo","https://dx.doi.org/10.3201/eid2803.211993","Unverified",0.267,0.389,0.9,1.0,"","BR","BR-AC"
"2022-01-08","211228_MâncioLima_UniversityofSãoPaulo_OcttoNov2020","Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.","2021-12-28","Regional","","Brazil; Acre; Mâncio Lima","2020-10-15","2020-11-15","Household and community samples","Multiple groups",1215.0,0.335,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Vanessa Nicolete","University of São Paulo","https://dx.doi.org/10.3201/eid2803.211993","Unverified",0.332,0.448,0.9,1.0,"","BR","BR-AC"
"2022-01-08","220101_England_UCLInstituteOfHealthInformatics_Primary","Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.","2022-01-01","Regional","","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2021-04-30","Multiple general populations","Multiple groups",4722.0,0.288,"Self-referral","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Krutikov","UCL Institute of Health Informatics","https://dx.doi.org/10.1016/S2666-7568(21)00282-8","Unverified","","","","","","GB","GB-ENG"
"2022-01-09","210921_Mumbai_UniversityofPittsburghMedicalCenter_Patients_Overall","From infection to immunity - Impact of COVID-19 across nine hemodialysis centres in Mumbai","2021-09-21","Local","","India; Maharashtra; Mumbai","2020-03-24","2020-05-17","Residual sera","Multiple groups",110.0,0.373,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Viswanath Billa","University of Pittsburgh Medical Center","https://dx.doi.org/10.4103/ijn.IJN_361_20","Unverified","","","","","","IN","IN-MH"
"2022-01-09","210921_Mumbai_UniversityofPittsburghMedicalCenter_Staff_Overall","From infection to immunity - Impact of COVID-19 across nine hemodialysis centres in Mumbai","2021-09-21","Local","","India; Maharashtra; Mumbai","2020-03-24","2020-05-17","Health care workers and caregivers","Multiple groups",85.0,0.435,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Viswanath Billa","University of Pittsburgh Medical Center","https://dx.doi.org/10.4103/ijn.IJN_361_20","Unverified","","","","","","IN","IN-MH"
"2022-01-09","211207_Milan_SanGiuseppeHospital_Total1stWave","Prevalence of SARS-CoV-2 amongst ophthalmologists throughout the first and second waves of the pandemic.","2021-12-17","Local","","Italy","2020-03-15","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",25.0,0.04,"Self-referral","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Matteo Sacchi","San Giuseppe Hospital","https://dx.doi.org/10.1097/MD.0000000000028192","Unverified","","","","","","IT",""
"2022-01-09","211220_Amsterdam_AmsterdamInfectionandImmunityInstitute_Overall","Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.","2021-12-20","Local","","Netherlands; North Holland; Amsterdam","2020-09-15","2021-04-15","Household and community samples","Multiple groups",563.0,0.108,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Myrthe Verburgh","Amsterdam Infection and Immunity Institute","https://dx.doi.org/10.1093/infdis/jiab616","Unverified","","",1.0,0.982,"","NL","NL-NH"
"2022-01-09","211223_TanjungPriok_CenterforIndonesia’sStrategicDevelopmentInitiatives_Primary","Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.","2021-12-23","Local","","Indonesia","2020-11-23","2021-02-19","Household and community samples","Adults (18-64 years)",3196.0,0.285,"Simplified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Olivia Herlinda","World Health Organization, Geneva, Switzerland","https://dx.doi.org/10.1371/journal.pone.0261931","Unverified",0.254,0.318,"",0.998,"","ID",""
"2022-01-09","211227_Kaduna_UniversityofGlasgow_KadunaCity_Primary","SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant","2021-12-27","Local","","Nigeria; Kaduna","2021-10-11","2021-11-05","Residual sera","Multiple groups",400.0,0.425,"Convenience","NR","IgG; IgM","High","Preprint","Gloria Chechet","University of Glasgow","10.1101/2021.12.21.21268166","Unverified","","","","","","NG","NG-KD"
"2022-01-09","211227_Kaduna_UniversityofGlasgow_Kofar-Gayan_Primary","SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant","2021-12-27","Local","","Nigeria; Kaduna","2021-10-12","2021-11-08","Residual sera","Multiple groups",402.0,0.535,"Convenience","NR","IgG; IgM","High","Preprint","Gloria Chechet","University of Glasgow","10.1101/2021.12.21.21268166","Unverified","","","","","","NG","NG-KD"
"2022-01-09","211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_Aug2021_WANTAI","Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations","2021-12-27","National","","Kenya","2021-08-01","2021-08-31","Blood donors","Adults (18-64 years)",176.0,0.83,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","James Nyagwange","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1016/j.jcv.2021.105061","Verified","","",0.953,0.979,"","KE",""
"2022-01-09","211228_Ticino_Ufficiodelmedicocantonale_Phase4_OverallAdjusted","Seroprevalence of the SARS-CoV-2 virus in the population of the southern Switzerland (Canton Ticino) - cohort study, results at 12 months.","2021-12-28","Regional","","Switzerland; Ticino","2021-05-03","2021-06-13","Household and community samples","Multiple groups",722.0,0.223,"Stratified probability","NR","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Ottavio Beretta","Ufficio del medico cantonale","https://smw.ch/article/doi/smw.2021.w30116","Unverified",0.192,0.257,0.951,0.989,"","CH","CH-TI"
"2022-01-09","220104_Wuhan_ZhongnanHospitalOfWuhanUniversity_IgG","Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown.","2022-01-04","Local","","China; Hubei; Wuhan","2020-03-21","2020-05-21","Residual sera","Multiple groups",3062.0,0.075,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Yueting Tang","Zhongnan Hospital of Wuhan University","https://dx.doi.org/10.1186/s12879-021-07010-w","Unverified","","",0.89,0.98,"","CN","CN-42"
"2022-01-09","220105_Bern_InselspitalUniversityHospital_ELISA_S1","Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study.","2022-01-05","Local","","Switzerland","2020-04-15","2020-11-15","Multiple populations","Multiple groups",3658.0,0.063,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Michael P Horn","Inselspital University Hospital","https://dx.doi.org/10.1111/all.15206","Unverified","","",0.862,0.982,"","CH",""
"2022-01-10","211102_Seattle_UniversityOfWashington_Baseline","25 Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis","2021-11-02","Local","","United States of America; Washington; Seattle","2020-07-20","2021-02-28","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",125.0,0.04,"Convenience","NR","IgG","High","Presentation or Conference","Georgene Hergenroeder","University of Washington","https://dx.doi.org/10.1016/S1569-1993%2821%2901450-8","Unverified","","","","","","US","US-WA"
"2022-01-10","211201_NorthernFrance_CentreHospitalierdeTourcoing","History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic.","2021-12-01","Local","","France; Northern France; Tourcoing","2020-04-01","2020-08-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",600.0,0.027,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Agnes Meybeck","Centre Hospitalier de Tourcoing","https://dx.doi.org/10.3390/microorganisms9122491","Unverified","","","","","","FR",""
"2022-01-10","211212_Italy_UniversitàdegliStudidiMilano_Overall","SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy.","2021-12-12","Regional","","Italy; Northern Italy","2021-03-15","2021-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",434.0,0.148,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Gianfranco Alicandro","Università degli Studi di Milano","https://dx.doi.org/10.1016/j.jcf.2021.12.011","Unverified",0.115,0.184,0.988,1.0,"","IT",""
"2022-01-10","211213_Estonia_UniversityOfTartu_Stage22_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","","Estonia","2021-12-01","2021-12-13","Household and community samples","Multiple groups",2290.0,0.815,"Stratified probability","NR","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.781,0.848,"","","","EE",""
"2022-01-10","211213_Sindh_ShaheedMohtarmaBenazirBhuttoMedicalUniversity_Primary","Seroprevalence of Anti-SARS-CoV-2 Antibodies in COVID-19 Patients in Hyderabad, Sindh","2021-12-13","Regional","","Pakistan; Sindh; Hyderabad","2020-08-01","2020-11-30","Residual sera","Adults (18-64 years)",1229.0,0.168,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Shahzad Rasheed Qureshi","Liaquat University of Medical and Health; Sciences","http://libraryaplos.com/xmlui/handle/123456789/8719","Unverified","","","","","","PK","PK-SD"
"2022-01-10","211221_GautengProvince_UniversityoftheWitwatersrand_PrimaryEstimate","South African Population Immunity and Severe Covid-19 with Omicron Variant","2021-12-21","Regional","","South Africa; Gauteng Province","2021-10-22","2021-12-09","Household and community samples","Multiple groups",7010.0,0.731,"Stratified probability","NR","IgG","Moderate","Preprint","Shabir Madhi","University of the Witwatersrand","10.1101/2021.12.20.21268096","Unverified",0.72,0.741,"","","","ZA","ZA-GT"
"2022-01-10","211223_Lima_UniversidadPeruanaCayetanoHeredia","SARS-CoV-2 antibody status at time of delivery and the risk of preeclampsia","2022-01-01","Local","","Peru; Lima; Lima","2020-08-01","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",440.0,0.375,"Convenience","NR","IgG; IgM","High","Presentation or Conference","Arianna Portmann-Baracco","Universidad Peruana Cayetano Heredia","https://dx.doi.org/10.1016/j.ajog.2021.11.1178","Unverified","","","","","","PE","PE-LIM"
"2022-01-10","220101_Philadelphia_ChildrensHospitalofPhiladelphia","36 Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy","2022-01-01","Local","","United States of America; Pennsylvania; Philadelphia","2020-04-15","2020-12-15","Pregnant or parturient women","Adults (18-64 years)",6192.0,0.092,"Convenience","NR","IgG; IgM","Moderate","Presentation or Conference","Jourdan Triebwasser","Children’s Hospital of Philadelphia","https://dx.doi.org/10.1016/j.ajog.2021.11.092","Unverified","","","","","","US","US-PA"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_AfterStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","","Germany; Bavaria; Wuerzburg","2021-03-01","2021-03-15","Essential non-healthcare workers","Multiple groups",109.0,0.046,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","","","","","DE","DE-BY"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_BeforeStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","","Germany; Bavaria; Wuerzburg","2020-10-01","2020-10-15","Essential non-healthcare workers","Multiple groups",139.0,0.007,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","","","","","DE","DE-BY"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_Children_AfterStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","","Germany; Bavaria; Wuerzburg","2021-03-01","2021-03-15","Students and Daycares","Children and Youth (0-17 years)",338.0,0.024,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","","","","","DE","DE-BY"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_Children_BeforeStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","","Germany; Bavaria; Wuerzburg","2020-10-01","2020-10-15","Students and Daycares","Children and Youth (0-17 years)",381.0,0.003,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","","","","","DE","DE-BY"
"2022-01-11","211006_UnitedStates_UniversityofMinnesota_EarlyTreatment","Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials","2021-10-06","National","","United States of America","2020-03-17","2020-05-20","Multiple populations","Multiple groups",123.0,0.29,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Sarah Lofgren","University of Minnesota","https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true","Unverified","","","","","","US",""
"2022-01-11","211006_UnitedStates_UniversityofMinnesota_PostexposureProphylaxis","Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials","2021-10-06","National","","United States of America","2020-03-17","2020-05-20","Multiple populations","Multiple groups",266.0,0.11,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Sarah Lofgren","University of Minnesota","https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true","Unverified","","","","","","US",""
"2022-01-11","211006_UnitedStates_UniversityofMinnesota_Pre-exposureProphylaxis","Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials","2021-10-06","National","","United States of America","2020-04-06","2020-07-13","Multiple populations","Multiple groups",542.0,0.04,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Sarah Lofgren","University of Minnesota","https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true","Unverified","","","","","","US",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_HungarianIntProgram","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Students and Daycares","Adults (18-64 years)",682.0,0.016,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified",0.007,0.026,"","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_HungarianProgram","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Students and Daycares","Adults (18-64 years)",956.0,0.006,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified",0.0,0.011,"","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_IntStudents","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Students and Daycares","Adults (18-64 years)",1832.0,0.021,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified",0.014,0.027,"","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_OtherHCW","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Health care workers and caregivers","Adults (18-64 years)",2926.0,0.018,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified",0.014,0.023,"","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_Physicians","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Health care workers and caregivers","Adults (18-64 years)",1552.0,0.015,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified",0.009,0.022,"","","","HU",""
"2022-01-11","211229_Lucknow_KingGeorgeMedicalUniversity_HCWs","SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health Workers.","2021-12-29","Local","","India; Uttar Pradesh; Lucknow","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",560.0,0.023,"Simplified probability","NR","IgG","High","Journal Article (Peer-Reviewed)","Tulika Chandra","King George Medical University","https://dx.doi.org/10.1155/2021/2404170","Unverified",0.011,0.036,"","","","IN","IN-UP"
"2022-01-11","211229_UttarPradesh_KingGeorgeMedicalUniversity_blooddonors_Overall","SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health Workers.","2021-12-29","Regional","","India; Uttar Pradesh; Lucknow","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",2163.0,0.019,"Sequential","NR","IgG","High","Journal Article (Peer-Reviewed)","Tulika Chandra","King George Medical University","https://dx.doi.org/10.1155/2021/2404170","Unverified",0.014,0.025,"","","","IN","IN-UP"
"2022-01-12","211119_IwateMedicalUniversity_IwateMedicalUniversity","Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine","2021-11-19","Local","","Japan; Tohoku; Morioke","2021-03-15","2021-05-31","Health care workers and caregivers","Adults (18-64 years)",10.0,0.0,"Unclear","NR","Not reported","High","Presentation or Conference","Hiromi Nagashima","Iwate Medical University","https://onlinelibrary.wiley.com/doi/full/10.1111/resp.14150_356","Unverified","","","","","","JP",""
"2022-01-12","211206_CochinHospital_ParisDescartesUniversity_Overall_Nonly","Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases","2021-12-06","Local","","France; Île-de-France; Paris","2020-06-01","2020-08-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",283.0,0.028,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Clothilde Gros","Paris Descartes Université","https://dx.doi.org/10.1016/j.jbspin.2021.105312","Unverified","","","","","","FR","FR-IDF"
"2022-01-12","211214_Amsterdam_UniversityofAmsterdam_Visit1","Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study.","2021-12-14","Local","","Netherlands; North Holland; Amsterdam","2020-06-24","2020-10-09","Household and community samples","Multiple groups",2497.0,0.09,"Convenience","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Liza Coyer","University of Amsterdam","https://dx.doi.org/10.1016/j.lanepe.2021.100284","Unverified","","","","","","NL","NL-NH"
"2022-01-12","211214_Amsterdam_UniversityofAmsterdam_Visit2","Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study.","2021-12-14","Local","","Netherlands; North Holland; Amsterdam","2020-11-23","2021-06-04","Household and community samples","Multiple groups",2075.0,0.236,"Convenience","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Liza Coyer","University of Amsterdam","https://dx.doi.org/10.1016/j.lanepe.2021.100284","Unverified","","","","","","NL","NL-NH"
"2022-01-12","211214_NewDelhi_AllIndiaInstituteofMedicalSciences_overall","SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.","2021-12-14","Local","","India; National Capital Territory of Delhi; New Delhi","2020-10-01","2021-02-27","Multiple populations","Multiple groups",643.0,0.504,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Alpesh Goyal","All India Institute of Medical Sciences","https://dx.doi.org/10.1016/j.eprac.2021.12.009","Unverified","","","","","","IN","IN-DL"
"2022-01-12","211217_Lilongwe_UniversitatsmedizinBerlin","SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi.","2021-12-17","Local","","Malawi; Central Region; Lilongwe","2020-08-24","2020-09-03","Multiple populations","Multiple groups",914.0,0.08,"Convenience","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","C Meinus","University of Malawi","https://dx.doi.org/10.1016/j.ijid.2021.12.336","Unverified","","","","","","MW","MW-C"
"2022-01-12","211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_GenPop3_Overall","Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS-CoV-2 in an unvaccinated cohort.","2021-12-23","Local","","Germany; Bavaria; Erlangen","2020-12-15","2021-03-15","Household and community samples","Multiple groups",1184.0,0.071,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","David Simon","Friedrich-Alexander University (FAU) Erlangen-Nuremberg","https://dx.doi.org/10.1002/art.42035","Unverified",0.057,0.087,"","","","DE","DE-BY"
"2022-01-12","211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_HCW2_Overall","Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS-CoV-2 in an unvaccinated cohort.","2021-12-23","Local","","Germany; Bavaria; Erlangen","2020-12-15","2021-03-15","Health care workers and caregivers","Multiple groups",455.0,0.112,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","David Simon","Friedrich-Alexander University (FAU) Erlangen-Nuremberg","https://dx.doi.org/10.1002/art.42035","Unverified",0.085,0.145,"","","","DE","DE-BY"
"2022-01-12","211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_Patients1_Overall","Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS-CoV-2 in an unvaccinated cohort.","2021-12-23","Local","","Germany; Bavaria; Erlangen","2020-12-15","2021-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",2869.0,0.042,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","David Simon","Friedrich-Alexander University (FAU) Erlangen-Nuremberg","https://dx.doi.org/10.1002/art.42035","Unverified","","","","","","DE","DE-BY"
"2022-01-12","211226_Chile_UniversidaddeChile_Overall","A cross sectional study found differential risks for COVID-19 seropositivity amongst health care professionals in Chile.","2021-12-26","National","","Chile","2020-09-11","2020-10-24","Health care workers and caregivers","Multiple groups",85529.0,0.072,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcela Zuniga","Universidad de Chile","https://dx.doi.org/10.1016/j.jclinepi.2021.12.026","Unverified","","",0.958,1.0,"","CL",""
"2022-01-12","211226_Male'_MaldivesNationalUniversity_overall","A sero-epidemiological study after two waves of the COVID-19 epidemic.","2021-12-26","Local","","Maldives","2020-10-15","2020-11-16","Household and community samples","Multiple groups",1940.0,0.134,"Stratified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Raheema Abdul-Raheem","Hulhumale’ Hospital","https://apjai-journal.org/wp-content/uploads/2022/01/AP-040721-1177.pdf","Unverified","","",0.9,1.0,"","MV",""
"2022-01-12","211227_Chicago_NorthwesternUniversity","COVID-19 vaccine intentions and uptake in a tertiary care healthcare system: A longitudinal study.","2021-12-27","Local","","United States of America; Illinois; Chicago","2020-05-26","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",4180.0,0.043,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Charlesnika Evans","Northwestern University Feinberg School of Medicine","https://dx.doi.org/10.1017/ice.2021.523","Unverified","","","","","","US","US-IL"
"2022-01-12","211229_Delhi_MaulanaAzadMedicalCollege_Overall_PopTestAdj","SARS-CoV-2 seroprevalence in Delhi, India: September October 2021: a population based seroepidemiological study","2021-12-29","Regional","","India; Delhi; Delhi","2021-09-24","2021-10-14","Household and community samples","Multiple groups",27811.0,0.975,"Stratified probability","NR","IgG","Low","Preprint","Pragya Sharma","Maulana Azad Medical College","https://www.medrxiv.org/content/10.1101/2021.12.28.21268451v1","Unverified",0.97,0.98,0.9,1.0,"","IN","IN-DL"
"2022-01-12","220103_Regensburg_UniversityHospitalRegensburg","[Low incidence of SARS-CoV-2 infections in healthcare workers at a tertiary care hospital: Results of a prospective serological cohort study of the first and second COVID-19 pandemic wave]","2022-01-03","Local","","Germany; Bavaria; Regensburg","2020-03-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",205.0,0.051,"Convenience","NR","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Julian Hupf","University Hospital Regensburg","https://dx.doi.org/10.1007/s00063-021-00890-5","Unverified","","","","","","DE","DE-BY"
"2022-01-13","122221_MaricopaCounty_ArizonaStateUniversity_popadj","Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona.","2021-12-22","Local","","United States of America; Arizona","2020-09-12","2020-10-01","Household and community samples","Multiple groups",260.0,0.14,"Stratified probability","NR","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Megan Jehn","Arizona State University","https://dx.doi.org/10.2105/AJPH.2021.306568","Unverified",0.072,0.24,0.998,0.995,"","US","US-AZ"
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityNo","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",947.0,0.289,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityYes","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",159.0,0.27,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationBachelor","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",422.0,0.299,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationCompletedSecondary","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",258.0,0.298,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationMastersOrHigher","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",300.0,0.273,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationPrimary","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",53.0,0.264,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationSomeSecondary","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",73.0,0.247,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Female","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",278.0,0.313,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Male","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",823.0,0.278,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Married","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",883.0,0.282,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationGovernmentEmployee","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",682.0,0.286,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationPrivateSectorEmployee","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",184.0,0.293,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationShopOwner","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",168.0,0.262,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationTaxiDriver","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",72.0,0.333,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Overall","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",1106.0,0.287,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionHamedan","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Local","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Hamedan","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",338.0,0.26,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionKermanshah","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Local","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Kermanshah","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",362.0,0.273,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionSanandaj","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Local","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Sanandaj","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",406.0,0.32,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Single","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",219.0,0.301,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","","","","","IR",""
"2022-01-13","211031_Belarus_StPetersburgPasteurInstitute_Overall","HERD IMMUNITY to SARS-CoV-2 among the POPULATION of the REPUBLIC of BELARUS AMID the COVID-19 PANDEMIC","2021-10-31","National","","Belarus","2021-05-14","2021-05-19","Household and community samples","Multiple groups",12926.0,0.384,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St. Petersburg Pasteur Institute","https://dx.doi.org/10.15789/2220-7619-HIT-1798","Unverified",0.376,0.455,"","","","BY",""
"2022-01-13","211113_Hannover_HannoverMedicalSchool_Overall_Roche+Neut","Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences.","2021-11-23","Local","","Germany; Lower Saxony; Hannover","2020-06-15","2021-06-15","Students and Daycares","Children and Youth (0-17 years)",667.0,0.016,"Convenience","NR","Total Antibody; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Mira Paulsen","Hannover Medical School","https://dx.doi.org/10.1016/j.jadohealth.2021.11.021","Unverified","","","","","","DE","DE-NI"
"2022-01-13","211227_Ghent_GhentUniversityHospital_Overall","Comparison of the positivity rate of anti-spike and anti-nucleocapsid SARS-CoV-2 IgG in asymptomatic pregnant women.","2021-12-27","Local","","Belgium; East Flanders; Ghent","2020-01-15","2020-11-15","Pregnant or parturient women","Adults (18-64 years)",265.0,0.015,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Laura Heireman","Ghent University Hospital","https://dx.doi.org/10.1080/01443615.2021.1997960","Verified","","","","","","BE",""
"2022-01-13","211228_Kanagawa_ ShonanFujisawaTokushukaiHospital_AbbottIgG-S","Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G.","2021-12-28","Local","","Japan","2021-04-15","2021-05-15","Health care workers and caregivers","Adults (18-64 years)",100.0,0.05,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Makoto Hibino","Shonan Fujisawa Tokushukai Hospital","https://dx.doi.org/10.2169/internalmedicine.8704-21","Unverified","","",1.0,1.0,"","JP",""
"2022-01-13","211231_RibeiraoPreto_ButantanInstitute_Primary","SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.","2021-12-31","Local","","Brazil; Sao Paulo; Ribeirao Preto","2019-10-01","2019-12-31","Blood donors","Multiple groups",546.0,0.0,"Unclear","NR","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Victoria Simionatto Zucherato","Butantan Institute","https://dx.doi.org/10.1016/j.jinf.2021.12.041","Unverified","","","","","","BR","BR-SP"
"2022-01-14","211218_Italy_SanRaffaeleUniversity_Overall","COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity.","2021-12-18","Local","","Italy; Milan; Milan","2020-02-15","2021-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",291.0,0.103,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Rossana Caldara","Vita-Salute San Raffaele University","https://dx.doi.org/10.3390/biology10121349","Unverified","","",0.97,1.0,"","IT",""
"2022-01-14","211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_May2020_Wantai","Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations","2021-12-27","National","","Kenya","2020-05-01","2020-05-31","Blood donors","Adults (18-64 years)",176.0,0.023,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","James Nyagwange","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1016/j.jcv.2021.105061","Verified","","",0.953,0.979,"","KE",""
"2022-01-14","220103_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report January 3rd, 2022 Report #15: October 2021 Survey Tracking seroprevalence in the vaccine era","2022-01-03","National","","Canada","2021-10-14","2021-10-23","Blood donors","Multiple groups",9627.0,0.98,"Sequential","","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Unverified",0.976,0.984,0.988,0.996,"","CA",""
"2022-01-17","211020_Bari_UniversityofSiena_ELISA_IgG","SARS-CoV-2: serological evidence of circulation in Southern Italy in late 2019?","2021-10-20","Local","","Italy; Apulia","2019-09-22","2019-12-31","Residual sera","Multiple groups",455.0,0.024,"Convenience","NR","IgG","High","Presentation or Conference","S Marchi","University of Siena","https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.096/6405069?login=true","Unverified","","","","","","IT","IT-75"
"2022-01-17","211130_Porto_CentroHospitalarUniversitáriodeSãoJoão","New-onset type 1 diabetes in children during the COVID-19 pandemic-a Tertiary Centre Experience","2021-11-30","Local","","Portugal; Norte; Porto","2020-03-01","2020-12-31","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",19.0,0.0,"Convenience","NR","Not reported","High","Presentation or Conference","Laura Leite-Almeida","Centro Hospitalar Universitário de São João","https://dx.doi.org/10.1080/2331205X.2021.2002558","Unverified","","","","","","PT",""
"2022-01-17","211209_Dusseldorf_HeinrichHeineUniversityDusseldorf_TestAdj","Underascertainment of COVID-19 cases among first responders: a seroepidemiological study","2021-12-09","Local","","Germany","2020-11-27","2020-12-04","Essential non-healthcare workers","Adults (18-64 years)",745.0,0.04,"Convenience","NR","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Insa Backhaus","Heinrich Heine University Düsseldorf","https://dx.doi.org/10.1093/occmed/kqab164","Unverified",0.031,0.062,0.995,0.998,"","DE",""
"2022-01-17","220112_KantohDistrict_EPSHoldingsInc","Prevalence of Salivary IgA Reacting with SARS-CoV-2 among Japanese People Unexposed to the Virus","2022-01-12","Local","","Japan","2021-04-26","2021-08-01","Household and community samples","Multiple groups",139.0,0.122,"Convenience","NR","IgG","High","Preprint","Keiichi Tsukinoki","EPS Holdings, Inc.","https://www.medrxiv.org/content/10.1101/2022.01.09.22268986v2.full-text","Unverified",0.073,0.189,"","","","JP",""
"2022-01-18","210730_Abruzzo_GDannunzioUniversity","Evaluation of IgG seroprevalence of the Sars-Cov-2 in different worker categories","2021-07-30","Regional","","Italy; Abruzzo","2020-08-01","2020-10-20","Essential non-healthcare workers","Adults (18-64 years)",216.0,0.051,"Unclear","NR","IgG","High","Journal Article (Peer-Reviewed)","E Toniato","G. D'Annunzio University","https://www.biolifesas.org/biolife/wp-content/uploads/2021/07/S3-Toniato-15.pdf","Unverified","","",0.912,0.973,"","IT","IT-65"
"2022-01-18","211130_Lublin_MedicalUniversityofLublin_HC","The impact of asymptomatic SARS-CoV-2 infection in children with pediatric inflammatory diseases on selected clinical and laboratory parameters","2021-11-30","Local","","Poland; Lublin; Lublin","2021-01-10","2021-05-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",31.0,0.065,"Convenience","NR","IgA","High","Presentation or Conference","Izabela Morawska","Medical University of Lublin","https://dx.doi.org/10.1080/2331205X.2021.2002558","Unverified","","","","","","PL","PL-06"
"2022-01-18","211130_Lublin_MedicalUniversityofLublin_JIA","The impact of asymptomatic SARS-CoV-2 infection in children with pediatric inflammatory diseases on selected clinical and laboratory parameters","2021-11-30","Local","","Poland; Lublin; Lublin","2021-01-10","2021-05-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",65.0,0.292,"Convenience","NR","IgA","High","Presentation or Conference","Izabela Morawska","Medical University of Lublin","https://dx.doi.org/10.1080/2331205X.2021.2002558","Unverified","","","","","","PL","PL-06"
"2022-01-18","211130_SantaMariadaFeira_CHEDV","Maternal SARS-CoV-2 infection: What to expect in newborns","2021-11-30","Local","","Portugal; Norte; Santa Maria da Feira","2020-04-01","2021-05-31","Perinatal","Children and Youth (0-17 years)",32.0,0.312,"Convenience","NR","Not reported","High","Presentation or Conference","Rosario Cunha","Centro Hospitalar de Entre Douro e Vouga","https://dx.doi.org/10.1080/2331205X.2021.2002558","Unverified","","","","","","PT",""
"2022-01-18","211203_Bissau_UniversityofSouthernDenmark","SARS-CoV-2 serosurvey among adults involved in healthcare and health research in Guinea-Bissau, West Africa","2021-12-03","Local","","Guinea-Bissau","2020-11-09","2020-11-24","Health care workers and caregivers","Multiple groups",140.0,0.18,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Christine Benn","University of Southern Denmark","https://dx.doi.org/10.1016/j.puhe.2021.11.013","Unverified","","",0.9,1.0,"","GW",""
"2022-01-18","211216_Aden_HadhramoutUniversity_Primary","SARS-CoV-2 seroprevalence in Aden, Yemen: a population-based study","2021-12-16","Local","","Yemen","2020-11-01","2020-12-31","Household and community samples","Multiple groups",2001.0,0.274,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Abdulla Bin Ghouth","World Health Organization Country Office, Yemen","https://dx.doi.org/10.1016/j.ijid.2021.12.330","Unverified",0.256,0.293,"","","","YE",""
"2022-01-18","211231_RiodeJaneiro_NationalInstituteofHealthforWomenChildrenandAdolescentsFernandesFigueira","SARS-CoV-2 seroprevalence and social inequalities in different subgroups of healthcare workers in Rio de Janeiro, Brazil.","2021-12-31","Local","","Brazil","2020-06-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1141.0,0.3,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Roberta Correia","National Institute of Health for Women, Children and Adolescents Fernandes Figueira","https://dx.doi.org/10.1016/j.lana.2021.100170","Unverified","","",0.994,0.996,"","BR",""
"2022-01-18","220101_SanLazaroHospital_NagasakiUniversity_OverallTestAdjusted","A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines.","2022-01-01","Local","","Philippines; National Capital Region; Manila","2021-03-08","2021-04-24","Health care workers and caregivers","Multiple groups",525.0,0.36,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Nimfa Putong","Nagasaki University","https://dx.doi.org/10.1016/j.lanwpc.2021.100353","Unverified",0.3,0.381,"","","","PH",""
"2022-01-18","220105_Managua_UniversityofMichigan","Burden of SARS-CoV-2 and protection from symptomatic second infection in children.","2022-01-05","Local","","Nicaragua; Managua; Managua","2020-03-01","2021-10-15","Household and community samples","Children and Youth (0-17 years)",1824.0,0.498,"Unclear","NR","Not reported","Moderate","Preprint","John Kubale","University of Michigan","https://www.medrxiv.org/content/10.1101/2022.01.03.22268684v1.full-text","Unverified","","","","","","NI","NI-MN"
"2022-01-18","220106_Amsterdam_UniversityofAmsterdam","SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.","2022-01-06","Local","","Netherlands","2020-06-24","2020-10-09","Household and community samples","Multiple groups",2483.0,0.091,"Simplified probability","NR","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Liza Coyer","University of Amsterdam","https://dx.doi.org/10.1136/bmjopen-2021-052752","Unverified","","","","","","NL",""
"2022-01-18","220109_France_UniversityofParisSaclay","Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort.","2022-01-09","National","","France","2020-05-02","2020-06-02","Household and community samples","Multiple groups",12114.0,0.045,"Stratified non-probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Josiane Warszawski","University of Paris-Saclay","https://dx.doi.org/10.1186/s12879-021-06973-0","Unverified",0.039,0.05,0.944,1.0,"","FR",""
"2022-01-18","220110_Grisons_ CantonalHospitalGrisons_Followup2_Overall","Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study.","2022-01-10","Regional","","Switzerland; Canton of Grisons","2021-01-04","2021-02-19","Health care workers and caregivers","Adults (18-64 years)",2315.0,0.162,"Convenience","NR","Not reported","High","Journal Article (Peer-Reviewed)","Katarzyna Szajek","Cantonal Hospital of Grisons","https://dx.doi.org/10.1186/s13756-021-01047-x","Unverified","","",1.0,0.998,"","CH",""
"2022-01-18","220110_Lebanon_LebaneseUniversity_Overall_TestPopAdj","SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.","2022-01-10","National","","Lebanon; Beirut, Mount Lebanon, North Lebanon, Akkar, Baalbek El-Hermel, Bekaa, Nabatieh, and South Lebanon","2020-12-07","2021-01-15","Household and community samples","Multiple groups",2058.0,0.185,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Abbas Hoballah","Lebanese University","https://dx.doi.org/10.1186/s12879-022-07031-z","Unverified",0.168,0.202,0.923,1.0,"","LB",""
"2022-01-18","220110_NewYork_F.Hoffmann-LaRocheLtd_Overall","Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study","2022-01-10","Local","","United States of America; New York; New York","2021-01-06","2021-07-21","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",212.0,0.108,"Convenience","NR","Total Antibody","High","Preprint","Ilya Kister","F. Hoffmann-La Roche Ltd","https://www.medrxiv.org/content/10.1101/2022.01.10.22268752v1.full-text","Unverified","","",0.81,"","","US","US-NY"
"2022-01-18","220110_VilanovadelCami_InstitutCataladelaSalut_Primary","Prevalence of SARS-CoV-2 Antibodies and Risk Factors in the Pandemic Epicentre of Catalonia","2022-01-10","Local","","Spain; Catalonia; Vilanova del Camí","2020-10-01","2020-12-31","Household and community samples","Multiple groups",2170.0,0.096,"Self-referral","NR","IgG","High","Preprint","Sandra Moreno","Institut Català de la Salut","https://www.researchsquare.com/article/rs-1199770/v1","Unverified",0.084,0.109,0.937,0.999,"","ES","ES-CT"
"2022-01-18","220111_Germany_UniversityMedicineGreifswald_Overall","Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany.","2022-01-11","National","","Germany; Berlin, Hamburg, Saxony, Baden-Württemberg, North Rhine-Westphalia; Berlin, Hamburg, Dresden, Stuttgart, Cologne","2021-01-15","2021-04-21","Health care workers and caregivers","Adults (18-64 years)",2784.0,0.052,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Mksoud","University Medicine Greifswald","https://dx.doi.org/10.1007/s00784-021-04363-z","Unverified","","",0.944,0.996,"","DE",""
"2022-01-18","220112_Zurich_UniversityofZurich_GenPop","High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study.","2022-01-12","Local","","Switzerland","2020-06-16","2020-09-15","Household and community samples","Adults (18-64 years)",472.0,0.035,"Convenience","NR","IgA; IgG","High","Journal Article (Peer-Reviewed)","Philip Bruggmann","University of Zurich","https://smw.ch/article/doi/smw.2022.w30122","Unverified",0.022,0.048,0.966,0.997,"","CH",""
"2022-01-18","220112_Zurich_UniversityofZurich_OAT","High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study.","2022-01-12","Local","","Switzerland","2020-07-01","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",122.0,0.098,"Convenience","NR","IgA; IgG","Moderate","Journal Article (Peer-Reviewed)","Philip Bruggmann","University of Zurich","https://smw.ch/article/doi/smw.2022.w30122","Unverified",0.051,0.172,0.966,0.997,"","CH",""
"2022-01-18","220113_California_StanfordUniversity_Incarcerated","COVID-19 policies in practice and their direct and indirect impacts in Northern California jails","2022-01-13","Local","","United States of America; California","2020-07-08","2021-04-30","Persons who are incarcerated","Adults (18-64 years)",690.0,0.128,"Convenience","NR","IgG; IgM","High","Preprint","Yiran Liu","Stanford University Medical School","https://www.medrxiv.org/content/10.1101/2022.01.11.22269106v2.full-text","Unverified",0.11,0.16,0.815,1.0,"","US","US-CA"
"2022-01-18","220113_California_StanfordUniversity_Staff","COVID-19 policies in practice and their direct and indirect impacts in Northern California jails","2022-01-13","Local","","United States of America; California","2020-07-08","2021-04-30","Essential non-healthcare workers","Adults (18-64 years)",292.0,0.082,"Convenience","NR","IgG; IgM","High","Preprint","Yiran Liu","Stanford University Medical School","https://www.medrxiv.org/content/10.1101/2022.01.11.22269106v2.full-text","Unverified",0.06,0.12,0.815,1.0,"","US","US-CA"
"2022-01-18","220113_Lorenskog_UniversityofOslo_Overall_TestAdj","Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.","2022-01-13","Local","","Norway; Akershus; Lorenskog","2019-12-15","2020-12-15","Pregnant or parturient women","Adults (18-64 years)",6520.0,0.017,"Sequential","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Anne Eskild","University of Oslo","https://dx.doi.org/10.1017/S0950268822000073","Unverified","","","","","","NO","NO-02"
"2022-01-19","210331_Wuhan_TongjiMedicalCollege","The Status of Pediatric Patients With Hematologic Malignancy During COVID-19 Pandemic in Wuhan City, China","2021-03-31","Local","","China; Hubei Province; Wuhan","2020-01-23","2020-03-10","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",113.0,0.0,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Zhujun Wang","Tongji Medical College","https://journals.lww.com/jpho-online/Abstract/2022/01000/The_Status_of_Pediatric_Patients_With_Hematologic.27.aspx","Unverified","","",0.84,"","","CN","CN-42"
"2022-01-19","210506_AmazonianBrazil_UniversityofSãoPaulo_Primary","Y Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated With Increased Coronavirus Disease 2019 (COVID-19) Risk in a Population-Based Cohort Study","2021-05-06","Regional","","Brazil; Acre; Mâncio Lima","2020-10-15","2020-11-20","Household and community samples","Multiple groups",1285.0,0.352,"Simplified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Vanessa Nicolete","University of São Paulo","https://academic.oup.com/cid/article/73/11/2045/6270997","Unverified",0.326,0.378,0.879,0.982,"","BR","BR-AC"
"2022-01-19","211020_Vaud_UniversityofLausanne_Center1","Prevalence of SARS-CoV-2 and associated risk factors among asylum seekers living in centres","2021-10-20","Regional","","Switzerland; Vaud","2020-05-15","2020-06-15","Household and community samples","Multiple groups",82.0,0.13,"Convenience","NR","IgG; IgA","High","Presentation or Conference","K Morisod","University of Lausanne","https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.250/6405568?login=true","Unverified",0.03,0.14,"","","","CH","CH-VD"
"2022-01-19","211020_Vaud_UniversityofLausanne_Center2","Prevalence of SARS-CoV-2 and associated risk factors among asylum seekers living in centres","2021-10-20","Regional","","Switzerland; Vaud","2020-05-15","2020-06-15","Household and community samples","Multiple groups",42.0,0.5,"Convenience","NR","IgG; IgA","High","Presentation or Conference","K Morisod","University of Lausanne","https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.250/6405568?login=true","Unverified",0.34,0.65,"","","","CH","CH-VD"
"2022-01-19","211231_Delhi_HamdardInstituteoMedicalSciencesandResearch","Asymptomatic SARS-COV-2 carriage and sero-positivity in high risk contacts of COVID-19 cases'","2021-12-31","Local","","India","2020-09-15","2021-02-15","Contacts of COVID patients","Adults (18-64 years)",407.0,0.289,"Convenience","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Ayan Kumar Das","Hamdard Institute of Medical Sciences & Research","https://dx.doi.org/10.1016/j.ijmmb.2021.12.012","Unverified",0.246,0.336,"","","","IN",""
"2022-01-19","220110_Surabaya_AirlanggaUniversity","Viral shedding and the durability of IgG antibodies to SARS-CoV-2.","2022-01-10","Local","","Indonesia; East Java; Surabaya","2020-05-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",45.0,0.289,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Lusida","Airlangga University","https://dx.doi.org/10.1111/1348-0421.12962","Unverified","","",0.915,0.97,"","ID","ID-JI"
"2022-01-19","220110_Wrocław_WroclawMedicalUniversity","Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors","2022-01-10","Local","","Poland; Silesia; Wrocław","2021-03-15","2021-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",93.0,0.25,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Maciej Majcherek","Wroclaw Medical University","https://dx.doi.org/10.3390/cancers14020325","Unverified","","","","","","PL","PL-24"
"2022-01-20","220113_HyogoPrefecture_KobeUniversity_Baseline1_AntiN_Primary","Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines' efficacy","2022-01-13","Local","","Japan; Hyogo Prefecture; Kobe","2021-07-19","2021-08-06","Residual sera","Multiple groups",1000.0,0.021,"Convenience","NR","Not reported","High","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2022.01.13.22269203v1.full-text","Unverified","","","","","","JP","JP-28"
"2022-01-20","220113_HyogoPrefecture_KobeUniversity_Baseline1_AntiS_Primary","Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines' efficacy","2022-01-13","Local","","Japan; Hyogo Prefecture; Kobe","2021-07-19","2021-08-06","Residual sera","Multiple groups",1000.0,0.387,"Convenience","NR","Not reported","High","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2022.01.13.22269203v1.full-text","Unverified","","","","","","JP","JP-28"
"2022-01-20","220113_HyogoPrefecture_KobeUniversity_Followup2_AntiN_Primary","Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines' efficacy","2022-01-13","Local","","Japan; Hyogo Prefecture; Kobe","2021-11-22","2021-12-08","Residual sera","Multiple groups",1000.0,0.039,"Convenience","NR","Not reported","High","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2022.01.13.22269203v1.full-text","Unverified","","","","","","JP","JP-28"
"2022-01-20","220113_HyogoPrefecture_KobeUniversity_Followup2_AntiS_Primary","Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines' efficacy","2022-01-13","Local","","Japan; Hyogo Prefecture; Kobe","2021-11-22","2021-12-08","Residual sera","Multiple groups",1000.0,0.908,"Convenience","NR","Not reported","High","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2022.01.13.22269203v1.full-text","Unverified","","","","","","JP","JP-28"
"2022-01-21","211229_Delhi_MaulanaAzadMedicalCollege_HCW","Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study","2021-12-29","Local","","India","2020-12-02","2021-05-25","Health care workers and caregivers","Adults (18-64 years)",625.0,0.514,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Pragya Sharma","Maulana Azad Medical College","https://www.cureus.com/articles/80002-seroprevalence-of-sars-cov-2-and-risk-assessment-among-healthcare-workers-at-a-dedicated-tertiary-care-covid-19-hospital-in-delhi-india-a-cohort-study","Unverified","","",0.947,1.0,"","IN",""
"2022-01-21","220107_Bamako_UniversityOfBamako","High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali","2022-01-07","Local","","Mali","2020-11-15","2021-06-15","Health care workers and caregivers","Adults (18-64 years)",238.0,0.618,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Anou M. Somboro","University Of Bamako","https://dx.doi.org/10.3390/v14010102","Unverified","","","","","","ML",""
"2022-01-23","210928_Moscow_RussianFederation","Seroprevalence of anti-sars-cov-2 antibodies among healthcare professionals in Moscow in april-december 2020","2021-09-28","Regional","","Russian Federation; Central Russia; Moscow","2020-04-14","2020-12-31","Health care workers and caregivers","Multiple groups",24373.0,0.221,"Unclear","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","Russian Federation","https://dx.doi.org/10.20953/1729-9225-2021-3-5-13","Unverified","","","","","","RU",""
"2022-01-23","220117_GranCanaria_InstitutoUniversitariodeInvestigacionesBiomédicasySanitarias","Role of the SARS-CoV-2 virus in the appearance of new onset type 1 diabetes mellitus in children in Gran Canaria, Spain","2022-01-17","Regional","","Spain; Las Palmas; Gran Canaria","2020-10-15","2021-08-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",33.0,0.03,"Entire sample","NR","IgG","High","Journal Article (Peer-Reviewed)","Yeray Nóvoa-Medina","Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS)","10.1515/jpem-2021-0727","Unverified","","","","","","ES",""
"2022-01-24","220119_JohnsHopkinsHospital_JohnsHopkinsUniversity_2021_Overall_All","Differentiation of SARS-CoV-2 previously infected and vaccinated individuals in an inner-city emergency department.","2022-01-19","Local","","United States of America; Maryland; Baltimore","2021-01-11","2021-03-10","Residual sera","Multiple groups",2824.0,0.238,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Evan Beck","Johns Hopkins University","https://dx.doi.org/10.1128/jcm.02390-21","Unverified",0.222,0.254,"","","","US","US-MD"
"2022-01-24","220120_LosAngelesCounty_UniversityOfSouthernCalifornia_Overall","Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study.","2022-01-20","Local","","United States of America; California","2021-04-09","2021-04-25","Household and community samples","Multiple groups",1335.0,0.669,"Stratified probability","NR","Not reported","Moderate","Journal Article (Peer-Reviewed)","Neeraj Sood","University of Southern California","https://dx.doi.org/10.1001/jamanetworkopen.2021.44258","Unverified",0.644,0.694,"","","","US","US-CA"
"2022-01-25","220110_Chongqing_ArmyMedicalUniversity_GenPop","SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020.","2022-01-10","Local","","China","2020-01-01","2020-03-31","Blood donors","Adults (18-64 years)",250.0,0.0,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shichun Wang","Army Medical University","https://dx.doi.org/10.1016/j.jfma.2022.01.004","Unverified","","","","","","CN",""
"2022-01-25","220110_Chongqing_ArmyMedicalUniversity_HCW","SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020.","2022-01-10","Local","","China","2020-01-01","2020-03-31","Household and community samples","Adults (18-64 years)",248.0,0.0,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shichun Wang","Army Medical University","https://dx.doi.org/10.1016/j.jfma.2022.01.004","Unverified","","","","","","CN",""
"2022-01-25","220117_KlangValleyAndPerak_HealthyMalaysiaSociety_LocalWorkers_TestAndSeroReversionAdj","Sero-Prevalence of Covid-19 among workers in Malaysia","2022-01-17","Regional","","Malaysia; Klang Valley; and Perak","2021-07-15","2021-09-15","Essential non-healthcare workers","Adults (18-64 years)",204.0,0.121,"Convenience","NR","Not reported","High","Preprint","Noorliza Mohamad Noordin","Healthy Malaysia Society","https://doi.org/10.1101/2022.01.16.22269388","Unverified",0.08,0.162,0.83,0.96,"","MY",""
"2022-01-25","220117_KlangValleyAndPerak_HealthyMalaysiaSociety_MigrantWorkers_TestAndSeroReversionAdj","Sero-Prevalence of Covid-19 among workers in Malaysia","2022-01-17","Regional","","Malaysia; Klang Valley; and Perak","2021-07-15","2021-09-15","Essential non-healthcare workers","Adults (18-64 years)",874.0,0.999,"Convenience","NR","Not reported","High","Preprint","Noorliza Mohamad Noordin","Healthy Malaysia Society","https://doi.org/10.1101/2022.01.16.22269388","Unverified",0.967,1.0,0.83,0.96,"","MY",""
"2022-01-25","220118_Denver_UniversityofColoradoDenver_Overall","Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020.","2022-01-18","Local","","United States of America; Colorado; Denver","2020-06-02","2020-07-28","Persons experiencing homelessness","Multiple groups",271.0,0.155,"Convenience","NR","IgG","Unclear","Journal Article (Peer-Reviewed)","Sarah Rowan","University of Colorado Denver","https://dx.doi.org/10.1093/cid/ciac039","Unverified","","","","","","US","US-CO"
"2022-01-25","220119_Scotland_PublicHealthScotland_ResidualSera1Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 19 January, 2022","2022-01-19","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-11-15","2021-12-19","Residual sera","Multiple groups",2815.0,0.874,"Stratified probability","NR","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/","Unverified",0.857,0.887,0.973,0.996,"","GB","GB-SCT"
"2022-01-26","210912_Turku_UniversityofTurku_Overall","Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study.","2022-01-19","Local","","Finland; Southwest Finland; Turku","2020-05-13","2020-12-17","Health care workers and caregivers","Multiple groups",222.0,0.081,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Paula Tahtinen","University of Turku","https://dx.doi.org/10.1080/23744235.2022.2027008","Unverified","","",0.963,0.99,"","FI","FI-19"
"2022-01-26","211217_Portugal_NationalInstituteofHealth_Primary","National COVID-19 Serological Survey (3rd phase)","2021-12-17","National","","Portugal","2021-09-28","2021-11-19","Household and community samples","Multiple groups",4545.0,0.864,"Stratified non-probability","NR","IgG","Moderate","Institutional Report","ISN COVID-19 Group","National Institute of Health","http://repositorio.insa.pt/handle/10400.18/7828","Unverified",0.852,0.876,"","","","PT",""
"2022-01-26","220117_Maryland_JohnsHopkinsUniversitySchoolofMedicine_Residents","Evaluating Immunity to SARS-CoV-2 in Nursing Home Residents using Saliva IgG.","2022-01-17","Local","","United States of America; Maryland","2020-10-01","2021-02-16","Assisted living and long-term care facilities","Multiple groups",124.0,0.57,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Morgan Katz","Johns Hopkins University School of Medicine","https://dx.doi.org/10.1111/jgs.17660","Unverified","","",0.988,1.0,"","US","US-MD"
"2022-01-26","220117_Maryland_JohnsHopkinsUniversitySchoolofMedicine_Staff","Evaluating Immunity to SARS-CoV-2 in Nursing Home Residents using Saliva IgG.","2022-01-17","Local","","United States of America; Maryland","2020-10-01","2021-02-16","Health care workers and caregivers","Multiple groups",28.0,0.79,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Morgan Katz","Johns Hopkins University School of Medicine","https://dx.doi.org/10.1111/jgs.17660","Unverified","","",0.988,1.0,"","US","US-MD"
"2022-01-26","220117_Quebec_McGillUniversity_EDM","Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021).","2022-01-17","Local","","Canada; Quebec; Montreal","2021-01-19","2021-07-20","Persons who are incarcerated","Adults (18-64 years)",600.0,0.273,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Nadine Kronfli","McGill University","https://dx.doi.org/10.1093/cid/ciac031","Unverified","","",0.995,0.998,"","CA","CA-QC"
"2022-01-26","220117_Quebec_McGillUniversity_EDRDP","Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021).","2022-01-17","Local","","Canada; Quebec; Montreal","2021-02-03","2021-03-24","Persons who are incarcerated","Adults (18-64 years)",300.0,0.147,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Nadine Kronfli","McGill University","https://dx.doi.org/10.1093/cid/ciac031","Unverified","","",0.995,0.998,"","CA","CA-QC"
"2022-01-26","220117_Quebec_McGillUniversity_EDSJ","Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021).","2022-01-17","Local","","Canada; Quebec; Saint-Jérôme","2021-03-30","2021-09-15","Persons who are incarcerated","Adults (18-64 years)",200.0,0.19,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Nadine Kronfli","McGill University","https://dx.doi.org/10.1093/cid/ciac031","Unverified","","",0.995,0.998,"","CA","CA-QC"
"2022-01-26","220119_Istanbul_IstanbulUniversity_Overall","Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children.","2022-01-19","Local","","Turkey; Marmara; Istanbul","2020-08-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",149.0,0.128,"Convenience","NR","IgG; IgA","High","Journal Article (Peer-Reviewed)","Fatih Haslak","Istanbul University","https://dx.doi.org/10.1007/s10067-022-06067-5","Unverified","","","","","","TR",""
"2022-01-26","220119_Scotland_PublicHealthScotland_BloodDonors2Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 19 January, 2022","2022-01-19","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-11-15","2021-12-19","Blood donors","Multiple groups",2493.0,1.0,"Sequential","NR","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/","Unverified",0.999,1.0,0.84,1.0,"","GB","GB-SCT"
"2022-01-26","220119_Scotland_PublicHealthScotland_PregnantWomen3Overall_Unadj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 19 January, 2022","2022-01-19","National","","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-11-15","2021-12-19","Pregnant or parturient women","Adults (18-64 years)",3060.0,0.872,"Sequential","NR","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/","Unverified","","",0.923,1.0,"","GB","GB-SCT"
"2022-01-26","220121_Ohio_OhioStateUniversity_Primary","Prevalence of current and past COVID-19 in Ohio adults","2022-01-21","Regional","","United States of America; Ohio","2020-07-09","2020-07-28","Household and community samples","Multiple groups",667.0,0.013,"Stratified probability","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Abigail Norris Turner","Ohio State University","https://dx.doi.org/10.1016/j.annepidem.2021.11.009","Unverified",0.002,0.027,"","","","US","US-OH"
"2022-01-27","220103_BritishColumbia_UniversityofBritishColumbia_Dec2020_Overall","Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks.","2022-01-03","Local","","Canada; British Columbia","","2020-12-22","Assisted living and long-term care facilities","Seniors (65+ years)",45.0,0.444,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Guadalein Tanunliong","University of British Columbia","https://dx.doi.org/10.3389/fimmu.2021.775420","Unverified","","","","","","CA","CA-BC"
"2022-01-27","220103_BritishColumbia_UniversityofBritishColumbia_May2020_Overall","Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks.","2022-01-03","Local","","Canada; British Columbia","2020-05-04","2020-05-14","Assisted living and long-term care facilities","Seniors (65+ years)",87.0,0.402,"Convenience","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Guadalein Tanunliong","University of British Columbia","https://dx.doi.org/10.3389/fimmu.2021.775420","Unverified","","","","","","CA","CA-BC"
"2022-01-27","220111_Rome_GemelliUniversityHospital","Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings.","2022-01-11","Local","","Italy; Lazio; Rome","2020-03-01","2021-04-30","Perinatal","Children and Youth (0-17 years)",59.0,0.152,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Danilo Buonsenso","Gemelli University","https://dx.doi.org/10.1007/s00431-021-04319-1","Unverified","","",0.85,0.98,"","IT","IT-62"
"2022-01-27","220116_Prishtina_PrishtinaStarts_IgMorIgG_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.","2022-01-16","Local","","Kosovo","2020-10-14","2020-12-17","Health care workers and caregivers","Adults (18-64 years)",475.0,0.175,"Entire sample","NR","IgM; IgG","High","Journal Article (Peer-Reviewed)","Rrezart Halili","Prishtina Starts","https://dx.doi.org/10.1186/s12879-022-07038-6","Unverified","","","","","","XK",""
"2022-01-31","220122_Arkhangelsk_LondonSchoolofHygieneandTropicalMedicine_TestAdj","Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.","2022-01-22","Local","","Russian Federation","2021-02-24","2021-05-28","Household and community samples","Multiple groups",1067.0,0.726,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ekaterina Krieger","London School of Hygiene & Tropical Medicine","https://dx.doi.org/10.3201/eid2802.211640","Unverified",0.642,0.831,0.89,1.0,"","RU",""
"2022-01-31","220122_Atahualpa_UniversidadEspirituSanto_Overall","Risk for Subsequent SARS-CoV-2 Infection and Severe COVID-19 Among Community-Dwellers With Pre-Existing Cervicocephalic Atherosclerosis: A Population-Based Study.","2022-01-22","Local","","Ecuador","2020-05-15","2021-04-15","Household and community samples","Adults (18-64 years)",519.0,0.63,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Stony Brook University","https://dx.doi.org/10.1177/21501319211070685","Unverified","","","","","","EC",""
"2022-02-01","200906_Kanagawa_KanagawaPhysiciansAssociation_HCWs_PopAdjust","Survey of the current status of subclinical coronavirus disease 2019 (COVID-19)","2020-09-06","Regional","","Japan; Kanagawa Prefecture","2020-05-18","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",504.0,0.021,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ikuro Matsuba","Kanagawa Physicians Association","https://www.sciencedirect.com/science/article/pii/S1341321X20303251","Unverified","","",1.0,1.0,"","JP","JP-14"
"2022-02-01","200906_Kanagawa_KanagawaPhysiciansAssociation_Patients_PopAdjust","Survey of the current status of subclinical coronavirus disease 2019 (COVID-19)","2020-09-06","Regional","","Japan; Kanagawa Prefecture","2020-05-18","2020-06-24","Patients seeking care for non-COVID-19 reasons","Multiple groups",988.0,0.027,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ikuro Matsuba","Kanagawa Physicians Association","https://www.sciencedirect.com/science/article/pii/S1341321X20303251","Unverified","","",1.0,1.0,"","JP","JP-14"
"2022-02-01","220121_Bavaria_LudwigMaximiliansUniversitat_Children_Overall","SARS-CoV-2 surveillance (09/2020 - 03/2021) in elementary schools and daycare facilities in Bavaria","2022-01-21","Regional","","Germany; Bavaria","2021-06-15","2021-07-15","Students and Daycares","Children and Youth (0-17 years)",509.0,0.077,"Convenience","NR","Total Antibody","High","Preprint","Anna Kern","Ludwig-Maximilians-Universitat","10.1101/2022.01.18.22269445","Unverified","","","","","","DE","DE-BY"
"2022-02-01","220121_Bavaria_LudwigMaximiliansUniversitat_Teachers_Overall","SARS-CoV-2 surveillance (09/2020 - 03/2021) in elementary schools and daycare facilities in Bavaria","2022-01-21","Regional","","Germany; Bavaria","2021-06-15","2021-07-15","Essential non-healthcare workers","Adults (18-64 years)",202.0,0.045,"Convenience","NR","Total Antibody","High","Preprint","Anna Kern","Ludwig-Maximilians-Universitat","10.1101/2022.01.18.22269445","Unverified","","","","","","DE","DE-BY"
"2022-02-01","220121_Thailand_MahidolUniversity_AtRiskOccupations_Overall","Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves","2022-01-21","Regional","","Thailand; Chiang Mai, Bangkok; Bangkok","2020-05-14","2021-05-21","Non-essential workers and unemployed persons","Multiple groups",1641.0,0.002,"Unclear","NR","Neutralizing ; IgG; IgA; IgM","Unclear","Preprint","Hatairat Lerdsamra","Mahidol University","https://www.medrxiv.org/content/10.1101/2022.01.18.22269501v1.full-text","Unverified","","","","","","TH",""
"2022-02-01","220121_Thailand_MahidolUniversity_HealthPersonnel_Overall","Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves","2022-01-21","Regional","","Thailand; Chiang Mai, Bangkok; Bangkok","2020-05-14","2021-05-21","Health care workers and caregivers","Multiple groups",472.0,0.0,"Unclear","NR","Neutralizing ; IgG; IgA; IgM","Unclear","Preprint","Hatairat Lerdsamra","Mahidol University","https://www.medrxiv.org/content/10.1101/2022.01.18.22269501v1.full-text","Unverified","","","","","","TH",""
"2022-02-01","220121_Thailand_MahidolUniversity_SharedEnvironmentCOVID_Overall","Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves","2022-01-21","Regional","","Thailand; Chiang Mai, Bangkok; Bangkok","2020-05-14","2021-05-21","Contacts of COVID patients","Multiple groups",1856.0,0.02,"Unclear","NR","Neutralizing ; IgG; IgA; IgM","Unclear","Preprint","Hatairat Lerdsamra","Mahidol University","https://www.medrxiv.org/content/10.1101/2022.01.18.22269501v1.full-text","Unverified",0.014,0.028,"","","","TH",""
"2022-02-01","220121_Thailand_MahidolUniversity_TravelersQuarantine_Overall","Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves","2022-01-21","Regional","","Thailand; Chiang Mai, Bangkok; Bangkok","2020-05-14","2021-05-21","Household and community samples","Multiple groups",553.0,0.28,"Unclear","NR","Neutralizing ; IgG; IgA; IgM","Unclear","Preprint","Hatairat Lerdsamra","Mahidol University","https://www.medrxiv.org/content/10.1101/2022.01.18.22269501v1.full-text","Unverified",0.238,0.328,"","","","TH",""
"2022-02-01","220124_Berlin_RobertKochInstitute_Dec2020_TestAdj","Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany.","2022-01-24","Local","","Germany","2020-12-08","2020-12-20","Health care workers and caregivers","Adults (18-64 years)",1223.0,0.046,"Convenience","NR","IgG; Total Antibody; Neutralizing","High","Journal Article (Peer-Reviewed)","Sara Tomczyk","BG Klinikum Unfallkrankenhaus Berlin gGmbH","https://dx.doi.org/10.1186/s12879-022-07057-3","Unverified",0.033,0.061,0.883,0.992,"","DE",""
"2022-02-01","220124_Berlin_RobertKochInstitute_MayJune2020_Overall","Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany.","2022-01-24","Local","","Germany","2020-05-18","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",1477.0,0.012,"Convenience","NR","IgG; Total Antibody; Neutralizing","High","Journal Article (Peer-Reviewed)","Sara Tomczyk","BG Klinikum Unfallkrankenhaus Berlin gGmbH","https://dx.doi.org/10.1186/s12879-022-07057-3","Unverified","","",0.883,0.992,"","DE",""
"2022-02-01","220126_HoChiMinhCity_PasteurInstituteOfHoChiMinhCity_PopAdj_Overall","Seroprevalence of SARS-CoV-2 Neutralizing Antibodies among Blood Donors in Ho Chi Minh City, Vietnam, August-November 2020.","2022-01-26","Local","","Viet Nam","2020-08-27","2020-11-07","Blood donors","Adults (18-64 years)",885.0,0.002,"Sequential","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Hanh Hong Ho Nguyen","Pasteur Institute of Ho Chi Minh City","https://dx.doi.org/10.4269/ajtmh.21-0259","Unverified",0.0,0.008,"",1.0,"","VN",""
"2022-02-02","211201_Chennai_YRCCARE","SARS CoV-2 seroprevalence and COVID-19 experience among people with HIV in India","2021-12-01","Local","","India; Tamil Nadu; Chennai","2020-12-15","2021-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",393.0,0.104,"Convenience","NR","IgG","High","Presentation or Conference","RT Khan","YRGCARE","https://journals.sagepub.com/doi/abs/10.1177/13596535211063242?journalCode=avta","Unverified","","","","","","IN","IN-TN"
"2022-02-02","211226_Timisoara_VictorBabesUniversityOfMedicineAndPharmacy_Overall","SARS-CoV-2 Seroprevalence in Western Romania, March to June 2021.","2021-12-26","Local","","Romania","2021-03-10","2021-06-10","Residual sera","Multiple groups",2443.0,0.456,"Sequential","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Tudor Rares Olariu","Victor Babes University of Medicine and Pharmacy","https://dx.doi.org/10.3390/medicina58010035","Unverified",0.436,0.476,0.995,0.998,"","RO",""
"2022-02-02","220125_UniversityofMissouri_UniversityofMissouri_Random","The MU Study of Seropositivity and Risk for SARS-CoV-2 and COVID-19: Crucial Behavioral and Immunological Data from Midwestern College Students","2022-01-25","Local","","United States of America; Missouri; Columbia","2020-09-15","2020-12-15","Students and Daycares","Adults (18-64 years)",833.0,0.149,"Stratified probability","NR","Not reported","Moderate","Preprint","Tyler Myroniuk","University of Missouri","https://www.medrxiv.org/content/10.1101/2022.01.24.22269758v1.full-text","Unverified","","","","","","US","US-MO"
"2022-02-02","220125_UniversityofMissouri_UniversityofMissouri_SelfReferral","The MU Study of Seropositivity and Risk for SARS-CoV-2 and COVID-19: Crucial Behavioral and Immunological Data from Midwestern College Students","2022-01-25","Local","","United States of America; Missouri; Columbia","2020-10-12","2020-12-15","Students and Daycares","Adults (18-64 years)",69.0,0.174,"Self-referral","NR","Not reported","High","Preprint","Tyler Myroniuk","University of Missouri","https://www.medrxiv.org/content/10.1101/2022.01.24.22269758v1.full-text","Unverified","","","","","","US","US-MO"
"2022-02-02","220201_Chattogram_icddrb_adj","SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March-June 2021.","2022-02-01","Local","","Bangladesh","2021-03-27","2021-06-13","Household and community samples","Multiple groups",2307.0,0.641,"Stratified non-probability","NR","IgA; IgM; IgG","Low","Journal Article (Peer-Reviewed)","Taufiqur Rahman Bhuiyan","icddr,b","https://dx.doi.org/10.3201/eid2802.211689","Unverified",0.6,0.681,0.877,0.991,"","BD",""
"2022-02-02","221230_Gyeonggi_HallymUniversityCollegeofMedicine_Overall","Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer.","2021-12-30","Regional","","Republic of Korea; Gyeonggi","2021-03-01","2021-03-12","Health care workers and caregivers","Adults (18-64 years)",228.0,0.0,"Unclear","NR","Total Antibody","High","Journal Article (Peer-Reviewed)","Seri Jeong","Hallym University College of Medicine","https://dx.doi.org/10.3390/diagnostics12010085","Unverified","","","","","","KR","KR-41"
"2022-02-03","220121_Athens_NationalandKapodistrianUniversityofAthens","Seroepidemiology of SARS-CoV-2 in pediatric population during a 16-month period prior to vaccination.","2022-01-21","Local","","Greece","2020-05-01","2021-08-31","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",3099.0,0.111,"Sequential","NR","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Filippos Filippatos","National and Kapodistrian University of Athens","https://dx.doi.org/10.1002/jmv.27608","Unverified","","",0.995,0.998,"","GR",""
"2022-02-03","220124_Estonia_UniversityOfTartu_Stage23_Overall","The study on the prevalence of the coronavirus in Estonia","2022-01-24","National","","Estonia","2022-01-11","2022-01-24","Household and community samples","Multiple groups",2301.0,0.828,"Stratified probability","NR","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused","Verified",0.8,0.854,"","","","EE",""
"2022-02-03","220124_LosAngeles_UniversityofSouthernCalifornia_PopAdj","SARS-CoV-2 seroprevalence among firefighters in Los Angeles, California.","2022-01-24","Local","","United States of America; California; Los Angeles","2020-10-20","2020-10-28","Essential non-healthcare workers","Adults (18-64 years)",686.0,0.093,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Karen Mulligan","University of Southern California","https://dx.doi.org/10.1136/oemed-2021-107805","Unverified",0.07,0.117,"","","","US","US-CA"
"2022-02-03","220124_SouthWales_PublicHealthWales_Overall","SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study.","2022-01-24","Regional","","United Kingdom of Great Britain and Northern Ireland; South Wales","2020-09-01","2020-10-31","Non-essential workers and unemployed persons","Adults (18-64 years)",991.0,0.07,"Convenience","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alice Puchades","Public Health Wales","https://dx.doi.org/10.1186/s12889-021-12478-x","Unverified","","",0.96,0.955,"","GB",""
"2022-02-03","220126_HillsboroughCounty_MoffittCancerCenter_Overall","SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, October 2020-March 2021.","2022-01-26","Local","","United States of America; Florida","2020-10-15","2021-03-15","Household and community samples","Multiple groups",867.0,0.195,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Giuliano","Moffitt Cancer Center","https://dx.doi.org/10.3201/eid2803.211495","Unverified",0.169,0.223,0.968,0.941,"","US","US-FL"
"2022-02-05","211215_Netherlands_NationalInstituteForPublicHealthAndTheEnvironenment_Overall_PopAdj_TesAdj","Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands","2021-12-15","National","","Netherlands","2020-06-09","2020-08-24","Household and community samples","Multiple groups",6813.0,0.045,"Stratified probability","NR","IgG","Low","Journal Article (Peer-Reviewed)","Eric Vos","National Institute for Public Health and the Environment","https://academic.oup.com/cid/article/73/12/2318/6189768?login=true","Unverified",0.038,0.052,0.943,0.999,"","NL",""
"2022-02-05","220101_Belgium_Sciensano","Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children and School Staff: an Observational Sero-Prevalence Prospective Cohort Study","2022-01-01","National","","Belgium","2021-12-06","2021-12-17","Students and Daycares","Children and Youth (0-17 years)",432.0,0.509,"Convenience","NR","IgG","High","Institutional Report","Joanna Merckx","Sciensano","","Unverified",0.437,0.592,"","","","BE",""
"2022-02-05","220101_Belgium_Sciensano_Brussels","Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children and School Staff: an Observational Sero-Prevalence Prospective Cohort Study","2022-01-01","Regional","","Belgium; Region of Brussels","2021-12-06","2021-12-17","Students and Daycares","Children and Youth (0-17 years)",61.0,0.473,"Convenience","NR","IgG","High","Institutional Report","Joanna Merckx","Sciensano","","Unverified",0.382,0.585,"","","","BE","BE-BRU"
"2022-02-05","220101_Belgium_Sciensano_Flanders","Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children and School Staff: an Observational Sero-Prevalence Prospective Cohort Study","2022-01-01","Regional","","Belgium; Region of Flanders","2021-12-06","2021-12-17","Students and Daycares","Children and Youth (0-17 years)",274.0,0.482,"Convenience","NR","IgG","High","Institutional Report","Joanna Merckx","Sciensano","","Unverified",0.379,0.612,"","","","BE","BE-VLG"
"2022-02-05","220101_Belgium_Sciensano_Wallonia","Prevalence and Incidence of Antibodies Against SARS-CoV-2 in Children and School Staff: an Observational Sero-Prevalence Prospective Cohort Study","2022-01-01","Regional","","Belgium; Region of Wallonia","2021-12-06","2021-12-17","Students and Daycares","Children and Youth (0-17 years)",97.0,0.586,"Convenience","NR","IgG","High","Institutional Report","Joanna Merckx","Sciensano","","Unverified",0.489,0.703,"","","","BE","BE-WAL"
"2022-02-06","211122_Montreal_UniversityOfMontreal_10-14","Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.","2021-11-23","Local","","Canada; Quebec; Montreal","2020-10-22","2021-03-22","Students and Daycares","Children and Youth (0-17 years)",529.0,0.068,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Kate Zinszer","University of Montreal","https://dx.doi.org/10.1001/jamanetworkopen.2021.35975","Unverified",0.042,0.094,0.95,1.0,"","CA","CA-QC"
"2022-02-06","211122_Montreal_UniversityOfMontreal_15-17","Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.","2021-11-23","Local","","Canada; Quebec; Montreal","2020-10-22","2021-03-22","Students and Daycares","Children and Youth (0-17 years)",221.0,0.072,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Kate Zinszer","University of Montreal","https://dx.doi.org/10.1001/jamanetworkopen.2021.35975","Unverified",0.034,0.11,0.95,1.0,"","CA","CA-QC"
"2022-02-06","211122_Montreal_UniversityOfMontreal_2-4","Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.","2021-11-23","Local","","Canada; Quebec; Montreal","2020-10-22","2021-03-22","Students and Daycares","Children and Youth (0-17 years)",332.0,0.048,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Kate Zinszer","University of Montreal","https://dx.doi.org/10.1001/jamanetworkopen.2021.35975","Unverified",0.029,0.067,0.95,1.0,"","CA","CA-QC"
"2022-02-06","211122_Montreal_UniversityOfMontreal_5-9","Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.","2021-11-23","Local","","Canada; Quebec; Montreal","2020-10-22","2021-03-22","Students and Daycares","Children and Youth (0-17 years)",542.0,0.05,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Kate Zinszer","University of Montreal","https://dx.doi.org/10.1001/jamanetworkopen.2021.35975","Unverified",0.034,0.066,0.95,1.0,"","CA","CA-QC"
"2022-02-07","210415_France_InstitutPasteur_HighSchool1_12-17","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France","France; Hauts-de-France","2020-03-30","2020-04-04","Students and Daycares","Children and Youth (0-17 years)",235.0,0.349,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","","",0.994,0.99,"","FR","FR-HDF"
"2022-02-07","210415_France_InstitutPasteur_HighSchool1_Under12","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France","France; Hauts-de-France","2020-03-30","2020-04-04","Students and Daycares","Children and Youth (0-17 years)",8.0,0.0,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","","",0.994,0.99,"","FR","FR-HDF"
"2022-02-07","210415_France_InstitutPasteur_PrimarySchool2_12-17","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France","France; Hauts-de-France","2020-04-28","2020-04-30","Students and Daycares","Children and Youth (0-17 years)",78.0,0.154,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","","",0.994,0.99,"","FR","FR-HDF"
"2022-02-07","210415_France_InstitutPasteur_PrimarySchool2_Under12","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France","France; Hauts-de-France","2020-04-28","2020-04-30","Students and Daycares","Children and Youth (0-17 years)",538.0,0.086,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","","",0.994,0.99,"","FR","FR-HDF"
"2022-02-07","211231_Cyprus_CyprusSchoolofMolecularMedicine_AntiS1RBD_TestAdjusted","Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population","2021-12-31","National","","Cyprus","2020-10-15","2021-05-15","Household and community samples","Multiple groups",194.0,0.066,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","George Krashias","Cyprus School of Molecular Medicine","https://www.mdpi.com/2076-2607/10/1/85","Unverified","","",0.925,0.933,"","CY",""
"2022-02-07","220202_Thailand_ChiangMaiUniversity_Overall","Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 among at-risk populations in Chiang Mai and Lamphun provinces, Thailand, during November 2020-January 2021.","2022-02-02","National","","Thailand; Chiang Mai and Lamphun","2020-11-15","2021-01-15","Household and community samples","Multiple groups",1651.0,0.009,"Unclear","NR","IgG; IgM","High","Journal Article (Peer-Reviewed)","Siriluk Takalay","Chiang Mai University","https://dx.doi.org/10.1371/journal.pone.0263127","Unverified",0.005,0.014,"","","","TH",""
"2022-02-08","220127_Dhaka_BRiCM","Seropositivity of SARS-CoV-2 IgG Antibody among People in Dhaka City during the Prevaccination Period.","2022-01-27","Local","","Bangladesh","2020-10-15","2021-02-15","Household and community samples","Adults (18-64 years)",239.0,0.422,"Convenience","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Zabed Ahmed","Bangladesh Reference Institute for Chemical Measurements","https://dx.doi.org/10.1155/2022/4451144","Unverified","","",0.983,0.981,"","BD",""
"2022-02-08","220128_Chile_UniversidaddelDesarrollo_Overall_PopAdj","Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile.","2022-01-28","National","","Chile; Coquimbo, Talca, Santiago","2020-09-25","2020-11-25","Household and community samples","Multiple groups",2493.0,0.104,"Stratified probability","NR","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Pablo Vial","Universidad del Desarrollo","https://dx.doi.org/10.1186/s12879-022-07045-7","Unverified",0.078,0.137,"","","","CL",""
"2022-02-08","220128_Zurich_UniversityofZurich_T1Children_testadj","SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland","2022-01-28","Regional","","Switzerland; Zurich","2020-06-15","2020-07-15","Students and Daycares","Children and Youth (0-17 years)",2473.0,0.044,"Convenience","NR","Not reported","Moderate","Preprint","Agne Ulyte","University of Switzerland","https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text","Unverified",0.021,0.062,0.983,0.984,"","CH","CH-ZH"
"2022-02-08","220128_Zurich_UniversityofZurich_T1Parents_testadj","SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland","2022-01-28","Regional","","Switzerland; Zurich","2020-08-15","2021-09-15","Multiple populations","Multiple groups",2045.0,0.058,"Convenience","NR","Not reported","Moderate","Preprint","Agne Ulyte","University of Switzerland","https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text","Unverified",0.035,0.078,0.983,0.984,"","CH","CH-ZH"
"2022-02-08","220128_Zurich_UniversityofZurich_T1Personnel_testadj","SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland","2022-01-28","Regional","","Switzerland; Zurich","2020-08-15","2021-09-15","Essential non-healthcare workers","Multiple groups",1608.0,0.046,"Convenience","NR","Not reported","Moderate","Preprint","Agne Ulyte","University of Switzerland","https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text","Unverified",0.023,0.067,0.983,0.984,"","CH","CH-ZH"
"2022-02-08","220128_Zurich_UniversityofZurich_T2Children_testadj","SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland","2022-01-28","Regional","","Switzerland; Zurich","2021-03-15","2021-04-15","Students and Daycares","Children and Youth (0-17 years)",2450.0,0.181,"Convenience","NR","Not reported","Moderate","Preprint","Agne Ulyte","University of Switzerland","https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text","Unverified",0.157,0.207,0.983,0.984,"","CH","CH-ZH"
"2022-02-08","220128_Zurich_UniversityofZurich_T2Parents_testadj","SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland","2022-01-28","Regional","","Switzerland; Zurich","2021-03-15","2021-04-15","Multiple populations","Multiple groups",1545.0,0.209,"Convenience","NR","Not reported","Moderate","Preprint","Agne Ulyte","University of Switzerland","https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text","Unverified",0.18,0.239,0.983,0.984,"","CH","CH-ZH"
"2022-02-08","220128_Zurich_UniversityofZurich_T2Personnel_testadj","SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland","2022-01-28","Regional","","Switzerland; Zurich","2021-03-15","2021-04-15","Essential non-healthcare workers","Multiple groups",1435.0,0.169,"Convenience","NR","Not reported","Moderate","Preprint","Agne Ulyte","University of Switzerland","https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text","Unverified",0.141,0.198,0.983,0.984,"","CH","CH-ZH"
"2022-02-08","220201_Mexico_NationalInstituteofPublicHealth_Overall","Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.","2022-02-01","National","","Mexico","2020-08-15","2020-11-15","Household and community samples","Multiple groups",9463.0,0.249,"Stratified probability","NR","IgG","Moderate","Journal Article (Peer-Reviewed)","Ana Basto-Abreu","National Institute of Public Health","https://dx.doi.org/10.1038/s41467-022-28232-9","Unverified",0.222,0.267,0.92,0.995,"","MX",""
"2022-02-08","220202_LakeCounty_UniversityofTexasMedicalBranch_Overall","EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study.","2022-02-02","Local","","United States of America; Illinois","2020-11-15","2021-01-15","Household and community samples","Multiple groups",1008.0,0.045,"Convenience","NR","IgG","High","Journal Article (Peer-Reviewed)","Ryan Kilpatrick","University of Texas Medical Branch","https://dx.doi.org/10.1007/s40121-022-00593-0","Unverified","","",1.0,0.996,"","US","US-IL"
"2022-02-09","220128_HongKong_TheChineseUniversityofHongKong","Effects of strict public health measures on seroprevalence of anti-SARS-CoV-2 antibodies during pregnancy.","2022-01-28","Local","","China; Hong Kong; Hong Kong","2019-11-15","2020-10-15","Pregnant or parturient women","Adults (18-64 years)",1830.0,0.003,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Hillary Leung","The Chinese University of Hong Kong","https://dx.doi.org/10.12809/hkmj219653","Unverified","","","","","","CN",""
"2022-02-09","220128_HongKong_TheChineseUniversityofHongKong_AND","Effects of strict public health measures on seroprevalence of anti-SARS-CoV-2 antibodies during pregnancy.","2022-01-28","Local","","China; Hong Kong; Hong Kong","2019-11-15","2020-10-15","Pregnant or parturient women","Adults (18-64 years)",1830.0,0.0,"Convenience","NR","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Hillary Leung","The Chinese University of Hong Kong","https://dx.doi.org/10.12809/hkmj219653","Unverified","","","","","","CN",""
